Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.3	31.5	24.6	15.1	11.7	14.2	15.8	11.8	12.8	29.8	17.2	21.4	22.0	24.8	20.4	15.0	16.9	15.1	42.9	31.5	17.6	15.7	27.7	20.2	13.9	21.5	11.9	17.8	15.3	13.6	15.9	19.7	19.2	16.2	23.4	21.3	26.7	28.8	14.4	33.5	28.0	18.5	16.9	12.2	22.0	27.5	16.4	27.8	21.1	8.5	13.2	16.9	8.7	19.7	9.1	16.4	25.3	15.6	10.6	14.2	21.5	11.3	12.5	12.9	16.3	22.6	11.4	15.5	16.3	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5	11.9	5.6	10.4	16.1	6.5	11.3	5.9	15.3	6.7	7.9	14.0	15.7	53.6	11.6	17.4	11.4	9.1	9.8	23.3	16.1	43.4	12.2	8.6	8.1	11.5	25.1	1.6	8.1	10.4	9.1	18.3	16.4	10.8	10.1	10.8	11.5	17.4	9.4	13.5	12.0	15.4	14.7	19.4	11.3	26.5	45.3	6.5	30.6	10.2	16.2	8.0
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 234.8;Proximal tubular cells: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	12.1	6.9	1.9	0.7	0.5	1.4	0.8	0.7	0.2	4.5	0.3	1.4	0.5	0.8	0.4	3.1	0.8	2.8	0.9	0.8	0.6	2.0	0.0	45.3	3.1	0.4	3.1	2.5	1.3	1.2	0.5	0.3	0.2	3.9	0.3	1.0	0.2	29.1	0.7	0.2	1.0	8.5	0.1	3.5	25.6	0.6	0.4	7.2	1.9	5.8	0.7	0.4	0.0	2.5	15.9	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.1	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8	0.0	5.8	12.2	3.3	1.3	16.6	8.9	15.3	2.7	7.9	1.8	3.9	1.2	19.9	1.2	8.3	1.4	10.3	0.0	5.5	1.2	2.1	9.6	1.1	234.8	4.3	33.4	15.0	5.5	9.1	6.0	3.4	5.4	1.7	0.0	4.9	48.7	6.3	6.5	4.2	72.0	6.0	0.0	2.5	1.5	0.9	0.5	1.1	7.2	6.8	4.2
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781002-104928237	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 98.3;Hepatocytes: 162.2;Kupffer cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.0;U-87 MG: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	25.7	38.1	6.3	9.8	13.1	15.8	23.0	2.3	8.5	8.2	14.8	8.0	6.5	4.4	7.8	9.6	7.0	7.9	13.6	10.7	7.5	3.7	7.1	33.3	12.7	29.4	18.9	2.3	8.7	5.4	1.8	3.3	20.1	10.2	9.4	9.4	7.7	6.3	8.7	21.3	12.1	8.1	25.2	16.1	12.8	7.3	8.8	8.0	16.9	5.8	2.2	5.0	16.4	20.0	1.8	0.2	11.6	1.5	0.1	0.6	0.1	0.0	2.7	2.2	0.0	6.5	2.5	2.0	2.8	10.9	0.9	1.0	0.4	0.4	3.8	3.1	2.8	10.7	0.0	1.2	0.1	0.8	0.0	0.0	0.4	0.9	9.5	11.8	0.0	6.7	17.0	0.7	11.1	0.2	10.6	1.0	0.3	0.0	9.8	0.2	0.3	2.3	5.2	3.1	0.5	0.8	0.0	0.0	0.2	1.8	1.8	0.3	0.1	2.9	0.5	0.6	4.5	0.0	1.9	1.0	3.0	0.2	3.9	3.1	3.8	1.8	2.3	39.0	0.0	0.0	2.2	0.8	11.6	0.2	1.0	0.2	1.2	0.3	0.0	0.2	1.8	0.6	0.0	10.6	0.1	1.5	0.1	0.1	0.1	6.3	13.1	2.3	4.0	7.5	3.7	18.9	2.3	10.2	8.0	98.3	9.4	5.1	4.8	26.4	11.9	7.8	12.7	2.7	9.1	10.4	45.2	21.2	0.0	3.8	1.5	9.3	3.2	0.0	1.4	4.6	28.8	3.1	46.1	162.2	63.2	0.0	8.7	25.2	103.3	0.7	28.7	31.4	25.3	2.8	2.4	0.1	4.9	3.5	26.5	17.0	5.5	45.3	16.4	1.2	0.7	16.9	7.4	4.4	2.3	8.9
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 382.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.7	1.8	15.1	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.2	0.9	0.2	8.7	0.1	0.3	15.2	5.8	1.0	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	6.2	14.7	0.1	10.4	0.0	0.0	12.9	0.0	1.0	2.0	2.3	4.7	2.4	0.3	1.7	8.7	0.3	21.2	15.3	1.8	10.7	0.2	0.8	34.9	0.9	4.2	0.1	0.5	4.1	4.3	2.8	1.2	0.0	2.1	5.2	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1	65.5	382.0	0.0	0.4	0.6	16.5	5.1	2.5	4.0	17.0	17.4	11.8	0.0	0.0	4.6	7.7	4.2	0.2	0.0	3.3	0.0	1.4	1.9	27.8	0.9	0.9	17.5	5.2	2.5	2.7	2.7	1.7	1.6	1.7	2.8	0.7	6.9	2.4	0.0	3.2	1.5	9.5	6.5	3.1	1.9	14.0	1.4	0.0	2.5	0.6	0.1
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	0.2	1.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.0	0.2	0.3	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	5.1	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2	0.0	0.6	0.0	0.2	0.1	14.3	0.8	0.0	2.7	0.0	7.0	424.1	0.1	0.0	0.0	8.5	0.8	0.0	0.0	0.0	1.1	0.2	1.5	0.0	0.0	0.1	9.5	0.0	0.6	0.0	15.5	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.4	0.0	455.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867292-68955392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Leydig cells: 465.4;Muller glia cells: 138.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	29.1	25.2	10.0	3.4	27.2	0.5	15.1	3.2	15.4	7.3	12.8	29.9	3.9	5.4	10.2	13.0	12.4	17.6	14.3	30.0	12.5	5.5	8.1	26.6	15.2	1.3	37.8	9.2	44.7	5.1	4.5	14.8	7.6	22.2	10.3	14.3	16.4	9.8	7.9	8.9	4.9	9.9	7.1	28.2	9.9	11.5	15.8	42.7	0.0	13.0	14.2	2.8	13.6	20.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	16.6	37.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.1	0.0	0.0	27.9	0.0	0.4	0.0	0.2	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.0	27.2	3.2	15.4	12.5	5.5	37.8	9.2	22.2	42.7	47.6	0.6	0.0	1.3	5.4	1.4	12.5	0.0	0.0	7.9	0.0	2.0	0.1	0.0	0.0	4.2	4.2	0.0	0.0	0.0	0.1	35.3	0.3	1.1	35.8	0.9	4.8	0.0	7.4	1.9	4.3	465.4	1.8	1.7	0.0	0.0	138.5	0.0	0.0	66.1	0.0	2.1	38.8	6.2	1.1	1.2	4.1	0.2	0.0	0.0	0.2
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8"									"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	9.3	16.7	1.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.4	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6	0.0	4.8	5.9	0.1	0.7	0.6	2.8	104.4	1.4	1.2	47.1	0.0	5.0	5.0	10.2	21.6	23.1	174.5	23.3	1.6	0.1	0.5	0.1	3.5	32.6	0.4	0.0	0.0	3.7	1.2	2.5	0.9	0.8	0.0	0.0	8.9	0.0	11.4	77.2	0.0	44.0	0.9	0.0	0.8	0.5	0.4	0.5	8.2	27.3	1.7	0.1
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168922938-169031322	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 47.4"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.7	58.1	0.0	0.0	0.0	0.0	0.3	0.0	16.0	35.2	0.0	0.0	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.1	17.9	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 235.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.0;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.0	0.0	0.6	2.2	0.5	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.8	0.2	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0.0	0.3	23.1	0.0	0.9	0.0	9.3	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.2	1.5	0.0	0.0	235.3	0.5	36.5	0.0	5.5	5.4	0.2	0.0	0.0	10.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.5	0.1	0.4	0.1	0.0	0.0	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 4.0;Club cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"		NA	NA		22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	9.9	2.0	12.5	14.0	5.0	12.3	3.7	3.4	4.1	4.1	15.2	2.1	0.1	19.1	3.6	2.2	21.4	0.2	1.5	1.3	6.3	2.2	15.5	10.9	27.9	16.9	0.0	5.2	7.3	1.8	2.7	0.0	6.1	7.1	2.1	13.1	1.9	2.7	5.1	1.0	0.1	3.1	23.0	4.1	5.2	6.3	0.6	2.2	0.2	7.4	7.9	7.7	18.3	8.1	8.0	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.0	4.0	0.0	6.2	0.1	7.3	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	4.0	2.3	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.7	0.0	0.2	0.9	0.2	0.3	0.2	0.0	0.0	0.0
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949577-16143074	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.5;eosinophil: 3.1;T-reg: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.5;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.0"	"Low region specificity"	"Detected in all"							"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	8.9	8.2	2.4	8.3	3.1	8.4	9.6	4.4	5.0	8.3	10.7	2.6	15.5	3.5	10.5	12.7	14.7	5.6	9.6	8.0	2.1	2.4	4.5	1.6	10.9	12.2	3.0	2.1	6.8	5.8	18.4	4.2	5.2	4.1	9.6	4.1	12.0	16.9	10.9	20.8	6.6	8.2	16.4	4.0	9.2	10.9	15.1	2.3	26.8	15.7	12.6	15.6	15.3	11.8	0.7	0.5	7.5	0.5	0.4	2.1	0.2	2.3	24.7	0.1	6.5	5.7	3.5	1.3	7.3	8.9	6.3	6.6	3.9	17.8	6.7	39.0	14.0	5.9	6.7	2.0	7.1	4.8	11.8	2.3	8.3	14.4	14.3	17.1	3.0	21.5	7.5	4.8	1.8	1.0	5.4	6.9	12.9	8.4	3.4	1.9	4.6	5.3	2.8	3.9	3.3	3.6	18.9	3.7	3.3	2.3	8.3	3.6	5.9	9.2	10.0	2.4	6.6	3.5	1.6	0.7	0.4	1.5	5.2	5.8	6.4	3.2	2.3	3.3	3.1	0.7	7.5	0.1	3.1	0.6	0.4	0.6	0.7	0.5	0.6	0.5	0.3	0.6	0.6	0.0	0.4	0.5	0.3	2.1	0.2	2.4	3.1	4.4	5.0	2.1	2.4	3.0	2.1	4.1	2.3	23.8	6.4	10.4	6.8	7.8	3.1	5.3	5.1	2.7	12.5	5.2	21.6	0.6	3.3	8.7	7.2	6.2	1.1	0.0	5.5	2.2	3.3	13.8	20.9	0.2	7.2	4.8	17.9	8.6	15.5	11.0	6.9	10.2	3.3	6.4	7.2	1.2	8.5	3.5	6.3	1.4	8.3	0.0	3.1	2.4	5.9	4.4	0.5	9.6	3.1	8.4
ABCC11	MRP8	ENSG00000121270	"ATP binding cassette subfamily C member 11"	Q96J66	16	48166910-48247568	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 37.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 2.7;Hepatocytes: 2.1;Late spermatids: 1.1;Spermatocytes: 3.3"	"Group enriched"	"Detected in some"	6	"breast cancer: 8.7;prostate cancer: 2.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.6"	"Group enriched"	"Detected in many"	5	"B-cells: 2.6;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"T-47d: 39.4"					"Not detected"	"Not detected"									NA	NA						"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.54e-4)"	0.1	0.0	0.8	0.1	0.8	0.1	37.3	0.2	0.5	0.1	0.1	0.1	0.1	0.2	0.1	9.3	0.1	0.4	0.1	0.1	0.4	0.2	0.1	4.0	0.1	0.1	0.7	0.1	0.4	0.1	0.0	2.0	0.1	0.6	2.7	0.0	8.4	0.1	0.1	0.1	0.9	0.1	0.1	0.4	0.1	0.0	3.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	2.6	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	9.3	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	2.6	0.2	1.2	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.5	0.4	0.2	0.7	0.1	0.6	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.4	0.0	0.2	0.0	0.0	0.0
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782732-99852192	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 28.4;kidney: 25.6;liver: 74.3"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 52.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 24.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.1"	"Group enriched"	"Detected in some"	5	"A549: 60.2;Hep G2: 60.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071145	Enhanced					NA	NA					"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0.0	0.0	60.2	0.9	3.0	4.6	3.5	1.0	0.1	0.3	0.1	0.2	12.9	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.2	60.0	0.1	0.0	0.2	0.6	4.1	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	11.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.9	7.4	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.2	0.0	0.0	4.9	1.0	0.3	4.1	0.2	0.3	0.3	0.0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.1	0.0	0.2	0.4	2.5	4.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.1	52.9	0.2	0.0	0.0	0.6	1.3	0.2	0.3	0.0	5.0	0.0	0.0	0.2	0.1	0.0	0.0	9.1	1.4	0.0	0.4	0.7	0.3	0.0	1.4	0.0	0.0	0.0
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692252	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 53.5;liver: 66.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.2;non-classical monocyte: 7.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"A549: 31.4;CAPAN-2: 24.0;OE19: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.5	36.0	0.4	17.0	0.4	0.5	7.7	0.3	0.4	1.9	23.9	0.8	14.1	10.3	1.6	4.6	5.3	1.0	53.5	0.8	0.4	0.4	13.5	66.2	9.0	10.3	0.6	0.0	1.0	22.2	1.7	0.8	3.5	1.5	5.4	7.7	0.8	4.7	23.6	0.4	4.8	37.0	2.5	4.6	4.9	12.8	1.0	0.0	0.8	4.5	7.0	7.9	7.1	3.5	0.0	1.6	1.3	7.6	0.3	0.5	7.4	2.2	31.4	0.0	0.1	1.8	2.8	0.0	4.2	5.2	0.3	0.3	1.7	24.0	0.0	3.3	8.2	5.9	5.7	0.0	0.4	0.4	0.0	0.0	0.6	13.2	9.5	7.1	0.0	0.0	3.1	2.3	1.2	2.5	3.5	0.5	0.0	0.0	0.0	3.3	7.3	0.0	0.0	0.0	34.9	4.1	0.0	0.0	0.1	13.7	13.6	0.0	0.2	7.6	1.3	0.0	0.0	1.0	0.0	6.9	0.2	1.4	0.1	3.3	0.0	0.0	0.0	3.4	0.0	0.3	0.3	2.8	0.0	0.0	6.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	1.3	0.3	7.6	0.2	0.5	7.4	0.4	0.4	0.3	0.4	0.4	0.4	0.6	0.0	1.5	0.0	17.9	5.6	2.4	103.4	8.4	1.2	2.5	262.4	0.0	23.9	14.0	0.0	0.3	5.0	84.3	55.0	1.4	161.4	0.0	92.3	3.0	3.5	62.4	0.0	155.5	27.5	1.6	22.7	4.9	18.2	59.8	8.3	13.8	3.3	4.6	85.5	3.7	82.4	153.0	2.8	7.9	0.1	0.0	5.2	0.7	0.6	9.3	0.8	2.5	66.2	81.6
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2"	"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.5	8.0	1.3	2.4	2.5	3.3	0.3	3.6	3.7	3.3	2.8	11.1	3.4	2.5	2.4	4.9	2.4	6.2	2.0	1.8	4.1	7.5	3.1	61.8	2.5	2.2	5.1	7.0	67.7	2.5	0.8	2.3	4.8	4.7	4.2	2.8	6.4	0.1	4.4	1.4	1.3	1.1	1.5	5.5	1.9	1.9	3.7	6.6	18.2	10.3	3.3	2.4	1.2	0.2	2.5	1.5	0.0	3.8	6.9	3.5	2.2	2.9	4.3	0.0	0.0	1.0	6.6	4.0	1.7	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0	8.9	28.3	3.7	6.2	3.8	0.0	3.1	5.1	6.7	11.4	22.7	21.6	0.1	0.0	5.2	3.2	11.3	1.4	0.0	2.6	0.4	3.9	38.5	53.1	0.0	3.8	0.0	0.0	2.5	1.0	1.7	6.4	6.3	1.7	19.0	3.2	0.3	4.1	9.3	1.8	32.7	0.7	0.0	3.9	0.6	9.1	6.6	0.2	2.2	7.8	3.7
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184018015	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	7.9	11.2	24.7	9.6	26.2	12.0	6.7	42.8	28.6	7.7	11.4	12.0	13.4	6.8	14.1	7.0	17.1	6.1	11.6	16.0	19.1	13.7	12.8	3.6	9.4	7.3	20.5	18.5	11.8	4.9	22.4	20.5	10.8	21.7	10.6	14.4	31.1	7.4	9.3	41.0	14.5	8.5	10.5	12.9	16.3	48.5	9.4	20.9	9.3	5.5	7.3	7.4	18.1	12.7	4.2	3.5	15.8	4.5	5.0	7.0	4.5	7.3	4.1	9.4	11.2	9.4	10.7	14.6	6.0	4.7	5.4	5.9	6.3	5.7	8.0	14.1	5.7	8.2	29.9	11.6	6.6	7.1	8.7	11.2	16.9	10.3	5.7	3.9	5.1	13.2	17.0	6.7	5.8	3.8	11.1	6.3	23.7	15.7	11.1	9.2	19.5	14.1	5.9	9.7	13.4	7.9	9.8	3.1	4.7	19.6	48.0	17.2	10.2	6.1	33.9	10.1	12.7	20.5	1.6	7.2	6.3	6.2	8.0	8.2	4.3	8.3	7.4	4.6	10.3	6.4	10.7	4.5	7.7	7.0	2.1	4.5	3.2	4.0	3.1	3.5	4.2	4.6	6.3	15.8	5.0	3.5	1.3	5.0	4.5	24.7	26.2	42.8	28.6	19.1	13.7	20.5	18.5	21.7	20.9	8.9	4.0	1.9	12.9	7.9	34.3	31.9	2.5	56.2	46.6	41.8	184.6	2.7	6.6	5.0	4.8	6.7	9.5	0.0	4.0	3.9	8.0	10.9	4.7	2.4	39.9	31.8	56.9	5.5	27.9	2.2	7.5	11.2	11.8	6.4	6.3	9.4	6.1	9.3	7.4	2.7	122.3	0.0	8.6	3.1	14.7	10.7	3.8	5.0	7.2	50.3
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 39.2;Intestinal endocrine cells: 21.0"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7"					"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA			Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.7	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3	0.0	0.0	0.0	0.0	0.0	39.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	21.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	1.2	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.0	0.1
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797401-21942529	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 47.6;Hepatocytes: 84.7;Sertoli cells: 129.4;Smooth muscle cells: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.6;BJ hTERT+: 10.1;CACO-2: 16.0;HSkMC: 21.0;U-138 MG: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	21.6	4.7	5.5	2.6	5.4	1.2	25.8	1.5	8.6	12.4	6.8	4.8	5.1	3.0	15.3	6.3	9.1	9.5	9.6	26.2	5.7	2.6	5.6	31.1	6.2	2.7	2.9	4.2	11.8	5.8	1.7	2.7	2.8	5.5	7.0	1.6	10.8	4.8	8.4	33.2	3.3	4.1	17.1	4.9	3.5	9.1	3.4	4.2	0.1	6.3	14.5	1.2	9.5	8.4	1.6	0.9	1.8	0.8	0.5	0.9	0.0	0.6	0.1	7.5	0.2	17.6	8.0	0.2	4.1	10.1	4.5	2.3	16.0	0.7	0.3	0.8	0.4	0.5	0.2	0.0	0.0	4.7	0.2	0.1	0.3	0.5	0.2	0.0	0.3	0.4	21.0	0.0	4.5	1.7	0.3	0.0	0.3	0.2	0.9	0.2	0.9	0.2	0.2	1.0	0.8	0.4	0.3	0.2	0.2	0.0	0.8	0.3	1.2	0.2	0.4	0.1	1.2	0.8	0.2	0.2	17.5	1.3	1.5	5.3	0.8	0.8	0.3	4.3	0.2	0.3	0.9	0.5	0.4	0.9	0.4	0.6	0.7	0.7	0.7	0.2	1.6	0.6	0.8	1.8	0.5	0.8	0.9	0.4	0.0	5.5	5.4	1.5	8.6	5.7	2.6	2.9	4.2	5.5	4.2	32.8	47.6	0.0	1.0	3.1	0.4	27.8	0.0	36.1	39.8	0.0	0.0	0.2	0.0	0.0	0.2	4.9	0.0	0.0	0.2	0.1	10.6	0.4	22.1	84.7	0.1	1.6	0.0	11.1	3.3	0.0	0.3	2.1	10.1	0.0	0.0	13.1	0.1	0.0	0.4	0.0	1.1	129.4	47.2	0.5	0.7	1.9	0.2	0.0	0.0	1.4
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724868-153744762	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 17.9;Syncytiotrophoblasts: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 33.1;PC-3: 23.4;SK-BR-3: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	13.8	20.3	2.1	6.0	2.7	5.0	8.9	1.1	2.5	6.2	15.9	2.7	12.7	12.5	21.4	9.7	4.7	6.1	8.8	10.4	2.0	2.0	7.0	14.3	7.5	10.1	3.0	1.9	6.0	11.7	2.2	6.5	23.1	2.0	7.1	2.3	9.3	6.1	7.3	14.7	3.0	46.2	8.3	2.7	9.1	4.6	24.0	1.7	12.1	3.8	6.5	4.9	7.8	9.8	1.9	4.8	4.1	5.4	1.4	7.7	3.4	5.9	1.8	1.2	5.2	3.6	1.5	16.2	2.9	3.2	2.0	3.5	1.2	3.2	1.6	33.1	3.9	5.4	0.8	0.7	0.6	0.2	5.3	1.0	4.7	18.5	15.3	4.7	2.9	10.6	3.0	0.8	2.2	0.2	2.1	3.1	2.2	2.6	5.8	2.7	2.1	2.0	2.7	1.5	1.4	23.4	3.5	2.9	2.5	1.5	0.6	1.3	5.4	7.6	23.1	11.8	1.5	1.7	4.9	3.6	2.6	3.5	6.7	3.2	5.8	2.5	3.8	3.3	9.9	3.6	0.7	4.8	4.1	1.6	5.4	7.7	1.9	1.9	2.3	4.8	1.5	2.1	1.5	3.1	1.4	4.7	3.0	0.6	3.4	2.1	2.7	1.1	2.1	2.0	2.0	3.0	1.9	2.0	1.7	0.0	1.4	0.9	1.5	2.9	2.2	2.0	5.1	0.0	2.3	3.5	2.0	10.8	0.0	3.3	0.5	3.5	13.5	0.0	6.0	14.8	3.3	0.7	0.0	5.5	12.1	7.9	5.8	6.2	17.9	1.9	3.7	7.4	1.7	1.0	4.1	2.6	5.3	2.3	5.3	2.2	0.8	6.5	4.1	2.7	4.8	1.1	22.9	1.5	3.5	1.6
ABCD2	"ALDL1, ALDR, ALDRP"	ENSG00000173208	"ATP binding cassette subfamily D member 2"	Q9UBJ2	12	39550033-39619751	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.1;brain: 30.1"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 55.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.2;HDLM-2: 12.4;Karpas-707: 22.2;SH-SY5Y: 13.4;U-266/70: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-3)"	"unprognostic (4.06e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.31e-5)"	"unprognostic (3.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-4)"	"unprognostic (5.04e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.74e-2)"	24.1	3.6	6.8	3.5	6.8	0.9	5.5	30.1	13.4	10.6	1.7	1.3	0.0	1.4	5.4	1.0	1.3	5.2	1.4	7.4	5.1	4.1	1.4	0.7	1.4	4.8	4.8	8.4	0.7	0.7	0.7	5.1	0.5	11.4	1.2	1.7	2.9	4.6	1.6	0.7	0.7	1.7	5.1	2.1	3.0	1.6	0.9	2.6	0.9	1.0	0.6	3.2	2.8	1.9	0.8	0.8	0.1	0.0	1.4	6.5	1.8	0.0	0.0	0.1	0.0	9.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.5	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	1.9	0.8	4.3	5.7	0.2	0.4	5.0	6.5	0.1	1.4	0.0	0.8	5.1	1.8	6.8	6.8	30.1	13.4	5.1	4.1	4.8	8.4	11.4	2.6	0.0	0.0	0.8	0.0	0.0	55.5	8.9	0.0	4.0	0.0	0.0	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.0	0.7	0.5	1.8	0.0	0.3	0.1	0.0	0.0	0.0	3.5	0.0	0.0
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418455-94518666	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA			Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	8.9	14.2	13.1	9.5	13.3	10.3	16.8	11.2	12.8	11.8	21.2	14.9	24.9	21.4	9.8	14.6	15.4	10.0	17.3	16.0	12.7	10.3	29.3	60.6	11.2	9.9	13.2	10.4	8.1	16.7	18.3	14.6	11.2	14.3	11.0	20.1	21.4	13.2	24.0	12.9	17.1	21.7	10.8	16.5	7.6	20.8	10.2	12.7	46.5	13.7	10.8	9.9	11.8	11.1	3.1	8.4	3.9	6.2	8.0	7.4	4.2	28.2	13.3	13.7	13.1	10.6	11.7	20.4	14.8	11.5	17.0	19.0	41.4	8.9	17.5	19.2	18.7	18.3	20.8	15.8	19.1	24.0	14.0	13.6	19.9	19.6	35.9	10.3	17.6	6.2	9.8	10.8	19.8	7.6	11.1	10.4	16.7	8.8	10.5	17.6	3.9	29.6	9.3	15.8	21.7	18.9	16.7	28.6	6.8	16.9	43.3	10.4	17.1	25.6	27.2	19.2	10.9	10.0	14.7	10.3	12.7	18.4	22.2	19.6	6.0	5.6	17.1	9.9	9.0	5.9	0.3	5.3	3.9	6.5	6.2	6.1	2.8	5.9	7.4	8.4	3.1	7.1	6.9	1.3	8.0	5.2	2.2	6.5	4.2	13.1	13.3	11.2	12.8	12.7	10.3	13.2	10.4	14.3	12.7	32.8	39.0	10.4	16.3	20.7	25.9	36.4	63.7	30.8	25.0	40.1	21.6	22.7	19.9	19.9	5.4	12.0	62.4	0.0	38.4	9.6	17.3	22.1	27.6	99.9	10.1	31.8	38.2	20.3	21.6	6.2	12.7	12.6	15.1	2.8	38.1	85.8	29.7	28.1	23.0	56.2	22.8	19.4	12.3	10.4	23.7	29.6	12.8	10.5	32.8	20.0
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 107.9;Syncytiotrophoblasts: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 19.2;neutrophil: 20.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 13.2;JURKAT: 19.6;MCF7: 16.5;MOLT-4: 15.3;OE19: 27.4;RPMI-8226: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	19.9	36.4	14.2	10.0	17.6	6.2	13.3	15.9	15.3	7.7	12.1	17.8	3.8	15.3	5.6	3.8	4.1	6.5	11.9	9.7	12.4	8.0	8.2	5.6	25.2	23.1	20.8	12.2	6.0	4.7	15.4	11.1	12.0	9.6	6.3	13.5	12.1	13.7	6.7	26.8	15.1	18.6	5.8	7.0	29.4	13.7	1.9	19.5	15.4	8.5	5.2	10.4	12.5	12.6	4.8	1.4	20.5	0.9	3.7	4.0	1.0	0.0	3.0	2.4	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.4	0.0	0.3	0.5	0.0	4.4	0.0	4.2	0.2	5.0	10.0	0.0	9.2	0.0	0.2	1.0	13.2	0.0	2.0	0.0	9.3	19.6	0.0	0.0	0.0	16.5	15.3	0.1	0.7	27.4	5.2	0.2	0.0	12.5	0.0	1.4	11.6	3.0	1.8	6.9	0.0	0.2	2.9	0.4	5.9	0.0	2.5	0.0	0.0	6.8	1.9	0.0	0.0	1.6	0.2	0.9	0.9	19.2	1.8	0.3	3.4	3.1	3.7	3.6	0.6	4.8	3.5	2.9	20.5	3.7	0.1	1.4	4.0	1.0	14.2	17.6	15.9	15.3	12.4	8.0	20.8	12.2	9.6	19.5	6.0	8.0	6.7	6.0	7.9	46.2	7.8	2.5	1.4	5.7	24.4	47.1	5.2	3.3	2.2	3.7	31.7	7.8	0.0	1.1	1.0	4.6	3.8	0.0	0.0	15.2	11.1	3.4	39.9	25.5	4.3	0.3	18.8	3.3	5.4	9.1	14.3	1.5	4.8	1.8	0.9	107.9	6.5	5.2	0.6	0.7	5.8	52.7	12.9	0.9	2.6
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7"									"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.6	18.8	5.6	0.0	0.2	0.0	32.9	0.7	0.6	1.0	1.6	4.1	0.2	0.0	0.2	0.1	2.4	5.5	0.1	0.5	1.4	5.3	0.8	0.2	0.1	5.6	0.0	0.2	0.0	0.1	2.3	2.2	0.1	0.5	1.7	0.4	0.4	0.0	0.6	10.9	2.6	0.0	1.9	25.5	0.0	1.2	0.0	16.5	0.0	4.0	0.0	0.2	3.9	0.4	0.5	12.7	0.1	0.0	0.0	0.7	0.7	0.2	0.0	5.2	1.9	0.0	1.4	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5	3.0	1.4	0.5	0.2	3.4	0.0	1.1	0.0	1.4	0.0	0.0	0.0	14.3	1.7	0.0	2.6	9.0	135.7	0.0	0.2	47.1	2.1	0.2	5.7	25.0	105.8	0.0	2.9	13.5	1.0	0.4	1.1	1.1	5.0	0.0	2.9	0.9	0.1	35.1	0.4	4.5	0.2	0.0	1.4	0.9	3.4	0.4	31.5	0.8	0.8	0.1
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	85	"intestine: 54.3;liver: 40.9"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 47.3"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	19.5	0.0	0.0	27.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	40.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	54.3	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	5.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882987	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 62.4;liver: 64.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 24.1"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.4	0.1	21.2	0.0	0.0	24.0	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	62.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	14.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	1.2	1.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12"	Q8N2K0	20	25294743-25390983	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease mutation, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA					"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	11.3	13.4	27.4	10.0	32.1	9.8	10.4	22.3	39.8	11.1	15.6	30.8	14.1	20.7	9.1	58.9	20.4	11.3	14.0	12.2	41.5	25.9	18.9	13.1	14.0	10.3	31.5	21.0	13.8	65.6	16.0	14.4	25.6	26.9	15.6	15.2	11.5	13.8	17.4	4.0	16.2	21.1	9.9	43.3	7.8	22.1	7.6	19.0	10.2	36.8	7.9	16.0	15.7	10.9	3.9	14.6	12.6	14.2	11.1	11.5	6.0	14.9	34.2	8.8	11.1	18.1	10.8	21.8	21.5	18.0	16.9	19.5	20.0	22.9	4.7	12.2	16.9	40.3	24.3	11.2	12.8	14.4	4.9	9.0	7.6	9.4	27.7	14.4	7.3	16.2	13.5	8.4	20.8	9.9	20.6	7.7	8.8	5.5	71.7	16.0	30.9	11.0	7.7	6.8	18.5	21.7	8.5	22.7	44.7	11.4	31.1	11.3	9.5	18.1	44.7	31.8	16.4	15.1	12.5	9.6	21.4	14.5	13.0	12.4	8.4	7.8	7.5	14.9	8.7	13.7	9.8	14.2	12.6	8.0	12.2	6.4	3.1	8.8	11.5	14.6	3.9	7.5	7.4	1.8	11.1	13.1	13.1	7.9	6.0	27.4	32.1	22.3	39.8	41.5	25.9	31.5	21.0	26.9	19.0	6.0	6.2	9.7	26.7	15.8	33.4	14.0	38.2	10.7	9.1	26.2	9.8	77.6	23.2	30.2	42.1	13.8	92.3	0.0	29.7	81.1	22.7	35.8	10.3	16.1	103.4	39.7	32.6	11.6	27.2	80.7	15.0	39.8	32.1	91.0	27.6	27.0	20.7	45.6	19.4	19.5	20.6	25.8	14.6	18.2	32.5	15.9	109.4	13.8	31.4	31.0
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.0	7.7	1.1	5.0	14.5	2.6	13.4	5.4	4.8	5.7	7.7	4.0	2.8	3.9	0.5	2.9	17.6	6.0	5.2	2.4	5.1	6.6	2.6	3.3	5.2	5.5	4.9	1.0	17.6	2.5	11.1	5.2	2.5	6.7	3.2	6.5	3.9	9.0	4.6	1.5	6.7	0.4	3.7	16.7	17.0	2.5	2.3	8.7	8.7	2.8	6.7	2.7	5.9	3.3	11.1	2.3	2.2	2.7	3.4	4.1	4.5	10.1	6.4	2.6	7.6	0.1	10.5	9.9	5.6	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3	0.0	2.6	8.8	2.6	7.7	13.8	4.8	0.0	17.4	5.7	3.5	3.9	2.2	1.7	2.9	0.8	7.8	13.6	0.0	1.6	0.4	2.1	1.3	10.5	53.3	8.1	14.3	0.0	26.4	14.6	0.4	6.4	9.6	3.3	14.4	2.2	10.8	1.6	0.0	7.8	15.4	3.0	0.0	3.5	0.5	2.3	21.5	0.5	3.2	4.5	2.0
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 651.0;Proximal tubular cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 51.9;SK-BR-3: 82.5"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.1	8.9	3.0	9.5	13.1	7.7	10.6	7.5	10.9	8.6	8.2	11.9	9.2	4.8	5.4	12.0	4.2	5.4	8.2	12.7	4.7	7.0	8.5	6.2	7.9	33.7	8.5	14.3	14.0	14.2	9.1	7.4	5.3	5.4	11.6	11.8	5.8	5.7	9.5	10.6	13.8	10.2	3.2	51.9	10.8	3.1	5.8	8.1	24.2	24.2	2.6	4.1	7.3	82.5	5.2	4.4	8.5	11.5	8.4	5.2	5.0	10.4	10.3	7.6	4.8	3.8	8.5	12.5	8.3	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9	38.7	31.4	45.5	55.9	29.7	37.5	2.4	109.5	17.4	19.4	62.8	13.7	77.1	140.9	89.4	3.0	25.4	292.3	23.3	69.3	52.5	32.7	64.1	18.5	651.0	74.1	7.9	52.9	34.4	86.5	6.4	33.1	68.8	55.6	86.6	63.2	33.0	78.8	122.8	31.1	601.4	14.2	32.3	25.8	17.5	11.7	31.0	83.1	42.0	60.0	69.8
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 686.3;Proximal tubular cells: 536.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3200000	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.8	14.1	23.6	21.6	31.3	16.6	12.0	7.2	11.8	12.2	9.5	30.0	12.3	12.6	15.5	26.6	12.6	0.9	39.3	4.6	12.1	38.6	9.2	8.9	18.5	35.6	14.8	0.1	16.9	21.9	1.5	19.7	6.2	9.9	20.0	18.3	7.7	11.9	33.9	16.3	0.5	19.5	21.4	5.3	5.7	31.0	50.5	46.2	41.3	0.6	33.9	26.9	0.5	16.6	1.1	19.5	9.4	13.1	9.5	10.4	13.1	15.7	7.9	24.2	27.9	32.2	7.4	18.2	9.5	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5	35.7	38.9	45.7	10.9	3.2	5.9	161.7	229.3	29.4	30.7	52.4	3.9	30.0	250.4	111.1	56.2	32.3	191.9	0.0	40.7	49.6	32.6	10.2	44.9	686.3	101.9	1.6	38.5	46.6	63.1	122.0	44.5	46.6	18.6	61.3	59.2	53.2	84.8	76.3	35.0	536.1	27.2	19.4	17.6	27.7	39.6	4.3	22.5	68.2	98.9	4.5
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084988-37406818	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	10.7	4.8	5.6	2.5	7.7	3.0	18.5	6.0	11.5	5.3	4.2	6.9	12.7	3.8	4.5	11.7	9.2	3.8	3.6	2.3	4.9		3.0	5.8	7.3	3.5	6.3	4.6	4.3	2.3	13.6	7.9	2.6	6.1	12.2	5.1	4.8	4.6	14.4	11.3	5.4	2.5	7.8	4.2	2.3	3.9	5.5	5.7	2.0	4.2	4.5	5.0	4.3	4.6	4.4	3.2	1.3	4.1	2.0	3.9	2.0	14.9	3.1	18.2	19.1	25.4	25.1	6.3	6.6	9.4	6.9	12.6	12.1	2.6	2.0	5.4	10.7	18.3	15.4	3.3	22.6	10.9	5.9	9.9	11.9	7.9	12.3	4.0	6.4	2.4	20.2	13.2	18.4	13.7	8.7	12.2	10.7	28.3	1.4	1.0	12.6	6.8	9.8	13.8	9.4	9.9	10.5	11.4	2.7	16.4	16.9	20.6	8.1	11.9	5.6	5.3	16.5	11.2	7.4	10.8	5.9	9.4	8.2	1.6	4.0	4.7	18.6	5.4	5.4	8.1	1.1	2.8	0.3	2.3	4.1	2.1	2.7	2.5	2.7	3.2	4.4	3.9	2.7	1.3	2.0	2.7	2.4	3.2	2.0											29.8	40.1	3.7	15.6	10.3	15.4	6.5	2.5	8.1	12.5	10.4	25.5	14.2	8.3	5.9	46.0	7.5	4.8	23.3	7.2	5.4	7.5	20.3	6.9	8.1	5.0	22.3	8.6	4.3	2.1	39.8	9.2	4.2	10.1	3.6	7.2	19.9	6.5	5.8	14.9	5.0	10.7	6.5	4.8	7.9	17.9	13.9	13.6	4.3	8.7	18.2
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	7.0	5.6	17.7	7.8	15.3	12.6	5.0	13.3	10.9	13.0	11.0	10.5	11.3	77.6	11.8	9.5	11.2	6.6	15.1	11.3	16.3	30.0	7.4	25.4	17.3	16.2	10.7	21.7	7.1	14.5	6.5	11.4	6.8	10.1	10.2	16.9	25.9	17.5	14.0	2.6	25.4	10.2	14.3	21.5	13.6	33.2	23.4	8.1	21.6	18.7	9.6	12.1	10.8	32.1	27.7	12.8	9.5	27.5	5.5	8.9	8.8	7.6	21.7	11.4	16.3	34.5	7.5	17.7	10.1	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0	53.6	43.4	62.8	34.2	24.3	36.0	330.8	53.5	152.6	51.2	55.8	23.6	30.2	291.8	28.7	45.7	27.1	38.4	23.3	23.5	17.3	29.9	27.0	42.8	232.4	67.1	28.6	39.0	43.6	39.4	18.0	43.4	40.9	49.0	30.7	34.0	51.0	23.3	33.6	42.8	350.1	27.0	0.0	32.5	64.2	67.3	23.6	12.8	30.5	42.5	35.5
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		85000			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.4	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.2	0.0	0.0	2.1	0.4	2.5	0.6	2.8	0.1	0.3	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	2.2	0.5	0.1	0.0	9.8	61.1	0.0	0.0	0.0	0.0	2.9	3.3	0.5	0.4	0.0	38.8	0.0	0.7	0.2	0.0	0.4	0.0	0.8	0.7	0.0	6.9	0.0	0.0	1.1	7.8	0.0	0.0	0.0	1.2	0.0	0.9	4.2	5.6	45.6	0.0	19.4	0.0	1.1	0.7	0.1	10.6	0.0	3.3	1.6
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 185.5;Hepatocytes: 244.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 35.3;RT4: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.4	7.7	2.5	3.8	13.3	5.6	35.3	4.0	4.0	4.8	5.5	5.4	9.0	3.1	4.3	6.8	4.5	3.3	10.7	4.2	7.6	2.8	3.2	4.0	4.4	17.7	7.2	3.4	2.6	9.3	3.3	5.4	3.6	5.1	12.0	4.3	4.1	3.1	5.3	16.1	7.6	2.5	1.9	13.5	6.7	4.2	7.7	3.6	8.1	47.5	3.1	4.6	11.4	17.8	3.8	8.7	10.9	3.9	7.9	6.7	4.9	5.4	3.8	5.1	3.5	1.2	3.9	3.2	3.9	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3	26.8	20.6	3.0	13.1	11.9	23.8	38.6	48.4	14.7	18.2	22.7	21.6	32.5	18.3	19.8	8.4	14.6	185.5	23.3	35.6	39.3	17.0	27.2	16.2	244.8	23.1	17.5	33.1	22.1	31.8	6.5	27.6	19.9	13.5	25.2	35.0	64.2	31.5	87.7	44.2	74.6	28.4	0.0	16.4	5.6	10.7	26.5	36.2	10.2	32.4	22.6
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 913.9;Late spermatids: 1666.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.8	26.6	41.5	22.8	18.8	18.8	33.7	21.7	23.1	21.7	19.2	36.5	18.0	11.2	16.9	20.3	28.5	17.5	40.3	23.6	19.6	27.3	41.0	32.8	24.1	79.8	26.1	37.2	18.9	19.2	21.5	20.3	25.2	23.0	24.6	42.0	33.1	21.9	25.6	24.2	40.0	36.0	50.1	47.2	30.0	26.6	42.1	25.6	33.9	25.5	45.3	44.8	13.5	32.0	43.4	28.3	18.9	19.9	20.3	23.9	15.9	19.7	32.7	29.8	59.1	34.9	28.3	32.2	28.1	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2	41.7	88.5	101.3	80.3	70.3	51.3	74.2	109.5	129.8	67.1	64.6	7.9	179.7	228.8	194.3	913.9	64.7	84.9	163.5	146.5	234.8	71.9	111.0	68.2	112.0	123.7	27.0	79.2	50.3	57.7	1666.6	87.5	74.7	77.6	116.4	107.9	64.8	155.5	108.7	86.7	241.7	43.6	90.5	79.3	111.8	121.7	79.7	157.0	93.8	114.3	108.3
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
AGPAT3	LPAAT-gamma	ENSG00000160216	"1-acylglycerol-3-phosphate O-acyltransferase 3"	Q9NRZ7	21	43865186-43986536	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.1"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 172.8;Early spermatids: 230.1;Late spermatids: 164.7;Rod photoreceptor cells: 181.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.36e-2)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.50e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.50e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.60e-2)"	12.0	10.2	21.5	11.1	23.0	5.8	12.7	14.6	22.7	6.4	20.1	18.9	8.5	27.4	5.1	10.4	13.4	8.1	8.6	11.6	19.9	15.1	33.8	30.2	9.9	9.0	21.7	11.4	5.4	12.7	17.1	7.3	7.6	13.6	7.9	7.6	10.6	24.0	8.0	59.1	10.2	34.6	5.8	25.2	10.2	11.1	11.7	11.4	7.2	14.1	15.0	7.0	9.8	6.6	1.3	4.5	2.4	10.6	0.7	3.5	2.0	26.9	15.4	3.8	10.5	7.8	8.6	3.0	12.5	15.7	15.9	9.8	15.1	19.7	9.1	9.5	14.8	14.9	10.5	6.6	13.8	4.6	43.5	17.6	4.0	9.5	20.2	13.6	14.7	9.1	10.2	11.9	14.0	5.9	14.9	11.9	3.1	22.5	15.1	5.7	11.6	0.1	9.1	1.8	10.7	10.9	15.1	4.4	24.6	12.6	26.6	13.3	9.7	15.2	17.4	11.6	1.6	12.0	16.0	17.6	10.1	0.1	15.1	12.7	12.1	18.0	5.7	13.1	29.4	9.1	0.0	4.1	2.4	1.5	8.9	1.5	1.3	2.1	2.2	4.5	1.2	1.7	1.9	1.0	0.7	10.6	1.1	3.5	2.0	21.5	23.0	14.6	22.7	19.9	15.1	21.7	11.4	13.6	11.4	11.9	23.1	7.5	7.5	7.1	36.1	31.3	20.4	32.1	22.7	24.4	172.8	13.2	8.3	23.9	230.1	11.7	47.3	0.0	25.5	0.7	8.9	14.4	4.7	59.5	16.9	62.0	13.3	15.4	24.3	164.7	7.2	22.0	1.7	27.9	21.9	27.1	23.5	20.1	5.3	42.8	181.7	6.5	7.8	9.0	2.1	9.7	10.1	9.2	19.3	12.2
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129979-161274061	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 51.8;Late spermatids: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 19.8;HEL: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	5.6	4.2	10.5	3.5	19.1	8.0	4.5	9.6	26.6	5.3	4.2	35.6	1.0	2.6	10.7	4.5	5.2	7.2	8.0	2.9	14.2	11.8	5.2	2.0	6.1	2.0	25.8	12.4	10.0	2.3	1.3	9.8	14.6	27.4	3.7	4.4	0.7	2.7	4.9	2.1	1.9	2.5	8.5	49.0	5.2	3.0	4.2	19.8	0.6	4.8	2.0	2.2	4.0	3.8	1.1	1.9	0.6	3.5	5.8	7.0	2.1	0.3	0.8	19.8	3.9	3.7	7.6	0.8	0.7	0.2	1.5	2.5	1.1	3.5	0.5	1.4	3.1	9.2	0.3	3.6	3.0	1.4	2.2	6.2	14.8	3.5	0.0	2.9	0.1	2.1	9.1	1.5	4.0	2.1	7.1	4.6	2.3	7.3	6.8	1.8	0.0	1.0	1.6	4.7	0.0	7.5	0.0	0.9	0.4	4.3	0.3	11.5	4.4	3.0	1.6	0.8	8.1	0.8	1.0	5.1	2.1	2.6	1.4	3.3	0.5	0.7	0.0	7.8	0.8	1.3	0.0	3.5	0.0	7.0	2.8	2.3	0.4	3.3	4.1	1.9	1.1	1.7	2.7	0.6	5.8	2.5	1.5	2.9	2.1	10.5	19.1	9.6	15.8	14.2	11.8	25.8	12.4	27.4	19.8	3.0	5.6	5.2	4.6	2.9	1.0	4.0	2.5	10.7	5.7	5.2	0.0	16.0	0.0	4.3	51.8	12.2	0.0	0.0	7.0	10.7	11.3	0.8	10.5	0.4	16.7	0.0	1.7	9.8	7.6	44.8	5.5	15.4	3.3	11.8	0.0	4.0	5.9	0.0	8.1	0.3	0.9	19.4	6.2	3.6	2.9	2.3	18.5	7.4	0.0	3.2
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230702523-230714297	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 309.0"	"Group enriched"	"Detected in many"	12	"Cholangiocytes: 828.0;Hepatocytes: 2051.9"	"Group enriched"	"Detected in all"	10	"glioma: 275.3;liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 111.1;THP-1: 42.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	110000000000			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	2.8	3.2	23.6	1.9	25.0	1.4	1.6	17.1	37.0	3.8	2.1	24.2	0.0	1.9	1.7	1.8	2.0	2.3	22.5	30.9	18.0	11.9	9.3	309.0	1.6	1.5	19.5	15.0	1.8	2.3	1.8	2.6	1.5	23.8	2.5	2.2	0.0	1.5	1.9	7.8	1.4	2.2	2.6	29.8	1.4	2.4	2.0	15.9	0.0	1.9	0.5	1.4	3.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	111.1	0.3	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	42.4	0.0	0.0	0.2	0.0	0.2	0.6	7.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	25.0	17.1	20.0	18.0	11.9	19.5	15.0	23.8	15.9	0.0	1.7	34.4	0.9	0.6	4.5	43.1	828.0	0.0	0.0	3.5	33.4	0.1	21.6	119.6	56.8	0.5	0.0	116.8	8.6	0.1	2.8	19.4	0.0	2051.9	1.8	3.2	0.0	34.4	50.3	31.9	3.7	0.0	8.5	1.0	0.0	89.3	18.7	0.0	3.2	123.3	42.2	12.9	6.4	0.4	0.4	0.0	0.6	4.5	0.0	1.3
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931978	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 114.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Group enriched"	"Detected in many"	5	"B-cells: 5.0;granulocytes: 8.4;T-cells: 2.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	20.2	13.7	10.4	11.0	17.4	17.3	14.3	23.3	12.9	12.2	12.6	7.5	10.3	8.3	13.8	8.2	10.7	14.7	8.9	14.9	10.1	6.8	13.4	13.1	9.7	9.5	11.6	8.3	23.3	12.3	19.2	17.6	10.7	10.9	10.1	8.1	7.4	10.7	11.5	15.6	11.3	10.3	10.1	11.4	12.5	12.7	33.9	11.3	17.9	15.3	8.8	9.7	14.5	20.9	5.0	1.1	8.4	0.9	0.7	2.9	0.7	23.9	12.2	10.8	9.5	10.7	10.7	22.9	17.4	8.5	12.7	10.5	11.9	9.1	23.7	19.0	9.0	7.5	20.7	17.2	8.9	21.5	16.8	7.2	15.0	13.3	10.4	8.0	21.7	11.8	10.2	7.9	16.4	16.8	5.9	9.2	8.9	41.6	11.6	12.1	5.5	16.1	9.8	25.1	14.4	13.3	19.8	17.5	18.4	7.8	12.1	13.6	19.8	22.8	8.7	9.3	8.3	11.1	13.5	12.0	13.1	15.1	18.4	32.7	21.1	29.5	26.5	10.6	13.8	12.7	0.7	0.6	1.7	1.7	0.3	1.3	5.0	1.9	1.6	0.8	1.3	2.9	1.5	8.4	0.7	0.9	1.1	2.9	0.7	10.4	17.4	23.3	12.9	10.1	6.8	11.6	8.3	10.9	11.3	32.8	25.4	17.3	13.4	26.7	19.8	17.1	7.6	21.4	27.3	5.2	7.9	12.0	3.3	11.2	54.5	16.3	12.2	0.0	10.5	9.1	14.6	17.6	11.5	12.5	8.0	17.5	20.7	19.0	15.5	17.5	33.4	16.8	3.3	11.8	12.5	8.9	13.9	10.5	36.7	7.6	15.4	32.3	23.7	114.9	37.5	26.8	11.3	13.8	11.2	22.6
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 165.9;Spermatocytes: 116.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	4.6	4.7	7.7	5.6	8.4	4.7	8.3	13.5	8.7	5.0	6.5	8.5	4.1	5.0	6.3	11.1	6.2	11.3	5.2	6.9	9.1	10.3	7.6	4.5	6.7	5.5	9.4	4.9	6.7	4.6	15.4	33.3	4.4	11.5	5.9	6.7	3.7	7.0	6.3	6.1	5.5	6.2	5.7	11.7	6.5	6.1	22.0	7.7	20.5	11.4	4.1	5.0	5.9	4.4	11.2	2.9	15.1	4.1	4.9	6.4	1.6	2.5	1.8	7.6	13.5	7.1	4.5	5.7	4.0	5.0	4.2	5.7	2.9	5.3	5.5	2.1	3.7	9.2	4.5	2.2	4.3	8.9	11.7	4.7	4.2	4.4	2.9	5.8	5.3	2.6	3.6	8.4	7.7	10.1	10.3	5.5	8.4	3.9	4.6	3.1	5.2	4.6	3.5	1.7	5.8	2.9	6.1	4.2	5.1	6.1	5.0	9.2	7.9	4.8	4.6	6.6	4.5	6.0	6.4	5.8	4.0	2.7	5.8	2.6	2.4	2.1	3.2	8.1	6.7	2.2	15.1	2.8	6.5	5.1	1.5	4.4	10.5	5.1	6.1	2.0	11.2	6.4	5.5	5.4	4.9	4.1	2.9	3.6	1.6	7.7	8.4	13.5	8.7	9.1	10.3	9.4	4.9	11.5	7.7	26.8	18.8	6.6	7.7	2.4	14.6	16.1	2.5	165.9	18.2	8.7	13.7	3.3	0.0	7.0	55.8	11.3	10.5	0.0	3.9	1.2	3.5	4.8	20.9	1.8	3.0	19.1	19.0	5.5	4.6	32.1	6.9	5.3	5.0	1.8	14.3	15.2	6.1	7.8	6.0	5.6	48.9	25.8	5.2	116.9	28.5	2.3	4.7	12.8	9.9	7.5
AL845331.2		ENSG00000259916			2	94588522-94604573	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	13	"adipose tissue: 12.1"	"Cell type enriched"	"Detected in single"	10	"Proximal tubular cells: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"ASC diff: 6.8"															NA	NA						"unprognostic (1.97e-1)"				"unprognostic (1.24e-1)"		"unprognostic (8.07e-3)"	"unprognostic (1.39e-1)"		"unprognostic (1.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.15e-3)"	"unprognostic (6.22e-2)"		"unprognostic (4.66e-2)"		12.1	0.1		0.0		0.0	0.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.9	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.3	16.1	11.4	10.5	17.8	13.3	31.0	15.2	14.1	20.4	19.8	21.4	19.6	9.7	3.8	10.6	41.4	6.1	16.3	12.5	16.7	18.8	6.4	12.4	12.7	16.2	25.2	20.1	25.0	16.5	11.7	32.4	10.8	7.5	18.6	17.0	7.3	8.0	18.5	8.4	9.5	30.7	9.8	11.9	27.9	5.7	7.1	15.3	17.9	62.7	6.0	4.0	24.6	12.1	13.7	9.6	6.9	28.7	13.3	11.4	11.3	23.5	21.9	11.9	20.5	14.6	12.7	21.9	18.1	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0	32.8	47.6	4.5	16.4	15.3	15.1	88.4	35.7	38.8	27.3	22.7	3.9	67.2	48.0	28.5	9.7	25.9	35.4	0.0	27.6	21.7	19.9	18.1	89.4	210.5	62.6	11.1	33.3	25.2	14.6	3.1	12.4	23.3	5.0	73.9	18.6	9.1	33.4	18.7	15.6	25.9	6.8	12.9	27.3	23.7	19.0	14.2	258.6	17.3	16.1	24.3
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MCF7: 31.6;SK-BR-3: 32.7"					"Not detected"	"Not detected"			HPA045132	Approved					NA	NA					"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	2.6	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	32.7	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.9	0.0	1.5	1.4	0.0	0.3	0.0	0.0	0.0	5.2	0.0	8.5	1.7	0.3	0.0	0.0	0.0	0.0	0.2	8.0	0.4	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.2	0.0	0.0	6.2
ALPI		ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456123-232460032	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"intestine: 133.2"	"Group enriched"	"Detected in some"	6	"Enterocytes: 45.5;Paneth cells: 17.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"CACO-2: 12.7"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	63.0	0.0	0.0	57.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.1	0.1	133.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	17.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0
AMN	amnionless	ENSG00000166126	"Amnion associated transmembrane protein"	Q9BXJ7	14	102922656-102933596	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 97.6"	"Cell type enhanced"	"Detected in many"	23	"Enterocytes: 1194.2;Paneth cells: 312.1;Proximal tubular cells: 301.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.2;Hep G2: 11.0;U-698: 5.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000817	Approved					NA	NA					"HPA000817: AB_1078146"	"unprognostic (2.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.39e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (8.02e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"	0.4	0.0	0.1	3.3	0.1	0.0	0.7	0.1	0.1	0.6	44.3	0.1	0.2	19.3	0.2	3.1	2.6	0.6	10.4	0.2	0.1	0.0	17.2	17.8	1.8	0.5	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.4	2.1	0.2	0.7	0.0	0.0	0.9	97.6	0.1	0.0	0.6	3.9	0.3	0.1	0.7	0.7	0.1	1.1	0.5	1.0	0.3	1.8	0.0	0.0	0.0	0.7	0.1	0.6	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	11.2	0.3	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.2	0.0	0.8	11.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.2	1.0	1.6	0.2	1.2	0.0	0.2	0.1	0.2	0.0	0.0	1.0	0.7	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.0	1.0	0.6	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.3	0.7	0.6	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	8.9	0.3	7.8	16.6	11.8	2.6	1.0	94.3	2.7	4.5	19.2	0.0	2.5	28.2	1.6	3.6	0.3	1194.2	0.0	0.6	2.9	0.9	12.4	4.6	44.8	0.6	1.6	18.4	0.6	0.6	4.3	0.6	0.2	6.8	0.0	201.5	0.1	6.5	312.1	0.7	301.0	1.2	0.0	0.5	10.0	13.4	18.2	1.1	1.0	192.4	65.0
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 145.0;Pancreatic endocrine cells: 173.2;Peritubular cells: 123.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.4;HBEC3-KT: 65.4;LHCN-M2: 17.7;TIME: 33.0;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	7750000	1500000	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.4	3.6	0.1	1.2	0.1	0.2	0.0	0.0	6.0	0.0	9.0	2.5	1.3	0.8	0.0	65.4	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.7	0.2	10.0	0.2	1.8	5.0	0.1	0.3	0.2	17.7	0.5	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.2	3.2	1.2	0.0	0.1	7.5	0.8	1.1	0.4	1.9	0.1	33.0	19.4	0.1	9.8	0.0	0.0	0.0	0.0	13.3	0.0	3.6	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7	35.7	4.3	0.5	32.6	12.5	0.1	3.6	2.5	4.0	10.3	14.0	0.0	5.4	0.0	91.5	0.5	17.6	26.4	0.0	15.3	96.9	44.0	38.8	2.3	145.0	7.4	0.0	0.0	20.9	1.6	0.4	81.4	6.1	8.5	3.6	8.6	4.1	173.2	7.0	123.8	3.7	0.0	32.3	98.2	0.0	0.9	10.0	33.5	1.9	1.7	72.4
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 gamma 1 subunit"	O43747	16	71729000-71809201	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 197.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		150000	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	23.2	29.8	20.4	19.2	26.3	59.1	22.4	31.8	29.2	19.7	20.4	29.2	19.8	19.2	19.6	23.9	30.1	17.9	18.7	14.5	18.5	17.4	32.8	29.5	23.8	20.0	24.2	20.1	18.3	25.6	53.5	27.4	25.1	27.9	20.8	23.4	20.8	28.2	20.2	30.0	27.7	24.4	16.0	20.3	24.3	24.8	26.5	26.7	30.0	23.1	21.8	28.3	18.1	20.1	7.5	8.5	17.6	8.8	7.6	9.0	4.2	16.5	24.3	18.7	19.0	20.0	19.1	16.2	17.2	16.5	23.1	22.3	23.4	18.4	20.6	16.6	23.4	16.8	21.2	25.2	18.9	31.1	8.3	13.0	13.4	12.7	17.7	11.8	16.1	44.7	15.9	13.5	30.8	19.1	14.6	19.5	14.1	17.8	8.7	22.6	29.5	14.9	13.6	17.0	13.1	10.6	24.0	15.0	22.0	21.6	19.0	17.2	10.3	21.3	13.5	9.5	20.1	23.5	12.8	23.0	19.9	15.5	10.6	12.6	13.8	17.9	42.6	16.0	13.1	16.9	5.8	7.9	10.9	8.3	8.8	8.3	6.3	7.3	9.0	8.5	7.5	5.9	7.2	17.6	7.6	6.8	6.0	7.3	4.2	20.4	26.3	31.8	29.2	18.5	17.4	24.2	20.1	27.9	26.7	29.8	33.2	26.0	27.0	25.5	25.6	10.9	48.4	20.1	19.4	34.9	68.7	10.8	16.6	16.6	197.4	21.8	29.4	0.0	18.7	11.5	18.8	36.6	20.7	51.9	14.6	28.6	22.4	25.2	31.0	105.9	16.4	23.4	21.9	10.8	21.7	16.7	25.1	24.1	18.7	36.0	62.0	19.4	22.8	25.0	34.2	33.8	20.5	22.3	17.8	42.6
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837950	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 573.5"	"Cell type enriched"	"Detected in many"	33	"Hepatocytes: 19896.2"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;T-cells: 2.4"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 253.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	220000000000	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0.0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0.0	0.7	0.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	253.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	1.3	1.6	0.0	0.2	0.4	1.7	0.7	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	2.4	0.7	0.3	0.0	0.2	1.8	0.8	0.5	0.8	1.7	0.0	0.7	0.0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	3.5	174.9	0.2	0.1	0.6	24.6	596.2	0.0	2.3	0.0	0.0	0.4	0.0	0.1	30.6	1.9	0.9	256.9	1.0	1.1	1.5	0.1	2.3	19896.2	3.1	0.0	1.7	472.6	569.9	110.5	20.8	0.6	0.0	0.0	0.5	0.1	0.2	0.3	4.6	2.2	0.6	6.5	0.7	10.3	9.1	0.5	3.5	2.9	0.3	0.3
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	321	"liver: 932.2"	"Cell type enriched"	"Detected in some"	61	"Hepatocytes: 43650.4"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 610.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	210000000000			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	932.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.0	2.9	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	67.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	610.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.8	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	153.8	0.0	0.0	0.0	0.0	647.1	0.0	0.0	0.0	0.0	0.5	1.7	0.0	1.2	0.0	0.0	186.9	0.5	1.1	0.0	0.0	0.0	43650.4	4.6	0.0	0.0	550.0	711.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.5	0.0	4.7	0.0	0.0	0.0
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	209	"liver: 112.2"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 1283.4"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	65	"Hep G2: 36.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	114000000	15000000				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.4	0.0	0.0	0.0	0.0	1283.4	0.0	0.0	0.0	13.5	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911694-30925516	"Blood group antigen proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 156.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8"									"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		NA	NA		250000	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	68.2	8.0	9.9	8.7	17.1	9.4	51.9	10.7	13.0	46.5	18.1	62.1	7.7	10.8	28.0	20.8	58.8	29.0	36.3	46.7	18.1	15.4	156.5	4.2	103.2	9.1	36.9	17.8	16.4	49.9	12.9	4.0	9.1	63.2	32.4	10.6	8.3	19.8	22.7	35.2	24.8	18.2	41.2	56.4	2.9	18.2	15.0	17.8	1.9	21.3	33.5	12.5	36.0	76.7	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.6	0.4	1.8	0.4	1.2	0.4	0.0	0.0	0.2	0.3	0.0	20.9	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	7.0	0.0	0.4	0.1	0.0	3.3	0.0	0.1	0.0	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	5.2	0.1	0.7	0.0	0.2	7.8	1.2	0.6	0.0	3.9	0.1	0.1	0.0	0.0	9.8	0.8	0.3	0.5	0.3	0.0	0.1	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.9	17.1	10.7	13.0	18.1	15.4	36.9	17.8	63.2	17.8	166.7	218.3	2.9	1.1	81.4	1.1	57.7	377.0	6.7	6.8	29.6	7.9	1.9	24.9	35.6	1.9	221.7	4.2	0.0	2.1	3.0	91.5	1.0	1.1	1.3	3.3	0.0	7.0	154.1	1.8	1.6	1.1	9.8	84.4	2.8	18.2	0.3	2.8	19.2	3.2	281.0	0.2	12.9	92.0	0.3	1.3	68.8	6.1	0.0	71.0	1.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 2.5;granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4"					"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950741-49958881	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2"	"Cell type enriched"	"Detected in some"	444	"Collecting duct cells: 3930.9"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.5;EFO-21: 6.9;HEL: 2.0;HMC-1: 4.2;OE19: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA					"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.1	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	178.6	0.0	0.1	3.3	0.1	0.1	0.0	0.6	0.1	0.1	96.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.2	108.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3930.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.6	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	0.1	28.1	1.3	0.1	0.0	13.4	1.3	0.9	51.2	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.0	0.1	28.8	14.3	13.0	1.5	6.2	12.8	5.0	1.1	19.2	0.1	0.2	21.3	2.3	0.2	47.6	0.4	1.1	7.1	32.9	0.0	1.9	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.1	44.2	3.2	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0	35.7	265.4	2.2	608.6	1708.5	1.4	2.1	104.4	136.5	215.0	1526.7	2.0	0.6	0.0	27.2	1.3	40.5	4.2	93.5	41.7	1.3	46.3	959.6	19.7	111.7	2.2	0.0	7.9	16.0	3.8	0.0	30.8	32.1	150.1	1.0	63.7	0.3	32.0	2.9	1.1	28.8	0.4	0.0	42.2	0.0	1.0	2172.4	42.0	43.3	3.5	2008.6
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852038-26865818	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 185.1;lung: 53.5"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 1024.3"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0.0	1.6	1.6	2.0	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2.0	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0.0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0.0	8.4	0.1	1.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2	1024.3	245.1	0.0	0.6	0.0	2.1	8.5	0.0	37.5	138.8	3.5	5.9	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.5	0.5	0.0	1.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	224.7	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961870-49965681	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"salivary gland: 217.9;testis: 76.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1235.0;Late spermatids: 3096.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 70.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	0.2	0.1	0.4	0.2	1.1	0.0	3.8	0.4	0.3	3.0	0.3	0.4	0.3	3.2	0.6	0.8	3.8	0.1	15.6	1.0	0.3	0.3	0.2	0.2	2.3	0.2	0.7	0.2	0.2	0.8	0.1	0.4	0.2	0.3	0.5	0.0	0.4	217.9	0.6	0.9	23.5	0.3	0.6	0.2	0.2	12.0	76.2	0.3	0.2	0.3	2.8	11.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	70.7	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.3	0.3	0.3	0.7	0.2	0.3	0.3	53.6	1.9	0.0	0.4	1.1	0.5	0.3	0.0	8.1	37.5	7.0	0.0	0.0	0.0	0.0	1235.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3096.0	26.4	0.0	280.0	0.0	0.0	45.4	4.3	0.0	18.0	0.0	1.4	19.4	0.3	76.9	15.2	0.6	0.0	0.0	0.0	0.7
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"kidney: 40.1"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 4.5;Collecting duct cells: 5.2"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;OE19: 5.1;SH-SY5Y: 2.1"	"Region enriched"	"Detected in some"	7	"cerebellum: 23.5"	"Low region specificity"	"Detected in many"			HPA015278	Enhanced					NA	NA					"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	0.6	0.1	1.1	0.0	0.1	0.3	1.6	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.7	0.5	40.1	0.2	0.1	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.5	1.2	0.2	0.2	0.4	0.2	0.3	2.0	0.1	0.3	0.1	0.0	0.0	0.4	0.2	0.0	0.0	1.1	1.2	0.0	0.9	0.0	0.0	0.2	0.3	0.0	0.0	0.2	1.4	0.0	0.1	0.7	0.3	0.0	0.1	0.1	0.0	0.0	0.1	1.1	0.0	0.2	0.4	0.6	0.0	0.9	0.0	0.6	0.4	5.1	1.0	1.0	0.1	0.5	0.9	0.0	0.5	2.1	0.7	0.0	0.7	0.3	0.0	0.1	0.0	0.6	0.9	0.0	0.5	0.2	0.2	0.0	0.2	0.2	0.4	1.2	0.2	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.5	0.8	0.2	0.3	1.1	0.2	0.2	0.2	0.3	0.2	0.6	1.1	0.3	0.3	0.7	0.5	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.7	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 81.4;Early spermatids: 99.6;Enterocytes: 64.2;Proximal tubular cells: 60.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"	"Cell line enriched"	"Detected in some"	52	"ASC diff: 79.4"															NA	NA						"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	72.7	1.2	0.6	1.3	0.8	0.0	25.6	2.4	0.9	0.6	3.9	0.6	0.6	3.9	0.6	1.1	1.2	1.2	2.3	21.5	0.6	0.0	5.3	5.9	0.6	0.6	0.6	0.6	1.0	3.0	10.2	0.6	0.9	1.2	1.2	0.8	0.8	2.7	0.6	8.8	0.9	5.7	0.6	1.0	0.6	0.3	5.5	0.6	0.8	1.0	3.0	1.6	1.7	0.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.5	0.0	0.0	79.4	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.6	0.8	2.4	0.9	0.6	0.0	0.6	0.6	1.2	0.6	6.0	8.2	0.0	0.2	1.3	0.0	81.4	15.3	4.0	1.2	33.2	0.0	0.0	5.0	1.1	99.6	0.8	64.2	0.0	0.2	0.3	0.2	0.4	0.0	16.8	0.1	0.0	0.0	1.8	0.0	14.4	2.0	0.1	0.0	0.0	3.8	0.0	0.3	28.1	1.8	60.8	0.0	6.5	2.1	1.1	0.7	2.3	0.0	0.0	2.1	1.4
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228940	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"intestine: 40.9;pancreas: 163.4"	"Cell type enhanced"	"Detected in some"	20	"Enterocytes: 43.3;Exocrine glandular cells: 9.2;granulocytes: 9.2;Intestinal endocrine cells: 12.6;Paneth cells: 16.9"	"Group enriched"	"Detected in some"	42	"colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced					NA	NA					"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.2	0.0	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	40.9	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	163.4	0.0	0.2	0.2	0.2	0.2	19.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	5.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	43.3	0.0	9.2	0.1	0.0	0.1	9.2	0.0	0.1	1.6	12.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.2	0.1	2.5	16.9	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	5.4	0.0
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 127.8;liver: 147.0"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 258.5"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	20	"neutrophil: 127.8"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 127.8"	"Cell line enriched"	"Detected in single"	27	"U-87 MG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA074762, CAB075684"	Enhanced					NA	NA					"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	7.8	0.3	0.6	12.9	0.7	9.8	0.6	0.7	1.4	0.2	0.3	0.1	1.0	0.0	0.2	7.8	0.7	3.0	0.8	2.0	0.4	0.2	0.8	147.0	8.6	12.0	2.4	0.4	1.2	0.3	2.8	0.4	1.4	0.6	0.4	0.0	0.5	0.4	0.8	0.4	6.9	0.3	1.0	0.5	15.8	0.7	2.5	0.4	0.4	0.5	0.1	0.4	1.3	0.6	0.0	0.2	127.8	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	25.9	0.1	0.0	0.0	6.2	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	127.8	0.0	2.3	0.0	0.0	1.7	0.6	0.7	0.7	1.4	0.4	0.2	2.4	0.4	0.6	0.4	0.0	19.3	4.3	0.1	0.3	0.0	1.2	5.1	2.7	5.7	0.0	0.0	0.3	0.0	0.1	1.9	0.1	0.0	0.0	0.2	0.5	0.4	0.0	7.0	258.5	43.2	0.0	0.0	8.0	34.5	0.8	0.3	57.7	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.7	1.3	0.0	0.1
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		340000	Vesicles	"Golgi apparatus, Cytosol"	"HPA037573: AB_10696938, HPA044874: AB_2679126"	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	46.9	37.4	26.7	30.3	32.9	15.0	35.7	34.4	38.8	48.8	36.7	37.3	39.9	36.0	39.8	61.6	38.6	32.6	38.0	39.5	28.7	30.6	39.1	61.4	34.0	27.3	30.4	24.7	45.1	65.2	49.7	64.7	46.0	38.3	42.4	39.6	29.3	62.0	46.9	25.8	31.9	47.1	41.9	34.3	34.9	38.1	37.9	29.7	39.0	44.1	29.3	39.2	46.9	42.1	22.7	29.1	46.2	33.0	34.1	39.5	26.7	24.7	20.7	36.3	26.5	44.7	47.8	19.6	62.3	55.4	28.2	33.8	65.2	32.8	26.0	53.5	69.5	40.9	33.4	40.5	36.6	39.4	35.8	18.9	55.9	15.0	35.5	50.8	34.3	32.7	41.6	30.5	46.6	43.5	39.7	42.7	25.8	28.7	36.6	53.1	39.7	30.8	30.5	22.8	51.4	27.7	26.9	35.3	39.6	34.2	26.8	24.9	25.0	34.7	33.8	17.6	35.1	43.0	30.7	39.0	35.7	17.6	33.7	28.8	21.5	19.0	37.9	21.0	32.2	42.3	46.2	26.4	26.3	30.5	33.0	39.5	22.7	30.2	29.3	29.1	20.7	29.1	26.6	23.1	34.1	32.1	24.4	28.3	26.7	26.7	32.9	34.4	38.8	28.7	30.6	30.4	24.7	38.3	29.7	32.8	42.8	17.5	25.2	28.0	19.4	40.3	30.6	48.2	45.5	29.6	3.9	13.9	8.3	32.0	9.5	32.1	50.4	0.0	32.8	30.7	36.6	44.9	38.1	51.8	26.5	17.5	38.6	35.6	36.5	5.6	44.5	24.8	21.9	45.1	66.8	15.7	39.0	28.1	38.9	27.0	11.7	19.4	38.9	40.0	50.4	30.4	25.3	24.9	34.6	42.9
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677273-25865172	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 29.8;Early spermatids: 17.6;granulocytes: 15.0;Late spermatids: 14.7;Melanocytes: 16.9;Peritubular cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"dendritic cells: 3.0;NK-cells: 4.7;T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 19.1;HMC-1: 12.7;RPTEC TERT1: 10.2;SK-MEL-30: 17.3"	"Low region specificity"	"Detected in all"							"HPA041496, HPA042509"	Uncertain					NA	NA					"HPA041496: AB_2677513, HPA042509: AB_2678032"	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	7.4	14.1	5.3	5.4	9.8	4.7	5.7	3.4	11.0	5.3	3.3	6.2	1.4	1.5	1.9	2.1	3.7	3.1	7.1	2.9	8.0	5.8	6.0	1.0	12.2	14.8	9.3	9.0	1.6	1.9	1.9	2.5	3.6	11.3	3.6	2.3	4.0	14.4	1.5	0.7	3.3	3.6	5.3	6.4	3.5	4.0	6.0	6.2	1.5	3.0	1.6	3.3	4.2	3.3	0.0	3.0	0.0	0.3	4.7	4.0	1.7	0.0	3.4	0.7	0.0	2.7	2.6	0.0	13.0	6.3	4.0	7.1	0.0	0.0	0.0	0.7	19.1	0.0	0.0	6.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.6	0.0	0.5	0.0	1.6	0.0	0.4	0.0	0.0	2.5	0.0	0.5	0.0	0.9	0.0	0.8	2.4	2.4	0.8	10.2	0.0	0.0	0.0	0.0	0.0	17.3	0.0	5.2	0.5	0.0	5.3	0.2	7.6	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.3	0.0	1.9	0.2	1.9	0.0	2.2	2.1	0.4	0.0	4.0	3.7	0.0	4.7	0.1	3.0	0.7	1.7	5.3	9.8	3.4	11.0	8.0	5.8	9.3	9.0	11.3	6.2	29.8	7.5	0.0	0.0	0.9	0.0	1.4	2.5	6.7	7.9	0.0	0.0	0.0	0.0	0.2	17.6	0.8	0.0	0.0	0.0	0.1	2.8	0.9	15.0	0.0	2.2	0.0	0.0	0.6	2.1	14.7	3.7	4.4	16.9	0.0	0.0	0.0	0.6	0.0	16.6	0.0	0.0	0.0	8.1	0.4	0.7	0.4	0.0	4.4	0.0	0.0
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 171.3;Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	11.1	11.5	7.2	8.3	16.4	15.7	7.9	5.0	12.5	13.6	5.8	24.4	8.7	9.5	13.7	9.2	8.5	10.8	14.6	19.6	7.2	5.4	12.9	12.3	36.9	7.5	17.7	6.9	8.6	13.2	36.1	17.8	11.2	12.8	5.0	3.6	10.0	12.0	9.0	11.2	11.4	8.7	9.1	12.5	10.2	6.1	9.7	16.2	2.1	16.4	6.4	6.0	5.7	11.3	4.2	1.1	6.4	3.1	0.0	1.0	0.6	14.0	7.2	9.1	10.7	4.6	6.3	16.2	6.7	3.9	5.7	4.7	22.6	16.3	7.1	8.2	5.6	7.4	12.0	8.2	5.5	5.6	7.1	7.7	8.2	6.0	11.7	7.3	15.3	13.4	4.2	4.3	6.9	4.2	4.6	15.0	6.5	5.6	1.2	4.0	5.3	6.9	9.7	3.9	16.1	5.1	6.1	3.7	4.0	31.3	3.3	14.6	4.0	6.5	8.5	5.6	12.4	3.2	20.5	9.8	0.0	12.5	7.4	5.0	3.9	7.5	3.0	2.5	14.5	6.3	0.0	2.3	3.1	1.0	3.1	0.6	1.3	0.6	0.5	1.1	4.2	0.7	0.4	6.4	0.0	2.7	1.1	0.1	0.6	7.2	16.4	5.0	12.5	7.2	5.4	17.7	6.9	12.8	16.2	202.5	171.3	5.6	2.8	9.6	29.4	38.0	35.7	16.0	45.5	15.7	221.9	0.6	5.0	31.2	0.7	19.8	4.2	0.0	10.0	26.5	10.6	5.3	11.5	13.2	17.6	12.7	11.5	24.5	33.5	1.4	10.3	21.3	10.1	7.2	3.3	10.4	18.9	5.8	4.6	15.8	44.2	0.0	5.1	3.9	9.0	8.4	7.2	5.7	5.2	3.7
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 47.7;Spermatogonia: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA					"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	12.8	7.0	4.8	7.6	10.6	4.6	9.6	8.0	5.8	13.1	8.8	5.3	30.2	4.8	12.0	9.5	7.3	9.1	7.4	5.2	6.7	4.5	10.8	41.4	6.7	11.2	9.6	3.2	13.1	4.6	6.8	4.2	4.6	9.5	11.5	6.4	10.7	5.8	21.4	6.6	5.6	7.8	11.3	6.3	14.4	7.1	7.9	9.7	14.9	6.1	4.0	7.4	12.7	12.2	2.8	2.1	5.1	1.7	3.5	2.5	0.5	9.4	4.0	8.4	13.6	12.5	17.0	10.6	11.4	15.3	9.2	12.8	3.6	7.7	13.6	25.7	16.1	6.1	8.0	20.1	5.2	14.5	12.4	11.8	6.9	8.9	7.0	13.9	11.9	4.4	11.2	3.5	10.0	8.6	10.3	15.9	10.6	7.7	10.5	12.1	5.1	10.9	8.1	14.1	0.0	7.7	11.0	9.0	11.3	7.8	15.8	6.5	10.8	4.5	0.5	5.9	8.2	3.4	6.6	17.8	12.6	4.2	15.2	15.4	3.0	2.9	10.8	5.8	15.0	6.3	5.1	1.5	0.4	1.2	1.0	2.5	2.8	1.4	1.1	1.2	2.7	1.4	2.2	2.8	3.5	1.7	2.1	1.0	0.5	4.8	10.6	8.0	5.8	6.7	4.5	9.6	3.2	9.5	9.7	14.9	9.6	13.0	14.5	12.9	1.6	3.9	2.5	5.3	11.4	10.4	0.0	1.7	1.7	4.8	9.9	20.3	4.5	0.0	8.5	10.5	16.6	10.9	9.2	43.9	7.9	0.0	8.7	28.8	29.5	8.5	13.3	8.6	10.1	47.7	6.0	2.8	6.4	5.8	14.5	8.2	3.4	0.0	20.6	23.2	49.4	11.8	5.6	8.7	4.5	13.6
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 5.3;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	8	"SuSa: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	5.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.2
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 195.4;parathyroid gland: 194.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 917.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 254.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		380000			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	17.4	25.6	22.4	16.2	40.3	10.5	26.9	74.2	67.4	17.8	121.9	14.2	56.1	92.3	13.1	38.3	34.9	17.7	65.8	41.1	26.1	18.7	162.7	34.6	35.1	9.6	19.2	27.6	17.4	78.6	194.4	25.0	19.2	34.1	22.1	65.7	24.1	84.4	53.7	19.0	40.5	195.4	17.7	20.7	13.7	25.0	17.0	13.9	9.1	101.2	13.7	16.2	14.2	23.1	10.3	22.0	6.4	29.7	10.4	30.2	17.2	33.7	12.4	12.9	6.5	26.0	25.3	66.6	20.2	40.3	24.9	35.4	49.8	24.2	26.7	28.6	23.9	25.3	44.1	25.5	42.6	36.3	9.8	28.3	15.5	23.5	42.0	19.9	38.9	21.9	28.1	71.5	29.0	38.3	35.2	30.5	16.3	25.6	25.8	22.0	67.0	15.7	14.1	30.4	53.6	25.0	15.2	30.3	23.6	90.1	34.8	12.7	11.2	31.4	59.6	254.2	33.2	15.7	22.6	26.9	14.2	19.9	36.7	40.9	12.5	9.7	20.5	43.6	22.5	83.4	6.4	13.3	6.1	23.2	20.9	24.8	10.3	26.4	24.9	22.0	5.3	30.2	22.0	1.6	10.4	29.7	11.1	20.3	17.2	22.4	40.3	74.2	67.4	26.1	18.7	19.2	27.6	34.1	13.9	256.1	246.7	58.7	265.3	245.9	76.0	62.7	540.1	113.8	203.6	731.0	375.0	70.1	316.7	432.8	25.0	117.9	917.6	93.5	278.3	130.8	110.9	297.5	43.8	66.4	114.8	96.9	169.4	90.9	77.6	11.5	109.0	130.5	197.4	47.7	304.0	513.0	192.4	264.8	94.7	289.6	141.6	32.3	179.2	17.9	27.5	235.0	56.5	95.6	365.5	236.0
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 109.8;skeletal muscle: 305.8"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 142.4;Muller glia cells: 63.9;Peritubular cells: 37.1;Sertoli cells: 84.1;Smooth muscle cells: 32.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;HHSteC: 9.6;RH-30: 10.7;U-87 MG: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022230	Enhanced					NA	NA					"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	12.6	3.9	61.4	2.8	80.1	2.3	6.5	30.4	109.8	4.7	6.6	27.4	2.4	3.7	4.2	7.4	15.3	6.0	5.3	35.4	42.2	27.0	3.3	2.5	3.8	2.4	45.6	37.9	9.9	2.6	2.4	4.6	3.6	58.0	13.8	5.6	12.5	3.1	14.2	305.8	2.8	4.4	5.4	51.5	2.7	2.8	3.9	28.3	0.0	2.6	17.7	2.5	5.5	1.3	0.6	1.4	1.7	0.4	0.6	0.5	0.3	0.0	0.0	32.9	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	2.9	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.7	0.6	0.3	0.5	1.7	0.6	0.2	1.4	0.2	0.3	61.4	80.1	30.4	52.0	42.2	27.0	45.6	37.9	58.0	28.3	0.0	0.0	0.0	0.8	0.5	0.7	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	26.7	0.0	0.0	0.0	0.0	63.9	0.0	0.0	37.1	0.0	1.9	84.1	32.5	0.3	0.2	0.5	0.1	0.0	0.0	0.5
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.4;heart muscle: 78.3"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 387.3;Cone photoreceptor cells: 161.0;Horizontal cells: 201.8;Late spermatids: 93.3;Rod photoreceptor cells: 178.0"	"Group enriched"	"Detected in many"	6	"glioma: 21.6;testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.7;JURKAT: 13.5;Karpas-707: 13.2;REH: 13.0;SCLC-21H: 49.1;SH-SY5Y: 21.1"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA					"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	1.9	12.8	34.0	2.5	30.8	2.1	1.8	42.8	146.4	1.8	2.4	4.8	0.0	2.4	1.8	1.8	2.0	1.8	1.9	78.3	48.3	54.6	1.8	1.8	1.9	2.3	39.9	42.6	1.8	2.3	1.8	3.0	1.8	94.4	1.8	2.3	17.3	2.2	1.8	1.8	2.0	2.7	2.2	18.5	2.1	2.0	18.6	6.9	0.0	1.8	0.0	2.1	1.9	0.1	0.3	0.1	0.0	0.0	0.1	2.2	0.3	0.0	0.8	0.3	8.7	0.0	0.0	0.0	0.1	0.0	0.6	0.6	0.3	1.6	20.7	0.9	0.1	2.0	0.2	6.1	0.0	0.2	3.9	1.1	1.8	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	13.5	0.0	13.2	0.1	0.3	3.7	0.0	1.1	2.9	5.3	13.0	7.1	0.6	0.0	0.2	49.1	21.1	0.1	1.6	0.0	0.0	1.3	0.9	0.0	1.1	1.1	0.0	0.4	1.3	0.9	4.7	1.9	7.2	0.2	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.6	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.7	0.3	34.0	30.8	42.8	66.6	48.3	54.6	39.9	42.6	94.4	6.9	0.0	7.9	0.5	0.3	0.2	387.3	15.7	0.0	0.0	0.0	0.0	161.0	0.0	0.0	0.0	33.6	0.3	0.0	0.0	0.0	0.1	0.6	0.2	1.1	0.0	0.2	201.8	0.0	0.0	0.0	93.3	1.7	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.4	0.0	178.0	0.0	0.0	21.3	3.2	0.3	0.2	1.9	0.0	0.4
ATP1A4	ATP1AL2	ENSG00000132681	"ATPase Na+/K+ transporting subunit alpha 4"	Q13733	1	160151570-160186977	"Enzymes, Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 13.1;seminal vesicle: 19.0;testis: 35.8"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 20.6;Early spermatids: 67.0;Syncytiotrophoblasts: 31.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BEWO: 10.8;HDLM-2: 26.8;RT4: 32.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.33e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (2.20e-4)"	0.4	0.3	0.4	0.8	0.3	0.0	2.2	0.4	0.3	0.3	0.3	0.0	11.2	0.0	0.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.2	0.2	0.3	3.8	0.3	0.0	0.2	0.2	0.0	0.3	13.1	0.0	0.6	0.0	0.4	1.2	19.0	3.2	0.3	0.5	1.6	0.3	1.1	0.3	35.8	0.0	0.9	0.2	0.2	1.6	8.9	5.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	1.1	0.0	5.5	0.2	0.0	0.8	0.0	0.0	0.0	1.8	0.0	20.6	0.0	0.0	67.0	0.0	0.0	0.0	0.0	11.9	0.4	0.7	1.1	0.0	2.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.2	0.2	0.0	31.9	0.0	0.0	11.2
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 239.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 1634.8;Proximal tubular cells: 927.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 127.3;RPTEC TERT1: 68.9;SH-SY5Y: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					NA	NA		4100000			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	3.9	26.3	48.7	8.6	45.1	1.3	14.9	39.4	92.1	8.7	43.8	34.5	11.3	61.3	19.8	11.2	28.7	9.4	50.1	36.0	86.3	68.2	239.7	30.6	16.9	1.9	82.3	52.6	11.5	33.0	130.6	16.7	8.3	111.5	9.8	34.8	15.5	55.7	15.4	55.1	11.2	51.2	17.8	64.0	9.6	69.5	8.4	25.9	0.9	60.1	23.7	13.9	12.3	9.0	1.4	8.4	10.5	3.0	5.6	9.1	1.4	12.3	30.2	9.8	7.5	2.3	0.4	3.4	6.1	5.0	6.4	6.7	36.8	25.0	0.0	23.1	4.8	7.2	14.6	5.4	11.6	6.6	0.1	2.4	0.7	22.8	17.1	3.7	0.5	1.1	1.3	2.9	4.7	6.1	11.2	5.8	0.9	0.1	0.1	7.3	4.7	1.0	1.9	3.9	127.3	6.5	0.1	11.9	2.1	68.9	15.4	7.8	57.2	36.1	36.4	1.6	12.5	7.5	1.2	12.3	4.9	13.2	8.3	21.8	0.7	0.9	0.2	5.9	1.8	6.6	10.5	1.0	0.1	2.9	3.0	1.5	1.4	3.4	1.1	8.4	0.2	1.0	1.1	0.3	5.6	0.9	0.4	9.1	1.4	48.7	45.1	39.4	92.1	86.3	68.2	82.3	52.6	111.5	25.9	223.4	199.8	17.7	144.1	46.6	22.3	136.8	749.1	187.4	257.0	1634.8	13.7	3.9	782.5	509.0	2.8	15.2	580.2	0.0	519.8	7.5	62.9	68.0	22.0	232.9	298.5	548.2	154.6	46.6	63.5	4.1	83.1	111.4	234.5	43.3	240.2	24.3	309.0	614.7	140.0	927.9	48.2	6.5	23.6	8.6	62.0	27.7	8.2	25.4	319.0	251.2
ATP1B2	AMOG	ENSG00000129244	"ATPase Na+/K+ transporting subunit beta 2"	P14415	17	7646627-7657768	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 148.8"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 345.9;Cone photoreceptor cells: 235.6;Muller glia cells: 268.9;Rod photoreceptor cells: 188.4"	"Cancer enriched"	"Detected in many"	17	"glioma: 200.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 13.5;HAP1: 4.1;K-562: 6.1;SuSa: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010698	Supported					NA	NA		17000			"HPA010698: AB_1845174"	"unprognostic (9.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.96e-3)"	"unprognostic (3.90e-3)"	"unprognostic (9.33e-2)"	"unprognostic (4.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.79e-2)"	4.1	6.5	54.7	2.5	61.6	8.1	2.5	62.9	148.8	9.4	3.4	25.1	0.0	2.7	8.0	15.1	3.4	10.9	4.4	5.0	46.1	33.4	6.9	3.4	3.9	2.9	42.4	41.9	23.3	3.3	3.8	10.8	5.0	68.9	4.6	3.8	28.4	3.3	7.6	4.6	2.7	3.0	5.8	58.7	4.8	2.4	4.3	25.7	0.0	4.4	0.0	2.6	3.3	2.0	1.3	0.7	1.5	1.0	1.3	2.0	0.5	0.0	0.0	13.5	0.6	0.4	0.3	0.1	0.2	0.0	0.5	0.3	0.5	0.0	0.4	0.3	0.1	0.2	0.4	4.1	0.2	0.2	0.1	1.7	0.3	0.1	0.1	0.2	0.1	1.3	0.8	0.0	0.5	0.0	0.1	0.0	0.3	6.1	0.8	0.0	0.4	0.3	0.4	2.8	0.1	0.3	0.2	0.0	0.2	0.1	0.1	0.2	2.6	0.0	0.1	0.1	8.2	0.2	0.3	0.0	0.2	1.0	0.1	0.2	0.5	0.2	0.1	1.2	0.3	0.3	0.9	1.0	0.5	2.0	0.3	1.8	1.3	0.7	1.4	0.3	0.8	1.1	1.0	1.5	1.3	0.2	0.7	0.2	0.5	54.7	61.6	62.9	50.8	46.1	33.4	42.4	41.9	68.9	25.7	0.0	0.0	0.0	0.2	1.6	345.9	2.8	5.1	0.0	0.0	0.0	235.6	0.0	0.0	0.0	0.2	1.8	0.5	23.3	0.0	0.1	2.4	0.4	0.0	0.0	0.3	17.5	0.0	5.5	1.5	0.2	17.3	0.6	0.0	0.0	0.0	268.9	0.0	0.0	43.5	0.1	188.4	25.8	22.8	0.4	6.3	1.0	0.2	0.0	0.0	0.1
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 712.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		100000	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	50.5	79.9	12.7	26.3	23.3	17.5	105.9	25.7	35.1	17.7	48.2	9.1	16.8	37.3	17.9	14.6	36.9	20.0	47.8	44.0	16.0	18.9	24.9	7.7	44.9	43.4	21.3	12.8	34.7	11.5	6.3	33.8	32.6	43.3	20.5	58.1	23.9	18.4	24.8	7.4	85.4	57.3	24.3	28.4	16.5	13.5	21.1	13.6	14.5	15.6	41.4	18.4	21.9	31.5	10.4	26.8	13.6	60.9	7.8	20.0	22.5	46.4	28.9	27.2	25.5	73.0	21.3	62.3	54.5	49.6	39.7	45.0	44.9	23.4	37.9	49.3	41.4	57.5	102.0	26.9	26.0	45.2	20.6	34.2	33.1	32.5	29.1	28.9	27.2	26.0	22.5	62.3	31.1	30.1	28.4	42.3	26.6	22.7	33.7	40.6	21.1	27.6	45.6	37.8	64.7	13.9	38.0	20.4	38.6	33.3	35.9	22.4	15.3	71.2	33.1	73.1	49.4	25.2	33.2	29.4	34.9	13.4	52.1	31.7	25.1	32.3	61.1	45.5	29.6	28.6	13.6	27.1	8.9	19.2	44.5	14.1	10.4	15.6	20.0	26.8	7.5	9.2	16.7	1.9	7.8	60.9	16.4	16.9	22.5	12.7	23.3	25.7	35.1	16.0	18.9	21.3	12.8	43.3	13.6	53.6	46.5	109.5	333.7	437.8	35.4	16.7	20.4	10.7	43.3	209.3	23.6	255.9	34.9	71.5	391.5	178.3	384.3	140.2	52.8	199.5	109.5	121.1	129.2	6.0	276.1	23.8	53.9	79.8	137.2	712.2	78.6	209.3	210.9	518.4	67.0	42.5	54.6	123.0	64.3	29.8	25.4	122.9	189.2	42.4	191.3	362.3	327.4	66.0	109.6	362.4
ATP1B4		ENSG00000101892	"ATPase Na+/K+ transporting family member beta 4"	Q9UN42	X	120362085-120383249	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skeletal muscle: 47.3;tongue: 26.1"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"HSkMC: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (2.59e-2)"	"unprognostic (6.02e-4)"						"unprognostic (5.78e-1)"		"unprognostic (5.29e-2)"				1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.2	1.7	0.1	0.0	2.4	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	0.0	47.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	26.1	2.5	0.0	0.0	0.7	0.2	1.4	0.3	0.7	0.3	1.0	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.2	0.1	0.7	0.3	0.3	0.5	0.1	0.2	0.3	3.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.7	0.0	0.6	0.5	0.4	0.3	0.2	0.0	0.0	0.3	0.4	0.4	0.1	1.3	0.3	0.3	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.7	0.3	0.3	1.4	0.7	0.3	0.2	0.2	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Not detected"	"Not detected"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.8	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	3.2	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.6	4.1	1.1	0.6	0.5	4.9	0.2	14.3	5.2	6.5	0.3	9.7	10.9	6.1	9.7	1.8	7.4	16.9	6.8	5.7	0.0	0.6	6.2	4.9	3.3	4.5	3.4	3.7	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.8	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.3	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.3	0.0	0.0	4.6	0.0	0.0	1.8	3.0	0.1	0.6	0.0	0.6	0.0
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 188.3;skeletal muscle: 319.7"	"Cell type enriched"	"Detected in all"	12	"Cardiomyocytes: 1592.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		38000000			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8.0	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5.0	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13.0	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	35.5	70.9	35.9	28.8	23.9	30.6	51.8	44.3	55.8	45.0	30.3	51.2	37.9	43.9	37.5	42.1	34.0	52.0	59.4	70.0	51.2	36.3	29.7	38.3	28.4	29.9	40.6	43.7	37.1	32.1	49.4	57.1	55.4	43.3	34.7	23.0	44.6	21.5	36.6	34.1	23.6	27.1	40.9	36.5	35.9	24.9	32.3	36.2	22.2	73.4	38.0	28.5	55.8	45.8	25.9	34.2	61.6	23.6	37.2	41.7	22.4	27.7	33.8	44.2	53.8	49.2	38.0	18.9	47.2	0.0	1.9	0.0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5.0	5.6	13.1	10.2	7.1	41.7	53.9	23.1	78.3	101.7	60.4	1592.4	45.9	96.4	83.0	48.8	60.9	28.0	1.7	40.8	10.7	37.6	123.8	23.3	60.6	31.5	51.2	89.3	43.9	110.5	56.0	79.4	131.8	41.1	50.1	9.0	28.1	40.7	64.1	19.0	80.6	24.0	82.4	70.2	78.1	23.9	39.0	51.8	126.0	61.6	55.1	95.2	25.6	17.0	66.5	93.6
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.4;salivary gland: 88.1"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 61.6;Intestinal endocrine cells: 94.0;Mucus-secreting cells: 112.7;Paneth cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.9;midbrain: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;HMC-1: 58.2;JURKAT: 32.7;MOLT-4: 52.0;SK-BR-3: 42.3"	"Region enriched"	"Detected in some"	15	"cerebellum: 75.4"	"Low region specificity"	"Detected in many"			"HPA007180, CAB010882"	Approved					NA	NA		100000000			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	2.1	4.9	0.9	36.9	1.6	24.3	2.7	10.9	1.7	2.3	15.4	1.8	48.8	8.1	3.4	2.8	4.5	2.2	16.0	2.6	0.9	0.7	3.4	1.6	7.8	25.6	4.1	1.4	2.1	20.2	0.0	0.8	1.7	1.4	7.4	9.0	8.7	88.1	47.3	0.9	9.4	26.1	3.0	1.0	36.4	25.5	1.6	1.2	82.4	4.2	6.0	47.5	5.4	2.6	8.3	10.8	21.1	1.0	2.5	7.8	3.9	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	39.3	2.4	0.1	0.0	0.1	0.6	0.0	0.0	4.8	0.4	20.5	1.2	0.0	0.3	22.3	58.2	0.0	0.0	0.1	0.0	0.0	0.0	32.7	4.1	25.4	0.0	24.4	52.0	24.0	0.2	11.1	0.3	5.7	0.0	9.0	0.0	0.7	2.5	0.7	0.3	42.3	0.0	0.2	2.6	5.5	0.1	0.0	0.4	0.1	0.0	9.4	2.8	13.8	0.5	15.9	0.0	9.1	1.0	21.1	7.8	0.6	6.1	6.9	4.8	7.2	1.0	8.3	3.6	4.4	9.0	2.5	0.3	10.8	4.2	3.9	0.9	1.6	10.9	1.7	0.9	0.7	4.1	1.4	1.4	1.2	0.0	3.4	44.0	0.4	0.8	0.0	2.2	5.1	1.4	2.3	22.7	0.0	0.2	0.0	1.7	0.1	3.6	61.6	0.0	10.8	0.2	2.0	6.5	33.4	0.8	2.8	0.0	94.0	7.4	3.5	0.0	0.0	2.6	11.8	0.0	112.7	0.2	17.0	46.0	0.7	0.2	0.1	0.0	3.1	0.0	0.7	0.3	0.0	20.8	41.2	2.5
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.8"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 311.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 59.7;LHCN-M2: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	8.7	5.1	23.4	12.5	53.8	40.5	8.8	30.9	44.1	9.0	14.0	4.1	4.0	17.8	8.2	5.8	6.5	8.4	11.3	5.2	29.0	11.8	7.4	10.0	9.2	11.8	7.8	31.5	7.6	7.4	13.7	8.7	11.7	9.2	6.4	14.8	2.9	5.6	6.9	10.9	11.3	12.8	8.7	6.1	12.7	12.4	9.8	16.4	5.7	6.3	6.0	12.3	9.9	7.4	27.1	16.2	41.5	25.6	8.4	16.3	6.2	4.2	21.5	8.5	4.1	12.4	19.7	3.9	13.0	42.9	12.6	20.2	8.6	3.9	8.4	0.9	18.1	14.6	3.8	7.4	3.6	35.5	2.9	8.7	3.0	7.6	7.5	40.3	12.5	5.0	16.3	6.9	39.5	59.7	14.9	3.2	3.2	4.9	3.1	92.7	6.7	3.9	5.4	6.6	5.9	10.3	5.6	27.4	3.5	12.0	19.8	8.0	4.4	15.1	4.3	3.6	18.0	6.3	1.4	2.2	34.5	5.6	12.6	14.2	2.3	3.6	9.0	15.6	3.5	7.6	2.7	13.0	6.7	7.1	13.6	9.0	27.1	12.4	9.0	16.2	27.0	4.6	5.7	41.5	8.4	25.6	2.9	16.3	6.2	23.4	53.8	30.9	44.1	29.0	11.8	7.8	31.5	9.2	16.4	41.7	42.4	79.2	52.7	179.2	311.6	18.9	45.9	29.4	36.4	50.6	145.3	117.8	1.7	21.2	1.8	49.1	113.3	0.0	24.6	36.9	79.9	37.8	30.1	35.8	157.7	286.0	87.9	47.3	100.2	6.0	27.0	213.2	52.3	116.4	24.1	78.6	21.7	48.2	30.1	23.1	99.9	32.3	51.5	12.9	122.1	178.9	191.3	55.4	45.3	59.3
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 85.3;Hepatocytes: 27.0;Horizontal cells: 98.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 5.4;RPMI-8226: 15.3;SCLC-21H: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA					"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	15.3	0.0	0.0	5.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2	0.0	0.0	0.0	0.0	0.5	85.3	7.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	27.0	0.0	98.5	0.0	0.6	1.0	5.7	0.0	0.0	3.3	0.0	0.0	14.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 18.6;brain: 23.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 5.0;Extravillous trophoblasts: 8.3;Rod photoreceptor cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.6;SH-SY5Y: 4.3;THP-1: 3.5;U-937: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced	Supported				NA	NA					"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.8	18.6	5.4	0.9	11.3	0.8	0.8	16.1	23.2	0.8	0.9	3.9	0.0	0.9	0.9	2.6	0.8	3.1	0.8	0.8	7.8	5.5	1.0	0.8	0.8	0.8	4.3	11.5	0.8	0.9	0.8	1.2	1.7	13.6	0.8	0.8	1.4	1.3	1.3	0.8	0.9	0.9	0.9	1.4	0.8	0.8	1.1	0.9	0.0	0.8	0.0	0.8	0.8	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	4.3	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	11.3	16.1	20.7	7.8	5.5	4.3	11.5	13.6	0.9	0.0	0.0	0.0	0.0	0.0	5.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626561-203744081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 153.7;Suprabasal keratinocytes: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.5;fHDF/TERT166: 45.1;SuSa: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	23.0	14.0	24.8	10.8	14.2	5.9	11.6	9.4	23.6	32.6	44.2	7.5	12.9	5.3	69.6	13.1	20.4	27.0	13.9	24.0	13.1	8.7	5.0	14.2	16.1	5.3	6.4	19.2	21.9	6.4	8.0	4.8	16.2	9.3	17.0	13.4	11.6	7.5	31.5	5.4	22.0	13.2	74.2	5.7	4.8	16.4	13.1	7.5	9.0	8.3	8.4	7.7	32.8	14.2	1.0	4.2	4.5	2.2	4.2	10.4	2.6	9.2	1.7	3.4	3.2	26.0	38.8	18.0	41.8	59.5	7.1	6.1	0.8	4.7	2.1	6.1	45.1	9.5	9.0	4.9	5.8	7.5	26.5	1.7	6.2	8.3	0.5	9.3	8.8	11.0	28.1	5.7	22.8	3.5	17.3	13.5	12.3	2.7	4.2	5.2	0.5	8.9	2.9	2.0	1.7	5.2	4.7	2.5	3.3	2.4	0.8	1.0	1.4	14.7	2.2	6.6	49.6	1.9	4.3	11.8	17.3	2.5	29.0	10.0	2.8	4.2	1.1	17.3	6.4	5.1	3.0	2.2	0.0	10.4	1.5	7.9	1.0	6.6	8.3	2.4	0.3	1.6	4.2	4.5	4.2	2.2	4.2	6.3	2.6	24.8	14.2	9.4	23.6	13.1	8.7	6.4	19.2	9.3	7.5	83.4	62.7	10.4	15.6	86.3	2.8	64.1	7.6	34.8	40.9	17.4	2.0	22.3	0.0	31.1	4.3	39.1	3.9	23.3	13.2	13.3	48.3	9.5	9.3	15.7	31.0	111.2	23.0	54.6	14.6	1.3	40.6	13.2	25.3	7.2	1.9	153.7	25.2	11.9	35.7	5.0	6.9	19.4	82.4	22.3	2.1	132.0	21.7	45.7	2.6	43.3
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA		28000	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	18.6	22.9	29.6	14.5	29.4	20.4	36.8	24.5	34.6	22.2	21.6	23.0	14.3	14.4	19.3	18.0	16.9	23.4	16.8	19.2	31.6	32.3	28.0	17.1	30.7	16.0	31.8	25.4	18.5	14.6	47.6	31.0	19.6	26.7	54.0	22.4	18.1	20.3	16.6	16.1	21.3	16.0	19.2	44.6	11.1	18.7	16.0	25.6	20.5	21.7	15.5	15.4	19.3	29.6	4.7	7.6	21.6	7.0	8.7	7.2	4.9	36.6	14.4	14.5	13.9	40.6	32.9	15.6	40.1	53.5	20.2	25.5	23.4	30.3	13.3	27.9	37.9	28.1	43.7	27.2	22.1	29.6	28.7	9.8	35.4	15.3	10.8	25.9	14.1	43.2	25.8	22.3	21.2	24.1	36.9	21.3	16.9	10.2	24.3	24.8	16.3	13.8	11.3	16.4	20.0	15.7	10.0	14.4	20.9	37.2	24.7	22.4	13.4	34.5	10.8	20.2	21.6	16.0	11.6	29.1	21.5	12.0	27.6	18.4	15.7	19.0	19.7	22.2	10.6	17.9	21.6	7.0	12.1	6.3	6.0	5.9	4.7	6.2	5.6	7.6	2.9	4.3	4.3	3.5	8.7	7.0	6.6	7.2	4.9	29.6	29.4	24.5	34.6	31.6	32.3	31.8	25.4	26.7	25.6	35.7	45.2	11.3	32.9	34.9	26.4	27.0	40.8	24.1	23.9	43.6	19.6	13.5	5.0	32.7	12.6	25.1	15.9	0.0	33.1	24.1	29.4	68.4	27.7	24.6	26.6	77.9	34.2	22.7	18.3	14.0	15.0	28.6	20.3	19.8	31.3	22.6	44.4	25.9	13.8	18.6	33.2	6.5	24.2	15.2	14.9	46.2	14.8	13.8	29.3	33.5
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	3.6	0.2	0.4	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.1	0.0	11.4	2.9	0.0	0.0	20.2	0.1	0.5	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4	29.8	42.2	0.0	12.3	0.6	1.4	0.6	2.5	72.3	29.6	0.0	0.0	1.9	0.0	7.2	3.0	0.6	15.4	0.0	2.3	2.2	0.3	21.6	9.2	0.0	0.2	0.0	32.8	0.0	0.0	1.1	0.0	0.7	1.7	0.0	62.9	1.3	3.1	17.3	0.0	1.9	5.6	0.0	0.5	0.7	0.6	1.0	20.1	0.0	69.5	9.5
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting alpha subunit"	P20648	19	35550043-35563658	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 120.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.3;Late spermatids: 15.2"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.2;U-138 MG: 1.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA039154, HPA076684"	Enhanced					NA	NA		790000			"HPA039154: AB_10672772, HPA076684: "	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	0.1	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.6	0.1	0.1	3.4	0.1	0.0	0.1	0.1	4.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	120.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	1.5	0.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.6	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.6	0.0	0.0	0.0	0.0	0.0
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting beta subunit"	P51164	13	113648804-113658186	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 156.3"	"Cell type enriched"	"Detected in single"	6	"Distal tubular cells: 1.7"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 8.9"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.9;RPMI-8226: 1.6;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced					NA	NA					"HPA045400: AB_2679314, HPA052649: AB_2681900"	"unprognostic (9.92e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.66e-1)"	"unprognostic (4.86e-1)"			"unprognostic (6.43e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.78e-2)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.1	2.0	0.1	0.0	0.1	0.1	1.5	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	6.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	156.3	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.9	0.0	1.6	0.0	0.0	2.6	0.9	0.2	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428632-154436516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain					NA	NA		160000			"CAB015218: "	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	29.8	37.8	36.6	20.0	50.3	27.5	22.1	59.2	82.7	28.4	26.5	39.4	27.4	24.0	20.6	43.2	29.1	29.6	23.0	35.1	40.8	47.5	42.4	26.9	37.9	21.8	36.5	40.5	24.4	42.6	67.1	41.5	66.1	60.1	41.6	24.7	29.8	35.9	29.4	18.4	30.2	24.2	22.9	39.4	36.4	27.6	21.2	24.2	22.1	39.7	20.9	21.4	27.3	21.1	20.1	68.4	64.0	56.6	23.7	28.9	33.8	22.6	21.5	18.5	31.3	29.9	16.5	34.6	16.7	23.8	26.1	38.0	20.3	28.3	13.4	70.9	35.9	45.2	24.3	27.1	15.5	14.4	12.2	28.0	7.7	27.7	20.1	37.7	12.4	56.9	22.0	26.6	24.5	14.1	28.5	36.1	10.3	9.2	37.9	17.1	33.1	9.0	18.8	6.9	33.4	22.1	13.9	12.3	34.7	27.6	19.0	18.4	19.2	14.6	59.7	31.4	18.0	26.3	30.6	27.9	19.1	17.2	32.4	27.2	54.7	58.8	15.8	22.7	26.9	19.1	37.4	53.9	64.0	28.6	56.6	28.9	17.5	23.7	24.7	68.4	20.1	21.4	23.5	60.0	23.7	43.4	39.0	26.9	33.8	36.6	50.3	59.2	82.7	40.8	47.5	36.5	40.5	60.1	24.2	35.7	60.5	43.2	34.7	26.9	103.3	32.9	58.6	68.3	39.8	92.5	45.2	127.4	16.6	60.6	1.4	40.9	65.9	0.0	45.6	84.9	39.2	41.1	75.1	34.5	216.4	122.3	85.5	57.1	139.0	4.3	38.3	101.8	69.2	65.9	52.9	70.3	39.9	58.6	40.0	42.5	46.1	64.7	33.5	33.9	5.6	28.7	164.3	38.7	44.1	39.7
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA		21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.6	13.8	8.5	15.2	14.2	12.4	4.9	4.7	8.8	10.1	13.3	8.8	15.0	1.2	8.7	9.7	13.9	14.5	13.0	8.0	11.8	10.3	13.6	10.7	10.4	6.9	8.8	4.6	19.6	9.1	11.6	16.2	6.9	12.6	7.1	5.0	38.9	42.3	15.0	5.7	1.8	4.1	5.4	8.8	0.1	0.1	8.8	18.6	11.7	5.3	23.4	12.4	7.3	6.7	14.0	11.5	16.3	7.0	4.2	8.6	0.3	12.6	5.6	17.2	23.4	2.5	11.5	0.1	10.0	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1	17.9	46.6	27.3	45.1	17.5	158.7	19.5	30.6	6.7	14.8	14.0	276.9	26.4	10.0	14.7	2.4	19.2	44.6	46.7	15.8	13.4	33.9	38.7	23.1	33.6	46.0	90.6	81.5	19.6	33.1	3.1	16.1	25.8	38.8	3.6	23.1	51.9	17.6	38.6	22.3	28.4	349.7	6.5	48.9	38.7	18.5	17.7	83.5	4.4	19.5	10.7
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712318-123761755	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 71.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	13.5	9.4	7.2	13.0	9.9	15.5	11.5	16.2	9.8	8.9	13.1	13.0	9.0	16.0	13.4	8.8	9.1	10.4	10.4	13.6	8.0	7.9	8.9	13.7	13.1	16.6	12.8	6.9	9.7	18.1	8.1	10.4	10.2	9.1	9.8	12.0	9.8	24.5	10.0	13.0	20.5	15.8	12.3	9.4	13.1	15.9	15.9	10.8	24.0	10.3	8.6	17.5	11.0	10.3	2.3	3.4	13.1	1.5	2.1	2.7	0.9	3.3	8.4	8.8	11.8	5.2	5.0	5.4	4.0	4.7	5.2	5.7	6.2	2.7	12.8	2.8	5.4	5.5	7.1	11.4	4.2	3.9	8.7	6.4	18.4	6.7	3.6	8.2	11.7	37.8	4.5	3.7	6.1	6.6	5.2	4.5	10.1	11.1	2.3	5.7	9.2	11.0	14.3	9.2	5.0	5.6	10.6	7.6	4.1	5.0	8.3	5.3	9.0	6.8	4.7	6.0	4.7	4.9	8.5	6.5	6.6	2.5	8.1	6.7	7.6	8.4	11.9	5.5	7.1	5.6	6.4	0.9	13.1	2.1	0.9	1.5	1.3	2.1	1.8	1.1	2.3	1.9	2.7	2.4	2.1	1.5	3.4	1.4	0.9	7.2	9.9	16.2	9.8	8.0	7.9	12.8	6.9	9.1	10.8	6.0	14.1	16.0	6.8	9.0	18.1	7.9	17.8	8.1	9.1	8.7	11.8	4.7	0.0	7.4	7.9	8.9	10.5	0.0	9.5	4.6	8.0	12.1	71.8	9.5	7.4	11.1	12.7	14.1	10.8	3.1	8.1	11.7	1.7	10.0	10.1	12.2	6.7	8.0	8.9	3.7	27.6	6.5	8.9	19.5	11.5	12.4	5.7	13.1	9.9	10.6
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	3.1	1.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	3.0	0.1	0.0	0.0	0.0	35.9	1.2	2.0	0.1	0.0	0.1	0.4	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.3	0.0	1.4	1.2	15.7	2.0	11.7	26.6	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	4.2	0.0	0.0	1.1
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 173.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol		NA	NA			Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.87e-4)"	20.4	35.7	35.4	21.8	35.3	84.2	28.5	29.1	56.4	23.3	28.3	32.2	26.7	19.2	13.9	35.6	21.9	20.0	22.0	24.8	41.2	44.7	47.6	56.3	25.8	28.5	43.6	31.5	12.9	87.0	32.5	36.3	35.0	33.9	27.0	32.0	32.4	34.8	22.2	27.9	20.1	20.2	19.1	34.8	33.2	25.2	15.3	24.8	16.3	38.7	19.5	24.7	23.2	16.5	23.7	58.0	173.6	78.0	8.8	14.2	87.6	23.7	23.2	19.3	24.2	29.7	15.7	23.6	21.4	31.8	41.6	36.0	24.9	26.0	22.1	19.8	22.6	49.4	19.7	45.0	32.2	19.6	20.7	46.9	27.6	40.1	35.8	47.1	42.9	53.7	19.3	42.5	45.8	40.6	26.7	20.0	31.0	27.5	48.5	34.0	25.1	17.7	71.5	31.8	34.5	49.6	25.1	18.5	60.2	43.3	29.3	45.5	22.5	14.4	57.1	53.6	22.8	23.4	77.2	10.1	21.5	18.3	38.7	51.4	39.3	57.7	24.5	29.2	61.2	33.5	31.9	78.0	64.2	13.2	48.1	13.0	23.7	14.2	12.7	48.1	19.1	10.8	10.9	173.6	8.8	44.0	58.0	13.7	87.6	35.4	35.3	29.1	56.4	41.2	44.7	43.6	31.5	33.9	24.8	74.5	137.9	144.5	130.3	298.3	238.3	92.4	122.3	100.4	66.0	268.7	96.2	165.0	170.8	307.8	2.7	147.4	174.0	23.3	286.0	191.3	151.0	308.8	203.1	213.0	743.7	122.3	214.8	101.3	356.6	8.6	73.1	420.3	266.6	357.1	190.7	203.9	311.9	371.7	61.5	175.0	164.2	77.6	135.2	133.6	224.9	313.3	415.2	116.5	165.6	262.4
ATP6V0C	"ATP6C, ATP6L, ATPL, VATL, Vma3"	ENSG00000185883	"ATPase H+ transporting V0 subunit c"	P27449	16	2513870-2520218	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 58.3;Ciliated cells: 45.5;Club cells: 33.0;granulocytes: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065100			Approved	Cytosol		NA	NA			Cytosol		"HPA065100: AB_2685421"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"prognostic favorable (1.07e-6)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.04e-2)"	56.5	68.2	61.2	53.6	83.5	87.2	24.1	76.0	156.7	27.7	42.9	39.2	25.2	55.2	28.0	21.9	48.7	25.6	23.0	32.5	64.3	70.1	78.0	37.3	40.5	37.1	55.4	74.2	27.2	42.7	41.9	52.3	35.1	70.4	35.7	19.5	40.1	54.3	30.3	108.8	38.7	52.8	18.3	41.9	48.3	59.0	30.4	29.4	25.1	25.7	34.7	29.2	20.8	29.6	15.9	28.2	50.6	42.5	13.0	16.1	18.2	29.7	31.9	17.3	24.6	21.9	10.9	41.3	44.1	13.9	18.5	17.8	29.7	38.6	15.0	40.6	21.1	31.7	36.2	18.4	26.2	9.3	38.3	54.8	17.2	25.7	36.3	31.1	27.2	53.0	19.7	19.6	23.4	12.3	18.8	13.2	16.9	40.6	28.8	16.0	58.0	27.4	71.1	33.5	19.6	39.2	44.0	15.0	47.1	32.5	17.7	56.4	45.8	37.1	43.1	35.3	16.1	41.5	34.8	31.5	29.8	35.5	44.8	31.5	53.7	65.5	27.5	26.2	20.1	30.1	22.1	32.6	50.6	14.8	36.3	15.1	15.9	13.4	16.1	20.4	15.4	15.6	13.5	43.7	13.0	42.5	28.2	13.2	18.2	61.2	83.5	76.0	123.3	64.3	70.1	55.4	74.2	70.4	29.4	23.8	58.3	0.5	0.1	0.9	0.5	0.0	0.0	45.5	33.0	1.8	0.0	0.5	0.0	0.5	0.0	0.1	3.2	0.0	0.2	0.7	0.5	0.0	16.3	0.5	0.9	0.0	0.0	1.8	1.8	0.0	0.6	0.7	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.5	0.7	0.0	0.1	0.4	1.0	0.9	1.0	0.7	0.9	0.1
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481237	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hofbauer cells: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA					"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	24.2	41.4	32.0	28.2	58.8	31.0	19.8	41.1	89.9	27.9	36.7	35.3	17.1	30.5	26.8	27.4	33.0	26.3	24.7	27.0	40.4	48.5	34.3	30.6	34.5	29.7	39.6	39.1	17.9	25.7	42.5	40.7	30.1	66.6	23.8	33.0	26.6	23.7	26.3	42.5	30.1	29.6	36.0	24.8	37.0	26.9	40.6	18.9	27.6	35.2	21.3	27.4	26.9	22.0	21.1	53.8	106.5	79.7	16.8	16.0	66.3	18.1	25.9	16.0	20.7	40.9	22.2	15.4	21.7	35.7	44.9	54.1	26.8	19.6	7.6	18.3	31.3	30.2	21.8	23.6	27.2	27.0	9.2	21.7	14.0	15.1	22.3	38.7	13.9	59.0	34.4	27.1	45.3	10.8	16.2	27.9	9.1	15.8	10.1	36.2	43.5	10.3	31.7	15.6	15.9	18.6	18.5	18.8	21.1	27.2	30.4	31.4	14.7	56.7	15.5	23.4	13.5	25.1	21.4	26.8	22.6	9.3	27.7	11.4	17.1	24.1	22.2	31.8	14.9	13.3	29.6	79.7	58.7	16.0	56.9	11.0	21.1	12.0	14.7	53.8	18.9	9.3	11.5	106.5	16.8	51.1	19.3	14.4	66.3	32.0	58.8	41.1	89.9	40.4	48.5	39.6	39.1	66.6	18.9	14.9	47.6	54.7	53.3	65.6	70.5	33.2	56.0	33.5	19.4	64.6	68.7	97.4	154.2	105.3	59.6	41.4	193.6	46.7	97.5	61.6	79.6	47.2	49.6	45.1	351.8	77.9	116.9	45.4	155.0	38.2	54.4	136.8	118.1	170.5	128.1	66.4	83.9	175.4	49.8	124.5	50.6	116.4	56.6	90.0	61.9	76.5	237.2	54.3	73.1	55.8
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154228	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 56.8"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 177.4"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 5.6;SuSa: 9.2;U-87 MG: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA055327: AB_2682784, HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	6.6	0.3	0.2	1.3	0.3	0.8	0.3	0.2	0.2	0.2	1.5	0.0	11.9	0.7	0.2	1.0	0.2	0.2	0.1	0.2	0.3	0.3	56.8	0.3	12.2	1.2	0.5	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.8	2.0	5.7	1.1	1.2	0.2	0.9	1.0	0.0	0.3	0.4	0.3	0.2	0.0	1.0	0.4	0.3	0.6	0.3	0.2	2.2	1.7	4.6	1.0	2.0	1.5	0.3	0.5	1.2	0.6	0.7	0.0	0.5	2.3	0.0	0.0	1.0	0.3	0.3	0.4	0.3	0.2	0.0	1.6	2.5	0.7	1.6	0.4	0.4	0.1	0.8	1.7	0.1	0.0	0.7	1.4	0.6	0.1	0.9	0.7	1.9	0.4	0.3	0.4	0.7	0.5	0.9	0.0	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	1.1	3.4	0.3	0.1	0.8	5.6	9.2	1.8	0.1	0.3	0.6	0.8	0.7	0.5	0.4	0.2	0.6	8.6	0.6	0.7	2.6	1.0	0.8	1.1	0.5	0.8	1.2	1.0	0.9	0.5	2.2	1.5	1.3	4.6	2.0	1.0	1.7	0.9	0.3	0.2	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	7.0	29.5	0.0	177.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.5	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP6V0E1	"ATP6H, ATP6V0E, M9.2"	ENSG00000113732	"ATPase H+ transporting V0 subunit e1"	O15342	5	172983757-173035445	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (2.24e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.25e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.02e-1)"	53.2	54.8	22.3	34.4	26.6	18.1	77.1	9.1	21.5	45.3	50.7	30.6	53.2	28.8	41.8	152.2	53.0	35.6	43.5	70.0	20.0	24.9	90.5	78.6	54.4	68.2	33.3	15.5	49.0	53.1	18.3	65.2	83.1	40.5	48.6	36.3	52.6	59.4	54.6	47.6	34.2	54.1	46.3	34.1	61.3	43.8	34.6	21.9	34.8	91.8	42.2	45.6	56.6	43.5	86.8	90.7	183.9	94.9	50.1	69.0	145.1	31.5	34.5	11.3	34.3	105.0	42.3	26.7	62.1	57.9	31.1	48.3	38.7	49.4	13.7	88.9	72.8	83.5	22.8	22.5	44.2	34.8	94.6	22.3	12.9	35.0	36.5	51.3	24.3	45.4	55.7	54.5	35.7	19.8	38.1	37.3	15.3	8.4	40.5	67.8	62.5	15.1	35.2	13.1	25.1	29.8	16.3	16.2	24.6	61.5	40.4	16.5	11.1	27.3	33.7	48.6	33.0	37.3	34.1	56.0	74.5	16.6	52.9	51.8	35.0	71.7	15.0	40.3	40.8	24.3	157.8	94.9	141.6	59.4	69.5	54.4	86.8	68.3	61.8	61.0	72.9	66.5	69.0	183.9	50.1	65.6	90.7	67.8	145.1	22.3	26.6	9.1	21.5	20.0	24.9	33.3	15.5	40.5	21.9	122.1	195.0	243.7	272.1	260.3	17.2	175.6	267.5	147.2	136.5	492.0	5.9	429.9	275.2	586.3	22.7	294.4	265.3	70.0	319.5	476.4	327.8	370.1	248.2	359.4	643.5	35.0	204.6	243.0	435.2	23.0	316.9	443.2	349.2	1058.6	186.8	258.2	473.5	340.1	315.7	579.4	18.7	239.3	199.8	88.1	109.0	248.7	704.7	265.8	182.5	358.6
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 467.9;Late spermatids: 569.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		2700000	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.4	11.6	14.6	12.7	30.9	13.8	15.6	13.8	21.1	14.5	20.1	21.8	20.5	20.9	32.9	20.1	16.1	16.6	33.0	18.2	19.1	9.5	9.1	18.5	18.0	16.8	25.5	13.6	21.7	18.6	12.6	18.8	13.2	22.6	23.6	10.6	21.1	15.8	21.5	16.7	9.9	6.1	18.3	17.8	14.6	8.6	10.6	23.7	39.8	24.3	28.3	10.4	24.2	16.5	18.1	21.0	25.0	11.0	21.7	13.6	10.1	9.3	8.2	16.6	17.8	19.3	26.6	17.2	15.0	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3	26.8	28.3	28.9	13.2	27.0	92.7	7.9	33.1	14.7	19.4	94.2	39.3	18.1	69.6	25.2	467.9	26.0	24.0	0.0	23.9	18.8	17.8	28.2	10.4	64.4	67.8	95.3	53.6	36.2	95.4	569.6	16.7	67.0	43.9	49.5	25.8	42.1	22.3	24.6	21.5	62.8	37.3	6.5	14.6	25.3	14.3	41.9	36.7	17.1	21.3	21.1
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935868-70965431	"Disease related genes, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 37.9;placenta: 29.0;salivary gland: 106.9"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	12	"monocytes: 1.4;T-cells: 1.0"	"Group enriched"	"Detected in some"	9	"BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3"	"Not detected"	"Not detected"							"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA			"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	0.6	0.0	0.1	0.1	0.1	0.0	4.4	0.8	0.2	12.2	0.1	0.1	6.9	0.1	0.5	0.4	0.5	5.0	0.1	0.3	0.1	0.0	37.9	0.1	2.1	0.1	0.1	0.1	2.0	1.1	0.0	1.7	29.0	0.1	0.6	0.0	7.4	106.9	1.1	0.1	11.8	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.3	0.1	1.6	1.1	0.1	0.2	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.2	0.2	0.4	0.8	1.7	2.0	13.8	0.2	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.8	0.0	12.7	0.4	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.1	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.3	0.9	0.4	31.3	0.0	1.8	0.3	0.0	0.3	0.4	0.1	0.6	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	1.8	0.1	0.8	0.4	0.0	1.4	1.2	0.0	7.9	143.1	41.4	0.0	0.6	0.6	0.0	0.0	0.5	41.7	0.7	0.7	0.0	0.0	10.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.3	0.5	0.0	1.1	0.0	3.4	0.0	0.3	0.4	1.3	0.4	54.2	0.0	0.0	0.6
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197367-20226819	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 116.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 69.7;eosinophil: 47.6;intermediate monocyte: 62.5;myeloid DC: 34.5;neutrophil: 116.0;non-classical monocyte: 54.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 34.5;granulocytes: 116.0;monocytes: 69.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles		NA	NA		240000	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.90e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.25e-2)"	17.1	29.9	31.7	25.8	45.0	14.4	13.2	39.2	72.9	12.2	13.9	15.9	5.5	16.2	10.6	12.2	15.3	10.3	14.8	13.9	33.8	47.8	53.9	18.0	22.8	17.5	46.9	47.1	10.9	12.2	18.8	23.6	18.5	64.2	11.0	16.5	17.3	12.8	10.9	18.2	18.2	21.1	15.0	19.2	20.9	10.7	24.0	12.7	10.3	12.7	9.3	17.5	14.3	12.4	4.9	34.5	116.0	69.7	4.8	7.1	51.1	10.8	18.2	22.7	7.4	31.0	19.2	20.4	24.5	15.7	31.6	32.7	20.5	6.4	19.3	10.0	23.3	32.2	9.3	17.9	16.3	33.7	8.1	12.0	13.4	8.2	15.7	36.4	9.5	28.0	17.1	14.9	19.6	18.1	34.9	19.7	25.8	19.9	18.7	33.7	6.1	27.8	11.3	16.8	16.0	8.0	11.5	29.2	10.0	29.2	17.2	17.6	25.4	11.8	16.0	77.9	19.6	20.9	17.5	20.8	15.9	12.2	26.2	19.5	7.6	10.2	22.7	22.0	22.8	40.3	15.9	69.7	47.6	5.7	62.5	6.2	4.9	5.9	6.1	34.5	4.3	6.1	6.0	116.0	4.8	54.1	8.4	7.1	51.1	31.7	45.0	39.2	69.0	33.8	47.8	46.9	47.1	64.2	12.7	23.8	20.2	30.3	24.8	51.5	100.1	14.0	12.7	12.0	11.4	27.9	96.2	100.2	68.0	38.5	22.5	24.8	23.6	46.7	33.2	46.1	30.0	15.5	21.9	30.6	167.3	179.6	71.4	28.3	171.7	15.9	18.1	165.7	99.5	87.4	19.6	39.2	37.2	20.4	26.5	193.9	117.5	12.9	37.6	83.9	46.7	62.6	104.2	27.7	20.0	18.2
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	17.1	23.1	25.1	16.8	36.7	6.5	15.7	26.2	58.8	13.6	11.1	11.4	7.6	12.1	14.1	10.9	10.6	12.2	13.7	19.0	28.5	28.0	35.0	18.1	12.9	15.9	23.2	33.3	14.4	12.9	21.3	29.2	20.2	45.1	13.2	13.7	11.5	10.4	12.2	11.7	8.5	12.8	14.5	15.0	14.3	12.1	13.0	12.5	10.7	26.9	8.4	15.6	15.5	10.7	10.6	16.3	27.9	24.3	10.0	12.5	10.8	29.1	17.5	9.3	6.9	24.4	15.8	11.5	21.9	21.8	24.6	29.1	12.9	29.6	18.8	25.1	17.4	39.3	11.8	18.3	17.0	35.2	12.3	14.1	18.3	13.3	15.3	26.0	9.8	22.1	15.1	22.2	33.0	15.9	14.8	18.5	12.2	23.3	15.4	27.3	13.2	18.3	7.2	8.1	26.5	17.0	10.6	16.4	14.2	27.5	21.0	11.9	10.2	12.3	11.7	38.3	17.3	24.5	11.6	22.0	14.3	14.5	31.7	15.3	20.2	7.3	17.9	27.7	20.4	13.8	8.4	17.4	20.6	9.1	24.3	10.2	10.6	7.7	8.9	16.3	10.2	9.0	9.7	27.9	10.0	22.1	8.8	12.5	10.8	25.1	36.7	26.2	58.8	28.5	28.0	23.2	33.3	45.1	12.5	29.8	23.7	18.1	27.2	31.0	29.7	39.1	12.7	41.5	18.2	29.6	15.7	32.6	54.7	34.3	128.0	23.1	13.6	23.3	27.3	30.1	23.0	29.4	23.1	15.3	87.3	35.0	15.0	18.4	45.4	117.5	22.5	45.4	18.6	26.2	12.6	31.4	26.9	14.4	17.3	112.2	20.4	19.4	32.5	10.5	20.2	28.7	62.6	17.5	13.4	25.0
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721649-10785110	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8"	"Cell type enhanced"	"Detected in some"	19	"Cytotrophoblasts: 101.4;Distal tubular cells: 38.1;Intestinal endocrine cells: 39.9;Syncytiotrophoblasts: 141.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 40.6;SK-BR-3: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	1.4	0.9	0.4	0.4	0.5	1.1	2.4	0.5	0.8	21.2	0.8	0.6	49.3	0.1	2.1	30.5	6.9	0.8	0.8	0.7	0.8	0.3	13.2	2.0	0.8	0.5	0.4	0.4	0.9	1.1	0.1	8.9	39.0	0.5	1.8	0.7	54.4	41.8	15.1	0.4	36.7	0.7	0.4	0.6	1.3	0.6	0.8	0.4	0.9	1.4	6.0	3.5	0.5	7.2	1.1	0.8	0.6	1.7	0.9	2.2	1.1	0.3	0.4	1.3	1.5	0.0	0.0	40.6	0.6	0.0	0.0	0.0	0.8	1.0	1.0	0.8	0.0	0.6	0.6	0.6	0.0	0.0	0.5	1.5	0.5	0.6	1.4	0.0	0.9	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.4	2.0	0.0	1.2	0.3	1.5	1.0	0.6	0.4	0.8	0.7	3.3	0.0	0.9	1.1	1.3	0.3	14.5	0.4	5.5	1.4	2.1	0.2	0.5	1.0	0.6	0.5	3.5	1.0	0.6	0.6	0.8	0.4	0.3	0.8	0.6	2.2	1.7	1.3	1.1	1.0	1.7	0.5	0.9	1.0	0.5	0.0	0.9	0.8	0.8	0.9	1.1	0.4	0.5	0.5	0.8	0.8	0.3	0.4	0.4	0.5	0.4	0.0	1.6	0.0	4.2	0.3	0.0	1.0	0.0	2.7	2.3	7.0	0.0	101.4	38.1	0.0	0.6	0.1	0.0	0.0	0.2	23.0	0.5	0.6	2.3	0.0	12.0	0.0	39.9	0.0	0.3	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	2.0	141.4	0.0	0.6	0.3
ATP6V1D	"ATP6M, VATD, VMA8"	ENSG00000100554	"ATPase H+ transporting V1 subunit D"	Q9Y5K8	14	67294371-67360265	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031515, HPA057316"	Enhanced		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA031515: AB_10600785, HPA057316: AB_2683409"	"unprognostic (1.10e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.60e-13)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.44e-2)"	18.2	51.9	43.9	13.8	47.7	9.9	15.9	23.6	54.1	13.1	19.9	13.5	20.9	16.2	13.8	30.2	33.6	17.9	14.8	52.6	39.8	45.2	52.0	19.9	14.5	11.8	39.7	44.9	10.4	12.4	21.8	28.8	17.2	39.6	21.4	20.3	10.8	15.7	18.1	31.8	14.7	16.8	16.1	29.4	9.7	17.8	14.0	23.0	14.7	34.1	25.2	15.3	16.6	17.0	14.7	35.0	39.2	34.5	17.9	28.5	23.9	62.0	12.9	26.5	16.6	17.7	18.8	18.7	48.0	22.1	29.4	24.6	14.8	21.9	5.1	20.1	28.7	28.2	23.4	14.4	22.4	39.8	22.1	9.9	5.4	17.9	12.0	32.5	5.3	19.8	13.5	16.4	20.6	15.6	32.5	18.4	13.6	11.9	15.7	42.2	15.0	15.4	12.0	19.1	22.6	15.5	12.0	22.0	8.1	39.1	24.6	33.2	14.6	30.9	20.1	41.3	25.0	28.5	15.7	29.6	44.2	32.3	21.1	30.7	16.8	12.1	7.2	44.2	10.8	24.5	32.2	34.5	37.3	18.6	33.6	15.7	14.7	20.1	20.0	35.0	14.5	15.1	16.8	39.2	17.9	33.3	26.7	28.5	23.9	43.9	47.7	23.6	54.1	39.8	45.2	39.7	44.9	39.6	23.0	50.6	50.0	34.2	59.3	85.5	56.9	137.6	43.3	182.0	63.7	78.5	51.1	84.1	310.0	120.5	149.9	33.7	68.6	93.5	42.7	73.5	53.9	61.4	40.4	40.0	114.2	82.6	52.2	20.3	37.5	68.5	30.5	59.4	75.9	57.7	39.8	86.6	96.8	63.1	47.7	271.8	92.4	12.9	27.8	77.2	60.9	120.9	172.2	35.9	33.7	102.9
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628818	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 391.3;Syncytiotrophoblasts: 400.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		61000	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	32.8	45.9	59.5	20.4	69.0	24.9	31.5	48.9	90.3	30.2	26.7	34.5	25.2	17.6	27.7	44.4	37.5	26.7	26.7	67.4	58.9	55.4	71.7	26.1	31.7	24.5	54.5	52.3	27.0	15.8	48.3	29.6	46.2	69.8	31.1	32.0	24.1	21.5	42.1	48.5	26.9	19.1	38.1	53.7	23.9	23.8	20.2	32.4	17.5	31.9	26.1	32.5	32.1	22.0	24.2	26.3	55.3	34.8	22.6	29.4	30.1	21.7	19.8	18.0	17.4	59.9	32.4	19.7	29.1	38.8	37.0	43.0	24.6	18.0	13.6	25.0	38.8	47.5	34.5	28.0	25.5	33.1	26.1	31.7	24.5	19.8	32.9	87.7	28.2	42.5	40.6	50.1	35.7	26.1	41.6	31.2	17.4	30.6	28.0	63.0	22.6	24.4	20.5	13.1	48.7	28.0	14.3	26.2	8.1	61.4	34.5	13.2	23.0	26.6	18.9	62.6	36.7	18.3	32.7	26.6	26.1	13.8	32.5	21.5	27.4	48.1	17.3	42.0	13.8	35.0	45.2	32.9	55.3	21.4	30.8	20.8	24.2	21.9	20.5	26.3	19.0	20.8	21.5	44.3	22.6	34.8	25.4	29.4	30.1	59.5	69.0	48.9	90.3	58.9	55.4	54.5	52.3	69.8	32.4	71.5	74.4	66.3	65.8	37.3	53.1	103.3	86.6	80.3	53.4	130.9	25.5	202.2	391.3	124.1	6.9	68.0	66.0	23.3	104.7	118.4	63.5	55.0	86.8	40.9	161.1	50.9	40.3	70.0	71.1	12.5	87.2	106.2	75.9	170.5	45.1	93.9	121.5	73.7	91.9	264.4	32.5	58.2	83.4	71.0	67.3	45.0	400.7	65.0	28.6	80.6
ATP6V1E2	"ATP6E1, ATP6EL2, ATP6V1EL2, MGC9341, VMA4"	ENSG00000250565	"ATPase H+ transporting V1 subunit E2"	Q96A05	2	46490750-46542557	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 240.2;Late spermatids: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 19.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075092	Enhanced					NA	NA					"HPA075092: "	"unprognostic (1.62e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.31e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.32e-2)"	3.4	3.1	6.2	2.7	5.7	1.9	4.0	1.9	7.7	2.7	2.2	5.0	7.0	1.3	2.4	11.4	1.9	2.5	2.3	2.5	4.3	3.5	3.0	2.7	2.4	3.1	4.4	2.9	3.2	9.0	3.0	4.1	2.3	5.1	3.6	1.7	0.8	6.8	6.0	5.6	4.0	2.0	2.4	4.6	3.1	2.5	28.4	4.4	1.6	2.9	0.6	3.1	2.8	4.6	2.8	4.3	1.1	2.1	0.5	4.3	1.1	8.3	5.2	1.8	4.2	1.7	3.2	0.9	3.0	1.1	1.3	0.7	1.6	1.4	5.0	5.4	2.7	4.2	2.0	4.1	2.0	2.9	7.7	3.6	1.2	0.9	1.2	2.0	2.1	2.5	2.7	19.1	1.8	4.1	1.5	1.3	5.3	3.6	8.8	0.9	5.3	1.4	6.3	3.7	4.2	4.6	3.5	4.4	6.1	2.6	1.8	4.9	10.5	1.9	2.0	4.0	3.2	1.3	1.0	1.2	1.4	5.3	2.5	2.0	4.5	3.5	5.2	2.1	6.5	2.3	0.0	2.1	0.4	2.2	1.0	3.0	2.1	4.0	4.2	1.7	2.8	2.9	4.3	1.1	0.5	1.1	4.3	2.4	1.1	6.2	5.7	1.9	7.7	4.3	3.5	4.4	2.9	5.1	4.4	3.0	0.3	7.5	8.4	5.0	11.9	5.2	2.5	5.3	3.4	3.5	11.8	2.4	8.3	2.7	240.2	2.2	0.4	0.0	2.9	1.9	3.3	4.4	0.0	2.4	1.9	17.5	3.4	3.1	7.3	150.8	9.2	5.6	5.0	5.4	1.2	16.0	3.0	0.0	6.3	3.7	25.0	6.5	4.1	2.7	5.1	7.0	0.7	4.4	1.8	3.9
ATP6V1F	"ATP6S14, VATF, Vma7"	ENSG00000128524	"ATPase H+ transporting V1 subunit F"	Q16864	7	128862826-128865844	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 1024.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009529, HPA048700, HPA062011"	Supported					NA	NA					"CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.28e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.33e-2)"	42.2	44.3	72.8	35.3	66.6	62.7	30.4	49.2	82.8	31.5	26.8	29.2	30.3	26.0	22.6	22.8	62.7	35.7	36.0	38.3	63.0	63.9	65.6	26.0	38.9	42.3	60.7	56.9	27.0	37.2	21.1	33.3	49.6	43.5	27.8	20.3	30.1	44.8	31.3	53.1	44.0	25.3	25.0	43.3	36.8	29.5	41.9	29.8	32.5	31.5	39.2	35.0	39.1	31.3	47.7	73.5	67.4	101.2	32.3	43.9	105.3	44.0	51.0	22.9	48.4	46.0	36.6	13.1	22.5	30.0	37.3	40.6	37.5	26.7	41.8	23.9	25.7	56.3	24.4	33.4	37.2	14.0	45.2	54.4	32.0	33.3	36.5	53.3	32.6	61.0	42.8	51.0	43.0	25.0	28.9	35.4	38.7	75.9	44.7	41.2	58.2	54.4	71.4	30.4	27.9	41.9	24.4	16.6	67.7	46.5	35.0	43.4	29.9	31.8	119.8	52.9	24.9	27.6	41.7	37.4	46.4	10.0	61.9	34.4	50.8	45.4	52.9	91.7	46.0	39.3	44.8	101.2	67.4	37.8	66.4	36.2	47.7	38.4	36.3	73.5	47.0	37.2	37.4	29.7	32.3	44.0	41.6	43.9	105.3	72.8	66.6	49.2	82.8	63.0	63.9	60.7	56.9	43.5	29.8	26.8	64.5	166.3	164.2	211.0	100.0	143.6	150.3	76.3	53.4	314.0	35.3	152.3	893.6	205.5	442.7	189.8	97.4	0.0	194.5	171.0	184.8	188.9	270.0	99.0	1024.3	514.9	108.7	105.0	280.3	674.3	152.1	338.9	241.3	249.7	87.7	129.3	222.3	82.7	120.2	704.9	64.1	84.1	184.9	202.1	98.8	285.6	335.7	137.1	88.4	298.2
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	18.2	17.6	36.2	8.8	30.1	21.8	33.6	28.5	22.6	23.6	17.0	23.6	22.0	17.7	24.9	20.3	44.1	41.4	27.0	21.5	19.9	14.0	18.6	17.0	22.3	34.2	42.1	37.8	31.5	27.9	57.9	18.9	23.6	24.8	22.3	28.7	32.5	37.6	32.2	39.6	36.4	23.9	42.8	52.2	33.2	35.4	23.2	28.3	48.4	31.4	27.3	34.9	38.4	67.2	101.2	36.5	54.4	44.9	29.7	19.3	15.3	30.0	31.9	50.7	99.4	30.9	24.8	22.7	26.4	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6	148.9	142.4	298.6	409.4	461.0	169.7	124.8	155.4	207.5	149.0	314.0	39.3	304.8	822.3	322.2	78.2	218.7	155.2	93.5	229.3	273.5	294.0	644.3	261.0	292.4	487.8	155.7	346.4	198.9	353.7	42.3	283.3	376.1	469.0	820.6	271.3	242.1	355.1	164.9	235.8	828.3	125.3	232.8	269.9	334.2	301.9	504.0	633.4	276.3	162.4	656.9
ATP6V1G2	"ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10"	ENSG00000213760	"ATPase H+ transporting V1 subunit G2"	O95670	6	31544462-31548427	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"brain: 91.9"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 76.0;Horizontal cells: 28.6;Muller glia cells: 16.3"	"Cancer enriched"	"Detected in many"	11	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;JURKAT: 4.7;Karpas-707: 7.1"									"CAB004616, HPA068667"	Enhanced					NA	NA					"CAB004616: AB_667829, HPA068667: "	"unprognostic (9.95e-2)"	"unprognostic (8.75e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.11e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.41e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.02e-1)"	2.8	3.3	41.8	3.5	25.7	1.8	1.6	91.9	53.3	1.8	2.3	8.1	0.0	1.5	2.5	2.4	2.2	1.8	1.9	2.9	39.4	27.1	2.6	1.6	2.0	4.7	26.6	29.5	3.1	2.1	2.9	1.2	1.7	43.7	2.6	2.0	2.0	2.0	3.3	4.3	2.0	2.7	2.1	16.3	3.4	1.9	2.7	6.4	0.0	2.3	0.0	4.8	1.7	0.2	0.7	0.7	0.0	0.1	0.8	1.5	0.1	0.2	1.7	3.1	1.5	1.3	1.7	0.0	0.6	0.0	0.0	0.2	0.0	0.9	1.7	0.7	0.6	0.4	1.4	0.1	0.6	0.1	6.4	0.0	0.5	0.0	0.9	0.2	0.7	0.6	1.3	0.8	0.5	0.3	2.3	0.5	4.7	0.7	7.1	0.8	0.2	3.3	1.1	0.0	0.2	0.5	0.8	0.0	0.7	0.0	0.0	2.8	3.8	0.0	0.0	0.0	0.8	2.0	0.3	1.6	1.9	0.3	0.1	0.0	0.7	1.5	2.4	0.7	0.7	1.4	0.0	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.8	0.7	0.7	1.2	1.5	0.0	0.8	0.0	0.0	1.1	0.1	41.8	25.7	91.9	53.3	39.4	27.1	26.6	29.5	43.7	6.4	0.0	0.3	0.0	0.5	0.3	76.0	2.0	0.0	0.0	0.0	1.8	13.7	0.1	8.3	0.2	0.0	0.5	0.2	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.5	28.6	13.7	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.2	16.3	0.1	0.0	2.1	5.0	9.5	0.0	3.1	0.0	0.7	0.1	0.1	1.9	0.0	0.1
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"ductus deferens: 16.9;kidney: 33.4"	"Cell type enriched"	"Detected in some"	43	"Distal tubular cells: 376.4"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028701	Enhanced					NA	NA					"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	1.8	1.3	0.4	0.0	0.0	0.0	0.6	6.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	376.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715557-53843558	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		48000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	14.1	25.1	42.2	9.7	41.5	14.0	15.8	22.5	46.2	14.6	12.1	12.0	10.5	8.3	13.7	19.3	18.1	13.1	11.6	17.2	39.0	25.5	36.6	11.3	13.8	11.1	21.4	30.0	15.0	11.7	27.0	20.0	14.0	30.0	19.6	12.0	12.7	16.4	18.2	17.3	14.4	8.3	14.6	14.7	10.2	13.3	10.8	11.3	15.3	30.0	11.5	12.3	15.3	11.0	12.0	16.3	30.6	17.0	18.8	17.7	9.3	19.2	13.5	12.3	13.3	21.9	14.0	10.5	21.4	19.2	24.6	24.8	12.5	22.3	12.2	20.1	17.2	33.6	30.2	20.3	26.5	21.7	19.1	16.5	13.4	14.1	15.2	31.8	8.6	15.0	20.9	32.9	16.8	26.3	23.1	16.4	14.0	16.9	6.0	31.2	13.4	13.5	13.6	12.1	15.8	8.0	11.7	5.0	7.7	34.8	25.8	9.9	16.4	12.3	22.1	33.3	14.4	28.1	7.3	19.1	10.9	10.0	26.0	11.6	12.8	12.8	14.2	26.3	11.7	11.8	19.0	11.5	30.6	11.5	13.0	13.1	12.0	14.2	13.7	16.3	10.8	13.8	14.3	13.8	18.8	17.0	13.4	17.7	9.3	42.2	41.5	22.5	46.2	39.0	25.5	21.4	30.0	30.0	11.3	35.7	20.6	45.5	34.9	26.3	65.4	25.0	28.1	28.1	37.5	55.8	106.0	58.8	89.5	44.6	6.6	20.4	29.0	0.0	27.2	36.4	26.2	27.6	15.1	20.3	58.3	58.8	33.9	30.7	34.6	6.2	40.0	49.3	28.7	37.9	16.0	52.6	36.9	27.5	45.3	44.2	68.3	19.4	20.3	15.0	47.2	27.5	83.6	39.2	19.6	31.1
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA		20000	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.3	17.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	28.1	8.0	0.1	0.0	1.4	4.0	0.0	0.0	4.4	2.8	9.9	1.0	0.4	0.0	2.4	0.2	0.3	0.0	0.0	0.0	0.3	0.1	6.3	0.0	3.2	0.0	1.2	3.5	0.8	1.3	1.1	0.3	9.7	0.0	3.1	6.1	0.3	3.1	9.3	0.2	5.9	0.0	0.7	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.7	0.4	3.4	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9	26.8	61.4	5.1	1.7	1.3	17.7	12.8	0.0	0.0	9.1	5.2	76.6	0.0	3.3	0.0	3.0	9.3	46.1	0.0	2.2	0.1	2.2	16.2	8.1	1.1	1.5	58.8	81.2	17.8	7.5	2.3	3.1	3.8	3.3	1.8	23.3	1.0	0.8	7.0	1.8	1.4	41.3	0.0	0.3	1.1	4.1	1.3	0.0	21.8	23.1	2.4
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5"	"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.2	3.5	0.1	0.1	3.6	6.6	5.0	19.9	19.4	21.0	13.1	2.6	8.9	0.7	6.0	27.5	8.3	15.2	0.1	4.2	24.7	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.8	6.3	11.1	15.5	11.0	0.2	0.1	0.4	12.1	4.9	0.2	0.2	0.2	11.0	1.0	0.1	0.1	0.2	2.9	58.5	0.4	0.3	0.4	12.3	0.1	0.5	3.8	0.6	12.6	17.1	0.6	2.7	4.6	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3											17.9	18.2	4.5	44.8	6.9	0.7	4.0	33.1	40.2	48.9	38.4	0.0	17.1	0.0	20.8	2.0	26.8	198.4	0.0	45.9	1.9	5.1	74.4	4.6	16.8	2.3	6.4	65.7	30.1	3.8	0.0	0.3	1.3	6.8	1.0	179.9	0.2	33.7	74.8	0.0	0.1	1.1	12.9	17.6	0.3	1.2	14.3	9.2	1.5	138.5	100.6
ATP8B2	"ATPID, KIAA1137"	ENSG00000143515	"ATPase phospholipid transporting 8B2"	P98198	1	154325553-154351307	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 12.3;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046680	Approved					NA	NA					"HPA046680: AB_2679749"	"unprognostic (1.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.40e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.52e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.77e-3)"	"unprognostic (6.58e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (5.29e-5)"	13.6	7.0	5.5	15.0	7.1	3.4	11.9	26.8	8.9	29.1	11.2	7.4	11.5	8.6	28.9	15.2	14.4	21.5	18.4	11.7	7.0	6.8	6.6	2.6	12.2	16.1	6.2	5.8	27.5	5.3	5.1	13.9	10.9	6.1	15.3	6.8	12.5	5.4	16.4	4.3	6.1	11.8	29.4	5.1	14.7	11.4	12.7	5.1	18.9	11.2	8.1	13.6	20.5	24.9	0.6	0.7	3.1	0.0	0.9	6.5	1.0	0.7	5.1	6.5	6.7	41.8	28.3	0.1	15.7	26.2	9.1	10.9	0.1	0.2	0.6	8.3	37.9	6.0	3.2	7.8	1.8	6.4	17.2	6.3	6.5	6.3	5.9	12.7	0.0	5.1	18.2	0.4	13.8	13.2	12.0	14.0	8.3	12.9	15.8	7.7	6.7	12.2	0.8	15.5	0.1	6.5	13.6	4.5	23.4	1.7	0.1	5.8	8.0	4.1	0.9	9.8	9.7	4.8	4.9	12.2	13.8	7.0	17.3	4.7	21.9	26.8	3.9	4.8	0.7	8.4	3.1	0.0	3.0	2.2	0.0	1.5	0.6	3.5	3.7	0.0	0.4	2.9	2.5	0.1	0.9	0.0	0.7	6.5	1.0	5.5	7.1	26.8	8.9	7.0	6.8	6.2	5.8	6.1	5.1	3.0	5.0	2.2	1.5	2.3	0.7	5.1	0.0	6.7	3.4	0.0	2.0	0.1	0.0	1.2	0.4	8.4	0.0	0.0	0.2	0.4	8.1	4.3	7.0	0.9	0.4	7.9	0.0	12.3	1.0	0.4	10.6	0.0	6.8	0.0	0.0	2.6	1.4	0.0	13.8	0.1	0.4	0.0	6.2	2.6	3.6	1.4	0.2	8.2	0.0	0.4
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	55.1	52.0	14.4	72.3	64.2	19.5	33.5	26.8	30.8	31.9	41.1	41.9	40.5	32.3	122.4	43.4	42.5	55.9	36.0	56.3	26.7	15.9	53.7	20.4	41.2	36.0	31.5	33.1	44.2	26.0	48.9	31.1	36.6	33.6	39.0	19.1	27.6	58.9	35.7	57.7	21.2	45.1	16.5	74.8	53.8	23.2	16.1	72.4	50.0	60.5	18.9	26.8	12.0	59.6	40.2	23.7	21.8	37.4	40.7	28.1	27.7	38.0	53.7	60.5	116.6	42.9	54.8	44.9	24.6	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1	104.2	111.8	94.7	188.6	125.9	40.7	56.9	135.0	112.4	95.5	122.1	43.2	414.9	31.5	221.9	4.3	139.7	190.7	23.3	182.9	352.4	105.7	160.9	92.5	177.7	341.5	30.2	99.2	204.4	127.2	16.4	97.5	153.8	151.8	150.5	117.5	122.3	207.2	171.9	93.0	136.1	33.7	155.2	85.4	143.9	179.9	114.0	450.0	97.8	147.8	228.6
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 156.0;intestine: 203.6"	"Cell type enriched"	"Detected in some"	19	"Erythroid cells: 11890.7"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1207	"HEL: 169.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		7800000000			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	1.8	0.4	0.5	11.5	0.5	156.0	0.4	0.3	0.4	0.3	95.4	1.5	0.0	0.0	0.3	0.0	0.6	0.7	0.0	17.6	0.5	0.4	0.8	2.9	32.2	0.2	0.9	0.0	0.8	0.5	0.0	1.0	24.0	0.6	1.1	203.6	2.6	0.3	0.1	3.1	0.2	0.4	3.2	0.5	14.3	0.3	0.3	0.0	0.2	7.5	0.0	0.2	4.5	16.0	0.7	0.7	0.0	0.3	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.5	0.5	0.5	0.3	0.4	0.5	0.4	0.9	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	624.8	11890.7	0.0	0.0	0.0	0.1	23.0	0.6	0.0	0.0	44.0	1.3	1.6	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.0	422.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0
CA12	HsT18816	ENSG00000074410	"Carbonic anhydrase 12"	O43570	15	63321378-63382161	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.5"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 155.1;Enterocytes: 240.0;Paneth cells: 157.9;Suprabasal keratinocytes: 220.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 109.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 39.0;ASC TERT1: 41.1;RT4: 41.3;SK-BR-3: 33.1;T-47d: 53.4;U-138 MG: 57.0;U-87 MG: 68.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008773, CAB025181, CAB062549, CAB068179"	Enhanced					NA	NA		29000			"CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394"	"unprognostic (2.01e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.47e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-1)"	3.7	0.3	4.7	15.0	27.4	0.3	14.5	3.7	2.3	15.7	32.0	2.6	5.0	0.4	9.8	12.3	42.8	8.5	2.6	1.6	4.9	1.4	103.5	0.3	1.2	0.3	1.8	0.2	2.1	43.8	0.3	3.9	5.9	16.9	3.8	30.3	8.5	8.2	17.9	0.5	44.1	2.4	18.1	0.1	0.4	2.2	1.3	6.7	0.0	1.7	18.4	25.9	10.6	14.5	0.3	0.2	0.6	0.7	0.3	0.2	0.0	0.0	39.0	0.6	0.1	5.2	41.1	2.1	2.8	2.5	0.4	0.7	0.2	0.1	0.0	9.6	2.3	15.4	0.2	0.0	1.9	1.1	0.0	1.4	0.0	2.6	0.0	0.1	0.0	0.0	15.5	2.1	11.9	3.8	0.0	0.5	0.0	0.0	0.0	0.5	22.4	0.0	0.0	0.6	0.0	6.1	0.0	0.0	0.0	0.0	41.3	0.3	0.0	0.1	33.1	0.0	0.4	53.4	0.0	0.0	57.0	3.0	1.8	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.7	0.2	0.1	0.0	4.7	27.4	3.7	1.3	4.9	1.4	1.8	0.2	16.9	6.7	0.0	5.8	1.5	18.6	155.1	0.0	0.6	0.0	2.7	3.4	38.4	0.0	0.4	46.4	14.9	12.0	0.0	240.0	0.0	48.3	1.7	5.1	14.8	1.1	0.0	0.6	0.0	8.1	0.0	0.0	3.0	0.0	2.2	21.9	0.0	92.2	2.5	15.0	157.9	0.0	59.0	0.2	0.0	3.9	0.0	0.0	220.4	1.5	0.0	95.7	16.3
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.7"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.5;OE19: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA		100000	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	2.6	2.6	2.0	1.9	3.1	0.5	2.9	2.4	2.4	3.2	18.2	0.8	0.0	14.2	1.8	1.7	6.7	1.4	25.6	5.8	1.6	1.9	10.4	17.1	9.5	2.4	2.0	0.1	2.2	1.6	9.3	6.5	1.0	5.7	2.6	3.7	1.9	7.0	1.0	1.9	7.1	56.7	1.9	5.2	2.2	7.0	0.9	0.9	0.4	10.3	3.9	5.6	2.9	5.2	0.8	2.1	3.2	2.5	0.5	0.5	1.0	0.2	0.3	0.7	0.1	0.5	0.5	0.3	0.8	0.9	0.1	2.4	5.8	4.5	0.3	0.4	1.0	5.1	1.9	1.8	2.3	0.1	1.3	0.8	12.5	1.6	5.3	1.2	0.2	0.5	1.9	0.4	0.2	1.0	1.5	1.3	0.5	3.1	2.4	2.1	0.0	0.2	0.2	0.3	24.6	0.3	0.2	1.8	0.1	6.7	0.2	0.2	0.0	0.4	0.0	1.3	0.9	0.4	0.6	1.2	2.3	3.3	0.1	1.3	1.0	0.4	1.5	4.8	1.8	2.2	3.2	2.5	1.3	0.4	0.7	0.2	0.2	0.2	0.1	2.1	0.8	0.3	0.5	0.9	0.5	0.8	0.9	0.1	1.0	2.0	3.1	2.4	2.4	1.6	1.9	2.0	0.1	5.7	0.9	3.0	7.7	1.4	2.1	1.5	1.5	5.2	5.1	10.7	12.5	12.2	31.4	0.2	8.3	3.2	9.1	2.1	16.9	0.0	1.4	0.2	3.1	2.1	0.0	4.7	0.9	0.0	4.6	9.8	3.0	10.4	0.0	2.2	5.0	0.0	3.2	2.0	3.1	4.9	0.0	16.1	5.1	0.0	1.0	1.2	2.3	2.8	0.2	1.0	3.4	1.8
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	16	"Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.7	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	22.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.1	57.1	4.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7	3.0	0.3	0.0	0.2	1.9	1.4	44.5	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	50.6	0.0	0.0	123.0	1.2	0.0	3.2	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.4
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463852-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"Disease mutation, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.1;stomach 1: 171.5"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 870.3;Erythroid cells: 2055.8;Muller glia cells: 1176.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 33.8;HEK 293: 142.4;THP-1: 59.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001550, CAB010102"	Enhanced					NA	Yes		790000000			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (6.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.57e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.49e-3)"	1.6	2.2	24.4	21.5	32.6	32.4	6.9	4.3	23.2	1.3	108.1	28.9	42.0	46.9	0.9	2.2	5.6	0.9	33.0	4.3	29.1	14.5	53.5	43.0	10.2	1.3	49.0	14.2	0.5	9.1	3.1	2.0	3.5	65.0	0.8	105.6	7.0	14.0	54.2	9.2	13.3	7.6	6.0	27.5	2.5	171.5	5.1	58.3	0.0	3.8	2.4	1.1	1.0	1.4	1.9	8.0	20.3	8.2	0.0	4.4	17.5	0.5	0.3	1.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	2.0	0.1	0.0	1.2	0.0	0.0	33.8	4.9	1.7	0.0	0.0	142.4	4.4	2.5	0.0	0.0	3.1	0.6	0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.4	11.2	0.0	2.7	0.1	0.0	0.5	1.1	0.0	0.0	0.7	0.0	0.0	1.3	0.0	59.7	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	20.3	3.1	4.4	0.1	8.2	4.4	0.6	0.0	0.4	8.0	1.9	0.0	0.0	6.8	0.0	7.1	0.8	0.0	17.5	24.4	32.6	4.3	23.2	29.1	14.5	49.0	14.2	65.0	58.3	14.9	56.8	27.3	1.0	80.5	23.5	18.5	400.0	0.0	1.2	153.5	60.9	10.7	295.1	50.5	65.5	14.6	870.3	2055.8	9.9	311.4	6.4	1.1	16.1	101.2	34.8	12.7	29.2	1.8	8.2	179.8	3.1	46.0	70.9	1.0	94.2	1176.2	10.3	374.2	2.1	304.9	61.5	0.0	7.3	1.7	2.3	97.6	14.3	5.7	229.3	0.3
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"skeletal muscle: 347.5"	"Cell type enriched"	"Detected in some"	14	"Erythroid cells: 280.4"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"HEL: 23.8;RH-30: 40.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004967, HPA021775, HPA026700"	Enhanced					NA	NA		31000000			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favorable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	18.0	0.4	0.2	0.1	0.2	0.5	0.6	0.2	0.1	0.5	0.3	0.0	0.1	0.1	0.6	29.0	9.5	1.0	0.2	1.3	0.2	0.1	0.2	0.2	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	6.6	0.0	0.0	5.5	0.2	347.5	0.3	0.4	1.4	0.1	0.1	0.3	0.5	0.0	0.0	0.3	14.1	3.4	0.7	0.5	0.5	1.8	0.0	0.0	0.0	0.8	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	23.8	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	40.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	3.0	3.4	0.0	0.9	0.5	0.0	0.8	7.6	0.0	0.0	0.0	5.9	0.6	0.0	0.7	20.2	0.0	0.7	280.4	0.2	0.0	0.6	0.5	0.0	0.0	0.4	0.0	0.0	1.8	0.3	4.7	0.3	0.0	0.0	0.0	0.3	16.0	0.2	1.7	0.0	0.5	1.4	0.0	0.1	0.5	0.9	0.9	1.4	0.0	0.6	0.3
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149936-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.7"	"Cell type enriched"	"Detected in many"	43	"Paneth cells: 2128.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 50.1"	"Cell type enriched"	"Detected in some"	7	"neutrophil: 37.0"	"Lineage enriched"	"Detected in single"	370	"granulocytes: 37.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.5;NTERA-2: 3.4;OE19: 3.9;RPTEC TERT1: 1.9;SuSa: 2.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 336.9"	"Low region specificity"	"Detected in many"			"HPA011089, HPA017258"	Enhanced					NA	NA		190000			"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	32.2	0.9	3.4	9.8	4.4	5.7	46.4	50.1	11.8	2.3	81.7	2.0	31.5	1.4	2.3	17.4	0.9	1.7	12.2	8.8	4.7	2.6	12.0	0.3	33.3	2.4	3.5	5.2	1.9	9.5	3.3	5.1	3.2	3.0	2.4	54.9	20.3	4.8	24.0	10.0	1.0	3.2	1.1	2.1	4.9	2.5	1.2	0.3	0.2	23.1	5.0	0.2	1.7	7.9	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.3	0.0	0.0	0.3	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	3.9	0.0	0.0	0.2	1.3	1.9	0.0	0.7	0.3	0.2	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.7	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	50.1	11.8	4.7	2.6	3.5	5.2	3.0	0.3	0.0	3.7	0.0	0.2	1.3	0.0	9.2	0.0	1.4	1.2	14.0	0.0	0.0	28.2	3.1	0.2	15.8	49.7	0.0	0.2	0.0	1.5	0.1	11.5	0.0	0.5	0.0	18.6	1.8	0.0	0.0	0.6	0.8	0.0	0.0	27.9	0.0	0.1	2128.8	0.0	18.6	0.0	6.5	17.9	0.0	0.0	1.0	0.0	0.0	32.8	0.3
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936529	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 26.4"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in single"	26	"liver cancer: 2.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.91e-1)"	"unprognostic (8.64e-3)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.76e-2)"	0.0	0.0	0.3	0.8	0.4	2.7	0.0	0.1	0.7	0.0	0.0			0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	26.4	0.2	0.3	0.4		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.0	0.0	0.3	0.7	0.1	0.0	0.3	0.8	0.0	0.3			0.1		0.0	0.0	0.0	1.9	1.6	4.7	1.1	1.9	1.1	0.4	0.2	0.3	0.3	0.7	0.1	0.0	0.5	0.4	0.1	0.0	0.1	0.5	0.6	0.6	0.2	0.2	0.3	0.6	0.2	0.3	0.1	0.4	0.3	0.4	1.1	6.8	0.0	0.4	1.7	0.8	0.0	0.2	0.4	0.5	0.3	0.5	0.4	1.6	0.1	0.5	0.2	1.0	0.5	0.3	0.6	0.4	0.4	0.2	0.2	0.6	0.4	0.2	0.2	0.3	0.1	0.5	0.6	0.3	0.4	0.8	0.2	0.5	0.3	0.7	0.4	0.4	0.6	0.9	0.4	4.1	1.1	1.0	0.8	0.7	0.8	0.9	0.8	0.6	0.3	1.9	1.1	1.1	4.7	1.9	0.7	1.6	0.5	0.4											0.0	4.3	0.0	2.5	0.3	1.7	1.4	0.0	2.7	2.3	1.8	3.9	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	1.4	5.8	35.0	0.1	3.2	0.0	1.3	0.6	0.8	0.3	1.9	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.3	0.6	0.3	0.2	0.0	0.0	1.3
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788409	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.7;fHDF/TERT166: 17.9;hTERT-HME1: 23.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012618	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	9.3	4.6	10.6	4.9	11.1	4.1	10.2	3.1	7.8	28.7	3.6	11.5	1.4	2.2	9.8	3.7	8.1	9.5	9.1	6.5	9.9	8.2	10.3	7.8	7.3	8.8	12.2	6.7	15.2	4.4	16.8	4.4	3.9	13.1	6.2	4.7	29.5	8.3	6.2	2.0	7.5	4.1	9.4	7.1	5.3	5.4	23.0	8.1	2.3	8.9	10.9	11.6	6.3	9.4	4.3	3.5	2.7	3.6	7.9	13.3	7.0	2.7	1.7	2.0	3.2	5.9	15.7	1.1	2.9	3.7	2.2	3.2	0.8	1.9	0.8	3.1	17.9	4.2	3.0	6.9	3.3	3.9	0.7	3.3	1.5	2.1	0.7	5.8	1.9	3.4	3.6	3.6	2.9	23.5	3.9	3.2	2.3	0.8	2.1	10.3	1.5	1.6	1.5	0.8	0.5	12.5	0.9	1.4	1.4	3.3	2.0	1.7	3.7	4.1	1.5	2.6	2.4	2.1	1.9	4.3	2.6	1.7	13.9	1.6	1.5	1.5	0.9	2.9	3.9	4.8	2.7	3.0	0.3	13.1	3.6	11.4	3.6	13.3	12.3	3.5	4.3	9.8	8.3	1.7	7.9	2.3	0.5	10.0	7.0	10.6	11.1	3.1	7.8	9.9	8.2	12.2	6.7	13.1	8.1	0.0	9.3	7.2	5.3	3.8	8.9	1.6	0.0	17.4	10.3	1.8	15.7	1.4	1.7	3.6	0.9	10.7	0.5	23.3	3.5	1.2	7.2	9.7	2.3	2.4	1.7	1.6	2.9	3.7	7.8	1.3	7.2	9.6	3.3	1.0	2.4	37.2	3.8	0.9	4.9	2.2	8.0	6.5	7.2	3.3	5.9	4.0	1.6	15.9	1.7	6.3
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, Predicted secreted proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"salivary gland: 1237.9"	"Cell type enriched"	"Detected in single"	404	"Melanocytes: 170.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 15.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 5.5;U-2197: 4.8"					"Not detected"	"Not detected"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	NA	NA		34000000			"HPA028550: AB_10600105, HPA028692: AB_10601883"	"unprognostic (2.54e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.28e-2)"		"unprognostic (2.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.29e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-1)"		0.3	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1237.9	0.0	0.1	24.9	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.6	0.4	1.5	0.3	0.4	15.4	1.6	1.2	0.5	0.9	1.8	0.3	0.3	1.4	0.9	0.1	0.2	0.6	1.0	1.6	5.5	0.6	0.5	1.3	1.6	0.4	0.1	0.8	0.6	0.6	0.8	2.0	1.1	0.4	2.0	2.0	0.0	1.0	0.9	0.1	1.2	0.7	1.4	0.7	3.4	0.1	0.8	1.0	1.5	1.1	1.0	0.8	1.5	0.6	0.3	0.2	1.0	1.0	0.9	0.2	0.9	0.3	0.9	1.5	0.8	0.3	2.8	1.5	4.8	1.2	1.5	0.5	1.7	0.6	1.8	1.4	1.1	0.3	0.2	0.4	0.2	0.4	0.3	0.8	2.8	0.0	0.6	5.6	15.4	1.5	0.4	0.2	0.4	0.3	1.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844379-66854153	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"intestine: 37.2"	"Cell type enriched"	"Detected in some"	58	"Paneth cells: 2512.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HAP1: 1.8;NTERA-2: 1.6;REH: 3.4;SCLC-21H: 2.7;THP-1: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047237	Uncertain					NA	NA					"HPA047237: AB_2679994"	"unprognostic (8.77e-4)"	"unprognostic (5.23e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.16e-2)"		"unprognostic (7.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (5.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.46e-2)"	0.2	0.2	3.2	0.4	7.5	0.2	0.2	3.9	7.7	0.2	37.2	0.3	0.0	4.8	0.3	0.9	0.3	0.2	0.2	0.2	6.3	0.5	0.2	0.2	0.2	0.2	0.7	2.9	0.2	0.2	0.2	0.0	0.2	1.8	0.2	32.0	0.0	1.1	0.4	0.2	0.2	22.8	1.0	0.1	0.2	0.2	0.5	1.3	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.9	3.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.5	3.9	7.7	6.3	0.5	0.7	2.9	1.8	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	2512.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.5	0.0
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60187347-60281412	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 41.0;brain: 26.8;parathyroid gland: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Intestinal endocrine cells: 33.7;Mucus-secreting cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	20	"basophil: 41.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 41.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 11.6;JURKAT: 11.4;K-562: 21.0;NB-4: 12.1;OE19: 18.4"	"Region enriched"	"Detected in some"	37	"cerebellum: 1413.4"	"Region enriched"	"Detected in all"	9	"cerebellum: 163.0"	"HPA024748, CAB025545, CAB047309"	Enhanced					NA	NA					"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	2.3	1.5	9.2	1.1	11.6	1.1	6.5	26.8	6.9	6.3	2.2	3.6	0.6	1.8	2.8	12.8	0.9	2.5	1.0	3.8	7.8	6.0	7.4	0.6	1.6	1.0	4.2	5.3	0.7	3.0	56.8	9.8	8.1	3.4	3.3	3.1	1.5	6.6	0.9	2.0	0.9	1.7	1.3	1.9	1.3	5.9	9.3	6.2	1.7	0.7	1.3	1.0	1.3	2.1	0.1	2.0	41.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.1	0.0	11.6	4.9	0.0	0.0	3.9	1.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.4	21.0	0.2	0.0	0.0	3.3	12.1	0.2	18.4	0.0	0.0	0.0	0.2	0.4	0.9	5.3	0.0	0.0	1.1	0.0	2.4	4.9	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	41.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.2	11.6	26.8	6.9	7.8	6.0	4.2	5.3	3.4	6.2	0.0	3.7	0.0	0.2	0.9	0.9	3.3	0.0	1.4	6.8	3.5	0.0	7.7	3.3	4.0	7.7	5.3	0.4	0.0	5.4	0.3	3.4	1.8	0.0	0.0	7.4	0.0	33.7	0.0	2.7	3.6	1.4	0.2	6.8	0.0	16.7	2.3	1.5	2.9	1.4	0.0	0.8	0.0	0.4	3.6	4.5	0.4	1.1	0.0	2.3	0.1
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in some"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.3	20.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.3	53.5	0.0	0.0	0.0	0.0	0.0	0.0	27.8	178.0	0.0	0.0	0.0	46.4	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	12.2	1.4	0.0	0.0	1.0	0.1	1.5	33.9	0.0	0.7	0.0	0.0	0.0	0.4	0.9	2.7	2.8	0.2	0.0	0.2	0.3
CBX1	"CBX, HP1-BETA, HP1Hs-beta, M31, MOD1"	ENSG00000108468	"Chromobox 1"	P83916	17	48070052-48101521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 239.1;Spermatogonia: 235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB012265	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		35000	"Nucleoplasm, Nuclear bodies"		"CAB012265: AB_297216"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.48e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.73e-2)"	17.4	19.1	39.4	19.5	40.5	8.6	25.5	40.0	39.7	31.3	18.8	22.0	15.4	11.1	39.6	29.3	18.7	22.5	16.4	18.3	35.0	33.4	22.9	12.5	15.6	18.6	32.2	38.0	47.6	12.4	27.8	20.7	19.9	30.8	23.1	19.9	13.5	15.5	29.3	35.4	16.7	11.8	32.8	41.8	18.5	14.2	39.6	31.8	30.9	23.5	12.9	26.1	20.2	19.6	12.7	7.6	25.0	9.1	6.3	9.5	4.1	38.5	22.1	72.9	34.3	14.8	13.3	40.4	35.9	17.4	35.1	37.7	57.8	15.5	26.6	38.5	28.2	27.0	15.5	26.8	22.7	62.0	49.3	21.6	21.6	22.2	21.2	9.0	20.5	13.4	9.4	12.7	26.1	33.5	27.0	28.6	32.2	26.8	12.4	28.1	24.1	57.3	14.0	27.7	21.1	28.7	43.2	60.4	17.0	20.3	22.2	25.9	64.6	24.8	8.2	12.9	54.8	38.9	14.6	19.9	49.1	45.3	20.8	36.1	17.5	39.6	25.6	13.4	9.1	21.7	2.8	9.1	11.2	9.5	9.1	7.9	11.4	8.6	7.8	7.1	12.7	9.1	7.5	25.0	6.3	6.4	7.6	8.4	4.1	39.4	40.5	40.0	35.1	35.0	33.4	32.2	38.0	30.8	31.8	62.5	22.2	26.7	28.9	38.7	41.3	65.0	12.7	44.2	37.5	40.1	19.6	47.7	29.9	61.5	24.8	37.9	9.6	0.0	25.7	68.8	49.4	25.7	38.2	14.9	56.4	47.7	38.8	20.9	29.1	41.0	74.2	25.3	38.8	51.3	25.2	83.7	31.1	7.0	86.3	22.4	31.7	38.8	34.0	239.1	235.7	31.7	23.2	21.9	28.9	17.7
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 491.8;Hofbauer cells: 1111.0;Ito cells: 465.9;Sertoli cells: 685.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Group enriched"	"Detected in some"	5	"ASC diff: 82.7;HEL: 39.3"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	82.7	0.8	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	0.1	0.0	0.1	0.1	39.3	0.1	6.3	0.0	0.0	0.0	8.0	3.1	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	0.7	2.7	4.5	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.5	10.4	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5	6.0	69.8	5.2	0.1	6.5	0.0	491.8	7.6	0.0	5.7	7.0	0.0	8.5	0.0	0.0	9.2	46.6	0.0	163.5	0.0	9.4	14.4	0.7	14.0	12.1	1111.0	0.0	0.0	465.9	196.7	2.3	0.6	68.0	15.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.3	685.6	31.5	4.7	0.7	4.1	15.3	1.3	0.0	0.1
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	50.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	14.2	0.0	0.0	12.8	3.1	0.0	0.0	0.0	10.3	0.0	8.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	11.0	0.1	9.6	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5	3.0	10.8	23.4	0.4	0.0	0.0	0.8	0.0	49.5	18.2	0.0	9.8	0.2	0.0	0.0	1.6	0.1	0.0	46.7	0.0	0.0	0.5	10.7	39.1	1.3	4.6	0.0	0.0	3.1	31.1	0.0	0.0	10.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	2.2	1.4	0.0	0.5	30.5	0.7	0.1
CELSR3	"ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2"	ENSG00000008300	"Cadherin EGF LAG seven-pass G-type receptor 3"	Q9NYQ7	3	48636469-48662915	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;pituitary gland: 11.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 16.2;Cone photoreceptor cells: 15.7;Horizontal cells: 28.6;Intestinal endocrine cells: 8.6;Rod photoreceptor cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.1;SH-SY5Y: 15.0;SiHa: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062866	Approved					NA	NA					"HPA062866: AB_2684886"	"unprognostic (7.80e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (9.12e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-6)"	"unprognostic (3.61e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.73e-1)"	0.7	4.0	10.9	1.2	8.3	1.7	0.8	19.7	11.1	0.6	1.3	0.0	0.0	1.2	0.8	1.2	0.6	0.7	0.7	0.5	7.1	1.4	0.6	0.6	0.8	1.4	2.0	10.4	0.9	2.6	1.4	11.2	1.0	3.6	0.7	1.2	1.4	0.6	0.8	0.5	1.2	1.3	0.8	3.3	1.0	2.1	5.4	1.4	0.0	0.9	0.0	1.0	0.7	0.7	0.3	0.1	0.0	0.1	0.2	1.5	0.4	3.9	2.9	4.9	2.9	0.6	0.9	1.3	0.3	0.5	0.6	0.9	5.5	3.0	0.8	0.8	0.2	2.5	0.5	1.5	0.2	0.3	13.1	0.8	1.3	11.3	2.0	0.9	1.3	2.1	0.4	3.9	0.3	7.0	0.2	0.0	2.8	0.5	4.0	1.0	4.2	0.1	0.0	2.7	1.4	1.3	0.3	0.7	4.1	0.0	2.7	11.0	15.0	13.2	0.3	0.5	0.7	6.5	2.5	0.1	4.8	4.7	6.4	2.3	0.3	7.2	3.5	3.4	0.9	7.6	0.0	0.1	0.0	1.0	0.0	0.2	0.3	0.2	0.2	0.1	0.0	0.3	1.5	0.0	0.2	0.0	0.0	1.1	0.4	10.9	8.3	19.7	11.1	7.1	1.4	2.0	10.4	3.6	1.4	0.0	0.3	0.5	0.1	0.3	16.2	2.5	0.0	0.0	0.0	0.0	15.7	0.2	0.0	0.1	2.8	0.0	0.4	0.0	0.0	0.2	0.2	0.1	1.1	0.4	0.2	28.6	8.6	0.6	0.0	1.6	0.3	0.0	0.0	0.0	1.8	0.8	0.2	0.0	0.0	0.0	11.2	0.0	0.0	5.9	3.4	0.4	0.1	0.0	0.2	0.0
CIDEA	CIDE-A	ENSG00000176194	"Cell death-inducing DFFA-like effector a"	O60543	18	12254319-12277595	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 79.9;breast: 32.6"	"Cell type enhanced"	"Detected in some"	15	"Late spermatids: 2.7;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.7;cerebral cortex: 1.9;olfactory region: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"hTEC/SVTERT24-B: 5.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 12.2"							NA	NA						"unprognostic (2.96e-2)"	"unprognostic (2.43e-2)"			"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"		"unprognostic (8.93e-3)"	"unprognostic (3.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.72e-2)"			"unprognostic (1.91e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.96e-1)"	79.9	1.5	0.1	5.8	1.7	0.2	32.6	0.0	1.9	1.1	8.0	0.0	0.6	0.2	0.2	0.2	2.1	0.2	4.9	2.4	0.2	0.0	0.2	0.3	0.2	0.3	0.1	1.5	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.5	0.0	2.1	0.3	1.0	3.0	0.8	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.3	3.4	0.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.9	0.2	0.0	0.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.9	0.0	0.0	0.0	0.4
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell type enriched"	"Detected in some"	15	"Proximal tubular cells: 679.1"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.1	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.7	0.0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	6.5	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.5	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	26.2	0.0	1.9	46.4	19.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	679.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534440-74587212	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 60.3;liver: 41.4"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 6.1;Hepatocytes: 26.1;Proximal tubular cells: 14.6"	"Group enriched"	"Detected in some"	10	"glioma: 4.4;liver cancer: 1.0;melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	69	"U-266/84: 42.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA008933, HPA073283"	Enhanced				"Secreted in brain"	NA	NA		1900000000			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	1.1	1.2	14.9	1.2	28.2	1.3	1.1	4.5	60.3	1.1	1.1	54.9	0.0	5.7	1.1	2.1	1.1	1.1	1.3	1.1	28.9	15.1	1.9	41.4	1.1	1.2	44.1	12.9	1.1	1.2	1.1	0.1	1.1	50.0	1.2	1.1	0.5	1.1	1.3	2.2	1.1	1.9	1.1	51.1	1.1	1.2	1.4	28.8	0.0	1.3	0.0	1.1	1.1	0.0	0.7	0.7	1.9	0.5	1.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	42.2	0.0	0.0	0.0	0.0	1.3	0.5	0.4	0.4	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.4	0.4	1.9	1.0	0.2	0.7	0.2	0.2	14.9	28.2	4.5	22.5	28.9	15.1	44.1	12.9	50.0	28.8	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	26.1	0.1	0.0	0.0	0.6	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	14.6	0.6	0.0	0.0	0.9	0.5	0.3	0.0	0.5	0.0	0.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.6;RPMI-8226: 98.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.2	13.9	10.1	9.5	12.3	7.3	42.4	10.8	10.2	14.8	14.8	8.0	11.1	13.0	13.7	11.7	11.6	15.6	15.3	20.5	10.6	19.4	6.0	12.9	7.0	12.8	18.0	25.2	20.1	11.0	15.8	12.8	23.1	8.4	12.9	15.6	13.6	76.6	9.8	11.5	13.4	12.1	15.2	6.8	8.3	14.6	11.6	98.6	58.2	43.1	11.0	5.8	8.4	60.2	14.4	25.2	25.2	10.4	13.5	15.9	13.5	3.5	7.2	14.3	58.7	17.3	10.8	18.4	13.2	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5	68.5	54.2	53.8	35.3	8.1	33.7	22.9	91.7	60.2	38.7	113.4	15.7	128.9	159.2	142.6	2.2	45.9	105.2	0.0	136.1	106.3	20.6	56.1	11.5	102.8	184.6	41.3	62.7	36.8	86.2	3.2	17.3	82.3	16.9	112.8	71.7	80.3	99.7	74.1	15.6	371.2	24.6	12.9	15.9	4.8	7.3	8.4	91.2	36.3	82.5	47.4
COL4A3BP	"CERT, GPBP, STARD11"	ENSG00000113163	"Collagen type IV alpha 3 binding protein"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.0;WM-115: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	30.0	25.5	16.5	17.1	21.9	17.9	21.4	34.4	21.2	26.9	19.9	14.9	21.5	13.5	20.5	11.6	21.9	17.1	17.4	14.9	15.2	16.3	21.1	22.7	19.6	13.4	22.5	12.4	17.9	12.4	24.6	25.9	17.8	18.2	19.0	14.6	14.8	17.5	16.1	33.4	14.2	19.3	18.9	16.6	17.2	17.0	21.3	20.7	17.8	37.4	14.3	15.9	21.8	19.1	6.4	9.8	20.9	16.6	5.1	8.8	5.7	16.6	8.6	8.3	7.2	52.0	14.5	11.1	9.4	11.6	7.2	9.6	12.9	9.6	8.1	20.3	9.9	10.0	10.1	12.6	12.9	11.1	9.9	5.8	6.7	9.5	6.8	13.2	6.6	7.8	10.9	9.2	8.5	9.7	11.8	8.3	10.7	12.1	12.2	9.5	8.8	7.9	5.0	10.7	3.8	6.4	6.7	11.0	7.4	11.8	20.2	6.4	6.4	11.8	8.3	11.6	18.3	8.1	11.4	11.3	4.9	5.9	8.8	7.7	11.3	14.9	9.4	8.5	11.4	45.0	5.0	13.9	10.6	6.0	15.6	5.6	6.0	6.2	5.6	9.8	6.4	5.9	5.8	20.9	5.1	16.6	5.7	8.8	5.7	16.5	21.9	34.4	21.2	15.2	16.3	22.5	12.4	18.2	20.7	56.6	58.5	6.4	28.0	16.7	30.7	32.7	22.9	71.0	75.1	17.4	21.6	13.6	18.3	19.6	83.3	28.1	19.2	0.0	19.2	13.9	20.9	36.3	47.5	17.9	31.6	41.3	26.4	55.9	33.0	73.0	32.2	37.4	49.0	19.8	15.6	31.1	21.5	13.1	39.3	22.3	33.1	19.4	19.6	41.5	31.5	23.3	23.2	21.3	14.3	38.3
COPA	HEP-COP	ENSG00000122218	"Coatomer protein complex subunit alpha"	P53621	1	160289273-160343400	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		260000	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	38.3	32.7	29.2	28.9	41.0	22.9	32.4	43.1	48.4	46.3	34.3	53.2	24.5	38.4	37.0	33.1	28.4	31.5	28.6	38.4	33.3	35.2	36.3	64.3	33.8	26.6	42.7	29.3	36.8	47.8	49.1	57.4	45.1	56.2	35.3	39.9	28.8	42.1	33.9	40.5	28.7	50.3	40.4	42.8	36.6	32.8	21.2	35.8	36.0	42.8	21.0	34.1	30.3	27.5	15.4	31.4	25.1	29.1	18.1	21.2	25.3	28.2	22.2	23.6	22.9	60.8	50.1	27.7	38.9	46.3	33.2	39.2	28.9	19.3	20.8	25.3	59.1	19.1	28.5	27.2	28.0	38.3	23.6	18.4	23.9	30.6	30.4	45.7	29.1	25.1	46.8	17.1	44.3	41.3	41.1	38.9	19.9	22.1	23.3	39.6	20.7	18.7	12.6	25.8	37.2	26.0	16.8	27.1	32.0	27.2	26.8	19.6	24.8	44.0	38.7	41.1	41.4	43.1	39.3	45.8	25.0	19.5	33.5	25.5	38.4	26.6	32.1	32.6	15.2	37.2	25.1	29.1	20.1	17.1	27.3	21.2	15.4	14.3	18.3	31.4	12.1	13.2	15.2	10.8	18.1	27.9	13.3	17.5	25.3	29.2	41.0	43.1	48.4	33.3	35.2	42.7	29.3	56.2	35.8	71.5	41.2	52.3	29.9	25.0	49.9	41.1	48.4	53.5	42.1	38.4	76.6	33.9	11.6	44.6	11.0	42.1	70.4	0.0	43.3	55.4	50.4	56.4	43.9	64.8	46.0	42.9	53.2	53.4	85.0	4.5	65.9	62.1	25.3	31.5	79.0	38.2	46.4	45.6	53.4	38.5	48.0	38.8	52.3	37.9	23.8	27.9	57.9	41.5	60.4	44.0
COPB1	COPB	ENSG00000129083	"Coatomer protein complex subunit beta 1"	P53618	11	14443440-14500027	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		400000	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	30.9	33.0	18.4	23.5	20.8	31.2	55.4	23.7	23.6	32.5	26.6	15.5	42.0	25.9	32.2	33.0	32.2	28.3	25.1	34.8	18.9	16.8	37.6	56.6	38.4	53.9	22.6	15.5	31.3	52.2	40.1	43.5	52.3	22.2	31.9	31.3	17.2	43.4	41.7	21.9	24.7	33.1	39.7	26.1	29.8	30.2	21.7	20.6	46.0	37.7	26.7	28.0	28.2	27.3	26.7	33.9	27.9	30.4	28.0	39.6	24.8	31.6	27.2	29.1	21.8	48.6	56.4	23.5	48.0	50.4	42.8	50.4	21.0	49.3	30.8	21.6	60.6	40.7	34.9	32.7	32.2	53.0	28.8	27.2	32.7	19.5	31.9	43.2	30.0	33.3	39.3	42.5	28.6	54.3	39.4	44.7	17.3	24.2	25.3	53.9	23.8	27.2	18.5	15.1	38.7	29.5	22.3	40.1	20.9	38.6	29.3	18.7	20.0	37.2	30.1	24.6	35.1	27.3	26.2	45.4	41.2	21.3	44.4	26.1	13.6	22.9	33.9	31.1	18.8	38.4	27.3	24.9	27.9	32.2	30.4	39.6	26.7	27.5	32.9	33.9	22.6	27.6	28.6	20.5	28.0	30.3	20.4	29.3	24.8	18.4	20.8	23.7	23.6	18.9	16.8	22.6	15.5	22.2	20.6	101.3	47.9	37.9	48.3	34.6	27.2	25.8	35.7	141.8	100.1	41.8	25.5	57.0	34.9	66.2	10.9	46.0	51.5	46.7	71.3	60.9	51.3	55.0	62.5	55.0	54.4	17.5	42.1	54.6	45.5	9.5	47.2	47.5	20.3	64.9	78.6	33.3	79.8	38.6	51.9	43.9	26.9	51.8	41.8	89.3	61.5	31.2	97.8	51.7	43.2	51.2
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"Coatomer protein complex subunit beta 2"	P35606	3	139355600-139389732	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	Cytosol		NA	NA		1000000	Cytosol		"HPA036867: AB_10672271, HPA058180: AB_2683630"	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	28.7	40.8	21.9	22.3	26.2	12.1	28.7	31.7	29.0	39.5	32.4	22.6	40.3	26.1	33.0	44.7	35.9	28.9	26.2	31.4	21.6	18.9	42.1	67.5	29.1	20.1	26.0	16.6	36.0	65.5	41.2	72.2	51.7	28.7	35.5	33.8	20.5	46.5	28.6	20.6	23.5	37.1	30.0	21.1	31.3	29.9	21.1	25.7	33.1	40.4	27.4	31.2	30.0	26.5	22.6	36.4	35.9	34.4	27.4	23.5	22.6	53.5	21.5	31.6	28.5	63.6	58.6	27.7	64.2	61.0	41.5	51.3	40.2	20.4	21.7	59.4	68.0	37.6	28.5	35.9	34.3	52.1	37.4	24.6	32.6	34.1	38.4	38.1	29.0	37.4	41.0	31.2	32.6	33.8	48.2	40.0	19.6	21.3	26.3	49.1	32.4	14.5	17.8	28.7	53.3	23.7	19.6	25.6	37.3	38.1	38.8	22.4	20.6	63.1	57.2	35.4	44.7	45.6	31.3	46.6	23.3	18.8	34.4	22.5	41.1	24.5	38.3	39.0	16.5	36.0	35.9	28.4	30.1	22.9	34.4	23.2	22.6	20.4	23.5	36.4	16.3	15.9	20.0	26.9	27.4	32.3	17.0	21.9	22.6	21.9	26.2	31.7	29.0	21.6	18.9	26.0	16.6	28.7	25.7	53.6	34.0	32.0	34.0	17.4	34.8	47.2	33.1	93.7	52.4	19.2	29.5	71.4	34.9	71.2	24.9	41.9	41.4	0.0	72.1	64.7	71.0	57.8	43.9	43.3	46.9	39.7	61.3	37.4	38.0	5.8	50.6	31.5	20.3	57.7	71.8	55.4	68.4	28.8	47.0	37.2	44.9	19.4	46.7	47.7	43.0	13.0	111.3	34.9	36.6	37.8
COPE	epsilon-COP	ENSG00000105669	"Coatomer protein complex subunit epsilon"	O14579	19	18899514-18919397	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034345, HPA041605, HPA043576"	Supported		Enhanced	"Golgi apparatus"		NA	NA		210000	"Golgi apparatus"		"CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563"	"unprognostic (1.48e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.75e-2)"	29.8	44.6	44.7	43.1	48.1	72.4	25.8	25.8	56.3	36.2	37.8	47.7	32.5	48.1	29.5	32.6	40.9	30.7	32.4	40.0	40.5	39.5	48.4	113.3	30.2	42.7	46.1	36.3	30.6	62.4	23.5	44.8	45.9	39.5	34.3	20.7	33.8	75.5	38.8	35.3	30.8	46.3	23.0	44.5	41.8	41.0	41.8	33.3	65.5	52.3	30.8	45.3	31.7	27.4	57.6	98.3	90.3	89.8	48.0	64.5	112.2	31.0	30.2	17.3	30.7	15.8	18.8	50.1	27.2	26.2	30.6	35.0	36.3	25.4	25.3	37.0	22.9	19.8	21.0	14.3	27.5	6.0	15.7	63.6	15.0	27.2	54.9	42.2	29.8	38.7	22.9	26.0	18.5	20.4	16.3	24.0	29.3	23.0	65.1	15.4	73.8	32.4	56.7	32.7	40.8	72.4	37.2	15.6	74.3	19.8	31.4	24.3	38.9	17.0	27.7	29.5	8.3	23.3	49.1	24.0	19.5	14.4	49.3	28.7	62.6	54.5	30.9	33.3	51.9	32.2	84.3	89.8	90.3	53.8	77.3	47.3	57.6	51.7	47.1	78.9	51.2	38.7	44.1	89.5	48.0	64.4	98.3	64.5	112.2	44.7	48.1	25.8	56.3	40.5	39.5	46.1	36.3	39.5	33.3	3.0	18.1	183.1	156.2	142.0	47.3	8.0	104.4	18.7	13.6	109.9	27.5	330.4	393.0	279.1	142.0	115.5	396.1	46.7	322.0	362.9	175.8	233.8	103.6	138.4	395.5	54.0	161.7	108.6	191.9	269.0	134.0	267.7	232.8	472.5	210.2	212.1	288.5	259.6	125.2	313.0	51.1	122.9	135.9	176.4	227.6	171.9	453.4	205.0	211.1	224.0
COPG1	COPG	ENSG00000181789	"Coatomer protein complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		110000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	25.2	39.4	21.1	22.2	28.0	20.1	37.3	23.6	50.3	43.3	42.1	24.3	50.6	34.2	27.6	66.5	29.5	24.4	34.5	33.4	24.2	26.7	32.4	72.1	36.5	39.4	23.0	21.6	28.6	75.6	47.6	49.7	49.3	34.9	45.1	45.1	22.4	59.9	45.5	24.1	24.3	32.4	29.1	20.7	29.0	36.3	23.6	16.2	26.9	33.0	22.0	27.7	19.9	24.1	15.7	31.9	34.9	33.0	31.1	31.8	26.0	32.7	16.7	24.4	21.1	57.2	46.4	26.0	53.5	51.1	36.9	46.7	30.6	20.4	18.0	31.2	75.9	30.0	19.8	20.1	31.5	40.2	21.9	8.3	29.9	22.1	49.4	52.1	22.6	32.2	48.4	27.8	29.5	48.7	40.6	33.2	13.9	10.4	43.6	44.4	49.8	13.2	23.1	14.5	48.1	20.5	14.4	22.9	34.8	46.0	27.3	15.2	17.8	41.1	30.7	49.0	28.0	34.0	33.1	44.8	20.1	19.1	42.4	20.6	34.1	16.2	31.6	49.1	17.3	38.5	34.9	26.8	20.2	26.2	33.0	31.8	15.0	23.7	25.7	31.9	15.7	18.5	21.6	21.3	31.1	29.7	29.4	23.6	26.0	21.1	28.0	23.6	50.3	24.2	26.7	23.0	21.6	34.9	16.2	14.9	29.8	27.4	13.9	7.8	8.7	19.3	17.8	16.0	18.2	26.2	3.9	52.4	36.5	39.6	7.8	19.4	69.2	46.7	40.7	53.3	25.8	24.8	14.0	53.3	34.3	4.8	37.1	35.6	31.0	3.1	38.0	19.0	21.9	44.1	67.9	14.2	35.7	37.4	29.4	28.8	7.5	19.4	17.3	21.1	16.4	8.9	60.4	20.1	38.2	17.5
COPG2	2-COP	ENSG00000158623	"Coatomer protein complex subunit gamma 2"	Q9UBF2	7	130506238-130668748	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045712	Approved					NA	NA		40000			"HPA045712: AB_2679428"	"unprognostic (9.48e-2)"	"unprognostic (3.31e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.23e-1)"	12.0	26.6	13.5	8.9	22.1	10.7	20.4	21.1	22.9	15.5	12.0	18.1	11.5	9.3	21.1	17.7	17.3	19.6	12.8	15.2	12.9	18.4	12.9	9.1	9.8	11.5	14.8	15.8	40.4	12.2	29.0	27.0	15.6	20.0	13.9	14.1	16.8	13.2	15.3	17.5	20.3	8.6	19.2	14.4	11.7	9.7	31.8	9.8	20.0	18.5	10.7	14.6	12.7	14.0	4.3	4.4	6.0	4.5	1.9	2.0	1.7	21.4	12.3	22.7	11.4	10.0	17.9	5.9	10.1	15.3	16.9	16.6	7.5	11.9	14.8	8.5	13.0	18.8	10.9	7.5	18.9	22.2	16.1	15.6	15.1	6.5	10.8	16.0	19.7	14.1	14.3	9.6	13.7	21.1	16.5	15.9	15.2	24.0	4.4	21.4	21.5	18.9	15.4	28.6	14.3	10.0	18.4	29.9	8.8	20.4	28.6	17.5	25.2	20.9	19.7	15.9	19.9	12.7	6.4	14.0	15.3	8.0	12.7	14.7	9.9	12.1	17.5	17.1	16.4	13.2	2.9	3.7	6.0	2.0	3.6	1.7	4.3	1.8	1.5	4.4	2.3	2.0	1.8	1.1	1.9	4.5	1.9	2.0	1.7	13.5	22.1	21.1	22.9	12.9	18.4	14.8	15.8	20.0	9.8	0.0	1.3	1.7	5.0	8.0	12.5	5.1	7.6	2.7	2.3	14.0	13.7	16.2	10.0	8.2	1.9	4.9	3.3	0.0	21.3	11.2	8.2	2.9	1.1	4.3	8.0	4.8	2.4	9.8	6.3	1.9	5.5	6.5	8.5	10.8	8.9	9.1	9.8	0.0	6.3	5.9	12.1	12.9	5.1	14.2	28.4	8.8	18.8	2.9	8.4	3.9
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 505.9;Club cells: 754.1;Hepatocytes: 1101.0;Muller glia cells: 606.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"EFO-21: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.9	4.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.1	1.8	4.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4	17.9	59.9	35.0	6.7	3.0	6.0	0.4	86.6	505.9	754.1	8.7	5.9	0.0	0.0	26.9	0.5	5.3	0.0	93.5	17.8	0.2	12.7	23.8	2.3	1101.0	0.6	4.8	0.0	42.4	37.9	0.4	0.3	3.4	0.0	2.8	0.0	606.4	111.7	0.0	0.4	0.1	13.8	0.0	2.6	0.0	0.0	2.3	0.2	4.3	0.0	44.8
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		790000	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	18.0	18.3	9.9	9.9	12.1	15.8	24.4	7.0	10.3	12.8	31.9	8.2	14.1	33.7	17.0	7.2	11.2	12.8	14.7	14.6	12.0	6.6	30.6	62.0	13.1	10.1	10.5	8.6	17.0	24.4	16.9	13.8	8.7	10.8	15.6	22.0	19.7	12.9	11.4	6.9	10.3	33.4	16.9	8.7	18.9	16.8	10.4	9.0	17.9	13.2	7.5	7.6	11.3	30.2	2.5	11.9	10.6	8.6	5.7	8.8	2.5	8.1	14.5	2.1	14.2	9.3	8.4	0.6	6.5	5.4	5.2	1.0	0.5	27.6	0.0	24.2	17.2	18.2	26.9	18.4	3.9	1.5	13.0	1.8	20.1	15.8	6.7	13.9	11.6	24.3	8.7	1.9	10.4	6.3	7.1	18.3	8.1	2.1	16.5	4.7	23.4	9.4	20.6	0.2	42.2	15.4	26.5	0.3	35.6	12.2	20.4	0.2	9.3	18.0	34.9	5.7	1.4	31.1	11.3	18.4	11.3	0.2	22.6	9.4	12.9	16.4	8.3	11.9	8.6	12.3	9.2	7.8	10.6	8.8	8.6	5.1	2.3	5.5	5.3	5.0	2.5	3.4	7.0	3.8	5.7	7.2	11.9	2.9	2.5	9.9	12.1	7.0	10.3	12.0	6.6	10.5	8.6	10.8	9.0	35.7	36.9	11.5	7.7	8.4	4.9	22.1	28.1	32.1	22.7	22.7	60.9	12.9	16.6	11.2	9.2	25.4	82.1	0.0	8.1	4.1	13.9	7.4	27.8	79.0	14.6	1.6	15.5	37.4	42.3	15.7	8.9	13.5	0.0	11.8	44.9	12.9	9.7	40.3	30.1	9.4	41.0	38.8	16.0	12.1	8.8	6.8	6.5	16.6	59.0	6.4
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 64.6;Hepatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.7	3.2	7.5	7.3	6.5	3.8	8.5	4.8	4.9	6.9	6.4	1.6	6.5	13.2	7.3	2.2	7.8	7.7	14.0	11.0	5.9	7.3	8.2	7.5	4.3	1.3	9.5	7.1	7.3	8.2	9.4	5.0	4.2	7.7	4.7	11.7	9.6	4.7	4.2	4.5	5.5	5.8	14.0	14.4	8.6	6.4	7.2	13.9	8.6	7.2	11.2	7.6	9.6	12.2	18.1	18.1	14.2	15.2	4.5	3.9	3.1	6.8	3.9	14.5	8.9	8.1	5.0	8.2	5.7	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7	11.9	20.8	8.9	5.1	1.5	3.1	12.4	15.3	4.0	3.4	10.4	13.7	64.6	21.6	10.7	1.1	3.6	39.8	0.0	9.3	16.0	2.8	4.8	2.3	80.0	23.6	14.3	13.9	6.7	13.5	2.1	6.4	8.2	6.8	26.2	26.9	10.5	9.8	21.0	4.9	28.3	9.9	6.5	3.2	29.8	16.3	2.3	45.7	7.1	25.3	4.6
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345681-87399795	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 116.1;Rod photoreceptor cells: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.3;RT4: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	4.6	10.1	9.3	5.1	9.6	1.6	10.5	7.4	8.4	9.0	9.4	5.5	24.1	19.6	10.0	12.6	17.0	6.8	8.7	5.9	5.2	5.4	12.3	21.5	4.2	3.4	5.4	6.6	7.2	4.6	15.5	9.1	13.7	5.8	14.8	7.0	9.8	8.3	32.3	7.2	15.0	19.1	8.8	6.8	4.8	4.9	3.8	4.7	7.4	27.1	8.4	8.0	22.4	15.3	2.2	2.3	3.4	5.5	13.0	9.5	3.0	7.2	5.4	6.6	2.3	6.3	5.8	4.9	7.7	7.2	4.7	5.1	2.8	3.8	3.0	6.8	6.5	9.4	9.1	1.1	10.2	6.7	4.3	4.6	6.6	3.8	3.6	4.1	4.1	4.1	4.7	35.3	3.8	3.0	6.0	6.6	5.0	0.3	4.4	12.3	7.1	5.1	4.1	1.4	2.6	8.0	2.3	9.1	0.5	6.0	34.6	1.1	5.2	9.4	10.9	4.9	4.7	6.9	1.5	3.5	10.9	4.7	14.7	7.2	6.7	9.6	4.2	7.3	0.0	6.4	2.0	1.4	3.4	7.4	1.7	9.5	2.2	7.5	6.0	2.0	2.2	6.1	6.6	0.9	13.0	5.5	2.3	6.3	3.0	9.3	9.6	7.4	8.4	5.2	5.4	5.4	6.6	5.8	4.7	20.8	7.7	4.4	49.0	14.9	16.1	13.2	7.6	32.1	36.4	50.6	43.2	116.1	8.3	6.6	18.7	6.5	24.7	0.0	7.6	5.2	7.3	20.4	7.0	28.8	12.0	14.3	7.0	5.5	7.5	33.1	14.7	7.4	18.6	6.4	13.1	24.1	8.0	7.4	13.1	15.3	76.5	6.5	8.3	2.5	3.6	13.4	41.0	7.0	10.9	43.1
CSNK1G2	CK1g2	ENSG00000133275	"Casein kinase 1 gamma 2"	P78368	19	1941149-1981338	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 218.1;Late spermatids: 503.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034868, HPA056572"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034868: AB_10671235, HPA056572: AB_2683178"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.51e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.83e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-2)"	18.7	22.2	24.8	34.9	19.5	38.1	16.7	30.8	28.9	14.1	19.0	18.2	18.9	27.0	16.5	19.0	22.1	16.9	20.4	16.0	23.3	18.3	19.3	17.9	21.8	35.1	17.3	21.2	18.6	27.0	11.4	24.4	16.7	18.7	18.7	8.7	19.7	26.6	16.0	29.0	23.3	22.1	15.1	12.7	39.1	24.1	58.5	17.4	20.6	16.5	18.1	32.2	17.1	17.1	4.0	5.9	11.2	14.1	3.5	4.9	2.3	23.3	12.6	17.5	27.5	6.2	11.6	14.7	14.5	9.6	11.1	13.6	10.3	12.8	14.7	12.2	9.2	6.1	16.9	9.4	17.7	4.9	13.3	20.4	10.4	20.5	17.4	9.9	16.5	26.4	11.5	11.7	11.5	7.4	8.5	13.1	18.4	21.7	50.6	7.3	13.6	32.8	21.8	31.8	6.5	14.2	28.6	11.1	23.8	8.3	24.6	28.3	23.2	11.0	18.1	16.0	6.9	11.5	27.3	15.6	14.0	11.0	29.3	16.8	32.7	17.3	18.0	14.2	15.7	14.6	2.8	4.0	5.0	4.9	6.2	3.5	3.9	3.6	4.2	3.9	4.0	2.9	4.1	11.2	3.5	14.1	5.9	2.5	2.3	24.8	19.5	30.8	28.9	23.3	18.3	17.3	21.2	18.7	17.4	14.9	17.0	12.0	15.7	19.5	44.1	10.1	7.6	13.4	14.8	10.4	39.3	9.9	8.3	15.1	218.1	19.9	22.5	0.0	25.3	17.2	15.8	22.1	29.9	14.0	12.9	23.8	29.2	14.1	17.0	503.0	19.0	20.5	13.5	5.4	20.2	21.3	24.4	16.5	17.7	12.6	37.2	12.9	14.4	15.6	13.1	22.1	15.2	27.3	18.0	28.5
CTGF	"CCN2, IGFBP8"	ENSG00000118523	"Connective tissue growth factor"	P29279	6	131948176-131951373	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 425.8;Ito cells: 621.2;Peritubular cells: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"naive B-cell: 11.6"	"Lineage enriched"	"Detected in single"	117	"B-cells: 11.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 131.2;HUVEC TERT2: 110.3;TIME: 227.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5200000	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	51.9	15.5	3.5	48.2	7.6	0.0	39.2	1.6	7.1	84.0	26.9	7.2	27.5	5.8	84.9	50.1	38.9	56.3	82.5	73.6	8.8	3.6	83.5	18.8	45.8	53.3	4.7	9.4	30.7	26.3	4.7	9.7	44.0	13.8	54.5	19.7	55.0	28.2	45.3	29.4	30.1	28.7	123.4	12.0	169.8	41.6	24.4	2.3	5.9	66.9	46.9	9.8	48.5	23.3	11.6	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	10.2	0.3	23.2	13.2	0.1	29.6	14.3	18.4	9.8	0.0	0.9	0.0	131.2	38.0	15.1	0.4	0.3	2.1	17.3	0.1	0.2	0.0	4.2	10.6	9.1	0.0	0.0	19.2	0.4	13.3	3.3	27.8	110.3	0.0	0.0	0.0	52.2	0.2	0.0	0.0	4.9	3.2	1.7	2.5	0.4	0.0	6.7	0.0	0.0	0.0	3.0	5.0	1.4	26.2	0.5	0.2	227.6	25.5	20.0	32.1	54.7	0.9	0.1	0.2	3.4	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.5	7.6	1.6	7.1	8.8	3.6	4.7	9.4	13.8	2.3	425.8	55.6	2.9	247.2	86.5	0.0	34.4	73.9	103.1	38.7	12.2	0.0	11.5	0.0	245.6	0.9	205.6	11.7	0.0	212.2	18.8	248.5	11.6	13.9	23.6	12.0	0.0	13.3	621.2	7.2	2.7	46.6	12.6	62.4	27.1	7.9	2.8	177.6	6.6	453.3	0.7	0.2	103.5	206.0	1.2	4.4	52.6	13.6	1.8	7.5	6.5
CUBN	"gp280, IFCR, MGA1"	ENSG00000107611	Cubilin	O60494	10	16823964-17129831	"Disease related genes, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 28.9;kidney: 79.7"	"Cell type enriched"	"Detected in many"	12	"Proximal tubular cells: 301.3"	"Cancer enriched"	"Detected in some"	15	"renal cancer: 24.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.2;ASC TERT1: 4.6;SK-MEL-30: 3.4;WM-115: 6.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004133, HPA043854"	Enhanced				"Intracellular and membrane"	NA	NA		240000			"HPA004133: AB_2732398, HPA043854: AB_2732510"	"unprognostic (1.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.61e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.24e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.93e-1)"	0.3	0.3	0.3	0.3	0.6	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.3	0.0	0.4	11.5	0.3	1.6	0.3	0.3	0.3	0.3	79.7	0.3	0.3	0.4	0.3	0.3	2.0	0.3	0.6	1.7	1.1	0.3	0.6	0.1	0.3	0.3	0.3	0.3	0.3	28.9	0.3	0.3	0.5	0.1	1.2	0.3	0.3	3.1	0.3	0.3	0.3	0.3	0.8	1.2	0.9	0.2	0.6	1.4	0.0	0.0	0.1	1.8	18.2	0.6	4.6	0.1	0.1	0.1	0.1	0.1	2.1	0.0	0.0	0.1	0.9	1.2	0.0	0.0	0.2	0.1	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.6	0.0	0.6	0.2	0.7	1.8	1.0	0.2	0.3	0.2	0.0	0.3	0.3	0.3	0.0	0.2	0.1	0.4	0.0	0.6	0.0	0.0	0.5	0.0	0.0	3.4	0.1	0.0	0.1	1.8	0.2	0.2	0.3	0.2	0.6	0.1	0.0	0.5	0.1	6.9	0.9	0.2	0.0	0.8	0.0	1.0	0.4	0.4	0.2	0.0	0.8	0.8	1.4	0.6	0.6	0.0	1.2	0.7	0.0	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	1.0	0.0	0.4	0.5	0.9	1.1	0.0	2.7	5.7	5.2	2.0	0.0	11.6	0.0	25.3	2.7	0.0	0.0	0.2	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.8	25.4	2.6	0.4	6.8	0.0	0.3	8.7	0.1	0.0	1.1	301.3	3.7	0.0	1.2	0.7	0.2	0.6	0.1	0.5	0.0	0.1
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell type enhanced"	"Detected in some"	21	"Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA					"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.3	0.1	0.0	0.3	0.0	7.2	0.0	0.0	0.4	0.2	22.0	0.9	0.2	5.9	0.0	5.4	6.9	0.4	4.4	0.2	0.0	0.6	0.3	1.5	3.2	0.1	0.2	7.1	0.0	12.0	0.1	0.9	0.2	11.5	0.2	1.3	0.2	0.0	0.4	0.0	0.2	0.1	7.2	1.8	0.7	0.0	0.2	0.0	1.4	0.3	0.1	1.0	9.0	2.3	23.3	0.3	0.1	0.6	1.0	0.3	3.2	0.0	0.4	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	3.2
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Group enriched"	"Detected in some"	16	"A549: 95.1;Hep G2: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	95.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.7	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.6	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	1.5	21.1	20.3	0.0	0.3	0.0	8.1	29.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.0	39.9
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	78	"kidney: 36.5;liver: 141.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 433.3;Proximal tubular cells: 109.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HL-60: 1.2;RH-30: 1.3;SiHa: 1.6;U-698: 2.3;U-937: 1.6"															NA	NA						"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.0	36.5	141.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	0.0	0.3	0.4	0.0	0.2	0.1	1.1	0.0	1.4	0.0	0.4	0.0	1.2	0.5	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	1.3	0.6	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.0	1.6	0.1	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.2	0.0	0.2	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	43.3	0.0	0.0	7.0	0.0	0.0	14.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.3	0.0	0.0	0.0	6.2	6.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP7A1	CYP7	ENSG00000167910	"Cytochrome P450 family 7 subfamily A member 1"	P22680	8	58490178-58500236	"Enzymes, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"liver: 50.4"	"Cell type enriched"	"Detected in single"	12	"Hepatocytes: 4.7"	"Cancer enriched"	"Detected in single"	96	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (5.20e-2)"			"unprognostic (1.93e-2)"	"unprognostic (1.77e-2)"		"prognostic favorable (3.19e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.2	0.5	0.0	0.4	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42876165	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 132.7"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 737.2"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Group enriched"	"Detected in some"	5	"BEWO: 6.8;HEL: 1.7;Hep G2: 2.6;SK-BR-3: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	6.7	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.2	0.1	0.2	0.1	0.4	0.7	0.3	0.2	0.0	0.0	6.8	0.1	0.0	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	1.7	0.2	2.6	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.1	0.4	0.5	0.6	0.3	0.3	0.5	0.1	0.0	0.6	3.1	0.3	0.4	0.3	0.1	0.3	0.3	0.6	0.3	0.2	0.4	0.1	0.3	0.3	0.4	0.1	1.4	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	737.2	0.1	0.0	0.0	10.4	10.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
DAGLA	"C11orf11, DAGLALPHA, KIAA0659, NSDDR"	ENSG00000134780	"Diacylglycerol lipase alpha"	Q9Y4D2	11	61680433-61747001	"Disease related genes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0"	"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.2;T-47d: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062497, CAB078793"	Approved	Supported				NA	NA					"CAB078793: , HPA062497: AB_2684784"	"unprognostic (2.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.99e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-2)"	3.7	2.5	7.2	2.8	13.3	1.1	3.0	12.0	22.0	3.1	6.0	3.6	3.1	4.4	2.7	3.8	4.7	3.8	2.9	3.8	8.6	6.0	2.3	0.5	3.2	1.3	3.7	7.4	1.2	8.8	1.7	3.3	1.7	4.5	3.5	3.7	2.5	7.9	4.0	3.1	1.1	5.2	3.2	1.4	3.4	2.9	3.3	2.7	0.0	1.6	2.0	1.0	1.7	1.4	0.0	0.8	0.0	1.9	0.0	0.1	0.3	5.4	6.2	4.8	1.0	1.1	1.8	0.8	2.6	0.7	2.9	3.1	3.6	11.2	0.0	2.6	2.3	4.5	3.2	0.8	0.0	1.2	0.0	3.2	0.0	4.6	5.5	1.8	0.0	1.0	0.9	0.3	3.7	0.0	1.7	0.8	0.4	0.0	0.0	1.3	2.6	0.0	0.0	9.9	1.9	6.0	0.0	0.7	0.0	1.0	1.3	10.0	5.5	1.4	2.4	1.7	1.2	12.3	3.1	3.4	1.9	8.7	5.2	3.0	0.0	0.0	0.0	5.2	1.4	3.0	0.0	1.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.3	7.2	13.3	12.0	21.5	8.6	6.0	3.7	7.4	4.5	2.7	3.0	0.3	0.0	0.3	0.3	1.1	0.7	0.0	0.0	2.3	3.5	0.0	0.0	0.0	1.5	0.0	0.6	3.1	0.0	1.9	0.1	0.5	0.7	0.0	0.0	2.2	0.0	4.1	2.5	3.3	0.0	1.7	2.7	0.0	0.0	5.6	1.7	2.4	0.0	3.9	0.4	0.3	0.0	0.4	1.2	2.9	0.3	0.0	0.0	4.5	0.0
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
DBI	"ACBD1, ACBP"	ENSG00000155368	"Diazepam binding inhibitor, acyl-CoA binding protein"	P07108	2	119366921-119372560	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Proximal tubular cells: 2068.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 225.5"	"Low region specificity"	"Detected in all"							HPA051428	Approved					NA	NA		7100000			"HPA051428: AB_2681482"	"unprognostic (1.24e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.45e-1)"	55.3	22.5	87.5	25.0	53.9	17.1	122.9	47.3	55.4	27.9	52.5	55.2	108.2	50.8	11.2	113.8	90.5	14.0	33.0	78.6	79.8	52.4	90.5	157.2	41.0	27.4	74.1	45.5	12.7	25.3	71.8	11.5	19.0	61.9	77.5	50.1	16.7	53.3	113.7	39.8	57.5	39.1	16.3	87.7	18.3	29.6	24.6	68.8	11.9	22.4	101.0	50.9	18.6	41.6	66.2	99.6	129.8	60.0	53.1	74.9	82.8	46.8	24.5	50.4	23.1	124.1	105.9	31.8	25.0	63.5	35.2	68.4	51.1	38.1	65.2	28.5	38.8	85.5	24.7	35.4	52.2	31.7	43.1	23.4	55.8	25.1	67.2	31.2	17.7	225.5	60.0	34.1	54.0	20.3	23.3	41.4	31.9	6.5	61.2	50.0	48.4	37.2	50.7	33.4	30.5	38.5	13.6	49.0	56.7	85.1	72.0	23.9	19.1	20.9	49.3	53.2	37.0	30.3	83.3	29.4	23.7	30.3	26.1	30.1	20.1	14.2	53.1	33.4	32.0	28.1	116.9	57.6	129.8	63.9	60.0	46.3	55.9	50.5	61.9	94.2	66.2	38.8	58.3	36.7	53.1	47.2	99.6	74.9	82.8	87.5	53.9	47.3	50.6	79.8	52.4	74.1	45.5	61.9	68.8	140.0	492.7	307.9	220.7	256.9	34.8	991.2	708.3	227.5	141.0	294.8	13.7	707.4	1014.6	377.5	616.1	206.4	599.6	70.0	587.5	492.1	310.5	420.2	415.4	1714.8	981.8	28.6	356.7	150.4	302.9	224.3	140.9	547.6	1003.8	1180.4	390.0	581.7	345.0	401.0	119.9	2068.7	52.4	148.8	258.8	222.1	33.0	598.7	431.8	249.6	547.7	287.5
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335283	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 170.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	22.2	18.6	8.8	16.6	12.7	19.4	20.1	30.4	16.3	13.1	16.7	14.6	13.8	14.4	15.0	13.9	16.0	13.2	15.2	15.0	8.3	8.3	15.9	33.9	16.6	15.3	10.5	10.7	14.6	21.6	20.3	17.9	12.0	13.2	13.8	18.2	19.3	16.8	15.2	24.8	26.9	16.6	15.7	10.1	17.8	18.5	64.3	12.3	17.4	18.0	16.9	20.8	16.2	13.9	21.1	21.1	27.0	28.6	22.1	35.4	22.5	2.0	12.4	17.7	16.0	9.8	13.1	15.3	10.0	14.2	22.0	23.0	26.4	15.3	16.2	9.5	12.6	8.9	12.2	0.1	5.7	22.8	6.7	11.3	9.6	8.1	21.6	21.1	20.5	9.3	16.1	11.3	16.7	12.7	9.1	16.8	5.0	9.7	7.0	13.4	14.2	0.0	29.7	11.1	7.7	5.2	28.4	9.6	23.4	13.1	11.5	11.6	15.3	23.6	5.4	12.7	8.1	12.1	18.2	10.2	10.4	9.3	8.6	9.2	15.1	7.8	37.7	3.4	16.8	13.4	27.0	22.1	19.0	23.2	28.6	22.3	21.1	20.9	25.3	21.1	19.0	19.0	18.0	4.1	22.1	17.7	6.5	35.4	22.5	8.8	12.7	30.4	16.3	8.3	8.3	10.5	10.7	13.2	12.3	11.9	17.9	27.3	15.3	8.4	17.8	6.6	12.7	29.4	20.5	10.4	11.8	16.5	26.6	35.6	170.5	17.5	27.5	0.0	57.8	18.6	16.1	14.9	10.5	12.4	25.9	9.5	21.1	11.6	14.6	32.4	19.2	19.7	3.3	43.3	14.6	16.0	37.9	34.5	14.9	17.4	15.7	12.9	12.3	78.8	7.4	9.2	26.4	25.5	20.3	15.7
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	26	"Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		270000	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.2	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	20.3	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	3.0	2.6	14.9	0.0	0.5	3.3	0.3	0.0	0.0	1.2	22.7	0.0	0.1	48.0	0.3	10.3	0.1	4.2	0.0	171.7	0.3	4.5	0.0	1.1	0.0	0.5	0.0	8.5	1.8	0.0	29.1	268.4	1.7	5.0	1.8	1.9	0.0	43.8	11.5	1144.5	391.6	0.1	6.5	0.3	15.6	2.9	0.3	0.3	0.5	1.2	0.0
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 90.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	0.0	4.0	0.0	0.3	1.8	10.1	0.2	0.0	0.2	1.8	0.0	0.7	90.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.4	3.7	0.0	0.0	0.0	0.0	2.3	0.1	0.3	0.6	0.7	0.3	0.2	0.1	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8	0.0	0.0	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.0	10.4	0.0	876.9	616.8	0.1	0.0	0.0	0.0	0.0	0.0	57.4	0.2	0.3	0.0	0.8	72.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.7	8.3	0.0	1451.1	0.0	0.0	0.9
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.2	0.0	0.0	0.0	6.4	0.2	0.5	9.9	17.0	0.0	0.0	0.0	0.0	0.6	17.5	0.0	11.7	0.0	16.4	0.0	10.1	0.1	0.2	12.5	0.5	0.2	2.7	0.1	0.0	7.6	0.0	0.6	0.0	0.5	0.6	0.0	0.2	0.0	6.4	0.1	2.1	0.0	9.6	8.9	17.8	0.0	0.0	0.1	4.5	5.1	0.0	0.0	4.1	9.5	2.0	5.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	5.1	0.0	0.0	0.0	27.5	1.6	0.0	4.8	8.6	0.7	0.0	0.0	0.8	17.8	7.2	2.1	0.0	13.2	1.1	0.0	0.0	0.0	0.0	12.4	0.9	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.4	0.0	10.2	19.4	0.3	12.1	7.9	0.0	1.4	0.0	0.0	0.0
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.9"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 35.3;Hepatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 5.6;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA					"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	7.6	9.8	7.7	7.9	9.4	3.7	7.9	10.9	12.3	4.0	14.5	8.6	0.9	11.8	3.4	2.7	16.6	2.9	11.1	8.1	6.6	5.9	6.4	43.9	3.3	2.2	7.5	9.4	2.0	2.5	10.6	7.1	2.6	15.7	3.0	14.1	4.3	6.9	3.2	1.4	12.3	10.2	5.7	20.0	1.9	16.9	1.3	7.3	1.1	2.3	7.9	4.0	6.0	5.0	0.1	0.0	0.2	0.1	5.6	4.9	0.8	13.4	8.0	29.3	7.3	19.7	20.7	15.0	9.4	4.6	3.3	7.4	3.9	23.7	1.1	0.8	7.2	11.3	12.6	22.2	27.5	7.7	4.6	6.4	15.2	8.7	10.2	12.2	14.8	9.9	18.0	6.4	16.8	8.0	10.9	6.5	1.6	18.1	31.5	7.3	7.1	3.4	1.5	13.4	8.2	4.8	2.3	11.5	3.9	21.4	10.1	5.2	11.2	4.8	32.0	4.1	13.9	5.4	0.1	2.4	6.7	7.9	11.2	11.4	1.5	4.9	24.9	10.2	0.0	1.7	0.2	0.1	0.1	4.8	0.0	4.9	0.1	2.1	3.2	0.0	0.1	0.7	2.3	0.2	5.6	0.0	0.0	0.2	0.8	7.7	9.4	10.9	12.3	6.6	5.9	7.5	9.4	15.7	7.3	0.0	5.6	0.0	2.3	1.5	22.3	2.4	7.6	1.4	6.8	10.4	35.3	1.2	5.0	6.1	3.7	1.1	16.0	0.0	7.3	21.6	3.9	2.4	5.8	43.3	1.6	25.4	2.9	4.3	2.7	2.7	1.1	0.7	0.0	0.0	12.4	4.4	12.1	24.6	1.1	5.6	15.9	6.5	3.8	0.2	1.2	6.0	1.7	12.8	12.4	4.4
ESCO1	"EFO1, ESO1, KIAA1911"	ENSG00000141446	"Establishment of sister chromatid cohesion N-acetyltransferase 1"	Q5FWF5	18	21529281-21600884	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 108.2;Spermatogonia: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042497	Approved					NA	NA					"HPA042497: AB_10794278"	"unprognostic (8.12e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.80e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.72e-2)"	8.7	7.8	10.2	15.1	9.7	18.1	14.0	22.2	13.3	11.5	13.1	4.7	11.5	7.7	10.0	13.7	11.9	7.9	6.8	7.7	10.4	8.2	9.4	11.0	8.8	11.9	9.4	9.1	10.7	9.0	16.4	29.0	14.6	10.8	9.6	7.9	5.7	11.9	13.8	15.1	10.1	17.2	8.0	12.9	14.1	8.7	24.3	9.9	16.6	11.7	8.4	12.6	11.7	9.5	4.6	2.7	8.8	2.0	4.2	7.4	2.2	6.3	3.1	6.8	3.3	6.5	7.1	7.0	3.9	8.1	5.9	8.0	6.2	4.3	11.6	9.2	5.3	6.4	9.3	8.5	5.6	8.1	11.8	5.6	8.6	4.6	10.4	10.1	14.4	8.9	5.9	12.0	4.4	11.7	7.8	7.7	9.1	12.1	11.7	8.0	7.4	10.8	15.2	13.8	12.9	7.5	7.2	8.3	12.7	11.3	10.2	10.3	7.6	7.8	9.8	16.3	10.9	6.8	10.2	4.0	7.3	7.3	5.4	5.0	29.0	16.4	13.3	7.2	8.5	7.1	6.6	1.2	7.9	6.9	2.0	6.0	4.1	6.0	6.2	2.4	4.6	7.3	7.4	8.8	4.2	1.7	2.7	5.9	2.2	10.2	9.7	22.2	13.3	10.4	8.2	9.4	9.1	10.8	9.9	11.9	22.7	15.4	20.2	9.5	38.9	32.1	5.1	14.7	21.6	10.4	19.6	20.7	16.6	20.2	6.5	12.7	14.0	0.0	11.9	13.6	10.1	17.5	28.8	6.8	11.8	28.6	10.9	12.9	6.3	6.4	19.5	15.0	15.1	18.0	12.7	15.2	16.8	17.3	21.2	14.2	34.9	25.8	9.2	108.2	95.6	10.9	31.5	27.4	10.8	27.1
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Group enriched"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	25.1	19.1	8.6	10.4	1.1	1.8	4.8	15.1	6.4	14.1	16.1	6.7	5.0	9.3	8.0	3.9	11.8	13.9	10.4	4.1	21.4	7.2	4.4	11.0	8.6	7.1	0.1	5.6	10.3	0.3	0.4	8.2	2.1	1.4	5.2	7.2	8.8	14.2	8.1	4.9	22.6	2.5	5.8	13.8	6.4	10.0	25.7	6.8	4.6	15.2	3.7	5.5	7.6	9.2	3.8	3.3	6.3	6.2	2.3	8.7	18.0	17.5	11.8	1.9	5.0	11.5	4.8	9.4	12.0	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2	0.0	6.6	2.2	0.7	2.1	1.5	1.1	0.0	2.7	5.7	0.0	3.9	1.0	0.0	0.3	3.9	0.1	5.3	70.0	0.0	5.5	0.9	0.2	1.1	1.1	4.5	0.0	1.2	0.6	4.1	0.4	1.7	3.5	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	1.8	6.5	0.3	30.1	77.3	0.5	0.8	2.9	4.0	0.9
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128116	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 453.2;liver: 370.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 8164.5;Hepatocytes: 5503.1;Paneth cells: 3221.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	7	"CACO-2: 26.2;Hep G2: 83.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		32000000	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		0.4	0.1	0.4	33.9	0.4	0.0	0.4	0.4	0.5	0.4	153.5	0.4	0.4	137.9	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.2	57.6	370.7	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	97.7	0.4	0.5	0.4	0.4	0.1	453.2	6.7	0.4	0.4	0.2	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	26.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	83.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	1.4	7.7	0.0	0.1	0.8	5.7	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.7	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.4	0.4	0.0	0.0	173.3	0.0	0.0	0.0	0.4	119.8	0.0	0.0	57.6	0.0	0.1	132.6	0.0	0.0	0.0	8164.5	140.2	0.0	0.1	0.0	0.3	133.2	5503.1	1.4	0.0	251.5	124.0	159.5	0.0	0.0	0.0	0.0	0.0	830.4	0.0	0.1	3221.0	0.0	668.9	0.0	0.0	0.0	0.0	0.1	0.0	1.1	51.0	1046.9	0.0
FABP12		ENSG00000197416	"Fatty acid binding protein 12"	A6NFH5	8	81524981-81531378	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.7;testis: 13.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 65.5;Late spermatids: 133.2"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;RT4: 1.1"	"Not detected"	"Not detected"							HPA044041	Enhanced					NA	NA					"HPA044041: AB_10962213"		"unprognostic (1.18e-1)"			"unprognostic (7.31e-3)"	"unprognostic (3.07e-1)"									"unprognostic (2.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0			0.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.0	0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2			0.0		0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	65.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.2	0.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.4	0.0	20.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Group enriched"	"Detected in some"	5	"Enterocytes: 422.5;Mucus-secreting cells: 344.1;Paneth cells: 175.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.5;NB-4: 3.9;RPMI-8226: 3.3;SH-SY5Y: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		46000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.4	0.4	0.4	0.1	0.0	0.3	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.5	2.5	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.3	0.5	0.0	0.1	0.4	3.9	0.2	0.2	0.5	0.3	0.3	3.3	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.2	0.3	0.1	0.9	0.4	0.4	1.5	0.2	0.7	0.3	0.6	0.3	0.3	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	422.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	344.1	0.0	0.0	175.6	0.0	18.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	64.7	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365625-31376850	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 420.9;skeletal muscle: 129.4"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2447.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"ASC TERT1: 120.7"	"Low region specificity"	"Detected in all"							"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	4400000	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	2.3	5.2	8.1	0.7	6.0	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11.0	5.3	21.3	1.9	4.3	1.3	9.8	6.0	2.2	0.4	0.3	0.7	1.1	13.7	5.0	1.5	3.0	4.4	14.0	129.4	0.9	0.6	13.0	3.4	3.9	3.6	2.0	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0.0	0.9	0.2	0.9	0.6	0.1	0.0	3.3	0.2	23.1	120.7	1.1	0.9	8.9	0.1	3.2	0.2	0.9	0.2	12.8	2.5	0.0	0.3	0.9	0.0	0.1	0.1	0.5	0.4	1.1	2.4	1.5	0.2	0.0	10.7	0.0	2.4	0.0	0.3	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.2	6.1	0.0	0.4	0.1	1.2	0.0	2.9	0.0	0.3	0.0	0.5	0.0	13.9	7.1	0.1	1.4	0.3	0.2	0.1	2.1	0.2	0.1	0.4	0.1	0.5	0.1	0.3	0.0	0.4	0.0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0.0	0.9	0.0	0.2	0.1	0.4	0.6	0.6	8.1	6.0	1.4	13.3	11.0	5.3	9.8	6.0	13.7	1.3	0.0	1.7	0.8	1.0	3.2	3.1	2447.6	5.1	2.7	2.3	26.2	2.0	2.1	383.0	0.3	2.1	0.8	0.0	0.0	0.3	1.3	14.9	3.8	1.1	0.0	96.1	7.9	0.0	3.7	20.0	4.2	6.4	17.6	8.5	0.0	0.0	2.7	0.5	3.6	7.4	399.5	8.1	0.0	32.3	0.3	0.1	2.6	1.4	1.0	0.1	5.2
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adipose tissue: 492.7;breast: 545.8"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 705.0"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	145	"ASC diff: 282.1;RT4: 139.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002188, CAB024961"	Enhanced					NA	NA		30000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0.0	1.8	0.2	0.6	2.9	4.8	1.0	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0.0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13.0	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0.0	0.7	7.4	7.3	0.1	15.4	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	282.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	139.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0.0	0.3	0.0	32.8	75.0	1.5	0.4	12.8	0.2	16.2	0.0	40.2	48.9	0.0	0.0	0.3	0.0	0.1	0.9	172.1	0.0	0.0	4.6	0.6	7.6	0.4	25.6	0.0	120.8	0.0	0.0	12.9	57.0	0.6	1.4	13.8	15.1	1.0	0.0	0.7	0.1	0.0	1.1	0.0	1.7	705.0	59.7	0.0	0.1	12.2	0.6	0.0	0.0	61.1
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 93.8;MOLT-4: 91.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.8	16.7	10.2	0.0	48.8	4.6	0.0	11.9	0.6	9.3	11.8	0.2	8.0	93.8	6.8	2.9	0.1	5.4	24.8	19.1	8.0	47.6	53.9	33.8	11.9	25.2	4.3	32.3	8.8	3.5	39.3	11.5	23.7	9.4	53.4	24.9	9.7	10.2	5.6	5.6	91.6	16.5	13.5	57.9	64.9	40.9	0.0	9.9	15.0	72.5	42.4	16.1	5.8	1.9	4.4	18.5	0.1	16.6	7.6	0.0	26.5	0.1	0.1	12.6	4.9	66.8	4.3	31.0	14.9	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6	268.0	1256.0	87.2	58.7	107.4	21.2	2.8	2.5	100.4	708.6	21.0	43.2	16.9	3.3	27.1	23.0	313.1	94.4	0.0	20.3	209.8	84.3	44.5	54.3	0.8	2357.3	20.6	189.4	31.9	161.8	37.2	5.8	624.3	195.7	1172.2	116.5	252.2	31.0	459.1	4.9	0.8	41.8	355.7	66.0	131.8	169.3	147.4	22.5	71.0	321.9	172.7
FABP6	"I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP"	ENSG00000170231	"Fatty acid binding protein 6"	P51161	5	160187367-160238735	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"intestine: 299.2"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 208.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.6;EFO-21: 19.8;HDLM-2: 8.7;NB-4: 8.1;RPMI-8226: 9.5;RT4: 9.1;U-2197: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012601, CAB024713"	Enhanced				"Intracellular and membrane"	NA	NA		650000			"CAB024713: , HPA012601: AB_1848435"	"unprognostic (3.03e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (5.35e-7)"	"unprognostic (3.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.35e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.85e-3)"	0.1	0.9	0.2	0.1	0.4	0.0	0.1	0.1	0.1	0.5	0.1	0.3	0.1	0.2	0.3	0.1	0.1	4.3	0.1	0.1	0.4	0.5	0.1	0.1	1.3	0.1	0.4	0.1	0.5	0.1	0.0	0.2	0.1	1.0	0.1	0.0	0.1	0.4	0.1	0.1	0.0	299.2	0.1	0.2	0.1	0.0	0.1	0.2	1.2	0.1	0.5	0.2	0.2	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	3.4	0.6	20.6	19.8	0.0	0.1	0.0	0.0	0.0	0.0	8.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	1.5	0.8	0.2	0.0	0.0	0.0	8.1	0.0	0.0	1.8	0.0	0.6	9.5	0.0	9.1	1.8	0.4	0.0	5.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	8.6	1.0	1.1	4.5	2.3	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.1	0.4	0.5	0.4	0.1	1.0	0.2	0.0	1.0	0.0	0.2	0.5	0.0	2.0	0.0	208.8	34.2	0.0	0.0	0.0	0.0	0.9	0.3	0.0	2.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.6	1.4
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779475-122784074	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 62.7;breast: 26.8"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 827.1"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1"	"Group enriched"	"Detected in some"	8	"AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3"	"Region enriched"	"Detected in all"	6	"olfactory region: 1471.1"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13.0	0.0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32.0	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1.0	2.1	1.3	11.2	1.3	1.2	5.7	7.0	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0.0	1.1	0.0	1.1	1.4	0.0	0.4	0.2	3.1	0.3	1.1	0.4	0.0	0.0	0.0	38.7	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.4	0.0	23.3	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0.0	34.8	15.5	51.6	27.3	32.0	16.4	11.4	30.3	11.2	6.9	0.0	0.0	0.0	0.1	10.9	6.8	0.4	0.0	0.0	0.0	0.0	11.8	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	162.7	1.1	0.0	0.0	0.0	2.5	4.8	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	827.1	0.0	0.0	0.0	0.2	37.4	0.0	0.8	0.0	0.0	16.6	5.9	0.0	0.0	0.0
FABP9	"PERF, PERF15, T-FABP"	ENSG00000205186	"Fatty acid binding protein 9"	Q0Z7S8	8	81458341-81461579	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 28.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.1;PC-3: 2.2"					"Not detected"	"Not detected"			HPA073619	Enhanced					NA	NA					"HPA073619: AB_2732229"															"unprognostic (2.99e-1)"			2.3	0.0	0.1	0.1	0.1	0.0	5.3	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.2	28.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FADS1	"D5D, FADS6, FADSD5, LLCDL1, TU12"	ENSG00000149485	"Fatty acid desaturase 1"	O60427	11	61799625-61829318	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 82.0;Rod photoreceptor cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042705	Approved					NA	NA					"HPA042705: AB_10795709"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (1.95e-9)"	"unprognostic (2.29e-2)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (2.79e-4)"	"prognostic unfavorable (1.33e-4)"	15.1	51.6	26.7	14.4	21.8	6.6	7.6	12.5	41.4	9.6	4.8	46.1	12.9	4.6	14.8	5.6	4.6	8.5	11.1	16.6	23.2	21.8	6.5	38.3	14.9	11.5	16.2	25.4	23.2	7.8	34.4	11.3	15.3	27.1	15.2	4.3	23.0	4.9	13.5	8.9	7.7	3.8	15.4	18.6	6.1	5.7	9.0	21.8	3.3	4.5	1.9	6.9	8.7	7.8	4.2	14.9	3.8	21.1	3.6	6.6	7.3	11.8	31.1	29.7	7.4	58.5	99.0	8.7	7.5	36.6	13.0	21.8	9.5	26.4	0.4	8.2	11.0	32.6	15.5	23.8	20.9	9.6	2.1	3.4	18.6	35.7	17.0	31.4	4.1	1.9	44.5	6.9	29.0	14.1	13.5	11.6	19.2	10.2	22.0	12.8	3.2	13.9	4.1	17.2	0.9	11.5	15.4	29.3	41.2	14.9	5.3	15.1	16.7	18.9	0.3	16.4	11.1	7.0	17.9	10.9	13.5	13.7	13.5	9.0	21.1	19.0	9.5	8.0	19.2	11.0	3.8	18.0	3.2	6.6	21.1	1.4	1.3	2.3	2.7	14.9	4.2	1.3	3.2	1.4	3.6	8.9	12.5	1.4	7.3	26.7	21.8	12.5	25.5	23.2	21.8	16.2	25.4	27.1	21.8	6.0	65.1	11.5	1.6	2.4	73.3	30.9	5.1	5.3	22.7	12.2	25.5	4.8	0.0	12.9	6.7	9.5	0.0	0.0	29.6	42.1	29.7	6.9	35.9	30.1	30.3	65.2	9.4	8.0	17.1	11.3	27.6	19.4	30.4	41.5	0.2	82.0	7.9	0.0	20.1	0.9	89.8	0.0	23.3	7.0	10.4	1.3	7.8	6.4	0.4	1.0
FADS2	"D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13"	ENSG00000134824	"Fatty acid desaturase 2"	O95864	11	61792980-61867354	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 204.5;seminal vesicle: 98.8"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 34.3;Muller glia cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 151.3;HBEC3-KT: 90.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006741	Approved					NA	NA					"HPA006741: AB_1078796"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.21e-2)"	"unprognostic (8.95e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.42e-4)"	7.1	85.9	34.3	10.0	31.7	7.5	20.2	10.1	48.5	23.7	4.9	28.6	204.5	9.3	19.9	10.3	3.2	8.9	6.6	8.2	24.4	29.9	3.8	38.0	9.7	6.7	28.1	20.1	8.6	3.1	41.5	11.8	12.8	26.4	32.0	4.3	16.7	5.0	98.8	3.0	26.1	3.6	39.3	17.9	3.3	3.6	10.4	24.0	8.4	2.5	3.2	9.2	10.6	6.5	3.5	13.3	6.9	9.0	6.3	9.4	3.8	1.4	53.2	79.1	43.7	72.0	151.3	20.6	8.9	80.5	13.1	35.8	3.3	17.8	0.3	1.2	19.6	19.9	1.5	51.7	90.4	5.6	0.6	1.1	30.2	10.6	7.8	56.8	1.8	1.7	56.8	2.7	47.6	4.3	19.6	38.7	28.4	1.7	24.5	6.0	1.3	17.0	10.0	34.5	0.0	14.0	23.0	1.4	74.4	52.0	0.4	23.5	28.6	5.8	0.1	2.3	19.5	2.2	22.3	15.6	1.4	14.2	0.9	1.2	11.4	10.0	4.0	1.4	10.1	16.0	4.5	5.7	6.9	9.4	9.0	2.2	1.6	3.5	5.0	10.5	3.5	2.0	4.4	3.1	6.3	7.5	13.3	3.0	3.8	34.3	31.7	10.1	25.2	24.4	29.9	28.1	20.1	26.4	24.0	8.9	13.1	0.0	1.0	1.4	6.9	3.6	2.5	0.0	6.8	3.5	3.9	1.6	0.0	5.8	1.5	2.9	0.0	0.0	15.7	18.4	8.5	18.5	4.7	12.9	16.1	4.8	5.2	3.1	3.2	3.5	23.9	3.8	8.5	34.3	0.0	29.9	4.9	0.0	22.3	0.2	13.0	0.0	10.8	0.9	0.5	0.5	2.6	4.4	0.6	0.7
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990582-89015785	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 40.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 40.1;T-cells: 30.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;Karpas-707: 44.7"					"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	450000	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	13.5	26.3	6.1	17.3	7.7	12.4	10.6	2.1	7.2	15.6	14.2	6.1	7.0	5.9	15.7	16.6	14.1	14.2	14.5	8.9	8.2	2.7	11.7	21.9	28.6	15.6	6.0	3.9	24.7	4.1	4.5	4.6	9.0	7.5	22.3	21.3	4.4	7.1	8.5	4.3	9.6	16.3	12.5	10.2	15.3	5.0	7.3	5.1	12.5	10.0	15.8	14.4	14.8	21.4	3.0	4.0	40.1	6.8	1.2	30.9	3.9	8.7	3.4	1.8	5.6	14.5	21.4	0.0	19.2	19.5	0.7	3.8	0.0	9.5	1.7	7.4	18.0	3.2	1.4	0.3	16.2	1.3	28.0	2.8	0.1	1.8	5.7	13.9	0.9	0.4	26.5	14.5	12.0	26.0	9.4	1.7	6.4	0.0	44.7	19.6	0.8	2.8	1.4	0.2	0.0	0.9	0.2	0.1	1.8	27.1	2.8	0.1	0.1	2.8	0.0	0.3	2.8	6.1	0.3	4.2	6.2	3.4	5.7	4.4	17.5	1.8	0.1	5.1	3.5	1.8	11.3	3.2	9.4	3.3	3.9	4.8	3.0	10.4	7.2	4.0	0.7	1.2	3.4	40.1	1.2	6.8	0.0	30.9	3.9	6.1	7.7	2.1	7.2	8.2	2.7	6.0	3.9	7.5	5.1	53.6	14.4	3.7	100.3	40.8	0.0	1.2	15.3	21.4	21.6	8.7	0.0	0.4	0.0	6.7	5.4	8.4	12.0	0.0	3.8	0.2	34.9	22.7	3.5	15.3	5.0	1.6	8.1	2.5	6.9	3.5	17.5	12.7	11.8	20.8	15.0	17.1	4.3	0.0	13.1	11.5	0.7	6.5	33.4	4.8	1.3	38.3	0.3	37.9	23.2	22.7
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 103.0;Hepatocytes: 169.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 155.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		1600000	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.6	24.8	11.5	7.9	18.7	12.7	24.7	4.7	6.1	5.0	9.2	25.9	16.1	7.9	3.9	3.6	14.0	19.7	11.1	21.7	0.9	3.7	48.3	16.3	18.5	34.6	5.3	8.8	2.5	12.1	5.7	12.7	3.0	1.7	5.6	7.4	24.6	7.0	1.7	40.9	9.5	14.0	22.4	3.7	14.4	8.5	6.5	15.6	5.6	30.3	28.7	16.0	6.9	155.8	12.6	4.4	27.8	16.8	9.7	7.3	15.1	6.0	11.3	9.5	2.1	8.1	4.4	9.6	10.8	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8	23.8	103.0	0.8	10.3	6.9	24.9	4.8	25.5	6.7	10.3	10.4	5.9	28.9	3.3	18.9	1.2	4.5	20.8	23.3	24.9	65.8	10.4	65.5	12.7	169.2	11.7	28.6	17.4	11.1	6.9	1.3	15.3	5.0	16.9	8.2	18.9	12.3	16.1	17.5	10.6	5.5	9.5	0.0	9.6	1.9	13.9	12.0	24.7	10.7	18.3	17.5
FDFT1		ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839309	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	20.8	44.3	26.3	22.7	27.7	30.6	57.5	19.5	43.6	27.6	41.7	45.9	20.0	44.6	26.9	29.1	59.4	27.5	19.9	27.1	29.8	32.1	24.9	45.9	30.7	23.4	36.2	34.4	22.9	18.0	17.1	18.2	22.1	47.4	38.8	32.9	32.4	46.5	20.6	71.2	38.4	30.2	18.0	56.5	18.4	35.4	41.3	40.5	25.9	24.7	32.2	25.4	25.8	34.2	44.0	30.5	42.2	19.6	22.6	31.0	29.0	21.6	10.5	47.1	18.8	10.2	17.5	14.3	8.5	14.5	9.0	18.7	14.7	26.8	30.1	4.2	8.5	52.3	18.0	23.3	71.0	7.3	5.0	24.9	14.1	8.0	35.0	21.7	7.3	9.9	15.7	18.0	20.1	10.0	6.9	11.3	35.0	20.3	39.7	8.8	14.1	25.7	17.4	41.2	18.0	6.2	15.8	10.9	61.8	41.8	78.8	15.1	9.4	7.4	12.6	21.3	18.7	20.7	21.3	14.1	4.2	10.5	1.9	5.3	8.2	20.7	32.8	7.4	24.8	12.4	42.2	19.6	22.6	21.6	17.2	20.8	44.0	22.7	21.2	30.5	35.3	21.5	20.3	18.6	22.6	11.7	22.7	31.0	29.0	26.3	27.7	19.5	43.6	29.8	32.1	36.2	34.4	47.4	40.5	50.6	130.3	65.1	88.1	46.6	14.4	61.6	107.0	89.7	86.4	75.0	13.7	242.8	74.6	133.2	225.3	35.0	92.9	46.7	248.7	118.9	42.5	90.7	54.4	67.1	77.6	11.1	75.9	16.5	49.7	171.1	71.4	48.9	96.2	125.4	83.9	56.6	133.6	63.2	50.2	63.4	19.7	51.8	62.1	181.7	75.9	77.7	146.3	48.4	83.2	141.3
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 83.6;RPTEC TERT1: 88.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA		81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	7.8	7.9	0.0	8.1	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.2	0.1	83.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.0	88.8	0.0	0.0	0.5	0.2	1.2	0.0	7.3	11.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2	461.6	156.4	0.0	7.8	0.8	0.0	0.3	35.7	178.0	316.2	301.8	0.0	307.8	112.7	15.6	0.0	0.0	0.0	0.0	1.2	101.0	3.8	4.7	4.7	0.0	26.1	0.0	1.7	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.4	4.1	0.0	0.0	286.0	0.0	0.0	0.1	0.0	0.1	0.1	216.6	0.0	0.0	8.6
FOLR2		ENSG00000165457	"Folate receptor beta"	P14207	11	72216601-72221950	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 838.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 27.8;intermediate monocyte: 20.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.8;monocytes: 27.8"	"Cell line enriched"	"Detected in some"	5	"U-698: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		12000000				"unprognostic (2.03e-1)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.98e-3)"	59.4	17.7	5.4	7.4	4.5	2.0	16.3	1.0	4.7	8.3	17.3	6.3	2.0	5.0	9.1	32.3	10.3	12.3	22.4	28.8	4.3	3.0	11.9	19.9	15.4	21.3	5.0	2.9	7.9	4.9	2.6	4.3	57.8	5.4	14.9	13.1	12.2	9.3	4.6	17.4	6.5	11.9	12.4	4.8	21.3	8.6	11.2	2.0	9.5	7.3	9.7	9.6	20.9	4.7	4.2	7.8	0.4	27.8	0.6	0.1	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.2	0.2	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.3	0.0	20.1	0.5	0.9	0.0	0.0	27.8	0.0	0.1	20.3	0.0	4.2	0.0	0.0	7.8	1.2	0.0	0.0	0.4	0.6	5.1	0.1	0.0	7.8	5.4	4.5	1.0	4.7	4.3	3.0	5.0	2.9	5.4	2.0	0.0	1.1	3.2	0.0	7.0	0.0	1.9	2.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.8	1.6	0.0	0.0	0.0	4.2	5.3	0.2	2.3	0.8	838.4	0.0	0.0	3.1	177.7	1.6	1.4	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.6	0.2	4.4	13.4	0.7	0.0	0.1
FOLR3	FR-G	ENSG00000110203	"Folate receptor 3"	P41439	11	72114869-72139892	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.4;bone marrow: 43.4;lymphoid tissue: 22.6"	"Cell type enriched"	"Detected in some"	15	"Distal tubular cells: 344.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 5.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"classical monocyte: 52.9;neutrophil: 73.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 73.4;monocytes: 52.9"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 35.6;U-2197: 31.5"														"Secreted to blood"	NA	NA		9600000				"unprognostic (1.47e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.90e-2)"	"unprognostic (8.39e-2)"	"unprognostic (9.99e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.03e-6)"	"unprognostic (4.17e-1)"	2.9	0.3	0.1	4.8	0.2	43.4	4.2	0.1	0.8	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.4	1.0	0.1	1.7	0.2	0.1	2.7	0.6	14.4	8.2	0.2	0.0	0.1	1.7	0.0	0.1	4.5	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.2	0.1	22.6	0.4	0.7	0.2	0.3	0.9	0.4	0.4	0.2	7.5	0.0	5.1	73.4	52.9	0.0	0.2	29.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.0	6.2	1.8	4.5	0.0	0.0	0.0	0.6	0.9	0.1	0.4	0.0	3.3	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	2.6	35.6	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.1	31.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	52.9	4.3	0.0	3.5	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	73.4	0.0	0.1	0.9	0.0	29.5	0.1	0.2	0.1	0.8	0.2	0.1	0.2	0.0	0.2	0.2	0.0	12.2	0.0	0.0	0.2	0.0	0.0	0.0	2.7	3.4	22.7	0.0	0.0	344.8	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	1.6	0.0	0.0	0.6	8.7	8.6	0.0	11.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.2;tongue: 46.8"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 279.5;Basal keratinocytes: 300.3;Glandular cells: 139.2;Suprabasal keratinocytes: 296.9;Urothelial cells: 386.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 6.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 94.2;U-2197: 63.2;WM-115: 142.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	22.4	3.7	1.5	8.2	3.1	17.9	3.6	1.1	2.8	5.4	2.8	1.5	0.2	0.8	2.1	2.0	35.2	4.4	24.4	5.8	2.3	1.3	2.2	4.4	7.7	1.7	2.6	0.5	2.6	9.9	0.4	2.0	3.2	6.5	3.1	1.7	0.6	5.4	1.0	6.6	9.2	2.0	3.6	3.5	1.6	8.7	1.5	2.3	0.3	2.1	46.8	16.5	16.6	4.6	0.0	6.9	1.0	1.6	0.0	0.6	1.1	36.6	5.4	0.6	2.4	5.5	5.5	5.3	34.3	31.5	29.7	16.7	1.7	30.5	0.0	7.5	23.7	46.9	6.9	2.2	27.6	25.5	1.1	0.0	2.2	0.5	4.0	6.9	1.4	0.8	2.3	2.8	23.3	35.2	14.5	9.5	0.0	5.3	0.2	38.9	1.5	0.0	3.0	2.5	3.1	94.2	0.1	3.0	0.1	13.8	2.4	0.0	0.0	2.0	0.0	25.7	1.6	0.1	1.3	23.7	35.2	7.2	63.2	50.2	0.0	0.1	0.1	49.5	0.6	142.9	0.0	1.6	0.0	0.3	1.1	0.2	0.0	0.6	0.3	6.9	0.0	0.6	0.0	1.0	0.0	0.5	0.8	0.0	1.1	1.5	3.1	1.1	2.7	2.3	1.3	2.6	0.5	6.5	2.3	6.0	4.1	0.0	279.5	300.3	0.0	0.6	0.0	9.4	19.4	0.0	0.0	1.1	0.0	14.2	0.1	11.3	2.8	0.0	3.1	3.8	23.0	139.2	9.2	0.0	1.8	0.0	10.9	8.0	0.6	0.0	0.3	9.0	42.2	1.8	1.2	0.0	23.7	0.2	0.0	0.0	0.0	0.0	40.8	0.2	0.7	296.9	14.8	0.0	0.7	386.7
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease mutation, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 258.1;pancreas: 68.9;salivary gland: 91.7"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"MOLT-4: 141.0;RPTEC TERT1: 323.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA		26000	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	0.3	0.2	0.2	0.2	0.1	0.0	0.7	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.3	2.8	0.3	0.3	54.7	0.2	0.1	0.2	258.1	2.2	0.2	0.6	0.1	0.0	0.4	68.9	0.0	0.3	0.6	0.1	0.3	0.0	0.1	91.7	0.1	0.1	0.2	0.3	0.1	0.1	0.4	0.2	0.2	0.0	9.5	0.2	0.3	0.4	0.2	0.6	0.4	3.2	0.0	1.1	8.4	14.1	2.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.2	0.0	0.0	0.0	0.0	141.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	323.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	1.1	0.2	1.8	14.1	0.2	0.4	5.1	4.1	0.0	8.4	0.0	3.2	1.6	2.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.1	0.8	1434.4	0.0	0.0	413.5	0.0	0.1	2501.8	465.3	14.4	1.3	0.0	0.0	8.3	0.1	1.1	0.1	0.0	2.4	2.9	0.0	14.6	5.5	4.3	15.4	8.6	2.6	0.0	14.4	0.0	0.5	33.3	0.0	7.1	3101.2	3.5	6.5	3.9	0.4	0.2	0.6	0.2	0.0	0.0	0.0
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675420-209676388	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 203.9;liver: 154.7"	"Cell type enhanced"	"Detected in many"	6	"Pancreatic endocrine cells: 558.7;Urothelial cells: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	62	"neutrophil: 89.5"	"Lineage enriched"	"Detected in single"	197	"granulocytes: 89.5"	"Group enriched"	"Detected in some"	6	"ASC diff: 77.1;HBEC3-KT: 116.4;PC-3: 29.2;RPMI-8226: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"	130.1	23.3	1.1	18.5	1.1	203.9	85.2	2.0	0.9	2.0	11.3	1.4	29.9	1.6	6.1	9.3	2.0	4.0	13.5	43.7	1.1	0.8	22.2	154.7	51.6	6.4	1.8	0.0	18.4	5.3	0.5	1.2	2.6	1.3	8.7	1.1	3.1	49.2	73.5	97.9	3.0	3.5	3.8	1.5	6.3	7.1	5.3	1.1	0.0	3.1	14.3	6.1	12.6	13.1	0.0	0.0	89.5	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.0	77.1	2.7	0.0	0.1	0.2	0.3	0.3	3.0	2.4	0.0	0.6	0.5	0.4	0.0	0.0	116.4	0.7	0.1	0.2	0.0	0.2	0.1	6.3	0.0	0.0	8.0	0.2	5.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	29.2	0.0	0.0	37.1	0.2	0.0	0.1	0.2	2.6	0.0	0.6	0.0	0.0	8.9	11.7	0.0	0.8	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	1.1	1.1	2.0	0.9	1.1	0.8	1.8	0.0	1.3	1.1	8.9	93.3	5.6	295.9	206.4	0.2	325.1	12.7	41.5	55.7	10.4	0.0	1.1	253.7	40.5	12.3	26.3	16.9	0.0	123.5	3.9	183.7	312.4	36.0	83.1	183.0	0.0	28.2	14.1	41.0	7.4	106.2	375.5	310.4	50.5	30.7	19.9	558.7	40.3	67.1	223.2	0.0	32.3	88.6	21.4	1.1	141.0	3.5	4.8	37.5	443.6
GIF	"IF, IFMH, INF, TCN3"	ENSG00000134812	"Gastric intrinsic factor"	P27352	11	59829268-59845501	"Disease related genes, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"stomach 1: 185.6"	"Cell type enriched"	"Detected in single"	108	"Exocrine glandular cells: 10.8"	"Cancer enriched"	"Detected in some"	11	"stomach cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039908, HPA040774"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA039908: AB_10796335, HPA040774: AB_10795626"			"unprognostic (2.78e-4)"								"unprognostic (1.04e-1)"		"unprognostic (2.45e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	7.1	0.0	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	185.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.3;Late spermatids: 44.8;Spermatocytes: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.1	9.9	10.1	13.3	11.0	9.4	15.5	11.0	13.7	7.6	22.0	8.9	12.3	14.9	38.3	17.3	15.7	13.4	20.9	11.3	11.3	22.5	12.7	11.2	18.2	14.9	7.1	15.3	17.5	18.8	8.6	8.7	20.7	16.1	19.5	17.7	25.2	17.9	12.9	8.5	29.2	17.7	18.3	24.6	29.1	10.4	9.7	11.9	8.9	26.8	16.3	9.6	8.5	30.0	12.9	6.3	16.5	11.0	19.2	15.2	19.6	47.1	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8	8.9	7.0	10.2	6.2	5.8	6.6	10.9	0.0	9.4	4.5	7.0	7.9	14.2	5.0	9.6	55.3	3.1	11.4	0.0	5.4	9.5	5.1	4.8	9.2	10.5	13.4	9.5	5.2	3.7	12.6	44.8	9.5	9.9	3.3	20.8	13.4	8.4	7.6	5.8	6.0	11.1	8.2	12.9	5.1	45.3	28.1	5.9	11.1	11.5	13.9	4.3
GLIPR1	"GliPR, RTVP1"	ENSG00000139278	"GLI pathogenesis related 1"	P48060	12	75480680-75503853	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.8"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 303.3;Hofbauer cells: 220.1;Kupffer cells: 261.5;Macrophages: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.8;U-138 MG: 79.5;U-87 MG: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011014	Approved				"Intracellular and membrane"	NA	NA					"HPA011014: AB_1849714"	"unprognostic (2.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.09e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.69e-9)"	"unprognostic (9.06e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	32.0	12.5	6.7	30.4	7.5	10.9	11.8	2.5	10.2	14.7	13.1	5.2	6.0	4.5	28.8	19.2	8.0	20.2	23.1	12.7	6.3	5.4	10.3	8.2	18.6	45.4	9.3	6.6	18.3	4.5	1.4	5.6	24.2	11.1	12.3	9.0	7.2	13.7	12.5	3.3	3.7	16.2	27.0	19.6	32.0	15.4	7.2	8.1	8.9	7.3	4.3	20.9	20.6	8.9	15.2	39.7	76.8	55.1	3.0	20.0	34.7	1.4	1.5	1.2	0.1	4.8	10.3	0.2	19.7	20.8	16.6	12.1	0.8	0.6	4.9	4.1	21.3	14.7	0.2	0.0	8.1	27.2	7.9	0.3	0.2	1.8	1.2	5.5	1.7	0.2	9.5	3.0	40.8	9.0	26.8	13.4	0.3	0.3	6.2	31.0	0.0	0.8	4.1	0.1	0.0	0.6	0.2	0.9	0.1	1.7	0.3	0.0	0.0	8.1	0.0	0.0	2.8	0.2	1.4	21.6	79.5	7.5	8.4	30.0	1.1	0.1	0.4	31.5	2.0	1.1	2.8	55.1	6.3	20.0	38.0	13.5	12.0	14.3	15.7	39.7	15.2	4.3	9.1	76.8	3.0	40.6	33.4	14.6	34.7	6.7	7.5	2.5	10.2	6.3	5.4	9.3	6.6	11.1	8.1	11.9	16.5	78.6	66.6	12.0	2.5	0.7	7.6	12.0	4.5	3.5	3.9	3.6	0.0	94.4	10.2	6.3	0.0	0.0	71.1	303.3	25.7	70.6	9.3	3.4	220.1	6.4	3.4	13.5	261.5	4.5	13.3	237.2	15.1	13.6	0.3	2.0	65.0	2.9	50.5	1.4	2.8	12.9	27.4	1.9	1.1	8.5	14.1	117.9	0.1	23.7
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850943-109880488	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3"	"Cell type enhanced"	"Detected in many"	8	"Suprabasal keratinocytes: 418.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056461, HPA065503"	Approved		Supported	Cytosol		NA	NA		280000	Cytosol		"HPA056461: AB_2683138, HPA065503: "	"unprognostic (1.18e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (4.17e-6)"	"unprognostic (3.28e-2)"	7.0	5.8	11.4	6.1	16.4	6.6	10.5	4.7	19.3	21.8	13.2	31.3	6.6	5.4	5.4	13.4	82.0	4.9	5.4	6.4	15.9	9.7	13.7	4.5	9.2	7.0	22.4	8.9	5.9	7.7	5.7	3.4	7.9	14.8	8.0	11.8	4.0	21.2	8.0	6.1	84.3	8.2	7.1	48.7	7.4	7.6	4.0	24.7	6.2	8.9	60.6	78.0	10.8	38.5	11.8	23.2	16.7	32.3	21.2	26.7	17.2	14.2	10.2	5.9	6.3	14.1	16.3	4.3	17.7	22.0	13.7	11.6	4.0	5.5	12.6	9.5	21.7	6.7	17.6	9.1	20.8	19.6	12.8	8.1	8.2	6.2	6.1	12.4	8.8	9.7	12.0	26.2	24.5	17.4	20.8	23.0	13.1	3.7	8.7	20.1	19.7	11.9	7.2	10.6	11.8	13.8	10.7	14.0	13.2	7.7	42.9	7.5	7.5	11.1	29.0	9.4	5.7	13.5	3.1	31.4	15.7	8.5	23.1	13.3	11.5	9.6	8.6	31.7	9.2	9.7	16.7	32.3	16.5	26.7	30.8	16.2	11.8	16.1	23.3	23.2	11.4	10.5	18.8	15.8	21.2	24.8	3.7	17.6	17.2	11.4	16.4	4.7	19.3	15.9	9.7	22.4	8.9	14.8	24.7	23.8	58.2	25.4	91.0	129.1	11.8	13.3	20.4	29.4	52.4	41.8	13.7	64.4	169.1	34.4	12.2	35.0	79.9	0.0	49.6	16.3	33.4	71.1	19.7	11.9	31.9	12.7	31.2	28.3	40.0	9.7	21.3	47.5	57.3	45.9	41.0	15.1	42.3	35.1	17.0	25.6	11.6	38.8	41.8	17.0	22.0	418.8	176.1	43.3	42.2	95.9
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103819-50111319	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.3;skeletal muscle: 106.9"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 94.2;Proximal tubular cells: 265.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044620	Enhanced					NA	NA		3800000			"HPA044620: AB_10796803"	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	116.3	1.2	2.4	3.6	3.0	0.3	44.9	1.6	3.9	0.3	13.4	12.2	0.4	16.2	0.3	3.0	1.2	0.3	8.1	3.9	4.3	2.7	30.6	31.4	4.0	1.6	6.8	1.2	0.2	1.8	2.3	0.3	0.2	13.5	0.5	0.9	0.1	17.7	0.5	106.9	2.0	23.5	0.5	24.7	0.2	0.8	0.3	2.0	0.0	0.7	14.1	0.3	1.1	0.3	0.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	9.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	11.9	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	3.0	1.6	3.9	4.3	2.7	6.8	1.2	13.5	2.0	3.0	2.7	7.4	0.2	0.0	2.9	4.8	12.7	0.0	2.3	5.2	7.9	0.0	36.5	0.3	0.0	0.0	7.8	0.0	0.6	0.0	0.0	0.1	0.0	94.2	2.4	3.2	1.2	1.8	0.3	0.0	0.0	0.2	1.7	1.8	4.2	2.7	0.6	5.8	0.0	265.1	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.1
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 321.8;Late spermatids: 797.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.8	108.3	9.5	74.2	31.2	23.2	22.7	29.7	23.5	37.5	45.2	61.0	27.3	50.7	44.1	29.0	25.5	53.6	57.3	64.5	42.6	56.3	23.2	65.0	52.2	64.2	20.2	84.2	42.4	31.8	26.7	44.2	23.0	47.4	35.0	34.4	33.1	40.1	26.3	65.2	36.6	29.5	25.7	69.7	38.4	34.3	25.1	95.7	46.9	51.8	51.9	30.2	59.8	105.5	21.6	17.8	23.9	26.9	30.1	14.2	31.2	40.1	45.7	74.2	42.1	46.0	47.2	64.1	28.6	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0	26.8	40.2	23.1	22.0	23.0	92.5	198.3	38.2	21.4	25.0	54.1	70.7	38.6	97.8	77.9	321.8	30.6	90.3	0.0	57.9	60.0	36.8	27.8	22.0	68.1	78.6	224.1	61.2	47.9	41.6	797.8	34.2	41.9	33.7	45.9	67.6	28.6	75.7	25.9	28.7	79.1	62.2	19.4	38.7	6.9	7.6	28.7	32.8	47.1	102.1	32.5
GPIHBP1	"GPI-HBP1, LOC338328"	ENSG00000277494	"Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1"	Q8IV16	8	143213193-143217170	"Disease related genes, Predicted intracellular proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.6;brain: 18.5"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 5.6;Endothelial cells: 23.6;Ito cells: 15.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.6"									HPA066302	Enhanced				"Intracellular and membrane"	NA	NA					"HPA066302: AB_2685654"	"unprognostic (2.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-3)"	47.6	2.2	0.0	0.3	11.5	0.1	9.0	0.6	7.5	1.6	1.7	17.9	0.0	0.4	1.6	0.2	2.0	2.2	3.7	8.3	2.1		2.6	0.7	13.0	1.3	18.5	2.9	1.9	0.6	0.3	0.0	4.0	9.7	0.7	0.4	1.1	0.5	1.1	16.0	1.6	0.3	1.5	12.8	4.2	0.4	1.4	10.2	0.0	0.6	0.4	0.7	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	5.6	0.0	0.1	1.3	0.0	2.8	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.1	23.6	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	15.4	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 922.0;Distal tubular cells: 441.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	23.1	18.3	12.8	22.9	79.0	43.7	13.0	19.5	29.9	20.1	19.7	21.8	22.6	11.6	13.7	31.9	22.6	18.3	21.2	27.6	24.7	26.1	18.5	26.6	10.9	42.7	33.9	21.5	20.4	42.3	45.5	20.9	34.0	34.3	37.2	18.0	22.3	18.8	41.9	17.0	12.0	41.5	8.9	34.8	19.9	13.3	42.2	22.0	41.3	32.9	6.1	21.1	33.4	38.1	51.2	16.0	23.6	38.4	25.7	19.0	19.9	17.8	14.0	14.1	21.2	20.4	21.8	34.3	18.8	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8	44.7	32.2	48.9	103.6	55.2	29.0	922.0	127.4	46.8	42.1	92.5	53.0	177.3	441.0	96.4	60.4	68.1	196.9	116.8	50.2	61.8	59.6	61.5	62.2	218.5	127.1	12.7	71.9	67.5	100.7	74.5	52.3	80.0	84.4	77.5	85.7	52.4	56.5	91.7	59.1	244.7	72.5	71.1	92.4	75.6	46.1	47.8	156.1	48.0	100.9	85.2
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3	0.0	2.6	0.0	0.1	23.7	4.2	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.1	2.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.3	8.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.6	0.0	24.7	0.0	0.1	15.6	0.1	0.0	0.0	0.1
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641390	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.8"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 44.7;Fibroblasts: 34.9;Melanocytes: 28.7;Urothelial cells: 95.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBF TERT88: 34.7;hTEC/SVTERT24-B: 33.4;LHCN-M2: 44.3;U-138 MG: 87.1;U-251 MG: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052060			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA052060: AB_2681712"	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.8	0.9	1.6	9.1	2.4	0.0	5.5	0.8	1.7	4.0	8.5	2.0	0.0	2.6	1.5	2.5	4.8	3.9	7.7	8.3	1.7	1.7	1.2	2.7	6.5	4.5	1.8	0.6	1.2	1.8	0.3	0.7	2.1	5.7	4.3	5.6	2.7	1.9	0.1	2.7	3.8	9.5	3.7	4.2	0.3	2.3	3.2	2.6	0.4	1.7	5.5	2.1	5.7	1.4	0.0	0.2	0.7	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	1.0	2.6	0.0	4.9	3.7	6.5	11.2	0.0	0.0	0.0	0.0	4.4	0.0	0.8	0.0	0.0	34.7	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	6.8	0.0	33.4	3.0	0.1	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.7	0.0	0.0	0.4	0.0	0.1	2.1	0.0	1.1	2.0	0.0	0.0	0.0	87.1	0.3	8.1	25.8	0.0	0.0	0.0	1.8	0.0	1.7	0.5	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.3	0.2	0.2	0.1	0.0	1.6	2.4	0.8	1.7	1.7	1.7	1.8	0.6	5.7	2.6	0.0	0.0	0.0	44.7	14.4	0.0	1.2	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.7	12.7	2.2	0.0	0.0	0.0	0.0	34.9	5.5	13.8	0.0	0.2	0.0	1.2	0.0	0.0	1.6	1.7	1.6	28.7	0.0	1.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	10.8	0.2	0.0	10.5	0.1	0.0	3.3	95.7
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105564-69118719	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;urinary bladder: 22.9"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.4;PC-3: 76.9;RT4: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031554, CAB033850"	Supported		Approved	Microtubules		NA	NA			Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.4	0.2	0.4	0.4	1.0	0.3	5.5	1.1	1.3	3.3	3.7	0.4	0.4	1.9	0.8	1.1	22.6	0.7	3.5	2.4	0.6	0.6	1.2	0.7	18.0	0.4	0.4	0.4	0.9	2.2	0.1	1.0	3.3	1.1	3.5	2.3	0.6	7.6	2.1	0.6	5.7	2.1	1.4	0.4	0.4	9.0	2.0	0.4	0.5	4.0	11.7	11.1	22.9	13.6	1.5	1.2	2.2	1.4	0.4	2.0	1.1	0.9	4.8	0.3	0.2	0.1	0.1	1.8	0.3	0.1	0.2	0.1	1.0	2.5	0.2	0.6	0.1	1.1	14.4	0.8	8.6	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.4	0.3	0.8	1.1	0.1	0.1	0.0	0.1	0.0	0.5	0.3	0.1	4.3	5.0	76.9	0.5	0.0	0.0	7.9	30.4	5.4	0.2	0.5	0.0	0.1	0.9	0.2	0.2	0.1	0.2	0.2	8.4	0.5	0.3	0.2	0.0	0.3	0.0	0.1	0.8	1.4	2.2	1.4	0.7	1.3	0.7	1.1	0.5	1.2	1.5	2.0	0.7	0.5	0.4	1.1	1.0	1.5	1.1	0.4	1.0	1.1	1.3	0.6	0.6	0.4	0.4	1.1	0.4	0.0	25.0	0.0	35.3	144.1	1.4	1.4	0.0	0.0	4.5	0.0	2.0	0.9	0.0	3.2	10.2	2.0	2.0	0.0	3.1	0.7	0.8	9.4	0.0	0.0	0.3	0.0	0.0	1.3	0.0	17.0	1.1	0.6	3.3	0.0	0.3	0.1	2.3	0.0	0.4	0.6	0.9	0.0	2.5	0.6	0.4	138.5	0.2	0.5	1.5	89.2
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Plasma proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 210.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004189, CAB026457"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.39e-5)"	"prognostic unfavorable (4.12e-4)"	38.2	38.7	18.1	18.1	27.7	15.9	37.4	18.1	27.0	39.6	30.4	24.7	38.2	22.5	34.8	43.2	35.3	38.7	30.9	37.5	17.9	15.9	33.9	92.0	29.9	20.9	19.8	16.6	40.1	210.4	40.5	40.0	44.4	22.5	35.9	29.4	26.1	105.2	34.3	80.2	27.6	36.1	29.9	18.5	23.0	39.2	39.6	19.3	20.8	39.0	45.7	34.7	31.9	31.0	10.9	22.4	11.6	28.8	10.1	12.3	12.4	34.4	27.7	29.0	46.2	74.2	91.1	41.3	86.0	88.3	39.1	56.0	24.8	35.3	10.5	10.4	124.4	39.5	27.6	43.2	56.3	64.2	16.7	26.7	33.5	35.0	60.5	72.7	23.9	29.2	67.3	45.8	56.8	64.0	61.5	53.3	16.9	31.8	14.1	61.0	35.9	13.7	12.5	28.1	33.9	18.4	12.8	56.4	20.9	31.9	41.1	24.2	27.7	37.5	39.5	33.5	37.7	31.2	23.4	66.9	47.9	30.5	66.1	36.0	16.7	13.7	18.6	60.7	17.8	43.8	11.6	20.0	9.1	9.3	21.9	12.3	10.9	10.6	11.1	22.4	7.4	9.6	8.9	11.5	10.1	28.8	14.7	9.8	12.4	18.1	27.7	18.1	27.0	17.9	15.9	19.8	16.6	22.5	19.3	71.5	78.3	34.3	93.1	62.4	40.0	194.7	68.8	192.7	135.4	71.5	41.2	101.3	114.4	97.3	89.3	67.6	127.8	23.3	105.3	136.3	141.1	173.9	65.9	177.0	82.5	65.2	92.7	87.8	59.9	303.9	137.8	58.4	54.0	82.0	181.5	47.2	115.6	122.0	164.4	96.7	35.3	64.7	111.0	124.2	118.4	67.9	180.2	35.2	119.7	133.4
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Predicted intracellular proteins, Predicted membrane proteins"	"Copper transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 68.7"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 139.7;Mucus-secreting cells: 80.7;Paneth cells: 106.6;Undifferentiated cells: 56.0"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.9;HEL: 11.0;HSkMC: 16.6;K-562: 30.8;LHCN-M2: 12.7;SuSa: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA005824	Approved					NA	NA		1200000			"HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	4.0	12.2	8.3	10.9	9.3	0.0	3.9	3.7	10.1	11.6	38.4	9.7	8.9	32.9	18.3	9.0	7.5	8.7	21.4	14.8	8.1	5.0	3.7	1.4	7.1	1.3	9.2	10.2	10.2	1.0	0.9	2.5	0.9	8.5	11.0	33.5	11.4	3.0	14.5	0.5	2.8	68.7	34.8	6.7	4.4	8.6	3.2	8.8	0.0	3.2	2.7	1.1	11.2	6.4	0.0	0.2	0.0	0.0	0.0	0.6	0.5	0.0	0.0	12.9	1.0	0.0	0.0	0.3	3.2	0.1	0.0	0.0	7.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	3.6	0.0	11.0	0.0	0.0	0.1	0.0	0.0	16.6	0.0	0.0	0.0	4.5	0.0	0.0	30.8	0.3	12.7	0.0	0.0	0.2	6.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.6	0.0	0.0	0.3	7.4	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.3	9.3	3.7	10.1	8.1	5.0	9.2	10.2	8.5	8.8	0.0	0.0	0.5	0.0	0.8	0.7	23.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.5	2.3	139.7	0.0	1.0	0.0	6.2	0.3	0.0	0.0	0.2	0.0	39.2	6.2	0.0	1.1	10.6	0.0	0.0	0.0	80.7	24.9	3.0	106.6	28.0	0.0	0.8	6.5	12.5	0.0	0.2	0.5	0.0	0.0	56.0	0.1
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 alpha subunit"	Q16665	14	61695513-61748259	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 47.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 47.8"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 119.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	31.9	62.0	15.6	45.2	17.8	125.2	24.9	22.7	18.5	45.7	15.3	12.3	23.5	10.8	17.7	31.3	31.2	21.7	50.0	19.4	17.5	16.5	76.4	42.7	42.8	27.3	18.3	11.0	34.5	12.7	13.7	26.8	24.2	25.1	17.6	13.9	14.0	24.6	36.2	8.0	17.4	16.9	18.7	27.2	57.3	16.0	21.1	12.4	24.7	26.9	18.4	28.8	37.8	21.5	6.6	6.0	47.8	6.8	6.2	7.9	5.1	38.0	15.2	15.3	43.7	24.3	39.2	20.7	31.7	38.2	39.9	36.0	6.6	12.6	9.3	23.9	39.1	11.4	9.0	9.8	52.0	50.0	4.0	5.1	5.7	14.0	11.4	54.2	2.4	6.2	68.3	16.5	29.3	31.4	53.9	25.1	5.4	3.8	0.0	119.1	7.9	7.4	2.9	13.8	6.0	20.1	0.5	34.3	2.7	51.5	25.3	12.9	14.3	59.4	8.5	20.9	21.8	8.9	4.5	14.9	90.7	20.3	30.0	26.6	5.0	7.2	10.6	47.8	4.7	24.5	11.2	6.8	47.8	3.8	5.5	4.9	6.5	5.0	4.4	6.0	6.6	7.9	5.1	18.2	6.2	5.6	2.9	3.4	5.1	15.6	17.8	22.7	13.2	17.5	16.5	18.3	11.0	25.1	12.4	65.5	115.1	54.6	71.5	94.4	49.4	37.3	86.6	33.5	69.4	247.7	47.1	22.6	87.9	226.7	3.1	113.7	30.7	0.0	216.2	57.6	82.5	54.8	217.2	23.7	123.2	147.8	63.8	177.4	143.9	3.6	22.5	156.8	97.8	76.7	36.5	141.2	213.6	23.0	45.6	116.2	52.0	51.8	129.7	27.4	24.9	76.9	21.3	60.6	34.8	75.6
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75362104	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797"	Approved					NA	NA					"CAB016797: , HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	5.6	28.9	12.4	8.7	31.1	12.1	16.4	14.4	36.3	13.9	23.0	10.9	7.1	18.9	9.0	14.4	35.0	6.5	8.2	4.0	21.8	16.5	12.1	53.5	12.1	7.0	9.8	19.4	15.2	8.4	16.2	11.4	9.2	29.6	12.4	19.7	7.8	12.4	4.5	3.4	36.1	19.0	6.8	17.0	7.9	14.6	14.0	8.8	13.9	12.5	23.2	12.4	6.2	18.1	4.3	12.5	23.2	11.0	9.5	6.5	5.1	15.3	6.0	61.4	21.1	13.0	25.2	15.4	4.4	12.4	9.0	20.1	22.6	37.8	13.7	16.1	7.1	58.9	19.4	31.9	51.8	9.6	4.6	11.7	10.5	9.1	17.5	19.2	8.7	7.7	16.3	30.5	31.5	15.6	4.5	7.2	19.7	11.2	21.0	14.2	10.0	16.0	8.8	26.2	3.9	4.5	11.3	18.4	19.6	37.1	35.8	21.3	9.7	9.7	10.1	8.8	22.1	10.0	22.9	8.4	4.9	7.3	5.2	7.5	6.7	8.5	18.9	7.1	17.1	10.1	6.7	11.0	6.3	6.1	6.9	5.1	4.3	4.6	6.4	12.5	4.2	4.5	6.2	23.2	9.5	7.4	3.9	6.5	5.1	12.4	31.1	14.4	36.3	21.8	16.5	9.8	19.4	29.6	8.8	17.9	33.4	7.5	8.5	36.9	20.9	5.7	12.7	32.1	22.7	26.2	17.7	16.3	3.3	12.1	38.1	7.6	33.8	0.0	18.8	21.6	10.5	13.9	24.2	22.5	11.5	38.1	41.2	9.8	19.3	19.5	8.6	12.3	15.1	2.8	50.6	10.3	11.9	20.1	5.6	6.3	13.1	12.9	8.2	21.0	14.0	80.0	39.0	8.7	20.2	17.3
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 206.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		310000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	14.9	7.2	120.5	13.8	7.0	27.9	8.1	2.4	9.5	3.4	6.9	12.5	21.6	15.9	5.4	3.4	80.3	11.8	30.0	69.5	3.6	3.4	36.0	5.9	6.6	16.9	11.1	12.8	4.2	15.3	8.4	18.1	7.2	2.1	3.5	14.8	10.5	43.5	2.8	6.9	11.5	15.6	21.6	6.0	3.8	8.3	16.9	17.6	53.4	23.2	10.3	5.0	12.3	6.2	3.6	18.2	9.6	17.0	4.2	2.6	13.0	2.7	2.2	5.9	8.9	21.7	2.3	15.4	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1	62.5	124.5	45.6	35.9	96.3	27.9	7.4	56.0	48.2	36.4	45.4	49.1	20.4	11.6	30.6	5.0	19.7	86.8	0.0	52.0	35.5	35.0	65.2	59.8	78.4	20.7	46.1	88.4	23.4	20.8	1.8	11.8	17.2	25.3	78.5	44.0	19.7	36.3	30.9	13.4	17.7	43.3	0.0	24.9	14.1	7.8	206.6	37.2	20.1	31.2	65.0
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell type enhanced"	"Detected in many"	24	"Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 35.4;RT4: 63.6"	"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria		NA	NA		820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.2	0.2	0.0	63.6	0.0	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3	3.0	6.7	7.5	3.6	0.1	0.0	4.5	68.8	0.0	0.0	29.6	0.0	0.2	0.0	0.0	1.5	0.0	76.1	0.0	0.0	0.1	0.0	10.3	4.6	901.4	0.2	0.0	70.2	16.0	17.8	2.7	1.4	0.0	5.0	0.0	249.3	0.0	0.1	126.7	0.0	0.3	0.0	6.5	0.0	0.5	0.4	0.3	7.9	0.0	248.3	15.4
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 259.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.5	18.8	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.8	4.5	0.3	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.0	60.9	7.9	0.0	0.2	24.9	0.0	6.2	0.0	1.4	4.4	0.1	0.2	0.3	13.1	0.9	0.0	0.2	7.8	10.4	1.6	0.1	0.5	0.0	18.8	31.6	0.1	0.4	5.9	7.7	0.0	31.3	0.2	14.3	1.2	1.3	3.4	1.8	4.4	0.1	0.0	0.2	5.9	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6	26.8	39.0	13.7	77.1	31.6	0.5	1.6	140.1	52.2	86.4	57.6	0.0	45.4	104.5	84.7	1.2	4.9	45.2	0.0	42.0	69.7	45.8	47.7	0.0	146.0	259.0	0.0	15.7	23.4	235.2	1.6	121.7	155.2	54.0	68.5	65.8	22.3	57.9	100.1	99.0	189.5	0.5	77.6	52.5	0.5	0.6	22.6	31.5	5.0	76.2	102.7
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell type enriched"	"Detected in many"	7	"Ito cells: 621.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	7.0	6.5	2.2	7.7	22.6	17.2	8.6	10.7	2.7	3.1	2.8	7.9	14.5	0.5	46.8	16.5	0.1	4.4	0.5	5.2	0.7	0.1	0.7	2.4	7.0	5.7	4.7	0.0	0.6	10.4	1.6	3.2	0.9	4.7	103.4	0.0	3.1	0.9	4.2	1.9	0.0	3.2	1.9	3.2	2.9	1.0	9.2	0.9	6.0	0.9	0.2	0.6	8.1	3.4	4.7	2.0	1.3	1.2	82.5	6.1	8.0	4.7	0.3	0.0	1.0	0.4	1.6	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7	65.5	28.7	5.2	10.9	23.5	0.7	4.5	40.8	1.4	12.5	87.2	0.0	9.4	0.0	63.1	1.0	75.0	34.2	0.0	21.9	85.1	58.4	6.6	22.0	2.8	6.1	3.2	2.4	621.2	31.6	2.2	69.6	3.5	57.3	2.8	12.8	1.4	55.1	20.7	65.0	0.5	0.5	32.3	38.8	0.4	4.1	15.6	7.8	6.4	13.9	8.3
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronoglucosaminidase 3"	O43820	3	50292831-50299468	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.9;bone marrow: 48.8;brain: 12.5;testis: 31.1"	"Group enriched"	"Detected in many"	16	"Early spermatids: 73.0;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.1;eosinophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Cell line enhanced"	"Detected in many"		"HEL: 22.4;HMC-1: 40.2;THP-1: 41.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049402	Uncertain				"Secreted to blood"	NA	NA					"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.12e-5)"	3.5	4.2	6.3	3.1	8.8	48.8	3.3	11.4	12.5	4.2	3.6	3.8	6.1	3.8	2.7	5.1	5.6	3.7	5.4	3.4	6.4	5.6	2.9	7.0	3.2	4.2	5.3	5.6	4.3	3.7	2.6	3.1	3.6	11.1	4.9	2.9	3.7	6.7	5.6	3.9	3.0	4.1	4.6	3.4	2.8	6.6	31.1	2.7	3.0	3.3	5.1	3.7	4.8	3.8	1.1	4.2	26.9	2.1	1.0	2.2	1.2	2.2	2.6	1.5	1.7	3.1	1.6	0.9	2.5	2.2	3.2	2.4	3.5	2.4	2.0	1.2	2.9	4.9	2.5	2.7	5.9	1.2	4.6	1.4	22.4	6.8	2.8	2.2	2.4	40.2	3.3	4.5	3.2	2.1	2.3	3.2	2.2	1.7	2.5	1.5	1.3	0.9	14.2	1.1	2.6	6.6	1.0	2.0	3.6	3.8	1.0	1.8	2.1	3.6	2.9	2.0	1.8	1.9	41.3	4.3	2.7	1.9	8.6	1.4	1.2	2.5	1.5	2.4	8.6	2.2	12.1	2.1	26.9	0.7	1.1	1.2	0.9	2.2	1.0	4.2	1.1	0.6	0.8	0.7	1.0	0.7	1.1	1.3	1.2	6.3	8.8	11.4	12.5	6.4	5.6	5.3	5.6	11.1	2.7	3.0	1.4	0.0	2.2	2.7	1.5	0.3	0.0	1.4	4.5	3.5	3.9	2.5	8.3	4.5	73.0	3.4	0.3	0.0	0.6	4.1	1.8	2.3	6.9	1.0	2.0	4.8	4.1	7.4	1.8	206.1	1.7	2.8	3.3	9.0	1.2	1.5	3.1	0.0	2.5	1.9	0.4	6.5	3.1	4.3	3.8	3.1	2.5	1.3	1.6	3.0
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase 3 (NAD(+)) gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	24.5	34.0	27.7	26.8	47.2	37.1	24.1	37.2	61.5	25.0	28.8	25.7	24.6	34.7	26.6	21.3	31.8	29.4	25.6	50.8	35.0	25.2	40.6	29.5	20.9	25.6	27.3	35.6	31.8	40.5	29.1	24.9	22.5	40.5	21.4	25.2	26.0	34.5	29.8	54.9	36.3	34.9	24.8	20.1	26.9	24.8	16.0	23.3	31.2	24.3	37.1	28.2	24.4	21.1	20.6	45.5	43.7	44.4	23.7	28.8	33.6	29.1	26.9	15.9	22.3	24.9	20.7	19.5	15.2	21.4	27.0	28.7	22.2	22.2	37.1	26.3	24.4	22.1	21.8	24.0	20.7	9.9	12.2	30.7	13.9	36.5	17.8	28.3	19.4	29.4	23.2	15.0	20.8	22.7	17.4	20.6	15.5	7.7	20.4	21.7	40.8	22.0	22.8	7.1	27.1	35.6	19.4	13.6	32.3	30.1	18.2	20.3	13.9	9.5	32.2	15.1	6.8	13.3	16.7	18.2	17.1	10.7	25.1	35.9	28.1	7.0	47.3	28.0	24.0	18.9	42.5	43.9	43.7	21.5	44.4	19.9	19.1	22.0	20.9	45.5	20.6	17.6	19.2	16.3	23.7	43.1	27.9	28.8	33.6	27.7	47.2	37.2	61.5	35.0	25.2	27.3	35.6	40.5	23.3	32.8	32.7	56.5	52.5	71.9	33.9	48.4	43.3	30.8	7.9	48.8	27.5	80.9	175.8	81.7	113.6	44.1	164.4	46.7	79.1	82.6	56.8	36.9	91.2	33.0	116.8	17.5	59.8	43.6	88.9	226.7	49.5	66.0	64.1	101.0	81.8	37.0	65.2	122.8	55.2	192.8	37.1	51.8	69.3	14.0	17.0	67.8	92.7	54.5	93.0	43.8
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium voltage-gated channel subfamily J member 11"	Q14654	11	17385859-17389331	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 63.1"	"Cell type enhanced"	"Detected in some"	17	"Cardiomyocytes: 11.3;Collecting duct cells: 5.2;Intestinal endocrine cells: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;HEK 293: 13.5;MCF7: 10.8;SCLC-21H: 9.2"	"Low region specificity"	"Detected in all"							HPA048891	Approved					NA	NA					"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favorable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.5	1.1	2.9	1.0	7.8	0.8	2.7	13.6	7.8	1.0	1.1	0.7	4.9	1.4	1.1	2.1	1.7	1.1	1.1	6.2	3.5	2.4	1.3	0.9	1.3	1.2	2.7	5.2	0.8	8.7	2.7	3.3	0.7	3.5	2.5	1.0	0.1	1.2	7.6	63.1	1.0	1.1	0.8	1.7	1.0	4.6	0.8	1.9	0.0	4.1	4.5	1.0	0.9	1.1	0.8	0.4	1.4	0.3	0.8	0.4	0.4	1.5	2.4	0.3	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	2.5	0.2	7.1	0.2	0.0	0.3	0.3	4.8	0.1	0.3	1.7	13.5	3.7	0.9	0.8	0.1	0.4	0.3	0.1	0.3	0.0	0.1	0.1	0.0	6.1	3.8	3.8	0.0	10.8	0.7	0.1	1.0	4.2	0.3	1.4	1.7	2.1	0.4	0.9	9.2	0.8	0.0	3.6	0.0	0.0	4.7	0.2	0.0	0.0	1.2	0.0	0.1	0.2	6.0	0.9	0.0	1.0	0.0	1.4	0.3	0.2	0.4	0.3	0.3	0.7	0.4	0.4	0.1	0.8	0.4	0.4	1.3	0.8	0.1	0.4	0.3	0.4	2.9	7.8	13.6	7.8	3.5	2.4	2.7	5.2	3.5	1.9	0.0	2.4	0.0	0.1	0.0	2.4	11.3	0.0	0.0	1.2	5.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	1.0	0.1	0.0	4.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.1
KCNJ8	Kir6.1	ENSG00000121361	"Potassium voltage-gated channel subfamily J member 8"	Q15842	12	21764955-21775581	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.1;pancreas: 47.6"	"Group enriched"	"Detected in many"	5	"Sertoli cells: 194.1;Smooth muscle cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.5;HSkMC: 8.6;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain					NA	NA					"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	14.6	12.9	3.2	2.7	3.4	0.0	14.7	1.7	5.1	7.7	6.6	2.3	3.6	2.0	10.6	4.5	6.7	5.9	6.3	60.1	2.2	1.7	6.4	29.7	12.4	3.5	2.9	3.0	12.4	47.6	1.7	3.8	4.9	3.7	10.6	1.6	8.8	2.9	15.7	15.0	2.4	3.8	13.2	2.6	3.8	6.5	3.4	2.8	0.9	8.4	7.0	1.2	11.4	5.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	5.2	3.4	0.0	5.7	4.6	6.6	3.4	42.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	1.9	0.0	2.1	1.3	0.0	0.0	0.2	0.0	0.0	8.6	0.0	2.5	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.2	1.9	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.4	1.7	5.1	2.2	1.7	2.9	3.0	3.7	2.8	3.0	19.8	0.0	0.4	1.1	0.0	24.3	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	6.6	0.3	0.0	22.1	0.2	0.0	1.2	1.8	1.5	0.0	0.3	0.0	1.7	0.0	0.0	12.2	2.0	0.0	0.7	0.0	1.1	194.1	65.3	0.0	0.4	0.6	0.2	0.0	0.0	0.1
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108038-32176568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 204.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	16.1	18.7	24.6	14.6	19.0	22.9	18.1	23.9	25.2	16.3	18.8	15.7	23.0	11.5	21.3	17.5	21.4	15.9	12.1	23.4	22.7	18.2	18.3	18.0	17.3	13.2	15.4	19.8	16.9	17.1	40.9	18.0	23.5	29.7	17.6	17.3	14.1	16.2	19.8	54.0	20.5	14.2	23.1	29.2	14.8	17.4	22.2	17.6	12.6	17.8	14.5	18.3	17.9	17.8	9.1	9.3	9.5	12.5	5.0	11.2	6.4	17.0	13.5	12.1	15.5	18.6	16.4	14.2	13.8	16.3	20.2	19.6	15.0	18.7	14.3	16.4	24.8	12.2	14.8	18.5	21.1	25.9	14.4	10.2	14.7	20.8	12.1	16.5	16.1	12.1	16.5	20.1	25.0	24.0	17.1	21.0	11.3	14.2	13.2	19.1	9.4	13.0	9.2	28.1	11.1	10.1	13.1	17.4	11.7	17.6	15.7	11.6	9.8	25.1	15.1	13.4	30.9	10.6	8.6	24.4	18.8	13.0	24.4	19.8	9.5	10.8	11.3	20.5	15.1	17.9	4.0	10.2	9.5	11.2	12.5	11.0	7.8	9.7	8.7	8.3	9.1	11.2	10.8	6.0	5.0	12.5	9.3	9.6	6.4	24.6	19.0	23.9	25.2	22.7	18.2	15.4	19.8	29.7	17.6	38.7	37.4	43.4	31.3	56.4	47.6	28.5	33.1	40.2	21.6	27.9	55.0	38.1	14.9	32.5	204.0	37.9	20.6	0.0	27.4	36.4	38.2	41.3	12.8	56.3	26.8	49.3	44.3	35.6	32.3	48.0	31.7	26.8	23.6	28.9	37.1	29.8	38.9	17.5	38.2	28.3	40.5	32.3	29.9	55.9	52.6	74.4	113.5	32.6	29.2	51.1
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886174	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 29.6;brain: 54.5"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.0;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		59000000	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	4.4	29.6	19.9	8.0	21.9	1.2	1.7	54.5	43.6	2.8	16.3	1.5	2.0	4.9	1.7	3.0	5.3	2.6	3.2	5.2	11.2	20.6	12.3	1.3	1.3	3.7	7.3	22.4	1.4	3.0	1.0	6.1	1.4	19.3	3.5	5.7	6.2	5.9	10.8	1.6	9.9	7.6	6.1	3.5	1.7	4.8	1.5	3.4	0.0	1.2	1.3	2.6	2.3	3.9	2.2	0.0	0.0	0.0	0.0	0.3	0.2	17.9	1.4	5.4	0.0	0.0	0.0	2.3	25.5	73.5	24.6	40.4	7.3	0.1	0.0	24.3	0.1	20.6	0.7	0.6	0.4	12.9	0.0	0.1	0.0	53.0	1.1	0.0	0.0	4.0	0.1	0.3	3.7	2.5	0.0	0.0	0.0	0.0	0.0	0.1	24.4	0.0	0.5	1.2	0.0	0.9	0.0	32.2	0.1	43.2	0.3	16.2	10.6	14.3	12.7	10.3	12.7	1.3	0.3	0.0	0.0	10.8	1.1	12.1	0.2	0.3	0.1	0.1	0.2	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.9	21.9	54.5	30.2	11.2	20.6	7.3	22.4	19.3	3.4	0.0	0.0	0.8	0.0	1.0	8.5	0.8	0.0	0.0	0.0	80.3	3.9	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	31.8	0.0	1.8	0.0	0.0	0.9	0.0	42.2	0.0	0.0	0.8	0.0	0.0	0.0	0.2	8.6	0.0	0.4	0.0	0.1	1.1	0.1	0.0	0.0	0.1
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.9	9.6	9.2	8.7	18.3	22.3	0.1	17.3	19.5	62.9	76.5	17.5	20.9	43.2	11.5	13.3	37.5	6.8	34.5	12.2	24.0	16.4	9.9	23.9	10.6	22.8	21.3	21.5	15.4	22.7	7.8	20.6	10.9	7.2	21.8	11.4	23.1	30.9	14.8	11.8	19.1	29.5	19.2	20.6	18.4	29.7	8.8	21.8	16.4	12.9	13.6	11.2	15.8	9.8	33.8	13.3	8.3	8.3	14.1	16.0	10.8	16.8	30.0	28.4	43.4	37.3	21.6	35.9	15.4	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7	26.8	44.7	44.2	21.0	19.6	8.0	43.2	10.2	46.8	26.1	26.2	2.0	31.2	99.5	46.8	71.4	104.1	38.5	0.0	96.6	44.5	25.9	23.1	63.4	92.3	227.4	6.4	15.6	68.2	96.6	22.8	21.3	135.7	40.5	251.5	30.0	93.7	42.5	30.2	32.9	217.2	12.6	32.3	24.7	46.4	13.2	19.9	46.6	30.5	39.9	21.7
LDLR	LDLCQ2	ENSG00000130164	"Low density lipoprotein receptor"	P01130	19	11089362-11133816	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 369.2;Alveolar cells type 2: 436.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 23.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009647, HPA013159"	Approved					NA	NA		12000000			"HPA009647: AB_1079243, HPA013159: AB_1852775"	"unprognostic (4.39e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.71e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.43e-4)"	24.6	50.7	6.1	13.7	5.6	11.9	20.0	4.7	9.1	15.4	10.3	17.2	4.8	12.3	14.0	6.5	33.6	12.2	27.2	11.3	7.4	5.0	5.3	33.4	28.7	5.2	4.2	4.9	42.4	26.7	9.6	4.3	9.7	18.9	11.3	6.6	7.1	11.4	4.6	3.2	12.5	15.1	15.1	14.6	8.7	19.5	6.3	9.1	2.1	4.8	17.5	13.2	13.2	13.8	0.4	1.0	23.6	1.7	1.6	3.7	1.8	27.3	12.7	15.8	7.5	21.5	41.1	5.3	5.9	22.9	10.7	23.4	13.2	26.2	9.3	23.5	11.4	35.2	21.8	8.0	47.4	5.1	6.5	1.5	4.5	8.8	11.8	31.8	4.6	25.6	50.9	17.8	36.1	7.8	7.4	11.6	7.5	9.2	53.7	8.0	10.3	5.9	5.9	16.9	13.8	17.2	4.1	11.5	11.7	26.4	22.0	3.7	3.9	5.0	11.5	0.9	11.9	4.8	10.9	12.5	9.3	6.7	5.8	10.7	6.6	5.5	5.6	10.9	11.0	21.1	23.6	1.7	0.1	3.7	1.6	0.9	0.4	1.5	1.1	1.0	0.4	1.6	1.5	0.6	1.6	0.5	0.4	1.0	1.8	6.1	5.6	4.7	9.1	7.4	5.0	4.2	4.9	18.9	9.1	369.2	436.1	9.6	159.5	127.4	3.8	21.8	101.9	97.7	208.1	14.0	5.9	17.8	1.7	47.9	1.0	47.6	71.0	0.0	77.9	25.8	39.9	168.7	71.8	120.7	12.0	1.6	59.3	25.2	10.4	0.4	18.1	19.4	54.0	1.8	66.6	2.7	63.1	19.8	6.7	0.2	6.7	6.5	32.5	3.9	1.3	172.4	40.3	20.3	29.9	183.1
LENG9		ENSG00000275183	"Leukocyte receptor cluster member 9"		19	54461796-54463711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"pancreas: 19.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 25.9;Mucus-secreting cells: 25.8;Rod photoreceptor cells: 25.8;Undifferentiated cells: 21.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 8.0;OE19: 9.7;RPMI-8226: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051671, HPA053556"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA051671: AB_2681568, HPA053556: AB_2682187"	"unprognostic (8.38e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.99e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.76e-2)"	2.9	0.6	0.0	2.6	0.9	0.2	1.8	0.0	1.0	1.4	5.7	0.9	0.7	6.8	1.3	0.3	3.0	0.7	5.0	1.9	0.4		0.5	6.4	2.1	2.0	0.8	0.2	2.2	19.3	0.1	0.0	0.2	0.7	3.4	1.5	0.0	7.0	2.2	2.6	0.2	5.8	1.0	0.5	1.7	4.7	0.7	0.2	0.2	0.7	2.8	2.6	0.7	0.4	0.5	0.0	1.9	0.4	0.0	0.7	0.0	4.8	1.5	0.1	0.1	2.1	2.0	0.0	0.7	1.9	0.3	0.3	0.6	4.5	0.0	2.3	1.8	0.0	8.0	0.5	1.4	0.0	4.8	0.0	1.1	0.0	0.2	2.7	0.0	0.0	2.8	2.4	0.0	1.6	1.3	0.9	0.8	0.0	6.8	0.6	4.4	2.1	2.9	1.1	9.7	0.0	4.1	0.4	8.4	0.8	0.0	0.8	0.3	0.0	2.8	1.3	0.5	4.6	0.0	2.1	0.2	0.1	0.0	1.6	0.6	0.0	0.6	1.3	2.9	4.0	1.9	0.4	0.1	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	2.2	10.3	0.8	4.0	0.2	0.0	1.4	0.0	1.8	2.0	0.2	0.0	2.5	1.1	2.2	25.9	0.0	3.7	2.5	2.7	11.2	0.0	2.1	3.3	4.8	5.2	3.7	7.2	0.0	6.1	2.1	1.7	0.0	25.8	9.2	2.9	17.8	1.8	2.8	25.8	0.0	6.6	0.5	2.5	2.8	0.3	3.8	21.4	13.7
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.6;ASC TERT1: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		150000	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	55.0	8.5	5.6	61.6	58.1	77.3	1.6	29.2	34.2	12.2	21.9	3.2	29.7	10.2	5.7	45.7	13.1	55.2	2.4	15.8	9.1	14.3	5.7	4.2	3.6	13.1	15.3	8.1	8.4	34.3	11.4	13.0	7.0	14.8	2.4	7.7	0.0	19.0	9.5	4.6	7.0	5.5	3.6	9.8	9.6	4.6	6.6	9.4	11.3	8.7	1.9	3.9	7.1	9.2	21.5	3.9	10.5	10.5	4.4	10.4	2.7	22.2	7.1	9.9	10.5	4.2	12.4	18.0	13.0	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2	38.7	42.2	50.6	22.0	15.8	5.2	8.5	45.9	14.7	13.6	31.4	0.0	28.4	18.3	29.7	4.4	53.1	3.9	23.3	31.7	28.0	34.8	15.2	27.7	46.5	503.3	15.9	20.9	52.8	514.1	1.8	10.6	167.0	45.5	27.9	9.4	29.4	17.5	5.9	20.5	14.6	1.3	6.5	21.8	4.8	10.9	10.9	16.7	33.0	8.7	20.1
LPCAT3	"C3F, MBOAT5, nessy, OACT5"	ENSG00000111684	"Lysophosphatidylcholine acyltransferase 3"	Q6P1A2	12	6976186-7018510	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.5;liver: 78.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.74e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.23e-1)"	16.4	24.4	4.2	8.8	5.0	8.1	15.1	15.7	5.4	7.9	37.5	6.1	8.1	43.4	8.2	7.8	13.6	9.1	11.3	20.2	4.1	2.7	37.3	78.2	20.3	17.9	5.2	5.3	13.9	38.7	4.6	9.4	29.0	4.8	13.7	17.2	8.3	22.2	8.2	19.4	13.3	85.5	12.4	4.9	11.3	22.8	7.6	4.0	14.1	14.6	10.3	13.7	15.7	8.5	5.3	13.9	32.3	33.7	11.5	10.8	12.4	6.2	11.6	5.0	14.1	35.4	16.7	10.8	3.6	15.5	10.0	17.1	24.7	32.7	6.8	2.1	5.8	21.4	15.8	6.0	13.4	7.8	16.7	7.3	13.7	10.3	22.1	7.6	7.0	14.7	26.3	7.8	9.6	4.8	6.4	9.3	10.5	7.3	4.9	6.5	9.5	8.6	8.7	16.8	22.4	6.8	9.1	7.1	7.0	12.3	48.9	4.4	4.2	21.9	33.9	2.4	16.5	3.4	9.9	3.8	6.2	9.3	10.9	2.6	6.2	4.4	10.0	7.7	7.4	5.4	13.9	20.8	32.3	8.6	30.0	10.0	5.0	9.0	9.7	13.9	5.3	8.5	8.7	20.0	11.5	33.7	7.9	10.8	12.4	4.2	5.0	15.7	5.4	4.1	2.7	5.2	5.3	4.8	4.0	65.5	29.7	4.5	32.1	20.9	5.2	0.4	15.3	13.4	23.9	19.2	0.0	71.1	10.0	25.0	1.5	9.8	66.7	0.0	29.4	45.9	18.4	22.1	13.9	52.5	36.0	11.1	41.5	14.1	18.0	1.2	17.0	13.7	6.8	16.2	22.8	12.3	18.9	24.6	6.0	34.4	3.9	19.4	9.4	14.6	30.6	19.4	55.5	13.8	32.4	25.1
LPCAT4	"AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2"	ENSG00000176454	"Lysophosphatidylcholine acyltransferase 4"	Q643R3	15	34358618-34367278	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 63.9;Paneth cells: 83.4;Undifferentiated cells: 62.1;Urothelial cells: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 41.5;OE19: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057321	Supported					NA	NA					"HPA057321: "	"unprognostic (2.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.44e-3)"	9.7	5.3	20.1	9.6	35.1	5.0	11.0	38.6	32.2	11.9	30.5	4.3	3.5	25.3	8.0	8.6	17.7	16.4	19.0	17.1	14.2	21.0	4.9	1.8	7.8	7.2	13.2	18.2	9.6	6.8	6.4	6.1	4.6	28.9	5.7	30.0	2.9	6.4	8.3	6.1	15.2	23.8	14.4	7.1	8.5	33.1	2.6	13.1	4.5	4.4	4.5	9.3	15.4	14.2	2.6	6.2	4.7	1.8	2.1	9.4	1.0	5.1	12.2	6.1	4.8	16.6	16.9	2.9	7.2	12.2	6.9	9.4	4.4	13.8	4.6	15.0	10.0	16.2	41.5	5.3	13.6	3.0	9.4	3.0	4.6	5.1	4.2	3.4	4.9	4.8	12.5	6.2	6.5	8.5	16.0	11.2	8.5	3.0	9.0	12.8	4.9	4.3	9.7	6.1	42.9	9.7	5.4	6.9	9.3	15.0	12.3	4.8	3.7	4.3	5.8	2.7	7.4	4.5	6.7	13.8	12.8	7.8	20.1	6.8	11.1	8.7	1.6	9.5	13.8	2.9	0.1	1.1	4.5	3.9	1.4	9.4	2.3	4.6	6.0	1.8	2.6	2.8	2.5	4.7	2.1	1.8	6.2	7.3	1.0	20.1	35.1	38.6	32.2	14.2	21.0	13.2	18.2	28.9	13.1	23.8	5.1	11.9	7.6	4.2	10.4	10.4	30.6	13.4	7.9	8.7	3.9	3.4	1.7	9.9	0.0	22.7	63.9	0.0	8.6	14.1	6.6	8.4	11.5	0.8	6.9	9.5	24.3	13.5	6.5	0.6	14.4	6.1	8.5	4.6	52.9	0.8	28.2	83.4	6.3	3.3	6.1	12.9	8.5	0.7	4.9	5.4	2.1	15.2	62.1	107.8
LPGAT1	"FAM34A, FAM34A1, KIAA0205, NET8"	ENSG00000123684	"Lysophosphatidylglycerol acyltransferase 1"	Q92604	1	211743457-211830772	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 288.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.70e-2)"	15.9	17.4	11.8	10.7	20.3	14.9	16.5	12.3	22.7	10.5	13.3	25.9	9.9	19.5	7.9	9.4	6.7	7.5	10.4	9.7	15.1	13.6	8.6	75.6	9.6	13.8	19.0	11.9	6.1	13.1	15.1	9.0	7.7	15.5	9.5	9.0	21.8	9.0	15.6	8.3	5.2	39.8	10.3	16.0	13.3	6.4	17.5	18.9	5.1	22.1	3.9	8.0	9.2	6.9	1.6	2.7	13.4	2.3	4.5	1.2	0.7	14.7	16.3	5.4	12.8	9.7	13.7	7.7	10.6	16.9	9.9	9.2	4.8	12.4	6.0	6.2	16.4	11.1	8.1	18.0	9.5	12.6	11.8	6.1	6.3	13.7	11.0	11.7	15.6	10.9	8.0	11.7	9.1	12.0	18.3	11.9	8.8	7.2	0.1	13.1	4.6	5.9	5.8	5.9	6.4	2.7	14.3	21.3	1.8	11.0	12.3	31.2	16.2	17.4	18.5	18.1	8.7	9.4	10.2	11.4	18.1	8.0	16.6	17.2	8.9	10.9	16.3	9.0	13.3	12.4	9.5	2.3	13.4	1.2	1.9	1.0	1.6	0.8	0.9	2.7	1.0	0.2	0.7	10.4	4.5	1.3	2.1	0.2	0.7	11.8	20.3	12.3	22.7	15.1	13.6	19.0	11.9	15.5	18.9	26.8	18.9	11.0	47.5	10.9	140.9	25.4	73.9	37.5	18.2	12.2	58.9	1.6	1.7	53.5	288.3	27.4	28.8	0.0	50.8	3.5	14.7	35.8	12.7	49.1	18.6	33.4	13.2	21.5	35.6	39.3	43.7	26.7	28.7	19.8	12.2	31.9	50.2	16.9	52.3	18.6	121.2	19.4	20.6	61.8	32.6	6.6	0.9	16.6	19.1	57.7
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 133.5;Muller glia cells: 95.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.4	2.6	7.9	3.4	3.6	8.0	4.6	4.1	1.5	5.3	3.5	0.7	13.5	2.4	4.9	9.7	4.2	6.5	7.0	8.2	8.0	7.5	12.1	10.1	3.7	0.0	4.4	0.0	3.2	5.8	4.9	5.0	3.5	11.7	2.8	3.5	8.6	1.9	4.6	2.2	3.0	0.2	3.1	3.8	10.0	4.5	12.5	0.1	7.8	1.2	4.7	14.5	4.2	25.5	4.0	4.1	4.8	2.9	1.5	9.4	5.0	7.2	11.6	0.7	0.2	2.7	14.7	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8	17.9	10.1	4.5	2.9	3.0	18.3	10.6	5.1	16.0	19.4	38.4	7.9	2.5	5.0	4.5	7.3	8.8	10.3	46.7	1.4	1.3	9.8	21.0	8.1	0.0	1.7	133.5	36.0	4.3	2.1	7.8	4.9	4.3	13.5	44.1	49.8	95.3	52.2	20.4	7.1	8.4	7.2	6.5	12.0	10.7	23.7	4.4	1.6	2.1	11.9	29.8
MBOAT7	"BB1, hMBOA-7, LENG4, LPIAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	10.7	63.1	16.8	14.8	24.2	15.9	7.9	11.3	37.8	10.3	17.7	9.2	15.6	30.3	10.5	8.0	10.5	11.5	14.3	6.9	18.5	23.4	10.5	11.6	11.5	14.7	10.0	18.8	15.1	24.4	23.8	12.4	11.9	21.6	11.4	6.1	8.1	10.8	28.8	7.9	10.0	28.5	6.5	9.2	14.4	16.4	30.8	6.8	7.6	12.7	5.0	6.3	22.6	17.5	0.3	2.9	30.6	2.1	0.9	0.5	0.8	14.2	8.5	1.3	14.0	4.6	3.6	12.3	25.0	8.9	5.8	11.5	4.8	16.2	3.7	11.2	5.4	2.5	29.2	0.0	5.1	1.1	5.1	16.6	3.9	9.2	3.1	4.5	9.0	57.3	6.7	3.4	2.8	2.0	4.6	10.4	2.7	14.7	11.8	2.0	8.6	2.6	3.2	5.9	2.5	18.2	8.4	2.4	7.5	5.8	17.3	0.5	3.7	16.7	10.2	5.1	0.1	10.3	0.8	20.7	12.3	4.4	3.6	9.9	5.4	9.3	1.5	17.7	6.4	8.1	15.7	2.1	30.6	0.2	1.5	0.5	0.2	0.2	0.2	2.9	0.3	0.1	0.2	30.0	0.9	0.8	0.8	0.2	0.8	16.8	24.2	11.3	37.8	18.5	23.4	10.0	18.8	21.6	6.8	11.9	26.6	12.2	44.1	12.4	15.8	6.5	30.6	13.4	14.8	41.8	5.9	38.6	5.0	45.1	1.1	16.6	88.9	0.0	28.7	43.8	12.7	39.8	76.1	13.9	28.4	28.6	40.8	14.7	36.9	1.9	17.8	32.1	8.5	19.8	45.8	22.4	34.4	40.3	14.5	12.2	6.8	38.8	23.4	3.9	14.5	18.9	43.1	11.4	38.5	48.0
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210389-83431071	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 57.7;Muller glia cells: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 15.6"	"Lineage enriched"	"Detected in many"	11	"T-cells: 15.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.9;OE19: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	30.7	35.3	16.3	4.6	17.7	0.8	27.1	5.5	13.1	5.9	6.7	5.4	39.2	18.1	3.8	7.4	24.5	4.2	13.5	21.3	10.5	14.0	3.6	12.4	7.7	6.0	16.8	11.8	10.0	3.3	30.0	11.1	2.9	16.3	7.9	10.1	9.3	7.8	30.2	25.7	10.1	8.7	18.7	17.2	6.3	20.0	13.4	7.2	1.4	6.3	20.9	4.5	13.7	14.9	0.0	0.0	0.0	1.4	0.0	15.6	0.5	8.8	18.3	0.4	0.0	15.6	14.6	0.0	5.7	14.7	6.1	11.9	42.9	7.8	0.0	15.0	13.4	12.2	9.3	13.6	5.1	6.7	0.0	7.6	0.0	11.7	0.0	20.0	4.3	16.1	15.9	10.3	12.3	8.4	10.3	9.5	0.0	6.1	0.0	8.3	9.9	0.0	4.9	0.0	48.5	7.2	0.0	15.4	8.5	18.1	4.2	1.8	4.7	9.7	14.4	0.3	8.3	0.0	10.6	10.0	3.8	4.6	1.2	0.0	3.4	3.9	0.0	0.0	0.0	11.2	0.0	1.4	0.0	0.8	0.3	15.6	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.3	17.7	5.5	13.1	10.5	14.0	16.8	11.8	16.3	7.2	17.9	8.9	0.0	4.2	1.6	16.7	35.8	5.1	1.4	6.8	5.2	2.0	0.5	1.7	10.0	4.4	1.9	8.0	0.0	8.4	0.6	7.1	5.6	0.0	12.4	6.8	12.7	0.0	4.9	57.7	4.2	23.9	9.5	0.0	5.4	4.0	93.9	12.7	5.8	35.0	2.6	6.4	0.0	3.3	4.9	1.5	3.0	0.7	0.9	5.5	1.8
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
MMAA	cblA	ENSG00000151611	"Methylmalonic aciduria (cobalamin deficiency) cblA type"	Q8IVH4	4	145618263-145660035	"Disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.7"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 28.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Approved	Cytosol		No	No			Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	1.7	3.3	1.4	1.4	1.7	0.5	2.6	2.3	1.5	1.5	3.1			4.2	1.4	2.6	2.3	1.5	2.0	1.8	1.2	1.5	4.3	14.7	1.7	1.3	1.4		1.3	2.5	1.4	0.9	1.1		1.3	3.5		2.0	1.3	5.2	2.3	3.4	1.2	1.2	1.6	1.9	2.0			2.2		1.7	1.6	1.6	4.2	4.2	4.1	10.0	5.8	7.8	2.9	2.3	1.3	4.3	2.2	10.4	10.4	0.9	5.9	4.7	2.4	1.4	1.8	4.7	7.9	2.0	3.9	1.2	1.9	2.1	4.5	1.6	5.5	1.0	3.5	0.9	1.4	7.5	4.2	3.2	6.5	6.4	2.5	6.6	4.1	7.4	9.5	1.0	5.4	5.1	2.9	7.6	1.6	1.6	6.1	2.2	3.6	1.5	1.5	14.1	1.8	2.1	1.7	3.4	7.2	3.2	2.2	3.7	2.0	6.1	3.8	1.6	4.6	1.5	3.0	1.9	3.6	4.0	4.2	3.4	4.1	3.8	3.2	6.3	8.4	5.8	4.2	7.8	6.4	3.6	3.3	5.9	7.8	0.0	5.8	10.0	4.2	6.1	2.9											11.9	3.5	2.2	7.3	2.6	2.9	7.0	12.7	4.0	15.9	10.4	2.0	6.9	13.3	8.5	7.0	3.3	8.8	0.0	10.8	2.8	3.8	5.2	8.1	28.6	4.5	0.0	2.4	7.4	2.7	4.7	4.4	2.6	1.7	3.6	4.9	2.2	7.8	7.0	2.8	15.3	1.5	0.0	3.1	6.7	4.9	1.0	6.4	1.7	5.9	9.5
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 875.4;Distal tubular cells: 1458.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	27.9	23.6	13.6	12.0	7.5	12.2	11.8	11.5	9.9	4.6	13.7	13.6	11.6	9.5	6.2	12.1	9.5	8.3	9.3	20.8	6.8	10.1	32.9	9.8	26.2	8.9	10.9	13.4	9.6	6.9	3.6	9.5	21.3	23.6	21.9	7.3	10.4	18.2	48.6	4.1	37.3	9.2	10.0	13.5	34.2	22.0	5.2	25.5	22.6	8.7	38.0	8.6	7.0	9.0	39.4	6.6	6.9	7.1	24.2	7.7	15.0	10.3	11.4	6.3	32.4	10.9	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8	110.2	37.1	53.6	36.9	40.5	51.2	875.4	183.4	44.2	47.8	101.2	9.8	19.1	1458.9	78.7	46.1	45.8	147.2	23.3	122.5	67.4	59.4	34.7	70.3	365.8	104.2	46.1	35.7	38.6	74.2	5.6	61.5	76.9	123.2	111.8	87.8	137.3	56.8	120.7	84.5	301.3	55.1	90.5	90.6	126.5	39.4	48.8	20.4	54.3	110.8	45.7
MPC1L	SLC54A3	ENSG00000238205	"Mitochondrial pyruvate carrier 1 like"	P0DKB6	X	40623566-40624136	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 26.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.1;BJ hTERT+: 1.1;PC-3: 1.9;U-2197: 1.4"					"Not detected"	"Not detected"									NA	NA																		"unprognostic (8.47e-4)"		"unprognostic (1.00e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MPC2	"BRP44, DKFZP564B167, SLC54A2"	ENSG00000143158	"Mitochondrial pyruvate carrier 2"	O95563	1	167916729-167937040	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 111.7"	"Cell type enhanced"	"Detected in all"	13	"Early spermatids: 1811.9;Late spermatids: 3927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 94.3"	"Low region specificity"	"Detected in all"							HPA056091	Uncertain					NA	NA					"HPA056091: AB_2683035"	"unprognostic (3.25e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.79e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.67e-1)"	13.5	22.5	22.6	11.5	21.6	33.5	23.0	15.0	25.3	11.7	26.8	12.1	10.2	27.1	7.8	12.5	12.2	9.9	25.2	46.2	19.0	17.7	46.4	92.9	9.9	11.4	18.8	16.7	9.6	14.7	9.6	18.4	9.9	13.5	34.4	24.8	11.9	20.6	10.8	45.0	9.3	26.3	13.1	16.5	7.4	29.6	111.7	11.4	12.7	11.9	23.5	10.9	11.2	8.1	23.4	28.7	45.3	18.5	27.4	40.2	37.2	18.3	17.6	7.8	17.7	19.5	18.1	1.7	30.1	16.9	14.2	16.6	40.8	10.3	31.9	21.9	17.2	11.6	14.9	10.5	16.3	14.7	40.8	15.7	13.9	18.0	32.4	13.1	15.0	10.3	11.6	14.9	25.5	14.7	12.4	12.4	23.7	17.1	18.7	25.3	8.5	22.2	15.5	12.9	42.3	22.1	11.7	14.2	25.3	94.3	16.1	12.4	12.6	17.3	20.6	16.6	18.9	37.0	19.3	11.4	15.3	11.3	22.2	13.9	24.9	28.3	35.1	39.4	13.6	8.0	41.0	16.6	45.3	23.7	14.6	25.3	23.4	29.3	25.0	28.7	20.6	27.7	26.5	31.8	27.4	18.5	20.7	40.2	37.2	22.6	21.6	15.0	25.3	19.0	17.7	18.8	16.7	13.5	11.4	32.8	46.1	92.5	122.7	112.0	55.3	407.2	440.8	125.8	42.1	123.9	21.6	444.8	868.7	156.5	1811.9	78.2	261.8	93.5	128.1	44.4	116.0	241.3	87.6	688.4	140.6	42.9	318.3	49.7	62.2	3927.7	98.4	101.0	114.7	412.0	246.3	79.1	95.6	240.2	106.1	749.3	55.3	64.7	116.9	623.0	121.0	100.0	287.0	99.6	339.8	130.5
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765103	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002977, HPA018502"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA002977: AB_2666735, HPA018502: AB_1854185"	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.9	6.8	20.4	14.0	17.9	9.9	11.8	14.5	15.6	8.3	8.6	8.7	7.2	8.3	9.4	9.2	19.7	9.3	9.0	12.0	17.8	13.4	8.1	10.2	9.7	18.7	12.1	11.5	7.4	11.7	16.3	10.2	37.9	8.8	10.8	9.1	7.9	12.1	13.0	22.2	19.8	10.9	8.3	8.2	18.0	9.7	11.0	9.3	32.6	9.6	10.7	23.1	10.4	7.7	3.3	7.8	7.4	1.5	6.2	4.8	1.8	13.2	8.5	9.2	7.5	2.1	2.5	12.4	11.8	15.2	12.0	17.1	8.2	10.5	29.0	17.5	9.5	11.6	12.1	18.5	17.1	18.8	11.7	11.2	1.8	13.2	3.5	6.4	8.5	6.3	6.8	11.9	13.2	0.2	11.5	7.2	9.7	5.6	7.5	8.6	11.4	12.4	2.2	4.2	14.8	12.9	6.6	14.6	12.8	9.4	15.2	13.7	8.5	4.5	10.1	3.7	7.6	12.9	4.9	9.1	7.9	6.3	1.0	17.5	9.6	9.8	44.2	1.6	5.5	6.1	0.0	0.9	7.4	3.5	1.5	2.6	2.7	3.9	3.2	2.2	3.3	3.5	4.7	2.4	6.2	1.3	7.8	4.8	1.8	20.4	17.9	14.5	15.6	17.8	13.4	12.1	11.5	8.8	9.3	14.9	6.2	3.4	9.6	10.0	0.0	7.9	2.5	1.4	5.7	5.2	0.0	8.8	0.0	5.1	0.0	3.6	2.8	0.0	5.7	6.0	4.3	6.1	1.1	8.1	4.0	0.0	9.2	3.1	8.2	0.4	5.2	5.2	3.3	1.0	7.6	0.0	8.1	6.5	4.9	2.9	0.0	6.5	2.7	1.2	2.3	14.6	8.7	6.9	5.2	10.8
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95832882-95925315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	16.4	10.4	14.2	12.1	19.9	5.3	15.4	14.9	23.3	14.1	13.5	22.6	4.9	8.0	14.1	7.5	15.5	13.3	15.4	13.8	18.1	13.9	16.9	4.5	14.3	13.6	27.5	13.6	14.5	11.0	15.9	8.2	25.1	21.3	17.6	14.5	19.6	18.8	12.3	6.8	9.7	9.5	18.2	30.0	10.5	13.6	29.0	21.8	12.2	11.3	7.7	11.7	13.4	14.3	5.4	6.6	9.7	4.9	11.8	14.2	6.6	9.4	10.1	23.3	16.9	8.2	12.7	19.5	17.7	15.8	17.6	15.9	23.9	19.2	6.8	21.2	18.6	14.9	13.1	19.0	19.3	15.9	12.4	9.2	14.1	25.3	13.4	18.8	23.9	11.7	10.6	12.9	23.1	23.2	18.0	26.5	15.3	17.4	6.5	16.5	7.0	11.9	11.1	18.9	22.8	14.3	10.0	13.6	6.4	18.1	50.8	14.9	17.4	17.5	14.8	7.9	15.3	11.7	10.2	27.1	20.6	18.9	15.0	16.3	6.1	16.8	6.2	8.6	6.6	20.8	9.7	3.3	1.4	11.4	3.9	12.3	5.4	7.7	14.2	6.6	4.8	4.1	11.0	0.9	11.8	4.9	3.4	6.9	6.6	14.2	19.9	14.9	23.3	18.1	13.9	27.5	13.6	21.3	21.8	3.0	7.5	5.1	13.3	9.2	0.0	14.0	0.0	9.4	12.5	8.7	0.0	8.0	8.3	15.9	48.9	19.5	7.3	0.0	14.6	26.0	14.0	13.2	18.5	0.9	11.0	0.0	15.5	10.4	9.1	87.8	10.3	7.5	3.3	9.0	9.1	0.0	14.2	2.9	11.3	20.7	0.0	32.3	20.0	34.6	16.4	5.3	7.6	7.9	8.4	13.2
MTMR6		ENSG00000139505	"Myotubularin related protein 6"	Q9Y217	13	25246201-25288009	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 60.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.30e-1)"	5.2	10.2	6.1	5.3	7.6	11.9	4.9	6.8	8.2	4.4	4.3			2.9	4.9	2.8	4.1	3.6	5.0	6.0	7.6	7.3	6.1	5.1	5.0	5.2	6.0		3.7	5.9	4.6	3.7	4.6		5.3	4.8		5.9	5.7	6.2	3.3	3.3	6.4	6.6	5.2	4.1	7.2			6.3		5.4	4.6	3.7	5.8	6.7	16.1	11.9	4.8	7.4	7.2	5.8	6.1	10.1	8.5	10.8	11.3	4.9	18.6	21.0	18.4	14.6	4.0	10.5	9.0	5.5	17.3	9.4	7.3	6.4	11.0	21.5	10.8	4.2	11.1	4.5	3.3	13.0	22.9	20.5	8.1	13.0	13.4	18.1	10.6	14.9	12.2	5.1	10.4	18.5	4.1	13.0	6.2	3.0	11.3	4.6	5.6	14.2	12.4	13.4	6.9	5.4	7.6	6.0	10.8	9.7	10.1	4.2	14.6	19.2	11.4	5.8	12.6	10.8	5.6	6.5	11.9	5.7	9.0	18.5	15.1	8.2	6.6	5.3	11.9	6.7	5.8	5.6	5.6	6.7	3.6	5.8	5.8	16.1	4.8	10.4	4.0	7.4	7.2											14.9	30.9	18.2	6.5	9.7	0.0	27.0	12.7	20.1	10.3	15.7	0.0	4.8	11.6	11.3	48.3	16.6	7.4	0.0	12.9	5.6	12.3	11.3	18.5	19.2	14.5	0.0	16.0	25.8	35.5	15.6	11.5	27.8	18.6	9.0	14.7	0.0	17.9	8.7	18.7	20.7	0.0	0.0	16.2	60.6	20.6	10.5	6.9	20.3	10.2	10.1
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307760-55425581	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 39.4;Ciliated cells: 48.2;Club cells: 39.8;Exocrine glandular cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	23.6	23.6	26.1	24.9	24.0	18.7	24.1	40.6	31.2	22.0	19.3	15.2	28.8	27.6	26.2	17.8	23.3	20.0	22.4	24.3	22.0	16.0	21.2	22.7	19.7	24.7	21.1	21.5	25.9	25.8	35.8	45.0	19.0	26.6	25.6	21.7	10.4	21.8	28.7	71.3	23.8	24.3	20.9	37.5	20.9	20.6	22.3	21.5	29.7	29.3	19.2	21.7	24.4	23.4	9.8	10.9	5.8	10.3	5.9	10.4	4.0	14.2	20.0	14.6	15.5	12.4	13.1	19.6	13.1	10.0	14.8	18.9	21.4	18.7	27.7	15.5	11.5	19.6	9.9	28.4	18.0	22.2	4.9	23.5	18.9	18.9	16.3	11.4	11.1	12.6	10.3	12.3	15.6	19.1	11.6	12.8	10.4	22.3	16.0	14.3	13.0	11.9	14.7	13.2	5.9	19.4	14.6	16.3	12.2	16.0	20.9	18.0	11.1	14.9	8.5	12.8	14.6	20.4	16.1	11.5	3.8	9.7	10.7	22.0	11.8	12.4	23.9	9.7	25.5	14.7	4.9	6.6	5.8	10.4	6.1	10.0	8.8	7.7	9.7	7.9	9.8	8.1	8.3	1.9	5.9	10.3	10.9	7.5	4.0	26.1	24.0	40.6	31.2	22.0	16.0	21.1	21.5	26.6	21.5	29.8	39.4	0.0	0.0	0.0	0.0	0.0	0.0	48.2	39.8	19.2	0.0	21.8	10.0	23.4	0.0	0.0	0.0	0.0	35.5	18.3	0.0	0.0	23.3	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	24.4	0.0	0.0	29.8	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99563761-99623999	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"intestine: 211.4;liver: 60.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 201.1"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Group enriched"	"Detected in some"	6	"AF22: 12.8;Hep G2: 14.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		450000	Cytosol		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.1	0.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.0	53.2	0.2	0.1	53.4	0.0	0.0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0.0	0.4	0.1	1.1	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.2	0.3	0.1	14.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.3	0.2	1.3	0.0	0.0	0.8	1.0	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.6	0.0	0.0	1.8	0.0	0.1	0.0	0.0	25.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	201.1	0.1	0.0	0.0	5.5	3.3	7.9	0.9	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	18.6	0.0	6.5	0.0	21.9	1.5	0.0	0.0	0.0	0.0	0.0
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 114.3;Pancreatic endocrine cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 21.0;HaCaT: 33.2;RH-30: 51.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	21.0	5.7	0.1	0.1	0.0	0.0	11.5	0.1	0.8	0.4	0.0	14.9	9.0	0.0	5.3	0.0	1.7	33.2	7.5	9.0	0.4	0.0	2.3	0.0	2.5	10.5	0.0	0.0	0.1	0.0	7.9	0.2	5.5	1.7	0.7	0.1	0.1	8.3	0.9	8.1	0.0	0.0	1.5	12.3	2.3	0.0	51.4	3.5	19.0	4.3	11.4	0.2	8.0	9.5	0.0	3.0	5.6	0.0	0.5	0.0	11.6	0.1	2.2	5.6	3.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3	50.6	12.0	0.8	8.3	0.3	8.2	1.9	15.3	24.1	19.4	7.0	9.8	3.2	5.0	40.6	14.7	0.6	114.3	0.0	41.1	1.1	0.5	42.9	0.0	15.3	0.7	0.0	6.4	0.0	0.3	1.5	0.9	0.9	3.3	3.6	33.5	29.9	76.1	53.7	0.7	13.0	29.0	0.0	0.2	9.5	3.8	5.6	3.9	0.0	38.0	58.3
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatogonia: 205.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA		53000	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (9.44e-5)"	"unprognostic (1.97e-1)"	23.6	27.4	25.3	20.2	31.8	27.2	27.3	36.7	41.7	26.0	25.8	24.4	23.7	26.2	27.9	31.0	27.5	23.9	20.2	23.6	25.4	29.0	24.3	25.9	18.3	27.0	27.7	31.9	31.0	26.6	38.8	42.2	26.4	34.9	24.9	30.0	22.1	24.3	23.5	33.2	26.9	27.6	25.4	25.3	18.4	22.2	36.9	25.9	28.9	27.9	28.0	24.9	24.7	22.4	9.4	6.4	6.7	3.2	8.6	19.4	9.4	23.0	17.8	31.8	31.2	12.7	18.1	26.4	17.6	17.9	26.1	31.8	21.6	18.0	25.6	20.2	13.2	16.9	23.4	23.9	21.2	37.1	9.4	27.2	18.1	12.3	33.5	14.6	33.7	22.8	14.7	15.7	20.8	18.3	13.9	18.2	31.2	42.9	9.0	20.1	8.1	35.2	38.6	44.0	18.1	32.2	37.8	37.8	34.1	20.1	20.3	34.2	25.1	52.7	11.3	20.3	20.4	12.1	22.8	14.2	18.3	18.3	19.0	20.3	17.1	26.4	92.1	16.5	22.4	22.1	1.3	3.1	6.7	15.4	3.0	19.4	9.4	16.4	16.6	4.2	7.9	17.8	17.7	1.4	8.6	3.2	6.4	14.0	9.4	25.3	31.8	36.7	41.7	25.4	29.0	27.7	31.9	34.9	25.9	29.8	25.1	24.4	55.4	29.3	47.7	26.2	15.3	37.5	40.9	29.6	11.8	87.4	33.2	58.5	2.8	22.8	26.7	23.3	52.6	55.3	37.2	37.1	33.6	18.8	25.1	47.7	22.0	20.9	11.6	10.1	45.1	15.5	47.2	33.3	27.8	58.9	51.8	82.6	50.9	40.7	33.6	19.4	49.5	120.6	205.2	28.1	43.8	31.6	33.7	41.4
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	20.0	10.6	14.4	14.7	5.3	5.4	17.0	13.8	10.3	21.6	17.5	15.6	13.5	39.6	9.0	6.1	17.5	24.2	24.3	14.3	30.6	9.8	17.5	19.3	15.5	13.2	5.0	30.9	11.0	3.2	5.7	21.3	12.7	6.3	13.0	14.8	22.0	5.7	11.8	7.2	15.1	12.3	34.3	17.0	16.9	17.1	23.3	21.6	10.1	13.8	8.7	11.1	12.3	24.0	11.8	16.0	18.6	16.4	7.6	11.3	11.3	15.5	24.7	6.3	15.6	28.2	9.4	23.5	14.1	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5	6.0	4.6	3.7	6.1	9.0	4.1	7.6	2.5	2.7	2.3	5.2	2.0	8.2	0.0	5.9	1.7	4.8	3.3	0.0	7.7	16.4	5.9	5.0	7.0	5.9	10.3	3.2	0.0	4.3	9.1	1.7	2.6	6.7	6.8	2.8	8.4	4.1	6.1	2.9	3.2	4.5	3.2	6.5	4.7	9.3	13.1	7.4	5.7	4.1	15.1	5.4
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	46.6	93.2	32.2	44.9	13.5	21.6	54.1	36.4	25.3	75.5	57.3	73.3	28.3	82.1	38.0	33.6	30.0	25.1	61.5	61.9	64.6	39.8	82.8	53.8	72.4	101.8	27.4	59.0	24.7	20.5	39.0	56.8	53.2	13.3	45.5	26.4	79.4	27.3	44.7	79.0	70.1	67.8	38.6	103.3	85.0	43.0	63.6	75.6	57.9	32.6	44.7	51.5	19.1	52.3	33.9	28.8	54.4	39.9	28.6	48.7	44.2	30.3	74.7	35.2	81.2	96.7	29.5	50.1	37.0	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3	29.8	22.5	33.5	67.6	117.7	287.4	27.7	63.7	36.1	59.1	68.0	269.0	166.3	127.6	180.3	23.8	58.6	14.6	46.7	172.7	210.0	82.7	60.4	46.0	102.6	183.6	38.1	86.1	27.0	26.9	65.0	56.7	62.9	123.2	55.9	70.8	61.6	165.1	38.6	55.2	140.8	268.7	12.9	66.0	19.8	83.3	116.3	74.0	40.6	110.8	81.0
NME1-NME2	"NM23-LV, NMELV"	ENSG00000011052	"NME1-NME2 readthrough"		17	51153590-51171744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 41.6;Basal keratinocytes: 34.1;Ciliated cells: 25.4;Club cells: 45.5;granulocytes: 20.9;Melanocytes: 21.9;Suprabasal keratinocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB002169, HPA008467, HPA041113, CAB076057"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (6.66e-4)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-6)"	"unprognostic (1.84e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	12.8	29.3	19.7	35.5	16.7	20.6	8.5	13.9	31.2	5.4	7.2	6.7	4.9	14.7	10.6	6.2	10.6	7.4	6.8	8.0	23.0	17.0	10.4	31.3	7.8	18.3	16.9	18.7	8.1	24.1	6.5	11.4	13.6	21.5	6.7	5.7	7.7	23.5	4.7	10.1	8.2	10.7	11.7	11.0	11.9	14.8	5.8	5.6	10.0	8.6	17.9	12.7	9.5	7.6	19.6	37.6	1.0	21.1	14.6	21.9	16.2	29.0	2.0	9.4	34.6	8.8	4.5	7.4	23.0	7.5	6.1	3.8	3.8	19.6	17.0	24.1	11.8	15.3	18.1	9.2	14.8	4.0	25.6	13.8	14.1	3.5	7.3	10.7	23.8	23.5	8.1	11.1	7.7	11.0	14.3	9.7	17.0	11.1	22.0	3.8	4.8	58.2	16.4	28.2	34.6	2.9	34.5	23.1	50.3	7.1	3.8	30.4	17.8	12.1	52.6	26.4	14.4	53.8	40.4	19.4	38.8	28.3	37.6	47.0	37.7	40.7	33.1	22.3	17.2	33.3	0.2	15.1	0.3	15.0	21.1	21.9	19.6	14.7	16.1	37.6	18.4	13.7	16.8	1.0	14.6	11.6	25.7	13.7	16.2	19.7	16.7	13.9	26.4	23.0	17.0	16.9	18.7	21.5	5.6	14.9	41.6	0.0	0.0	34.1	0.0	1.7	0.0	25.4	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	20.9	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.3	8.1	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	45.4	0.0	0.0	0.0	0.0
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 115.1;Club cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	89.1	131.0	31.4	54.7	70.2	102.4	86.6	61.8	64.3	94.6	72.1	105.7	47.5	75.0	100.2	63.3	48.6	57.1	65.8	84.3	78.0	90.4	194.5	63.0	91.4	153.0	76.6	99.5	44.2	92.6	98.5	61.0	107.4	67.1	56.3	53.7	86.3	50.6	68.1	158.5	49.8	124.4	46.7	205.0	201.3	47.8	104.0	119.7	102.4	112.7	71.5	44.3	38.0	95.6	92.8	61.7	65.9	76.3	57.1	91.3	66.0	64.8	98.2	88.4	114.8	85.9	49.3	50.7	45.7	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4	26.8	56.3	13.7	6.1	12.9	0.9	0.0	22.9	115.1	150.2	5.2	0.0	10.6	31.5	37.0	0.4	14.4	5.6	23.3	30.1	24.4	10.8	3.7	39.5	37.1	14.9	0.0	14.0	31.9	41.2	1.1	23.9	13.6	10.1	88.4	24.3	0.2	47.4	14.0	12.0	26.2	0.8	6.5	5.7	0.5	5.0	13.0	7.3	18.1	29.3	6.8
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7900000	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.7	0.2	9.6	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	14.0	0.1	19.2	0.9	1.2	10.0	0.6	3.8	0.1	13.7	31.3	0.0	5.5	5.5	5.2	2.3	4.4	6.4	3.5	1.2	0.7	2.3	2.5	0.1	4.7	1.9	1.2	17.0	0.2	4.6	12.5	2.3	9.5	6.5	0.1	18.3	2.0	0.5	13.7	10.6	20.7	15.6	1.7	0.5	14.9	5.6	8.7	2.6	9.7	8.3	4.6	5.0	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6	32.8	63.8	51.1	124.1	64.5	115.4	25.8	76.5	58.9	55.7	120.4	56.9	65.8	51.4	53.1	16.8	69.7	85.0	0.0	33.3	35.7	82.8	109.1	50.7	52.9	65.1	62.0	130.1	72.4	57.8	13.2	138.4	78.5	77.6	175.9	94.2	102.4	38.5	89.7	119.9	123.2	117.3	116.4	86.4	1.4	41.7	57.3	38.6	61.8	96.6	69.8
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	34.5	34.4	21.5	13.9	17.6	46.8	34.6	10.4	13.6	25.6	44.6	12.8	40.7	9.7	21.7	33.7	25.1	20.0	39.9	26.9	16.6	16.5	20.2	61.2	13.5	27.5	16.9	11.3	31.9	19.2	22.0	17.3	19.4	11.7	46.9	10.6	32.2	44.4	44.0	13.7	7.5	15.3	83.9	12.4	17.8	27.1	13.3	10.9	19.6	21.0	14.2	14.5	64.1	27.5	13.1	28.6	18.2	6.3	1.2	13.7	5.2	0.1	50.4	44.8	61.6	18.0	31.6	10.0	23.7	28.6	35.9	30.9	33.6	29.3	0.5	17.9	37.8	13.0	0.6	24.2	25.5	10.6	20.3	36.2	24.4	6.9	44.9	34.0	17.8	9.0	40.6	13.4	22.0	2.1	25.9	23.0	35.1	25.3	4.3	26.7	41.3	15.5	22.4	45.7	12.3	11.2	78.4	10.0	12.7	24.9	0.2	13.1	71.0	6.0	0.4	22.1	17.2	30.0	41.8	28.7	25.7	37.4	17.1	5.9	0.5	0.3	13.3	11.2	3.2	29.6	4.1	6.3	18.2	7.5	5.6	6.5	12.3	7.7	8.3	8.7	13.1	13.7	7.1	2.2	1.2	4.8	28.6	0.4	5.2	21.5	17.6	10.4	13.6	16.6	16.5	16.9	11.3	11.7	10.9	0.0	11.5	29.0	48.4	28.6	13.9	34.0	35.7	4.0	4.5	55.8	2.0	59.9	212.2	109.2	3.5	43.9	11.0	186.9	35.0	20.4	74.3	109.3	29.9	119.9	107.7	7.9	43.4	47.9	41.0	14.6	82.6	23.2	59.1	66.7	34.5	18.6	75.4	17.3	89.1	59.0	5.4	51.8	95.1	1.4	43.5	21.5	18.2	14.9	56.3	48.5
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115172-138139443	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.1;testis: 36.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.3	5.2	12.3	0.6	18.4	0.3	3.7	3.5	13.9	7.1	1.2	3.9	4.7	0.5	4.1	18.2	1.0	28.1	6.8	2.9	12.0	10.7	15.4	0.6	3.6	0.6	9.4	9.9	4.5	3.5	12.1	8.9	0.4	13.1	4.2	1.1	4.8	3.1	3.9	0.4	0.4	0.5	2.6	4.2	0.4	2.2	36.2	4.8	0.0	9.6	0.3	0.4	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	0.0	0.0	0.0	0.6	0.4	0.6	0.2	0.1	1.5	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	1.9	0.0	0.8	0.0	3.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	25.6	0.0	5.9	2.2	0.0	0.7	3.8	1.5	0.5	1.3	0.0	0.6	0.0	0.0	0.8	0.4	0.6	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	18.4	3.5	13.9	12.0	10.7	9.4	9.9	13.1	4.8	6.0	6.9	0.0	9.1	0.6	11.4	2.8	2.5	327.9	26.1	31.4	13.7	0.4	72.9	18.8	516.0	3.4	0.0	0.0	3.6	0.0	3.2	7.9	0.0	0.5	0.1	6.4	5.2	1.3	0.0	184.0	8.3	0.7	10.1	1.0	2.5	15.8	5.2	0.0	13.1	66.5	21.6	0.0	1.0	142.0	20.4	0.3	0.0	0.0	1.1	5.6
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017909	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	11.7	12.2	7.0	14.4	11.0	7.7	13.5	9.2	10.9	12.2	12.0	11.9	14.6	13.5	16.1	13.2	16.1	16.3	8.8	13.7	9.9	6.8	18.0	17.5	11.1	12.9	9.2	10.3	14.5	20.6	12.1	13.3	22.1	8.8	13.2	12.7	13.5	20.8	17.6	20.1	10.3	13.4	13.3	7.1	14.2	13.4	9.0	8.2	12.6	17.5	14.3	15.1	13.9	15.7	26.4	23.5	43.3	22.7	23.0	25.8	14.3	17.9	11.2	15.3	11.1	12.5	16.8	13.7	17.6	13.6	25.9	19.7	18.7	15.8	18.1	9.2	13.7	24.3	6.3	13.7	19.4	15.4	21.6	13.3	11.8	15.0	15.2	16.7	14.9	12.7	13.7	21.3	23.0	27.4	12.4	13.9	13.7	19.7	14.0	9.7	8.5	12.5	6.4	12.9	12.7	14.7	7.4	13.4	15.2	13.0	15.5	4.7	8.1	12.0	13.2	15.7	12.4	14.8	13.9	12.4	5.1	20.4	12.7	25.0	16.6	22.4	16.3	9.7	19.8	11.3	22.0	20.1	43.3	25.8	20.7	23.6	26.4	24.2	21.9	23.5	24.4	18.7	17.7	22.5	23.0	22.7	21.1	19.4	14.3	7.0	11.0	9.2	10.9	9.9	6.8	9.2	10.3	8.8	8.2	26.8	20.2	17.6	7.9	4.4	12.2	9.2	20.4	44.2	21.6	8.7	13.7	42.3	33.2	22.4	1.9	8.3	11.2	0.0	26.1	34.3	7.8	7.3	9.3	8.3	29.6	9.5	4.1	6.7	6.7	1.5	10.9	12.4	15.1	29.7	8.8	14.6	25.4	7.0	6.7	12.8	12.2	12.9	7.4	9.1	13.2	3.6	16.5	13.8	12.8	5.9
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.0"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 303.5;Hepatocytes: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		1100000	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	10.8	10.5	11.7	8.3	14.0	7.3	9.1	8.3	19.0	7.6	11.2	7.3	8.8	9.2	7.1	8.8	7.9	5.4	7.1	62.1	10.8	8.2	26.0	48.5	7.2	9.6	9.2	10.3	5.8	12.2	15.6	6.2	5.8	10.0	8.5	12.1	6.7	14.4	7.8	100.0	6.0	8.9	14.7	6.1	6.5	13.6	4.2	6.1	14.0	14.0	32.6	8.7	10.9	6.2	11.4	25.5	13.1	18.5	18.2	19.1	13.5	8.3	6.2	14.3	26.6	16.7	18.6	4.5	8.4	14.4	10.4	9.4	7.1	13.9	8.6	10.5	16.0	11.0	8.0	56.7	2.0	11.0	13.6	15.3	12.4	33.3	8.7	9.6	20.7	18.5	16.0	6.3	5.9	8.5	18.2	20.5	12.5	8.9	34.4	24.7	5.7	22.3	11.2	2.8	0.0	5.6	25.1	33.8	30.8	19.7	7.4	21.1	17.6	30.9	0.4	19.1	3.1	21.6	20.9	11.2	15.2	14.8	6.3	4.1	18.5	19.0	13.2	3.1	27.7	9.8	9.3	14.2	13.1	14.4	18.4	14.8	11.4	15.6	14.5	25.5	10.3	14.6	13.3	2.4	18.2	18.5	9.2	19.1	13.5	11.7	14.0	8.3	19.0	10.8	8.2	9.2	10.3	10.0	6.1	50.6	27.8	20.7	7.7	10.2	17.5	303.5	28.1	24.1	31.8	26.2	33.4	7.2	23.2	10.7	12.2	12.6	17.2	23.3	9.3	2.1	17.9	10.5	23.3	274.2	21.7	6.4	19.1	20.3	31.4	3.4	13.8	18.2	13.5	10.8	24.6	13.2	9.5	11.5	18.0	21.1	11.9	0.0	15.1	2.1	1.2	7.0	1.7	27.7	25.8	7.6
NPAS2	"bHLHe9, MOP4, PASD4"	ENSG00000170485	"Neuronal PAS domain protein 2"	Q99743	2	100820152-100996829	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 49.7;Urothelial cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 45.0;PC-3: 34.2;RT4: 27.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019674	Uncertain	Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019674: AB_10601275"	"unprognostic (2.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (5.47e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (3.55e-7)"	"unprognostic (7.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-3)"	6.6	11.5	16.8	8.2	24.8	1.2	10.1	7.6	23.0	11.9	14.4	4.3	1.3	26.7	8.8	4.9	32.4	8.2	13.6	27.3	15.3	6.8	15.9	14.1	5.3	3.6	6.2	14.1	3.3	32.5	1.7	12.7	14.2	10.3	12.2	15.1	6.5	23.7	7.0	12.7	18.5	20.2	17.9	11.0	5.7	19.1	9.9	8.5	0.5	6.3	6.0	13.4	22.4	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	4.0	22.7	0.0	0.2	22.4	9.7	3.3	7.5	22.4	3.1	6.7	0.4	1.8	0.0	9.0	1.2	45.0	0.1	3.3	5.5	3.2	0.2	1.3	0.0	4.0	10.3	10.6	0.0	0.9	8.2	9.0	7.5	12.1	12.6	12.6	2.4	0.1	0.0	2.4	8.1	1.5	0.2	0.4	6.6	34.2	0.1	0.5	0.2	16.0	27.5	0.0	0.4	0.0	1.3	16.8	0.2	0.2	0.2	4.8	2.3	3.1	4.5	3.2	0.0	0.0	0.0	24.5	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.0	1.3	0.0	16.8	24.8	7.6	23.0	15.3	6.8	6.2	14.1	10.3	8.5	0.0	10.7	0.0	7.4	3.4	4.4	13.2	20.4	2.7	10.3	12.2	0.0	0.5	0.0	11.2	49.7	6.5	22.4	0.0	13.3	0.8	5.6	17.5	0.0	12.9	0.1	27.0	8.7	15.4	0.3	7.9	6.6	0.7	3.3	1.0	9.9	3.6	12.8	11.0	4.9	12.1	0.4	0.0	4.4	0.4	1.7	5.6	0.2	0.0	9.9	36.3
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586898	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.7;T-cells: 14.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		27000	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	13.4	38.8	17.4	11.2	30.9	26.4	15.8	7.1	25.1	10.1	8.7	65.6	3.4	10.2	11.1	11.7	12.8	8.2	11.2	7.1	23.4	14.3	9.9	10.3	17.8	13.0	46.0	15.4	12.0	7.9	51.8	9.9	18.9	27.7	9.7	8.9	12.0	25.4	10.1	13.7	17.0	12.2	10.9	41.4	11.5	12.0	9.5	38.4	7.0	8.3	5.3	10.7	10.8	10.8	3.6	32.7	3.8	5.8	4.6	14.5	4.1	5.3	10.7	4.6	7.4	15.0	11.6	10.5	9.3	20.2	9.9	21.5	7.1	7.8	4.5	7.2	13.4	33.8	15.0	5.8	16.0	8.8	3.5	4.6	1.6	9.7	16.0	21.4	6.1	7.4	11.1	15.9	20.9	70.4	19.6	9.7	5.2	4.8	12.1	11.1	8.1	2.5	3.6	3.2	6.1	9.6	3.6	7.2	11.2	23.0	13.3	1.9	3.7	11.1	16.2	13.7	7.4	4.0	4.8	12.5	21.0	4.1	8.3	8.0	7.5	23.1	3.1	46.3	5.4	9.4	1.8	4.1	3.8	14.5	3.8	9.8	2.4	5.9	9.9	1.7	3.6	2.7	7.3	3.7	4.6	5.8	32.7	7.7	4.1	17.4	30.9	7.1	25.1	23.4	14.3	46.0	15.4	27.7	38.4	23.8	44.3	6.2	23.3	8.2	5.0	4.4	10.2	0.0	15.9	8.7	17.7	11.6	0.0	9.3	1.1	11.4	11.3	0.0	12.8	6.2	6.5	30.4	10.4	7.9	25.1	3.2	3.5	7.4	9.2	1.4	8.3	17.9	11.8	2.8	4.8	16.2	23.5	14.0	9.9	4.7	12.4	0.0	9.0	12.6	20.4	12.7	19.9	20.3	4.5	51.4
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541315	"FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 77.0;liver: 29.8"	"Group enriched"	"Detected in some"	9	"Cholangiocytes: 10.2;Early spermatids: 13.1;Hepatocytes: 27.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.9;Hep G2: 17.2;SCLC-21H: 14.8"	"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Low region specificity"	"Detected in all"			"CAB070127, CAB070128"	Enhanced					NA	NA					"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.5	0.1	0.1	0.0	0.2	0.0	0.4	0.5	0.2	0.3	42.0	0.0	0.0	30.5	0.4	0.3	0.3	0.3	11.4	0.1	0.1	0.1	0.7	29.8	0.2	0.0	0.1	0.0	0.5	1.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	77.0	0.0	0.1	0.1	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	14.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	10.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	13.1	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.0	27.0	0.0	0.0	1.7	1.8	1.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686734-68745809	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	18.3	12.6	10.2	16.5	13.2	18.7	17.4	20.7	15.2	19.0	12.2	12.1	12.2	9.2	18.6	18.0	14.0	16.6	8.5	12.1	12.2	6.6	12.1	11.1	12.5	21.4	13.2	10.2	19.8	12.5	14.2	16.2	23.5	12.2	12.6	15.3	11.3	13.0	11.8	13.9	14.8	15.8	13.7	12.5	19.7	12.0	20.5	15.9	40.6	12.5	13.1	22.5	17.8	13.1	13.6	7.0	9.5	14.2	20.6	17.0	8.0	17.1	22.1	26.4	19.1	7.8	10.0	28.6	18.8	10.9	28.3	23.7	22.2	14.6	31.5	18.4	9.0	12.6	19.8	29.6	13.9	37.9	29.5	22.0	35.9	15.9	18.7	4.9	31.6	12.2	5.3	6.6	22.6	14.8	9.9	16.9	18.3	42.8	22.7	17.7	20.8	26.0	27.6	29.0	6.6	21.7	26.6	31.8	18.9	12.2	18.3	15.6	16.0	20.8	15.7	11.3	21.5	23.5	15.3	10.3	15.5	15.8	18.0	22.9	9.9	19.8	38.2	11.9	23.1	18.2	6.3	6.5	9.5	13.1	8.5	17.0	13.5	13.0	14.0	7.0	13.6	16.2	14.5	1.7	20.6	14.2	5.5	13.4	8.0	10.2	13.2	20.7	15.2	12.2	6.6	13.2	10.2	12.2	15.9	11.9	15.3	27.4	14.6	15.3	20.5	11.3	12.7	20.1	14.8	8.7	17.7	24.8	10.0	15.4	26.7	16.1	8.4	0.0	15.4	25.3	16.3	13.0	15.1	6.7	15.5	12.7	8.2	17.8	11.1	7.1	35.9	19.8	18.6	27.9	11.3	22.6	17.1	7.0	20.5	5.8	31.5	12.9	14.6	52.6	42.8	15.4	11.8	25.9	13.0	10.0
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440260-229508341	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	20.6	20.0	17.4	16.3	21.6	16.2	25.4	29.8	24.0	19.6	17.7	27.2	15.5	13.2	23.0	18.4	18.5	22.2	13.5	22.7	17.6	17.0	19.5	15.6	19.8	27.8	20.9	20.3	27.3	17.8	33.3	23.3	23.0	20.6	19.1	18.3	15.5	17.8	21.2	28.6	21.8	16.2	20.9	19.4	19.1	17.1	19.4	20.9	38.0	21.7	18.0	22.8	20.2	17.9	9.0	10.5	7.5	13.6	7.6	10.9	7.3	14.3	11.6	18.2	9.4	13.1	14.1	35.5	11.9	12.2	17.8	16.2	13.7	14.2	20.9	10.4	11.8	7.9	19.1	25.1	12.6	19.1	12.6	31.2	12.6	12.0	10.3	10.5	25.5	10.3	11.0	9.5	12.8	15.3	12.4	14.8	18.0	28.4	10.1	13.9	6.5	18.8	10.9	27.2	20.2	10.6	18.4	18.9	20.5	10.1	12.7	15.6	19.4	17.8	11.2	13.0	9.3	17.4	20.3	12.9	8.1	9.9	14.0	17.7	9.7	12.0	22.5	9.2	14.9	16.8	7.5	8.2	6.1	8.8	8.2	10.9	9.0	9.3	9.7	10.5	7.1	9.6	10.0	2.9	7.6	13.6	6.0	8.6	7.3	17.4	21.6	29.8	23.4	17.6	17.0	20.9	20.3	20.6	20.9	8.9	17.6	3.7	5.2	8.0	16.0	17.3	7.6	9.4	10.3	14.0	7.9	18.2	5.0	7.2	1.1	8.7	2.9	0.0	7.4	11.1	10.6	5.8	7.0	9.5	8.5	15.9	9.8	12.3	12.3	1.9	11.5	7.1	6.8	9.0	7.1	11.6	6.2	6.5	11.3	6.8	11.9	0.0	9.9	12.3	16.7	9.4	15.3	7.0	9.5	5.5
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706834	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	20.2	14.0	13.8	22.2	15.3	37.5	19.0	24.7	14.9	17.8	15.2	14.4	18.9	9.8	19.7	16.0	21.6	17.8	15.6	15.1	12.3	10.2	13.4	22.9	17.7	21.6	12.2	10.5	21.0	15.1	23.3	17.3	29.2	12.6	15.1	13.4	12.4	16.3	19.9	30.7	19.9	16.3	16.0	11.0	18.7	15.0	26.8	13.8	34.4	15.9	18.9	26.4	18.4	21.1	3.9	3.5	6.5	3.3	5.5	7.6	2.2	19.2	9.7	21.4	18.6	9.5	11.2	20.8	15.1	14.4	23.1	24.8	16.1	9.0	36.6	25.3	13.7	19.2	14.1	25.0	14.9	37.5	19.2	18.6	19.6	10.7	16.6	7.1	28.3	18.3	11.8	12.1	24.1	17.5	8.8	13.6	12.4	45.4	11.8	15.5	10.4	20.9	17.2	16.6	7.4	10.5	27.7	27.4	34.4	10.2	19.1	23.7	13.7	12.9	21.4	12.9	35.4	13.8	10.3	12.4	23.5	13.3	11.0	23.5	15.0	21.5	37.0	5.8	13.1	27.6	2.4	2.5	5.5	5.9	2.4	7.6	3.6	7.1	6.8	3.5	3.9	4.4	4.3	6.5	5.5	3.3	2.0	3.1	2.2	13.8	15.3	24.7	14.9	12.3	10.2	12.2	10.5	12.6	13.8	17.9	21.0	16.6	35.4	67.9	13.1	10.9	10.2	17.4	11.4	15.7	15.7	17.8	1.7	7.7	20.7	23.4	10.7	0.0	5.2	18.0	24.9	29.7	3.5	24.5	15.1	15.9	20.1	12.9	17.1	16.4	16.1	16.8	20.3	6.4	12.1	8.0	12.4	3.5	13.8	9.1	12.5	12.9	23.6	29.1	20.3	69.4	20.0	20.2	14.6	28.0
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 50.6;Late spermatids: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.8	11.0	12.0	17.7	3.7	5.5	43.1	11.2	5.9	15.4	11.3	16.2	11.4	15.7	5.2	7.2	16.7	11.3	20.2	11.0	24.2	10.3	11.4	12.2	40.1	7.5	4.7	20.3	8.6	4.0	4.6	23.7	12.0	4.2	8.1	7.1	22.1	8.4	10.2	6.8	10.8	5.5	11.3	8.5	10.0	13.1	37.8	12.5	3.5	13.3	14.5	10.0	25.8	11.1	6.5	8.9	13.7	8.1	7.0	18.6	15.6	14.0	17.0	9.6	16.0	21.1	8.7	18.4	14.0	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5	3.0	5.0	11.5	5.6	9.3	6.5	7.3	2.5	12.0	11.4	3.5	5.9	11.9	0.0	5.9	50.6	7.4	3.8	0.0	5.2	17.5	5.8	6.6	4.7	7.9	6.8	4.8	1.2	13.5	8.8	71.9	10.3	7.4	0.0	4.6	9.7	3.5	5.5	3.5	9.6	3.1	13.1	0.0	6.1	27.7	19.6	10.2	6.3	8.7	10.3	4.4
NUP160	"FLJ22583, KIAA0197"	ENSG00000030066	"Nucleoporin 160"	Q12769	11	47778087-47848555	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	14.3	11.0	9.6	16.2	13.3	13.3	14.2	23.0	11.3	13.5	10.5	12.9	11.2	9.2	16.6	10.6	12.8	14.5	8.8	9.9	10.7	6.2	11.6	11.3	13.0	15.1	12.2	6.4	21.4	15.9	20.4	14.6	22.4	11.3	11.4	12.1	12.2	13.3	10.1	11.7	12.4	12.3	13.2	13.9	14.4	11.8	13.7	14.1	34.6	16.8	6.6	16.9	12.0	15.2	10.8	11.0	8.5	6.2	6.0	11.2	4.7	5.7	7.6	12.8	8.9	7.6	8.8	16.6	7.4	5.5	10.0	11.7	9.6	8.7	7.8	5.0	6.7	10.1	12.6	23.4	7.3	11.3	6.8	16.2	8.6	33.0	10.4	5.1	25.2	5.9	6.9	4.6	7.1	14.0	4.1	7.9	12.8	24.0	11.1	5.3	9.8	16.8	11.1	19.2	12.7	8.0	20.3	19.3	7.0	5.1	10.1	10.6	12.1	17.5	8.7	6.6	11.8	10.9	9.7	5.3	11.1	9.6	18.5	9.9	4.8	4.6	20.3	5.5	10.8	10.9	5.7	5.1	8.5	7.2	6.2	9.7	10.3	8.4	7.6	8.2	10.8	11.2	8.3	2.8	6.0	4.3	11.0	6.4	4.7	9.6	13.3	23.0	11.3	10.7	6.2	12.2	6.4	11.3	14.1	20.8	16.8	21.7	27.2	20.4	24.6	7.2	12.7	10.7	17.0	19.2	41.2	27.3	13.3	12.7	21.7	16.9	9.7	23.3	14.3	24.6	19.8	25.3	19.6	11.5	13.4	6.4	18.4	14.7	6.6	10.0	22.5	14.9	10.1	9.0	12.8	21.7	12.9	5.8	20.5	9.6	48.5	19.4	14.4	13.5	18.5	24.2	25.7	24.5	11.8	28.2
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.3"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	10.2	11.1	7.6	12.6	9.2	14.3	14.0	13.3	8.7	9.2	9.3	10.1	9.6	5.8	9.8	6.7	16.6	8.3	7.6	9.2	5.6	6.3	8.1	9.6	13.1	16.6	6.5	6.7	10.8	13.3	12.6	13.6	9.1	7.3	9.5	9.3	11.2	9.9	8.3	10.9	16.4	9.0	11.0	7.7	12.2	9.5	60.3	7.3	26.5	9.2	11.3	17.3	8.5	10.5	6.1	7.9	6.3	10.7	6.0	12.0	7.0	10.9	21.0	17.4	23.7	13.2	13.1	15.6	15.4	12.2	28.3	18.9	25.3	8.8	19.2	5.8	16.9	18.3	32.6	39.0	19.1	21.2	15.4	18.8	17.1	39.2	19.9	8.4	29.2	17.3	9.1	9.0	29.7	15.2	8.3	16.2	25.0	37.5	13.7	19.9	27.8	24.9	11.9	23.3	21.1	20.2	22.9	37.7	19.6	8.7	12.4	24.5	11.8	39.9	15.2	5.9	13.4	16.7	10.8	13.1	23.5	16.7	23.6	27.5	11.7	21.6	26.0	13.7	18.7	17.3	6.3	5.3	1.9	9.3	10.7	12.0	6.1	7.9	9.0	7.9	5.9	8.1	8.6	0.8	6.0	5.9	3.3	9.5	7.0	7.6	9.2	13.3	8.7	5.6	6.3	6.5	6.7	7.3	7.3	0.0	13.0	7.5	5.2	5.8	14.9	2.7	7.6	4.0	2.3	5.2	43.2	6.4	1.7	5.5	10.1	6.8	3.2	0.0	5.6	5.9	6.9	7.5	5.8	3.8	7.4	19.1	8.7	12.9	4.9	3.1	8.9	7.2	1.7	4.6	6.7	7.5	7.5	0.0	11.0	1.9	25.0	25.8	4.2	41.6	37.7	9.8	7.2	7.0	6.0	7.2
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557919-135648757	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	13.7	12.6	11.4	14.2	11.9	10.8	13.1	23.3	10.5	12.5	11.9	13.4	11.4	9.0	17.6	9.7	19.3	16.1	7.4	9.5	8.6	6.1	10.3	8.3	12.2	16.1	11.7	6.9	17.4	10.3	23.0	20.9	13.1	10.6	10.6	14.7	14.6	18.4	11.3	16.6	15.1	13.8	14.7	10.8	16.7	12.7	17.4	11.4	31.6	12.4	13.4	22.1	15.6	14.4	4.9	5.7	2.2	6.1	5.3	6.0	2.7	22.1	18.1	24.4	23.8	5.8	9.6	15.9	14.1	10.9	22.0	24.6	18.7	16.2	28.4	11.2	8.4	22.2	17.3	30.6	15.8	28.5	14.0	21.9	16.5	18.7	8.5	4.4	32.1	13.0	5.2	7.2	21.5	14.5	7.7	16.3	20.3	38.2	13.6	16.5	15.1	34.6	9.8	37.4	17.4	16.1	26.0	22.7	22.5	6.7	17.9	24.4	24.9	23.3	19.1	11.4	19.3	11.0	12.3	13.2	18.1	9.0	21.9	26.9	10.1	18.8	38.6	18.4	25.3	24.3	2.2	2.5	0.8	4.9	6.1	6.0	4.9	6.0	5.2	5.7	4.3	5.1	5.6	1.1	5.3	3.3	3.8	5.6	2.7	11.4	11.9	23.3	10.5	8.6	6.1	11.7	6.9	10.6	11.4	11.9	12.0	10.7	5.4	11.6	6.6	3.7	10.2	8.1	7.9	15.7	11.8	10.4	3.3	7.6	0.7	7.4	3.6	0.0	8.3	8.0	7.5	7.6	8.1	8.1	8.9	4.8	8.7	9.2	12.1	1.9	7.5	7.8	10.1	9.0	9.8	4.5	9.1	7.0	7.1	3.7	9.2	0.0	7.6	16.3	12.1	13.6	6.4	6.4	8.6	8.2
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420309	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.0;lymphoid tissue: 44.2"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 33.4;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 47.0;U-266/84: 52.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		28000			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	1.6	4.1	4.0	25.6	5.2	31.0	3.7	12.6	6.7	1.7	4.2	8.0	3.3	4.9	1.8	7.0	5.6	2.9	4.0	2.0	4.1	5.3	6.8	13.8	5.3	25.6	4.9	3.5	1.4	11.4	7.2	10.9	4.3	4.5	4.2	3.9	6.3	6.8	4.4	7.2	3.8	16.4	1.6	3.6	25.3	5.6	6.6	6.1	44.2	6.5	3.1	23.1	5.6	1.8	6.7	6.8	1.0	3.9	6.2	9.3	3.6	8.4	14.9	7.4	19.1	0.0	0.0	29.4	0.1	0.0	1.8	0.0	7.6	13.8	34.4	11.9	0.0	0.8	4.9	16.3	0.0	0.7	27.6	12.1	13.3	16.9	8.0	0.0	42.5	4.8	0.0	0.0	0.0	0.0	1.3	0.0	26.0	20.5	37.0	0.0	21.1	22.5	16.9	8.5	2.6	3.1	0.0	0.0	47.0	3.6	7.9	8.5	8.5	10.7	14.3	4.5	3.4	13.6	35.4	0.1	0.0	2.5	0.0	6.5	37.6	52.0	30.0	0.0	23.8	0.0	0.0	2.9	1.0	9.3	3.9	7.4	6.7	6.7	9.0	6.4	4.5	5.6	7.3	0.1	6.2	2.4	6.8	5.6	3.6	4.0	5.2	12.6	6.7	4.1	5.3	4.9	3.5	4.5	6.1	14.9	4.8	32.0	1.2	1.4	16.7	9.6	10.2	2.7	6.8	5.2	13.7	13.4	3.3	5.0	18.8	0.7	1.1	23.3	3.8	3.8	0.5	3.1	4.7	11.6	14.7	33.4	7.9	4.3	12.8	16.6	0.6	8.0	1.7	2.8	4.6	3.2	3.5	0.0	0.4	3.4	20.9	0.0	0.3	3.8	10.0	2.0	4.1	37.3	3.8	1.6
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 42.7"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 15.2;Late spermatids: 6.7;Sertoli cells: 6.5;Spermatocytes: 26.5;Spermatogonia: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	43	"MCF7: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.1	1.5	0.0	0.0	1.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.4	0.6	0.1	0.0	0.8	0.9	0.4	0.1	0.1	0.1	3.4	0.2	0.1	0.1	42.7	0.0	0.3	0.3	0.0	0.1	1.2	0.1	0.6	0.6	1.8	0.2	0.9	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.8	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.6	0.4	0.5	0.0	0.5	0.8	0.3	1.8	0.9	0.0	0.6	0.7	0.0	0.1	0.3	0.1	0.9	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	6.5	0.1	26.5	5.1	0.5	0.0	0.0	0.0	0.2
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125561-131234670	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 131.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 43.7;neutrophil: 131.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 131.5;monocytes: 43.7"	"Cell line enhanced"	"Detected in all"		"K-562: 73.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048789			Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA		100000	Nucleoplasm	"Vesicles, Focal adhesion sites"	"HPA048789: AB_2680521"	"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	16.9	10.3	11.5	13.8	13.9	29.4	12.9	13.0	14.4	10.2	11.4	19.8	10.4	9.0	15.0	13.7	16.1	12.1	10.2	9.7	9.5	8.1	19.0	15.1	11.7	13.3	13.2	8.8	14.2	17.0	16.7	16.9	13.0	11.3	11.1	10.8	15.3	13.0	11.1	15.5	17.5	11.7	11.1	14.3	35.8	12.3	63.7	13.3	27.4	11.8	7.6	16.8	10.7	11.2	1.2	16.8	131.5	43.7	1.2	0.8	17.9	6.8	9.8	8.4	5.0	6.8	6.6	8.8	6.1	6.3	8.0	6.5	8.0	5.0	11.1	4.9	8.4	8.3	15.7	11.3	8.0	7.8	8.0	5.5	6.9	14.0	15.6	6.0	10.8	7.5	7.1	7.4	10.2	8.3	5.1	8.1	7.4	73.0	6.4	8.2	12.8	14.2	16.4	9.1	9.9	8.6	5.0	10.6	11.1	9.2	6.3	7.1	7.4	10.2	9.4	5.3	6.3	12.4	27.0	7.0	14.1	7.9	9.2	9.9	5.6	10.9	10.8	6.9	6.5	8.5	3.5	43.7	17.3	0.7	18.4	0.8	1.2	0.7	0.6	16.8	1.1	0.7	0.7	131.5	1.2	15.0	1.5	0.4	17.9	11.5	13.9	13.0	14.4	9.5	8.1	13.2	8.8	11.3	13.3	17.9	19.9	15.2	9.5	7.7	29.6	24.0	15.3	16.0	15.9	22.7	43.2	10.9	8.3	9.1	225.7	14.6	13.6	0.0	13.1	9.3	11.4	11.4	8.1	11.9	75.5	15.9	19.5	18.4	255.0	282.5	21.6	77.0	10.1	15.4	14.3	14.8	12.0	5.8	19.1	6.7	31.6	6.5	8.1	90.1	44.5	9.5	9.2	11.8	16.3	9.3
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 131.7;Late spermatids: 308.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	8.8	10.9	9.1	13.7	21.4	4.1	15.3	18.9	12.6	9.2	8.6	5.6	5.8	7.3	9.6	9.0	11.7	10.6	9.1	7.9	11.1	6.8	11.9	16.4	9.5	9.3	11.5	5.1	13.1	17.2	8.9	13.1	9.0	8.8	9.3	10.7	7.3	9.7	9.6	9.1	10.9	7.1	10.5	7.6	7.8	9.3	25.8	9.7	19.1	10.3	12.6	12.7	8.0	10.2	8.9	3.8	1.7	6.8	5.9	10.5	5.0	10.0	10.8	16.8	9.9	6.1	5.9	12.2	12.1	9.8	18.3	17.6	19.8	12.2	17.1	11.4	6.4	21.7	8.7	23.1	13.4	29.7	15.3	15.3	16.1	9.0	21.0	4.6	11.6	10.9	4.3	7.1	15.6	14.9	4.1	10.7	10.3	14.5	12.7	13.9	11.7	13.4	13.9	28.6	15.8	33.4	16.5	13.3	12.1	16.9	12.3	14.9	10.4	11.2	13.1	12.7	13.0	8.5	8.1	5.7	14.4	10.2	11.6	13.5	8.5	18.4	18.2	9.8	8.5	19.3	0.0	4.8	1.7	6.1	6.3	10.5	8.9	7.8	7.5	3.8	7.9	9.6	8.4	0.1	5.9	6.8	3.6	7.7	5.0	9.1	21.4	18.9	12.6	11.1	6.8	11.5	5.1	8.8	9.7	8.9	5.0	11.1	14.4	23.1	10.8	4.1	10.2	8.1	14.8	15.7	17.7	18.4	10.0	10.8	131.7	9.3	3.1	23.3	11.1	17.4	12.4	7.0	8.1	11.9	7.4	6.4	3.5	11.6	6.2	308.3	8.9	3.7	20.3	4.6	6.6	10.8	9.6	7.0	7.8	10.1	17.1	12.9	13.2	34.7	19.4	24.0	7.9	8.9	7.4	9.7
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120124	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.1	18.4	6.0	17.5	7.7	12.6	12.8	8.1	7.4	12.4	12.8	8.7	14.9	8.1	13.0	14.7	22.0	12.6	7.8	12.3	5.7	5.4	11.4	8.6	9.0	16.4	6.0	5.1	12.6	11.7	12.6	15.2	17.6	10.6	13.7	16.0	11.2	11.7	9.6	18.0	11.3	14.5	11.4	9.3	16.5	11.5	17.8	6.2	28.4	16.4	18.5	20.8	13.6	11.0	19.4	18.1	30.6	17.2	13.2	26.7	13.0	32.0	23.7	20.9	9.5	17.3	23.0	46.3	20.7	19.5	32.7	22.4	30.2	17.5	21.8	14.8	16.0	22.6	23.8	36.5	32.0	41.1	30.7	20.8	23.4	12.8	27.0	22.1	33.0	7.4	17.7	14.1	25.4	18.9	21.9	26.6	29.1	41.4	8.3	30.2	22.3	24.5	27.4	20.6	30.2	37.9	16.2	29.6	16.5	25.7	24.2	10.9	7.8	15.6	16.8	14.8	24.6	29.4	19.2	8.6	11.8	12.9	16.5	28.3	12.6	23.8	37.4	13.5	27.0	19.7	30.6	14.7	16.4	13.8	17.2	15.0	19.4	16.9	14.0	18.1	17.7	15.3	17.3	4.3	13.2	14.2	15.3	26.7	13.0	6.0	7.7	8.1	7.4	5.7	5.4	6.0	5.1	10.6	6.2	6.0	11.0	22.6	21.0	10.1	7.4	7.9	22.9	28.1	11.4	15.7	7.9	61.2	21.6	20.4	2.3	14.2	9.2	23.3	17.3	79.0	11.7	10.2	7.0	8.6	31.3	3.2	5.8	10.4	14.3	4.0	18.1	16.9	6.8	19.8	15.7	17.6	16.1	10.5	17.7	18.0	17.2	19.4	10.3	50.2	37.0	8.3	33.6	17.3	20.7	10.6
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	16.9	14.2	12.7	15.2	13.8	7.6	19.6	15.6	13.5	20.1	13.1	17.9	18.3	12.4	18.4	11.5	17.4	13.1	9.1	14.7	10.9	10.0	15.7	13.7	12.6	20.3	15.2	9.2	15.7	22.6	14.1	13.2	18.8	12.9	16.6	14.1	17.7	14.2	14.2	20.0	18.7	16.6	16.2	12.1	22.7	14.4	13.8	16.4	28.6	18.9	12.1	24.2	18.4	14.2	10.6	8.1	5.1	8.6	6.1	9.7	3.3	9.0	15.8	13.9	21.8	8.9	11.2	21.8	15.7	9.0	15.4	19.5	22.6	8.5	26.1	16.8	8.6	14.4	14.5	23.8	13.8	26.2	12.2	16.7	29.9	16.8	21.0	6.1	30.6	19.5	6.8	7.3	22.4	14.3	5.8	12.1	15.1	30.5	14.6	12.8	9.7	22.0	12.7	12.2	10.3	9.4	21.6	19.2	8.7	10.1	12.6	5.7	9.6	18.7	11.9	6.1	12.0	12.7	13.0	9.4	12.6	13.7	17.9	23.9	9.0	18.3	28.0	11.2	21.3	17.6	4.4	8.3	5.1	6.3	8.6	6.6	7.3	7.4	6.2	4.2	10.6	7.8	9.7	3.3	6.1	7.2	8.1	7.9	3.3	12.7	13.8	15.6	13.5	10.9	10.0	15.2	9.2	12.9	16.4	3.0	5.6	6.2	4.5	7.0	11.7	12.6	10.2	2.7	4.5	3.5	5.9	9.5	3.3	7.6	27.2	5.3	3.4	0.0	6.7	10.5	4.7	5.3	0.0	3.2	6.7	6.4	9.8	6.2	10.3	58.0	9.5	6.0	8.5	10.0	5.8	11.1	5.5	0.0	9.9	3.8	9.5	12.9	8.2	4.9	10.0	7.4	5.5	6.9	7.6	5.6
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163841-45188015	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047162	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA047162: AB_2679963"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	9.0	12.0	8.0	12.3	9.3	26.4	12.8	11.3	11.4	8.7	13.2	6.6	15.8	9.0	9.1	11.0	18.1	10.4	8.0	5.3	7.4	8.6	10.8	13.6	10.4	17.6	7.1	8.4	9.9	11.7	8.2	16.1	12.9	16.8	11.9	9.6	8.2	11.3	15.0	6.5	10.8	18.1	6.2	6.3	19.3	13.4	20.0	7.5	41.3	12.2	5.5	19.5	10.7	15.3	8.2	10.3	37.6	16.2	11.8	12.5	12.3	24.3	11.7	22.4	14.5	10.5	11.0	23.9	20.4	13.6	15.8	16.1	25.3	10.9	26.7	9.6	13.4	11.8	17.2	27.5	16.6	22.9	14.2	29.2	23.4	18.3	15.4	11.0	61.7	24.9	13.3	11.5	20.2	15.4	7.6	17.4	23.6	24.2	28.2	16.2	16.3	27.9	16.0	16.8	16.2	12.1	29.7	13.6	18.7	12.3	23.7	14.0	13.6	20.3	12.6	24.0	17.9	7.8	16.4	15.8	33.6	30.2	17.3	17.1	19.7	15.9	39.3	12.6	16.0	23.3	19.7	15.7	31.0	8.8	16.2	12.0	8.2	10.6	10.0	10.3	7.4	12.5	8.5	37.6	11.8	9.2	5.7	10.1	12.3	8.0	9.3	11.3	11.4	7.4	8.6	7.1	8.4	16.8	7.5	8.9	24.7	25.2	40.1	76.0	14.5	9.0	22.9	33.5	18.2	31.4	11.8	20.7	11.6	16.5	34.0	19.0	21.4	70.0	18.1	32.1	18.9	47.3	32.5	32.4	24.1	12.7	16.7	35.0	41.1	58.5	13.6	24.9	23.6	23.4	22.0	9.7	22.7	31.6	13.1	17.4	16.3	25.8	14.7	31.2	39.5	78.2	47.4	37.1	22.2	77.6
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148515	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	23.7	14.5	13.5	18.2	15.2	28.4	25.7	26.0	17.2	23.1	20.0	14.6	17.9	15.3	22.9	18.2	21.4	22.5	15.1	17.0	12.2	10.8	16.4	20.3	17.8	22.8	20.5	13.1	25.3	19.3	13.3	16.8	22.8	14.9	19.8	19.7	12.2	20.0	24.1	17.8	21.2	18.4	24.7	14.7	23.6	19.2	19.6	20.0	36.1	19.8	18.1	22.1	24.1	21.8	10.0	11.4	7.7	10.0	21.6	16.5	7.5	17.1	6.8	21.8	15.7	18.6	17.8	19.2	17.4	25.1	25.8	26.6	16.0	24.6	26.0	14.7	17.3	14.0	11.6	23.4	19.4	32.4	17.1	13.7	15.7	8.5	15.2	17.6	30.4	19.0	16.2	14.0	20.4	21.7	11.4	22.1	17.1	26.9	16.4	18.6	15.0	32.0	14.3	34.9	20.9	6.1	25.1	34.4	9.9	15.3	16.5	13.2	11.0	16.1	19.1	14.0	17.8	8.1	18.7	14.7	20.8	18.6	24.7	21.1	10.7	3.9	24.8	14.8	17.9	18.2	6.5	7.5	7.7	12.2	9.0	16.5	9.0	12.9	11.7	11.4	10.0	13.8	13.0	3.5	21.6	10.0	8.4	12.5	7.5	13.5	15.2	26.0	17.2	12.2	10.8	20.5	13.1	14.9	20.0	20.8	11.8	23.1	37.0	31.3	13.7	9.9	7.6	18.7	12.5	10.4	19.6	36.3	24.9	18.9	7.9	20.4	11.5	0.0	24.2	38.9	30.9	23.1	23.1	11.9	19.3	7.9	13.8	18.4	18.3	5.6	25.3	17.0	16.9	30.7	18.4	11.8	15.9	21.0	24.4	17.2	19.1	32.3	26.8	38.4	40.1	25.5	32.7	27.7	21.7	29.4
NUP58	"KIAA0410, NUP45, NUPL1"	ENSG00000139496	"Nucleoporin 58"	Q9BVL2	13	25301524-25349800	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 182.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039360	Approved					NA	NA					"HPA039360: AB_2676463"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.06e-1)"	14.6	15.5	14.8	18.9	19.0	31.2	19.9	23.8	20.6	15.0	12.8	16.4	13.1	12.3	17.3	13.4	15.2	15.0	15.0	16.4	16.5	18.0	17.6	17.2	24.3	20.5	14.1	14.6	24.9	13.3	9.8	30.6	32.3	19.2	17.0	15.9	14.3	14.0	14.3	23.2	14.8	12.4	17.4	15.2	17.9	13.7	47.1	13.5	34.1	20.8	14.0	19.1	22.9	18.5	3.4	5.1	11.9	8.1	2.8	5.7	4.2	13.3	8.1	19.6	14.7	6.6	9.5	14.9	20.1	15.0	21.3	17.5	13.5	14.5	23.0	9.8	11.3	18.3	14.9	22.3	16.4	34.1	21.3	11.0	32.2	7.6	9.3	12.3	23.3	38.3	6.4	22.5	17.6	39.4	10.5	13.0	20.0	17.1	10.0	23.8	5.3	29.8	16.3	11.7	21.5	7.1	20.8	26.0	10.4	11.6	10.5	23.4	11.7	12.9	9.8	16.1	16.7	6.7	21.1	10.6	13.8	13.8	13.2	23.4	12.4	10.3	31.5	10.2	13.7	23.5	1.7	8.1	2.3	3.5	7.2	4.6	3.4	4.5	4.1	5.1	2.9	5.1	4.4	11.9	2.8	7.6	2.7	5.7	4.2	14.8	19.0	23.8	20.6	16.5	18.0	14.1	14.6	19.2	13.5	38.7	79.9	8.9	22.3	0.0	32.9	0.0	12.7	10.7	25.0	24.4	51.1	21.7	10.0	12.6	104.3	17.9	8.1	0.0	9.4	32.8	11.6	29.3	22.1	23.7	20.6	23.8	9.4	22.1	39.4	182.1	17.8	32.1	0.0	15.4	18.5	28.7	14.7	3.5	23.3	22.7	44.0	19.4	0.0	77.6	80.2	0.0	33.1	14.9	18.3	23.8
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.1	25.7	15.8	29.1	18.5	19.8	16.1	28.3	21.7	18.2	17.1	21.0	13.4	20.0	24.1	13.7	21.5	22.1	20.9	16.9	14.3	15.1	16.8	27.5	16.2	29.0	15.2	14.2	26.6	18.6	14.0	21.3	24.1	17.4	19.8	17.7	16.2	18.8	20.2	27.1	18.8	20.2	23.3	14.2	26.0	16.4	70.9	17.6	45.5	16.8	17.3	29.6	18.9	19.4	10.7	21.1	6.2	22.3	13.7	16.9	12.5	32.0	30.5	22.6	19.2	7.1	8.1	21.1	24.3	16.7	25.6	25.6	20.6	18.9	36.1	13.4	15.5	17.2	19.1	27.5	16.8	24.8	52.2	29.3	29.0	15.3	19.0	8.6	26.6	28.9	8.3	11.6	16.9	14.1	11.4	18.8	21.7	35.4	35.3	17.5	15.5	48.0	20.3	21.4	29.0	27.2	43.4	26.4	30.7	12.3	24.9	25.3	18.0	23.2	26.5	12.1	16.9	21.5	13.6	14.6	40.3	23.7	13.0	39.4	25.6	69.7	33.2	16.6	23.2	30.0	6.2	20.7	4.2	12.0	22.3	16.9	10.6	12.0	13.2	21.1	10.7	8.2	10.5	3.3	13.7	11.8	18.3	10.7	12.5	15.8	18.5	28.3	21.7	14.3	15.1	15.2	14.2	17.4	17.6	23.8	21.9	40.6	17.0	30.3	10.8	12.6	20.4	24.1	19.4	8.7	5.9	23.7	8.3	21.3	98.8	27.0	16.6	23.3	14.1	38.8	21.5	15.3	22.0	11.0	44.5	60.4	20.7	30.1	34.9	254.9	23.0	47.7	20.3	90.2	22.7	18.3	20.1	23.4	21.5	13.6	15.4	19.4	12.2	71.6	37.3	28.0	18.2	26.6	27.6	12.9
NUP62CL	FLJ20130	ENSG00000198088	"Nucleoporin 62 C-terminal like"	Q9H1M0	X	107123427-107206433	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 40.6"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 12.0;Distal tubular cells: 18.3;Spermatogonia: 9.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"pons and medulla: 18.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.3;NK-cells: 1.7;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A549: 13.8;CAPAN-2: 14.9;HeLa: 19.9;K-562: 14.0"									HPA001884	Approved					NA	NA					"HPA001884: AB_1079512"	"unprognostic (1.62e-2)"	"prognostic favorable (5.66e-5)"	"unprognostic (8.80e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.52e-3)"	0.5	12.4	1.2	2.9	2.6	1.4	2.6	0.3	0.6	1.7	3.1	3.2	8.7	2.4	2.0	40.6	2.3	15.0	2.3	1.6	1.7	2.2	5.5	2.0	2.4	1.4	1.1	1.2	4.4	12.6	2.5	9.0	0.7	18.3	1.0	2.7	1.1	2.5	10.9	0.5	1.5	3.3	0.2	1.3	0.6	1.3	11.0	1.7	3.3	8.6	1.0	3.4	1.4	1.4	4.3	0.2	0.6	0.5	1.7	2.6	0.6	8.3	13.8	1.2	0.0	0.0	0.0	6.0	0.0	0.5	0.3	0.3	1.3	14.9	4.8	1.6	0.0	7.7	7.5	8.8	3.0	0.0	0.0	11.3	0.5	19.9	2.4	0.0	0.0	0.0	0.1	4.1	0.0	2.1	0.0	0.0	7.5	14.0	1.2	0.0	4.1	1.8	0.0	1.8	11.9	5.0	0.0	0.0	0.4	4.5	2.2	3.6	4.1	4.9	1.5	0.0	5.3	0.0	0.2	0.0	0.0	4.6	0.1	0.0	1.6	5.5	2.6	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.4	0.7	4.3	2.6	0.2	0.1	3.3	1.3	1.5	0.0	1.7	0.5	0.2	1.1	0.6	1.2	2.6	0.3	0.6	1.7	2.2	1.1	1.2	18.3	1.7	3.0	0.0	3.2	3.2	1.6	0.2	0.8	2.5	12.0	1.2	8.7	0.0	1.3	18.3	1.6	6.4	0.0	1.1	0.0	3.0	0.7	0.2	0.8	0.0	1.8	0.7	1.6	0.0	0.0	0.0	1.5	0.3	0.0	5.0	0.0	2.5	1.2	0.9	0.0	0.7	4.5	0.0	6.5	0.0	4.2	9.7	2.5	0.8	0.0	2.5	2.3
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	21.6	12.9	13.7	22.1	14.2	17.9	19.1	43.0	17.9	17.1	17.2	17.2	12.5	16.1	24.1	16.9	19.6	19.0	15.8	14.7	12.7	8.8	14.9	19.8	17.5	25.4	17.5	12.7	21.4	18.5	12.0	13.5	18.8	13.9	17.3	21.8	15.3	16.8	16.3	17.0	23.5	18.4	20.1	15.6	24.6	16.1	24.5	14.1	28.5	17.8	14.0	26.2	15.8	18.2	17.1	19.0	17.6	20.8	12.6	20.5	13.5	22.5	25.7	18.9	13.0	7.3	11.4	26.3	16.4	13.0	38.6	36.3	22.0	21.7	20.8	9.5	14.0	25.1	19.5	30.9	17.3	34.4	6.5	25.0	17.3	29.6	19.2	6.0	17.8	14.5	10.9	10.8	26.9	11.7	8.9	29.5	17.1	21.3	13.4	18.7	24.9	33.4	21.9	14.1	28.1	23.7	23.4	40.9	18.9	14.7	16.5	14.4	13.8	20.2	26.0	14.4	22.0	29.3	20.3	10.8	28.9	26.8	18.5	26.0	8.3	6.8	26.6	14.9	16.3	17.7	5.2	20.8	17.6	14.6	18.1	20.5	14.2	15.7	14.0	17.1	17.1	15.5	11.8	6.7	12.6	12.9	19.0	13.3	13.5	13.7	14.2	43.0	17.9	12.7	8.8	17.5	12.7	13.9	14.1	6.0	12.2	15.0	7.2	5.5	7.8	7.5	10.2	9.4	11.4	7.0	9.8	17.8	6.6	14.0	2.0	14.2	7.3	46.7	16.9	18.4	14.3	6.5	10.5	19.5	19.7	6.4	7.5	20.9	11.1	2.5	13.3	16.2	8.5	13.6	9.7	4.5	15.0	7.0	9.2	7.9	7.4	32.3	6.1	17.4	30.4	6.1	10.6	12.9	10.7	6.7
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5420160	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 103.0;Spermatocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	10.8	12.4	8.1	17.2	8.8	13.2	14.1	15.0	9.2	9.0	12.5	6.6	8.1	7.4	10.1	12.2	13.1	10.5	7.7	15.3	8.0	5.6	11.3	25.7	9.1	17.8	6.9	6.9	9.9	11.1	11.9	12.4	10.0	7.5	9.6	14.3	6.9	11.7	12.5	33.4	11.8	12.4	10.2	7.7	20.0	11.4	34.4	8.4	28.9	15.8	10.3	23.1	10.9	10.5	24.2	7.4	3.5	8.6	12.2	10.5	7.4	20.6	22.8	18.4	15.5	8.8	9.0	19.9	15.8	14.2	29.2	26.7	19.5	8.7	37.6	6.5	15.4	16.8	20.9	31.7	18.7	32.5	10.4	21.8	16.4	20.4	14.2	12.4	13.4	17.3	6.7	13.6	21.6	33.3	10.4	19.9	15.1	18.7	9.9	20.3	10.0	20.5	9.2	19.4	19.6	11.5	20.2	20.8	18.0	13.4	9.5	8.0	15.5	19.4	9.4	11.8	15.2	10.5	15.6	12.2	12.4	14.1	13.0	28.8	6.4	8.4	18.6	14.7	15.1	19.1	3.5	4.9	2.2	8.2	7.3	8.1	24.2	9.1	9.8	6.9	23.2	9.5	10.1	0.5	12.2	8.6	7.4	10.5	7.4	8.1	8.8	15.0	9.2	8.0	5.6	6.9	6.9	7.5	8.4	11.9	16.2	36.6	23.6	19.7	12.9	8.9	12.7	13.4	19.4	15.7	15.7	27.0	10.0	20.2	103.0	8.5	8.8	0.0	22.2	20.9	10.1	18.0	7.0	15.8	10.5	9.5	13.2	8.0	4.1	21.6	14.1	11.5	3.3	18.0	9.1	8.9	19.4	14.0	10.3	7.0	10.4	12.9	13.2	115.8	53.5	14.9	30.1	18.1	16.8	38.1
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730105-56850286	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain					NA	NA					"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	14.2	12.2	14.8	15.6	29.7	33.7	12.6	16.8	29.1	12.7	12.4	14.4	4.4	7.2	15.0	9.8	16.8	12.0	8.6	11.5	26.1	11.2	9.9	6.9	12.6	19.1	13.1	16.7	13.4	9.8	16.5	9.6	14.1	23.8	13.9	14.5	23.0	10.4	10.2	15.5	16.3	11.2	14.5	20.7	17.8	11.1	29.3	13.9	28.0	27.4	10.4	22.5	11.5	13.2	12.0	16.9	54.1	21.3	15.1	14.6	11.9	19.3	24.1	21.8	23.8	8.4	9.2	24.2	17.0	13.8	42.3	29.1	33.1	19.5	30.4	17.1	16.0	16.1	34.8	41.3	24.2	41.8	9.3	22.6	20.3	17.4	27.0	10.4	26.9	24.4	9.2	10.6	28.7	18.1	8.8	24.3	27.8	24.6	6.0	20.8	13.9	36.2	23.1	27.7	13.3	27.0	43.9	36.8	30.7	16.4	13.0	19.4	12.8	44.3	15.6	13.9	24.3	11.8	16.8	16.2	20.1	22.6	16.8	19.2	10.5	14.4	50.8	14.1	25.5	19.6	5.1	14.3	54.1	11.9	21.3	14.6	12.0	9.1	12.9	16.9	11.6	9.5	13.2	3.6	15.1	20.9	8.8	11.0	11.9	14.8	29.7	16.8	29.1	26.1	11.2	13.1	16.7	23.8	13.9	6.0	10.5	14.1	9.6	10.6	26.7	10.1	2.5	5.3	14.8	8.7	9.8	17.9	10.0	18.6	8.9	11.3	5.1	0.0	22.2	27.0	13.1	10.3	17.3	5.5	23.6	36.5	4.7	10.4	19.1	6.2	21.6	21.3	15.1	33.3	10.3	11.2	18.4	7.0	12.7	9.2	18.1	12.9	17.6	53.7	64.0	14.1	8.6	19.2	12.9	15.3
NUP98	NUP96	ENSG00000110713	"Nucleoporin 98"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 93.4;Late spermatids: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074810			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA074810: AB_2686714"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	20.2	13.5	8.7	23.5	11.7	40.8	23.5	14.2	13.2	18.0	15.3	14.6	17.8	11.2	19.2	17.5	18.6	17.3	17.1	18.2	7.8	8.0	12.8	20.1	20.7	17.4	11.4	8.7	25.5	19.0	25.7	23.6	20.7	12.7	18.6	15.2	17.8	17.4	25.0	35.2	18.5	15.7	20.8	10.4	18.3	16.0	57.0	10.6	27.5	20.9	15.0	26.6	22.6	19.3	8.9	9.9	24.9	10.0	6.1	13.2	8.7	29.8	23.4	19.3	21.3	21.4	17.6	17.0	21.3	24.9	29.3	26.4	25.7	37.1	29.2	10.1	25.5	29.6	32.2	33.9	21.0	40.0	20.7	24.5	31.3	19.2	17.6	18.0	39.9	26.4	20.0	14.5	16.1	29.4	13.0	22.7	33.4	38.9	23.5	31.1	12.2	40.1	13.0	24.4	32.8	18.0	24.5	23.5	14.0	16.7	23.6	17.8	11.9	30.9	25.1	14.2	21.0	15.4	15.7	16.6	23.5	20.4	25.5	19.4	14.2	24.2	31.0	15.9	17.2	24.7	19.1	7.9	15.5	11.0	10.0	11.0	8.9	10.7	9.7	9.9	7.8	12.2	10.5	24.9	6.1	6.3	2.7	13.2	8.7	8.7	11.7	14.2	13.2	7.8	8.0	11.4	8.7	12.7	10.6	26.8	25.1	21.4	28.7	44.3	14.4	14.3	25.5	13.4	22.7	7.0	15.7	18.8	3.3	11.1	93.4	20.3	12.8	23.3	10.3	14.1	19.3	22.7	17.4	20.2	15.1	14.3	20.6	16.5	15.1	116.3	15.8	20.9	15.1	27.9	14.0	12.4	10.6	12.7	13.4	7.4	14.9	32.3	23.7	48.2	32.6	44.2	38.9	20.2	16.2	23.9
NUPL2	"CG1, H_RG271G13.9, hCG1, NLP_1"	ENSG00000136243	"Nucleoporin like 2"	O15504	7	23181827-23201011	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	13.3	21.1	19.4	27.0	17.1	23.3	14.4	25.9	30.4	15.4	16.4	12.3	26.8	15.4	19.5	26.5	17.9	17.7	18.7	24.3	16.1	16.1	17.8	16.2	14.7	23.2	14.9	19.9	16.7	14.6	22.3	19.7	10.8	15.2	16.5	16.9	12.5	20.3	20.8	16.9	21.6	14.9	19.1	14.6	20.1	15.2	32.2	16.9	19.7	20.8	16.8	19.6	17.7	16.7	16.4	13.8	22.9	8.7	13.9	12.3	9.8	12.1	7.0	9.0	17.0	8.9	11.4	6.6	10.1	7.6	10.8	11.4	9.0	13.6	20.4	9.0	7.0	24.3	14.7	15.5	8.8	13.5	5.9	16.4	14.1	14.9	8.9	11.1	28.7	17.2	5.5	10.7	10.3	6.6	8.3	11.3	11.5	23.7	14.4	10.7	3.5	13.7	16.7	17.1	14.9	10.0	12.6	8.1	15.3	11.9	9.3	11.9	11.4	10.6	5.6	15.6	15.1	7.1	31.4	11.5	7.8	9.8	13.4	16.2	19.0	28.6	22.5	7.3	21.5	17.8	22.9	8.7	7.6	11.4	8.4	10.2	16.4	12.2	11.3	11.5	14.0	11.5	12.3	8.5	13.9	7.1	13.8	12.3	9.8	19.4	17.1	25.9	30.4	16.1	16.1	14.9	19.9	15.2	16.9	14.9	8.6	15.3	14.1	11.9	20.9	15.4	5.1	17.4	12.5	22.7	19.6	14.9	33.2	19.5	230.4	12.2	7.4	0.0	11.6	11.0	12.2	10.0	13.9	5.0	23.6	22.3	15.0	14.1	16.5	25.9	23.3	16.2	8.5	24.4	10.9	16.0	15.1	14.4	19.4	22.3	23.0	12.9	19.8	24.4	11.8	11.8	5.5	20.2	16.8	11.9
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Cell type enhanced"	"Detected in some"	24	"Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.9;SK-MEL-30: 22.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.9	0.0	0.0	22.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.6	0.0	40.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	1.7	2.9	3.9	0.6	0.1	0.0	0.0	0.1
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.7	12.9	2.7	7.6	8.0	8.8	8.0	6.2	9.0	11.7	8.3	9.8	9.3	14.3	8.4	5.7	6.8	8.2	11.4	11.9	11.0	8.6	11.5	15.8	10.9	11.8	9.8	12.7	10.1	8.2	14.8	9.3	9.8	7.6	10.0	13.6	16.2	11.6	9.9	11.5	9.3	9.8	0.5	6.2	14.9	12.4	7.2	23.4	17.1	4.8	3.9	7.2	9.9	17.0	12.6	4.6	18.6	11.9	6.1	7.3	8.8	9.6	8.9	11.1	12.8	4.5	10.3	11.2	7.5	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0	0.0	10.3	2.9	5.0	2.7	6.2	9.8	7.6	5.3	4.5	10.4	3.9	17.5	10.0	11.3	38.3	4.9	6.3	0.0	5.9	13.9	6.5	5.4	9.3	13.9	7.7	4.8	2.4	6.7	2.7	11.5	6.6	3.7	5.0	6.4	9.8	8.3	7.4	7.6	3.9	16.1	6.5	0.0	3.1	26.1	12.0	3.9	11.8	5.0	9.6	2.4
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55750979-55842830	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.4;liver: 53.2"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.2;Hepatocytes: 64.8;Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.8"	"Low region specificity"	"Detected in all"							HPA022979	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA022979: AB_2671018"	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	8.2	5.6	4.9	8.2	8.2	5.1	8.4	3.1	5.3	6.2	11.9	3.0	29.8	9.3	5.2	15.8	6.6	4.9	10.1	12.1	5.1	4.7	17.0	53.2	11.6	7.8	6.2	4.9	5.2	7.5	4.2	5.3	19.4	5.5	7.5	12.7	5.3	7.1	32.1	10.8	4.1	9.8	8.3	5.0	10.0	12.5	8.0	3.9	3.0	5.7	5.8	5.2	8.1	9.9	2.0	12.1	56.4	15.3	6.2	2.7	6.5	8.7	8.1	6.1	2.2	8.2	8.0	15.7	3.4	4.6	5.5	5.4	9.1	11.4	2.4	26.8	5.4	5.1	4.9	3.5	5.8	5.0	38.8	8.2	21.7	2.4	16.9	7.3	8.2	17.2	6.6	7.7	3.2	6.0	6.8	10.6	7.4	15.6	8.8	6.0	7.6	6.5	6.7	6.6	0.0	7.2	3.3	8.8	2.0	5.8	6.5	3.0	6.9	1.7	3.8	14.5	14.0	10.1	14.3	7.7	6.3	4.5	7.0	4.5	24.9	7.8	1.5	5.8	13.6	10.8	15.1	15.3	56.4	2.5	12.6	1.5	2.0	1.6	2.5	12.1	1.4	0.9	2.2	15.9	6.2	13.2	0.9	2.7	6.5	4.9	8.2	3.1	5.3	5.1	4.7	6.2	4.9	5.5	3.9	3.0	7.2	5.1	2.5	0.9	3.8	15.3	17.8	2.7	0.0	8.7	2.0	42.8	10.0	11.2	13.2	7.3	11.8	0.0	12.0	61.2	6.7	1.4	15.0	64.8	19.2	1.6	12.6	9.2	22.6	15.4	15.3	12.6	11.8	10.8	16.2	3.5	8.3	7.0	24.4	30.7	2.2	12.9	10.3	9.8	8.1	1.3	56.2	8.5	14.3	1.7
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283152-287215	"Enzymes, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"pancreas: 286.5"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 253.2"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.2;HEK 293: 11.6;Hep G2: 8.6;Karpas-707: 4.0;MCF7: 6.1;SH-SY5Y: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	0.3	0.3	2.1	0.2	1.5	0.3	0.2	15.3	3.0	0.2	0.7	4.3	0.2	2.9	0.2	0.3	0.2	0.2	0.8	0.4	2.8	3.0	0.2	0.2	0.2	0.2	4.0	0.5	0.4	286.5	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	1.0	0.2	5.4	0.2	10.2	0.3	2.8	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.1	5.2	0.2	0.7	0.1	11.6	0.0	0.3	8.6	1.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.2	0.0	0.4	4.0	0.2	6.1	0.2	0.6	0.4	2.1	0.0	0.1	0.0	1.1	0.0	0.0	2.2	5.0	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.5	15.3	3.0	2.8	3.0	4.0	0.5	2.2	2.8	0.0	0.3	0.0	0.0	0.5	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	253.2	0.6	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.0	0.2	39.2	0.3	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.9	0.0
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596491	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 351.0;skeletal muscle: 497.0"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 766.1;Collecting duct cells: 359.4;Kupffer cells: 351.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056731	Approved					NA	NA					"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	90.7	41.9	6.9	5.9	14.6	0.4	49.1	2.5	9.1	12.3	30.9	9.0	150.6	13.6	10.7	13.7	29.0	14.7	15.6	351.0	9.2	3.7	27.7	39.5	14.1	6.1	18.2	2.4	46.6	102.9	0.8	8.1	19.4	26.1	29.3	8.4	4.4	8.4	150.6	497.0	10.2	46.2	20.7	13.9	19.0	21.2	10.8	17.4	1.0	13.4	12.3	2.5	23.8	46.4	0.7	7.1	15.6	26.1	1.4	0.0	4.7	0.0	8.0	0.3	2.0	107.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.7	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.5	0.1	0.6	0.0	0.6	1.6	0.5	0.2	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	14.2	15.6	0.0	26.1	0.0	0.1	0.0	0.0	7.1	0.7	0.0	0.0	1.0	1.4	15.6	0.2	0.0	4.7	6.9	14.6	2.5	9.1	9.2	3.7	18.2	2.4	26.1	17.4	29.8	13.6	12.6	245.0	9.3	0.0	766.1	28.1	96.4	52.4	359.4	0.0	2.7	11.6	4.3	10.2	89.9	112.9	0.0	4.7	0.7	44.7	113.9	4.7	93.7	42.3	0.0	53.1	160.8	351.0	2.5	124.3	29.1	86.0	1.8	47.0	11.6	8.2	42.1	42.1	35.5	0.3	161.7	181.3	0.2	0.5	8.2	9.2	5.7	27.3	131.1
PDZD4	"FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L"	ENSG00000067840	"PDZ domain containing 4"	Q76G19	X	153802166-153830565	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 71.6"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 14.4;Ciliated cells: 8.1;Ito cells: 6.2;Rod photoreceptor cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5"	"Group enriched"	"Detected in many"	25	"NK-cells: 1.5;T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"AF22: 16.1;NTERA-2: 8.2;RH-30: 11.4;SCLC-21H: 19.6;SH-SY5Y: 19.0;U-2 OS: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003878	Enhanced					NA	NA					"HPA003878: AB_2162807"	"unprognostic (9.18e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-2)"	3.3	5.8	42.8	2.6	36.7	2.5	2.0	40.1	71.6	2.3	3.5	5.1	0.4	2.5	4.4	2.2	3.3	7.9	2.8	3.3	40.8	14.8	1.6	1.7	3.0	2.6	9.9	24.9	1.7	2.6	1.5	7.4	1.2	9.0	4.5	2.3	1.8	4.3	10.5	3.6	4.8	3.3	5.0	7.0	7.0	2.3	3.4	6.4	0.0	1.6	0.0	1.6	2.4	1.4	0.0	0.0	0.0	0.0	1.5	3.5	0.6	0.0	1.0	16.1	4.1	0.0	0.1	0.0	0.4	0.0	0.5	0.5	0.4	0.0	0.0	0.2	0.0	5.2	0.1	2.9	0.0	0.1	0.0	0.5	0.0	1.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	3.1	0.1	0.5	8.2	0.0	0.2	0.0	11.4	0.0	0.0	0.0	19.6	19.0	0.8	0.0	5.7	5.7	1.8	0.1	0.0	0.0	9.5	0.2	1.1	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	3.5	0.0	0.8	0.0	1.5	2.0	0.0	0.0	0.1	0.9	0.0	1.5	0.0	0.0	0.0	0.6	42.8	36.7	40.1	49.2	40.8	14.8	9.9	24.9	9.0	6.4	0.0	0.0	0.0	0.0	0.2	14.4	1.4	0.0	8.1	2.3	0.0	5.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.3	1.1	0.0	0.0	1.6	1.7	6.2	1.0	0.0	0.6	0.0	3.3	0.0	0.0	2.5	0.5	0.0	3.5	0.0	12.9	0.0	1.7	0.2	3.4	0.6	0.0	3.2	0.0	0.1
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1020.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		1000000000	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.3	36.3	10.7	17.3	45.7	17.6	24.8	11.9	24.4	15.2	17.3	31.6	11.8	5.4	17.8	29.8	11.7	3.5	15.4	9.7	12.5	15.4	15.2	34.7	7.4	32.1	31.3	10.1	42.1	21.7	9.2	13.8	8.6	11.2	20.3	10.7	6.6	15.8	16.5	16.3	7.7	3.4	14.7	26.6	14.8	15.2	14.6	15.0	13.1	35.3	13.2	33.8	22.2	11.0	17.9	9.4	7.6	11.0	16.9	14.7	15.9	19.0	13.7	14.5	21.5	4.8	15.7	14.6	20.9	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5	20.8	24.3	20.2	26.1	17.2	33.9	11.7	43.3	26.8	11.4	69.8	3.9	19.3	167.5	63.4	7.6	44.9	37.6	0.0	38.3	59.7	34.6	21.4	55.5	161.7	189.6	58.8	16.6	35.0	46.9	8.9	45.8	63.2	64.1	131.7	14.5	69.3	37.3	28.5	57.0	1020.8	23.8	38.8	38.8	11.4	48.3	17.8	25.4	31.0	16.7	18.0
PEX11A	"MGC119947, MGC138534, PEX11-ALPHA"	ENSG00000166821	"Peroxisomal biogenesis factor 11 alpha"	O75192	15	89677764-89690783	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.32e-2)"	20.0	10.0	13.1	5.4	11.7	0.8	18.0	6.1	10.9	6.6	14.4	7.7	27.1	13.9	5.8	9.6	5.8	8.8	8.1	8.8	13.0	6.9	10.4	32.8	5.4	2.1	6.5	7.7	11.9	10.8	8.8	8.5	3.2	8.4	16.3	10.7	8.1	9.2	21.9	18.6	4.4	15.7	7.0	5.6	3.4	9.6	12.5	10.6	1.4	11.0	3.7	3.7	11.2	12.5	3.2	3.5	4.4	1.8	5.6	7.3	3.1	5.9	3.6	2.8	0.2	14.6	5.3	2.3	3.0	5.1	4.5	7.4	2.5	7.2	2.7	3.3	3.4	6.4	8.0	0.0	4.5	5.2	4.3	10.1	4.1	4.0	3.5	10.5	2.7	1.4	6.5	5.6	2.6	4.4	3.5	3.1	2.7	0.0	1.1	3.3	6.0	0.0	0.3	1.6	12.1	6.7	0.0	0.0	2.4	3.7	4.0	2.0	5.3	9.5	32.9	8.7	5.3	8.7	2.6	2.8	2.9	3.0	8.0	2.3	3.2	5.4	0.1	7.3	0.3	2.6	2.3	1.4	4.4	7.3	1.8	4.2	3.2	3.7	4.1	3.5	2.0	4.6	5.3	1.6	5.6	1.3	0.8	3.3	3.1	13.1	11.7	6.1	10.9	13.0	6.9	6.5	7.7	8.4	10.6	6.0	5.9	0.0	8.0	1.5	7.9	6.9	10.2	17.4	7.9	5.2	2.0	8.0	5.0	5.2	18.7	2.7	18.0	0.0	4.0	6.0	4.3	12.1	1.1	32.6	3.4	17.5	3.5	4.3	1.8	27.5	4.9	0.9	3.3	1.0	9.6	13.7	6.5	11.5	2.5	9.0	8.5	0.0	3.1	15.4	7.0	1.8	2.3	1.3	10.9	9.5
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		430000	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	15.8	26.4	31.5	12.1	28.0	11.7	15.3	14.7	27.2	19.2	15.7	18.5	13.7	14.7	11.2	21.7	13.7	21.1	14.2	59.1	22.7	19.3	18.4	12.6	12.1	12.7	27.0	21.0	13.7	46.5	15.6	21.2	14.7	20.8	20.2	11.6	14.1	30.5	22.6	86.0	9.2	16.3	16.9	24.3	10.3	13.4	13.8	18.6	7.5	20.7	19.8	10.4	12.0	9.8	24.9	48.8	3.3	35.4	20.0	24.3	32.1	7.1	52.0	29.7	18.9	19.2	34.9	43.7	16.6	21.2	20.3	18.1	18.9	16.3	15.2	20.2	20.5	24.3	18.9	6.4	37.5	6.4	13.6	13.2	4.8	34.2	41.5	23.9	9.5	19.5	43.5	30.9	11.6	14.0	18.4	26.6	11.9	11.5	14.1	31.4	40.6	13.8	20.0	23.5	47.6	22.4	11.5	13.0	25.1	32.1	11.9	14.6	13.8	17.9	21.0	8.6	14.8	15.9	26.4	21.6	42.5	13.2	11.7	15.3	9.4	9.1	9.3	24.0	6.9	25.4	2.9	35.4	3.3	24.3	34.2	20.9	24.9	21.1	21.9	37.5	16.5	15.0	21.3	1.7	20.0	24.0	48.8	22.9	32.1	31.5	28.0	14.7	27.2	22.7	19.3	27.0	21.0	20.8	18.6	89.3	132.7	80.4	156.2	133.5	37.9	336.8	191.1	136.5	125.1	205.9	21.6	300.5	633.3	164.3	214.6	110.1	411.5	70.0	220.3	372.9	227.8	244.3	120.2	179.9	249.5	63.5	254.7	94.5	103.8	640.4	189.8	148.3	317.2	367.9	241.4	126.9	202.0	354.2	210.0	509.4	53.8	84.1	248.0	93.6	149.9	141.4	220.8	93.5	262.8	160.3
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664365-89679427	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 187.5;breast: 62.6"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 49.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	176	"ASC diff: 70.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		8900	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1.0	0.4	1.1	0.0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0.0	0.7	8.0	0.3	1.5	1.5	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	70.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1.0	1.8	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	49.1	0.0	0.0	0.0	1.8	1.3	4.9	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.4	0.2	0.4	0.0	0.0	0.0	0.7
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Cell type enhanced"	"Detected in many"	12	"Syncytiotrophoblasts: 1518.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Group enriched"	"Detected in many"	5	"ASC diff: 201.9;HHSteC: 174.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.3	2.4	201.9	27.5	36.6	9.3	7.2	5.7	6.5	4.4	0.6	0.0	0.1	19.0	36.6	0.3	3.2	0.0	9.8	11.8	0.0	15.5	0.4	16.5	174.9	1.8	28.4	29.1	3.3	13.9	0.0	4.6	7.0	0.0	2.8	3.4	22.0	0.8	4.2	6.3	4.4	0.0	5.7	10.2	1.5	0.1	0.0	10.8	0.2	5.4	4.3	1.1	9.1	4.4	2.2	4.1	11.0	0.0	1.7	8.8	0.0	2.0	2.0	6.2	0.0	3.1	0.9	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4	17.9	63.4	41.2	370.9	183.2	2.2	58.6	89.2	24.1	69.4	12.2	0.0	148.6	23.2	64.2	3.3	59.0	94.5	116.8	13.9	494.8	114.6	78.6	397.7	505.9	405.3	11.1	14.3	96.3	188.8	7.8	36.8	170.1	82.7	39.7	15.4	42.6	57.0	23.0	65.0	211.8	4.8	12.9	104.0	7.7	23.3	94.9	1518.0	59.8	29.9	214.1
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55535050	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 254.8;Leydig cells: 203.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.3;fHDF/TERT166: 28.4;HMC-1: 48.9;HSkMC: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	56.3	26.7	12.5	14.8	14.6	0.6	57.9	10.6	18.5	34.5	30.9	26.1	18.0	17.3	36.8	26.0	18.4	20.4	61.0	33.7	13.4	10.8	34.5	42.0	15.9	17.3	20.8	10.1	16.5	17.6	16.9	10.1	22.4	21.4	82.0	24.7	29.8	9.8	24.0	18.4	16.6	25.4	39.6	28.2	10.2	21.7	18.1	14.5	4.4	32.7	9.6	10.0	43.1	18.1	5.4	13.6	3.3	0.7	2.7	9.5	1.6	2.0	4.9	1.4	2.9	93.3	10.9	2.0	4.4	12.4	2.4	5.8	3.4	3.6	2.0	4.2	28.4	6.7	1.3	5.1	2.5	2.8	1.3	4.0	0.2	2.1	4.2	14.7	0.5	48.9	35.8	5.3	3.6	2.2	4.9	4.0	1.9	0.0	5.7	4.9	1.2	1.3	1.0	3.3	0.2	4.0	0.4	2.4	0.1	9.3	15.9	1.8	1.2	4.4	0.9	2.6	6.4	3.2	0.3	4.9	0.8	1.5	3.7	3.1	3.5	1.4	2.4	3.3	0.2	4.0	0.0	0.4	3.3	1.5	0.4	1.6	5.4	5.2	3.2	1.9	3.4	9.5	7.5	0.3	2.7	0.7	13.6	2.2	1.6	12.5	14.6	10.6	18.5	13.4	10.8	20.8	10.1	21.4	14.5	6.0	10.3	3.9	48.9	0.0	5.2	0.0	15.3	4.0	10.3	27.9	2.0	2.2	5.0	22.3	30.3	45.0	26.9	0.0	24.7	9.6	32.8	109.6	25.6	50.5	11.0	1.6	1.2	254.8	14.9	19.1	203.1	3.6	0.0	7.2	23.2	14.3	28.1	29.4	83.1	24.5	4.8	58.2	0.0	47.0	18.1	0.0	4.1	4.3	14.9	41.0
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291504	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4;MAIT T-cell: 9.4"	"Lineage enriched"	"Detected in single"	52	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"A549: 34.1;CAPAN-2: 37.1;OE19: 63.6"	"Low region specificity"	"Detected in many"							HPA055540	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055540: AB_2682839"	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	1.4	4.7	8.3	5.3	20.9	0.2	17.5	2.0	11.1	30.4	18.2	28.1	13.4	27.5	7.7	4.1	9.1	38.1	31.2	1.5	13.6	7.1	4.7	1.1	3.7	0.8	37.1	6.5	2.4	19.8	0.6	4.1	1.8	16.6	10.7	15.3	6.7	45.8	19.0	0.3	19.0	21.9	3.3	26.0	1.4	22.2	2.2	25.8	0.7	2.2	5.9	5.0	12.1	5.7	0.0	0.1	0.1	0.0	0.0	9.4	0.3	20.0	34.1	0.5	0.0	0.0	0.1	0.0	2.0	0.0	6.3	4.9	9.8	37.1	0.0	21.9	2.9	0.0	11.1	0.0	4.4	2.9	0.2	0.6	0.0	13.7	0.0	7.6	0.0	1.3	1.3	1.9	3.2	4.3	13.9	1.0	0.0	0.1	0.0	0.0	22.8	0.1	0.0	15.2	63.6	0.0	0.0	0.0	0.5	16.0	3.2	4.3	10.2	5.6	9.4	14.7	1.5	12.3	0.6	1.1	13.9	9.2	0.1	14.8	0.1	23.3	16.5	3.9	0.0	11.4	0.0	0.0	0.0	4.4	0.0	9.4	0.0	2.0	2.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	8.3	20.9	2.0	11.1	13.6	7.1	37.1	6.5	16.6	25.8	6.0	6.9	0.0	113.1	0.0	17.7	0.0	188.5	167.3	64.8	21.0	9.8	0.2	3.3	295.2	0.2	3.3	108.1	0.0	125.6	5.1	0.0	71.8	1.1	0.4	0.9	15.9	8.2	0.0	1.3	1.4	0.0	1.3	0.0	4.6	39.9	12.1	100.4	109.1	0.0	1.0	190.0	0.0	0.0	0.3	28.1	0.0	0.7	0.0	113.0	167.4
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	105.3	52.6	5.0	5.5	5.6	5.1	2.5	4.4	0.8	0.7	0.6	8.3	5.7	0.8	0.3	0.1	1.0	0.0	1.3	0.1	0.6	6.1	2.5	0.0	0.0	65.0	0.4	4.9	4.1	3.6	4.8	0.0	0.4	0.0	5.5	0.4	0.0	0.0	6.2	1.2	6.1	0.0	0.0	0.2	0.8	4.6	0.0	4.1	1.7	2.3	0.5	6.4	0.7	0.0	3.0	25.8	2.1	95.5	0.2	0.0	0.0	0.0	4.5	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7	23.8	20.5	11.5	20.0	0.0	3.2	0.0	56.0	8.1	23.9	21.0	0.0	102.0	18.3	16.0	5.7	50.7	10.7	23.3	7.9	10.3	54.5	13.7	3.5	84.4	36.2	0.0	2.4	854.4	45.1	12.0	1011.7	10.2	0.0	1.0	10.3	146.0	8.7	7.0	374.8	18.2	2.5	135.8	0.0	4.3	2.5	0.0	179.8	4.3	7.8	16.5
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 1270.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 19.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 44.9;BEWO: 38.7;HHSteC: 47.5;HSkMC: 61.9;U-87 MG: 65.7"	"Low region specificity"	"Detected in all"							CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	200000000			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	126.5	44.6	20.2	21.8	20.1	5.4	27.0	10.3	21.1	41.5	35.4	30.9	6.9	11.8	28.0	74.6	23.9	41.5	49.9	37.8	18.1	15.9	32.2	13.9	22.6	96.5	15.1	12.2	38.6	83.6	7.4	9.0	117.5	19.5	28.7	12.5	36.4	36.8	22.5	19.8	17.7	14.4	50.1	11.1	25.7	18.7	30.9	11.5	74.7	13.7	11.4	9.5	40.5	26.7	4.7	10.4	19.6	6.7	2.5	1.0	1.6	2.6	0.3	18.6	0.0	44.9	13.7	38.7	1.0	3.2	3.7	2.2	15.2	3.0	0.6	31.2	4.5	0.0	30.7	5.7	0.1	1.7	0.3	0.0	5.5	0.6	7.0	47.5	0.0	6.9	61.9	1.5	9.6	0.1	14.7	8.1	0.6	1.7	8.7	1.2	0.7	0.5	22.9	3.3	2.3	15.2	0.2	0.0	0.3	0.0	0.0	2.0	7.0	0.7	21.6	31.1	3.2	0.2	21.6	1.7	9.2	0.2	4.7	0.1	3.8	0.9	0.9	65.7	6.3	1.5	19.6	1.6	16.1	1.0	3.8	0.8	4.7	0.2	1.0	1.4	2.1	0.0	0.6	0.7	2.5	6.7	10.4	0.4	1.6	20.2	20.1	10.3	18.2	18.1	15.9	15.1	12.2	19.5	11.5	0.0	2.9	0.0	24.8	36.1	0.4	0.8	5.1	41.5	7.9	26.2	0.0	13.0	1.7	2.5	12.9	11.7	0.0	0.0	90.6	73.4	153.4	2.1	0.0	1.9	1270.7	3.2	0.0	117.9	171.6	15.0	285.1	24.8	33.7	6.4	0.8	12.7	13.7	0.0	187.0	8.2	0.5	32.3	27.1	4.9	6.6	31.2	26.5	4.3	0.6	11.3
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;salivary gland: 28.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 11.0;WM-115: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048046	Enhanced					NA	NA		17000			"HPA048046: AB_2680239"	"prognostic unfavorable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	3.7	17.4	15.5	2.9	34.9	1.5	4.5	16.1	46.3	3.5	14.8	45.8	1.8	3.3	8.1	5.3	6.4	3.8	6.1	3.1	19.9	9.4	1.3	1.3	2.1	1.4	39.7	17.3	1.3	5.6	1.1	0.6	1.4	18.4	9.0	3.2	2.8	28.9	10.7	1.4	11.3	3.4	8.9	25.6	1.3	4.4	7.2	40.2	0.0	1.3	0.2	1.2	6.8	3.8	0.1	2.7	0.0	0.0	0.7	0.0	0.7	4.8	0.6	0.6	0.4	0.6	0.4	0.3	4.6	0.9	0.6	1.6	0.0	0.1	0.0	3.0	1.2	0.9	0.5	0.0	3.9	0.5	0.1	0.0	3.0	5.5	3.4	1.3	0.0	0.3	1.0	2.8	2.9	1.8	11.0	1.9	0.1	0.2	1.7	1.2	4.0	0.0	0.7	0.1	3.3	7.6	1.4	0.5	0.0	0.7	2.3	1.3	4.1	0.2	4.2	10.2	0.1	5.7	0.0	8.0	4.8	2.4	3.7	5.7	1.6	0.4	0.1	10.3	0.2	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.7	15.5	34.9	16.1	20.8	19.9	9.4	39.7	17.3	18.4	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	27.1	0.0	0.0	2.9	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.3	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.2	0.0	0.1	2.2	0.8	0.3	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7	0.0	0.0	0.0	0.4	0.6	16.5	2.8	0.0	0.0	0.0	0.0	21.6	8.3	0.0	0.2	0.2	0.3	2.0	0.0	0.3	44.0	0.2	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.4	2.7	4.8	0.0	0.4	0.1	19.4	0.0	0.4	0.5	0.6	0.5	41.4	0.0	0.0	0.9
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.5	8.3	1.7	4.5	65.2	5.8	11.2	11.3	9.1	7.1	6.3	7.1	10.7	6.3	6.7	8.5	4.4	9.5	2.6	4.7	2.2	8.1	23.1	8.7	3.7	11.3	21.4	6.0	11.0	11.4	6.1	4.7	5.5	7.3	5.8	4.7	7.4	6.4	6.3	6.2	8.0	13.1	5.0	10.8	17.9	7.7	3.8	14.1	7.0	2.4	6.4	8.5	21.0	17.9	6.5	1.1	7.7	6.9	10.4	6.4	5.0	4.1	5.1	24.7	15.2	5.3	16.1	8.5	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5	6.0	16.9	27.0	63.2	39.3	8.8	42.3	63.7	5.3	13.6	48.8	7.9	56.2	28.2	55.9	14.2	38.0	114.0	23.3	57.3	27.0	25.2	72.1	11.5	41.9	27.6	11.1	49.4	84.1	28.5	4.2	44.8	24.9	40.5	27.9	80.0	34.7	98.9	112.2	36.7	37.9	7.5	64.7	32.2	42.2	28.2	36.0	141.7	36.2	41.4	167.2
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	19.4	15.2	14.5	16.0	17.7	35.0	14.4	25.9	22.0	13.1	16.6	16.0	14.2	19.5	17.9	14.8	15.8	15.8	14.9	11.8	11.7	10.0	14.0	16.6	13.3	18.7	10.8	12.7	18.6	23.3	14.9	20.6	15.4	13.4	18.6	11.4	20.2	17.4	11.7	18.4	17.0	19.1	12.1	12.7	19.0	16.3	17.3	13.5	24.5	19.5	15.2	22.3	15.8	14.5	3.7	4.3	3.7	3.6	4.5	5.2	2.6	17.1	12.6	15.7	35.3	8.5	7.0	13.1	12.3	10.5	12.3	10.7	22.2	10.9	23.7	4.0	10.6	13.7	13.2	15.6	11.9	13.8	20.5	31.1	17.7	12.6	14.7	8.7	36.6	22.6	9.2	8.5	16.3	15.0	8.0	9.1	13.8	48.4	17.8	12.0	13.2	21.8	23.3	16.5	9.6	15.3	20.0	12.3	20.0	6.2	15.1	22.5	19.8	10.8	20.8	11.0	11.0	17.3	19.3	12.8	22.1	13.6	17.4	24.6	21.4	19.8	34.4	12.9	23.5	21.8	0.1	2.3	3.7	5.2	1.4	3.0	3.0	3.3	3.8	2.6	3.7	3.0	4.3	2.6	4.5	3.6	4.3	1.7	2.6	14.5	17.7	25.9	22.0	11.7	10.0	10.8	12.7	13.4	13.5	35.7	28.2	12.7	8.8	22.3	31.1	4.4	25.5	17.4	20.5	17.4	92.3	14.5	5.0	10.8	6.8	14.2	16.9	23.3	14.7	10.9	16.5	15.7	16.1	20.3	13.8	38.1	17.2	17.8	15.8	4.2	13.8	18.3	18.6	7.2	19.6	18.3	17.2	10.5	16.6	5.4	23.8	12.9	15.9	14.2	11.8	27.0	16.2	18.1	19.0	18.4
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078907	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 35.6;U-266/70: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	7.7	8.5	7.4	3.5	11.5	3.3	6.3	15.8	23.2	11.3	7.0	5.5	1.1	3.0	6.2	3.7	8.7	6.1	12.6	9.9	6.3	7.8	8.4	6.0	4.6	1.9	8.0	10.1	3.7	5.4	33.6	26.3	11.5	13.8	9.6	5.9	5.6	18.9	3.7	25.7	7.6	3.6	16.4	4.6	3.4	8.4	2.8	3.7	5.6	14.4	9.6	3.5	16.6	10.8	0.7	1.3	4.9	7.6	1.1	2.6	2.0	1.2	0.8	4.1	2.1	2.4	0.0	2.5	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.9	3.7	3.4	0.2	0.1	35.6	3.6	3.5	3.3	0.4	0.1	2.1	4.1	0.4	1.6	0.1	0.2	0.3	0.2	1.7	0.1	5.6	0.0	1.9	0.8	0.2	2.3	6.5	0.8	4.2	0.7	0.8	0.1	3.8	4.9	4.2	2.0	2.4	0.1	1.4	2.7	2.1	0.2	0.4	0.4	0.3	1.3	35.6	0.1	2.0	0.6	1.8	0.8	0.7	2.3	4.9	2.6	5.5	0.2	0.2	0.6	1.7	1.3	0.7	1.0	1.8	0.2	1.1	7.6	0.8	0.0	2.0	7.4	11.5	15.8	17.9	6.3	7.8	8.0	10.1	13.8	3.7	6.0	2.4	0.0	5.2	7.7	59.9	33.6	10.2	13.4	5.7	1.8	33.4	2.4	0.0	1.5	1.1	2.4	3.8	0.0	3.7	1.6	7.0	6.0	0.0	14.9	5.9	6.4	13.3	0.6	12.4	0.4	4.6	7.2	3.3	2.8	7.6	9.3	1.7	7.0	4.9	3.3	10.1	0.0	11.2	1.5	3.1	7.5	2.2	2.9	4.9	18.0
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Early spermatids: 31.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.2;fHDF/TERT166: 19.3;HSkMC: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.1	18.2	17.0	0.1	12.3	9.5	12.6	6.8	0.0	0.5	0.0	1.2	19.3	4.3	0.1	6.0	1.4	6.9	0.0	4.2	0.0	0.1	0.4	9.2	0.0	0.1	18.0	0.6	0.9	1.5	6.5	2.5	0.0	1.2	0.4	11.8	1.4	0.0	0.0	2.5	0.0	6.4	0.0	7.1	3.2	13.5	5.7	3.6	7.2	2.1	0.0	4.7	4.9	0.0	0.1	6.4	12.0	4.9	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6	0.0	6.1	0.0	3.8	0.5	1.2	1.4	7.6	0.0	0.0	12.2	5.9	0.0	24.9	1.5	31.1	4.5	0.0	23.3	3.6	0.1	3.8	16.3	0.0	1.5	0.2	1.6	2.9	12.3	2.6	12.4	6.9	0.3	6.8	0.0	0.2	16.1	3.2	0.0	12.0	3.7	2.8	0.0	4.7	3.4	4.9	0.6	0.2	0.0	0.0	0.9
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 205.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.8;ASC TERT1: 22.8;BJ: 27.9;BJ hTERT+: 38.1;HEL: 17.5;HMC-1: 74.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		25000000	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.8	22.8	0.0	27.9	38.1	0.2	0.2	0.0	0.0	1.0	1.3	4.7	0.0	1.7	0.1	2.5	0.2	0.0	0.0	17.5	0.1	0.0	8.3	1.2	74.3	11.6	0.3	1.4	0.0	0.0	10.3	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.3	2.0	3.6	0.0	0.1	0.1	0.1	2.3	0.0	0.1	0.0	2.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.6	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1	0.0	10.0	0.9	2.4	8.9	0.0	1.1	0.0	1.4	2.3	40.1	0.0	0.1	0.0	0.5	0.0	6.0	0.0	0.0	0.4	0.2	4.7	1.9	205.3	0.0	25.3	0.0	1.7	36.8	10.7	0.0	1.4	22.9	3.3	4.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.3	0.3	0.7	0.5	0.6
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 318.6;Glandular cells: 122.9;granulocytes: 329.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 95.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in all"			"CAB000113, HPA001335"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.6	0.5	0.0	21.8	95.4	0.1	0.8	3.4	4.0	0.0	0.0	0.1	0.6	2.9	0.0	1.7	0.3	0.0	0.0	0.2	0.5	0.0	3.2	0.0	0.1	0.2	0.6	2.7	6.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	4.6	0.1	3.2	0.1	0.0	0.0	0.0	6.7	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9	318.6	102.3	0.5	47.5	105.6	0.0	1.9	0.0	8.1	53.4	0.0	0.0	0.1	0.0	0.8	0.2	14.3	0.0	0.0	0.2	0.2	36.1	122.9	329.1	0.0	11.5	0.0	1.2	6.7	16.5	0.0	0.0	112.3	33.7	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.2	0.0	21.7	0.1	0.4	24.8	0.5	0.0	1.3	107.5
RAE1	Mnrp41	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351010-57379211	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	9.2	10.0	9.4	11.1	15.2	28.6	12.0	18.1	18.3	9.5	9.7	11.5	9.3	8.0	13.0	13.9	14.0	12.2	7.9	8.1	9.8	11.0	9.2	10.7	7.1	12.5	8.1	12.6	12.1	9.1	12.3	13.7	13.5	10.4	9.2	11.4	9.4	8.9	11.0	9.6	14.8	8.8	11.3	7.3	12.1	8.6	64.8	8.3	19.4	11.7	11.5	17.3	10.0	11.5	17.0	16.6	39.1	21.5	11.8	20.2	17.8	12.8	15.9	15.8	9.0	9.6	8.8	14.4	10.4	14.7	51.4	19.9	50.4	10.3	20.6	14.6	15.0	19.6	17.1	29.7	25.6	42.4	6.2	13.4	14.1	14.2	22.3	18.0	16.9	12.7	12.9	23.1	22.1	24.8	8.6	15.5	14.1	24.7	10.0	16.1	34.7	25.2	14.8	10.0	24.5	28.0	14.1	15.4	13.7	12.0	13.5	17.3	14.3	17.7	40.4	18.2	12.9	22.0	14.8	9.0	21.9	19.7	12.9	17.3	10.9	23.3	23.5	15.3	10.5	10.9	9.1	21.5	39.1	15.6	18.1	18.9	17.0	15.2	15.5	16.6	16.3	20.2	18.4	19.4	11.8	17.9	12.6	12.9	17.8	9.4	15.2	18.1	18.3	9.8	11.0	8.1	12.6	10.4	8.3	17.9	14.7	22.4	14.7	15.2	14.6	8.5	12.7	21.4	12.5	17.4	13.7	44.8	23.2	28.2	84.3	14.2	7.9	23.3	12.5	32.5	15.6	10.5	36.9	11.3	33.3	3.2	6.3	10.4	63.2	48.9	20.1	28.8	10.1	27.1	13.0	17.6	17.6	20.4	21.2	16.6	15.0	19.4	15.0	94.3	78.1	18.3	58.9	21.5	18.0	14.9
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Collecting duct cells: 455.4;Extravillous trophoblasts: 356.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Cell line enhanced"	"Detected in all"		"OE19: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	18.4	12.4	11.1	12.5	12.8	20.1	14.7	22.3	12.1	11.4	12.3	13.8	18.3	23.5	16.3	20.4	16.3	10.6	15.3	16.7	14.4	23.3	14.8	12.4	11.5	10.2	10.4	36.4	14.4	14.0	16.8	16.0	16.0	15.4	19.3	20.7	17.7	21.7	18.1	14.6	21.8	16.0	8.6	74.7	12.7	29.5	19.8	17.2	15.8	25.7	14.9	12.2	19.3	16.9	9.9	17.8	10.5	16.9	23.0	34.1	26.2	23.6	26.5	13.4	13.3	25.4	14.8	17.3	12.8	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1	53.6	33.1	41.7	69.2	138.9	39.0	58.4	94.3	28.1	45.5	455.4	27.5	88.3	104.5	97.1	10.8	89.6	83.8	93.5	79.0	356.6	77.0	126.4	39.3	76.9	61.7	49.3	71.2	62.0	61.6	4.2	67.3	70.3	55.6	119.0	76.9	41.2	124.5	79.5	82.0	81.7	31.3	64.7	79.6	48.8	70.5	212.0	37.3	67.5	84.5	98.4
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.4	11.3	16.3	14.7	19.0	17.0	15.8	16.6	13.2	13.8	12.1	28.1	8.9	29.1	12.9	17.3	17.0	15.6	27.8	17.3	20.1	17.7	13.5	30.3	14.0	19.8	11.1	35.3	10.2	14.3	13.2	21.5	16.8	13.6	21.0	12.7	32.4	16.1	18.2	10.2	15.6	14.4	20.5	9.3	13.6	14.8	25.0	14.0	12.2	23.1	23.7	10.9	14.7	12.7	16.1	10.2	8.1	16.3	25.0	14.4	19.1	10.1	18.5	13.4	19.8	26.4	11.2	16.0	11.1	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9	71.5	71.1	34.9	25.8	49.5	43.3	85.9	33.1	57.6	70.5	55.8	68.7	22.7	1.7	31.3	59.8	43.8	25.7	0.0	44.1	15.0	32.3	38.2	83.1	49.9	41.1	30.2	102.2	27.0	44.0	22.0	35.6	64.2	45.5	49.5	50.9	18.7	36.5	25.9	52.6	15.4	37.7	45.3	62.9	74.1	59.2	59.2	34.0	44.5	31.5	31.5
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 136.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.0	8.7	0.0	0.4	0.0	6.1	0.1	0.0	0.0	0.7	0.0	0.4	11.2	25.8	0.0	0.0	0.4	0.0	0.0	0.0	26.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	3.2	136.6	5.6	0.0	0.0	2.3	0.5	0.1	0.0	0.0	20.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3	29.8	5.1	10.5	43.6	15.7	12.3	15.5	63.7	5.3	12.5	22.7	2.0	2.6	11.6	920.8	3.9	54.2	0.0	0.0	932.2	6.9	95.1	21.2	0.0	6.6	16.2	3.2	41.3	319.8	11.5	8.3	25.0	2.8	8.5	23.4	0.5	79.7	450.0	0.0	4.2	2.7	7.0	25.8	22.5	2.3	4.1	30.6	3.2	2.5	0.8	27.7
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Collecting duct cells: 12.2;Cone photoreceptor cells: 7.9;Enterocytes: 17.1;Pancreatic endocrine cells: 9.4;Paneth cells: 14.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 41.9"	"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		96000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	41.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	8.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	12.2	7.9	0.0	0.0	0.5	0.0	0.0	17.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	9.4	14.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 897.1"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 11448.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	14	"classical monocyte: 1.2;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.5;monocytes: 1.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 155.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	420000000000			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	39.0	2.0	1.4	2.4	3.1	0.3	27.0	0.0	2.1	0.3	1.8	0.0	0.1	0.5	0.4	0.4	0.3	0.4	2.1	1.2	1.4	2.2	7.9	897.1	1.5	1.0	0.2	1.1	0.5	4.7	0.3	28.3	1.8	0.4	0.9	0.6	5.6	1.8	0.5	0.4	0.4	0.6	0.3	0.1	0.3	0.7	0.4	0.0	0.0	0.3	0.5	0.2	0.6	1.6	0.0	1.5	0.0	1.2	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	37.5	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	155.4	0.0	1.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.2	0.3	17.6	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	3.1	0.0	2.1	1.4	2.2	0.2	1.1	0.4	0.0	0.0	3.4	60.7	0.2	0.7	0.0	0.4	853.5	1.4	1.2	22.7	5.9	0.2	82.9	7.1	2.2	0.7	2.1	46.7	0.2	11.9	6.8	1.7	0.0	11448.6	18.7	0.0	60.0	171.2	183.3	1.9	2.8	2.0	1.7	0.0	33.0	0.7	46.4	10.5	5.3	393.5	0.2	0.0	0.8	2.8	13.4	0.6	1.1	19.1	1.1	0.9
RGL1	RGL	ENSG00000143344	"Ral guanine nucleotide dissociation stimulator like 1"	Q9NZL6	1	183636085-183928531	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 46.1;Kupffer cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.6;HSkMC: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019788	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA019788: AB_1856215"	"unprognostic (3.08e-1)"	"unprognostic (5.25e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.49e-5)"	"prognostic favorable (4.32e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.88e-2)"	22.1	15.7	22.1	16.9	24.8	1.5	19.7	14.2	23.2	18.1	9.9	25.5	8.8	7.9	17.4	11.5	9.9	14.4	20.3	15.0	21.5	15.0	25.7	14.3	18.4	17.4	18.2	16.3	18.7	6.3	10.5	9.7	14.2	19.1	12.5	11.9	21.0	7.8	11.1	3.0	8.4	9.4	19.8	19.6	37.5	7.6	13.0	20.4	1.7	9.1	2.9	8.9	18.1	12.6	0.0	2.4	0.2	5.2	0.0	1.1	1.2	0.1	0.7	13.7	2.1	18.6	8.6	13.9	6.3	10.6	2.9	3.6	6.1	0.4	0.1	5.9	4.4	2.2	0.3	0.9	1.6	2.8	0.2	1.0	0.1	1.4	6.2	5.0	0.2	0.7	29.2	0.3	7.3	1.7	13.7	10.6	1.4	0.0	10.1	6.0	0.0	1.4	0.1	4.9	0.4	0.4	11.8	0.9	12.0	0.8	3.8	1.7	4.1	1.9	2.1	1.0	4.6	0.1	0.1	7.7	4.1	1.6	12.8	3.4	1.0	0.2	0.0	4.3	0.1	11.3	0.0	2.1	0.0	0.2	5.2	0.4	0.0	0.8	0.0	2.4	0.0	1.1	0.6	0.2	0.0	1.8	0.0	0.6	1.2	22.1	24.8	14.2	21.9	21.5	15.0	18.2	16.3	19.1	20.4	8.9	10.5	2.2	2.1	7.2	2.4	7.5	5.1	16.0	11.4	5.2	0.0	3.9	5.0	2.6	10.2	13.6	2.1	0.0	0.8	1.7	10.8	3.3	3.5	2.1	33.6	7.9	0.0	46.1	85.8	11.8	12.0	15.6	5.0	1.0	0.8	26.6	0.8	0.0	19.4	23.7	1.9	25.8	4.7	1.6	2.7	4.1	4.3	0.5	0.4	1.4
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Cell type enriched"	"Detected in some"	50	"Erythroid cells: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"HEL: 87.8;K-562: 86.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	116.8	0.2	0.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein (gene/pseudogene)"	Q9H310	1	156369212-156385219	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 23.2;kidney: 16.9;ovary: 5.9"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in some"	15	"cerebellum: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0"					"Low region specificity"	"Detected in all"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	23.2	0.1	0.3	0.3	0.0	1.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.1	16.9	3.3	0.1	0.0	0.1	0.1	5.9	0.2	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.3	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	1.1	1.2	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.2	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	21.0	0.0	0.0	16.6	0.3	10.7	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	4.3	0.1	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	1.0	0.0	1.1	0.1	0.0	0.4	0.9	0.0	0.0	0.0	2.2	0.4	0.4	0.0	0.0	0.0	0.0
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496613	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 63.6;Urothelial cells: 75.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;hTCEpi: 4.5;RT4: 4.5;SK-MEL-30: 2.7"	"Region enriched"	"Detected in some"	5	"olfactory region: 10.4"	"Low region specificity"	"Detected in many"			"HPA041874, HPA043317"	Enhanced					NA	NA					"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.0	0.5	60.6	0.2	0.0	0.0	0.2	4.4	0.2	304.0	0.3	0.3	0.3	0.2	0.0	8.6	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.1	37.3	0.3	0.2	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	115.4	185.9	0.5	91.8	0.6	0.3	0.0	0.2	0.0	0.6	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.6	1.6	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	4.5	0.3	0.3	0.8	0.0	2.7	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.6	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	8.8	1.1	0.8	0.4	0.0	0.0	0.0	14.0	0.0	0.0	13.3	1.1	1.6	0.0	0.0	0.0	0.3	0.0	0.1	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	63.6	1.2	4.0	0.0	0.0	2.4	0.0	0.4	0.1	0.1	15.6	0.0	0.0	0.0	75.2
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 173.1;liver: 93.7;placenta: 65.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 24.9;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	"Vesicles,Lysosomes,Rods & Rings"		NA	NA			Vesicles	"Lysosomes, Rods & Rings"	"CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201"	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (1.83e-5)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"	21.2	173.1	7.9	3.5	21.4	1.8	25.0	4.3	10.1	4.7	28.6	13.4	1.1	8.8	4.3	3.5	2.8	4.7	8.0	3.2	7.4	5.1	2.2	93.7	5.8	5.3	6.3	5.1	14.3	2.9	3.3	4.4	65.9	9.4	4.3	4.9	10.7	8.6	2.3	3.0	6.3	21.3	4.4	5.7	5.0	2.7	7.7	11.4	0.5	4.0	1.1	5.6	3.6	10.0	3.1	24.9	1.2	6.5	0.2	0.4	2.5	9.3	22.6	7.4	29.1	4.9	10.5	0.0	6.6	7.5	8.2	5.2	27.0	29.9	27.0	19.0	4.4	13.4	14.2	18.8	44.3	3.9	12.9	18.9	7.6	22.4	43.5	16.6	13.0	6.6	17.9	9.0	15.6	11.1	14.0	22.3	4.9	14.3	11.6	1.5	18.5	4.0	17.4	6.7	11.6	23.4	16.9	5.9	53.9	0.7	13.1	13.9	5.4	35.8	48.4	33.5	4.5	27.1	14.7	2.1	1.3	8.8	6.6	10.1	2.7	1.1	4.4	5.3	15.8	12.8	0.0	6.5	0.0	0.2	3.7	0.2	3.1	0.1	0.4	8.2	1.7	0.1	0.1	1.2	0.2	0.5	24.9	0.0	2.5	7.9	21.4	4.3	10.1	7.4	5.1	6.3	5.1	9.4	11.4	3.0	2.4	18.5	3.1	4.9	5.0	4.8	12.7	4.0	1.2	3.5	27.5	8.8	3.3	5.1	13.9	11.2	9.2	23.3	6.6	9.3	5.9	10.5	1.1	105.2	42.5	15.9	10.3	15.4	14.0	10.8	8.3	10.1	45.5	5.4	14.0	52.5	5.9	14.2	4.9	2.4	7.4	0.0	2.1	27.8	1.7	2.8	36.3	2.5	8.8	3.8
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 300.1;Hepatocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 204.0;CAPAN-2: 141.3"					"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	31.0	28.6	61.1	41.9	204.0	117.7	12.5	3.3	73.7	8.0	42.8	24.6	141.3	13.1	2.6	7.8	36.6	55.6	33.6	119.4	7.0	4.4	13.9	7.3	18.2	49.2	39.4	10.2	8.0	64.0	36.2	31.1	54.8	21.6	15.2	29.1	20.4	40.1	3.2	48.6	11.6	12.2	21.2	9.1	8.2	5.4	22.6	41.1	34.9	34.9	3.8	14.7	6.6	31.2	64.1	18.5	35.0	22.0	6.0	0.8	9.5	0.7	6.8	11.2	6.0	20.2	14.6	32.0	5.1	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4	50.6	300.1	34.7	3.9	3.3	4.0	2.9	35.7	9.4	23.9	0.0	5.9	2.0	0.0	12.5	52.9	9.3	13.7	0.0	59.1	53.1	9.3	26.0	5.8	153.5	29.3	25.4	24.8	41.7	97.6	68.6	3.4	8.2	55.6	17.2	15.7	11.8	21.6	2.9	1.4	3.8	4.7	0.0	4.4	0.9	1.1	1.9	14.5	5.2	16.8	3.5
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		370000	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.6	14.1	19.0	34.8	62.4	53.4	20.6	30.6	45.9	20.1	29.2	12.6	27.8	24.4	33.1	44.8	23.5	18.0	13.0	28.6	30.8	35.5	18.9	26.2	20.3	25.9	41.6	37.7	44.2	43.3	39.0	23.8	11.9	44.1	56.9	28.9	23.3	12.7	40.6	14.8	42.0	32.8	20.8	65.1	27.7	22.0	33.5	33.3	55.8	43.6	15.7	19.0	26.7	54.2	25.6	44.1	27.7	43.2	44.0	27.4	14.2	47.7	24.4	21.3	27.0	28.5	35.5	37.5	25.3	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4	125.0	163.3	99.5	107.7	133.6	35.0	136.8	201.2	147.2	103.5	176.2	29.5	158.8	401.3	140.3	42.8	125.8	592.0	70.0	143.6	134.4	129.4	170.2	138.2	1150.9	181.7	39.7	225.9	115.4	211.6	39.0	170.6	166.5	182.2	152.3	388.8	98.9	131.8	498.1	161.5	617.2	27.0	77.6	119.7	10.6	19.8	149.3	112.0	172.0	297.8	155.6
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	31.4	17.6	5.6	14.0	1.5	0.2	17.7	8.8	8.5	8.2	7.0	3.7	19.2	0.0	3.2	6.2	4.5	31.1	2.4	62.1	5.5	0.1	1.6	0.0	1.6	18.8	1.3	1.3	0.1	0.8	57.5	7.4	17.6	11.5	0.9	0.0	0.7	12.3	4.4	18.8	0.0	0.3	5.0	24.0	34.2	0.6	2.0	23.8	10.6	47.2	1.6	13.1	6.6	44.8	2.0	2.3	4.4	0.3	1.3	32.7	10.5	1.2	59.2	61.4	129.2	0.1	9.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4	86.4	91.4	3.0	135.6	101.2	0.1	0.8	298.1	2.7	63.7	40.1	0.0	2.4	26.6	54.9	0.0	1.1	102.7	23.3	19.0	43.0	9.7	42.4	5.8	520.4	2.2	20.6	10.4	6.7	9.6	0.0	0.6	5.4	20.3	1.0	72.0	0.0	67.3	73.7	1.1	68.3	0.0	0.0	7.1	0.7	12.8	200.1	209.7	4.4	66.5	356.0
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321178	"Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	25.2	30.7	19.0	24.2	24.7	20.6	25.5	16.2	24.9	37.9	47.0	22.6	38.1	47.7	29.6	30.8	30.1	24.7	41.6	30.6	19.5	20.7	33.2	58.3	27.0	19.9	24.7	17.5	24.7	66.8	22.3	48.1	44.1	20.2	23.2	27.9	22.3	63.5	33.4	42.6	25.5	57.1	32.0	21.9	25.9	27.2	26.4	20.5	29.0	38.2	32.8	28.6	25.8	24.2	26.9	60.8	29.1	44.6	23.2	27.7	41.2	21.2	32.3	26.0	10.0	42.3	47.0	86.4	43.6	53.3	51.0	58.9	26.7	17.5	19.5	20.0	69.0	28.7	8.7	33.4	38.8	26.2	16.9	34.7	23.8	26.2	64.4	58.1	27.1	21.1	41.6	31.4	53.3	33.2	37.6	60.4	26.2	25.4	28.9	39.3	43.9	26.4	29.8	29.5	27.7	39.2	25.7	18.6	34.6	31.0	16.0	14.6	18.2	19.1	17.8	17.0	22.8	22.9	26.4	45.1	21.0	24.0	31.3	37.3	24.0	33.3	45.1	39.7	38.1	34.6	28.0	44.6	28.1	24.5	38.4	27.2	26.9	24.6	23.7	60.8	22.2	20.3	21.2	29.1	23.2	29.5	54.2	27.7	41.2	19.0	24.7	16.2	24.9	19.5	20.7	24.7	17.5	20.2	20.5	44.7	52.3	27.4	45.1	34.9	14.7	37.0	17.8	72.3	47.8	26.2	9.8	98.1	56.3	69.8	20.2	33.5	63.9	0.0	95.6	135.9	66.7	49.4	41.6	54.2	93.9	11.1	39.7	36.8	34.0	6.8	49.5	49.1	25.3	67.7	75.6	30.7	74.0	53.4	49.5	72.3	20.1	12.9	43.2	42.4	36.5	35.1	141.0	40.1	67.8	50.4
SEH1L	"SEC13L, Seh1, SEH1A, SEH1B"	ENSG00000085415	"SEH1 like nucleoporin"	Q96EE3	18	12947133-12987536	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039964	Uncertain					NA	NA					"HPA039964: AB_10795241"	"unprognostic (5.14e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.05e-2)"	20.1	13.0	21.9	17.7	20.5	12.4	16.8	23.8	31.3	12.6	16.6	16.7	8.6	13.0	16.9	14.7	18.8	12.1	11.3	14.3	26.3	20.0	17.5	28.3	12.1	25.5	16.9	13.5	20.8	26.6	12.6	19.7	14.2	16.7	11.7	16.4	10.3	16.7	11.2	33.6	16.6	13.5	15.5	15.2	17.7	12.3	16.4	13.5	32.2	15.1	18.9	23.6	17.3	12.4	15.4	23.1	3.2	19.0	13.3	14.0	12.2	14.7	11.4	8.9	14.1	6.3	9.4	13.0	12.8	13.2	15.2	17.5	29.3	7.8	31.9	15.7	14.9	13.6	7.5	20.7	14.7	19.8	8.8	13.3	19.8	11.2	17.3	14.3	53.9	13.2	6.7	11.6	17.5	26.0	6.3	7.9	14.7	26.6	11.9	12.2	16.0	28.9	23.4	11.2	60.1	11.9	19.5	20.7	20.7	11.7	15.0	17.3	10.4	16.4	12.5	12.9	6.7	7.8	18.0	6.3	15.6	36.1	23.4	22.4	8.8	12.8	34.3	10.2	19.6	10.0	2.5	14.5	3.2	8.9	19.0	12.1	14.7	10.7	11.1	23.1	15.4	14.0	11.7	1.6	13.3	15.0	12.6	7.2	12.2	21.9	20.5	23.8	31.3	26.3	20.0	16.9	13.5	16.7	13.5	6.0	19.8	14.5	32.5	48.5	7.6	11.8	17.8	8.1	19.4	12.2	11.8	19.9	8.3	11.8	6.9	14.6	10.1	0.0	11.4	26.7	21.0	21.0	7.0	20.5	19.7	3.2	18.4	15.4	11.9	8.5	8.6	18.0	15.1	14.4	17.9	5.1	13.4	14.0	10.3	13.8	9.3	12.9	17.6	10.7	12.6	52.2	19.8	10.1	23.0	33.3
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 34.2;T-cells: 16.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	5.6	14.0	15.2	12.0	20.9	12.9	8.1	20.7	24.5	6.5	18.8	7.9	5.3	13.2	6.5	6.0	12.6	6.6	7.1	9.4	14.5	18.3	28.3	66.8	5.3	17.0	15.3	17.0	13.6	9.7	7.4	11.8	10.4	15.1	7.6	12.5	5.7	7.7	8.0	11.7	6.3	13.4	8.1	15.0	8.2	10.1	5.0	11.0	13.9	7.7	7.3	17.8	11.3	9.1	4.5	3.0	34.2	2.6	4.8	16.0	5.6	10.2	32.6	16.7	18.1	5.7	12.4	26.9	26.3	11.1	22.2	21.5	40.8	20.8	21.5	20.5	13.7	27.4	13.2	31.9	45.8	24.1	52.5	26.7	15.8	29.4	17.8	8.4	30.8	20.0	10.1	9.0	24.6	10.8	13.2	17.0	20.0	22.6	17.1	16.1	36.0	35.9	2.4	13.1	17.4	10.7	30.2	17.1	23.0	8.4	40.4	28.5	18.2	25.3	24.0	12.8	14.4	11.6	10.2	16.5	17.6	27.9	12.9	34.2	21.8	25.6	49.1	28.9	27.8	18.3	34.2	2.1	10.4	11.3	2.6	9.4	4.5	16.0	12.6	3.0	3.8	12.7	12.9	0.6	4.8	1.7	1.4	12.7	5.6	15.2	20.9	20.7	24.5	14.5	18.3	15.3	17.0	15.1	11.0	3.0	15.7	26.8	27.4	17.3	52.5	14.8	12.7	13.4	11.4	17.4	45.2	35.0	21.6	24.5	0.9	12.0	58.5	23.3	16.4	61.7	22.4	20.3	9.2	86.9	14.8	73.1	30.0	7.4	9.4	2.0	43.7	8.0	10.1	7.2	18.2	24.5	26.6	17.5	32.9	46.2	47.8	25.8	27.4	3.0	3.0	18.9	25.9	42.7	18.0	23.5
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA		81000	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	14.4	8.1	11.5	8.7	13.9	4.1	10.7	40.2	22.9	14.5	19.0	15.5	13.6	24.4	13.8	17.7	6.5	14.9	12.9	11.3	12.5	9.8	9.2	3.4	16.4	5.4	18.3	13.7	10.6	7.0	17.1	6.9	16.2	18.4	8.8	8.4	9.1	8.4	13.8	2.7	15.7	44.8	19.9	13.7	8.3	8.2	5.6	16.9	4.3	7.5	5.1	5.5	10.7	11.2	2.2	15.7	8.9	14.8	4.3	9.8	8.3	15.2	5.9	0.6	1.8	16.0	17.0	1.6	9.3	32.9	11.9	9.6	9.7	16.8	0.6	8.9	21.7	10.0	11.2	2.8	20.3	5.2	4.2	3.6	1.8	9.8	7.0	11.0	1.4	14.8	11.7	3.0	10.4	9.9	33.2	26.0	4.4	0.1	0.5	19.3	2.5	0.6	2.2	0.7	5.6	14.3	1.4	11.7	4.1	17.5	2.4	3.2	15.9	5.1	0.6	13.8	4.4	4.9	10.8	21.4	10.5	8.3	9.3	4.5	2.4	0.9	0.0	25.6	8.2	8.4	8.9	14.8	7.1	9.8	11.1	7.5	2.2	6.7	6.6	15.7	1.0	4.1	5.1	2.8	4.3	6.1	2.5	7.0	8.3	11.5	13.9	40.2	22.9	12.5	9.8	18.3	13.7	18.4	16.9	11.9	4.0	0.9	4.8	12.4	61.6	2.4	12.7	18.7	3.4	5.2	45.2	0.9	1.7	28.4	54.3	14.7	10.8	0.0	13.5	37.4	14.4	3.9	13.9	0.8	32.6	9.5	5.2	17.2	20.0	97.0	16.1	21.3	32.1	7.2	5.7	7.8	29.0	5.8	13.8	12.3	23.1	12.9	13.0	1.1	0.5	9.5	9.2	13.1	2.5	2.6
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684214-63728039	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.4"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 48.8;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9;U-698: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	10.5	12.1	12.1	15.7	11.6	4.3	7.6	14.3	12.9	9.2	9.6	15.1	3.9	6.2	8.4	10.3	5.7	5.9	8.9	5.5	13.1	12.6	24.7	29.4	10.3	18.5	13.0	7.0	7.4	14.1	15.5	6.4	49.4	11.1	9.0	8.7	6.7	5.7	7.0	4.4	4.8	8.9	7.9	19.6	16.5	5.8	8.2	9.8	15.4	7.8	3.7	19.1	8.6	7.3	3.2	0.5	8.8	3.3	0.5	2.0	0.5	10.5	3.4	1.7	4.8	6.2	5.8	20.3	8.7	6.1	5.4	6.1	1.5	6.0	23.9	2.6	4.4	4.5	11.3	2.7	5.1	8.8	9.3	3.1	2.2	2.0	2.4	7.6	3.9	6.9	4.2	8.3	4.7	7.5	5.5	2.6	4.5	1.2	0.7	7.8	3.9	4.5	0.0	1.1	1.7	7.3	1.1	4.7	1.9	8.6	5.3	1.0	2.8	6.1	5.7	4.5	5.4	7.4	1.4	2.9	7.6	5.2	5.3	4.3	5.7	3.5	31.1	5.5	0.0	3.2	8.8	0.3	2.8	1.0	2.3	1.0	3.2	1.0	0.7	0.5	0.8	1.5	1.1	0.4	0.5	3.3	0.3	2.0	0.5	12.1	11.6	14.3	12.9	13.1	12.6	13.0	7.0	11.1	9.8	11.9	14.4	11.2	4.9	8.7	3.5	3.2	25.5	2.7	3.4	48.8	0.0	19.1	0.0	5.2	1.6	5.4	6.7	0.0	7.7	24.8	16.2	8.0	10.5	37.6	19.7	9.5	17.9	8.0	53.2	0.8	5.8	20.6	16.9	3.6	9.4	7.3	11.2	11.6	15.9	20.9	5.1	6.5	19.4	6.7	2.7	11.8	27.6	7.5	8.1	4.8
SGPP2	"FLJ39004, SPP2"	ENSG00000163082	"Sphingosine-1-phosphate phosphatase 2"	Q8IWX5	2	222424517-222560948	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Urothelial cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.4;EFO-21: 8.2;hTCEpi: 25.9;RPTEC TERT1: 25.6;SCLC-21H: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.69e-2)"	2.9	7.8	5.4	3.1	12.8	1.2	3.9	14.6	8.4	8.6	16.2	2.2	19.5	12.9	2.2	2.0	19.9	10.4	11.5	5.8	5.0	6.1	16.1	0.7	7.7	2.7	4.4	3.8	1.9	3.7	30.5	12.1	0.3	17.1	2.3	13.4	0.3	8.6	22.1	1.1	16.5	23.5	1.3	3.2	1.4	18.3	1.8	3.3	1.7	16.9	9.8	13.9	8.1	9.3	1.1	0.5	1.3	0.5	0.4	2.3	0.2	0.8	0.8	0.3	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	9.4	0.4	8.2	0.0	0.1	0.2	0.2	0.0	0.0	0.2	3.0	0.7	0.2	0.1	0.0	1.0	0.5	0.0	25.9	0.0	0.1	0.0	0.0	0.5	0.2	0.4	0.0	0.5	0.2	0.8	0.3	5.6	0.3	0.4	0.2	0.4	25.6	2.5	10.4	0.4	0.0	1.1	0.1	0.5	0.1	0.1	0.0	0.1	0.3	0.4	0.3	0.3	0.2	0.6	0.1	0.1	0.1	1.3	0.5	0.2	0.4	0.2	1.0	1.1	1.9	0.5	0.0	1.1	0.4	0.2	1.3	0.4	0.2	0.5	2.3	0.2	5.4	12.8	14.6	8.4	5.0	6.1	4.4	3.8	17.1	3.3	3.0	7.8	0.5	2.3	3.3	4.7	4.9	10.2	10.7	11.4	12.2	5.9	0.1	1.7	12.9	6.9	0.1	11.8	0.0	1.6	0.2	0.8	5.6	0.0	0.0	0.2	1.6	1.2	0.0	0.0	2.5	0.6	0.4	0.0	0.0	5.8	1.1	6.9	13.6	0.4	0.2	6.8	0.0	0.2	0.5	0.2	12.5	2.1	0.0	9.3	38.2
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775417-69797289	"Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 121.2"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 130.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042727	Approved					NA	NA					"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favorable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	2.7	0.5	0.1	0.6	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	4.3	0.1	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.5	0.6	0.3	0.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.9	0.1	0.1	0.8	0.5	0.0	0.1	0.4	0.5	1.1	0.1	0.6	0.0	0.3	0.0	0.1	0.9	0.1	0.6	0.1	0.0	0.3	1.7	0.5	0.3	0.4	0.8	0.5	0.2	0.3	1.0	0.6	0.4	2.7	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	10.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	130.2	0.1	0.0	0.0	1.8	2.7	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066846	"Disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"intestine: 40.9"	"Group enriched"	"Detected in some"	29	"Enterocytes: 5.1;Proximal tubular cells: 6.4"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;HAP1: 2.5;NB-4: 1.2;U-2197: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004795	Approved					NA	NA					"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favorable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849263	"Predicted membrane proteins"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.3;breast: 15.2;skin 1: 17.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 62.9;Late spermatids: 160.4"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.0;BJ: 4.9;BJ hTERT+: 4.0;HaCaT: 3.7;HBEC3-KT: 1.6;U-266/84: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016662	Enhanced					NA	NA					"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	20.3	0.5	0.6	0.9	0.7	0.0	15.2	0.1	0.6	3.7	1.6	0.0	2.1	0.1	2.0	0.8	12.5	0.8	1.4	1.2	0.4	0.2	0.2	0.2	1.2	0.1	2.7	0.0	0.4	1.1	0.9	3.7	0.3	0.9	0.9	0.4	0.0	2.0	0.5	2.3	17.7	0.4	2.4	1.6	0.3	0.5	4.9	1.1	0.0	1.4	11.2	2.9	4.6	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	2.0	0.1	0.2	4.9	4.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	3.7	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.7	0.1	0.6	0.4	0.2	2.7	0.0	0.9	1.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.4	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.4	21.8	0.0	0.0	0.0	0.1
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.8;HMC-1: 3.7;NB-4: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	1.0	2.1	0.2	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.1	3.8	0.6	0.7	0.1	0.0	3.7	0.3	0.1	0.0	0.2	0.3	0.0	1.2	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.6	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.2	0.3	1.1	0.3	0.7	0.4	0.2	0.0	0.3	0.3	0.7	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3	20.8	52.4	3.0	3.9	0.8	3.6	6.3	5.1	17.4	22.7	8.7	0.0	1.6	8.3	0.8	1.2	4.7	1.2	0.0	1.8	7.2	2.4	5.7	24.3	4.7	110.2	1.6	1.2	8.6	163.4	0.4	2.0	201.4	1.7	1.0	4.0	7.6	0.6	0.9	0.7	6.8	3.0	19.4	5.0	0.5	1.7	0.9	6.8	1.7	2.2	2.7
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	11.3	15.1	12.8	9.6	26.2	9.6	20.8	14.7	22.1	20.8	11.3	38.2	8.4	35.3	12.3	12.7	17.3	15.4	12.1	12.9	14.5	14.2	16.1	18.0	18.6	7.9	40.0	15.4	10.4	20.6	29.8	21.7	16.4	29.7	18.0	11.8	18.7	26.9	14.8	17.6	15.6	11.6	11.0	33.1	9.5	12.5	8.7	31.0	15.8	29.9	8.7	16.5	12.9	13.9	4.1	9.8	3.0	9.5	8.3	7.1	4.6	7.7	10.0	13.2	12.1	14.7	12.5	44.4	8.4	30.5	8.0	9.4	12.6	14.6	4.8	16.6	9.4	15.3	10.7	11.9	7.9	9.4	6.9	7.2	11.4	12.1	14.3	15.6	7.7	23.0	13.7	9.9	14.9	15.2	19.6	9.5	9.8	9.8	2.4	9.3	8.9	9.1	5.2	19.6	8.2	6.9	5.9	12.1	8.5	9.7	11.6	9.1	8.1	6.4	19.5	8.5	16.0	21.9	5.1	11.4	8.2	6.9	9.2	4.4	6.0	8.1	2.0	23.1	4.2	3.4	0.7	6.6	2.4	6.4	9.5	5.8	3.6	5.0	6.3	9.8	4.1	7.1	6.6	3.0	8.3	6.0	4.1	3.8	4.6	12.8	26.2	14.7	22.1	14.5	14.2	40.0	15.4	29.7	31.0	35.7	40.3	11.5	22.2	13.7	23.8	12.0	28.1	45.5	43.3	54.1	17.7	20.6	3.3	25.3	0.8	14.3	8.6	70.0	24.8	18.3	17.5	32.8	67.2	38.4	29.8	27.0	15.7	9.8	13.3	1.5	8.9	25.8	25.3	9.0	13.5	27.5	20.6	14.7	8.1	8.8	16.5	6.5	12.4	5.5	12.8	11.7	16.2	7.9	16.1	19.0
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"kidney: 143.2"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 177.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.9"	"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.0	0.0	0.3	0.0	1.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	143.2	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.0	0.3	1.0	1.4	1.5	0.1	0.3	0.3	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	36.6	0.0	0.0	177.4	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189688	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 50.7;salivary gland: 61.2"	"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 203.2;Mucus-secreting cells: 402.7;Undifferentiated cells: 269.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	5.5	11.0	10.8	9.4	24.1	2.7	26.2	11.4	18.1	5.1	28.5	37.2	0.0	24.6	5.7	1.9	3.8	4.1	50.7	4.1	15.5	9.9	4.5	2.9	6.5	3.5	36.1	13.5	5.6	5.3	11.2	5.5	3.3	30.0	14.8	36.3	8.5	61.2	2.1	8.5	23.0	28.8	6.6	27.7	2.9	36.3	5.5	26.7	2.0	5.6	6.8	18.3	4.2	3.6	3.6	9.8	0.5	1.2	3.6	3.0	0.4	4.8	24.1	24.8	9.6	6.2	4.0	5.1	4.5	3.4	3.2	3.4	9.6	7.7	7.2	6.1	3.9	2.9	14.7	4.7	5.2	5.0	7.2	5.9	2.0	4.3	1.4	1.9	2.6	3.6	4.2	1.9	7.2	4.3	2.4	5.3	3.1	3.3	4.9	5.0	5.1	4.6	2.2	2.9	55.9	7.9	2.5	7.0	2.9	3.8	16.5	4.4	2.8	9.1	4.0	3.5	2.8	2.2	1.3	8.8	8.1	5.4	6.1	5.7	4.1	3.7	8.0	4.2	1.5	6.5	0.5	0.7	0.2	1.9	1.2	3.0	2.7	1.8	2.3	0.9	3.6	2.0	2.7	0.3	3.6	0.8	9.8	1.6	0.4	10.8	24.1	11.4	18.1	15.5	9.9	36.1	13.5	30.0	26.7	14.9	37.4	13.4	18.3	20.4	45.1	14.0	99.3	10.7	38.7	31.4	119.8	0.9	1.7	45.3	45.7	23.6	29.9	0.0	41.4	2.1	14.8	203.2	18.4	7.4	3.6	76.3	71.5	6.7	7.3	70.8	79.1	10.2	194.0	0.0	402.7	27.8	49.2	77.2	27.3	9.6	76.9	71.1	24.5	27.0	21.5	26.2	1.1	12.1	269.5	16.9
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 88.6"	"Group enriched"	"Detected in some"	9	"Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 7.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 14.6"	"Group enriched"	"Detected in some"	10	"BEWO: 10.2;HAP1: 5.6;HeLa: 11.4;SuSa: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA					"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	88.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	14.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A4	KCC1	ENSG00000124067	"Solute carrier family 12 member 4"	Q9UP95	16	67943474-67969601	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041138	Approved		Approved	Endosomes		NA	NA			Endosomes		"HPA041138: AB_10794544"	"unprognostic (5.07e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.26e-1)"	16.6	18.3	9.2	8.0	8.8	3.1	26.5	7.0	12.7	19.4	16.5	20.1	12.0	5.1	20.7	9.7	11.8	13.8	15.5	24.4	12.2	5.2	10.7	17.1	19.5	6.6	11.4	8.2	14.2	11.9	30.1	8.1	32.6	18.1	17.8	4.3	23.0	10.5	20.7	14.6	16.9	8.6	27.4	10.0	10.2	10.9	17.6	9.8	8.8	21.0	9.1	8.4	16.5	16.6	1.0	2.4	8.3	5.4	2.7	1.6	1.6	5.0	6.8	5.3	10.0	17.6	15.5	28.6	15.6	16.2	13.5	11.8	13.6	8.2	1.8	7.7	21.5	7.5	9.3	2.5	19.3	10.2	1.8	2.0	1.3	8.9	14.9	20.0	0.1	6.4	17.1	12.7	18.1	6.6	15.8	8.3	3.4	4.1	1.5	18.5	0.8	1.9	5.1	4.0	1.5	3.6	2.0	10.0	1.6	7.4	4.4	0.0	3.2	29.7	1.8	2.6	13.8	14.2	2.0	11.2	19.3	13.7	8.5	6.7	9.3	2.3	3.0	11.2	1.4	16.6	8.3	3.9	2.0	1.5	5.4	1.0	0.4	0.9	0.9	2.4	1.0	0.8	0.7	1.4	2.7	3.8	1.1	1.6	1.6	9.2	8.8	7.0	8.6	12.2	5.2	11.4	8.2	18.1	9.8	14.9	7.8	2.2	12.2	9.0	1.0	25.6	2.5	6.7	10.3	14.0	0.0	24.6	0.0	10.9	2.1	14.3	0.0	0.0	7.1	13.5	13.6	12.7	1.1	7.5	6.9	0.0	0.0	14.1	4.6	1.3	18.4	4.4	10.1	16.2	0.0	21.0	12.7	0.0	34.3	3.4	0.8	38.8	27.6	9.7	6.6	4.5	53.1	1.5	0.0	8.6
SLC12A5	"KCC2, KIAA1176"	ENSG00000124140	"Solute carrier family 12 member 5"	Q9H2X9	20	46021690-46060152	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 64.6"	"Group enriched"	"Detected in many"	13	"Bipolar cells: 205.2;Cone photoreceptor cells: 361.3;Rod photoreceptor cells: 172.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 13.7;NB-4: 28.3;SK-BR-3: 14.3;U-2 OS: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072058	Enhanced					NA	NA					"HPA072058: AB_2686485"	"unprognostic (2.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.44e-4)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.61e-4)"	"unprognostic (8.78e-4)"	"unprognostic (3.25e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-2)"	1.4	11.2	21.1	2.0	28.8	1.5	1.7	52.1	64.6	2.3	2.1	2.7	0.0	2.2	1.6	2.2	1.3	1.7	1.9	2.1	20.5	19.2	1.4	2.2	2.7	3.1	9.5	32.1	2.0	3.6	1.5	4.8	3.3	15.3	1.5	2.1	4.9	1.9	1.8	1.5	1.5	2.1	1.6	6.3	2.8	3.1	3.4	5.8	0.0	1.3	0.0	2.6	1.2	0.5	1.3	0.2	0.1	1.5	0.7	5.7	1.3	0.0	8.6	3.8	2.8	0.3	0.0	0.8	0.3	0.0	0.0	0.3	1.1	0.0	3.2	13.1	0.2	3.4	0.8	2.5	1.3	0.2	2.0	3.3	2.7	1.6	13.7	1.5	0.0	3.8	0.5	0.0	0.0	0.2	5.9	0.8	3.1	5.1	0.0	0.0	13.0	1.9	28.3	1.4	1.2	4.4	3.2	2.4	0.7	1.3	0.0	4.7	6.7	1.7	14.3	4.1	3.7	5.2	8.1	1.3	1.5	16.3	0.1	0.6	0.0	2.1	4.5	3.5	3.3	0.1	0.0	1.5	0.0	2.6	0.8	1.0	1.0	0.3	0.4	0.2	1.3	5.7	3.2	0.1	0.7	0.2	0.0	3.5	1.3	21.1	28.8	52.1	36.4	20.5	19.2	9.5	32.1	15.3	5.8	0.0	0.0	0.0	0.0	0.5	205.2	0.8	0.0	0.0	0.0	0.0	361.3	1.1	1.7	0.0	1.6	1.6	0.0	0.0	0.2	2.6	0.4	0.4	0.0	0.5	15.2	12.7	19.1	3.7	0.6	3.4	0.0	3.2	5.0	1.0	0.4	12.9	0.5	0.0	0.0	0.2	172.9	0.0	0.4	1.4	2.5	0.5	1.4	0.0	0.4	0.0
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229996-34338060	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.4;neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 27.2"					"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	8.7	5.8	7.4	12.4	11.1	27.5	7.0	10.2	14.1	14.7	8.0	12.7	3.6	8.3	6.3	8.7	24.9	4.7	6.3	6.9	6.8	6.9	18.6	4.9	11.5	10.9	9.9	8.4	5.8	5.1	5.4	10.9	5.2	12.5	5.0	7.4	9.7	9.3	4.9	10.5	8.6	10.2	6.0	9.2	11.1	8.0	38.5	10.9	18.2	10.6	8.2	13.6	8.2	21.2	2.0	1.0	18.5	1.4	0.6	2.3	0.7	2.6	3.2	2.0	2.9	6.5	7.6	1.4	4.0	9.3	3.1	4.5	1.8	4.4	1.9	3.7	4.2	2.8	27.2	4.8	3.3	3.7	0.7	3.2	14.6	8.2	4.2	4.0	8.7	16.0	4.4	5.8	9.1	18.4	7.0	9.4	5.2	3.2	4.3	4.2	0.9	0.9	6.9	1.5	2.3	3.5	4.4	3.5	1.8	3.5	6.8	4.4	3.2	4.4	0.1	0.9	4.7	1.9	3.0	5.8	3.6	2.6	12.4	0.9	3.8	4.1	1.2	4.3	6.5	1.5	9.4	1.1	2.3	0.5	1.4	0.3	1.2	0.8	0.7	0.7	2.0	1.3	1.1	18.5	0.6	0.6	1.0	2.3	0.7	7.4	11.1	10.2	14.1	6.8	6.9	9.9	8.4	12.5	10.9	20.8	18.9	18.2	3.9	1.0	12.8	7.4	5.1	5.3	5.7	5.2	80.5	2.5	0.0	4.2	9.2	16.3	10.3	0.0	4.1	1.3	2.0	4.8	4.7	6.7	11.9	7.9	6.4	14.1	38.6	5.3	7.5	14.4	0.0	1.0	7.3	8.0	8.7	12.7	8.1	17.8	54.2	19.4	2.0	38.5	20.4	0.6	0.9	12.8	6.0	20.5
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050376-1112035	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 25.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	10.1	6.4	5.7	14.1	7.3	4.3	13.0	2.4	8.3	6.5	11.5	5.6	6.6	28.0	7.2	7.6	4.7	8.9	29.4	27.9	6.1	3.8	20.4	31.3	10.0	10.3	5.8	3.2	8.5	12.4	8.2	11.5	3.8	7.9	10.2	7.0	15.5	10.9	8.7	3.2	7.9	20.3	8.2	4.9	17.9	15.2	14.5	7.4	12.2	13.3	5.5	6.9	7.1	34.5	1.4	4.2	0.5	6.9	2.5	2.7	2.2	2.1	6.0	3.3	10.4	0.5	0.5	5.2	0.1	0.7	0.5	0.0	14.3	3.8	0.0	11.8	0.2	4.1	4.4	2.7	3.6	0.0	13.0	3.6	2.8	7.5	4.9	7.6	0.0	6.3	1.1	0.5	0.0	1.1	0.2	3.3	1.3	4.0	0.1	0.0	6.9	8.4	0.0	7.2	8.4	9.6	25.3	14.4	11.8	4.0	8.7	1.8	2.3	3.2	0.0	3.6	2.1	5.8	1.6	2.8	0.0	3.4	0.0	0.0	0.2	0.0	1.4	0.0	0.4	1.7	0.5	3.4	0.0	2.5	5.4	2.6	1.1	2.4	2.7	4.2	1.4	2.5	2.5	0.0	2.5	6.9	1.8	2.4	2.2	5.7	7.3	2.4	8.3	6.1	3.8	5.8	3.2	7.9	7.4	8.9	17.5	5.4	5.2	6.3	17.7	32.1	40.8	10.7	14.8	27.9	2.0	0.2	1.7	23.0	0.3	14.9	28.8	0.0	15.7	0.3	7.3	14.6	8.1	29.2	15.8	265.4	12.7	9.2	20.4	1.3	3.4	12.2	15.1	1.8	16.5	6.6	28.0	17.5	5.3	26.1	2.9	19.4	7.2	0.7	4.5	5.9	0.2	3.3	14.2	13.2
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199986	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 67.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 400.4"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"	"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Low region specificity"	"Detected in all"			"HPA053615, HPA062714"	Enhanced					NA	NA					"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.9	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	23.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	400.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 181.4"	"Cell type enhanced"	"Detected in some"	18	"Cholangiocytes: 28.1;Enterocytes: 37.5;Mucus-secreting cells: 25.2;Proximal tubular cells: 82.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;RPMI-8226: 2.4;SH-SY5Y: 1.2;SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014963	Enhanced					NA	NA					"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	1.4	0.1	0.1	0.1	142.8	0.0	10.7	34.6	0.1	0.5	0.1	0.1	3.4	0.1	0.1	0.1	12.5	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	1.8	0.0	14.9	17.1	0.1	2.1	181.4	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	28.1	0.0	0.0	3.5	11.8	0.0	8.3	0.0	0.0	0.0	37.5	0.0	6.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	25.2	0.0	0.2	8.6	0.0	82.9	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.9	0.3
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 128.6"	"Cell type enhanced"	"Detected in many"	25	"Cytotrophoblasts: 97.7;Proximal tubular cells: 272.5;Syncytiotrophoblasts: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.0;EFO-21: 11.4;Hep G2: 32.6;HHSteC: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	0.7	0.9	2.6	0.5	6.2	0.4	0.9	2.5	3.6	0.9	0.5	15.1	0.0	0.4	0.9	0.7	0.6	1.1	0.9	0.6	3.4	3.1	128.6	7.0	0.8	0.5	9.3	2.1	1.8	3.0	0.4	0.6	12.9	6.5	2.3	0.5	8.1	1.7	0.6	0.6	1.0	0.4	0.9	7.8	0.5	1.7	2.7	5.6	0.0	0.8	0.0	0.6	1.0	0.4	0.6	2.4	2.7	0.4	0.7	0.9	0.0	0.0	0.0	0.9	3.3	5.1	4.8	10.0	2.1	1.2	1.1	0.9	0.0	0.0	0.1	11.4	0.1	0.0	1.2	0.0	1.5	2.7	0.0	0.3	3.9	0.2	32.6	11.4	0.0	2.9	6.5	4.5	6.6	3.3	3.2	0.0	0.0	8.7	0.2	0.0	0.3	0.0	0.4	6.1	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.4	0.1	0.0	2.4	0.5	0.6	1.7	0.1	0.1	0.1	2.4	5.2	0.0	0.3	0.6	0.0	0.4	0.0	0.2	2.7	0.4	0.3	0.9	0.2	0.2	0.4	0.3	0.3	0.1	0.6	0.6	0.6	1.3	0.7	0.3	2.4	0.3	0.0	2.6	6.2	2.5	3.6	3.4	3.1	9.3	2.1	6.5	5.6	0.0	2.1	0.0	1.1	1.1	0.7	0.5	0.0	5.3	0.0	7.0	0.0	97.7	13.3	0.1	17.2	0.2	0.0	0.0	0.8	4.5	1.1	3.2	0.0	11.6	8.1	0.0	0.0	0.0	0.8	22.8	2.8	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	272.5	0.2	0.0	0.3	1.1	0.9	0.5	66.4	0.0	0.0	0.5
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"brain: 85.4;placenta: 44.8;retina: 23.5"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 657.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 85.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA					"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4.0	8.9	1.2	0.3	34.0	0.0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1.0	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0.0	0.3	0.0	1.9	0.3	1.8	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	25.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.4	4.0	8.9	12.3	0.8	1.4	5.4	85.4	0.5	0.0	0.0	0.0	0.5	0.0	2.6	1.6	0.0	6.7	0.0	0.0	3.9	99.4	0.0	0.1	0.4	0.3	0.0	0.0	0.0	5.3	1.1	0.4	0.0	0.0	13.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.1	657.3	0.0	0.0	0.3
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 374.3"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0	0.0	0.0	7.0	0.6	0.5	0.2	0.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	23.3	0.4	0.1	0.0	0.3	0.0	374.3	0.0	0.0	0.0	15.4	21.0	0.0	0.6	0.3	0.0	0.0	0.0	7.4	9.8	0.0	0.0	0.0	1.4	0.0	0.0	0.9	1.5	0.4	0.1	0.0	0.0	0.2
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 44.5;prostate: 64.7;urinary bladder: 29.6"	"Group enriched"	"Detected in some"	10	"Basal glandular cells: 246.2;Erythroid cells: 93.5;Glandular cells: 129.8;Urothelial cells: 212.7"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2"	"Group enriched"	"Detected in some"	5	"GAMG: 79.4;RT4: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Supported		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	2.2	2.1	15.6	1.5	21.5	10.3	2.4	4.6	24.2	2.9	1.6	33.7	0.0	1.9	1.1	1.4	1.1	1.0	8.7	8.2	33.7	11.7	10.1	1.5	4.1	2.4	28.0	23.4	1.0	1.5	1.2	0.4	2.0	44.5	64.7	1.8	0.0	2.6	3.2	3.4	1.7	2.1	3.9	34.9	2.6	2.0	1.0	44.0	0.0	3.6	0.0	2.6	29.6	3.0	0.7	0.3	2.4	0.1	1.8	7.2	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	79.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	1.1	0.0	0.0	0.7	0.3	0.3	0.1	0.1	2.4	2.0	0.0	0.1	0.6	2.0	2.4	0.0	0.7	0.5	3.4	0.4	1.8	0.0	0.3	7.2	1.1	15.6	21.5	4.6	24.2	33.7	11.7	28.0	23.4	44.5	44.0	0.0	1.1	1.3	246.2	0.2	0.3	6.7	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	93.5	0.2	0.0	0.1	129.8	0.0	0.0	0.1	0.0	0.0	17.8	1.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.7	0.0	212.7
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683686	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.3;kidney: 5.7"	"Cell type enriched"	"Detected in some"	5	"Collecting duct cells: 73.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"					"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.2"	"Region enriched"	"Detected in some"	4	"basal ganglia: 17.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.8	1.0	0.0	0.1	0.4	0.6	0.9	0.0	0.7	0.1	0.0			0.3	0.1	0.3	0.0	0.0	0.1	0.3	0.1	0.1	5.7	0.0	0.2	0.1	0.0		0.1	0.0	0.3	0.1	0.0		0.2	0.0		0.2	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.1	1.3			1.0		0.0	0.1	0.1	0.4	0.4	3.3	0.3	0.4	0.8	0.1	0.2	0.4	0.4	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.4	0.2	0.4	0.7	0.0	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.4	0.3	0.6	0.0	0.3	0.4	0.5	0.3	0.2	0.4	0.3	0.1	0.7	0.1	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.3	0.3	0.4	0.3	1.0	0.4	7.2	0.4	0.3	0.4	1.1	0.3	1.4	0.3	3.3	0.3	0.2	0.2	0.4	0.2	0.3	0.1	0.4	0.2	0.3	0.8	0.4	0.2	0.4	0.8	0.1											6.0	14.8	0.0	0.5	0.6	1.2	0.5	0.0	2.7	3.4	73.3	2.0	0.3	0.0	0.0	0.9	0.7	1.1	0.0	0.0	0.2	1.1	0.3	3.5	0.0	0.3	1.6	0.0	1.8	0.3	1.0	0.6	0.8	1.7	0.0	0.3	0.8	0.1	0.0	0.7	0.0	1.7	0.0	0.0	0.5	0.4	0.1	0.7	0.0	0.0	0.4
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 30.1;SK-BR-3: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	30.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	6.8	0.0	0.0	0.0	1.7	1.7	0.6	0.1	0.3	0.0	29.9	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.4	30.6	1.4	2.3	1.8	0.0	0.0	1.7	9.1	0.0	0.0	51.2	0.0	0.7	0.0	0.0	0.8	0.0	29.9	0.1	0.0	3.5	0.6	0.3	0.0	0.0	0.0	1.7	0.0	1.7	0.0	2.9	5.8	0.0	9.8	0.0	0.0	0.2	0.0	0.2	0.6	0.1	0.0	1.7	0.3
SLC15A2	PEPT2	ENSG00000163406	"Solute carrier family 15 member 2"	Q16348	3	121894089-121944102	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.2;ductus deferens: 35.8"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 92.3;Club cells: 31.8;Muller glia cells: 64.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.4;U-937: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.72e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.74e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.60e-2)"	1.0	1.2	13.8	1.9	15.0	3.3	3.2	4.0	15.3	35.2	1.8	7.6	35.8	1.5	1.5	26.2	3.6	7.4	4.2	2.0	14.6	5.3	7.4	1.1	12.9	3.6	5.3	12.9	1.0	3.6	2.4	3.6	1.6	6.8	26.5	2.1	15.1	14.6	25.1	0.8	0.7	2.2	0.9	4.0	6.1	1.1	3.9	6.7	0.0	4.6	0.5	3.8	3.6	2.6	4.2	1.6	2.4	2.5	0.3	0.3	0.3	1.9	0.9	1.1	0.4	1.3	0.7	1.4	0.2	0.1	0.5	0.6	1.8	3.2	3.5	0.2	0.1	0.6	2.1	0.8	1.9	0.6	2.8	0.6	5.0	1.3	0.8	0.2	5.3	5.0	1.1	5.5	0.6	0.4	0.6	0.3	1.0	0.8	1.5	0.6	1.4	1.0	8.4	5.8	2.1	0.5	1.2	0.5	1.0	1.3	1.2	0.4	0.4	0.5	0.3	0.1	1.7	0.3	4.7	0.1	0.4	0.3	0.4	0.4	1.9	0.5	5.0	0.6	7.1	0.5	2.4	1.1	0.4	0.3	0.4	0.3	3.3	0.3	0.2	0.3	4.2	0.3	0.3	0.6	0.3	2.5	1.6	0.2	0.3	13.8	15.0	4.0	11.0	14.6	5.3	5.3	12.9	6.8	6.7	92.3	21.4	4.4	2.1	0.5	1.0	1.9	7.6	12.0	31.8	10.4	0.0	2.1	3.3	0.3	0.3	0.8	0.2	0.0	7.5	0.6	0.6	22.7	3.5	0.0	2.1	0.0	0.0	1.3	10.0	0.6	6.1	3.8	0.0	1.0	1.0	64.9	2.6	0.0	4.9	1.1	2.4	0.0	0.1	0.5	0.1	0.5	1.1	0.0	0.6	8.2
SLC15A3	"hPTR3, PHT2"	ENSG00000110446	"Solute carrier family 15 member 3"	Q8IY34	11	60937084-60952530	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Hofbauer cells: 82.1;monocytes: 92.8;Muller glia cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 36.4;BJ hTERT+ SV40 Large T+ RasG12V: 44.2;HHSteC: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047880, HPA057642"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA047880: AB_10959455, HPA057642: AB_2683487"	"unprognostic (5.61e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (8.79e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.78e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	27.2	7.5	7.7	23.5	8.3	36.8	9.3	2.0	7.0	11.0	16.3	10.6	8.1	9.0	10.3	7.4	12.0	8.6	15.4	11.1	8.2	5.4	8.9	9.1	30.1	24.2	12.2	5.9	16.1	6.6	1.9	5.0	26.6	9.8	10.2	6.7	13.2	5.8	5.5	4.0	4.2	14.0	9.7	12.6	40.0	9.8	5.0	8.3	8.6	5.6	6.5	19.3	11.4	9.3	5.0	10.8	15.0	12.5	0.1	1.4	2.2	3.4	0.1	1.3	0.0	7.7	5.5	13.4	0.8	13.5	36.4	44.2	0.0	1.7	5.6	0.1	5.9	9.3	1.1	0.0	0.4	1.3	5.6	0.0	0.1	0.1	0.2	21.4	0.2	0.5	3.9	0.1	9.8	0.0	0.1	2.1	0.0	0.0	1.1	2.3	0.2	0.0	0.8	6.4	0.0	0.2	2.4	0.1	1.7	0.0	0.8	0.0	0.0	1.7	6.8	0.6	0.3	2.8	4.3	0.0	0.2	1.1	0.8	0.1	0.0	0.0	3.5	2.3	0.1	9.7	0.0	9.5	0.9	0.1	12.5	0.1	5.0	0.0	0.0	6.0	2.4	1.3	1.4	15.0	0.1	6.4	10.8	0.0	2.2	7.7	8.3	2.0	7.0	8.2	5.4	12.2	5.9	9.8	8.3	8.9	19.9	9.3	0.2	1.4	1.3	1.7	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.3	5.5	10.1	0.0	0.0	1.9	10.4	4.1	0.2	15.0	2.4	82.1	4.8	0.0	16.0	47.0	2.9	7.5	37.0	1.7	92.8	0.9	202.1	1.2	0.9	4.6	0.0	4.2	12.9	3.5	0.5	0.7	1.3	2.2	0.0	0.9	0.3
SLC15A4	"PHT1, PTR4"	ENSG00000139370	"Solute carrier family 15 member 4"	Q8N697	12	128793191-128823983	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 67.3;Late spermatids: 84.4;Muller glia cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016713	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016713: AB_1856978"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (5.14e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.56e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.57e-1)"	12.7	7.0	6.6	11.4	7.3	17.6	10.7	8.7	10.2	11.6	8.8	16.0	4.2	5.4	17.2	5.7	9.1	12.3	10.0	9.8	8.4	5.0	8.1	20.4	10.9	14.8	13.8	6.6	10.4	8.2	8.4	6.2	8.8	9.7	7.4	5.4	16.1	8.4	8.8	35.1	9.7	8.2	12.2	10.2	12.2	7.9	27.8	10.1	29.7	9.1	7.3	17.8	11.9	10.5	2.0	20.1	12.1	2.4	4.2	5.0	1.7	6.2	10.3	2.6	5.7	23.4	15.2	9.7	10.9	9.2	7.9	9.0	4.6	9.1	22.8	5.7	9.5	7.9	7.1	7.2	6.7	8.6	11.1	6.6	3.1	6.2	8.2	24.4	10.5	3.3	9.8	12.4	6.5	17.2	23.5	5.4	4.6	5.1	14.4	16.0	4.3	5.4	2.7	9.3	6.8	6.0	4.6	5.7	8.8	15.2	8.0	4.7	3.9	4.4	8.4	11.6	7.4	11.3	2.9	8.1	8.7	4.9	4.3	6.6	4.8	10.6	10.5	11.7	7.4	0.1	0.0	1.8	4.4	5.0	2.4	2.5	1.9	0.9	2.9	1.1	2.0	1.0	2.5	12.1	4.2	1.0	20.1	0.4	1.7	6.6	7.3	8.7	10.2	8.4	5.0	13.8	6.6	9.7	10.1	17.9	10.1	9.7	6.1	9.2	10.3	8.3	5.1	0.0	6.8	21.0	11.8	4.5	1.7	21.0	67.3	4.8	5.5	0.0	9.4	4.8	9.8	7.2	11.5	16.3	18.7	14.3	10.4	13.5	21.5	84.4	11.5	18.6	23.6	19.0	4.3	87.4	19.6	4.9	12.7	3.7	15.6	6.5	9.2	8.0	10.6	8.0	3.3	19.2	6.1	6.0
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	20.2	4.7	14.6	12.4	10.1	8.6	48.0	10.9	8.3	8.6	13.9	16.0	11.8	22.2	15.3	9.9	6.4	19.4	20.4	20.3	16.3	13.9	20.7	18.2	12.9	18.6	17.9	23.2	1.9	12.0	24.9	12.7	25.0	13.9	20.8	11.6	23.0	14.8	9.6	3.9	13.6	11.7	47.2	5.6	15.2	12.2	23.0	15.3	10.6	0.4	16.2	8.5	21.2	0.6	16.2	21.9	0.9	8.8	14.0	8.3	14.6	16.3	16.1	7.8	6.8	22.4	24.1	14.7	10.2	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5	0.0	1.6	15.2	6.7	79.3	17.1	109.7	5.1	0.0	1.2	0.0	149.2	57.9	0.0	2.0	102.1	20.4	27.6	0.0	2.9	62.5	30.5	13.5	9.2	34.7	13.7	19.1	3.4	8.0	9.1	75.6	10.9	4.8	37.1	1.8	14.9	221.8	5.1	5.7	7.1	10.2	246.9	0.0	20.6	35.1	10.2	34.5	38.4	6.9	13.6	0.9
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 26.2;Melanocytes: 42.2"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.4;HEK 293: 12.7;RPMI-8226: 24.2"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.4	0.0	0.1	0.5	0.8	5.1	0.2	4.1	0.9	0.1	1.4	0.0	29.4	0.0	0.5	0.1	12.7	4.7	0.3	4.8	0.0	5.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.8	0.1	0.0	2.0	6.2	0.7	9.0	0.1	1.9	3.5	4.3	24.2	0.0	0.4	6.8	2.1	0.1	0.6	1.1	2.3	1.2	0.8	0.0	0.1	1.1	0.3	1.6	2.0	0.0	1.1	0.2	3.8	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8	8.9	26.2	0.9	10.0	8.7	6.2	7.7	0.0	1.4	5.7	5.2	2.0	1.1	1.7	0.1	7.2	0.7	3.9	0.0	11.1	1.7	2.5	2.8	1.1	19.7	20.5	1.6	6.3	5.5	13.5	5.2	0.0	14.3	42.2	1.0	2.8	1.7	3.1	0.0	0.0	15.2	0.6	0.0	1.0	9.8	9.8	12.9	1.0	0.5	5.0	0.9
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"		10	89430299-89556641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 28.0;kidney: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Region enriched"	"Detected in many"	6	"pons and medulla: 11.7"	"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.8;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria		NA	NA			Mitochondria		"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	2.3	1.3	1.0	0.1	0.7	0.0	2.4	1.3	0.6	4.9	1.6	2.6	6.2	0.1	2.0	28.0	0.5	2.2	0.1	4.0	1.8	0.8	55.6	1.0	3.3	0.1	0.8	0.3	1.8	13.3	0.0	5.0	5.9	11.7	1.4	0.1	16.3	0.9	7.9	4.4	1.1	0.8	0.5	0.6	0.1	1.7	2.4	0.3	0.0	3.8	0.7	0.0	1.8	1.5	0.7	0.5	1.8	0.3	0.9	0.3	0.0	0.2	0.0	0.1	0.1	3.0	22.8	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.1	3.7	0.0	0.0	8.1	0.2	1.1	1.4	1.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.8	0.0	2.7	0.1	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.7	0.2	0.3	0.8	0.9	0.1	0.5	0.0	0.0	1.0	0.7	1.3	0.6	1.8	0.8	0.8	0.3	11.7	0.3	3.0	3.8	0.0	1.5	0.0	0.0	2.0	2.5	8.1	4.5	14.0	0.0	14.3	13.3	0.0	3.0	1.1	0.0	0.0	3.7	0.6	1.1	0.8	1.1	1.7	1.1	3.2	17.4	0.6	0.0	3.0	25.0	1.0	0.0	0.0	0.0	0.0	3.5	0.0	25.1	55.2	0.3	12.9	1.4	0.1	0.2	0.3	7.6	0.0	0.0	1.4
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 5.2;Hepatocytes: 6.8;T-cells: 4.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 16.9;GAMG: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	9.5	16.9	4.0	2.4	2.5	1.4	1.7	1.0	2.5	2.2	5.0	5.4	10.7	6.1	1.6	1.5	20.0	15.0	3.1	5.2	0.9	7.5	2.1	2.5	1.3	13.0	2.8	0.8	5.8	1.6	6.0	3.3	2.7	2.9	8.9	5.5	2.8	1.7	2.3	4.7	3.6	1.5	1.6	4.9	1.3	1.7	1.4	1.0	2.1	2.7	0.1	1.1	3.0	1.7	1.3	6.2	4.6	1.3	3.3	1.4	3.3	2.3	1.4	3.0	6.3	0.3	4.1	2.2	0.6	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3	0.0	1.0	2.2	0.7	0.5	0.1	0.3	0.0	1.4	0.0	5.2	0.0	1.6	0.0	0.8	0.0	1.8	1.5	0.0	0.2	0.4	0.4	0.7	3.5	6.8	0.4	3.2	0.0	2.5	0.3	0.0	0.9	1.7	0.0	1.0	0.3	0.9	0.5	0.0	0.0	1.0	0.4	0.0	0.4	0.0	0.0	1.4	2.1	4.3	0.4	0.9
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 50.8;Peritubular cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ: 34.4;GAMG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.2	4.0	2.9	16.6	7.9	4.2	0.0	34.4	10.6	14.0	8.0	0.0	0.3	0.0	0.5	13.3	27.0	0.6	0.4	14.6	8.2	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.2	3.5	7.2	8.5	5.3	0.0	0.0	0.0	0.0	3.2	0.0	0.2	1.0	11.0	0.0	3.0	6.6	7.9	0.0	6.9	0.0	0.7	5.1	3.8	19.3	0.1	1.0	0.2	0.4	0.0	13.6	3.6	14.9	17.1	0.0	0.0	0.0	15.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1	0.0	1.1	0.0	3.2	0.7	4.5	3.5	5.1	4.0	3.4	3.5	0.0	4.2	3.3	3.7	0.0	2.7	0.0	0.0	2.1	2.7	4.8	3.2	2.3	50.8	0.8	3.2	8.1	2.5	1.5	0.0	14.1	0.0	3.3	1.0	0.0	6.1	3.1	0.0	19.4	5.4	1.1	12.9	5.6	0.1	0.0	1.1	1.7	0.0	0.0	4.8
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82228397-82261129	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (1.19e-7)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	10.4	4.8	3.9	16.9	5.2	11.2	8.8	1.0	5.2	8.0	10.5	3.8	1.7	8.0	4.8	4.7	12.4	5.0	10.4	7.4	4.1	3.8	10.9	3.7	19.0	14.2	9.6	0.6	8.3	3.9	1.4	3.6	36.7	8.4	6.9	4.3	42.9	8.1	4.8	81.2	2.1	8.0	4.5	8.0	17.3	13.9	12.7	6.9	3.9	8.7	7.3	11.0	13.0	7.4	3.7	10.3	40.4	12.4	9.9	6.2	5.4	11.5	5.8	0.1	0.1	2.6	8.3	11.5	48.2	29.7	34.3	38.9	2.7	30.2	0.1	38.0	34.0	29.7	4.1	4.1	69.9	14.4	20.7	0.2	22.0	42.9	50.4	44.2	32.3	27.2	17.1	10.3	23.0	10.6	45.1	18.6	0.4	0.1	6.8	29.7	3.1	0.3	31.8	0.4	4.8	47.0	0.1	0.5	7.6	18.1	0.5	0.7	0.3	46.4	41.3	0.6	4.8	6.0	27.2	32.2	68.4	1.1	1.0	50.3	22.1	0.3	1.0	33.5	20.4	0.6	17.5	12.4	34.6	4.1	11.7	6.2	3.7	3.5	4.6	10.3	2.8	1.8	2.2	40.4	9.9	11.8	6.1	3.0	5.4	3.9	5.2	1.0	5.2	4.1	3.8	9.6	0.6	8.4	6.9	8.9	12.7	14.3	34.8	5.8	9.7	4.8	7.6	14.7	14.8	54.1	3.9	56.0	0.0	116.4	3.0	22.8	93.3	0.0	16.0	1393.3	24.4	12.4	75.9	0.8	262.7	120.8	20.1	17.2	103.7	2.7	2.8	101.0	13.5	232.6	23.8	21.4	199.4	84.2	3.5	3.8	7.4	0.0	14.7	1.6	7.1	5.8	626.2	40.6	16.6	118.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 68.0;Proximal tubular cells: 176.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	5.5	1.2	1.8	4.0	7.8	11.6	3.0	11.7	1.0	2.9	1.7	17.3	0.3	3.3	9.4	0.1	0.3	0.0	1.1	1.1	0.3	1.4	0.3	1.1	1.7	11.6	0.3	0.3	5.7	0.1	1.7	0.1	25.2	2.4	0.4	0.2	0.6	1.9	0.5	0.2	0.3	0.3	0.0	0.2	0.1	0.8	0.1	2.0	0.2	0.7	0.4	0.3	5.6	17.8	5.6	0.3	0.0	0.2	0.7	0.4	0.2	0.8	0.3	0.0	0.9	0.6	0.2	3.2	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8	11.9	17.3	3.2	5.2	2.7	11.1	1.1	15.3	0.0	5.7	68.0	5.9	28.5	3.3	2.9	0.4	4.4	1.3	23.3	0.8	29.3	13.9	2.7	4.7	4.5	3.7	3.2	3.4	3.1	1.0	1.1	16.7	0.8	10.1	1.0	0.9	2.3	1.3	0.2	11.0	176.8	17.7	0.0	5.2	3.0	2.0	3.1	29.4	4.6	0.5	5.0
SLC16A5	"MCT5, MCT6"	ENSG00000170190	"Solute carrier family 16 member 5"	O15375	17	75087727-75106162	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 45.5;Collecting duct cells: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.4;neutrophil: 22.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 22.1;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"A549: 23.1;OE19: 24.8;RPTEC TERT1: 24.7;RT4: 49.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (8.43e-3)"	"unprognostic (8.07e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.53e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	6.0	1.0	0.9	6.3	1.0	4.1	4.9	2.0	1.1	8.9	18.7	1.5	7.5	19.4	6.6	14.6	6.9	9.4	15.3	8.6	1.2	0.9	35.0	2.3	16.9	7.5	1.7	1.2	8.3	4.1	3.6	2.0	30.8	2.3	13.0	5.7	9.5	5.2	15.2	7.9	8.8	30.5	4.7	1.5	6.8	14.6	4.9	1.0	1.8	13.3	9.5	8.8	15.3	11.0	0.7	2.5	22.1	8.4	0.6	1.0	2.4	4.8	23.1	0.4	0.0	1.2	1.5	7.9	2.7	7.0	2.7	1.9	6.0	14.0	0.0	3.3	8.4	0.3	14.0	1.1	3.8	1.0	0.0	0.0	1.7	10.7	3.0	5.5	0.0	0.0	3.7	4.6	2.8	0.0	0.0	5.6	0.2	0.3	0.0	0.2	0.8	0.1	2.4	1.8	24.8	0.0	0.5	0.0	0.1	24.7	49.0	0.0	0.1	6.8	1.6	3.4	4.1	11.4	2.4	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.5	2.4	8.4	2.1	0.3	3.1	0.2	0.7	0.4	0.1	2.5	0.2	1.0	0.3	22.1	0.6	1.6	0.0	0.4	2.4	0.9	1.0	2.0	1.1	1.2	0.9	1.7	1.2	2.3	1.0	35.7	30.9	0.0	6.8	2.3	0.0	4.8	7.6	45.5	30.7	83.7	0.0	16.4	5.0	5.3	41.8	2.9	30.7	0.0	1.2	3.2	3.3	9.6	6.9	0.0	6.1	0.0	6.4	17.2	8.4	26.5	0.6	5.4	6.8	4.6	11.9	0.0	0.7	19.8	0.0	1.8	0.0	0.0	1.9	0.3	1.7	1.1	16.4	0.5	10.1	13.3
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.5"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 21.6;Kupffer cells: 17.4;Rod photoreceptor cells: 39.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	13	"SK-MEL-30: 107.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	7.8	3.4	3.0	6.6	6.3	8.1	6.2	3.7	6.2	2.2	0.8	3.1	9.8	0.9	2.8	32.5	12.4	1.5	1.6	1.4	3.2	4.2	0.9	1.4	9.7	4.6	4.7	1.4	1.8	1.2	0.4	2.4	2.4	6.9	0.8	1.0	13.0	3.5	11.0	10.3	4.2	1.2	0.9	2.7	6.3	1.1	2.2	0.9	1.5	3.3	6.6	7.9	3.7	3.3	0.6	2.7	8.5	4.7	1.1	2.9	1.2	0.4	0.3	0.1	0.1	0.1	0.1	3.1	0.1	3.9	0.3	0.2	0.1	0.5	3.5	0.3	0.0	0.0	0.1	0.6	0.0	0.1	1.0	0.2	0.2	0.4	4.5	0.7	1.2	0.2	0.1	0.0	0.2	0.2	0.3	0.1	0.5	0.2	0.8	0.0	3.9	1.6	0.7	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.3	0.8	0.0	0.1	2.1	107.0	0.8	3.1	0.7	0.5	1.2	0.2	0.1	0.3	0.8	3.1	3.2	8.1	0.9	0.5	1.1	4.7	0.3	2.9	4.4	1.5	0.6	1.2	2.3	2.7	0.3	0.8	1.6	8.5	1.1	2.2	0.6	2.6	1.2	3.0	6.3	3.7	6.2	3.2	4.2	4.7	1.4	6.9	0.9	0.0	4.5	0.8	0.1	0.2	4.8	0.6	0.0	2.7	6.8	8.7	21.6	0.1	0.0	0.0	0.5	0.9	0.0	0.0	0.0	8.6	0.9	0.2	1.1	0.0	5.5	0.0	0.0	1.3	17.4	0.0	0.0	12.8	10.1	1.0	0.0	5.8	0.0	0.0	1.8	0.2	39.6	0.0	0.1	1.6	0.4	0.4	0.3	5.7	0.0	0.0
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596067-59789855	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.5"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	10.0	2.2	9.2	4.3	4.5	9.2	6.4	8.3	5.4	4.8	1.1	1.1	2.2	8.6	2.7	12.3	4.4	8.9	34.7	2.0	1.9	16.4	5.7	9.4	12.1	3.2	3.3	4.7	13.7	2.2	9.5	2.1	5.5	3.8	3.7	2.7	6.2	2.6	4.2	9.4	4.6	10.5	3.7	16.8	12.8	6.2	2.3	12.8	4.0	8.6	9.4	9.7	8.5	5.8	2.8	0.3	9.1	3.0	7.2	2.4	0.1	2.3	0.5	0.3	10.7	16.3	0.1	9.9	6.4	3.4	3.1	0.2	5.9	5.1	2.3	16.7	3.2	0.5	0.6	1.2	5.2	1.4	0.3	9.2	10.4	0.3	5.6	14.9	0.1	8.4	3.2	0.9	9.8	6.1	1.2	6.2	0.1	11.2	5.5	2.1	4.3	2.2	0.6	1.0	3.1	0.3	0.0	2.4	7.6	14.4	2.6	0.6	0.0	0.2	4.7	0.6	0.3	1.8	0.0	8.1	2.7	14.8	0.3	10.8	0.1	8.6	9.3	0.0	1.3	0.3	2.0	0.0	5.4	3.7	7.2	2.4	4.3	4.8	2.1	5.8	4.9	6.9	0.2	3.0	9.1	2.8	4.8	2.4	2.2	4.3	6.4	8.3	2.0	1.9	3.2	3.3	5.5	2.3	26.8	21.3	14.7	5.7	9.0	23.7	116.7	104.4	24.1	15.9	43.6	9.8	0.2	19.9	46.2	85.1	7.1	0.7	0.0	57.0	0.2	12.5	1.9	9.3	10.5	3.0	7.9	0.0	11.1	27.7	90.6	6.4	8.4	3.3	1.8	24.4	1.3	30.7	0.0	9.6	1.0	5.3	6.5	16.0	4.1	3.0	11.0	0.6	20.8	0.9	2.8
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell type enhanced"	"Detected in some"	9	"Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA			"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.4	0.7	1.2	0.2	0.0	0.0	6.1	0.5	0.0	0.0	0.0	1.3	3.5	0.4	1.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.9	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	4.0	0.0	0.0	1.4	0.1	0.1	2.0	0.0	0.0	0.0	4.5	2.0	0.3	6.5	0.3	1.0	0.6	7.8	0.2	0.0	0.0	3.6	0.3	0.0	11.5	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8	0.0	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.6	4.0	0.0	5.0	0.0	0.0	0.9	0.2	0.0	2.1	0.0	0.5	0.0	0.9	0.9	4.1	0.6	0.0	0.0	0.0	0.1
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650761-59736002	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 58.0;kidney: 70.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 218.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	0.7	58.0	5.7	2.0	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10.0	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3.0	6.0	14.3	2.4	3.4	6.5	0.0	11.2	4.4	3.1	0.9	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	4.2	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.7	8.7	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.1	1.8	0.0	0.4	0.1	0.0	2.3	0.1	0.3	4.4	6.1	0.1	0.4	3.3	2.3	0.0	16.4	1.6	7.5	2.7	0.2	5.7	0.0	0.2	2.8	7.9	0.1	0.3	0.0	8.8	2.8	3.6	2.6	0.4	0.9	0.1	8.3	0.0	0.0	0.0	0.0	14.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.7	4.6	9.9	4.3	10.0	2.6	6.7	5.5	8.2	6.5	0.0	0.0	0.0	1.1	0.1	4.7	2.8	0.0	4.0	9.1	7.0	0.0	0.0	21.6	0.7	0.1	0.0	17.7	0.0	0.0	0.8	1.2	12.7	0.0	0.0	0.1	3.2	19.3	0.0	10.5	0.4	12.7	0.0	3.3	1.0	15.5	11.2	0.2	30.3	11.3	218.2	0.8	0.0	2.8	0.3	0.1	0.1	0.0	0.0	12.8	5.7
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782897-25832059	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	56	"kidney: 67.6;liver: 17.9"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 44.6"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	389	"RPTEC TERT1: 38.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050513			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	67.6	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930726	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	333	"liver: 80.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 29.7"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA038270	Uncertain					NA	NA					"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 62.3"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 127.1"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Cell line enriched"	"Detected in single"	217	"RPTEC TERT1: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	62.3	13.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.9	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781191	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 86.6;Enterocytes: 45.7;Hepatocytes: 37.5;Paneth cells: 43.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 5.8"	"Not detected"	"Not detected"							HPA055564	Approved					NA	NA					"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.2	0.0	0.2	1.8	0.2	0.0	0.2	0.2	0.2	0.2	12.8	0.2	0.2	14.8	0.2	0.4	0.2	0.1	14.9	0.2	0.2	0.1	2.2	27.2	0.2	0.2	0.2	0.2	0.2	14.2	0.0	0.2	0.2	0.2	0.2	14.2	0.2	0.2	0.2	0.2	0.0	24.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	1.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.8	5.8	0.0	0.2	0.4	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.1	1.3	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	86.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.8	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	37.5	0.1	0.0	12.6	0.6	1.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	43.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73654155	"Disease related genes, Predicted membrane proteins"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 155.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.7;ASC TERT1: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	7.2	5.8	6.4	2.9	6.8	2.9	9.6	6.3	6.8	4.9	7.8	4.7	12.5	6.5	5.1	17.2	5.0	3.4	6.2	6.2	4.5	6.7	24.3	13.2	7.6	4.9	5.0	4.5	3.4	8.7	155.6	9.3	12.6	6.7	6.9	8.6	6.6	15.5	8.6	3.5	4.8	12.9	4.6	5.9	4.3	6.0	4.1	4.7	3.0	30.5	2.6	7.1	5.9	4.3	5.2	9.9	12.4	10.6	12.0	9.4	6.0	2.8	3.8	3.9	6.2	41.7	31.1	5.2	9.3	23.5	2.5	8.9	2.5	6.9	2.6	4.5	13.1	5.9	5.0	5.4	2.3	4.5	1.8	6.3	1.1	2.1	5.9	8.4	2.1	4.4	14.2	3.5	5.7	4.0	10.7	6.4	3.5	2.7	2.9	8.8	1.9	0.8	1.2	2.8	11.9	2.3	1.9	4.8	11.1	6.6	7.9	1.5	2.7	1.9	5.6	5.4	6.0	2.5	13.2	9.3	1.2	1.1	5.0	2.2	8.2	11.4	0.7	4.2	4.6	3.7	12.4	10.6	4.2	8.5	9.7	8.3	5.2	9.4	8.1	9.9	3.7	7.8	8.6	7.4	12.0	6.0	7.4	8.2	6.0	6.4	6.8	6.3	6.8	4.5	6.7	5.0	4.5	6.7	4.7	20.8	20.2	7.8	12.1	8.5	7.8	5.3	15.3	14.7	9.1	48.8	27.5	14.4	3.3	12.2	27.9	15.0	21.9	0.0	11.9	12.0	22.1	30.0	13.9	31.0	53.7	0.0	11.6	25.8	26.5	32.1	6.9	22.4	10.1	7.2	42.3	7.3	16.7	17.5	10.6	30.8	24.7	0.0	8.0	11.1	2.3	9.8	19.1	7.9	15.0	18.6
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338097-22379503	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 75.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.3;Horizontal cells: 1.6;Muller glia cells: 1.3;Rod photoreceptor cells: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"hypothalamus: 20.2;pons and medulla: 75.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	222	"SCLC-21H: 26.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7"	"Low region specificity"	"Detected in all"			"CAB037130, HPA039226, CAB078204"	Supported	Supported				NA	NA					"CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400"					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.5	0.5	7.6	0.5	1.1	0.5	0.5	0.2	13.8	0.5	0.5	1.3	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	1.1	20.2	0.5	0.5	0.5	0.5	7.1	2.1	0.5	1.5	0.5	5.3	0.5	75.2	0.5	0.5	1.4	0.5	0.5	0.5	0.5	0.5	0.5	5.9	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	1.1	0.2	8.4	1.1	20.2	7.1	2.1	75.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A7	"BNPI, VGLUT1"	ENSG00000104888	"Solute carrier family 17 member 7"	Q9P2U7	19	49429401-49442360	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 150.0"	"Group enriched"	"Detected in some"	27	"Bipolar cells: 377.4;Cone photoreceptor cells: 347.5;Rod photoreceptor cells: 343.9"	"Cancer enriched"	"Detected in some"	6	"glioma: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 21.2;K-562: 6.7;REH: 3.9;SCLC-21H: 4.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6"	"CAB037183, HPA050458, HPA063679"	Enhanced	Supported				NA	NA					"CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086"	"unprognostic (1.79e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.26e-12)"	"unprognostic (8.36e-4)"	"unprognostic (4.27e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.17e-3)"	2.1	1.2	58.3	1.0	27.6	1.0	1.7	52.7	150.0	1.3	1.3	1.5	0.0	1.1	1.2	1.2	1.4	1.3	1.3	1.4	74.3	1.7	1.1	1.0	1.1	1.3	6.0	36.4	1.0	1.0	1.0	0.1	1.0	20.0	1.0	1.2	9.1	1.1	1.1	1.4	1.6	1.3	1.2	0.9	1.0	1.1	1.5	0.0	0.0	1.2	0.0	1.2	1.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	1.7	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.3	0.5	1.3	0.1	1.9	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.1	0.3	0.0	0.4	0.0	0.3	6.7	1.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	3.9	0.1	0.1	0.0	0.0	4.9	0.4	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	2.4	0.9	0.0	0.4	0.3	0.3	0.6	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	27.6	52.7	76.0	74.3	1.7	6.0	36.4	20.0	0.0	0.0	0.0	0.0	0.1	1.1	377.4	2.4	0.0	0.0	0.0	0.0	347.5	0.1	0.0	0.0	4.0	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	11.1	0.0	0.0	0.0	0.0	6.1	0.3	1.7	0.0	0.0	13.3	0.1	0.0	0.4	0.0	343.9	6.5	2.8	1.0	2.3	0.5	0.0	0.0	0.0	0.0
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357079-100422059	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9"	"Group enriched"	"Detected in some"	4	"Enterocytes: 4.1;Extravillous trophoblasts: 1.7;Kupffer cells: 3.5;Paneth cells: 1.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 2.1;RPTEC TERT1: 1.1;SuSa: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB079058		Supported				NA	NA					"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.1	0.3	2.0	0.1	3.7	0.1	0.1	0.0	10.7	0.1	1.1	0.0	0.0	1.8	0.4	0.2	0.1	1.0	0.1	0.1	6.9	2.2	0.3	1.2	0.2	0.1	0.8	1.0	0.2	0.2	0.1	0.4	1.0	3.6	0.1	1.0	1.7	0.1	0.1	0.1	0.1	12.4	0.1	0.5	0.1	0.2	0.4	0.1	3.9	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.4	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.0	3.7	0.0	10.7	6.9	2.2	0.8	1.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 25.4;intestine: 10.8"	"Cell type enriched"	"Detected in some"	37	"Intestinal endocrine cells: 133.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.8"	"Region enriched"	"Detected in single"	4	"midbrain: 2.0"	"Group enriched"	"Detected in some"	12	"intermediate monocyte: 2.3;non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in single"	18	"monocytes: 6.0"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced					NA	NA					"HPA006877: AB_2667690, HPA063797: AB_2685125"	"unprognostic (8.03e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	0.0	25.4	0.2	0.8	0.1	0.0	0.0	0.0	0.2	0.2	8.8	1.3	1.3	1.4	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.0	2.7	0.0	0.0	2.8	0.0	0.0	10.8	0.0	0.1	0.3	1.1	0.2	0.0	0.2	0.2	0.0	0.1	1.3	0.4	0.0	0.3	0.2	6.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell type enriched"	"Detected in some"	22	"granulocytes: 603.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 91.2"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.2	91.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3	8.9	27.6	0.0	0.0	1.6	0.6	0.2	0.0	1.4	4.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.4	603.6	0.0	0.7	0.0	8.5	11.6	1.8	0.0	0.6	0.6	1.7	0.0	0.0	0.3	0.1	0.0	4.6	0.0	0.7	0.0	0.2	0.2	0.1	2.4	0.0	0.0	0.0	0.0
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610301-49612720	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 1.1;Syncytiotrophoblasts: 1.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basal ganglia: 8.8;hypothalamus: 3.4;pons and medulla: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 12.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	14	"basal ganglia: 17.7;pons and medulla: 20.9"	CAB079011		Supported				NA	NA					"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.1	0.3	0.0	2.2	8.8	0.1	0.1	0.0	0.5	0.1	1.5	0.0	1.1	1.3	0.3	0.1	0.1	0.1	0.2	0.1	0.0	3.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.7	3.4	11.9	0.4	0.3	1.4	0.4	0.6	0.2	0.1	1.9	1.5	3.1	0.1	1.2	0.2	1.2	0.2	0.1	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	12.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.8	0.0	0.5	0.0	3.4	0.1	0.0	11.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45544411	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 133.1;Syncytiotrophoblasts: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 37.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	9.0	7.8	7.1	8.2	13.5	10.5	12.5	9.6	8.9	5.0	9.7	6.0	9.4	31.2	4.3	4.6	2.3	4.6	3.5	3.2	7.1	6.1	4.7	14.1	13.9	14.1	8.7	4.4	8.1	5.4	1.8	3.5	32.9	11.5	4.7	2.0	17.8	6.0	3.5	3.5	6.1	16.5	2.3	5.9	11.7	5.7	3.4	3.4	11.8	9.6	2.8	4.1	3.1	3.1	0.9	4.9	37.6	6.4	0.4	1.1	2.4	10.6	9.7	1.9	7.9	0.6	0.8	15.9	5.0	0.8	4.6	2.9	22.4	9.9	9.9	9.9	1.2	3.9	5.5	3.9	3.6	1.1	9.1	19.3	20.8	5.2	15.5	2.7	13.5	3.2	1.0	2.8	4.9	1.6	1.3	3.8	10.6	24.8	4.3	1.6	11.9	18.3	12.6	11.4	4.7	11.3	25.0	2.2	28.7	2.1	6.4	11.8	10.4	5.6	9.3	4.3	2.7	7.0	16.0	4.6	6.0	7.5	1.6	8.1	1.8	6.6	9.0	2.7	22.1	4.8	0.6	6.4	8.5	0.3	6.0	1.1	0.9	0.5	0.7	4.9	0.3	0.8	0.5	37.6	0.4	3.7	1.5	1.0	2.4	7.1	13.5	9.6	8.9	7.1	6.1	8.7	4.4	11.5	3.4	44.7	4.6	0.8	1.7	2.2	18.0	2.4	2.5	1.4	10.3	0.0	0.0	133.1	0.0	7.8	3.3	2.8	9.3	0.0	4.2	16.2	2.9	3.6	1.1	10.9	24.0	7.9	0.0	1.8	11.6	3.2	6.1	5.9	3.3	0.0	3.1	8.6	6.8	5.3	10.6	1.9	3.6	0.0	3.8	1.2	4.1	1.4	303.1	2.2	7.6	0.9
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169486003	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.7"	"Cell type enhanced"	"Detected in many"	12	"Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	23.1	11.1	1.9	5.3	4.4	4.8	14.2	7.4	6.1	5.9	5.4	2.8	2.7	2.1	5.0	9.0	7.5	10.0	17.5	14.8	2.7	2.1	8.6	23.4	9.2	3.1	2.8	1.7	10.3	14.4	6.8	16.3	22.1	4.7	9.4	2.8	16.4	10.4	4.6	75.7	7.5	6.6	11.3	3.7	1.8	9.4	7.3	1.8	3.6	7.9	21.6	3.9	10.4	9.8	1.4	1.9	3.0	4.6	2.6	3.3	0.7	4.5	3.2	7.3	5.7	22.8	8.4	16.2	3.6	2.7	3.0	4.2	13.1	4.8	4.0	4.2	2.4	5.5	4.9	8.8	5.4	3.3	11.5	8.2	3.8	10.4	11.9	12.4	9.6	3.8	9.9	7.9	4.8	12.3	4.2	4.4	7.1	15.4	2.6	5.0	3.0	4.9	4.3	16.6	8.8	4.9	0.0	15.8	4.6	7.9	9.7	6.4	8.6	5.0	8.7	17.8	8.7	5.5	6.3	3.7	3.6	5.0	4.4	7.1	3.6	3.3	1.3	5.3	3.7	4.7	0.0	1.7	3.0	0.9	0.7	3.3	1.4	1.1	2.1	1.9	1.2	3.1	3.0	1.1	2.6	4.6	0.7	1.0	0.7	1.9	4.4	7.4	6.1	2.7	2.1	2.8	1.7	4.7	1.8	8.9	17.1	0.9	13.6	26.3	4.7	24.0	7.6	13.4	11.4	5.2	2.0	19.6	0.0	7.1	4.4	2.3	6.3	0.0	4.6	3.0	20.6	10.4	10.3	23.1	6.2	6.4	8.6	0.6	3.7	0.4	6.4	5.7	20.3	0.0	4.4	2.6	8.2	5.7	4.6	1.8	4.7	0.0	9.4	3.4	3.4	44.2	130.8	1.5	4.7	21.3
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.3	0.4	7.4	0.1	0.2	0.3	0.6	18.7	0.5	0.4	0.2	0.1	4.6	0.5	0.5	0.5	0.8	0.1	1.2	0.1	1.0	0.8	1.7	0.2	0.2	3.3	0.4	0.1	0.9	0.3	0.0	0.3	0.2	0.9	0.0	1.8	0.1	0.7	3.2	0.6	0.3	0.3	0.2	0.2	0.2	0.3	1.1	0.1	0.6	2.1	0.5	2.7	0.3	0.2	0.5	0.5	0.5	4.2	0.4	0.2	0.1	0.7	1.4	0.3	0.5	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5	8.9	3.2	0.0	0.4	0.0	2.9	0.3	0.0	0.0	0.0	1.8	0.0	45.5	1.7	1.7	0.3	0.5	6.4	0.0	0.0	7.0	0.9	0.3	0.0	11.4	4.6	0.0	1.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.8	0.6	0.0	0.0	2.2	0.1	0.0	1.0	0.0	0.1	0.0	134.3	0.0	5.6	0.3
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490444-4587469	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;kidney: 31.2"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 1: 151.8;Cholangiocytes: 35.7;Enterocytes: 37.3;Hepatocytes: 62.7;Proximal tubular cells: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	30	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.9;HDLM-2: 31.6;HUVEC TERT2: 14.9;RPTEC TERT1: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA					"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	3.3	1.4	8.6	3.4	10.2	0.3	2.9	4.7	12.4	4.0	17.9	2.7	0.5	21.0	4.0	28.8	1.7	1.9	16.3	2.0	10.0	10.2	31.2	29.1	12.8	1.8	8.6	5.8	0.7	1.8	0.4	5.2	5.1	6.7	4.3	6.6	1.9	3.1	2.4	2.2	1.2	40.4	5.6	5.3	0.5	3.4	0.8	4.4	0.0	25.0	1.8	5.0	3.5	1.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.9	0.7	4.4	11.5	13.9	3.9	4.7	9.8	1.5	1.4	7.8	0.2	6.1	0.3	2.4	1.8	0.0	1.6	2.6	1.3	31.6	2.1	0.0	6.6	0.0	0.4	0.4	0.0	0.9	0.1	5.6	0.0	0.7	14.9	0.1	0.0	0.0	1.0	0.1	0.0	0.1	1.9	4.7	0.8	0.0	0.0	0.0	31.0	2.7	1.0	0.9	0.3	1.7	0.0	3.7	0.6	0.2	8.0	2.3	0.1	4.4	1.3	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	8.6	10.2	4.7	11.7	10.0	10.2	8.6	5.8	6.7	4.4	151.8	2.7	0.8	1.0	0.0	0.7	0.8	35.7	4.0	9.1	0.0	0.0	0.0	3.3	5.5	3.5	7.0	37.3	0.0	0.7	0.0	0.9	1.7	0.0	62.7	0.1	0.0	0.0	3.1	2.1	6.1	0.3	0.1	0.0	0.0	6.5	0.8	5.8	8.6	0.0	37.2	0.9	0.0	1.1	0.0	0.2	0.5	0.1	0.8	4.8	0.2
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 160.9"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 139.4;Early spermatids: 85.3;Rod photoreceptor cells: 160.3;Syncytiotrophoblasts: 225.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.5;BJ hTERT+: 4.9;fHDF/TERT166: 3.4;Hep G2: 5.7;NTERA-2: 6.4;SCLC-21H: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA					"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	1.7	4.1	65.1	1.9	79.4	1.8	3.7	7.2	160.9	2.0	1.7	9.8	0.0	1.8	2.1	1.8	1.7	1.7	1.7	2.1	47.6	11.7	1.7	20.5	1.9	2.5	15.2	43.1	1.6	4.2	1.6	0.4	2.1	27.6	1.7	1.7	0.0	3.9	1.7	1.7	2.3	1.6	1.8	17.2	1.8	2.6	2.4	16.3	0.0	1.7	0.0	2.4	1.7	0.3	1.1	0.7	3.9	0.7	1.2	0.9	0.4	0.0	0.2	1.1	0.1	0.5	4.5	0.0	1.1	4.9	0.2	0.3	0.2	0.0	0.1	0.1	3.4	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.4	0.5	5.7	0.2	0.6	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	2.2	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.3	0.5	0.0	2.3	0.0	0.3	1.1	0.0	0.6	0.2	0.2	0.5	0.1	0.6	0.0	0.0	1.1	0.0	0.3	3.9	0.7	0.8	0.5	0.3	0.3	0.4	0.5	0.4	0.7	1.1	0.9	0.7	2.1	1.2	0.4	0.6	0.4	0.4	65.1	79.4	7.2	64.9	47.6	11.7	15.2	43.1	27.6	16.3	3.0	3.7	0.0	0.0	2.6	48.2	2.8	0.0	1.4	0.0	0.0	139.4	14.9	0.0	0.1	85.3	0.3	0.0	0.0	2.9	0.8	2.6	0.4	0.0	5.4	3.1	6.4	0.0	0.0	0.0	59.1	0.0	0.5	1.7	55.1	0.0	10.6	0.7	0.0	0.0	0.0	160.3	0.0	1.0	0.2	1.2	1.0	225.3	0.0	0.0	0.1
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 579.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.5	1.9	2.2	6.0	13.8	0.0	0.0	0.8	1.9	34.7	1.7	0.0	10.5	0.3	0.3	26.3	6.3	2.8	0.9	0.3	12.9	0.0	0.1	0.0	0.4	0.4	0.1	11.1	13.0	5.3	2.2	0.4	0.0	0.4	0.0	0.1	3.6	0.0	0.0	0.1	2.5	0.0	2.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	2.1	6.3	0.3	10.5	0.0	1.0	0.0	1.9	3.2	0.0	7.6	0.0	0.0	0.0	8.8	14.5	4.9	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6	3.0	0.3	0.5	10.4	9.5	7.7	33.9	0.0	5.3	1.2	0.0	2.0	25.3	0.0	0.4	0.6	1.1	0.0	0.0	0.0	13.5	11.8	3.2	0.0	0.2	38.2	3.2	0.0	1.3	63.4	1.9	4.0	11.0	6.8	3.6	0.0	579.8	0.3	0.0	0.0	0.0	11.3	6.5	4.7	0.2	0.1	6.1	7.7	0.0	0.0	3.3
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Melanocytes: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7;U-266/70: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.7	2.9	1.7	8.8	3.8	2.5	2.4	7.1	3.5	3.0	5.1	0.8	0.5	12.2	1.6	11.1	3.7	10.8	3.4	0.9	3.1	4.9	1.3	6.3	3.5	7.5	8.1	10.6	5.9	1.1	18.8	4.0	6.2	1.0	1.8	12.3	4.9	30.9	2.1	3.3	9.0	7.0	1.2	4.9	3.5	3.3	0.4	30.3	1.2	1.9	7.5	3.6	4.4	4.0	72.7	0.8	4.8	11.7	0.4	4.1	4.9	7.9	4.3	34.0	16.8	29.6	6.0	21.4	21.7	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5	0.0	2.4	14.5	2.0	17.7	5.4	4.4	2.5	4.0	1.2	1.8	31.4	0.9	0.0	1.4	23.4	4.5	0.7	0.0	8.1	1.1	5.6	2.5	6.9	10.9	17.4	6.4	8.1	9.2	4.5	34.0	10.3	9.5	81.0	5.4	6.2	14.7	8.6	0.0	28.0	1.2	16.5	0.0	9.0	1.1	0.6	5.4	2.1	2.5	4.4	0.9
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 34.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 34.6;monocytes: 22.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	39.3	5.7	3.4	16.0	5.4	16.2	45.0	0.9	3.0	20.7	15.8	5.0	50.4	4.9	14.3	33.7	33.9	18.1	31.2	10.0	4.5	2.2	23.7	4.1	23.4	17.7	8.2	0.9	33.3	24.6	0.2	9.1	25.8	4.9	35.2	13.8	5.2	99.0	55.7	6.9	18.6	12.1	23.1	5.3	19.8	17.9	21.7	6.1	14.9	6.5	28.4	25.9	48.3	44.9	7.0	34.6	0.9	22.4	6.9	5.6	7.4	23.8	44.1	10.6	16.0	27.7	23.6	25.1	34.1	39.0	25.6	37.2	40.0	27.0	26.2	16.7	84.6	14.7	38.5	30.9	40.5	19.1	17.3	28.0	43.4	16.9	37.5	71.7	30.2	25.6	38.3	101.3	30.0	76.2	8.6	13.6	35.0	45.8	69.4	13.6	40.6	13.8	81.3	18.5	85.5	19.4	15.7	12.0	37.2	14.3	52.2	16.4	12.0	16.8	46.0	36.5	8.6	26.5	39.9	10.1	15.4	24.7	12.0	27.7	43.1	41.6	21.8	29.0	37.7	37.7	0.0	11.5	0.9	5.3	19.9	4.4	7.0	3.1	3.7	17.8	2.5	0.7	2.3	0.3	6.9	22.4	34.6	5.6	7.4	3.4	5.4	0.9	3.0	4.5	2.2	8.2	0.9	4.9	6.1	0.0	15.9	11.9	134.3	51.3	0.1	19.9	20.4	4.0	7.9	0.0	0.0	80.4	3.3	26.8	14.6	17.1	22.0	93.5	55.3	97.4	44.3	44.4	28.8	0.5	33.9	0.0	10.3	26.4	16.8	10.3	17.5	27.3	18.6	10.8	88.4	0.6	35.9	74.6	18.4	23.9	0.8	6.5	22.6	4.4	4.3	24.7	20.4	20.8	50.3	96.8
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.1;testis: 23.3"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 52.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6"	"Region enriched"	"Detected in many"	6	"cerebellum: 152.9"	"Low region specificity"	"Detected in all"			"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA			"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.4	0.5	3.2	0.5	9.6	1.2	0.8	52.1	12.8	0.4	0.5	0.6	0.0	0.6	0.8	4.2	0.4	0.5	0.5	0.4	4.8	4.0	0.4	0.5	0.5	0.5	1.6	3.4	0.6	0.9	0.6	0.0	4.3	3.0	0.9	0.6	0.1	0.7	0.9	0.5	9.2	0.5	0.5	1.4	0.7	0.5	23.3	0.9	0.0	0.6	0.0	0.6	0.4	0.0	2.0	0.7	2.2	0.7	0.5	0.6	0.1	0.1	0.1	0.3	0.3	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.2	6.6	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.5	0.0	0.3	5.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.2	2.6	0.0	1.1	0.3	0.1	0.0	0.3	1.0	0.2	0.1	0.4	0.1	24.6	0.1	0.3	0.1	1.6	0.7	0.5	0.6	0.4	0.4	1.0	0.5	0.3	0.3	2.0	0.6	0.6	2.2	0.5	0.4	0.7	0.3	0.1	3.2	9.6	52.1	6.5	4.8	4.0	1.6	3.4	3.0	0.9	0.0	0.0	0.0	0.6	2.9	12.3	1.6	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	29.3	0.0	0.0	0.0	0.3	8.5	1.0	0.2	0.0	0.0	0.4	22.3	0.0	0.0	0.0	27.3	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.7	0.0	0.3	1.7	1.5	5.9	33.4	0.0	0.0	0.1
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142632	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"retina: 70.1"	"Group enriched"	"Detected in some"	17	"Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	58	"T-cells: 5.7"	"Cell line enriched"	"Detected in some"	9	"HHSteC: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049124	Enhanced					NA	NA					"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	2.0	0.2	1.1	0.6	0.6	0.0	1.2	0.6	0.7	0.9	1.0	0.7	0.6	4.1	1.3	1.2	2.1	2.2	9.6	2.9	1.7	1.1	0.7	2.8	0.9	0.6	1.2	0.6	3.8	0.6	0.0	0.6	0.6	1.1	0.9	0.0	70.1	0.6	0.6	2.1	1.2	5.3	0.6	1.3	0.6	1.1	0.9	0.6	0.6	0.6	0.6	0.6	2.5	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.6	0.6	0.7	1.7	1.1	1.2	0.6	1.1	0.6	0.0	0.6	0.0	0.0	0.0	228.0	0.4	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.0	0.0	7.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.2	0.0	2.9	1.1	0.2	66.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC20A1	"Glvr-1, GLVR1, PiT-1"	ENSG00000144136	"Solute carrier family 20 member 1"	Q8WUM9	2	112645857-112663827	"Predicted membrane proteins, Transporters"	"Host-virus interaction, Phosphate transport, Symport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 198.3;Enterocytes: 165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 87.9;U-87 MG: 85.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019279, HPA035834"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB019279: , HPA035834: AB_2674809"	"unprognostic (1.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (6.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-3)"	23.4	9.9	11.9	38.8	16.0	51.3	18.9	25.6	29.1	9.4	42.7	10.6	4.7	12.3	11.7	8.6	11.0	12.2	22.7	17.0	12.0	12.3	16.3	40.2	23.1	27.6	13.5	16.8	7.7	25.7	7.4	13.3	59.8	20.6	15.3	19.1	17.8	10.4	12.2	25.6	10.2	21.8	13.1	15.5	23.8	13.8	13.3	9.1	19.0	12.8	9.5	22.4	21.6	14.4	3.8	17.9	12.3	25.2	19.9	27.1	13.0	10.9	9.0	11.8	9.5	9.0	22.1	9.1	29.6	35.5	13.2	17.2	13.7	27.1	19.9	16.4	11.0	51.3	11.5	12.9	22.5	19.4	10.9	13.2	16.9	9.2	13.0	13.4	9.6	30.0	11.2	8.9	46.6	32.7	87.9	16.8	8.6	31.3	20.9	57.2	4.3	13.1	37.4	19.8	5.1	24.4	12.4	10.6	5.6	19.1	50.8	10.8	10.2	14.9	9.1	20.4	5.5	9.3	6.9	36.4	24.3	16.0	8.4	22.9	8.7	22.4	16.7	85.5	9.3	29.3	3.8	14.5	12.3	24.2	25.2	27.1	3.8	10.4	17.4	10.9	2.1	8.3	13.1	6.1	19.9	14.7	17.9	6.0	13.0	11.9	16.0	25.6	29.1	12.0	12.3	13.5	16.8	20.6	9.1	11.9	32.9	31.8	53.3	100.2	60.0	31.1	22.9	36.1	31.8	8.7	198.3	36.6	11.6	14.7	0.9	44.4	165.9	23.3	12.2	11.8	33.2	30.0	24.3	49.9	25.2	19.1	34.2	46.1	48.3	2.0	3.4	60.3	25.3	8.2	39.4	21.5	21.0	83.4	4.6	3.8	74.9	0.0	22.1	4.8	17.4	54.1	62.1	52.4	51.1	43.9
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 90.6"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 151.7;Urothelial cells: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA					"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	7.3	5.2	12.2	6.3	17.8	2.3	8.0	24.2	22.2	8.5	14.2	28.6	4.9	28.0	10.9	6.8	19.4	15.4	9.4	37.3	16.7	17.3	11.3	23.1	9.3	4.1	22.4	14.4	5.7	30.2	15.1	8.1	8.3	32.8	8.4	11.8	19.0	90.6	11.6	69.9	12.6	18.2	12.1	21.6	4.7	8.8	11.1	18.3	5.6	48.6	19.8	10.5	14.6	11.5	3.2	5.2	3.1	3.0	9.6	7.5	4.1	18.0	5.0	6.9	5.7	3.9	3.3	15.3	16.6	28.9	8.6	21.5	13.4	48.3	6.1	19.6	14.9	4.9	29.7	3.8	16.9	15.3	1.5	3.1	9.7	1.8	7.6	5.6	3.4	4.4	3.6	15.4	8.9	8.8	6.1	4.2	4.9	9.3	5.0	16.3	5.0	6.1	5.6	6.8	17.6	3.2	5.2	7.5	6.4	7.9	17.8	1.8	7.1	4.5	7.8	4.5	5.7	6.3	6.0	13.1	18.7	6.4	4.4	9.0	3.3	7.4	4.4	5.8	6.8	10.1	3.1	3.0	0.3	5.6	2.2	6.3	3.1	6.0	5.2	5.2	3.2	7.5	5.6	1.2	9.6	1.9	3.0	5.8	4.1	12.2	17.8	24.2	19.9	16.7	17.3	22.4	14.4	32.8	18.3	26.8	15.2	6.4	151.7	87.8	13.6	54.5	15.3	64.3	14.8	15.7	15.7	19.5	11.6	26.9	7.6	15.8	30.9	0.0	26.9	19.4	12.7	56.3	3.5	28.4	9.1	6.4	11.5	6.2	7.6	7.5	6.6	6.9	10.1	9.0	10.7	16.4	37.9	12.9	11.0	5.0	10.0	6.5	16.0	3.6	4.3	65.0	21.3	8.5	10.0	128.7
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121789-160158718	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"liver: 175.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 709.2"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Not detected"	"Not detected"			HPA029846	Approved					NA	NA					"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	175.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.3	0.3	0.0	0.5	0.0	0.0	0.9	0.9	1.8	1.6	0.6	0.7	0.4	0.2	0.5	0.5	1.4	0.4	0.5	1.0	0.1	3.1	0.3	0.0	1.8	0.7	1.5	0.9	0.6	0.6	2.4	0.0	1.5	1.1	0.0	2.0	0.0	1.0	0.3	0.1	0.9	0.5	0.3	0.3	0.2	0.0	1.1	0.0	0.3	0.7	0.0	1.8	1.5	0.2	0.9	0.6	0.0	2.5	0.0	1.6	1.5	0.3	0.1	0.0	0.6	0.7	1.7	1.2	1.4	2.8	0.9	0.2	1.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	7.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.3	43.3	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	709.2	0.1	0.0	0.0	14.1	12.6	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	1.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	2.9	0.0	0.1
SLC22A10	"hOAT5, OAT5"	ENSG00000184999	"Solute carrier family 22 member 10"	Q63ZE4	11	63137867-63369718	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	32	"liver: 41.7"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 15.5"	"Cancer enriched"	"Detected in single"	14	"liver cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.17e-2)"				"unprognostic (9.77e-2)"		"unprognostic (7.07e-3)"	"unprognostic (7.46e-4)"			"unprognostic (7.62e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555626-64572875	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"epididymis: 22.2;kidney: 47.6;placenta: 64.7"	"Group enriched"	"Detected in some"	17	"Cytotrophoblasts: 554.5;Syncytiotrophoblasts: 1271.5"	"Group enriched"	"Detected in some"	14	"liver cancer: 3.7;renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4;SuSa: 1.9"					"Not detected"	"Not detected"			HPA026076	Enhanced					NA	NA					"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	4.4	0.0	0.1	22.2	0.1	0.1	0.0	0.1	0.1	0.1	47.6	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.1	64.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	554.5	5.0	0.0	1.0	0.0	0.0	0.0	0.3	13.6	0.6	0.0	0.0	0.0	44.6	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	0.1	0.0	1271.5	0.0	0.0	0.0
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	349	"kidney: 70.1"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 149.1"	"Group enriched"	"Detected in some"	207	"liver cancer: 4.0;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA024575	Enhanced					NA	NA					"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favorable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278315	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 16.4"	"Cell type enriched"	"Detected in single"	23	"Proximal tubular cells: 6.5"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.2"					"Low region specificity"	"Detected in all"			"HPA035603, HPA035962"	Enhanced					NA	NA					"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.1	0.3	0.0	2.3	0.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.3	0.0	0.2	0.3	0.0	0.5	0.9	0.2	0.1	0.6	0.8	0.5	0.7	0.1	0.4	0.1	0.0	2.2	0.0	0.1	0.0	0.8	0.0	0.5	0.1	1.5	0.8	0.0	0.9	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.0	0.5	0.0	0.4	0.1	0.1	0.0	0.3	0.7	1.2	0.3	0.3	0.4	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976498-116070054	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.6;brain: 27.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 10.7;Cone photoreceptor cells: 9.8;Kupffer cells: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.1;hTERT-HME1: 27.9;NB-4: 15.2;THP-1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Uncertain					NA	NA					"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	2.9	4.5	7.0	3.2	14.1	34.6	2.3	8.6	11.1	2.6	2.1	27.8	0.7	1.7	1.9	2.2	5.5	2.4	2.9	6.1	9.9	8.0	4.9	1.3	6.3	1.7	20.0	8.1	2.0	4.2	7.5	4.5	2.9	15.1	2.8	2.7	2.5	4.6	2.7	0.8	11.8	1.7	1.7	14.1	3.5	4.8	1.8	17.6	0.0	4.0	0.8	1.9	2.5	4.6	0.5	0.3	3.9	2.9	0.2	0.0	0.3	1.6	0.1	1.2	0.0	2.2	2.7	0.8	2.7	3.9	1.6	2.9	0.0	0.3	1.8	2.9	1.3	1.4	2.5	2.0	5.5	1.6	0.0	1.3	1.8	1.9	0.2	7.3	2.7	2.5	2.7	21.1	0.0	27.9	0.1	0.0	0.0	0.1	0.0	2.7	1.5	0.0	15.2	1.7	1.5	1.3	0.0	0.0	0.0	2.3	0.9	1.3	1.1	4.6	0.9	7.8	1.9	0.2	16.5	0.0	2.9	1.6	0.5	0.6	2.8	2.6	0.2	3.1	4.5	4.6	1.0	2.5	0.9	0.0	0.7	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	3.9	0.2	2.9	0.0	0.0	0.3	7.0	14.1	8.6	11.1	9.9	8.0	20.0	8.1	15.1	17.6	0.0	10.7	0.8	2.9	2.5	2.1	7.5	0.0	4.0	2.3	5.2	9.8	0.5	1.7	1.1	0.6	0.0	0.0	0.0	0.3	0.3	1.3	0.8	1.1	0.0	2.9	7.9	8.1	1.3	8.6	0.0	0.9	5.9	1.7	1.0	0.2	0.8	1.7	0.2	0.4	0.1	2.0	0.0	1.0	0.2	0.2	2.6	0.0	0.5	0.4	0.9
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Predicted membrane proteins"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 9.5"	"Group enriched"	"Detected in many"	66	"dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5"	"Group enriched"	"Detected in some"	18	"NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4"					"Low region specificity"	"Detected in all"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	3.5	0.2	0.2	0.4	0.2	16.0	0.2	0.1	0.2	0.1	0.7	0.0	0.0	0.0	4.9	0.8	0.1	0.3	0.7	0.1	0.2	0.1	1.1	0.3	1.6	0.0	0.2	0.0	0.9	0.1	9.6	0.1	0.3	0.2	0.2	0.0	0.0	0.6	0.0	0.2	0.3	0.1	1.6	0.2	0.8	0.2	26.4	0.0	2.2	0.1	0.8	0.1	0.1	0.1	0.0	5.1	5.0	9.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.4	0.0	5.0	9.5	1.6	0.0	2.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	23.3	0.0	0.1	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.2	23.1	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	35.7	0.2	0.4	0.0	0.0	0.0	0.0
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 71.4;liver: 44.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 511.8;Late spermatids: 354.1;Paneth cells: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.6;Karpas-707: 20.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced					NA	NA					"HPA067812: AB_2685902, HPA071461: AB_2686401"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	3.5	1.6	0.5	11.4	1.2	1.4	3.2	0.1	2.0	2.6	36.6	0.8	2.9	36.7	3.1	15.2	6.1	4.7	21.9	8.5	0.9	1.1	18.2	44.3	8.7	8.3	1.0	1.7	2.9	3.0	4.1	1.5	4.9	1.3	4.0	3.7	4.2	8.6	4.3	1.0	6.5	71.4	3.7	1.2	4.7	8.1	2.8	0.8	3.1	8.1	7.6	5.4	4.5	4.4	2.1	8.9	21.7	15.0	2.7	4.6	6.0	1.4	8.7	0.0	4.9	0.9	1.4	3.6	2.9	5.2	1.7	3.0	5.1	21.6	0.6	9.2	3.9	3.7	4.7	0.2	0.4	0.4	4.3	0.7	0.1	2.1	4.6	9.6	0.0	4.0	4.0	0.9	1.4	0.3	1.5	0.0	3.0	0.1	20.1	0.9	4.4	0.1	0.6	0.5	7.0	1.9	1.5	0.0	2.7	0.8	3.0	0.1	1.6	1.1	12.6	10.4	0.1	2.4	2.5	0.2	1.3	2.8	4.0	0.2	3.6	0.8	0.2	5.3	2.7	5.0	15.3	15.0	12.6	3.5	14.3	2.0	2.1	2.8	2.5	8.9	1.3	1.5	2.2	21.7	2.7	10.8	6.4	4.6	6.0	0.5	1.2	0.1	2.0	0.9	1.1	1.0	1.7	1.3	0.8	6.0	8.1	3.9	17.1	6.5	1.2	8.6	71.4	16.0	9.1	26.2	0.0	70.1	6.6	24.6	135.4	3.2	511.8	0.0	7.7	17.5	12.2	13.4	16.1	138.4	40.5	0.0	19.0	6.2	27.6	354.1	9.8	18.7	18.6	14.4	72.1	5.0	15.7	245.4	7.1	76.4	1.0	0.0	11.3	1.9	2.4	7.8	151.6	15.3	106.9	17.1
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 61.8"	"Group enriched"	"Detected in some"	13	"Distal tubular cells: 77.9;Proximal tubular cells: 187.0"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.8;SuSa: 1.0;U-2197: 3.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA008549, CAB068236, CAB068237"	Enhanced					NA	NA					"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	61.8	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.3	0.2	1.9	0.1	0.0	2.7	0.0	0.6	0.3	0.0	0.1	0.1	6.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.2	1.0	0.2	0.1	0.0	0.2	0.0	3.8	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.3	0.1	0.0	0.0	0.2	0.6	0.3	0.2	0.1	0.8	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.4	0.0	0.0	77.9	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	187.0	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.0
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348268-160452581	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 98.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	4.1	6.9	1.0	2.1	1.3	0.0	5.2	1.8	0.9	7.6	4.1	0.9	4.1	0.2	14.2	11.8	4.1	9.0	9.0	1.1	1.2	1.3	2.4	15.2	12.7	9.7	2.2	0.9	10.3	1.3	0.0	0.9	17.8	1.9	18.9	0.6	0.9	34.5	23.0	98.6	5.1	2.7	10.8	4.4	0.3	2.9	3.4	0.6	0.4	3.4	5.7	2.1	3.2	7.3	0.0	0.0	0.8	0.0	0.1	1.5	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.0	0.0	23.6	14.7	0.8	0.0	0.0	0.5	4.5	2.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	7.5	4.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.0	1.3	1.8	0.9	1.2	1.3	2.2	0.9	1.9	0.6	14.9	62.8	0.0	0.3	4.1	0.0	1.6	5.1	1.4	10.3	0.0	0.0	0.4	5.0	9.1	0.4	0.3	0.7	0.0	2.5	0.2	11.0	3.4	2.3	56.3	0.6	0.0	0.0	0.0	0.6	0.9	31.4	1.5	3.3	0.0	0.4	0.0	33.9	0.0	23.0	2.1	0.0	0.0	11.4	0.2	0.1	5.8	0.3	0.0	0.4	0.7
SLC22A4	"DFNB60, MGC34546, OCTN1"	ENSG00000197208	"Solute carrier family 22 member 4"	Q9H015	5	132294443-132344206	"Disease related genes, Predicted membrane proteins"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Ciliated cells: 89.7;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 23.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.1;U-138 MG: 14.9"	"Region enhanced"	"Detected in all"		"cerebellum: 72.4"	"Low region specificity"	"Detected in all"			"CAB015468, HPA036974"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB015468: , HPA036974: AB_2732474"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.42e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.17e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.06e-2)"	2.7	4.1	3.5	3.8	5.0	22.4	3.1	3.1	4.7	2.4	5.9	4.4	1.8	4.6	2.1	3.2	0.8	14.7	2.6	3.0	3.9	4.9	15.4	1.6	7.2	3.8	3.2	2.0	5.0	1.0	7.7	6.9	6.8	12.6	5.4	3.1	13.8	2.6	4.1	9.2	1.7	18.1	1.5	9.9	7.7	2.2	0.9	2.7	0.5	1.0	2.7	0.8	2.5	2.2	0.0	1.7	23.0	3.5	0.0	0.0	0.6	1.1	1.7	0.1	0.4	0.8	0.6	0.5	7.6	35.1	5.9	6.1	0.7	1.9	0.3	2.1	4.4	4.4	1.9	0.0	1.2	4.1	1.4	0.2	0.1	3.3	0.1	0.6	2.3	0.0	1.4	0.2	3.2	3.0	2.1	2.5	0.2	3.0	4.0	4.5	0.6	0.0	5.4	0.2	0.1	1.9	0.0	0.4	0.2	0.9	0.1	0.5	0.2	8.3	0.5	0.2	0.2	0.3	1.4	3.1	14.9	1.4	5.8	1.9	0.0	1.5	0.0	4.4	2.7	1.7	0.0	3.5	3.5	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	23.0	0.0	0.2	0.2	0.0	0.6	3.5	5.0	3.1	4.7	3.9	4.9	3.2	2.0	12.6	2.7	3.0	0.0	0.0	1.0	0.7	1.6	0.8	2.5	89.7	13.6	0.0	0.0	0.6	0.0	3.2	0.0	2.1	5.3	70.0	0.3	1.6	1.4	2.2	0.0	0.0	4.2	3.2	1.2	0.6	1.5	0.0	0.6	4.3	0.0	0.0	0.4	1.5	1.2	1.4	0.0	4.9	0.3	0.0	1.0	0.4	0.2	0.4	2.1	0.0	1.1	0.9
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 22.3;SiHa: 23.0"									HPA063062			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favorable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.6	8.7	0.5	7.0	2.8	1.3	12.1	1.6	1.8	2.8	3.9	6.4	7.5	1.7	3.8	1.6	8.1	8.7	5.8	4.3	3.3	2.2	7.1	0.9	22.3	2.9	4.7	1.4	1.5	1.3	8.1	1.9	9.9	4.8	0.7	3.2	4.0	1.1	2.6	6.2	2.1	1.4	0.6	6.3	3.8	0.8	0.0	9.4	8.4	9.1	3.0	2.1	23.0	18.0	4.4	1.9	8.3	1.8	0.4	0.5	2.5	5.9	2.0	3.8	7.4	0.1	1.8	3.6	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7	8.9	5.1	2.7	5.9	6.8	6.5	5.2	20.4	6.7	3.4	15.7	11.8	16.6	1.7	8.8	1.4	3.0	46.4	0.0	4.5	4.8	4.0	12.8	0.0	5.9	4.0	9.5	6.9	1.3	8.7	2.3	6.1	2.6	5.0	0.0	12.6	8.7	5.4	25.9	3.9	23.2	7.4	0.0	1.9	7.2	2.5	5.5	6.9	2.9	16.1	7.8
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984983	"FDA approved drug targets, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 94.2"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 213.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA					"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.2	0.2	0.8	0.2	1.3	0.2	0.2	0.4	1.4	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	1.8	94.2	0.2	0.2	0.2	2.4	0.6	0.2	0.2	0.2	0.1	0.2	4.1	0.2	0.2	9.4	0.2	0.2	0.2	0.2	0.2	0.2	2.4	0.2	0.2	0.2	0.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.4	1.4	0.8	1.8	2.4	0.6	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 88.9"	"Group enriched"	"Detected in some"	16	"Hepatocytes: 185.6;Proximal tubular cells: 86.1"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enriched"	"Detected in single"	19	"Hep G2: 14.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA					"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.8	88.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.3	2.5	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.6	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015839	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	341	"brain: 33.7;kidney: 127.3;retina: 93.5"	"Cell type enriched"	"Detected in some"	30	"Proximal tubular cells: 197.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enriched"	"Detected in some"	25	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA					"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1.0	0.1	0.1	3.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	127.3	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.2	0.1	33.7	0.1	0.1	93.5	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	0.7	0.1	0.1	1.3	33.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.0	0.0	5.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 24.8;intestine: 94.3;liver: 25.4"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 18.7;Hepatocytes: 17.5;Proximal tubular cells: 25.1"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.8;Hep G2: 11.1;JURKAT: 13.0;Karpas-707: 9.2;RPMI-8226: 9.0;U-266/70: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047612	Enhanced					NA	NA					"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.3	0.0	0.3	0.5	0.5	0.8	0.3	0.3	0.3	2.3	22.1	0.3	0.8	11.6	0.3	1.6	0.3	24.8	1.8	0.3	0.3	0.3	18.0	25.4	0.6	0.4	0.3	0.3	0.4	0.9	0.0	0.3	0.3	0.4	2.7	0.3	0.3	1.0	0.6	0.3	1.0	94.3	0.3	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.2	4.4	0.7	0.1	0.0	0.3	0.0	0.2	1.8	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.8	1.0	4.7	2.5	0.0	0.1	0.2	0.0	0.0	0.1	6.7	0.1	0.1	0.6	11.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	13.0	0.1	9.2	0.0	0.1	4.6	0.8	0.1	0.7	0.1	5.6	0.2	9.0	0.4	0.3	0.2	0.3	0.2	1.6	0.0	0.6	4.3	0.1	0.3	0.3	0.2	0.1	0.0	14.3	1.7	6.2	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.0	0.7	0.0	0.1	4.4	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	18.7	3.4	0.0	3.9	0.4	5.0	0.1	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.3	0.0	17.5	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.5	0.0	25.1	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.1
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 215.7;Cone photoreceptor cells: 108.0;Horizontal cells: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	6.6	55.6	14.7	6.1	17.5	5.4	6.3	15.9	27.2	8.6	4.6	19.3	4.0	5.0	9.5	7.1	4.6	12.4	7.8	5.4	14.4	14.5	6.0	27.7	7.4	7.2	14.9	16.6	29.4	7.5	15.1	12.5	25.1	16.4	9.0	5.0	22.1	4.2	8.4	2.6	8.5	6.3	7.8	17.5	11.7	7.1	8.5	11.4	5.3	18.6	2.2	7.4	18.7	6.4	4.2	6.0	3.1	2.5	0.8	2.8	2.0	10.7	12.7	17.0	6.4	12.0	6.8	21.7	4.6	6.3	5.4	5.1	6.5	12.3	4.9	5.0	6.4	15.5	10.4	4.7	12.6	10.3	3.0	8.5	6.8	2.2	24.4	6.8	9.5	4.0	5.7	7.3	13.7	8.2	11.5	7.9	8.1	4.6	4.2	7.2	4.0	10.3	5.3	6.0	8.6	7.8	9.6	11.2	7.3	3.0	17.6	5.7	6.4	8.8	9.3	32.7	6.3	5.1	5.6	6.8	12.3	5.7	14.7	8.8	5.9	10.9	13.2	4.3	5.7	19.3	0.0	2.5	0.2	2.8	1.8	2.6	4.2	2.2	2.0	3.6	2.9	2.1	2.1	3.1	0.8	2.1	6.0	1.3	2.0	14.7	17.5	15.9	25.3	14.4	14.5	14.9	16.6	16.4	11.4	6.0	7.4	9.5	4.0	6.5	215.7	5.5	20.4	4.0	13.6	14.0	108.0	3.6	0.0	4.0	3.5	7.7	0.5	0.0	4.7	4.8	8.9	5.5	8.1	58.7	9.5	81.0	6.9	22.1	27.3	7.0	18.7	8.3	15.1	7.2	1.5	26.4	2.9	5.1	27.6	1.3	64.3	12.9	5.6	0.5	9.6	5.4	3.3	7.1	3.1	10.1
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"retina: 91.1"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 301.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	6.2	5.3	4.5	7.7	5.0	2.6	9.3	7.0	3.4	8.9	5.0	5.6	7.5	3.7	10.6	12.2	4.2	9.0	6.2	4.1	4.7	4.1	7.9	4.7	12.0	6.0	5.3	2.6	9.7	6.6	6.5	6.1	8.9	4.0	6.0	4.1	91.1	6.4	8.3	3.8	8.5	4.5	5.0	6.8	7.8	4.2	10.8	3.2	6.9	9.0	4.6	4.8	6.0	5.3	3.8	2.6	4.7	1.5	2.3	1.8	0.4	1.5	3.1	3.3	3.0	5.0	8.4	4.1	3.9	4.2	3.8	2.5	1.4	6.6	2.1	12.9	3.7	1.3	4.2	3.9	4.2	2.3	2.1	2.9	4.6	2.3	6.8	7.2	3.0	6.3	7.1	6.2	2.1	12.8	5.4	6.6	4.9	4.8	7.2	6.2	6.4	1.9	2.8	4.3	13.5	1.2	2.0	1.0	1.4	5.8	6.0	1.6	2.3	1.0	2.9	8.0	4.8	6.2	4.2	9.4	3.9	3.9	1.5	2.6	2.9	5.2	2.5	4.1	6.5	3.3	4.7	1.5	2.1	1.4	1.3	1.8	1.4	1.5	1.2	1.1	3.8	1.1	1.5	1.7	2.3	0.6	2.6	0.3	0.4	4.5	5.0	7.0	3.4	4.7	4.1	5.3	2.6	4.0	3.2	6.0	3.2	1.4	1.2	1.3	26.9	1.9	0.0	4.0	5.7	0.0	25.5	3.3	0.0	1.1	1.1	7.0	2.8	0.0	1.1	2.0	1.5	1.1	2.3	1.5	1.7	19.1	1.7	4.3	2.2	1.8	2.8	1.5	1.7	0.0	2.2	23.4	1.7	0.0	2.1	0.5	301.7	0.0	1.4	10.4	6.4	0.9	2.1	0.8	2.1	0.8
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.8"	"Group enriched"	"Detected in some"	18	"Bipolar cells: 68.2;Cone photoreceptor cells: 257.2;Horizontal cells: 92.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"K-562: 5.7;NTERA-2: 2.0;SCLC-21H: 5.2;U-87 MG: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.2	6.1	4.0	0.2	11.2	0.3	0.1	2.4	31.8	0.2	0.2			0.2	0.5	0.2	0.2	0.2	0.3	0.2	8.9	4.0	0.3	0.2	0.1	0.2	8.2		0.2	0.2	0.2	0.0	0.3		0.2	0.2		0.2	0.2	0.2	0.3	0.2	0.2	10.7	0.2	0.2	0.4			0.2		0.1	0.2	0.0	1.2	1.0	2.6	1.3	1.7	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.2	0.1	0.3	0.0	0.1	2.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	5.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.0	6.8	0.0	0.1	2.6	0.8	0.9	0.7	0.8	1.0	0.9	0.8	0.6	0.5	1.2	1.1	1.0	2.0	1.7	1.3	1.0	0.8	0.4											0.0	0.0	0.0	0.0	0.0	68.2	1.7	0.0	0.0	0.0	0.0	257.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	92.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	7.7	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212646-19722937	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 18.2;granulocytes: 26.5;Late spermatids: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"basophil: 7.1;eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 7.1"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	7.0	2.5	10.9	4.6	11.0	1.0	3.6	7.4	9.2	17.6	8.9	5.5	7.0	2.9	26.3	19.0	15.3	17.2	14.5	1.7	27.1	12.0	1.2	0.6	6.2	1.5	4.5	3.4	14.8	1.2	7.9	1.6	3.0	5.3	8.5	4.1	5.5	6.1	13.8	26.4	5.2	4.4	21.7	2.9	1.7	2.7	1.7	3.1	0.9	2.5	11.0	4.9	8.1	20.7	0.0	0.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	6.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.2	0.0	0.0	0.4	0.0	41.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.8	0.0	0.3	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.9	11.0	7.4	6.5	27.1	12.0	4.5	3.4	5.3	3.1	3.0	0.6	0.0	1.0	1.0	9.4	0.4	0.0	0.0	2.3	1.8	0.0	5.4	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.3	1.5	0.7	26.5	0.0	0.6	1.6	7.5	0.6	0.0	14.9	3.4	0.0	0.0	0.0	2.6	2.9	0.1	0.9	3.9	0.0	1.4	0.0	3.1	0.5	0.4	3.6	2.9	0.0	0.6	2.7
SLC24A4	NCKX4	ENSG00000140090	"Solute carrier family 24 member 4"	Q8NFF2	14	92322581-92501483	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.6;brain: 28.1"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 223.9;Cone photoreceptor cells: 188.5"	"Group enriched"	"Detected in some"	5	"glioma: 0.5;melanoma: 0.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.7;SCLC-21H: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063206			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA063206: "	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.58e-2)"	1.8	1.0	4.9	3.8	6.0	8.6	0.6	1.1	11.7	0.8	0.9	9.6	6.3	0.9	0.6	0.7	0.8	0.8	1.9	0.9	4.7	3.2	0.5	0.7	2.3	2.7	10.8	4.7	1.0	0.6	0.5	1.8	1.2	28.1	0.7	1.0	4.6	0.7	1.2	2.4	0.8	1.2	1.4	14.2	5.0	0.9	2.9	5.7	0.0	0.6	0.0	1.4	1.5	0.8	0.1	2.3	1.3	11.6	0.2	0.2	2.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.6	2.7	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.4	0.2	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.1	0.6	0.0	0.4	0.0	0.3	1.1	0.0	0.3	0.1	0.1	0.3	0.0	0.3	5.2	0.0	0.2	0.2	0.5	0.1	0.3	1.2	0.6	0.2	1.5	0.3	0.1	0.4	0.1	0.1	0.2	0.3	0.3	0.2	7.9	0.0	0.0	11.6	0.2	0.0	0.0	0.0	2.3	0.1	0.0	0.0	1.3	0.2	9.4	0.4	0.0	2.0	4.9	6.0	1.1	7.3	4.7	3.2	10.8	4.7	28.1	5.7	0.0	3.4	0.0	0.1	0.0	223.9	1.2	0.0	1.4	0.0	0.0	188.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	3.5	0.0	0.0	1.8	26.6	4.6	0.3	4.0	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.0	8.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1
SLC24A5	"JSX, OCA6"	ENSG00000188467	"Solute carrier family 24 member 5"	Q71RS6	15	48120972-48142672	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		Albinism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 71.9"	"Cell type enriched"	"Detected in some"	4	"Melanocytes: 72.6"	"Cancer enriched"	"Detected in single"	162	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	751	"SK-MEL-30: 75.0"	"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7"	"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (3.47e-2)"				"unprognostic (1.80e-1)"	"unprognostic (1.35e-1)"			"unprognostic (1.92e-3)"					0.1	0.1	0.5	0.1	0.6	0.1	0.6	1.5	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.5	1.0	0.3	0.1	0.2	0.1	1.7	0.1	0.1	0.1	0.1	1.5	0.1	0.4	0.1	0.1	71.9	0.2	0.1	0.1	15.4	0.7	0.1	0.6	0.1	0.1	3.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.6	1.5	0.5	0.5	1.0	1.7	0.1	0.4	0.4	0.0	0.3	0.0	0.0	2.2	6.1	0.3	0.0	1.4	0.0	0.0	2.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	3.8	0.0	0.0	72.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0
SLC25A1	"CTP, SLC20A3"	ENSG00000100075	"Solute carrier family 25 member 1"	P53007	22	19175575-19178830	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 221.7;Hepatocytes: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		19000				"unprognostic (2.12e-1)"	"unprognostic (3.98e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.03e-2)"	42.5	23.6	11.6	16.1	12.8	5.5	59.1	9.1	12.2	14.9	33.8	14.6	17.6	50.1	12.9	16.4	20.2	12.4	25.1	9.2	14.0	17.6	26.2	60.2	12.2	18.8	15.6	9.1	20.7	25.1	14.8	12.7	15.1	18.0	19.1	15.4	13.6	19.3	16.3	4.8	14.0	53.9	13.8	16.6	12.0	16.1	14.5	13.8	9.9	20.1	13.0	13.7	14.7	15.2	14.2	5.6	38.5	9.2	4.9	8.4	4.0	24.8	25.5	20.2	16.8	50.0	24.9	20.7	19.6	22.4	15.4	21.0	30.6	17.4	15.1	9.3	25.1	16.4	20.8	19.0	31.3	8.8	15.1	37.4	7.7	21.7	60.5	35.3	14.6	24.4	34.6	19.2	17.6	13.8	17.2	14.4	12.2	41.1	14.1	17.1	63.0	9.0	17.4	13.4	39.2	15.5	16.0	10.1	6.6	45.6	30.4	12.5	15.9	18.9	36.7	10.5	12.9	27.9	37.9	14.0	18.7	16.7	14.3	12.0	18.4	8.9	7.7	19.3	7.0	9.4	3.6	6.2	38.5	7.3	7.2	4.7	13.4	8.4	7.9	5.6	14.2	7.5	6.3	3.3	4.9	9.2	4.4	7.7	4.0	11.6	12.8	9.1	12.2	14.0	17.6	15.6	9.1	18.0	13.8	8.9	13.9	19.3	22.4	19.6	8.1	6.4	30.6	8.1	9.1	31.4	2.0	120.4	43.1	27.7	24.4	9.2	221.7	0.0	39.5	122.5	22.9	31.5	2.3	166.9	41.0	12.7	39.4	22.1	23.7	72.6	26.7	19.7	27.0	29.7	90.6	20.4	33.4	101.7	27.6	99.7	3.8	12.9	19.1	17.3	24.7	26.6	106.8	17.5	86.4	25.2
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.4;SK-BR-3: 38.8"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	10.2	4.9	2.7	5.9	3.2	5.2	6.3	3.3	5.2	4.2	9.5	3.9	7.5	13.9	1.3	3.8	12.2	5.4	8.2	4.3	2.1	2.5	21.0	51.8	3.3	4.6	3.7	4.6	2.4	17.4	10.7	2.1	2.1	3.5	5.6	4.4	4.7	16.8	6.6	2.0	5.9	11.2	1.8	4.7	1.6	7.4	21.8	2.5	7.8	3.3	7.7	8.7	4.3	3.4	0.9	0.7	0.0	1.2	3.6	1.9	0.7	14.2	26.4	2.5	12.6	0.9	0.7	5.0	6.0	2.0	7.8	5.9	16.0	6.1	6.4	4.7	1.4	3.8	9.2	3.6	6.3	1.4	4.7	20.4	5.2	16.1	50.4	1.1	11.7	6.4	0.5	3.3	5.5	1.1	1.5	4.5	9.1	8.7	8.1	2.6	26.8	17.1	12.4	2.6	6.0	19.9	13.0	5.4	20.2	6.9	12.9	16.7	11.3	5.7	38.8	1.3	0.7	16.6	6.5	1.9	6.0	19.8	8.7	11.0	5.0	2.5	3.7	2.6	12.4	5.2	0.0	0.9	0.0	0.8	1.2	1.5	0.1	0.5	1.9	0.7	0.9	0.5	0.4	0.0	3.6	0.2	0.4	1.0	0.7	2.7	3.2	3.3	5.2	2.1	2.5	3.7	4.6	3.5	2.5	0.0	2.1	0.0	5.5	0.0	2.9	3.3	17.8	13.4	5.7	14.0	0.0	11.3	21.6	15.4	23.8	0.5	9.3	0.0	20.3	4.7	0.9	3.9	0.0	37.7	6.8	0.0	4.7	3.1	0.3	65.6	2.0	0.3	0.0	1.0	15.4	1.5	9.6	24.6	1.8	75.1	3.8	0.0	0.2	8.4	2.3	0.0	3.5	1.5	28.8	4.3
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940251	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		17000			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	11.8	17.5	17.8	11.9	20.8	10.3	11.7	18.2	34.3	11.1	15.7	16.3	10.3	17.3	12.4	10.1	18.9	16.1	14.3	82.1	19.8	17.7	24.2	22.6	10.6	13.3	19.5	16.3	12.1	15.3	16.0	12.3	13.3	18.7	12.0	13.7	22.2	16.8	15.6	100.8	16.9	14.6	13.0	13.8	12.8	12.3	5.2	9.6	17.4	14.6	42.4	14.0	15.1	10.5	26.9	50.1	39.3	53.9	42.7	32.4	51.4	16.5	44.9	22.9	22.4	22.6	14.0	16.2	18.8	19.3	33.0	27.4	28.1	8.3	25.8	25.6	18.3	16.1	33.2	29.7	34.0	13.1	32.5	37.7	28.3	24.9	24.3	23.1	12.1	34.5	20.1	22.2	29.1	24.7	16.0	22.8	27.9	12.4	25.1	27.8	29.9	39.0	12.0	12.0	18.4	30.1	35.5	14.1	23.3	25.4	17.4	20.5	21.3	23.7	26.8	21.5	12.0	24.8	19.3	15.3	14.8	9.7	20.0	35.9	13.4	8.1	9.7	29.2	20.6	36.4	32.7	53.9	39.3	32.4	53.0	30.0	26.9	25.1	28.9	50.1	23.0	25.3	27.5	35.1	42.7	47.8	33.3	29.1	51.4	17.8	20.8	18.2	34.3	19.8	17.7	19.5	16.3	18.7	9.6	23.8	21.8	25.3	43.8	33.9	56.9	133.9	56.0	21.4	10.3	62.8	15.7	118.0	157.5	53.9	10.7	38.3	80.6	23.3	47.0	120.4	39.9	34.3	39.2	56.3	97.1	44.5	26.5	28.3	40.3	16.2	28.1	40.6	49.0	141.5	43.6	45.0	38.7	50.7	36.0	151.2	45.3	51.8	41.5	14.1	30.9	38.8	85.7	41.5	73.0	33.1
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171784370-171999859	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	6.4	6.7	8.8	6.2	18.2	2.9	9.2	17.9	25.0	10.6	12.2	5.7	5.2	4.2	10.4	7.1	11.5	6.9	5.9	42.4	9.9	13.4	10.7	1.9	5.2	6.5	10.4	12.4	10.0	3.5	16.4	14.7	4.7	15.2	10.6	10.0	11.0	21.7	14.8	84.7	7.6	5.7	14.3	7.1	5.6	9.0	4.3	6.2	5.8	10.1	23.8	8.4	10.0	6.7	6.4	3.6	5.1	4.6	6.6	8.1	2.9	7.2	5.3	5.6	13.0	16.7	18.9	0.1	9.2	15.7	12.6	12.1	2.8	6.8	22.9	6.1	10.8	9.8	9.1	11.8	11.6	15.8	14.0	11.1	10.0	7.7	6.7	6.4	20.0	10.0	16.5	11.5	14.6	4.2	6.8	13.0	9.1	6.9	10.5	8.0	4.4	14.1	8.4	4.5	6.1	7.5	14.7	8.1	11.9	13.2	6.3	7.9	2.5	5.8	13.7	7.3	3.8	5.0	5.9	8.9	10.5	4.6	11.6	6.3	14.2	9.1	23.2	14.5	10.6	7.1	5.1	3.0	1.6	6.5	3.9	7.3	6.4	4.5	6.8	3.6	3.9	6.3	8.1	0.2	6.6	4.6	0.6	4.5	2.9	8.8	18.2	17.9	25.0	9.9	13.4	10.4	12.4	15.2	6.2	0.0	6.0	1.5	11.2	6.2	25.4	94.4	0.0	13.4	22.7	17.4	23.6	6.0	16.6	1.5	2.5	7.0	5.6	23.3	2.9	1.2	7.0	4.3	10.4	0.2	4.0	35.0	13.8	8.6	7.3	1.7	11.5	5.4	15.1	6.4	7.0	18.3	1.3	3.5	23.0	10.9	22.1	12.9	11.8	3.2	9.0	6.8	1.0	8.7	7.4	4.6
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.1	14.3	16.5	5.7	2.8	2.3	23.2	4.1	3.1	10.0	10.1	25.6	15.2	7.3	19.6	2.6	21.8	9.7	18.5	5.9	11.8	2.8	12.2	8.3	13.5	19.9	6.7	10.5	6.5	6.1	6.3	8.5	7.7	3.8	11.4	1.1	23.3	2.8	4.8	17.8	0.0	9.8	29.1	17.3	8.9	4.1	9.8	16.8	23.8	15.3	7.9	26.0	14.2	30.2	24.3	28.7	9.0	8.1	6.6	7.4	16.6	17.5	12.4	5.7	14.3	4.6	9.1	10.1	12.2	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6	8.9	9.3	10.5	6.9	6.5	34.3	7.1	38.2	14.7	6.8	17.4	51.1	25.9	23.2	17.3	9.5	16.9	23.5	0.0	16.5	20.5	14.8	9.8	13.9	124.1	20.1	9.5	36.2	12.3	22.7	6.7	12.0	19.6	20.3	2.8	19.4	22.1	18.9	24.6	14.9	50.8	47.6	12.9	8.3	5.4	9.1	6.9	16.7	5.7	23.3	12.2
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA060316: AB_2684251"	"unprognostic (1.65e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favorable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (1.39e-5)"	3.1	9.3	9.2	3.4	18.3	3.7	5.5	13.6	20.6	4.8	3.8	6.1	4.2	2.2	6.7	11.0	4.3	9.7	4.6	7.7	8.7	15.8	5.2	4.1	4.6	4.1	7.3	11.4	6.8	4.5	5.6	15.0	3.6	11.2	5.1	4.1	5.7	5.1	6.7	3.4	4.7	3.6	7.7	5.3	3.5	4.8	10.2	4.2	4.2	5.7	4.6	5.3	3.1	3.8	7.5	9.3	8.7	7.2	8.1	9.5	4.9	6.9	9.1	6.5	4.8	4.4	4.2	3.5	5.2	7.0	10.2	10.2	3.6	4.2	4.7	18.2	7.0	12.5	3.9	9.4	3.9	10.1	6.0	11.9	1.5	8.4	8.5	6.2	5.9	2.8	3.9	4.7	12.8	3.9	6.0	5.6	6.6	4.1	6.7	16.1	10.6	6.2	8.3	5.5	7.5	15.0	5.3	8.5	9.4	5.9	3.0	8.2	7.3	5.5	5.6	8.8	4.5	3.6	3.3	3.7	5.5	3.6	12.5	10.5	6.3	16.1	4.1	10.0	7.3	4.9	5.8	7.2	5.2	6.4	5.8	7.8	7.5	5.4	6.1	7.5	4.6	4.2	7.0	8.7	8.1	5.2	9.3	9.5	4.9	9.2	18.3	13.6	15.6	8.7	15.8	7.3	11.4	11.2	4.2	6.0	2.1	8.3	6.8	8.9	8.8	3.2	7.6	26.8	1.2	3.5	2.0	8.0	14.9	9.4	9.0	4.4	3.8	0.0	7.9	7.3	6.0	4.1	3.5	3.8	4.6	6.4	8.6	4.9	3.3	5.1	4.6	5.1	8.5	2.8	4.0	8.5	7.5	4.5	7.8	8.3	12.7	6.5	6.2	21.6	39.2	7.3	4.5	7.0	5.2	4.7
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40810111	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 26.0;liver: 66.4;pancreas: 24.9"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 37.5;Hepatocytes: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042146	Approved					NA	NA					"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.46e-4)"	1.0	1.1	1.4	4.7	1.7	1.6	2.6	1.0	2.0	1.3	13.2	1.0	0.2	16.3	1.6	1.5	1.8	1.2	3.1	1.9	1.3	1.6	4.0	66.4	1.6	2.0	1.6	0.9	1.8	24.9	0.8	1.0	1.8	1.5	1.0	2.6	0.9	1.4	1.6	2.5	1.3	26.0	1.5	1.4	1.5	2.0	3.8	1.0	2.7	8.0	2.9	3.8	1.2	1.1	1.7	3.4	0.0	3.1	2.4	5.0	1.6	5.0	9.9	9.9	13.5	3.6	4.8	12.5	3.8	1.9	4.2	2.7	10.5	9.7	32.1	4.3	6.2	8.3	8.3	15.4	10.3	3.7	7.6	7.7	24.2	4.9	13.6	6.9	8.6	3.1	5.2	4.5	5.3	13.0	2.6	6.5	14.7	12.4	5.1	6.5	16.4	6.4	3.8	21.2	18.8	5.1	15.9	8.1	6.9	5.1	4.6	5.5	13.6	6.9	10.9	5.9	6.9	9.1	12.8	6.2	5.3	8.5	8.1	10.7	5.8	5.5	18.8	5.6	7.0	10.6	0.0	1.3	0.0	4.3	3.1	2.7	1.6	2.9	2.8	3.4	1.7	3.0	5.0	0.0	2.4	1.0	0.7	1.8	1.6	1.4	1.7	1.0	2.0	1.3	1.6	1.6	0.9	1.5	1.0	3.0	0.3	0.0	1.0	0.2	1.1	1.2	2.5	0.0	0.0	0.0	0.0	2.0	6.6	1.7	3.6	0.4	1.3	0.0	3.8	37.5	0.5	1.5	0.0	30.8	1.6	0.0	1.2	0.6	1.9	5.4	0.6	0.6	1.7	0.0	0.2	0.3	2.2	0.6	0.0	3.1	1.8	0.0	0.8	4.1	7.7	0.1	1.3	0.0	3.0	0.8
SLC25A16	"D10S105E, GDA, HGT.1, ML7"	ENSG00000122912	"Solute carrier family 25 member 16"	P16260	10	68477999-68527474	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036243, HPA044580"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036243: AB_2675019, HPA044580: AB_10962723"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-3)"	18.7	8.0	6.4	5.5	8.9	7.0	15.5	9.6	13.5	5.1	6.9	8.1	4.8	8.1	7.7	7.8	5.9	5.4	8.8	5.9	8.4	7.3	12.0	22.6	10.2	9.2	7.8	8.6	6.3	21.1	6.9	7.3	7.1	9.2	17.3	6.4	8.5	15.0	6.6	9.4	6.5	11.0	8.4	6.3	6.4	9.4	3.5	6.6	6.4	7.8	4.8	7.7	6.4	5.4	3.2	2.9	5.0	2.7	2.4	2.5	1.2	3.0	1.2	3.5	4.8	4.7	5.7	3.8	4.1	4.5	2.7	2.9	7.1	2.0	3.2	3.0	8.1	1.4	1.8	11.0	2.1	6.8	2.4	6.8	1.7	3.2	3.1	5.8	5.4	3.8	4.9	5.4	5.0	7.1	4.0	2.2	2.9	1.9	5.4	5.6	2.8	3.1	3.9	0.8	0.8	15.9	1.7	2.5	1.0	7.3	9.8	2.5	2.0	5.9	5.8	4.6	2.5	3.2	2.2	9.5	4.1	5.3	6.6	4.7	5.5	2.9	5.2	3.9	4.5	1.8	4.0	2.7	2.7	1.7	1.9	1.6	1.7	1.6	1.4	1.8	3.2	1.6	2.5	5.0	2.4	1.5	2.9	1.7	1.2	6.4	8.9	9.6	13.5	8.4	7.3	7.8	8.6	9.2	6.6	41.7	20.2	6.9	5.6	5.7	16.9	8.0	15.3	13.4	7.9	12.2	37.3	14.4	10.0	6.6	7.7	5.8	13.8	0.0	16.7	23.1	7.2	16.0	8.1	35.0	9.4	19.1	14.5	14.7	7.2	9.2	2.8	5.8	1.7	3.6	7.8	8.5	12.2	7.0	7.4	19.2	31.5	0.0	8.9	4.1	2.5	5.9	50.0	4.3	7.4	8.6
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA052708: AB_2681924, HPA060972: AB_2684400"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	9.7	15.0	10.2	10.2	10.9	3.3	16.8	12.9	14.1	11.8	7.2	12.2	7.5	6.4	22.4	22.6	8.7	13.7	7.4	5.5	10.4	13.4	18.6	19.7	9.0	11.8	10.3	7.7	26.5	12.4	14.3	13.0	14.9	11.9	12.6	8.7	9.5	11.4	10.3	4.6	10.9	7.1	12.1	11.4	8.8	8.9	12.1	9.5	12.6	14.7	10.4	11.2	7.1	8.7	10.2	6.8	5.9	4.9	10.3	11.7	6.4	13.4	7.4	12.6	11.0	8.0	9.7	10.3	12.2	13.4	19.5	21.5	10.8	5.1	15.9	7.5	12.0	11.1	10.8	18.3	10.1	20.0	16.3	24.5	17.8	11.5	11.1	11.3	20.5	9.5	9.6	13.5	17.2	11.1	9.0	11.8	13.3	25.7	7.6	15.8	11.5	12.3	13.2	10.6	19.1	12.3	13.5	19.6	23.2	16.1	11.4	8.7	7.9	25.2	15.5	15.0	12.8	12.9	6.1	6.9	11.0	15.1	9.7	11.0	8.4	16.3	15.1	12.0	10.4	11.9	5.9	4.4	5.1	7.0	4.9	9.2	10.2	8.1	7.5	5.7	9.5	11.7	9.3	1.8	10.3	3.9	6.8	10.8	6.4	10.2	10.9	12.9	14.1	10.4	13.4	10.3	7.7	11.9	9.5	17.9	7.4	10.7	13.0	14.7	11.7	3.1	7.6	12.0	17.0	12.2	7.9	34.1	18.3	16.2	6.5	9.3	6.3	0.0	15.3	27.0	16.0	15.6	4.7	21.2	11.5	11.1	5.8	5.5	7.3	8.5	25.0	7.6	15.1	25.2	3.3	10.6	14.6	5.8	25.1	15.9	7.0	32.3	10.8	37.1	36.6	15.1	23.9	10.0	7.7	13.3
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;BEWO: 12.9"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.5	0.9	3.4	0.6	5.7	0.0	12.9	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.0	3.7	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.5	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.6	0.4	0.0	0.6	0.1	0.8	2.9	1.3	2.1	4.2	1.2	0.0	0.1	0.6	1.2	0.5	0.4	0.6	1.0	2.6	3.7	1.4	0.2	0.2	0.5	0.3	0.4	1.4	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6	26.8	15.9	0.0	0.2	0.0	0.5	1.4	0.0	28.1	12.5	0.0	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.5	4.6	5.8	67.6	0.2	0.0	0.0	2.5	4.6	0.6	0.9	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.6	3.2	0.0	0.0	2.7	4.8	0.1	1.5	0.0	0.0	0.1
SLC25A19	"DNC, MCPHA, MUP1, TPC"	ENSG00000125454	"Solute carrier family 25 member 19"	Q9HC21	17	75272981-75289510	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 59.5;monocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.28e-1)"	"unprognostic (7.05e-3)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.13e-1)"	8.1	18.5	9.9	14.0	15.7	6.7	5.7	9.0	10.9	6.5	7.9	4.3	2.6	8.5	5.8	3.1	6.8	6.0	5.8	7.9	7.1	6.0	9.1	9.2	10.7	19.3	9.6	5.7	5.4	10.6	4.5	4.1	10.8	9.2	5.1	8.5	3.2	5.4	3.8	10.6	4.5	6.8	6.6	12.3	12.2	8.0	35.5	8.7	9.3	7.7	3.9	16.8	7.8	5.8	19.4	18.2	1.2	14.7	5.3	10.4	8.3	9.4	11.7	2.1	6.3	4.8	2.5	6.9	6.2	2.4	7.1	7.3	20.2	6.0	30.3	4.5	2.2	6.2	8.4	15.0	7.1	8.9	8.8	24.1	13.8	14.0	19.3	4.1	19.6	15.7	2.1	4.0	11.1	9.0	1.6	11.7	15.4	16.8	14.5	2.2	19.7	20.2	19.7	4.6	18.6	23.1	15.8	6.9	28.7	4.9	6.6	21.3	5.3	6.6	17.7	7.6	3.7	11.1	15.9	4.1	4.3	8.5	8.2	16.5	36.0	17.3	31.8	3.3	22.6	5.3	0.2	12.7	1.2	10.4	14.7	10.4	19.4	8.1	9.6	14.8	16.3	9.3	9.6	1.1	5.3	8.4	18.2	9.8	8.3	9.9	15.7	9.0	10.9	7.1	6.0	9.6	5.7	9.2	8.7	6.0	7.9	29.8	9.4	13.5	1.3	0.6	2.5	2.7	7.9	7.0	2.0	5.7	19.9	5.9	12.0	7.1	5.1	0.0	4.6	59.5	8.6	6.2	11.5	2.8	41.1	3.2	2.9	3.1	11.0	18.8	2.8	30.8	23.6	62.3	4.8	1.5	4.6	5.5	3.2	4.7	5.8	6.5	7.2	33.0	10.5	11.3	7.4	13.1	9.7	6.4
SLC25A2	ORNT2	ENSG00000120329	"Solute carrier family 25 member 2"	Q9BXI2	5	141302629-141304045	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 12.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 8.6;Late spermatids: 8.3;Spermatocytes: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA042146	Uncertain					NA	NA					"HPA042146: AB_2677874"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.81e-1)"		"unprognostic (2.62e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.82e-10)"	"unprognostic (2.56e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.14e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	12.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.4	0.0	0.5	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.0	0.0
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 35.4;RPMI-8226: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA		13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.5	3.6	5.0	11.5	4.4	0.7	8.0	4.3	5.6	5.8	5.6	6.9	6.6	5.7	12.6	6.8	1.4	8.8	3.5	4.2	16.8	4.2	9.2	7.0	7.1	5.2	9.6	17.8	5.6	4.0	7.5	1.2	2.2	7.2	10.1	8.2	35.4	7.3	3.7	10.5	4.8	1.8	8.1	10.2	3.8	2.1	48.7	6.0	3.5	1.4	5.1	7.4	0.0	4.0	5.2	11.3	4.5	5.8	6.4	1.1	9.3	5.8	13.1	9.1	7.7	9.1	6.8	8.4	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6	6.0	2.4	7.5	2.3	1.5	1.1	31.1	7.6	5.3	2.3	0.0	5.9	1.7	3.3	3.2	1.1	3.1	38.0	0.0	3.7	1.9	4.1	2.4	1.1	55.2	15.8	0.0	7.0	9.2	13.2	1.0	9.8	7.5	1.7	40.5	10.8	2.8	4.0	13.5	11.7	12.5	1.1	0.0	2.2	7.1	7.0	1.1	1.0	13.8	12.8	2.0
SLC25A21	"ODC, ODC1"	ENSG00000183032	"Solute carrier family 25 member 21"	Q9BQT8	14	36678431-37172866	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.6"	"Cell type enriched"	"Detected in many"	11	"Erythroid cells: 93.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 15.5;Karpas-707: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000662	Uncertain					NA	NA					"HPA000662: AB_1080000"	"unprognostic (6.81e-3)"	"unprognostic (6.98e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.07e-1)"	1.3	2.1	1.1	1.0	2.0	8.8	1.4	0.4	2.5	3.0	1.9	0.7	0.1	1.1	4.0	1.4	2.9	1.8	1.2	2.2	1.1	1.4	2.8	1.1	1.9	0.1	1.4	0.7	4.6	5.2	0.9	1.8	0.4	1.7	3.1	0.4	3.6	2.9	0.9	9.6	0.9	2.4	3.0	1.2	0.9	2.6	25.6	1.0	0.2	3.3	2.2	1.3	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.8	0.7	0.2	2.0	0.0	0.6	0.0	0.3	0.5	1.0	0.4	0.1	0.7	0.0	0.9	0.2	0.0	0.7	0.0	0.4	0.4	0.5	5.9	0.6	0.6	0.6	0.6	0.0	0.0	0.5	0.8	0.0	0.3	0.6	2.4	0.0	15.5	34.0	0.5	1.8	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.5	2.4	1.5	0.0	1.6	0.1	0.8	0.3	2.2	0.0	1.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	2.0	0.4	2.5	1.1	1.4	1.4	0.7	1.7	1.0	0.0	0.0	0.0	1.7	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	1.0	0.4	0.0	93.5	8.3	0.0	0.8	2.3	0.0	0.0	0.2	1.6	1.7	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.2	3.4	5.4	0.0	0.7	3.1	1.5	0.0	1.0	3.0	2.1	0.6	0.0	0.0	0.8	0.6
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798333	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.0;pancreas: 43.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	4.9	5.2	23.3	8.3	19.0	5.7	2.7	32.2	45.0	3.5	4.1	3.4	2.5	10.3	3.2	2.3	4.4	5.0	3.8	3.2	27.8	13.2	4.1	14.2	4.6	7.5	9.6	22.8	4.8	43.0	4.0	13.4	4.4	13.5	5.2	2.9	4.6	11.4	4.2	1.1	5.8	8.5	3.3	2.8	5.3	6.8	6.6	2.6	3.5	3.1	3.0	5.1	4.5	2.4	2.5	3.1	4.0	5.7	3.6	7.2	2.3	23.4	15.2	8.9	8.0	3.8	6.8	8.4	11.2	9.4	12.5	7.9	15.0	16.1	7.0	8.4	9.3	14.2	20.8	9.8	13.5	2.8	13.2	18.1	6.4	7.5	9.2	16.2	10.4	10.9	6.8	8.2	9.5	10.2	3.9	5.7	8.3	13.1	11.1	5.5	14.2	10.8	9.8	19.3	14.5	23.4	12.8	4.9	16.6	7.4	3.9	44.3	19.9	6.4	15.5	8.0	1.4	7.5	5.3	5.6	14.0	9.4	6.4	10.5	9.7	5.7	9.0	16.8	9.3	8.3	0.0	2.4	4.0	6.6	5.6	4.2	2.5	4.1	7.2	3.1	2.1	2.5	4.2	1.5	3.6	5.7	0.9	2.2	2.3	23.3	19.0	32.2	37.4	27.8	13.2	9.6	22.8	13.5	2.6	6.0	10.4	2.2	6.3	11.2	147.0	1.8	5.1	2.7	4.5	8.7	31.4	5.9	3.3	22.2	11.5	4.9	7.0	0.0	17.0	8.9	7.4	13.6	2.3	15.3	4.0	41.3	12.5	1.8	1.8	5.6	4.4	2.6	3.3	6.4	7.3	13.4	14.1	7.0	4.6	5.6	29.9	0.0	6.1	1.4	6.3	11.7	2.6	5.2	5.0	8.1
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	11.8	12.9	20.2	8.5	14.8	13.3	16.5	7.9	27.2	10.3	12.6	15.8	9.2	9.7	11.1	12.9	14.3	13.1	10.1	19.5	16.9	12.8	15.7	22.7	10.0	15.2	17.6	11.8	20.0	21.2	16.2	11.6	11.9	14.6	10.8	13.4	12.6	16.1	12.6	29.8	16.5	11.0	16.8	14.3	11.4	12.7	18.3	12.6	12.0	19.0	14.2	12.9	13.4	10.8	12.0	12.2	3.6	7.1	10.5	14.4	9.1	6.3	6.2	3.8	7.7	8.5	8.8	8.0	5.3	10.2	7.2	6.8	8.1	8.5	6.5	3.2	9.7	8.8	4.7	4.4	9.9	7.4	6.8	10.3	9.9	4.9	11.7	10.2	13.8	8.4	12.0	19.7	5.7	13.8	6.9	5.3	13.2	4.4	8.7	8.6	7.9	5.8	15.9	11.1	14.4	3.6	6.0	6.9	11.0	5.9	4.7	2.9	8.9	7.7	6.7	12.6	7.0	5.6	10.9	6.0	7.6	7.2	9.5	9.3	12.9	16.8	8.4	10.5	13.2	8.2	1.3	6.8	3.6	10.9	7.1	9.9	12.0	12.1	11.1	12.2	10.2	14.4	12.3	0.4	10.5	4.1	11.6	11.1	9.1	20.2	14.8	7.9	27.2	16.9	12.8	17.6	11.8	14.6	12.6	29.8	20.3	23.3	31.4	31.8	17.7	96.8	20.4	13.4	12.5	17.4	11.8	29.9	29.9	25.2	20.6	19.7	19.1	0.0	38.7	36.6	33.9	31.6	18.5	34.2	26.5	11.1	17.9	9.2	19.0	19.2	15.0	17.8	35.4	20.8	25.5	22.4	26.4	14.0	20.5	46.3	21.5	19.4	29.5	21.4	30.2	32.1	27.3	46.5	33.0	33.6
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA			Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.4	2.4	8.0	9.1	6.3	0.1	1.1	3.7	1.1	0.2	0.0	2.9	0.8	5.5	2.0	2.6	4.1	1.1	3.5	0.7	0.0	11.8	0.0	26.3	2.9	4.8	0.1	0.3	9.8	14.8	0.0	9.4	5.8	0.2	8.0	0.1	0.0	0.9	0.8	0.0	0.1	1.2	2.0	3.1	0.0	3.1	0.1	6.0	7.5	7.3	0.8	5.5	0.3	2.9	3.6	5.9	0.0	0.8	5.0	3.3	0.5	1.0	3.2	0.0	16.2	0.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9	3.0	2.9	0.0	3.6	0.8	20.5	7.0	0.0	6.7	2.3	5.2	27.5	0.0	0.0	0.6	23.2	3.1	0.3	0.0	0.6	0.0	2.5	5.8	1.1	1.7	0.2	19.1	5.8	2.5	0.3	16.0	2.8	0.1	1.7	0.0	1.3	8.3	0.3	0.0	4.9	0.5	38.2	0.0	2.3	0.5	0.7	2.0	0.0	0.0	1.5	2.1
SLC25A28	"MRS3/4, MRS4L"	ENSG00000155287	"Solute carrier family 25 member 28"	Q96A46	10	99610522-99620609	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 121.1;Late spermatids: 296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.87e-3)"	"prognostic favorable (2.18e-6)"	"unprognostic (8.59e-3)"	"unprognostic (6.86e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.80e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.62e-3)"	26.2	29.8	30.6	22.1	37.5	52.2	23.7	34.8	31.7	21.7	28.5	29.1	33.9	16.5	21.1	34.7	28.0	22.3	25.8	27.2	26.7	25.2	19.2	31.8	25.3	26.5	31.9	24.6	29.0	28.9	25.6	21.4	19.9	28.8	29.1	24.9	21.8	29.3	35.0	35.1	32.9	19.7	37.3	21.5	30.1	21.2	34.1	34.6	13.5	24.1	18.1	25.8	29.6	36.5	3.0	9.5	6.2	2.5	2.3	4.6	1.0	13.8	13.8	8.7	21.1	16.4	20.4	9.0	16.3	19.8	22.5	18.6	10.8	17.2	17.7	10.1	14.7	10.3	23.4	10.7	15.3	13.8	13.1	13.8	7.7	20.0	11.2	16.4	13.8	10.9	17.2	22.7	14.5	28.8	29.3	15.9	15.8	5.6	13.7	11.4	18.6	11.9	31.2	2.0	11.1	10.8	15.0	10.5	9.9	14.6	14.9	5.9	7.4	9.3	10.2	12.1	11.9	18.4	13.9	9.5	13.9	9.5	18.5	19.8	11.3	7.2	8.7	13.3	26.8	5.7	0.0	2.5	6.2	4.6	2.2	2.1	3.0	3.3	2.8	3.5	3.0	2.5	2.3	2.2	2.3	2.1	9.5	3.6	1.0	30.6	37.5	34.8	31.7	26.7	25.2	31.9	24.6	28.8	34.6	11.9	8.3	4.3	14.5	22.6	30.1	17.3	17.8	0.0	5.7	5.2	19.6	15.5	6.6	3.7	121.1	16.5	6.7	0.0	6.9	7.9	13.6	20.8	5.8	17.9	8.6	41.3	4.1	7.4	8.7	296.1	11.8	12.0	18.6	9.0	10.5	23.8	5.0	9.9	17.0	7.3	29.6	12.9	15.3	22.1	7.2	24.0	12.1	7.4	9.0	17.8
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 233.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		5500000	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	35.7	71.2	23.6	38.3	27.2	24.6	48.9	25.1	50.2	29.8	69.6	22.4	33.8	53.9	38.5	35.9	54.6	30.1	55.1	233.5	22.9	25.3	60.2	72.6	47.0	75.5	27.8	26.0	39.6	59.7	55.5	29.1	34.2	31.6	33.8	53.3	30.9	53.5	33.5	190.6	33.8	76.0	46.7	19.6	35.6	51.4	16.9	15.1	42.0	41.5	125.8	44.4	38.5	31.9	46.8	82.3	33.4	78.5	43.3	56.6	76.3	74.7	58.4	77.5	64.2	70.6	117.4	99.9	65.6	87.5	85.1	71.2	104.8	39.3	102.2	39.0	79.5	38.5	64.4	78.6	88.7	89.8	38.4	62.7	60.9	43.1	69.5	86.9	71.3	48.4	111.0	79.4	61.8	88.9	128.1	120.1	53.0	65.6	30.3	101.4	55.8	66.1	79.6	71.7	64.7	96.0	75.6	80.8	113.4	110.0	75.1	39.8	53.4	78.5	70.7	108.3	68.5	95.5	78.0	80.7	47.4	44.8	52.0	65.6	51.4	60.4	71.5	37.4	42.1	61.0	24.4	59.5	33.4	40.1	77.2	47.4	46.8	45.7	44.3	82.3	33.3	47.9	45.3	26.4	43.3	78.5	50.3	56.6	76.3	23.6	27.2	25.1	50.2	22.9	25.3	27.8	26.0	31.6	15.1	199.5	265.4	295.0	454.5	334.1	211.9	1401.5	384.7	145.9	192.2	204.1	74.6	677.0	741.1	434.4	31.9	273.0	744.3	163.5	762.2	755.9	400.5	371.4	205.5	373.5	527.3	276.5	300.1	249.2	430.8	19.5	236.2	288.2	415.0	543.8	392.0	226.4	536.4	501.2	241.1	802.3	176.2	297.5	387.5	94.1	178.4	316.8	681.4	269.7	620.6	559.0
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 3550.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"HEL: 47.7;hTERT-RPE1: 27.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.8	4.2	4.5	4.1	5.9	7.3	6.6	3.0	3.9	2.2	2.5	4.1	8.2	6.2	3.7	2.5	14.5	4.9	4.1	8.2	3.0	1.0	2.2	47.7	7.0	1.4	4.9	2.7	1.9	6.2	8.0	4.8	4.8	27.9	3.4	5.0	10.5	3.1	3.5	1.6	3.2	11.3	2.3	4.7	3.3	3.3	2.2	2.4	6.8	2.1	1.4	1.9	4.1	6.4	3.0	4.4	1.8	4.1	5.5	10.9	1.6	6.4	5.8	2.5	0.9	3.9	10.2	6.5	6.8	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6	35.7	79.2	39.5	104.8	82.9	35.3	31.5	48.4	21.4	84.2	73.3	64.8	32.1	13.3	81.9	645.6	82.4	66.7	3550.9	197.4	63.8	90.2	258.9	35.8	34.3	36.1	6.4	19.5	100.7	50.6	772.4	48.6	101.8	65.8	8.2	33.2	41.6	177.5	34.5	35.0	24.5	60.7	19.4	95.7	12.5	47.1	47.0	15.3	22.7	43.1	139.3
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"		"Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 4236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.3	2.7	5.5	3.0	0.3	5.0	2.7	0.9	3.3	3.3	7.1	1.8	2.4	2.0	3.3	2.6	2.6	10.4	2.9	2.2	4.0	8.9	1.6	4.9	8.3	6.1	1.4	1.6	2.2	7.1	5.1	1.4	7.8	2.4	4.2	3.8	1.9	2.0	5.1	1.6	3.2	4.4	2.3	7.1	2.6	1.4	3.3	7.5	5.1	8.8	6.7	3.2	1.4	12.6	5.1	2.6	1.2	1.8	0.2	1.5	1.7	3.5	7.9	3.6	3.1	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3	80.4	55.4	33.5	125.8	39.2	174.4	4236.1	140.1	112.4	42.1	68.0	98.2	59.7	837.3	68.4	15.8	25.9	41.2	0.0	65.1	47.9	24.6	55.0	11.5	83.9	50.1	151.0	51.6	24.5	7.6	7.7	43.1	7.9	180.5	15.4	35.7	473.2	51.1	24.6	106.1	140.9	178.4	103.5	194.8	24.0	35.3	15.8	33.9	10.7	48.8	46.9
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468400-119471319	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 2147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		7800000	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.25e-2)"	"prognostic favorable (7.35e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	26.0	28.9	26.8	32.2	29.5	36.5	36.6	21.8	39.0	23.0	74.1	16.3	26.0	120.7	22.5	18.3	64.1	17.5	39.5	31.4	22.5	18.8	80.7	71.0	38.3	53.8	27.2	23.8	18.1	128.2	22.5	14.6	30.7	24.2	18.9	84.9	20.1	58.3	21.5	16.6	42.1	157.5	33.6	20.5	34.3	68.2	16.8	17.1	87.0	31.1	59.9	47.0	30.8	33.8	51.6	97.8	18.5	113.2	33.4	48.0	84.9	82.0	78.9	30.9	53.1	19.8	29.2	57.4	30.7	33.5	64.8	58.0	65.5	52.1	104.2	41.3	29.4	46.8	57.8	75.8	64.1	59.2	27.5	73.1	35.1	47.7	46.6	25.1	95.3	58.0	31.7	72.1	66.7	42.6	24.7	67.2	53.7	28.1	43.2	35.3	182.7	84.3	96.8	65.0	112.7	127.2	46.3	39.1	80.8	49.3	66.0	37.4	35.4	52.7	80.3	62.1	32.9	33.1	48.3	27.9	30.7	44.4	68.3	110.0	50.7	62.9	83.4	33.9	97.5	49.5	10.1	68.1	18.5	20.7	113.2	23.9	51.6	30.1	26.9	97.8	39.7	30.1	28.3	11.3	33.4	84.9	53.9	48.0	84.9	26.8	29.5	21.8	39.0	22.5	18.8	27.2	23.8	24.2	17.1	151.8	244.7	335.6	401.9	724.7	105.3	125.5	328.6	187.4	221.8	177.9	56.9	945.1	2147.0	467.3	2.7	209.6	1628.0	163.5	919.2	321.7	246.2	228.4	191.3	343.1	785.8	25.4	385.2	119.1	477.4	13.9	134.6	447.5	519.6	300.2	755.1	85.2	524.3	956.2	104.0	1138.1	131.4	129.4	460.4	8.9	116.7	839.4	1329.0	292.0	958.7	657.9
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392724	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		7200000	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	18.5	19.7	12.1	12.2	14.0	23.7	14.4	8.2	12.2	9.8	16.5			28.9	14.3	4.8	16.4	10.4	7.0	9.4	10.3	8.2	18.4	5.4	11.1	14.4	9.4		25.6	38.7	10.1	14.0	8.6		12.4	8.8		45.0	12.5	6.1	14.9	23.3	7.7	5.8	15.4	19.2	2.4			16.3		9.5	14.2	11.2	62.2	85.7	3.7	69.0	30.1	43.6	71.2	22.2	48.7	34.6	35.3	24.0	46.8	37.5	34.1	32.7	25.2	25.1	64.4	27.2	82.8	27.6	22.4	38.0	14.5	23.2	40.7	7.9	20.7	73.8	45.2	33.4	73.5	56.3	32.5	55.2	77.2	75.0	19.7	29.0	32.7	37.3	26.1	31.5	19.5	24.6	47.4	60.1	62.3	43.9	8.8	65.7	30.4	28.6	64.2	30.7	56.0	56.6	88.9	23.1	70.1	97.0	21.0	38.9	67.0	42.7	25.7	14.4	50.2	34.0	50.6	8.1	55.8	3.8	31.4	13.9	2.4	58.1	3.7	29.4	69.0	43.6	62.2	40.4	34.8	85.7	47.5	38.1	37.2	3.0	30.1	67.9	41.0	38.7	71.2											137.0	195.3	871.5	1042.4	1022.6	282.9	87.0	257.4	128.5	280.9	300.1	92.3	1322.2	1405.9	633.0	8.9	418.0	863.0	303.7	1275.3	963.9	807.0	855.9	337.0	132.8	1090.5	228.8	892.0	411.9	1235.3	26.5	618.4	976.3	715.3	1354.4	1107.0	100.8	835.0	866.6	344.4	1021.3	199.6	336.3	860.1	13.3	52.8	1155.2	1458.6	553.5	1380.0	1328.6
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.3	0.0	1.8	0.2	0.4	4.2	1.9	0.1	0.0	0.0	4.5	2.6	0.7	2.3	0.0	1.8	1.3	0.1	0.0	0.0	2.6	0.9	3.4	3.1	13.3	0.2	2.1	9.1	0.6	0.2	0.1	0.0	1.0	0.3	2.9	3.5	0.0	0.4	2.9	1.3	3.6	1.0	1.7	7.2	7.3	0.0	0.3	0.7	5.1	0.2	1.4	0.5	0.2	1.2	0.4	9.2	1.4	2.1	4.8	1.0	4.8	1.3	7.0	3.2	1.2	1.7	4.4	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1	0.0	0.6	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	1.3	0.0	0.3	3.3	0.2	0.1	1.1	9.0	0.6	0.0	0.0	1.3	0.3	0.0	0.9	0.0	1.7	0.0	0.6	0.2	0.6	0.2	0.4	8.5	0.1	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.6	0.1
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	9.9	30.9	10.2	10.2	19.3	16.3	8.4	9.1	18.0	11.6	8.2	12.6	14.1	8.7	11.6	14.6	6.9	9.2	10.0	5.1	9.4	30.5	12.4	6.9	12.8	14.3	10.5	17.4	18.3	7.9	14.9	25.6	21.1	17.2	11.8	5.1	15.6	12.2	14.8	6.5	13.1	11.9	11.6	9.3	17.3	7.3	4.8	7.3	1.8	18.1	4.9	6.7	9.8	14.1	0.4	1.3	0.1	2.3	0.1	4.9	1.9	0.5	8.2	9.7	7.5	4.9	3.6	11.2	4.7	5.9	10.6	6.6	9.4	1.7	0.1	9.6	4.9	7.7	3.1	5.4	3.5	4.2	11.2	9.7	0.0	10.4	8.7	12.9	0.0	1.5	6.6	5.7	5.1	2.3	1.0	8.9	1.9	4.0	11.9	6.2	7.7	0.4	0.2	4.3	2.3	8.0	0.4	1.0	4.3	9.6	9.0	3.8	11.9	4.7	11.8	12.2	15.8	14.1	0.2	6.6	8.6	5.0	7.3	0.5	13.5	5.1	1.3	4.4	0.0	6.8	0.0	2.3	0.0	1.8	0.9	2.6	0.4	3.2	2.6	1.3	0.2	4.9	2.0	0.1	0.1	0.3	0.0	4.0	1.9	10.2	19.3	9.1	18.0	9.4	30.5	10.5	17.4	17.2	7.3	6.0	12.0	0.9	9.3	4.0	28.0	2.0	0.0	2.7	5.7	12.2	55.0	12.2	1.7	6.3	0.4	14.1	3.9	0.0	5.3	7.0	8.2	9.4	1.1	2.0	14.0	3.2	9.8	6.2	5.9	0.2	15.8	8.3	3.3	2.8	2.5	21.0	3.9	3.5	11.7	4.8	37.6	32.3	4.7	0.2	1.5	4.1	21.7	5.7	2.8	5.2
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960737-149993455	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 81.9"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 676.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	8.5	15.6	2.6	23.2	3.7	1.3	4.7	6.3	2.3	3.8	81.9	3.0	29.4	5.4	4.8	14.2	8.3	3.1	2.6	3.1	2.5	2.6	3.8	1.6	6.8	5.3	3.7	2.3	5.1	2.9	21.4	11.1	16.9	7.6	6.1	75.0	4.9	27.9	36.7	11.2	6.0	13.4	4.3	5.5	3.0	2.4	2.8	3.0	5.2	2.7	4.4	13.0	4.1	2.8	1.6	1.7	7.0	3.3	2.5	3.0	1.1	3.3	3.0	3.8	6.2	4.6	3.3	0.9	3.1	2.8	2.5	3.1	15.7	1.8	2.5	24.2	3.3	6.1	2.4	3.6	7.3	4.6	2.0	2.3	3.2	2.4	1.8	3.5	5.9	5.5	3.6	4.3	4.2	5.5	6.3	6.0	3.2	0.8	2.6	10.6	1.0	2.2	3.1	1.2	1.1	4.8	3.3	5.9	1.3	55.5	14.7	1.1	2.9	5.5	1.3	9.4	3.1	2.6	3.5	28.5	5.9	4.4	5.1	3.7	1.8	2.4	1.5	5.4	7.2	8.4	7.0	1.1	0.8	2.5	0.8	3.0	1.3	1.5	2.1	1.7	1.6	2.1	2.2	1.0	2.5	3.3	1.7	2.6	1.1	2.6	3.7	6.3	2.3	2.5	2.6	3.7	2.3	7.6	3.0	41.7	13.7	7.5	12.5	4.0	16.1	6.7	7.6	6.7	14.8	31.4	15.7	160.9	1.7	5.2	17.7	15.3	151.8	0.0	8.6	5.2	16.0	21.5	87.8	2.4	26.4	6.4	20.3	16.5	13.8	9.9	16.1	12.2	86.0	16.2	37.7	15.0	9.4	147.9	11.7	4.4	80.3	0.0	10.2	9.2	10.2	4.4	676.5	9.6	53.2	4.9
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8"	"Cell type enriched"	"Detected in some"	11	"Enterocytes: 543.6"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 1.9;NB-4: 1.5;RPMI-8226: 7.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA036055	Approved					NA	NA					"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	0.3	0.3	0.3	42.8	0.3	0.0	6.1	0.3	0.3	0.4	110.1	0.2	0.3	58.4	0.3	1.2	0.3	0.6	53.5	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.3	0.0	0.3	0.2	0.2	0.5	92.7	0.2	0.3	14.4	0.3	0.3	106.5	1.2	0.3	0.3	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	543.6	0.0	0.0	0.0	0.0	0.2	27.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.7	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.4	0.0
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660635-107717809	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"thyroid gland: 79.2"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 10.6"	"Low region specificity"	"Detected in all"			HPA042860	Approved					NA	NA					"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.1	0.0	0.8	0.2	0.5	0.0	0.2	0.0	2.9	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.2	3.3	0.0	0.2	0.0	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	79.2	0.0	0.1	0.8	0.1	3.1	0.1	0.1	0.2	0.1	0.5	0.3	0.7	0.3	0.5	0.0	0.7	1.5	0.4	0.3	0.2	0.3	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.2	0.5	0.2	0.1	3.5	0.9	0.0	0.3	0.2	0.4	0.4	1.1	0.0	0.9	0.4	0.0	8.3	0.1	0.8	0.0	0.4	4.6	0.7	0.0	0.4	0.0	0.0	0.8	0.2	1.3	0.0	0.0	0.1	2.5	0.1	0.0	0.0	1.7	0.2	0.0	0.4	0.7	0.7	0.5	0.2	2.8	0.7	0.7	0.3	0.8	0.4	1.7	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.5	0.0	1.4	0.5	0.2	0.1	0.6	0.0	0.0	3.0	11.4	0.0	0.6	1.4	5.6	0.7	0.0	1.4	4.5	0.0	2.0	0.2	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.1	1.1	8.7	4.7	0.0	0.2	1.6	7.0	0.6	0.3	2.0	0.9	1.4	6.8	1.0	0.0	0.4	0.1	0.0	1.1	0.0	1.1	0.0	0.9	1.7	0.3	1.3	0.0	1.0	0.0	1.2
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.3	5.7	6.4	12.3	9.8	18.8	5.7	6.8	6.9	6.3	24.8	6.0	7.3	9.7	6.8	7.4	6.5	4.7	6.3	6.7	4.9	3.1	13.6	6.2	7.8	7.4	9.4	3.1	6.7	14.9	6.8	5.8	6.5	9.3	10.2	25.4	7.7	9.6	7.4	8.8	6.7	19.5	6.8	4.8	10.6	19.7	7.7	9.9	7.7	5.5	5.4	6.3	5.1	6.6	0.9	8.8	5.2	10.7	0.5	3.3	4.5	4.5	5.1	7.3	8.2	23.1	11.6	6.2	7.5	9.9	14.6	15.7	9.7	4.2	6.5	2.6	6.4	16.2	6.1	6.8	6.9	4.2	4.8	6.8	5.9	14.5	18.7	16.8	2.8	9.2	15.8	24.8	9.9	7.2	12.6	4.5	6.7	4.5	7.4	3.5	5.4	5.4	14.8	10.4	12.5	9.9	2.8	2.7	7.9	10.7	4.5	1.8	3.5	9.8	12.1	14.1	10.6	6.3	10.5	3.6	6.3	5.3	8.5	17.1	8.8	9.2	2.9	5.3	11.1	15.9	5.2	10.7	2.1	3.1	10.0	2.8	0.9	1.9	2.0	8.8	0.2	1.1	1.6	1.5	0.5	8.9	5.0	3.3	4.5	6.4	9.8	6.8	6.9	4.9	3.1	9.4	3.1	9.3	9.9	3.0	5.1	0.8	2.4	2.9	1.5	6.4	2.5	2.7	1.2	1.8	13.7	7.5	0.0	2.5	1.2	2.9	43.3	0.0	5.6	13.1	4.3	1.9	0.0	4.2	6.2	4.8	19.5	5.5	5.2	0.7	3.4	7.0	5.0	4.6	32.0	2.0	5.2	36.6	8.9	5.1	6.4	0.0	5.7	2.5	5.7	3.0	8.8	3.8	23.5	0.8
SLC26A7	SUT2	ENSG00000147606	"Solute carrier family 26 member 7"	Q8TE54	8	91209494-91398152	"Predicted membrane proteins"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"thyroid gland: 194.5"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 22.7;Distal tubular cells: 11.6;Intestinal endocrine cells: 43.5;Ito cells: 15.4"	"Group enriched"	"Detected in some"	11	"renal cancer: 8.7;thyroid cancer: 32.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 3.0;HEK 293: 1.7;U-266/70: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.83e-3)"	0.3	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.2	1.6	0.2	0.0	0.2	0.0	1.4	0.2	0.3	0.1	0.1	0.3	0.1	0.1	13.0	0.1	0.1	1.7	0.1	0.0	0.1	0.3	0.1	0.3	4.4	0.7	0.1	0.0	8.6	0.8	0.1	0.2	0.2	0.1	0.0	0.3	0.1	1.5	0.2	0.0	0.0	194.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.3	0.0	0.0	0.0	3.0	0.1	0.2	0.0	1.7	0.3	0.1	0.0	0.0	0.0	1.2	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.8	0.0	0.6	3.1	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.8	0.0	0.0	0.0	22.7	0.0	0.0	11.6	0.0	4.4	0.6	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.1	0.0	43.5	15.4	0.6	1.0	3.4	0.0	3.3	0.0	0.7	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.2	0.0
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943514-36024868	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 65.2"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 26.1;Late spermatids: 8.8;Spermatocytes: 42.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;RT4: 2.9;T-47d: 1.0;THP-1: 2.3;TIME: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA					"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.3	0.2	1.3	0.5	2.2	3.7	0.3	4.2	1.8	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	2.1	0.2	0.2	0.2	1.1	0.7	1.7	0.2	0.3	0.2	0.1	0.2	1.9	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.9	0.2	65.2	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.2	5.4	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.4	0.0	0.0	0.8	2.9	0.8	0.0	0.0	0.0	0.1	0.2	1.0	2.3	1.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	1.3	2.2	4.2	1.8	0.8	2.1	0.7	1.7	1.9	0.1	3.0	1.4	0.0	0.3	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.1	0.0	0.0	0.6	1.2	8.8	0.9	0.4	1.7	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	42.9	0.3	0.1	0.2	0.0	0.0	0.1
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 108.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	6.4	0.1	0.1	0.0	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.1	0.1	0.0	0.1	108.4	0.1	0.1	1.9	0.1	0.1	0.1	0.1	17.8	0.1	0.1	0.2	0.4	1.1	2.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	51.6	0.0	0.0	0.0	0.0	25.8	0.0	4.0	4.5	1.8	0.0	0.0	1.7	2.9	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.6;SK-MEL-30: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: AB_2732311"	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	14.5	14.3	13.1	5.2	13.9	2.0	9.3	20.1	19.3	11.8	6.4	44.1	10.1	4.6	8.9	6.4	5.9	14.7	11.0	18.3	12.9	10.0	5.2	5.2	8.5	6.7	22.0	17.2	23.2	14.5	26.1	9.8	7.5	16.1	11.0	2.6	9.6	26.7	13.0	24.2	13.7	3.7	5.5	13.4	7.1	10.9	9.6	19.3	1.3	9.9	4.7	5.3	6.9	8.8	0.5	7.4	0.3	9.9	1.7	3.2	4.6	3.6	1.8	2.5	6.1	17.6	9.8	2.1	2.6	7.0	3.0	4.5	0.2	11.3	1.2	5.0	4.4	2.8	4.4	0.2	4.1	0.7	1.4	0.8	0.7	0.2	1.3	3.4	0.3	4.0	9.0	2.9	3.0	1.2	12.5	2.0	2.4	0.4	0.7	1.9	1.5	2.0	2.9	0.7	3.6	3.2	2.8	2.0	0.8	1.9	1.1	0.8	1.8	1.8	0.9	29.1	1.6	3.2	0.9	1.2	5.9	3.9	4.7	1.8	2.5	1.8	0.4	6.1	3.2	4.1	0.0	9.9	0.3	1.7	4.7	3.2	0.5	1.2	2.1	7.2	0.3	1.6	2.1	0.0	1.7	1.8	7.4	0.7	4.6	13.1	13.9	20.1	19.3	12.9	10.0	22.0	17.2	16.1	19.3	3.0	14.0	1.5	14.9	6.0	8.2	16.7	10.2	4.0	9.1	8.7	25.5	3.7	1.7	9.3	0.7	4.7	0.1	0.0	4.1	14.7	9.7	10.3	2.3	5.8	24.7	6.4	5.2	9.2	20.6	1.7	19.8	9.1	8.5	5.4	2.6	9.7	4.9	0.0	11.0	2.7	17.6	6.5	5.2	8.1	4.3	4.0	1.9	6.1	1.3	7.0
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236395	"Enzymes, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 168.1"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	27	"basophil: 27.3"	"Lineage enriched"	"Detected in many"	27	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 2.5"	HPA026089	Enhanced					NA	NA					"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	1.1	8.1	0.7	4.1	0.8	1.2	3.4	1.5	1.0	0.5	4.2	0.4	1.3	2.5	0.2	17.5	1.2	2.6	1.3	0.2	1.1	1.1	39.4	168.1	1.7	0.8	0.3	1.0	0.7	6.3	2.0	10.4	7.4	3.0	1.2	4.0	3.2	0.6	0.3	0.2	0.6	5.3	0.1	0.3	0.4	0.4	0.7	0.1	0.1	1.0	0.2	1.3	1.4	0.8	0.1	0.0	27.3	0.0	1.0	0.5	0.2	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.5	9.3	2.5	0.0	0.2	0.4	0.2	32.2	8.2	0.2	0.8	12.6	10.1	13.2	16.6	8.3	0.1	23.1	9.5	0.0	0.7	0.0	0.0	0.0	0.0	6.1	4.0	0.0	0.0	2.9	0.6	15.6	0.6	36.0	0.6	0.0	0.0	0.6	1.7	16.3	14.9	0.9	3.1	0.4	0.0	0.4	1.7	8.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	27.3	0.0	0.4	0.4	0.0	0.4	0.1	0.4	0.4	0.0	0.1	0.1	0.1	0.2	1.0	0.0	0.0	0.5	0.2	0.7	0.8	1.5	1.0	1.1	1.1	0.3	1.0	3.0	0.1	0.0	0.6	0.9	0.8	0.9	0.7	0.3	0.0	54.9	6.8	8.7	0.0	236.8	10.0	0.3	0.4	0.1	20.6	0.0	1.7	2.6	0.0	1.8	5.8	188.9	14.3	1.6	4.1	3.7	2.5	0.0	0.3	0.1	0.0	0.0	18.6	0.5	1.6	28.1	0.0	112.0	1.5	0.0	0.1	1.8	2.5	0.3	45.9	4.3	21.1	4.4
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	4.0	0.2	1.7	0.8	35.6	6.9	3.1	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.2	1.7	0.3	12.5	1.7	1.4	0.4	0.3	2.3	0.8	2.2	1.0	4.3	1.4	2.9	4.6	4.7	0.2	0.9	0.6	4.8	0.2	0.4	0.7	0.2	18.8	0.1	4.1	4.1	8.6	1.9	7.1	0.3	0.4	1.0	0.5	3.5	3.9	0.8	8.3	1.5	2.4	2.2	4.1	1.1	0.8	1.7	4.4	0.0	1.3	1.2	0.1	2.0	4.8	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4	17.9	43.8	4.5	9.1	10.4	0.8	2.5	38.2	0.0	7.9	3.5	0.0	24.4	0.0	3.1	0.4	20.2	2.5	0.0	6.4	10.1	17.3	4.2	25.3	25.9	29.3	1.6	4.1	131.3	31.9	2.4	17.5	32.9	21.9	45.1	16.0	1.5	3.7	33.6	13.4	3.4	1.0	6.5	12.8	1.1	3.4	6.8	7.3	15.9	9.1	2.6
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340646-128361470	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 56.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	7.7	7.1	9.9	7.0	13.6	2.5	4.9	9.4	26.5	6.5	25.7	15.8	5.2	54.0	6.6	5.6	26.1	4.4	9.8	7.7	11.6	15.9	17.7	20.8	5.8	5.0	14.8	9.6	5.6	11.3	9.8	5.4	5.8	21.9	5.7	8.3	6.7	7.5	7.3	6.7	24.3	56.1	8.1	11.6	5.1	8.6	13.2	7.9	6.8	12.7	15.2	14.9	8.5	9.5	3.7	7.2	2.6	6.2	1.9	8.1	3.3	10.2	20.1	10.3	13.2	15.7	4.8	11.8	8.7	5.5	10.1	7.3	14.4	10.1	9.6	7.0	9.3	12.1	35.2	12.4	10.0	3.1	9.6	19.1	5.7	17.7	12.5	8.5	10.5	9.2	6.3	13.7	10.4	8.3	4.5	11.4	13.0	13.5	6.7	9.2	25.2	12.4	10.1	4.6	23.2	32.0	15.2	10.1	17.8	17.2	15.5	17.9	9.8	14.5	26.7	9.5	5.4	13.3	4.0	16.7	12.1	11.8	13.2	10.7	6.0	8.5	3.1	12.3	6.3	13.6	0.0	4.1	2.6	8.1	5.6	6.1	3.7	5.2	6.4	7.2	1.7	4.1	4.3	1.6	1.9	6.2	6.4	3.6	3.3	9.9	13.6	9.4	26.5	11.6	15.9	14.8	9.6	21.9	7.9	0.0	1.4	3.0	1.2	2.5	9.3	2.8	7.6	1.4	0.0	8.7	11.8	4.9	1.7	12.4	2.2	3.3	75.1	0.0	13.8	5.7	3.8	2.4	9.2	15.5	9.9	7.9	12.6	4.9	7.1	3.6	1.1	2.9	1.7	12.6	14.0	4.8	20.8	31.7	3.9	8.1	6.2	6.5	2.7	8.8	6.9	5.4	4.3	1.7	12.4	2.6
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Ligase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 157.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 114.0;Hepatocytes: 338.0;Late spermatids: 303.5"	"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA007292, CAB056160, CAB068239"	Enhanced					NA	NA					"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favorable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	1.3	2.0	5.4	1.4	5.3	1.1	2.0	1.9	3.9	1.7	1.0	1.7	1.2	1.0	1.1	1.1	1.4	2.6	1.1	1.3	3.7	3.8	1.9	157.6	0.9	1.4	4.3	2.5	1.4	2.6	1.1	1.3	0.8	3.4	1.4	0.8	1.3	2.7	2.1	1.4	1.1	0.9	1.5	2.7	1.1	1.1	2.3	3.0	1.4	1.8	0.6	1.4	1.1	1.6	13.3	10.8	2.2	3.0	9.6	18.7	8.9	16.0	22.0	3.9	4.1	3.7	3.9	2.4	0.9	2.1	3.1	4.3	1.7	3.5	20.9	2.7	1.1	0.6	3.4	4.5	14.1	1.3	9.7	14.9	14.0	22.9	18.3	5.6	7.3	5.0	4.5	2.4	0.4	8.5	5.3	1.5	15.9	12.9	0.0	3.7	13.1	18.1	15.5	2.4	13.5	12.9	9.1	0.1	28.4	10.1	7.6	5.4	7.3	0.0	21.7	4.7	1.1	6.4	6.4	1.2	0.0	2.8	0.0	1.8	13.8	15.4	8.5	4.5	13.7	0.8	0.0	2.4	2.2	8.7	3.0	18.7	13.3	11.2	11.4	6.5	8.9	13.9	14.3	0.3	9.6	2.1	10.8	13.3	8.9	5.4	5.3	1.9	3.9	3.7	3.8	4.3	2.5	3.4	3.0	0.0	8.2	11.5	13.1	8.0	11.5	5.6	22.9	9.4	5.7	5.2	0.0	6.4	33.2	10.3	114.0	11.9	1.3	0.0	13.3	2.3	7.6	17.0	4.7	338.0	9.1	9.5	9.7	15.4	11.3	303.5	10.0	8.9	15.1	1.8	3.5	6.1	7.4	0.0	8.9	39.7	7.6	6.5	15.5	8.8	13.2	12.3	2.9	10.2	4.7	12.1
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 22.4;Cytotrophoblasts: 39.8;Extravillous trophoblasts: 30.2;Muller glia cells: 39.4;Syncytiotrophoblasts: 23.0"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"BEWO: 31.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.5	23.2	6.3	0.5	6.8	0.3	2.9	0.6	2.8	4.1	0.9	8.2	0.0	0.6	4.2	0.5	7.2	19.5	2.7	20.6	3.2	3.3	0.2	0.3	0.9	0.4	10.4	0.0	9.7	0.3	0.2	7.7	19.6	13.3	3.7	1.8	1.7	3.9	0.4	0.5	2.2	1.1	1.0	12.7	0.3	0.6	11.3	15.1	5.4	3.9	8.7	5.5	1.5	3.2	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	31.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.6	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	2.4	0.0	2.2	1.5	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.2	3.1	0.0	3.7	0.0	2.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	6.8	0.6	2.8	3.2	3.3	10.4	0.0	13.3	15.1	0.0	0.0	0.0	1.0	2.9	0.0	22.4	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	30.2	0.9	0.1	0.0	0.0	3.4	3.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	0.6	23.0	0.0	0.0	0.0
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.1	0.4	0.1	1.8	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	7.6	1.4	0.0	7.0	0.0	0.4	10.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	34.1	40.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	88.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252230-45277845	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"gallbladder: 28.7;intestine: 49.3"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 26.0;Paneth cells: 17.3;Undifferentiated cells: 59.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;NB-4: 2.3"					"Low region specificity"	"Detected in all"			"HPA046068, HPA055623"	Enhanced					NA	NA					"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.8	18.5	0.2	0.1	25.7	0.4	0.1	0.3	0.2	28.7	0.1	0.2	0.2	1.0	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	1.6	0.1	0.2	13.8	0.1	0.1	0.1	0.1	0.2	49.3	0.1	0.2	0.1	8.5	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.6	0.2	1.3	0.5	0.6	0.7	0.0	0.1	0.3	0.1	0.1	0.0	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.5	0.6	0.2	0.0	0.0	0.7	0.0	0.1	0.2	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	1.5	0.0	0.1	0.3	2.3	0.2	0.9	0.3	0.2	0.4	1.3	0.0	0.2	1.1	1.6	0.0	0.1	0.3	0.6	0.2	0.6	0.3	0.4	0.5	1.2	0.2	0.8	0.2	0.3	0.4	0.6	0.3	1.3	0.2	0.1	0.4	0.1	0.2	0.5	0.3	0.1	0.2	0.6	0.4	0.7	0.2	0.6	0.5	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	7.2	0.9	0.2	0.1	2.7	0.4	12.7	8.1	7.9	0.0	2.0	11.0	0.0	0.0	0.4	0.4	26.0	0.0	0.0	1.6	0.4	0.2	8.1	0.0	0.8	1.6	13.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.5	0.0	17.3	0.7	0.3	4.6	0.0	0.0	1.9	1.7	0.3	3.9	0.9	59.6	0.1
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 7.6;Ductal cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA					"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.9	0.0	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.5	0.0	0.1	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.7	7.6	4.0	1.2	1.8	0.0	0.1	0.0	17.3	1.0	0.0	0.3	0.0	2.6	0.1	0.1	0.1	1.1	0.0	1.9	0.0	2.9	0.0	2.4	1.3	0.0	0.7	0.0	1.8	3.4	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.1	0.0	2.4	0.1
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219505-44234151	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.2"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 192.2;Extravillous trophoblasts: 188.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	25	"eosinophil: 117.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 117.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved					NA	NA					"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	42.9	40.9	5.8	9.4	9.6	17.9	57.2	10.4	15.2	21.2	35.8	5.9	6.9	5.2	19.8	11.7	22.8	14.9	24.4	46.8	5.4	6.4	14.7	23.2	15.3	14.4	5.5	8.4	12.5	35.8	8.7	15.2	23.2	9.8	21.4	7.4	18.0	15.7	8.4	53.0	23.8	12.4	39.0	5.3	11.4	33.0	8.8	4.8	53.9	18.8	17.2	11.1	28.7	20.7	0.5	4.7	117.2	4.5	0.3	0.9	0.7	16.5	16.5	11.8	19.0	18.2	1.7	70.5	12.2	4.8	17.1	11.7	18.0	6.8	33.7	12.3	3.6	10.6	20.6	21.1	14.7	10.4	19.1	19.4	29.1	11.4	23.3	2.9	32.7	28.1	2.2	3.8	25.1	8.8	34.8	42.9	27.6	39.3	19.9	9.3	18.2	26.9	21.9	17.9	42.9	11.1	18.0	23.8	40.8	10.0	9.7	15.2	19.6	3.5	11.9	8.6	12.7	16.1	20.7	64.9	9.4	15.4	12.7	23.1	13.6	17.7	43.0	5.7	26.7	11.3	1.8	1.4	117.2	0.6	4.5	0.4	0.5	0.3	0.4	0.8	0.3	0.1	0.3	0.2	0.3	3.6	4.7	0.9	0.7	5.8	9.6	10.4	15.2	5.4	6.4	5.5	8.4	9.8	4.8	0.0	10.9	0.8	7.7	9.5	9.0	38.3	20.4	8.1	6.8	7.0	13.7	192.2	3.3	21.3	0.4	24.6	0.5	0.0	50.3	188.6	38.1	6.0	8.1	12.1	53.2	4.8	30.0	19.6	23.3	1.5	30.5	11.7	33.7	11.8	2.4	4.7	45.0	3.1	50.5	0.9	10.8	90.5	16.5	0.3	10.0	13.7	35.1	3.5	5.3	6.8
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.9"	"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;CAPAN-2: 21.4;K-562: 16.1;T-47d: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	5.4	1.3	2.5	2.8	3.2	1.2	13.2	10.3	5.1	1.9	4.0	3.1	4.8	5.6	1.2	5.2	2.7	3.0	3.2	9.0	2.9	3.3	6.4	1.5	3.4	2.5	3.3	3.5	1.0	7.8	11.3	5.9	3.3	7.0	4.2	2.3	2.2	6.0	6.3	68.9	1.9	4.3	0.9	1.7	2.0	6.6	0.9	2.0	1.6	4.2	18.0	2.5	1.5	2.2	1.6	1.6	0.2	0.1	0.1	4.1	1.2	5.8	4.4	3.5	0.7	0.3	0.0	16.7	0.2	0.0	0.2	0.3	7.0	21.4	2.6	5.5	0.0	1.1	5.9	3.3	4.2	0.0	0.1	9.6	5.7	5.4	0.5	0.7	9.5	0.1	0.3	1.7	0.6	1.9	1.7	0.3	2.0	16.1	0.0	0.0	12.1	0.7	13.4	10.1	7.3	4.6	0.7	0.0	12.1	8.9	4.4	7.1	3.2	0.3	9.2	0.6	0.4	26.0	2.1	0.0	0.1	5.8	0.1	0.0	0.1	0.3	0.2	0.4	0.2	0.2	0.0	0.1	0.0	3.5	0.0	1.1	0.6	2.2	4.1	0.8	1.6	4.1	4.1	0.2	0.1	0.1	1.6	0.4	1.2	2.5	3.2	10.3	5.1	2.9	3.3	3.3	3.5	7.0	2.0	3.0	4.6	1.4	4.4	0.6	2.5	9.7	5.1	5.3	7.9	14.0	11.8	40.5	3.3	4.3	0.0	0.7	2.1	0.0	5.8	12.3	1.0	2.8	4.6	0.5	3.8	4.8	2.4	0.0	0.6	0.0	0.0	0.0	0.0	1.0	8.5	2.3	3.2	3.5	0.4	0.6	3.3	0.0	2.3	0.1	0.2	0.0	11.3	1.3	10.7	2.5
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319258-71381423	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 36.0;Extravillous trophoblasts: 36.5;Hofbauer cells: 32.2;Syncytiotrophoblasts: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.8;Hep G2: 22.0;RT4: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	11.3	4.0	6.4	6.6	8.3	1.9	6.8	3.2	12.6	8.3	6.1	11.3	2.4	4.1	12.1	4.6	3.5	9.4	7.4	3.6	8.0	5.5	3.9	12.5	11.1	10.5	9.8	6.5	15.8	7.4	7.1	2.8	24.6	6.7	8.3	6.0	4.6	7.5	5.4	2.1	3.7	4.9	8.9	8.0	9.4	8.9	4.9	7.7	9.3	6.7	1.3	6.2	18.4	10.0	3.6	19.3	2.8	12.9	5.7	4.0	5.6	1.2	7.4	1.1	4.7	4.2	3.3	19.8	1.4	1.4	0.4	0.2	8.1	5.2	4.3	4.0	2.8	2.0	11.7	3.4	1.9	0.0	3.4	3.3	1.3	0.6	22.0	2.0	1.0	2.8	3.2	8.1	0.2	0.3	0.9	1.9	5.3	3.9	4.1	0.5	11.4	2.7	2.1	2.5	11.4	2.7	3.4	0.4	3.4	1.7	17.5	5.6	5.9	3.9	12.8	1.0	3.5	1.9	2.3	3.1	0.1	2.4	1.3	0.0	1.1	1.8	2.4	5.1	14.5	0.8	2.8	12.9	1.4	4.0	10.1	3.4	3.6	3.2	3.6	19.3	1.5	2.6	3.6	1.0	5.7	6.3	13.6	3.4	5.6	6.4	8.3	3.2	12.6	8.0	5.5	9.8	6.5	6.7	7.7	3.0	0.6	0.5	1.7	0.2	1.1	0.6	2.5	2.7	3.4	0.0	0.0	36.0	0.0	4.3	3.3	1.1	1.3	0.0	7.9	36.5	2.6	2.8	2.3	4.9	32.2	0.0	1.7	3.7	7.8	10.5	2.6	9.5	1.7	10.0	2.7	2.4	6.6	11.5	1.4	1.4	0.2	0.0	0.3	0.5	4.7	0.0	26.5	1.0	2.7	1.2
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306870	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.7"	"Group enriched"	"Detected in many"	8	"Horizontal cells: 158.9;Intestinal endocrine cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	35.7	8.3	7.6	2.5	6.4	0.8	6.5	4.2	9.7	2.0	2.5	2.0	0.3	4.5	2.4	5.3	1.3	4.2	1.8	1.7	9.4	15.7	3.4	3.8	1.2	1.8	12.2	5.4	3.2	13.0	0.5	1.6	0.8	7.0	3.0	2.0	11.5	1.1	1.0	2.1	1.4	5.4	2.0	3.1	1.1	7.1	1.3	1.1	0.3	4.3	0.3	0.7	2.3	0.5	1.3	1.1	4.3	1.1	4.3	1.3	0.3	0.0	10.6	6.3	24.5	0.3	0.1	1.2	0.9	0.0	0.8	0.4	6.0	0.2	0.0	1.2	0.9	4.1	0.1	2.4	0.2	0.2	0.0	1.3	0.1	0.3	8.7	1.9	0.1	1.5	0.8	8.2	0.1	0.4	1.5	0.7	2.2	1.7	0.1	0.6	5.2	0.9	0.4	8.0	0.7	0.6	4.0	1.0	0.9	1.6	0.2	4.2	35.6	0.6	2.2	0.4	5.7	2.7	2.8	0.3	8.8	12.3	0.8	0.2	0.5	0.0	0.0	1.1	0.3	3.9	2.0	1.1	0.6	0.8	0.5	1.3	0.7	0.5	0.7	0.4	1.3	0.7	0.9	4.3	4.3	0.5	1.1	0.3	0.3	7.6	6.4	4.2	9.7	9.4	15.7	12.2	5.4	7.0	1.1	3.0	0.3	0.0	0.2	0.1	1.8	2.3	0.0	1.4	0.0	0.0	15.7	0.2	0.0	4.3	0.0	0.0	1.3	0.0	0.2	0.2	1.1	2.2	0.0	0.6	0.4	158.9	98.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.2	4.4	1.9	0.0	0.4	0.0	1.3	0.0	0.9	0.3	6.0	0.3	0.2	0.0	0.6	0.0
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell type enhanced"	"Detected in many"	20	"Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		36000000	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.7	15.6	12.8	3.2	1.5	0.5	44.8	7.1	15.4	8.8	12.9	72.7	30.1	4.1	21.2	2.1	6.2	10.1	2.8	16.5	3.9	2.4	2.6	6.7	9.0	49.6	4.5	3.6	1.9	1.9	12.7	5.5	5.9	26.0	1.4	3.5	15.0	0.9	3.9	19.2	1.7	2.5	8.2	5.3	3.9	1.6	4.1	5.7	8.0	5.2	6.8	4.8	8.3	26.3	3.1	19.2	1.1	4.6	3.2	8.0	5.8	1.4	16.0	0.7	1.5	2.5	15.8	2.6	6.5	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5	0.0	2.6	23.8	35.5	254.3	8.1	23.0	25.5	28.1	9.1	26.2	62.8	686.5	5.0	47.8	4.0	9.9	16.8	303.7	10.3	412.9	42.1	25.5	5.8	1.3	74.8	4.8	17.6	0.6	1.3	0.0	7.2	3.2	20.3	61.3	13.7	394.9	72.4	18.7	13.8	1.6	31.1	0.0	20.2	0.0	1.7	208.3	2076.2	17.3	9.0	98.7
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709487-46736347	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 51.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041015	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041015: AB_2677252"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	4.7	4.6	2.6	4.3	3.3	0.1	8.7	2.1	3.1	11.4	6.7	2.7	6.7	2.6	5.4	6.6	4.8	5.6	10.2	6.7	3.3	1.4	2.6	51.5	4.8	3.4	2.2	2.0	7.1	22.9	15.0	4.2	8.3	3.8	18.0	8.8	9.8	11.5	11.0	2.1	2.4	3.0	9.7	2.3	1.9	12.4	3.4	1.0	0.8	18.1	4.5	4.6	7.1	5.7	0.0	0.0	13.8	0.0	0.3	0.0	0.0	0.0	0.0	4.7	4.8	19.5	16.7	14.3	9.1	12.4	4.2	5.1	0.3	16.0	0.0	6.9	16.5	0.0	0.1	0.0	0.4	2.0	0.0	0.1	1.3	0.0	7.6	13.8	0.0	0.0	24.2	0.4	2.6	0.0	4.9	1.7	0.0	0.1	0.0	7.2	16.6	0.0	0.4	1.7	20.0	1.2	0.0	0.7	0.0	0.0	4.3	0.0	0.7	1.8	3.0	24.8	3.5	2.3	3.7	1.0	9.1	4.0	7.2	1.1	0.1	0.0	0.0	0.0	0.0	1.9	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.6	3.3	2.1	3.1	3.3	1.4	2.2	2.0	3.8	1.0	6.0	4.6	0.0	6.8	0.6	0.0	2.2	10.2	33.5	11.4	1.8	0.0	1.9	0.0	5.2	0.1	4.1	2.2	0.0	4.9	12.8	11.7	28.1	5.8	41.2	0.9	0.0	3.5	9.2	2.8	0.9	24.5	0.3	1.7	0.0	60.1	5.6	5.1	2.9	16.3	0.7	0.5	12.9	3.9	0.4	0.2	0.9	1.7	0.0	6.6	10.2
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 12.0"									"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	4.3	7.8	8.5	6.1	15.3	3.5	6.2	22.9	17.0	4.1	4.9	6.4	17.2	3.9	7.7	9.0	2.8	5.0	5.2	8.5	11.0	13.4	19.5	4.9	4.5	7.1	9.5	10.9	6.6	28.8	18.6	14.0	21.0	9.7	7.6	6.0	10.4	6.1	11.4	13.6	4.2	4.8	10.4	9.6	5.3	6.1	4.5	6.2	1.6	9.2	2.4	6.4	4.5	5.3	2.2	4.6	1.5	1.1	1.2	1.6	0.3	2.6	1.3	1.7	7.6	1.6	3.4	0.7	1.6	2.0	1.8	1.3	1.8	1.8	3.4	0.9	2.2	1.6	2.2	3.2	0.9	0.9	2.3	2.9	1.7	2.8	2.6	2.5	1.6	1.8	1.3	3.2	2.7	2.3	8.4	0.7	2.7	0.7	7.6	1.0	2.8	0.3	0.7	2.5	1.7	2.1	4.6	0.2	3.8	5.6	0.7	4.1	2.3	0.8	12.0	2.7	2.1	6.2	0.8	0.5	0.7	1.2	0.7	0.8	7.1	1.9	3.3	1.5	1.2	1.8	1.5	0.4	0.9	0.9	1.1	0.7	2.1	0.8	0.8	0.2	2.2	1.6	1.1	1.2	1.2	0.7	4.6	0.2	0.3	8.5	15.3	22.9	17.0	11.0	13.4	9.5	10.9	9.7	6.2	17.9	12.9	16.6	8.2	2.9	57.0	29.0	7.6	8.1	4.5	24.4	280.8	7.0	11.6	4.7	5.9	3.3	3.4	0.0	4.9	7.6	4.5	8.0	2.3	5.8	5.2	35.0	10.4	4.9	3.1	8.5	8.6	4.2	3.3	2.8	4.9	15.4	3.5	2.9	9.2	20.7	194.1	0.0	6.2	3.9	5.1	2.8	16.7	7.5	7.3	5.4
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	2.1	0.7	1.8	0.0	1.4	0.7	0.1	1.3	5.4	0.7	3.0	0.0	7.4	0.2	1.1	0.1	5.5	5.6	0.0	0.5	1.0	0.0	4.7	0.0	0.6	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	13.5	0.4	0.3	0.4	0.6	0.1	0.6	0.1	0.1	1.6	0.0	0.5	0.0	0.9	2.0	1.6	0.7	0.2	0.5	0.0	1.7	0.0	22.1	0.0	0.0	0.0	0.2	8.0	0.2	0.7	2.8	2.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3	0.0	4.8	0.0	0.8	1.8	0.1	5.7	0.0	9.4	2.3	0.0	0.0	1.9	3.3	1.2	0.0	0.4	0.0	0.0	0.2	0.5	0.3	11.7	0.0	0.9	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.8	2.9	1.4	0.3	0.5	0.0	0.1	0.0	0.0	1.6	30.7	0.0	0.3	1.4
SLC2A13	HMIT	ENSG00000151229	"Solute carrier family 2 member 13"	Q96QE2	12	39755021-40106089	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.7;parathyroid gland: 43.0"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 87.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006584, HPA061679"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA006584: AB_1849755, HPA061679: "	"unprognostic (1.66e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.16e-2)"	3.8	7.2	9.8	3.3	18.0	1.2	3.0	4.0	27.7	13.0	7.4	2.8	0.3	6.0	5.9	5.3	3.7	2.9	4.0	4.9	8.2	14.1	10.7	6.2	3.7	1.9	14.9	11.0	3.1	5.0	43.0	11.1	4.6	4.8	3.0	6.8	2.4	4.2	2.6	1.2	2.1	8.3	4.7	2.7	2.3	5.6	2.0	4.1	0.6	2.2	0.9	1.4	3.9	3.9	2.0	0.1	1.5	0.5	0.6	0.9	0.0	0.6	3.6	2.6	1.2	18.5	7.7	5.3	5.8	4.1	2.6	3.4	0.0	1.7	2.2	4.3	4.6	3.6	0.3	1.8	1.8	2.2	1.9	5.4	1.7	9.1	1.3	2.9	4.9	2.9	3.8	1.7	1.2	2.2	1.5	1.2	2.2	0.7	5.7	5.9	0.6	0.7	4.1	2.9	0.0	2.5	0.0	4.0	1.2	4.8	2.2	3.3	3.4	2.3	4.5	1.5	4.1	2.5	4.3	1.1	3.5	1.3	12.4	3.4	4.5	0.1	1.4	6.4	2.8	2.2	0.0	0.5	1.5	0.4	0.2	0.3	0.1	0.4	0.9	0.0	2.0	0.2	0.5	0.8	0.6	0.1	0.1	0.1	0.0	9.8	18.0	4.0	19.8	8.2	14.1	14.9	11.0	4.8	4.1	8.9	17.1	4.7	1.7	3.7	4.3	3.5	10.2	5.3	2.3	8.7	0.0	5.0	0.0	4.3	2.5	5.2	35.1	0.0	10.9	2.1	7.1	2.7	10.3	8.5	7.2	87.4	19.5	8.0	7.9	2.1	21.3	7.4	15.1	6.4	21.3	2.0	8.7	29.4	7.1	6.4	1.3	6.5	6.1	0.9	1.9	4.5	3.1	4.4	11.1	1.4
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 52.4"	"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 60.6"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.4	3.1	0.1	0.1	0.6	3.0	0.4	0.1	0.2	0.4	0.4	0.3	0.1	0.0	0.3	0.8	0.8	0.1	0.3	0.1	0.2	0.3	0.1	2.0	0.2	0.2	0.1	0.1	2.7	7.4	0.0	0.6	0.5	0.3	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.0	52.4	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.6	0.4	6.9	0.7	1.3	1.7	0.2	0.0	0.3	0.3	0.2	0.2	0.6	12.6	0.0	0.0	0.0	0.2	20.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.1	0.5	5.3	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.9	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.0	25.2	0.0	1.3	0.3	0.1	0.5	0.3	0.1	0.1	0.1	0.2	0.3	0.0	0.3	5.5	0.7	1.8	1.0	0.2	1.2	0.5	1.0	0.8	0.4	0.6	0.7	0.9	6.9	1.3	0.2	0.3	1.7	0.2	0.1	0.6	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.2	0.0	0.6	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	3.7	2.3	0.0	0.0	1.3	0.9	1.9	0.0	9.2	0.4	0.2	0.0	0.0	8.0	4.4	0.9	0.3	3.1	1.7	0.0	0.0	0.0	0.5	5.8	2.5	0.0	0.4	0.0	4.2	60.6	2.7	0.1	0.3	3.2	0.0	0.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 433.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	68	"CACO-2: 7.3;Hep G2: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	1.7	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.3	0.0	0.0	0.0	6.7	8.9	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936275	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 166.3"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 462.0"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 30.2;neutrophil: 55.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 55.6"	"Group enriched"	"Detected in many"	5	"BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA		33000000	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	48.8	10.0	9.5	25.2	10.5	166.3	26.4	13.1	24.3	9.4	10.0	6.8	1.8	4.2	10.3	8.2	13.2	8.0	25.6	22.8	10.8	13.6	10.3	14.1	32.4	12.8	13.3	3.3	18.8	6.1	6.9	10.9	43.9	13.7	15.0	6.9	14.8	3.8	3.9	13.6	7.4	5.8	18.7	15.4	16.4	7.0	10.6	12.5	3.3	15.7	7.0	13.6	51.8	10.5	1.8	2.4	55.6	4.6	3.6	6.4	3.5	0.0	0.7	6.6	2.5	2.4	8.5	143.6	2.3	2.5	2.3	5.4	154.0	1.0	0.1	0.0	1.6	3.2	0.0	0.2	0.3	4.2	4.5	0.1	8.9	0.6	20.2	6.7	3.2	13.0	3.5	0.2	6.1	2.8	5.4	2.1	0.7	4.1	2.1	2.1	0.0	0.2	3.4	29.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.0	113.9	0.0	0.4	2.1	2.9	1.5	5.6	0.2	0.0	6.2	0.4	8.5	1.5	1.5	30.2	4.6	7.0	6.4	0.5	5.3	1.8	4.4	4.9	2.4	1.7	2.8	3.8	55.6	3.6	0.2	0.1	5.8	3.5	9.5	10.5	13.1	13.3	10.8	13.6	13.3	3.3	13.7	12.5	134.0	147.7	116.7	2.9	115.1	27.9	8.4	7.6	18.7	48.9	3.5	58.9	41.5	0.0	0.2	2.4	227.7	0.0	0.0	0.0	218.4	149.1	3.8	462.0	1.0	97.9	4.8	1.2	85.3	85.8	1.9	9.5	229.2	173.7	1.0	0.0	19.2	0.8	0.2	7.4	1.2	68.8	116.4	236.4	1.4	0.6	71.6	93.1	133.8	0.0	2.8
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281667-7288257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5"	"Cell type enhanced"	"Detected in many"	26	"Cardiomyocytes: 120.2;Sertoli cells: 32.3;Smooth muscle cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 10.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB016544	Enhanced					NA	NA					"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	9.9	1.4	0.6	1.8	0.7	1.1	6.4	0.0	0.6	4.7	13.9	0.2	4.0	1.0	4.2	7.0	11.8	3.2	2.9	37.2	0.3	0.1	0.7	1.2	0.5	0.7	0.8	0.1	1.9	0.4	2.9	1.2	0.8	0.5	6.3	1.4	6.4	4.6	3.8	76.8	0.9	3.3	23.5	0.2	0.2	3.8	1.5	0.0	0.0	1.2	33.5	1.6	18.6	1.6	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.8	1.5	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.8	0.8	0.3	0.2	0.1	0.0	1.8	0.0	0.3	10.8	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.6	0.2	0.0	0.4	0.0	0.2	0.8	0.2	0.1	2.4	0.6	0.8	0.0	0.1	0.0	1.0	0.0	1.3	0.0	1.8	0.8	0.1	0.0	0.0	1.5	0.0	0.2	0.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.0	0.6	0.3	0.1	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.7	1.5	0.0	120.2	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.1	5.7	1.5	0.8	0.0	0.0	0.0	0.4	0.5	0.0	2.0	0.1	0.0	0.0	1.8	0.0	3.6	0.0	0.0	6.8	0.0	0.5	5.6	0.1	0.2	8.1	0.2	0.0	32.3	25.1	2.1	2.7	1.0	0.8	0.0	1.0	0.3
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035107-9088478	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.7;intestine: 84.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 42.2;Late spermatids: 12.6;Paneth cells: 28.8;Proximal tubular cells: 18.8;Spermatocytes: 44.4"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 19.7"	"Group enriched"	"Detected in some"	5	"Daudi: 51.3;THP-1: 13.0;U-266/70: 41.3;U-698: 48.2;U-937: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005449, HPA075145"	Enhanced					NA	NA					"HPA005449: AB_1078985, HPA075145: "	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	5.2	2.2	10.3	4.1	15.0	36.7	3.7	1.1	9.9	2.4	50.4	9.2	0.7	44.8	0.8	4.9	2.5	1.5	0.6	1.4	8.6	6.0	16.2	0.6	0.9	8.1	14.1	2.4	1.6	0.6	0.5	1.9	2.1	10.4	6.7	1.6	0.8	1.8	2.4	25.1	3.1	84.1	1.9	17.8	3.1	0.7	30.2	15.4	0.0	0.8	3.7	7.3	1.8	2.5	19.7	0.7	3.0	2.1	0.6	0.3	0.8	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.2	0.0	0.1	0.4	0.0	51.3	0.0	0.1	0.0	0.1	0.4	0.0	0.1	6.6	0.0	0.0	0.9	0.0	0.1	0.8	0.5	0.8	0.7	0.1	0.0	0.8	0.0	0.0	0.1	0.7	0.0	0.0	0.3	2.8	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.0	0.0	13.0	0.0	0.8	0.2	0.1	0.0	41.3	0.0	48.2	0.1	18.5	0.1	3.0	2.1	0.2	0.2	0.5	0.1	3.4	0.2	0.2	0.7	19.7	0.3	0.2	2.2	0.6	0.1	0.4	0.1	0.8	10.3	15.0	1.1	9.9	8.6	6.0	14.1	2.4	10.4	15.4	0.0	0.0	6.7	1.8	1.8	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.1	42.2	0.5	2.6	0.0	0.0	1.0	0.5	0.6	1.1	0.0	4.2	0.0	1.2	0.0	1.2	12.6	2.6	1.8	0.0	1.0	2.2	0.2	0.4	28.8	0.4	18.8	0.0	6.5	0.3	44.4	3.4	0.5	0.5	0.0	2.5	0.1
SLC2A6	"GLUT6, GLUT9, HSA011372"	ENSG00000160326	"Solute carrier family 2 member 6"	Q9UGQ3	9	133471095-133479137	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.7;brain: 17.3"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 49.1;granulocytes: 45.2;monocytes: 68.5;Rod photoreceptor cells: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 27.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.0;granulocytes: 15.6;monocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.7;HMC-1: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042272, CAB046014"	Uncertain					NA	NA					"CAB046014: AB_2270444, HPA042272: AB_2677924"	"unprognostic (2.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.71e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.36e-2)"	"unprognostic (6.28e-3)"	3.8	3.1	7.2	12.7	8.3	10.5	2.1	8.1	16.3	1.4	2.5	4.3	0.0	3.3	2.3	3.1	1.8	1.4	3.6	3.0	9.1	12.1	2.3	2.7	7.4	10.8	12.4	9.1	1.7	3.2	1.1	1.8	2.5	17.3	1.6	2.1	2.9	2.2	2.2	2.1	1.9	4.9	3.3	7.3	10.6	4.0	2.2	2.4	1.7	1.6	0.0	7.1	4.9	1.1	4.0	7.0	15.6	27.7	0.4	0.6	3.1	2.5	4.7	1.7	5.1	1.0	1.5	1.3	2.6	4.5	2.7	2.7	2.3	3.7	2.1	6.6	2.6	12.6	4.1	1.1	3.2	0.6	15.7	0.8	2.6	3.5	2.7	3.4	0.0	37.0	2.1	0.5	4.0	0.5	0.2	2.7	2.5	0.4	2.2	1.9	6.1	1.5	2.7	2.5	1.2	5.6	1.0	2.8	11.7	3.8	7.5	2.0	2.7	3.9	2.1	1.3	1.0	8.0	1.1	6.9	6.5	2.5	6.8	2.1	1.1	0.8	3.0	1.6	0.6	1.4	15.6	7.2	0.7	0.6	14.6	0.4	4.0	0.1	0.4	6.4	3.9	0.2	0.5	0.4	0.4	27.7	7.0	0.1	3.1	7.2	8.3	8.1	16.3	9.1	12.1	12.4	9.1	17.3	2.4	3.0	5.5	19.9	1.3	0.3	24.3	2.0	5.1	2.7	0.0	3.5	49.1	0.3	0.0	32.4	6.3	4.7	1.8	0.0	7.9	0.5	1.9	1.1	45.2	0.0	4.6	22.3	3.5	2.5	19.2	1.3	0.9	31.5	3.3	68.5	1.5	3.9	16.6	31.7	0.0	0.0	45.6	32.3	7.2	2.2	6.6	0.4	0.2	3.8	1.2	0.5
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039931	Uncertain					NA	NA					"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	7.2	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	19.3	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A8	"GLUT8, GLUTX1"	ENSG00000136856	"Solute carrier family 2 member 8"	Q9NY64	9	127397138-127408424	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 119.6;Late spermatids: 229.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 33.8"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 33.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 46.6;Hep G2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011935	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA011935: AB_1849760"	"unprognostic (6.49e-2)"	"prognostic favorable (2.57e-6)"	"unprognostic (9.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (9.86e-6)"	"unprognostic (1.70e-1)"	"prognostic favorable (6.55e-6)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.04e-3)"	10.9	24.5	11.4	13.3	11.3	3.5	10.4	15.0	15.2	9.0	19.8	11.7	37.0	17.7	9.5	17.4	8.7	6.0	9.4	9.8	10.4	9.3	8.7	25.7	8.1	7.3	12.5	10.2	6.7	12.1	5.7	5.5	13.2	8.7	18.5	6.5	12.5	9.4	28.3	22.6	11.6	17.0	44.1	10.3	11.3	13.1	30.6	9.3	1.2	9.1	6.9	4.3	42.4	9.1	2.4	33.8	6.9	5.6	1.2	6.3	2.0	1.8	7.2	3.2	7.2	0.0	0.0	10.2	2.8	1.9	4.5	2.7	46.6	1.7	2.8	6.4	1.5	7.2	9.7	3.9	4.5	1.1	2.6	6.2	0.4	5.7	27.5	4.2	0.0	3.0	0.1	4.2	0.4	1.8	2.2	3.5	3.9	2.9	6.3	1.8	13.1	0.0	0.0	5.2	10.2	11.3	1.0	4.5	7.8	4.2	19.3	5.4	3.7	6.7	11.5	2.5	4.3	7.4	1.6	3.0	0.0	4.7	0.3	6.2	19.5	18.2	4.2	3.1	0.0	3.4	0.0	3.0	6.9	4.9	5.6	3.5	2.3	1.6	3.3	4.6	2.4	0.3	1.2	0.2	1.2	5.1	33.8	6.3	2.0	11.4	11.3	15.0	15.2	10.4	9.3	12.5	10.2	8.7	9.3	8.9	9.6	5.4	6.1	9.8	11.1	6.1	7.6	5.3	4.5	5.2	9.8	66.2	13.3	12.0	119.6	7.4	15.1	23.3	14.7	10.8	11.6	11.0	6.9	23.6	59.6	6.4	11.6	12.9	12.4	229.4	10.0	8.2	25.3	8.2	13.3	14.9	15.9	21.5	11.0	12.2	7.7	12.9	8.1	38.0	10.9	9.3	56.3	6.9	15.6	5.5
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 43.4"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 16.4;Proximal tubular cells: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 20.6;myeloid DC: 16.7"	"Group enriched"	"Detected in many"	31	"dendritic cells: 16.7;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 29.6;Hep G2: 14.2;hTCEpi: 12.5;THP-1: 12.5;U-937: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA					"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	5.6	2.8	1.0	1.3	2.0	1.2	3.2	0.6	1.2	2.6	10.4	2.3	5.7	7.8	1.7	12.0	5.8	2.6	1.7	2.7	1.0	0.9	43.4	17.7	4.7	2.8	1.9	0.7	1.5	1.3	1.5	1.8	8.8	2.1	4.6	1.1	4.1	10.8	15.6	1.1	2.4	12.0	1.4	4.1	3.0	1.2	1.3	2.3	3.0	2.9	3.4	3.9	7.1	3.9	0.2	16.7	0.6	20.6	0.1	0.2	4.9	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.2	1.5	0.0	2.2	0.4	0.0	4.5	0.0	29.6	0.0	4.8	0.1	0.0	0.0	14.2	1.0	0.1	4.0	2.2	12.5	0.0	3.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.2	1.4	0.0	0.2	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	20.6	0.4	0.1	4.1	0.2	0.2	0.2	0.0	16.7	0.1	0.1	0.0	0.6	0.1	0.4	6.6	0.1	4.9	1.0	2.0	0.6	1.2	1.0	0.9	1.9	0.7	2.1	2.3	0.0	0.0	1.4	11.1	0.8	0.0	2.1	0.0	4.0	3.4	3.5	2.0	16.4	3.3	0.4	3.9	1.4	2.9	0.0	0.9	1.3	1.1	1.0	1.1	4.9	9.3	0.0	0.0	2.5	6.5	2.8	0.0	10.2	0.0	1.0	0.8	0.8	0.4	0.0	0.4	47.2	0.4	0.0	1.0	0.7	1.2	0.5	7.1	0.5	1.0	8.8
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211578742	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 53.3"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	11.4	16.6	9.3	7.5	11.4	15.5	17.3	5.2	13.6	13.0	15.3	6.9	4.9	17.2	7.1	7.6	9.0	9.2	12.9	6.1	9.7	7.9	13.4	53.3	12.0	3.5	9.5	8.0	9.5	8.9	8.8	4.8	9.3	8.7	7.3	8.9	7.7	5.9	9.2	3.6	13.9	28.1	7.5	8.3	10.7	6.4	12.5	5.5	3.1	11.0	5.2	4.4	7.7	8.4	0.5	2.5	3.9	4.2	1.3	1.7	1.0	4.7	6.9	3.8	4.9	16.6	7.7	33.7	13.0	9.6	6.9	6.9	3.0	22.6	2.6	11.4	11.9	9.6	8.1	5.7	7.5	8.3	6.7	4.3	2.1	14.1	6.9	9.3	7.4	4.8	11.5	19.0	8.8	14.4	10.4	4.2	1.6	8.4	12.5	8.5	4.3	1.4	4.6	11.7	5.1	5.5	4.5	1.8	9.6	21.5	12.7	3.8	6.7	12.7	6.7	29.0	7.5	3.4	9.7	6.8	5.2	12.1	17.3	10.3	5.5	8.4	2.2	4.8	7.5	4.5	3.9	3.9	1.3	1.2	4.2	1.7	0.5	0.9	0.8	2.5	0.3	0.9	1.2	0.4	1.3	3.2	1.7	0.8	1.0	9.3	11.4	5.2	13.6	9.7	7.9	9.5	8.0	8.7	5.5	8.9	9.8	5.1	7.2	25.3	10.9	17.9	17.8	6.7	2.3	34.9	5.9	9.8	1.7	5.4	21.7	18.0	37.9	46.7	10.7	27.0	15.0	12.6	4.7	83.9	29.4	6.4	9.1	15.4	33.3	2.8	9.2	15.1	20.3	5.4	23.6	26.5	7.9	31.7	7.1	29.5	8.5	6.5	11.6	33.0	9.4	40.4	20.5	10.2	20.5	11.4
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA055032: AB_2682677, HPA057328: AB_2683411"	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	15.9	17.9	10.3	11.9	13.1	5.4	15.3	21.1	13.7	16.6	14.4	14.2	10.6	12.6	22.5	12.1	16.8	13.8	13.5	13.5	10.6	8.7	17.9	18.4	14.3	17.9	17.3	8.1	17.8	23.7	15.7	19.8	18.1	13.2	13.7	15.3	14.8	17.2	12.4	18.8	15.2	14.3	14.1	20.1	16.2	14.9	12.8	15.9	21.3	17.8	9.9	18.8	15.0	14.2	4.3	3.9	12.5	3.1	9.2	6.1	2.6	18.3	13.8	14.2	12.4	18.1	16.3	15.8	17.3	17.1	14.2	13.0	10.7	17.4	8.8	11.5	13.7	16.4	11.6	16.9	11.9	18.2	17.7	9.4	19.1	7.9	13.6	11.6	20.0	11.9	12.1	18.7	19.1	15.4	14.5	11.4	6.3	16.1	11.8	16.2	6.8	10.5	9.2	21.4	20.7	7.3	9.4	17.2	12.9	15.7	16.2	10.7	16.3	13.6	14.7	13.6	13.9	8.1	9.2	9.7	18.2	10.1	11.9	20.3	16.1	27.9	13.1	16.2	15.7	18.3	12.5	3.1	2.6	3.6	2.7	4.9	4.3	3.3	4.0	3.9	3.8	5.0	4.6	3.5	9.2	3.0	3.2	6.1	2.6	10.3	13.1	21.1	13.7	10.6	8.7	17.3	8.1	13.2	15.9	8.9	6.9	8.8	4.1	8.0	4.9	3.5	10.2	4.0	1.2	7.0	5.9	17.2	5.0	6.6	1.6	9.8	7.2	0.0	7.4	12.5	9.8	7.6	3.5	15.5	9.4	1.6	3.5	9.2	6.3	0.4	6.1	6.4	8.5	4.6	8.5	6.3	8.0	7.0	7.4	7.9	6.1	12.9	5.1	11.1	8.9	5.5	23.0	5.0	9.8	4.3
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	15.6	14.2	5.0	13.1	6.4	10.3	12.7	7.4	7.6	13.3	10.8	6.2	17.2	10.8	13.3	13.7	10.8	9.4	13.2	9.3	5.9	5.6	13.0	43.1	18.1	25.6	7.7	4.6	10.5	19.1	17.1	17.7	25.2	9.2	11.9	14.7	10.8	17.5	18.1	5.7	12.6	15.8	9.0	8.1	16.2	13.3	7.5	6.4	24.7	13.2	10.9	17.4	10.5	11.1	5.5	8.2	13.9	14.9	8.4	10.7	5.9	10.9	5.7	6.2	13.6	13.2	13.5	15.7	7.2	19.3	8.8	11.6	5.8	7.9	4.4	15.7	14.7	7.0	10.9	7.2	10.7	13.5	6.9	4.5	8.6	9.7	10.4	14.8	11.3	9.2	15.4	6.9	14.8	18.1	8.5	14.2	8.4	5.2	19.3	11.9	4.9	8.2	5.7	6.6	5.5	7.1	4.1	11.1	5.7	7.8	12.8	3.4	6.7	12.9	14.5	9.3	4.9	7.2	6.3	15.3	20.8	8.0	19.2	11.5	13.1	6.9	4.9	21.2	9.3	5.5	13.9	10.7	7.4	10.7	10.4	9.2	5.3	9.9	8.4	8.2	5.5	8.9	9.6	5.3	8.4	14.9	7.7	7.2	5.9	5.0	6.4	7.4	7.6	5.9	5.6	7.7	4.6	9.2	6.4	29.8	16.3	25.1	16.5	50.9	8.9	3.2	15.3	10.7	12.5	22.7	5.9	26.3	1.7	20.8	0.6	24.6	16.0	0.0	23.0	19.6	25.5	36.1	36.9	38.5	19.8	4.8	21.9	35.0	29.4	0.9	15.8	29.5	30.4	14.4	32.0	7.8	29.1	24.6	15.6	16.2	12.4	6.5	22.3	6.2	7.6	55.8	34.9	29.8	20.1	24.8
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221562-113264492	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.7;salivary gland: 57.9"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 81.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.0;intermediate monocyte: 16.2;myeloid DC: 9.9;neutrophil: 5.0;non-classical monocyte: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.9;granulocytes: 5.0;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013810	Approved					NA	NA					"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.51e-2)"	7.8	12.1	5.0	4.9	6.1	4.6	6.0	3.7	6.7	10.6	16.2	6.7	21.2	20.7	4.9	7.8	9.8	4.8	5.7	5.8	5.0	4.9	15.4	55.7	8.8	3.5	5.6	4.0	6.3	11.4	5.8	9.4	7.9	7.4	10.3	8.1	8.5	57.9	21.7	3.0	14.3	41.8	4.6	5.8	8.6	9.3	4.7	5.0	2.6	6.3	6.8	9.8	5.8	5.2	1.0	9.9	5.0	17.0	2.5	2.0	4.3	8.2	8.9	7.3	16.0	16.7	12.0	26.9	14.6	22.3	10.1	11.9	12.6	7.2	6.4	5.9	12.5	12.9	20.4	13.7	8.3	11.4	5.6	7.7	5.3	7.9	14.1	40.9	9.6	8.1	14.4	18.9	13.1	21.5	6.8	9.2	7.5	12.0	12.0	9.6	8.7	6.5	4.9	11.8	31.6	10.0	6.8	19.1	6.4	9.3	10.3	6.9	9.0	14.1	28.3	38.2	10.7	14.4	8.3	8.4	7.6	4.7	15.2	8.7	7.2	14.7	9.0	12.6	9.1	8.9	1.3	13.0	1.5	1.5	16.2	2.0	1.0	1.0	1.5	9.9	0.9	1.2	1.1	5.0	2.5	17.0	1.4	1.1	4.3	5.0	6.1	3.7	6.7	5.0	4.9	5.6	4.0	7.4	5.0	32.8	31.0	8.2	8.3	13.5	12.2	7.0	17.8	25.4	40.9	5.2	31.4	14.3	8.3	15.5	0.2	8.4	47.6	0.0	23.5	21.7	15.1	32.7	4.7	81.5	41.2	6.4	8.6	12.3	27.6	0.5	5.8	27.2	11.8	11.8	14.4	11.3	18.9	11.8	6.7	23.2	11.2	6.5	12.2	11.9	34.9	13.8	18.8	2.5	16.6	16.2
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724462-38729372	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 38.3"	"Cell type enriched"	"Detected in some"	14	"Horizontal cells: 55.6"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	12	"MOLT-4: 5.5;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported				NA	NA					"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			1.0	1.1	4.6	1.0	38.3	1.5	1.0	4.9	25.8	1.0	1.0	0.8	0.0	1.0	1.0	1.0	1.0	1.1	1.0	1.0	3.9	9.7	1.0	1.0	1.0	1.0	4.4	6.8	1.0	1.1	1.0	4.1	1.0	10.4	1.0	1.0	0.7	1.0	1.0	1.0	1.0	1.1	1.0	4.4	1.0	1.0	1.6	7.9	0.0	1.0	0.0	1.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	4.6	38.3	4.9	11.9	3.9	9.7	4.4	6.8	10.4	7.9	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042430, HPA060345"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042430: AB_10806238, HPA060345: AB_2732647"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	11.3	17.3	6.5	9.9	8.6	3.1	12.1	9.4	9.4	18.8	13.1	10.5	29.9	11.3	14.0	22.9	11.8	12.3	11.5	12.9	7.8	6.7	19.4	38.3	12.8	13.6	9.4	5.6	13.6	42.4	18.8	24.6	13.9	8.9	15.0	10.5	9.2	26.6	33.9	7.0	9.4	15.2	10.4	8.2	11.9	12.4	8.9	8.8	14.9	26.1	5.8	10.7	10.2	11.6	6.0	16.7	12.1	8.3	6.9	10.8	6.0	14.9	10.4	5.4	6.7	20.0	17.3	10.2	11.2	15.0	13.6	13.4	5.9	16.0	7.7	18.1	9.1	14.2	12.7	9.3	11.0	15.4	10.9	9.6	8.0	5.0	11.6	29.0	8.8	7.1	13.8	22.1	7.2	28.1	15.2	14.9	7.3	6.4	18.6	12.2	9.5	3.5	5.2	5.2	12.6	10.0	4.0	6.0	23.1	13.9	9.5	6.3	5.2	9.4	21.9	19.9	8.0	6.9	11.2	15.4	8.0	4.0	14.7	11.7	21.9	7.7	8.1	11.5	7.2	11.4	12.1	8.3	6.0	9.4	6.5	10.8	6.0	6.8	7.4	10.7	4.1	6.5	6.3	1.8	6.9	6.3	16.7	6.1	6.0	6.5	8.6	9.4	9.4	7.8	6.7	9.4	5.6	8.9	8.8	20.8	20.6	11.9	10.4	7.9	16.4	21.8	22.9	21.4	18.2	10.4	25.5	15.7	5.0	13.3	10.1	11.3	14.8	0.0	13.5	23.4	14.7	16.8	11.5	43.1	17.3	17.5	12.0	18.4	16.2	9.1	17.3	15.9	11.8	14.4	14.7	17.2	15.0	3.5	20.1	15.5	19.9	12.9	17.2	17.2	7.2	8.3	31.5	15.8	12.1	9.1
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 128.7"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Group enriched"	"Detected in some"	12	"HEL: 6.7;U-937: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA			"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	7.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	81	"BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0	443.7	1050.6	0.0	0.1	0.0	0.0	0.6	40.8	125.8	178.6	19.2	0.0	1.6	5.0	57.7	3.5	0.0	0.0	0.0	7.1	0.0	0.0	3.5	26.7	0.0	0.2	0.0	0.0	0.0	0.0	14.0	1.1	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236554	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 10.4;kidney: 14.8"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 20.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA023776	Enhanced					NA	NA					"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0.0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	1.6	0.2	0.2	0.2	0.0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.7	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	6.0	0.4	0.2	0.0	0.1	3.0	0.0	0.0	0.0	3.7	0.2	0.0	4.0	2.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.7	0.0	9.7	0.1	0.1	0.6	1.1	1.2	1.3	0.5	0.0	0.0	0.5	0.0	1.5	0.6	1.4	0.3	0.7	3.4	0.1	0.4	0.5	0.4	1.9	0.1	1.1	0.5	0.4	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	11.0	18.0	14.0	9.2	19.8	6.3	20.5	24.1	22.9	19.2	25.3	10.0	8.0	12.0	20.1	15.1	10.0	13.6	12.7	10.6	15.2	13.8	15.7	20.8	24.2	10.3	16.3	11.6	15.8	11.6	13.0	24.4	12.6	21.4	24.9	31.6	13.1	19.4	11.4	9.1	15.9	14.5	18.9	12.2	14.0	18.8	8.1	14.5	18.6	14.2	8.2	11.8	17.4	12.0	9.4	24.6	21.6	28.4	8.7	15.1	17.2	2.0	5.0	9.1	10.7	24.9	22.8	7.3	6.1	5.4	5.1	7.1	4.3	37.8	7.6	7.5	7.5	14.2	8.1	10.9	4.9	6.6	10.8	8.1	8.6	6.8	7.6	16.4	11.1	6.0	11.6	12.0	6.0	11.8	12.1	12.2	11.2	11.0	12.6	7.5	19.0	3.0	16.9	4.9	26.0	8.2	9.6	8.9	8.1	15.8	8.8	6.0	6.6	11.2	21.1	9.7	10.9	18.7	22.9	11.3	7.4	5.0	8.1	4.9	9.4	13.6	2.8	6.2	19.9	10.5	21.6	28.4	11.6	9.8	22.1	15.1	9.4	10.6	11.9	24.6	8.7	13.6	12.6	7.0	8.7	21.5	9.1	13.6	17.2	14.0	19.8	24.1	22.9	15.2	13.8	16.3	11.6	21.4	14.5	41.7	25.2	6.9	15.8	13.2	6.9	5.2	17.8	16.0	10.3	15.7	11.8	20.9	6.6	8.2	5.8	14.3	15.8	0.0	7.9	15.9	17.7	17.6	21.8	17.4	14.5	11.1	14.5	47.3	30.6	4.9	15.3	13.6	20.3	10.8	73.6	18.1	8.5	14.0	18.0	9.3	6.4	19.4	16.5	7.5	9.7	12.9	23.0	13.8	25.5	7.4
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	11.4	17.2	10.5	9.7	12.2	10.9	21.9	5.9	18.4	16.2	22.7	20.5	13.4	13.5	11.5	24.2	17.2	23.1	14.3	12.8	10.3	10.9	18.8	43.6	14.5	18.9	12.0	9.7	10.6	30.6	18.8	16.2	29.8	12.7	14.1	23.1	10.3	16.9	14.7	12.9	15.9	13.0	9.0	13.8	12.1	19.8	8.8	10.3	8.8	13.3	12.5	13.0	11.3	11.4	7.5	18.5	24.2	15.7	7.8	10.9	6.9	20.5	23.7	8.1	11.5	17.4	14.1	11.9	21.2	20.7	21.2	25.6	25.5	36.3	7.7	10.1	23.2	29.0	29.6	21.8	16.3	17.6	10.2	14.7	8.5	14.9	19.9	20.3	16.2	18.4	15.0	27.6	18.7	17.7	12.1	12.4	11.1	16.1	12.8	15.7	19.5	7.9	13.4	16.8	23.1	28.9	8.5	14.5	23.6	19.2	16.8	9.4	15.2	22.1	24.0	12.1	15.9	35.2	12.7	8.9	12.8	13.1	23.0	11.9	20.0	13.6	8.5	15.5	13.3	15.8	11.4	14.4	24.2	10.2	15.7	10.9	7.5	9.2	9.6	17.5	7.3	5.8	10.6	15.9	7.8	10.6	18.5	8.8	6.9	10.5	12.2	5.9	18.4	10.3	10.9	12.0	9.7	12.7	10.3	8.9	17.1	6.7	10.5	12.6	4.5	4.2	10.2	20.1	6.8	15.7	0.0	27.3	3.3	23.0	2.5	11.9	18.8	23.3	28.6	22.7	14.8	16.6	2.3	14.9	21.4	6.4	12.2	12.3	10.1	1.0	9.2	11.9	10.1	30.7	30.3	9.4	20.7	17.5	10.3	10.5	4.6	6.5	7.3	5.6	4.1	15.3	40.2	9.6	17.4	22.6
SLC35A3		ENSG00000117620	"Solute carrier family 35 member A3"	Q9Y2D2	1	99969351-100035637	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015253	Uncertain					NA	NA					"HPA015253: AB_1857106"	"unprognostic (1.05e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.34e-2)"	10.7	9.4	6.5	16.7	6.8	5.9	16.2	7.4	8.9	12.4	31.4	5.5	16.2	29.1	10.5	10.8	14.9	9.5	12.5	7.1	5.4	4.8	13.2	21.9	18.0	10.9	7.0	6.3	7.9	13.8	12.8	8.6	12.2	9.6	14.4	32.7	6.0	22.3	21.9	7.5	10.0	41.0	15.3	7.6	6.3	19.9	5.1	5.6	24.7	15.3	7.9	8.1	13.9	13.0	4.3	9.0	6.4	3.7	7.7	5.2	3.2	17.4	4.7	4.3	4.5	9.8	8.6	17.3	15.6	9.5	6.2	9.0	3.1	9.5	9.4	19.6	9.0	8.7	10.1	8.1	7.0	14.2	11.5	5.9	8.5	6.7	7.4	6.2	13.5	1.0	4.6	7.9	7.4	14.6	7.4	7.1	7.5	14.0	14.1	12.5	4.3	8.9	7.1	5.3	10.0	15.9	2.8	13.2	5.9	11.3	10.1	5.6	3.1	10.8	20.9	8.2	4.2	12.7	10.3	8.2	9.4	8.5	20.7	8.3	8.4	9.8	7.0	15.0	8.5	3.9	6.4	3.6	2.0	4.2	3.7	4.7	4.3	4.2	4.9	3.1	3.4	5.2	4.4	1.2	7.7	2.9	9.0	4.8	3.2	6.5	6.8	7.4	8.9	5.4	4.8	7.0	6.3	9.6	5.6	74.5	25.8	14.7	19.1	22.1	16.3	7.4	22.9	64.3	35.2	52.4	19.6	15.3	6.6	14.1	3.5	17.5	139.9	0.0	13.4	24.2	13.2	46.0	16.2	42.7	12.4	9.5	19.0	23.9	17.4	0.0	12.4	12.9	8.5	9.0	96.8	16.0	18.6	71.9	12.4	28.5	22.5	6.5	15.1	11.9	5.7	26.0	19.5	21.8	78.5	31.8
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	18.0	28.2	14.8	12.6	15.0	10.7	17.7	16.2	24.8	18.3	18.9	35.8	19.0	13.0	22.6	23.4	14.3	18.6	27.1	17.7	15.2	10.9	32.3	35.5	16.1	12.9	17.1	14.6	16.7	38.1	27.4	11.1	26.1	19.8	19.0	20.2	23.8	49.6	20.4	17.5	15.6	16.4	20.5	24.7	18.4	20.6	16.3	18.7	12.2	19.3	17.8	17.6	19.6	14.3	12.9	14.4	21.8	8.6	10.8	21.1	10.2	23.1	13.3	16.7	32.0	27.5	29.1	12.2	25.4	42.1	25.0	30.8	11.7	21.6	5.2	22.9	31.4	26.9	22.1	11.4	28.6	17.6	15.3	14.7	10.4	10.5	13.9	25.7	22.2	17.0	29.8	30.1	23.0	11.3	34.6	18.3	11.9	14.9	22.4	29.9	27.2	8.2	18.6	7.4	69.9	15.5	8.2	10.8	26.4	27.0	17.2	20.8	20.0	12.5	13.9	28.6	10.9	25.8	20.4	18.1	19.7	13.1	19.6	22.1	17.3	19.7	12.1	26.3	17.7	40.0	21.8	8.6	13.2	21.1	6.5	17.8	12.9	11.9	16.1	7.7	7.7	11.0	14.2	0.7	10.8	2.3	14.4	9.6	10.2	14.8	15.0	16.2	24.8	15.2	10.9	17.1	14.6	19.8	18.7	6.0	11.5	22.3	25.5	11.9	9.7	6.7	43.3	5.3	11.4	26.2	2.0	50.8	11.6	69.2	0.4	9.8	13.7	0.0	64.7	44.1	30.6	27.0	34.6	15.3	32.9	9.5	18.9	16.0	9.9	1.2	21.6	10.0	50.6	32.5	20.3	42.2	56.9	27.4	18.7	11.5	12.5	0.0	16.7	15.2	67.3	12.2	29.4	13.1	29.9	18.4
SLC35B4	"FLJ14697, YEA4"	ENSG00000205060	"Solute carrier family 35 member B4"	Q969S0	7	134289332-134317051	"Predicted membrane proteins"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 50.1;Cytotrophoblasts: 73.7;Syncytiotrophoblasts: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049779	Approved					NA	NA					"HPA049779: AB_2680878"	"unprognostic (1.84e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.00e-1)"	7.8	10.1	9.6	7.4	16.8	2.7	5.3	22.4	21.6	6.8	5.4	10.8	4.8	4.5	9.4	10.1	5.0	6.8	6.1	4.0	10.1	12.4	15.9	11.6	5.1	6.3	9.4	9.6	10.3	4.0	6.4	6.7	17.5	12.7	8.4	5.7	9.9	3.8	10.0	3.5	4.9	5.9	10.8	8.6	6.5	5.2	6.9	8.6	6.8	5.4	2.0	7.2	6.4	4.3	3.2	6.5	1.3	4.6	4.0	5.7	2.9	3.8	12.8	11.3	16.8	11.0	9.3	5.8	9.7	8.1	8.6	7.3	4.9	3.6	12.9	3.3	10.4	11.3	4.1	16.6	8.6	14.4	8.1	12.4	8.7	7.5	6.5	8.1	12.2	7.9	8.1	3.7	10.3	8.8	6.5	8.3	9.0	8.4	4.8	12.9	3.4	10.8	9.0	23.3	3.9	11.6	7.9	9.9	6.3	4.8	4.7	4.0	23.2	8.6	2.9	10.6	9.8	1.6	7.0	9.2	11.3	3.7	6.7	9.5	15.9	21.8	15.0	20.1	11.6	12.9	1.3	3.4	0.7	3.8	4.6	5.7	3.1	3.5	4.7	6.5	3.2	3.4	5.0	0.4	4.0	3.5	4.5	3.7	2.9	9.6	16.8	22.4	21.6	10.1	12.4	9.4	9.6	12.7	8.6	8.9	4.8	6.4	4.8	1.9	50.1	5.3	7.6	8.1	9.1	1.8	43.2	73.7	10.0	7.7	1.5	8.7	3.1	0.0	4.6	21.6	9.3	4.4	1.1	14.4	18.3	39.7	4.1	4.9	8.6	2.9	10.3	8.6	5.0	3.6	3.8	16.4	6.9	3.1	11.7	13.6	20.5	6.5	4.2	10.8	21.7	2.9	69.6	7.1	3.1	3.4
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813015	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.7"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 49.8;Enterocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.30e-2)"	14.9	4.8	5.1	7.2	4.5	1.5	14.3	4.4	7.3	7.0	13.8	4.4	4.9	17.4	7.1	3.2	22.5	6.1	8.8	5.3	5.4	3.9	6.0	74.7	7.1	7.1	3.9	3.6	4.9	11.4	4.9	7.8	10.5	5.6	6.0	9.8	3.6	15.5	7.0	8.5	3.4	17.4	6.8	5.0	6.5	13.4	7.4	4.8	5.6	5.2	7.0	10.9	9.4	8.6	4.7	8.3	9.9	10.5	4.3	16.7	8.6	5.2	13.7	3.1	8.0	10.2	10.3	10.5	11.6	10.0	6.7	7.5	6.2	8.7	5.0	5.5	13.1	10.0	14.0	6.5	6.8	3.2	13.0	7.8	2.8	11.0	11.2	22.4	5.5	8.7	12.3	8.2	5.1	5.6	8.1	8.8	5.1	6.3	7.5	7.1	11.5	2.8	4.2	13.9	19.4	19.4	3.8	5.2	11.8	7.5	13.3	3.1	4.5	8.6	8.3	4.7	3.4	7.4	2.9	13.3	14.1	8.2	24.8	8.2	5.5	12.9	2.5	10.1	7.2	7.7	5.0	10.2	9.9	10.2	10.5	11.1	4.7	16.7	13.4	8.3	3.6	8.5	7.4	1.6	4.3	6.9	7.2	10.8	8.6	5.1	4.5	4.4	7.3	5.4	3.9	3.9	3.6	5.6	4.8	0.0	9.1	3.0	8.5	3.2	1.7	49.8	25.5	8.1	4.5	5.2	2.0	12.0	0.0	18.1	3.4	7.6	46.6	0.0	37.1	12.3	11.0	8.0	2.3	37.2	13.3	3.2	9.2	6.7	7.1	4.1	6.1	5.3	1.7	9.0	30.4	2.5	36.3	43.2	5.3	3.5	1.0	0.0	5.2	4.3	3.3	2.0	12.8	5.2	19.9	16.9
SLC35D1	"KIAA0260, UGTREL7"	ENSG00000116704	"Solute carrier family 35 member D1"	Q9NTN3	1	66999332-67054099	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.91e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.63e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (2.12e-3)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.20e-1)"	4.0	6.3	5.1	7.5	7.0	4.7	4.7	6.6	5.5	6.2	16.2	7.5	4.8	9.9	5.4	3.8	5.3	4.4	4.4	3.8	4.7	3.8	8.1	50.4	3.8	5.7	7.4	4.0	6.4	7.2	6.4	8.7	6.0	5.4	5.6	17.3	7.1	3.9	4.0	6.9	6.2	14.3	5.4	4.0	4.0	8.0	4.1	5.6	11.1	5.1	4.0	6.4	5.8	6.5	2.3	1.8	9.7	2.4	5.1	4.3	1.4	5.0	2.9	8.9	7.5	9.3	10.8	10.6	11.3	15.0	8.2	5.8	6.2	1.2	15.6	5.0	8.9	9.7	7.7	6.1	7.2	10.4	15.5	2.8	11.6	6.1	12.2	7.8	13.1	7.7	10.5	16.1	9.7	6.9	13.3	3.1	6.6	7.0	8.3	19.9	1.7	8.0	4.1	3.7	13.6	4.0	6.2	18.4	1.7	3.8	9.6	1.1	4.0	17.1	5.3	7.2	5.2	4.4	9.8	3.4	15.4	3.6	9.4	10.8	17.4	9.0	8.7	11.0	2.0	6.5	9.7	1.5	4.0	3.4	1.1	4.2	2.3	2.6	2.7	1.8	1.7	3.7	3.3	0.3	5.1	2.4	1.0	4.3	1.4	5.1	7.0	6.6	5.5	4.7	3.8	7.4	4.0	5.4	5.6	6.0	2.1	4.3	4.7	4.8	6.9	2.6	33.1	6.7	2.3	5.2	11.8	30.4	0.0	2.8	37.3	4.2	36.7	23.3	8.6	4.0	7.2	5.6	4.6	84.4	6.2	6.4	14.5	6.7	9.2	6.6	5.8	3.8	1.7	1.0	14.9	21.0	7.2	14.4	4.2	8.4	8.7	0.0	3.9	7.6	6.7	6.8	13.6	6.9	13.4	7.4
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96320706-96383710	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.6"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	8.7	6.1	5.9	7.8	13.6	4.6	8.8	1.6	10.8	7.9	23.8	21.2	4.2	30.7	8.3	8.7	8.7	7.8	16.2	7.3	7.8	5.2	20.1	27.9	13.2	17.6	13.7	4.7	10.5	26.0	8.0	5.1	10.5	9.2	8.0	22.6	13.1	8.5	5.3	2.8	5.7	39.6	11.2	14.3	6.5	18.7	5.1	9.8	2.7	14.3	5.0	7.5	10.0	8.0	1.5	2.4	1.6	1.4	1.9	5.3	1.0	11.3	8.9	5.6	11.5	7.1	14.7	10.6	5.1	10.8	7.9	6.7	18.2	37.6	0.2	8.5	4.5	18.6	16.5	7.7	8.0	7.0	5.3	6.3	4.1	3.7	31.2	10.5	0.0	0.0	12.0	9.5	6.1	17.4	15.6	17.2	0.0	7.6	0.1	8.7	7.7	0.0	0.0	4.9	21.2	10.3	0.0	0.0	0.0	18.8	6.9	2.1	13.1	4.4	8.9	22.6	19.4	5.6	8.2	15.3	5.5	5.9	7.9	4.9	0.0	0.3	0.0	11.3	0.0	7.5	1.6	1.4	1.0	1.8	1.0	2.4	1.5	2.2	3.5	2.4	0.3	0.7	1.7	0.1	1.9	0.8	0.1	5.3	1.0	5.9	13.6	1.6	10.8	7.8	5.2	13.7	4.7	9.2	9.8	8.9	8.3	0.9	7.2	4.6	0.5	6.9	30.6	6.7	5.7	12.2	2.0	23.1	10.0	6.1	0.1	11.3	52.6	0.0	21.1	37.7	5.0	13.5	4.6	41.4	17.3	1.6	9.2	10.4	16.1	0.2	10.0	9.4	16.9	7.2	45.1	7.7	22.3	38.6	5.6	18.0	3.5	12.9	7.6	1.5	1.9	4.6	22.2	8.4	27.7	13.9
SLC36A1	"LYAAT-1, PAT1, TRAMD3"	ENSG00000123643	"Solute carrier family 36 member 1"	Q7Z2H8	5	151437046-151492381	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.3"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 49.3;Enterocytes: 37.0;Kupffer cells: 22.4;Late spermatids: 21.6;Paneth cells: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.9;monocytes: 6.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035937	Approved					NA	NA					"HPA035937: AB_10672995"	"unprognostic (5.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (6.30e-5)"	"unprognostic (1.86e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-1)"	5.6	4.7	5.1	6.0	11.1	19.3	4.4	43.3	15.3	3.8	11.1	5.0	11.6	32.5	4.6	3.8	5.4	3.8	8.3	3.7	4.2	4.1	7.3	3.5	6.0	4.5	6.0	6.8	4.0	6.5	32.1	6.3	4.4	13.9	9.9	17.5	4.1	5.1	7.6	7.6	3.9	28.7	5.2	4.1	9.2	4.8	11.2	5.0	7.1	3.7	3.6	4.2	7.2	4.5	1.7	2.1	15.9	6.6	0.3	1.9	0.8	3.9	6.8	3.6	2.4	9.0	6.6	19.3	11.5	6.4	8.0	9.0	15.6	5.8	9.1	6.8	13.7	8.5	9.7	11.3	7.1	7.9	2.5	9.8	2.8	11.1	5.2	11.6	6.7	15.5	4.8	8.3	6.7	4.4	2.2	7.0	5.0	6.4	8.0	6.7	4.3	1.9	3.4	3.5	4.9	6.4	0.0	8.6	3.6	2.1	5.9	3.2	6.2	7.1	8.6	4.1	7.6	6.5	9.8	7.0	10.7	6.0	17.3	6.4	3.8	5.3	5.9	6.8	11.8	7.0	15.9	6.6	2.5	1.2	2.8	0.8	1.6	1.1	1.9	2.1	1.7	0.9	0.8	14.5	0.3	2.8	0.4	1.1	0.8	5.1	11.1	43.3	15.3	4.2	4.1	6.0	6.8	13.9	5.0	0.0	1.7	0.0	1.0	1.3	1.2	2.2	7.6	0.0	1.2	1.8	2.0	0.5	0.0	1.6	49.3	1.0	37.0	0.0	1.7	7.2	2.3	2.8	1.1	1.7	12.1	1.6	0.0	4.9	22.4	21.6	4.6	3.8	1.7	1.0	6.1	0.8	1.6	21.0	11.0	3.9	0.8	0.0	1.9	0.5	1.9	1.1	0.2	2.1	6.9	1.8
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314978-151347590	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1"	"Cell type enriched"	"Detected in some"	9	"Proximal tubular cells: 44.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.9;NB-4: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA044002, HPA062229"	Enhanced					NA	NA					"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	2.6	0.5	0.1	0.0	0.2	0.1	0.1	60.3	0.1	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	1.1	2.0	0.0	36.8	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1.0	0.4	0.0	0.1	0.0	0.6	0.3	0.8	0.3	0.2	0.3	0.4	0.0	0.7	0.0	1.5	1.5	0.3	0.8	0.3	0.0	1.9	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.1	1.4	0.2	0.3	0.4	2.0	1.2	0.0	0.2	0.5	0.4	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0.0	0.2	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC36A3	"PAT3, TRAMD2, tramdorin2"	ENSG00000186334	"Solute carrier family 36 member 3"	Q495N2	5	151276762-151303766	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	17	"testis: 14.5"	"Group enriched"	"Detected in some"	57	"Early spermatids: 47.0;Late spermatids: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA							"unprognostic (5.41e-1)"				"unprognostic (5.38e-1)"		"unprognostic (7.01e-2)"	"unprognostic (2.13e-1)"				"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.57e-2)"		"unprognostic (2.18e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144171-93197964	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	8.0	11.0	16.0	12.6	19.3	24.1	6.5	20.7	20.2	8.0	7.3	8.7	2.1	3.0	10.4	3.6	7.8	6.2	8.4	9.2	14.2	14.8	13.7	11.0	8.2	7.0	16.8	10.3	8.6	8.0	8.0	17.2	8.7	17.6	7.5	9.4	5.4	5.4	9.1	3.4	5.9	4.2	11.5	20.0	5.7	6.4	6.0	13.4	5.6	12.7	2.3	9.2	8.6	7.7	1.6	2.9	8.1	7.7	0.8	2.6	1.8	5.1	9.3	19.0	3.8	6.7	13.7	10.7	9.0	15.0	13.4	16.3	7.4	17.0	6.3	5.2	8.3	7.0	6.4	5.8	3.3	12.3	10.5	6.8	7.2	19.5	4.9	5.3	18.1	10.8	6.6	10.4	7.7	4.9	6.3	7.1	9.0	0.6	0.1	13.6	1.3	7.9	13.7	7.6	2.0	9.4	3.6	11.3	2.6	4.5	7.7	17.6	22.9	13.1	5.1	3.2	14.5	9.3	5.3	7.9	25.3	7.8	14.9	13.0	2.6	5.2	0.0	5.7	7.6	13.0	0.2	7.7	8.1	1.3	3.9	1.8	1.3	1.0	1.6	2.9	1.6	2.6	1.7	2.5	0.8	2.5	1.1	0.8	1.8	16.0	19.3	20.7	20.2	14.2	14.8	16.8	10.3	17.6	13.4	11.9	8.6	18.2	35.2	27.2	21.1	7.7	12.7	21.4	6.8	19.2	21.6	9.5	29.9	19.1	1.7	18.0	0.7	0.0	37.9	21.2	11.6	37.1	4.6	6.4	13.1	25.4	26.5	10.4	59.0	3.1	16.7	44.6	20.3	10.0	17.4	13.3	27.9	5.8	14.5	12.3	23.0	6.5	17.6	6.2	2.7	28.0	13.6	10.7	4.3	23.7
SLC37A1		ENSG00000160190	"Solute carrier family 37 member 1"	P57057	21	42496008-42581440	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 254.9;Late spermatids: 218.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 48.5;MCF7: 19.3;OE19: 20.9;SK-BR-3: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030418, CAB034154"	Approved					NA	NA					"CAB034154: AB_2190373, HPA030418: AB_10601602"	"unprognostic (1.44e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.61e-2)"	4.7	6.6	7.2	15.8	5.3	7.5	7.3	8.0	6.1	6.3	28.6	2.7	5.1	31.0	2.4	10.6	9.8	6.9	18.4	2.3	3.4	4.9	4.7	4.0	8.0	6.1	3.5	4.6	3.9	4.8	2.2	14.0	9.7	3.9	10.8	13.7	5.5	14.5	9.0	6.4	4.6	45.9	3.0	7.1	7.0	16.7	16.8	3.3	9.3	9.3	4.4	16.2	7.1	5.9	7.8	13.1	23.0	10.5	4.1	6.7	4.0	5.2	2.1	0.5	1.0	0.0	0.1	4.6	0.2	0.0	0.2	0.1	1.2	10.7	3.7	5.5	0.0	3.3	2.1	1.0	2.7	0.0	1.7	2.6	48.5	1.8	0.1	1.3	1.0	4.8	0.2	1.6	0.0	0.1	0.0	1.6	4.2	0.9	5.2	0.0	19.3	3.6	2.6	3.7	20.9	1.2	3.7	0.0	0.1	4.5	10.0	5.7	0.7	3.1	16.9	1.2	0.5	6.3	5.4	2.8	0.0	1.0	0.0	0.0	10.0	6.1	3.6	0.0	8.0	0.5	2.1	3.2	23.0	5.2	8.6	6.7	7.8	3.6	4.6	4.6	5.4	3.1	4.3	3.8	4.1	10.5	13.1	1.8	4.0	7.2	5.3	8.0	6.1	3.4	4.9	3.5	4.6	3.9	3.3	17.9	23.0	14.6	7.2	1.9	2.7	3.2	20.4	22.7	10.3	12.2	5.9	5.4	0.0	21.7	254.9	4.6	47.1	0.0	27.2	4.9	3.2	22.1	1.1	4.9	7.7	3.2	28.9	4.9	6.4	218.7	6.6	5.1	6.8	21.6	37.8	37.2	27.4	56.0	2.5	1.1	4.1	0.0	3.3	25.0	4.6	1.4	7.2	7.5	35.5	16.1
SLC37A4	"G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d"	ENSG00000137700	"Solute carrier family 37 member 4"		11	119024114-119030906	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"liver: 42.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 183.4;Hepatocytes: 134.8;Muller glia cells: 96.7;Proximal tubular cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.4;HEK 293: 17.3;Hep G2: 21.6;MCF7: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038939, HPA038940"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038939: AB_2676279, HPA038940: AB_2676280"	"unprognostic (4.77e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.34e-2)"	"unprognostic (5.39e-2)"	2.1	3.7	4.8	4.8	3.7	1.4	3.7	7.8	5.9	1.7	5.0	2.7	13.6	26.0	2.6	15.9	2.5	4.0	6.9	4.6	3.7	4.9	29.6	42.2	3.3	4.7	3.7	3.1	3.3	15.5	5.9	2.2	3.3	2.3	4.3	5.3	3.0	4.6	13.6	27.7	2.0	6.7	1.9	3.1	3.4	1.8	4.5	1.4	2.9	3.3	3.3	2.4	1.7	2.3	1.2	0.7	2.7	3.7	2.0	4.1	1.2	0.4	7.2	2.6	1.9	4.7	1.9	1.5	0.2	5.9	1.6	4.1	16.4	1.2	1.8	4.0	2.3	3.4	0.4	1.1	8.2	2.5	2.1	17.3	5.4	1.6	21.6	1.7	3.1	0.9	0.0	2.3	0.8	4.4	6.6	5.4	0.4	2.1	4.8	2.7	15.1	0.1	6.9	0.1	1.6	8.6	4.4	0.0	8.5	1.8	7.6	3.3	3.3	0.0	0.4	2.7	3.5	3.2	2.3	0.0	0.0	2.6	0.1	2.8	0.8	1.3	0.5	0.7	7.9	0.7	0.0	1.9	2.7	3.3	3.7	2.8	1.2	1.9	4.1	0.7	1.1	1.6	2.3	0.0	2.0	1.5	0.2	2.1	1.2	4.8	3.7	7.8	5.9	3.7	4.9	3.7	3.1	2.3	1.4	3.0	5.6	6.7	7.2	1.5	6.4	3.6	183.4	8.1	4.5	15.7	0.0	22.4	26.6	25.4	9.2	6.3	26.5	23.3	22.1	16.5	3.7	9.0	0.0	134.8	24.5	15.9	23.7	21.5	9.1	1.9	8.9	7.0	3.3	16.2	17.5	96.7	18.6	24.6	9.9	134.4	11.0	0.0	4.1	7.1	22.6	2.4	12.7	4.6	37.7	5.1
SLC38A1	"ATA1, NAT2, SAT1"	ENSG00000111371	"Solute carrier family 38 member 1"	Q9H2H9	12	46183063-46270017	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 374.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 77.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039460, HPA052272"	Uncertain	Supported				NA	NA					"HPA039460: , HPA052272: AB_2681781"	"unprognostic (8.92e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.74e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (2.01e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.55e-2)"	5.3	3.1	9.2	18.4	14.9	11.7	44.8	28.7	24.1	7.8	23.1	15.2	26.0	8.7	13.4	5.4	14.3	10.9	9.0	23.7	11.9	16.5	11.5	5.8	7.7	30.5	12.6	13.3	9.9	21.0	51.9	22.5	45.0	24.7	16.2	20.5	7.1	14.1	29.9	62.9	15.8	16.8	14.6	22.4	15.6	17.9	1.3	8.7	26.5	22.5	16.6	27.1	14.5	8.5	21.2	15.4	8.8	0.3	22.2	26.5	14.4	15.2	15.9	5.7	21.4	2.6	0.9	29.3	12.2	19.9	5.5	8.8	27.2	15.1	34.9	23.3	14.8	17.2	23.4	19.1	25.0	10.4	21.5	10.1	2.4	26.4	10.1	22.7	24.5	0.9	4.5	38.5	1.7	67.3	13.9	12.4	22.6	12.6	29.3	17.5	19.0	21.7	4.3	21.2	0.0	24.9	19.6	1.4	24.3	21.7	21.9	23.0	15.9	25.3	31.1	14.3	23.2	18.1	18.1	26.0	4.3	4.1	0.1	12.4	28.0	24.0	77.9	14.0	48.3	3.7	0.3	0.3	8.8	19.4	0.0	26.5	17.9	20.3	22.3	12.0	21.2	23.8	21.2	0.8	22.2	0.1	15.4	21.4	14.4	9.2	14.9	28.7	21.1	11.9	16.5	12.6	13.3	24.7	8.7	32.8	36.5	89.1	59.0	86.8	374.0	184.5	40.8	29.4	33.0	202.4	133.5	88.8	3.3	51.7	0.1	21.5	54.6	0.0	40.0	70.3	12.8	33.7	3.5	5.9	10.4	7.9	38.9	4.9	9.7	0.0	2.0	19.2	25.3	7.2	68.9	47.9	44.6	40.3	0.7	1.0	55.9	0.0	40.3	0.0	0.4	107.3	155.3	109.7	62.4	59.6
SLC38A2	"ATA2, KIAA1382, SAT2, SNAT2"	ENSG00000134294	"Solute carrier family 38 member 2"	Q96QD8	12	46358189-46372867	"Predicted membrane proteins"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Basal keratinocytes: 993.3;Suprabasal keratinocytes: 942.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 135.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035180	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA035180: AB_10669901"	"unprognostic (6.61e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.68e-2)"	44.7	45.4	19.9	23.3	34.5	27.0	72.0	34.5	40.6	36.2	25.5	23.6	20.0	11.6	45.2	16.2	47.1	36.6	46.8	39.2	24.2	14.0	27.4	102.9	51.9	34.5	54.4	15.2	49.3	27.3	54.3	16.2	76.6	32.6	25.7	17.8	17.7	36.6	20.3	47.8	69.5	25.1	40.4	60.0	28.6	29.2	19.7	43.8	40.7	32.0	35.6	26.2	36.0	49.3	12.1	24.7	17.9	13.5	30.0	15.3	12.7	8.4	20.0	17.4	47.6	40.5	40.9	12.6	40.1	103.1	35.2	29.1	11.9	16.1	0.0	54.0	68.5	23.5	29.2	12.1	37.3	34.5	6.8	6.8	11.0	24.4	36.6	62.3	8.9	11.7	40.9	81.3	22.2	135.9	86.7	29.8	12.4	10.8	17.1	62.4	10.6	10.9	13.1	14.8	0.0	20.9	9.9	12.9	21.0	21.5	19.1	11.5	9.9	27.1	7.6	24.4	19.7	15.4	20.9	49.0	16.9	13.4	7.2	6.3	19.7	18.6	10.4	16.3	32.4	8.3	17.9	13.5	10.5	14.3	7.8	11.1	12.1	12.0	14.2	20.8	11.9	15.2	15.3	10.5	30.0	10.1	24.7	13.9	12.7	19.9	34.5	34.5	40.6	24.2	14.0	54.4	15.2	32.6	43.8	77.4	94.1	77.1	114.9	993.3	38.3	137.9	99.3	25.4	56.9	54.1	66.8	40.9	5.0	36.4	4.2	142.4	78.6	186.9	43.6	41.4	160.4	157.7	78.7	245.9	47.8	50.9	73.5	233.9	166.5	5.0	243.7	110.6	237.8	20.8	107.5	73.3	64.3	63.0	79.9	22.3	73.5	278.1	220.9	7.2	14.7	942.6	32.2	136.8	67.6	105.8
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 107.8"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"					"Cell type enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Hep G2: 32.4;SCLC-21H: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	0.7	0.3	3.4	0.3	5.2	0.5	0.7	2.4	10.5	0.3	0.3	10.3	0.0	0.7	0.4	0.4	0.6	0.4	0.4	2.0	4.1		1.5	107.8	0.3	0.4	3.4	4.0	2.4	11.6	1.8	0.7	0.6	7.8	0.4	0.3	22.2	0.9	0.3	10.4	0.5	0.4	0.3	4.7	0.3	0.9	0.7	5.2	0.0	0.6	1.9	0.4	0.3	0.0	1.1	1.0	5.6	0.8	1.5	0.8	0.2	0.0	0.0	0.8	4.9	0.0	0.0	1.3	0.0	0.0	0.9	0.4	2.9	0.1	0.1	0.8	0.0	0.2	0.0	1.3	0.0	0.6	0.1	0.4	0.0	0.6	32.4	0.1	0.3	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.0	0.4	0.3	0.0	0.1	0.2	10.8	0.9	0.5	0.1	0.0	1.5	1.3	0.2	0.0	0.2	0.9	0.0	0.7	0.3	0.0	0.1	0.1	0.2	0.1	5.6	0.8	0.9	0.6	0.2	0.4	0.7	0.5	0.4	0.2	1.1	0.6	0.8	3.3	1.5	0.2	1.0	0.4	0.2											0.0	0.0	1.9	0.1	0.0	86.1	2.8	15.3	0.0	0.0	0.0	176.7	0.2	0.0	0.7	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	93.4	0.1	7.9	3.4	0.0	3.3	0.0	2.0	0.0	0.0	1.0	0.0	75.9	0.8	0.0	0.4	1.4	112.3	0.0	0.0	1.0	1.8	0.0	1.1	0.0	0.0	0.0
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 128.2"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 251.9"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;NK-cell: 1.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 3.0;NK-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.8;LHCN-M2: 21.7;RH-30: 7.2;RT4: 42.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.2	0.1	0.1	1.4	0.0	0.0	0.1	0.1	0.2	0.1	0.9	0.0	0.3	0.0	1.7	0.1	0.6	0.1	0.3	1.1	0.0	0.0	5.9	128.2	0.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	1.0	0.1	0.4	0.2	0.1	0.3	0.0	2.9	0.4	0.1	1.4	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.4	0.2	0.7	0.0	0.1	0.3	3.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	8.8	1.1	1.7	1.0	2.8	0.9	0.9	0.5	2.0	0.0	1.7	3.7	0.0	0.5	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	21.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.2	0.0	0.0	42.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	15.3	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.4	1.9	0.4	0.0	251.9	0.4	0.0	0.0	3.1	3.9	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.6	0.0
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell type enhanced"	"Detected in many"	14	"Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	23.0	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	24.2	0.0	10.2	0.0	35.6	27.6	54.3	0.0	7.7	0.0	13.1	53.5	16.6	4.0	26.8	0.0	3.8	40.4	0.5	0.1	0.0	0.4	5.9	24.1	47.8	5.4	0.0	5.8	9.3	12.5	0.0	0.1	21.3	0.1	87.9	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.1	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.7	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6	0.0	1.1	0.8	1.6	23.7	0.6	0.4	0.0	1.4	0.0	5.2	17.7	0.1	0.0	4.9	0.4	3.1	2.3	23.3	67.4	0.4	5.6	0.9	4.6	0.4	2.5	0.0	0.0	0.0	0.0	0.7	2.3	1.1	8.5	2.8	12.3	0.0	93.7	3.5	1.1	0.0	0.2	0.0	1.0	0.0	0.0	7.4	0.0	8.5	19.1	0.9
SLC39A1	"ZIP1, ZIRTL"	ENSG00000143570	"Solute carrier family 39 member 1"	Q9NY26	1	153959099-153968184	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 292.9;Extravillous trophoblasts: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.27e-2)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (5.26e-5)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (2.36e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-2)"	32.5	31.8	12.5	20.6	19.3	3.8	28.0	11.1	14.0	21.8	24.1	16.6	18.2	15.9	28.7	20.8	25.6	20.8	31.9	25.5	13.2	9.3	39.0	53.7	34.7	19.5	20.7	10.1	28.1	27.8	20.7	13.0	65.5	16.2	29.5	17.2	20.1	21.9	22.3	18.6	25.6	22.4	22.2	18.6	28.1	23.6	14.9	17.4	15.2	46.9	24.5	18.5	23.7	28.5	17.4	22.3	26.9	34.7	11.1	14.1	20.4	24.1	27.9	22.8	19.2	21.6	22.2	50.1	15.7	38.1	26.2	29.0	41.1	62.4	9.4	50.3	21.5	21.9	54.4	23.1	23.8	15.0	29.4	18.7	12.8	29.7	18.1	24.7	9.7	14.9	26.8	22.2	20.6	20.6	24.5	18.7	10.9	12.0	11.0	21.0	49.2	9.8	12.5	32.3	49.8	22.1	11.1	19.8	11.4	41.0	17.5	10.2	23.9	29.6	76.1	27.1	30.6	40.8	20.8	16.9	24.3	22.1	17.2	22.5	13.3	17.0	12.1	17.3	7.7	32.1	5.9	27.3	7.8	14.1	30.6	8.8	13.9	10.7	10.6	22.3	17.4	11.7	10.6	26.9	11.1	34.7	20.2	10.1	20.4	12.5	19.3	11.1	14.0	13.2	9.3	20.7	10.1	16.2	17.4	8.9	3.5	16.6	81.5	50.3	7.0	11.8	50.9	5.3	3.4	50.6	2.0	292.9	11.6	174.0	0.7	65.7	26.4	0.0	99.6	244.0	77.9	82.7	36.8	23.7	103.7	17.5	18.5	31.3	47.4	2.0	44.8	38.9	45.5	117.2	28.0	38.0	101.5	25.9	58.4	35.1	5.8	45.3	63.7	14.4	23.2	46.7	128.0	19.2	32.9	64.0
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.0;thyroid gland: 39.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		49000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	6.6	10.9	16.0	6.0	24.8	3.7	6.2	10.8	41.0	9.8	3.8	4.2	4.9	3.6	9.4	3.3	3.5	8.5	7.6	4.7	15.0	11.2	7.8	2.1	6.3	6.5	8.5	24.4	7.4	5.7	5.8	5.7	10.7	15.7	16.7	4.0	1.4	4.8	6.5	3.3	5.7	5.7	6.7	10.2	14.4	4.3	7.9	6.2	10.6	39.9	1.7	6.4	6.1	4.9	9.4	18.4	19.3	2.7	11.0	4.6	1.5	2.9	9.9	18.9	5.2	3.7	8.8	9.8	13.7	6.7	6.6	3.3	14.8	10.6	4.1	20.9	7.8	5.1	4.2	11.5	12.6	8.4	2.1	8.6	4.6	15.4	12.1	4.1	16.8	1.9	5.2	1.8	7.3	8.4	23.4	14.8	4.2	13.3	5.8	10.6	2.8	4.8	5.2	22.0	17.2	7.8	11.3	6.6	10.2	28.8	4.9	7.3	10.0	13.7	28.0	7.2	34.5	4.5	10.5	14.5	12.1	14.0	7.9	7.1	2.0	1.2	2.4	9.7	7.9	12.2	19.3	2.7	1.9	4.5	2.5	3.5	6.8	4.0	3.7	3.3	9.4	3.5	4.6	0.5	11.0	1.8	18.4	3.9	1.5	16.0	24.8	10.8	39.7	15.0	11.2	8.5	24.4	15.7	6.2	3.0	10.9	18.2	9.3	22.8	21.9	7.3	7.6	6.7	29.6	34.9	7.9	41.3	1.7	17.6	23.2	27.0	2.9	23.3	9.5	54.8	20.3	18.5	12.7	2.5	21.6	7.9	15.0	24.5	18.1	11.5	17.5	29.7	6.8	8.2	5.1	15.6	17.5	2.9	17.7	14.9	19.9	12.9	13.8	47.8	27.0	17.9	19.6	21.5	4.5	6.4
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367249-22434129	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"		"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 135.5;pancreas: 77.2"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 491.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 66.5"	"Low region specificity"	"Detected in all"							"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		950000	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	15.0	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3.0	6.4	4.0	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19.0	5.0	1.8	2.5	0.5	2.9	8.7	3.9	10.4	13.9	3.9	7.8	14.0	11.8	8.5	15.0	66.5	23.5	37.1	46.2	9.9	10.4	8.5	17.6	61.2	11.5	19.2	18.7	38.8	10.8	11.0	8.3	11.1	46.5	33.3	5.7	9.1	12.5	15.3	41.6	29.1	11.9	10.4	7.5	7.2	10.7	11.9	4.8	8.6	3.6	23.7	16.6	10.7	12.3	7.3	22.2	8.6	4.5	6.6	10.3	15.3	6.6	31.0	8.7	5.2	8.3	5.7	29.2	14.9	18.4	15.4	6.2	5.6	13.6	41.3	7.6	17.0	0.0	0.5	2.5	8.3	0.1	8.7	5.0	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8	3.0	4.8	3.7	8.8	29.7	7.1	50.1	50.9	0.0	3.4	7.0	2.0	0.2	1.7	48.7	0.4	31.6	63.6	0.0	63.9	2.1	30.9	17.2	0.0	491.4	1.5	46.1	32.0	31.9	15.9	1.8	22.2	1.6	42.2	4.6	51.4	4.6	55.6	28.8	39.3	21.4	7.4	0.0	46.7	0.0	2.4	18.3	0.5	4.9	33.7	9.8
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"HaCaT: 23.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Plasma membrane"	"Cytoplasmic bodies"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	1.3	0.3	0.4	5.6	1.2	0.0	44.3	0.0	0.8	0.0	13.0	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.2	1.0	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.3	0.1	6.1	3.3	1.2	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.8	4.2
SLC39A3	ZIP3	ENSG00000141873	"Solute carrier family 39 member 3"	Q9BRY0	19	2732204-2740152	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 234.7;Late spermatids: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042139, HPA058526"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA042139: AB_10793875, HPA058526: AB_2683743"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.75e-3)"	"unprognostic (9.22e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.80e-2)"	11.1	15.5	13.3	8.3	18.0	23.9	13.3	10.6	28.0	12.7	10.8	14.0	8.3	10.2	14.3	19.5	10.5	14.6	10.5	11.7	14.4	13.0	11.0	23.6	9.0	11.7	11.5	12.9	11.0	11.9	17.8	15.5	10.6	14.9	10.8	8.8	10.7	12.4	11.7	11.2	8.1	9.4	14.0	11.1	12.9	9.3	50.1	8.8	13.0	12.5	6.8	9.4	14.2	7.8	24.4	38.0	29.6	17.5	13.1	17.5	15.4	11.9	9.7	7.3	18.0	15.2	10.4	7.4	8.7	10.3	16.1	16.5	10.5	7.8	7.4	5.6	14.9	12.8	9.7	11.2	11.6	10.1	0.0	8.0	32.5	7.2	10.5	16.8	26.9	47.6	9.3	18.8	11.9	9.8	5.8	8.2	13.9	35.6	33.1	10.8	7.7	13.2	20.2	7.8	10.6	12.9	17.5	4.8	22.0	7.6	9.3	10.1	9.2	7.6	5.4	18.1	4.9	9.5	35.3	5.0	11.3	6.2	17.5	12.6	9.0	14.1	7.0	8.5	90.6	13.4	16.4	17.5	29.6	17.5	16.1	15.4	24.4	15.4	14.9	23.4	24.4	12.9	14.5	7.8	13.1	15.5	38.0	9.7	15.4	13.3	18.0	10.6	28.0	14.4	13.0	11.5	12.9	14.9	8.8	3.0	3.2	33.4	14.3	9.2	19.5	6.7	28.1	5.3	5.7	7.0	7.9	32.9	14.9	40.6	234.7	14.4	18.4	70.0	53.8	46.9	22.6	24.4	25.3	27.7	57.4	46.1	23.1	17.2	18.1	338.5	19.8	24.6	23.6	28.9	16.6	28.8	36.0	20.3	26.2	18.0	15.4	25.8	15.1	118.7	27.5	8.5	22.1	20.0	23.4	14.6
SLC39A4	"AEZ, AWMS2, ZIP4"	ENSG00000147804	"Solute carrier family 39 member 4"	Q6P5W5	8	144409742-144416895	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 77.7"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 153.2;Proximal tubular cells: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CAPAN-2: 17.7;Hep G2: 45.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.59e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.04e-4)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.87e-1)"	0.2	0.0	0.5	1.1	0.2	0.1	0.2	0.2	1.1	0.2	73.9	0.2	0.2	42.1	0.2	0.4	0.2	0.3	0.7	0.2	0.2	0.0	8.3	0.4	1.3	0.2	0.2	0.2	1.5	0.6	0.0	0.3	0.4	0.2	0.4	0.1	0.2	0.5	0.2	0.2	0.0	77.7	0.2	0.2	0.2	1.2	0.4	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	17.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.4	0.7	0.1	45.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.2	1.1	0.2	0.0	0.2	0.2	0.2	0.2	17.9	22.7	23.4	28.9	16.7	0.1	5.6	22.9	26.8	13.6	40.1	0.0	15.3	43.1	36.9	1.1	9.8	153.2	23.3	37.2	53.2	13.5	30.9	36.9	22.7	29.1	3.2	40.9	7.4	15.7	1.3	7.5	21.5	20.3	27.1	76.6	7.1	53.4	115.8	6.0	139.9	1.0	6.5	11.4	1.6	32.4	26.2	9.4	12.9	78.9	35.2
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	51	"CACO-2: 22.8;Hep G2: 32.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	22.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.9	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	2.2	0.0	0.6	0.6	0.2	12.7	0.0	0.0	3.5	110.0	0.0	16.6	0.3	0.4	0.1	260.0	0.0	17.7	0.0	0.1	0.1	0.0	140.6	0.1	0.0	24.3	2.5	1.3	0.0	0.0	0.0	0.0	1.0	92.0	0.5	12.1	142.5	0.0	149.4	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	142.6	0.0
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108532-36129385	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 212.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 361.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	11.1	12.6	14.3	8.6	13.4	4.3	63.5	19.4	14.7	15.7	8.7	16.0	68.7	4.1	24.7	24.5	9.8	27.7	10.3	8.2	14.2	17.5	12.3	7.7	7.9	8.2	18.3	8.7	30.5	15.5	32.1	23.9	52.5	16.0	55.2	5.9	25.1	15.5	51.5	7.7	22.6	5.7	12.7	21.7	11.2	8.1	9.9	13.5	8.0	15.7	10.7	11.3	23.8	20.2	12.6	25.2	22.2	14.6	12.9	15.6	9.7	10.4	13.2	31.7	18.6	33.5	24.8	8.3	28.5	33.8	19.1	22.5	7.3	11.6	11.3	14.4	27.4	13.3	25.5	27.6	26.7	29.1	25.1	10.0	4.9	18.6	10.6	21.3	16.5	12.4	22.6	59.1	29.0	25.3	17.6	2.8	9.4	2.5	22.8	26.8	16.0	16.2	3.7	7.6	5.7	7.5	16.8	18.1	14.8	21.3	35.2	33.4	29.4	35.1	10.3	48.1	13.6	14.0	7.8	4.6	46.7	7.8	8.8	14.3	21.5	20.8	8.6	16.1	11.7	24.5	19.5	9.8	22.2	13.0	14.6	15.6	12.6	11.1	11.5	12.2	12.3	9.8	14.2	7.5	12.9	13.7	25.2	12.2	9.7	14.3	13.4	19.4	12.4	14.2	17.5	18.3	8.7	16.0	13.5	35.7	16.0	13.7	44.4	40.8	40.2	16.6	10.2	42.8	60.3	40.1	31.4	5.4	1.7	46.8	16.8	10.8	2.8	0.0	32.7	50.5	40.3	212.3	23.1	7.9	18.4	22.3	24.5	7.4	15.6	14.6	34.5	25.1	64.1	24.4	6.7	35.8	34.0	0.0	44.9	13.9	25.8	38.8	37.6	43.4	22.9	65.1	19.9	16.0	4.1	55.4
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	14.7	25.1	9.0	12.1	9.5	6.1	15.8	11.9	11.9	24.7	19.8	12.2	43.3	17.3	20.1	24.6	14.4	13.6	25.6	20.7	8.7	8.9	24.6	55.1	20.2	11.6	12.6	9.6	14.4	49.2	37.1	24.2	43.8	18.8	22.8	22.9	16.8	48.0	41.7	10.4	11.3	18.8	20.1	10.6	15.2	21.1	9.5	10.7	9.9	28.2	14.4	17.0	16.6	13.9	2.6	3.4	6.2	2.8	4.2	5.1	2.1	8.5	9.9	15.2	14.1	22.9	15.7	13.3	22.9	30.1	17.8	21.0	16.2	8.3	6.4	11.2	25.5	13.8	9.7	11.5	13.5	15.9	8.1	10.2	10.9	11.6	20.8	16.6	10.8	13.2	14.8	11.4	15.7	17.0	17.6	14.2	6.8	11.9	10.5	12.2	9.7	5.9	6.3	6.5	12.5	9.1	6.4	8.9	10.6	11.9	10.7	9.9	8.0	9.3	22.0	12.5	9.6	21.3	10.1	14.0	16.4	10.0	12.2	15.2	16.5	14.5	5.7	9.9	10.3	18.1	6.2	2.4	2.3	5.1	2.8	4.8	1.8	3.2	3.9	2.3	2.6	2.9	3.3	2.4	4.2	1.6	3.4	3.0	2.1	9.0	9.5	11.9	11.9	8.7	8.9	12.6	9.6	18.8	10.7	23.8	33.3	14.5	25.7	32.1	27.2	29.7	28.1	22.7	33.0	24.4	27.5	88.4	5.0	60.8	0.6	33.7	62.8	23.3	75.1	113.6	62.0	56.4	19.7	31.1	38.7	11.1	24.3	29.4	17.0	1.9	42.6	23.9	38.8	27.9	109.3	41.2	56.0	56.2	40.3	20.1	22.2	19.4	33.9	7.9	10.6	35.8	141.1	27.4	54.4	33.5
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 67.3;salivary gland: 54.6"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038832, HPA038833"	Approved					NA	NA					"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	22.0	2.0	3.7	11.4	5.5	10.3	6.1	2.8	4.3	31.4	18.1	2.2	1.1	2.1	3.9	7.3	1.7	7.2	2.6	17.8	4.3	3.5	6.2	18.4	67.3	8.6	5.1	1.6	5.4	42.1	25.7	6.7	44.8	5.9	5.7	14.9	4.3	54.6	2.3	1.8	5.1	3.4	3.0	8.8	6.5	2.5	2.3	3.2	7.5	4.9	2.3	5.6	5.8	6.0	3.1	2.7	1.0	1.5	11.5	10.5	3.4	5.5	5.5	1.2	0.0	4.6	10.6	2.9	0.6	45.5	1.7	2.7	0.2	20.6	5.4	6.0	0.1	5.7	0.4	3.8	1.2	1.0	9.3	11.3	14.1	11.6	0.1	1.8	33.1	4.8	5.6	1.4	0.8	2.6	4.5	0.6	13.4	14.1	49.4	8.8	3.7	11.9	15.5	3.7	7.5	5.4	3.0	0.0	17.6	9.6	2.1	1.6	4.0	15.5	0.2	1.5	1.1	3.8	12.4	3.1	5.5	2.1	11.2	8.7	22.1	9.2	25.6	9.1	21.7	5.0	0.0	1.5	1.0	5.6	1.0	9.8	1.3	10.5	9.0	2.7	3.1	7.9	5.4	0.1	11.5	0.3	1.0	3.9	3.4	3.7	5.5	2.8	4.3	4.3	3.5	5.1	1.6	5.9	3.2	723.6	227.4	10.4	9.5	10.4	0.8	22.6	7.6	1.4	27.3	5.2	3.9	12.1	10.0	1.9	0.3	8.0	3.3	23.3	28.2	184.5	25.7	10.8	3.5	22.1	43.3	3.2	23.1	6.7	29.8	0.4	1.1	25.3	27.0	16.2	72.2	4.5	16.3	7.0	1.1	8.1	1.2	6.5	14.6	2.7	5.9	6.0	50.7	13.8	56.9	6.8
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 256.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 49.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.9	0.2	0.0	0.1	0.2	49.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1	3.0	1.0	1.5	0.2	0.0	12.5	0.3	63.7	0.0	0.0	40.1	9.8	0.0	53.0	18.3	10.9	0.0	32.7	0.0	12.6	0.0	0.2	1.4	0.0	2.8	0.1	20.6	0.0	0.6	0.0	3.3	1.1	0.0	0.0	2.8	3.8	1.6	3.4	7.2	0.4	256.0	11.9	0.0	0.1	0.7	0.3	0.1	0.1	0.0	8.0	0.5
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Syncytiotrophoblasts: 652.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 132.2;SiHa: 134.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		210000000	"Plasma membrane"	Nucleoplasm	"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.4	69.3	7.1	22.0	8.6	6.9	65.6	28.6	11.0	15.0	13.3	66.2	31.2	18.1	31.8	16.8	28.7	57.0	12.9	56.2	8.0	32.9	12.2	13.0	50.5	29.2	79.9	15.2	19.0	15.1	132.2	18.3	56.1	5.5	8.7	39.4	25.0	40.1	9.2	79.2	15.6	19.4	11.8	20.5	23.5	16.2	10.7	35.4	10.5	9.2	12.1	5.8	134.7	50.5	97.2	12.0	18.1	19.9	16.0	15.3	22.8	22.4	20.1	49.9	55.3	57.4	15.0	23.9	43.6	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8	44.7	40.7	54.9	229.6	193.7	59.3	10.9	20.4	36.1	40.9	47.1	62.8	187.9	28.2	148.4	23.7	94.0	85.3	93.5	129.2	134.7	88.4	145.6	82.0	22.5	178.6	50.9	80.9	70.6	47.5	19.5	28.1	97.7	212.6	153.3	33.1	212.1	128.6	31.6	28.7	161.8	52.2	6.5	137.2	12.6	29.8	131.6	652.9	75.6	40.7	193.5
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560579-189583758	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.4;lymphoid tissue: 170.2"	"Group enriched"	"Detected in many"	5	"Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	18.2	126.4	3.9	10.1	5.5	3.9	47.4	1.8	3.5	20.0	25.7	3.7	13.9	34.4	24.7	24.3	6.3	25.9	25.2	37.1	4.1	4.3	14.4	42.1	45.9	170.2	5.1	1.9	50.9	24.0	4.6	9.8	51.3	6.4	18.4	15.8	11.6	10.2	16.6	12.3	4.9	44.7	13.6	5.8	76.4	11.3	16.2	3.5	17.0	20.8	6.4	8.8	11.1	20.4	0.1	22.7	64.7	20.8	0.8	17.3	20.1	0.0	1.3	0.1	0.0	93.2	0.6	4.5	0.0	1.1	0.3	0.5	21.3	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.3	75.5	0.3	7.8	0.3	0.2	19.9	6.5	0.0	0.2	0.0	2.1	2.2	2.9	7.7	0.2	1.1	0.0	3.1	4.9	0.2	16.0	0.3	0.0	0.8	0.4	0.9	3.1	0.1	0.9	0.1	6.2	0.0	7.4	36.8	1.1	0.0	0.1	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	20.8	32.9	0.4	4.7	0.6	0.0	11.3	1.0	22.7	0.1	17.3	3.7	64.7	0.8	0.4	3.7	1.0	20.1	3.9	5.5	1.8	3.5	4.1	4.3	5.1	1.9	6.4	3.5	116.1	32.3	28.1	45.3	8.1	3.7	37.5	142.7	53.5	39.8	31.4	3.9	335.3	41.4	23.9	6.9	30.8	119.4	70.0	64.9	10.7	46.3	32.2	9.2	223.5	72.3	6.4	17.9	211.8	1044.2	4.7	112.2	26.2	8.5	1.8	50.3	9.6	51.2	77.2	55.2	100.1	43.2	64.7	18.1	5.0	0.9	7.0	2060.1	8.4	30.8	19.7
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.8	9.6	6.1	9.7	7.6	7.5	8.3	11.2	11.0	11.4	10.1	4.8	6.2	15.7	7.1	10.2	9.5	11.3	5.9	8.2	3.9	28.8	9.0	3.8	9.5	0.7	7.3	0.0	11.0	9.5	6.9	13.0	9.3	9.5	7.0	12.8	7.0	6.6	9.1	6.7	7.0	1.1	7.2	2.9	4.4	8.3	18.3	3.8	2.6	13.5	5.1	6.5	8.6	7.7	7.0	5.3	5.5	4.0	8.7	13.6	8.8	12.4	11.6	22.0	14.6	5.2	10.6	5.0	8.4	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3	3.0	16.5	12.6	19.3	18.4	12.9	157.4	10.2	9.4	12.5	0.0	47.1	1.7	1.7	8.2	1.5	20.4	0.0	0.0	9.4	12.7	8.0	15.4	6.9	1.8	2.7	17.5	5.8	4.3	2.2	1.7	9.2	3.2	8.5	0.0	0.8	18.0	8.8	0.6	8.9	13.7	21.3	0.0	19.4	6.8	15.0	15.8	2.6	8.5	1.0	20.0
SLC41A2	DKFZP434K0427	ENSG00000136052	"Solute carrier family 41 member 2"	Q96JW4	12	104802553-104958744	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.1;liver: 54.1"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 33.6;Hepatocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 4.4;plasmacytoid DC: 13.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 13.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.6;SK-BR-3: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038658	Approved					NA	NA					"HPA038658: AB_10671747"	"unprognostic (7.19e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.06e-3)"	"unprognostic (3.05e-2)"	"prognostic favorable (9.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.30e-2)"	6.1	7.0	3.8	5.2	3.9	0.5	7.1	9.2	5.4	4.9	19.9	2.3	15.9	14.5	3.0	7.9	1.6	2.1	6.8	3.0	2.9	5.5	4.6	54.1	4.5	2.0	2.8	4.0	4.2	12.0	5.7	21.5	16.1	3.4	2.2	7.2	2.0	5.9	14.9	0.9	1.6	37.1	4.0	2.4	1.9	16.8	4.3	2.1	1.0	5.8	0.3	2.7	2.2	2.7	0.6	13.0	0.3	0.2	0.3	0.9	0.3	6.0	13.8	0.5	2.9	11.8	8.6	5.5	4.3	7.0	3.0	5.1	8.6	5.9	2.5	4.7	8.4	11.0	0.6	3.1	1.4	5.6	29.6	7.8	0.2	5.5	3.8	2.6	0.9	3.4	2.9	1.2	3.2	0.9	6.5	3.8	1.6	0.2	6.5	0.5	2.8	1.2	0.0	1.3	10.9	4.4	0.5	6.0	5.9	11.9	0.2	5.5	1.4	7.3	24.4	1.2	2.2	9.5	0.0	1.1	4.5	3.2	4.8	4.8	7.8	9.6	3.2	7.2	0.5	3.1	0.2	0.2	0.0	0.2	0.1	0.9	0.6	0.2	0.1	4.4	0.3	0.4	0.2	0.3	0.3	0.1	13.0	0.1	0.3	3.8	3.9	9.2	5.4	2.9	5.5	2.8	4.0	3.4	2.1	17.9	8.1	6.0	2.6	2.2	2.8	0.8	20.4	1.4	4.5	7.0	0.0	1.4	0.0	23.5	21.0	1.4	29.0	0.0	33.6	15.7	9.3	3.9	0.0	45.9	5.4	4.8	1.2	1.3	2.2	3.4	2.0	9.7	0.0	31.5	8.3	2.6	26.2	8.7	6.0	6.2	0.0	0.0	5.0	2.9	1.9	1.9	7.6	1.0	9.7	4.7
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515786	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 27.0;liver: 91.8;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 40.8;Hepatocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 23.8;NB-4: 28.3;U-937: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	4.7	3.3	0.8	2.2	0.8	9.3	7.4	0.7	1.3	6.0	4.8	0.9	3.9	2.5	5.0	6.8	4.1	3.3	27.0	3.2	0.7	0.6	3.4	91.8	2.9	3.3	0.8	1.1	6.5	100.5	0.1	1.3	1.8	0.7	6.2	2.8	11.4	14.9	2.1	7.5	5.6	2.6	7.0	0.9	2.5	7.6	3.1	0.7	0.8	7.4	2.9	3.1	7.6	3.5	3.1	8.2	8.1	6.0	6.9	11.1	5.2	0.4	0.6	0.7	8.0	10.5	7.7	0.1	4.2	5.4	1.2	3.1	2.5	1.1	23.0	1.1	3.1	1.5	0.3	7.1	0.4	1.5	1.1	1.8	11.8	0.2	23.8	13.8	20.7	2.9	9.7	1.7	2.0	9.3	2.9	5.3	13.8	16.5	4.3	1.5	0.8	0.1	28.3	2.6	10.4	5.4	19.7	3.9	10.2	0.2	0.0	9.4	1.4	0.7	0.1	9.2	0.2	0.6	10.5	2.1	1.2	2.9	10.6	0.6	4.8	1.5	13.5	0.6	27.3	1.6	8.1	6.0	0.7	11.1	2.4	9.5	3.1	5.2	8.0	8.2	1.7	5.1	7.2	0.5	6.9	0.1	1.9	9.1	5.2	0.8	0.8	0.7	1.3	0.7	0.6	0.8	1.1	0.7	0.7	0.0	8.2	0.8	1.6	6.3	5.0	4.9	40.8	1.4	1.2	0.0	0.0	0.1	3.3	2.5	22.9	4.6	0.9	23.3	30.5	0.4	5.4	1.9	3.5	109.6	6.1	0.0	5.8	14.7	7.6	11.8	14.4	1.8	5.0	0.0	6.1	0.0	18.0	0.0	7.4	0.0	0.3	6.5	6.2	0.5	0.4	3.1	0.1	6.4	9.8	0.9
SLC43A2	MGC34680	ENSG00000167703	"Solute carrier family 43 member 2"	Q8N370	17	1569267-1628886	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 92.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 312.2;Syncytiotrophoblasts: 788.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021564	Enhanced					NA	NA					"HPA021564: AB_1857169"	"unprognostic (5.95e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.84e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-1)"	5.5	2.7	5.4	13.7	5.7	12.2	3.6	14.8	11.9	2.6	2.6	5.0	2.1	7.0	2.1	4.1	1.4	5.9	3.9	1.6	5.6	7.2	15.8	3.0	6.8	8.3	5.1	3.8	2.3	1.6	1.5	6.2	92.7	5.8	2.8	2.4	4.9	4.0	3.5	23.2	1.3	11.6	4.7	3.5	8.9	2.8	1.5	1.3	5.0	5.8	2.2	3.5	5.0	1.3	1.3	3.1	15.0	5.4	0.5	0.3	2.0	0.9	2.6	0.8	7.6	1.6	1.3	10.4	0.5	0.3	1.8	0.8	15.5	1.7	4.5	5.2	0.8	0.7	1.8	4.6	0.9	0.3	0.0	0.4	0.8	2.3	3.9	1.9	0.1	1.4	1.6	1.4	1.1	0.5	0.2	7.3	0.5	1.9	0.0	0.3	3.6	9.2	0.9	0.8	2.4	0.3	2.6	0.0	5.3	3.5	8.9	3.1	1.6	2.3	6.3	0.2	3.4	6.3	5.4	9.5	0.2	1.1	2.0	0.6	0.5	9.4	2.2	0.4	0.9	0.2	2.5	5.4	5.3	0.3	4.6	0.1	1.3	0.2	0.2	3.1	1.2	0.2	0.2	15.0	0.5	4.5	1.7	0.2	2.0	5.4	5.7	14.8	11.9	5.6	7.2	5.1	3.8	5.8	1.3	14.9	40.5	18.3	5.4	4.2	22.8	2.7	15.3	21.4	22.7	34.9	23.6	312.2	16.6	21.0	2.9	4.5	16.2	0.0	6.3	29.6	10.2	7.2	11.5	1.3	81.4	19.1	10.9	16.5	88.0	1.9	10.0	84.8	0.0	73.9	12.2	23.6	6.4	21.6	8.5	19.3	35.8	0.0	5.7	3.1	3.2	3.8	788.9	3.8	10.0	4.2
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 73.5;ASC TERT1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		270000	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.9	5.8	1.6	1.9	73.5	58.1	5.0	5.8	15.3	3.8	5.1	6.2	18.5	9.2	3.0	22.0	4.3	13.8	4.7	8.4	6.5	8.0	3.8	11.5	4.1	7.7	4.9	2.2	5.9	32.2	6.9	7.3	6.6	9.8	12.0	4.8	0.3	19.2	4.3	9.8	9.1	2.6	8.9	12.3	5.6	1.9	6.1	6.9	5.2	16.3	7.7	3.0	8.2	9.1	8.2	9.9	9.0	6.9	10.2	3.8	3.4	4.1	4.2	14.8	9.8	6.9	7.4	5.0	5.0	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4	32.8	21.6	15.9	31.4	62.7	7.6	9.3	56.0	14.7	9.1	101.2	221.9	44.4	3.3	16.4	2.4	38.4	140.4	0.0	31.4	7.9	49.9	25.3	98.1	132.6	20.0	6.4	151.0	54.0	50.8	2.9	101.8	39.6	70.9	122.6	158.5	6.7	33.4	123.8	75.0	23.3	44.8	38.8	27.0	1.4	1.7	65.0	59.0	15.3	134.8	29.5
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644559	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 210.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 62.3;SK-BR-3: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA		78000	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	29.3	14.2	25.1	21.4	28.3	23.4	31.6	24.2	33.9	24.7	23.0	40.7	21.7	10.5	21.0	17.3	31.8	24.8	24.9	29.1	21.2	17.9	29.4	9.1	39.4	46.7	26.1	18.4	14.2	16.5	21.6	8.6	114.9	31.8	19.9	20.3	36.6	22.1	28.8	51.6	29.0	19.1	19.3	37.5	49.4	44.0	51.6	21.2	30.4	26.9	26.4	39.2	29.0	26.3	19.0	17.8	86.0	45.9	13.1	21.8	22.8	62.3	1.5	14.0	8.3	21.2	13.1	39.9	13.6	33.4	22.4	26.5	14.0	29.9	12.6	18.2	37.6	2.7	48.3	2.1	10.4	14.5	0.3	1.8	8.0	7.9	0.5	23.5	0.1	6.8	14.1	13.9	8.4	7.4	18.3	17.1	5.9	3.8	2.1	34.0	45.9	6.6	6.1	4.9	18.5	5.6	14.2	19.9	0.5	7.3	33.2	1.3	8.4	10.7	60.1	1.5	15.2	23.4	0.6	15.6	10.1	3.6	12.0	3.4	0.8	1.4	12.4	2.5	5.6	11.2	22.9	7.2	39.3	21.8	19.6	17.2	17.7	15.1	16.5	3.7	19.0	16.5	16.8	86.0	13.1	45.9	17.8	16.5	22.8	25.1	28.3	24.2	33.9	21.2	17.9	26.1	18.4	31.8	21.2	50.6	29.0	40.2	16.9	8.7	11.9	32.2	20.4	16.0	39.8	87.2	13.7	107.9	1.7	38.7	130.7	26.0	27.4	46.7	39.5	210.6	15.5	11.6	19.7	0.9	32.0	3.2	9.2	66.9	28.0	20.6	35.9	7.7	5.0	4.6	17.2	33.6	29.3	37.4	53.0	3.8	2.9	58.2	18.6	3.0	2.7	7.4	78.1	41.7	20.9	16.5
SLC44A3	"CTL3, MGC45474"	ENSG00000143036	"Solute carrier family 44 member 3"	Q8N4M1	1	94820342-94895246	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 14.8;RPTEC TERT1: 43.5;RT4: 29.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047433	Enhanced					NA	NA					"HPA047433: AB_2680046"	"unprognostic (8.06e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.63e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (9.09e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.31e-3)"	1.8	7.3	9.1	6.1	8.3	0.0	5.3	6.6	5.6	5.9	19.8	3.9	4.5	16.5	4.8	5.1	6.6	5.1	16.3	4.5	6.3	5.0	21.4	3.9	6.7	0.4	6.1	3.6	2.7	22.2	5.3	22.2	3.9	5.8	7.2	22.9	9.5	16.0	8.5	1.6	3.7	17.2	2.9	5.4	0.5	17.9	1.6	4.2	2.6	5.4	0.9	4.1	11.0	6.3	0.0	0.0	0.0	0.0	0.0	5.2	0.1	9.5	1.3	0.3	0.0	1.1	1.4	6.7	0.1	1.4	0.3	1.6	8.9	2.4	0.0	6.6	0.1	3.0	3.2	1.4	2.3	0.6	0.0	1.7	0.0	0.5	0.7	0.4	0.0	0.0	4.3	2.1	0.7	0.0	2.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	0.1	0.4	14.8	0.3	0.7	0.3	0.5	43.5	29.0	4.5	7.3	0.4	4.6	3.2	3.3	2.6	0.3	0.0	0.2	1.5	0.6	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	8.3	6.6	5.6	6.3	5.0	6.1	3.6	5.8	4.2	23.8	7.9	0.0	27.4	2.7	0.5	6.5	33.1	4.0	3.4	12.2	0.0	13.2	13.3	27.9	20.6	1.0	14.8	0.0	24.6	0.5	5.2	16.6	1.1	1.6	1.1	0.0	15.6	0.6	0.3	2.5	4.6	0.7	5.0	1.8	32.8	14.5	30.4	31.6	10.3	28.4	0.2	0.0	2.1	0.1	0.2	3.3	5.6	0.0	40.5	25.0
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.6;intestine: 65.7"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 245.0;Enterocytes: 364.2;Exocrine glandular cells: 194.5;Glandular cells: 195.5;Mucus-secreting cells: 268.8;Paneth cells: 234.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.0"	"Cell line enriched"	"Detected in some"	5	"OE19: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA046977, HPA054176"	Enhanced					NA	NA					"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.3	2.4	0.2	11.2	0.3	0.2	2.1	0.2	0.3	5.9	43.6	0.3	7.6	23.7	2.9	3.0	0.6	10.9	34.6	0.2	0.2	0.0	20.4	0.3	9.1	0.6	0.2	0.2	4.9	7.3	0.0	5.0	5.1	0.5	25.7	8.6	0.3	12.0	4.4	0.2	0.1	65.7	1.2	0.2	0.6	23.7	0.8	0.2	0.4	0.5	0.7	4.2	6.3	1.9	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	13.2	0.0	0.1	0.0	0.4	0.0	2.0	0.0	0.2	0.0	1.1	0.0	0.1	0.4	0.3	2.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.5	0.2	20.8	29.0	6.7	17.5	0.5	0.0	0.3	30.6	245.0	54.6	62.8	0.0	0.2	3.3	91.8	2.2	0.5	364.2	0.0	194.5	0.3	1.8	195.5	2.3	0.0	0.5	0.0	44.9	0.0	0.0	2.9	1.4	2.0	0.0	2.8	268.8	0.4	123.2	234.4	0.4	56.6	0.6	0.0	0.4	0.2	0.2	0.4	0.6	0.0	158.0	88.5
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 63.4;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA047455: AB_2680054, HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	1.0	0.4	2.4	1.0	1.5	0.0	6.3	1.0	3.6	1.0	1.8	1.0	1.0	0.9	1.0	1.0	7.7	3.7	1.0	2.2	2.8	2.8	2.0	1.0	1.0	1.0	2.3	1.0	1.0	1.8	5.6	3.7	3.8	1.0	1.0	2.9	1.0	1.6	1.0	1.5	11.3	1.0	1.0	1.0	1.0	1.3	32.6	1.0	1.0	1.0	1.0	1.8	2.2	1.9	3.2	0.3	0.6	0.3	0.5	1.1	0.3	0.2	0.2	4.5	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	2.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.5	0.6	1.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.4	2.4	2.6	0.0	0.0	1.7	0.0	4.5	2.9	0.6	0.0	0.0	2.1	7.1	4.8	1.0	11.1	0.0	4.6	0.0	11.8	0.2	0.0	13.7	0.4	1.2	0.0	1.4	2.0	1.9	3.0	0.2	0.0	0.7	0.4	0.3	0.2	0.4	0.1	0.9	3.2	0.8	1.1	0.1	2.4	0.6	0.4	0.6	0.5	0.2	0.3	0.6	0.3	2.4	1.5	1.0	3.4	2.8	2.8	2.3	1.0	1.0	1.0	0.0	0.6	0.0	0.6	1.6	3.7	0.6	0.0	2.7	1.2	0.0	0.0	6.8	0.0	0.1	63.4	0.4	0.4	0.0	0.8	3.2	0.2	0.8	0.0	0.0	1.0	0.0	2.4	3.1	0.0	27.3	0.9	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	5.8	3.2	0.0	0.2	3.1
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394756-28407197	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.7"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 67.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	3.1	17.8	4.6	2.5	7.0	1.3	5.1	13.2	5.2	2.9	43.8	5.2	9.4	45.4	2.2	4.5	1.8	6.7	3.0	2.2	4.4	6.0	3.8	17.9	3.2	4.9	4.0	4.0	4.4	5.0	8.1	7.8	5.0	5.0	3.7	2.7	6.1	5.7	5.8	2.0	2.0	52.7	2.6	4.6	4.9	2.3	2.2	4.2	2.2	4.0	0.4	1.2	2.4	2.4	2.7	2.6	7.1	5.9	2.9	1.7	0.8	1.7	7.4	2.5	4.1	2.0	0.4	7.8	2.1	1.5	1.7	2.0	67.6	2.1	0.2	1.2	1.1	5.0	5.8	2.8	4.7	1.5	4.3	6.6	0.0	4.6	5.7	0.7	0.0	3.4	1.0	8.7	1.8	5.4	2.4	0.1	0.6	2.8	0.4	0.3	2.3	0.0	0.2	1.5	1.7	1.0	0.1	2.0	0.8	1.3	3.9	6.6	3.5	14.5	6.8	0.9	3.6	5.3	1.1	0.2	0.2	3.0	0.4	2.2	3.1	3.5	0.1	0.4	0.4	1.6	7.1	1.6	1.1	0.8	5.9	1.4	2.7	0.9	0.7	2.6	1.7	1.0	1.7	2.3	2.9	4.3	1.1	1.6	0.8	4.6	7.0	13.2	5.2	4.4	6.0	4.0	4.0	5.0	4.2	11.9	4.0	3.2	1.9	0.3	25.6	1.8	15.3	4.0	1.2	7.0	3.9	16.6	0.0	2.8	3.4	1.0	1.3	0.0	3.9	7.3	3.1	2.2	1.1	24.9	21.1	19.1	1.2	2.5	13.0	13.5	3.7	3.9	0.0	1.0	2.1	1.6	3.5	0.9	3.2	4.1	5.6	6.5	1.0	0.0	0.2	0.3	3.7	0.0	1.2	1.4
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.6;kidney: 51.1;liver: 44.9"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 40.8;Proximal tubular cells: 54.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 11.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 12.2;plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.9;granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"A549: 13.2;AN3-CA: 10.6;Hep G2: 25.4;U-266/70: 19.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced					NA	NA					"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	2.2	45.6	0.8	0.4	2.2	1.1	0.6	1.0	3.1	13.2	1.2	3.7	1.3	0.7	7.6	12.2	0.9	2.4	1.7	3.5	4.7	0.5	51.1	44.9	3.0	3.5	0.9	2.5	5.0	0.2	0.2	7.2	0.3	11.4	2.6	0.5	4.3	1.1	5.5	12.1	10.4	0.6	3.5	2.3	1.9	0.5	15.5	0.6	0.9	4.7	5.7	1.2	0.6	4.5	0.1	6.9	12.2	1.3	0.0	0.7	0.4	0.0	13.2	0.4	10.6	0.3	0.0	0.0	0.4	0.3	1.6	1.5	0.0	0.4	0.1	2.5	1.9	5.3	0.0	4.7	0.3	0.4	0.0	6.2	0.1	7.0	25.4	0.1	0.1	0.3	0.2	2.4	1.2	0.2	1.8	3.7	0.0	0.0	0.0	0.0	1.8	0.0	0.2	1.4	0.1	0.5	0.1	0.1	0.1	0.0	0.8	2.5	2.2	4.3	0.0	1.1	3.7	4.5	1.2	0.0	0.1	0.5	0.2	1.2	19.8	7.8	0.0	0.5	0.1	2.3	0.2	1.3	12.2	0.3	1.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.7	0.3	0.0	0.2	6.9	0.0	0.4	0.8	2.2	1.0	3.1	4.7	0.5	0.9	2.5	11.4	0.6	6.0	3.0	0.0	2.2	4.1	0.3	3.8	5.1	1.4	0.0	1.8	0.0	0.0	3.3	0.1	11.3	0.7	0.0	0.0	0.0	0.0	2.3	1.3	5.7	40.8	1.5	0.0	0.0	0.0	1.6	2.7	3.4	0.6	1.7	0.0	0.0	1.2	0.0	0.0	1.4	54.2	0.7	6.5	1.0	0.2	0.7	5.8	0.0	0.0	0.0	1.3
SLC47A2	"FLJ31196, MATE2, MATE2-K"	ENSG00000180638	"Solute carrier family 47 member 2"	Q86VL8	17	19678288-19718979	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 55.5"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 69.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.9;HeLa: 1.5;hTCEpi: 6.7"					"Not detected"	"Not detected"									NA	NA						"unprognostic (4.52e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (5.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.71e-2)"	0.2	0.3	3.0	0.1	4.4	0.1	0.3	0.2	0.4	0.1	0.2	10.3	0.6	0.2	0.2	6.5	0.2	8.6	0.1	0.3	6.2	5.5	55.5	0.1	0.1	0.1	1.1	0.1	0.6	0.1	0.1	0.0	0.1	12.8	0.1	0.1	0.7	0.1	0.3	0.7	1.8	0.4	0.2	2.0	0.1	0.1	0.2	2.8	0.0	0.3	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	1.2	0.0	0.2	1.9	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	6.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.8	0.0	0.3	0.0	0.1	0.3	0.5	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	3.0	4.4	0.2	0.4	6.2	5.5	1.1	0.1	12.8	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.0	5.2	0.0	0.1	5.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	69.0	0.2	0.0	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.1
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248385-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.7;placenta: 32.7"	"Cell type enriched"	"Detected in some"	66	"Erythroid cells: 1261.4"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 0.4"	"Low region specificity"	"Detected in all"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		160000000			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0.0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0.0	1.0	8.4	0.1	0.3	0.0	0.7	1.9	0.0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.5	1.4	1.7	0.6	0.7	1.0	0.3	0.4	0.3	0.8	1.4	3.2	0.7	0.6	0.3	0.4	1.4	0.5	0.5	1.1	1.3	1.3	1.7	1.6	2.2	0.0	0.8	2.3	0.8	0.5	0.8	0.8	0.5	0.2	0.6	4.8	3.5	0.4	0.6	1.0	3.5	0.9	0.7	0.5	2.5	0.7	1.9	0.3	0.8	2.2	1.0	1.3	1.4	0.5	0.7	2.5	1.8	1.0	2.4	2.1	1.4	1.4	1.0	2.3	1.1	1.6	2.2	1.1	6.1	1.0	2.0	1.1	0.9	1.0	1.1	1.0	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0.0	6.0	1.1	0.0	0.9	0.0	0.4	0.7	0.0	0.0	1.2	19.2	0.0	0.3	3.3	0.0	0.5	0.0	0.0	1261.4	0.0	0.9	0.3	0.4	0.0	0.0	1.3	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.9	0.4	0.0	0.7	0.0	0.0	0.5
SLC4A10	"NBCn2, NCBE"	ENSG00000144290	"Solute carrier family 4 member 10"	Q6U841	2	161424332-161985282	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 31.2;brain: 48.1"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 116.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 31.2"	"Lineage enriched"	"Detected in single"	78	"T-cells: 31.2"	"Cell line enriched"	"Detected in some"	11	"Karpas-707: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034755, HPA076725"	Enhanced					NA	NA					"HPA034755: AB_10670296, HPA076725: "	"unprognostic (4.64e-4)"	"unprognostic (3.88e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.89e-3)"	"unprognostic (5.99e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.26e-1)"	1.0	3.7	21.6	1.9	24.1	1.2	1.3	14.9	48.1	1.1	3.3	2.1	0.0	1.4	1.0	2.8	1.0	1.8	1.5	1.0	20.4	10.8	1.0	1.3	1.1	1.1	4.3	29.6	1.0	2.9	1.0	4.4	1.0	17.7	1.3	2.7	1.7	1.0	1.1	1.0	1.0	1.5	1.1	1.9	3.0	1.3	1.4	3.5	0.0	1.0	0.0	1.5	1.3	0.3	0.0	0.0	0.0	0.0	0.4	31.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	31.2	0.0	0.6	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	21.6	24.1	14.9	37.9	20.4	10.8	4.3	29.6	17.7	3.5	0.0	0.0	0.0	0.0	0.0	116.7	0.4	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	1.8	1.2	8.4	0.0	0.0	0.0	0.0	2.2	2.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.9	0.2	0.0	0.0	4.4	0.0	0.0
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 76.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.9	52.8	10.4	21.4	10.4	6.1	23.8	19.4	10.5	15.9	13.8	30.0	25.6	9.6	42.6	9.2	23.4	15.7	10.6	9.4	2.9	27.6	15.8	12.6	25.7	15.2	17.0	6.5	40.6	8.9	8.3	18.0	4.6	17.1	8.8	13.6	38.9	8.1	12.3	30.6	18.6	11.2	24.7	21.5	19.6	14.7	5.7	11.2	13.0	12.1	8.6	31.2	17.7	33.5	16.5	8.2	13.8	12.8	19.0	21.4	10.9	21.0	28.5	8.8	11.8	5.4	32.7	16.3	42.9	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5	8.9	10.9	6.7	4.5	9.8	7.9	3.6	17.8	1.4	2.3	19.2	23.6	28.5	14.9	31.0	0.6	9.8	17.3	0.0	30.9	9.0	16.2	5.0	48.3	31.4	23.1	14.3	26.5	14.7	15.1	1.3	12.7	9.9	25.3	9.0	11.1	22.3	39.3	14.0	18.7	18.9	8.8	12.9	15.5	3.2	7.7	6.0	76.5	8.3	18.9	3.1
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627327-219641980	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.6;ovary: 30.2"	"Group enriched"	"Detected in many"	17	"Cardiomyocytes: 201.0;Horizontal cells: 527.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"myeloid DC: 2.3;plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.12e-4)"	1.8	5.4	11.8	1.6	22.5	1.2	2.0	8.8	22.0	2.8	1.3	3.0	0.4	1.4	3.4	2.6	2.9	2.7	2.3	103.6	10.4	8.2	1.6	1.0	1.3	1.4	6.5	9.0	30.2	2.7	4.5	9.9	2.5	24.1	4.2	1.1	4.9	3.1	4.3	1.2	1.6	1.3	3.1	1.6	2.6	1.4	4.2	3.5	0.0	1.5	0.0	1.3	1.6	0.9	0.0	8.9	0.0	0.1	0.0	0.0	0.0	6.2	0.2	2.2	6.5	0.4	0.4	4.4	3.9	4.1	5.3	3.8	4.5	3.6	0.0	1.5	1.4	9.2	3.6	1.1	7.1	1.6	0.0	1.0	0.0	0.0	0.1	1.1	0.1	0.3	3.1	6.7	0.0	2.1	13.4	0.0	0.0	0.2	0.0	1.5	2.1	0.0	0.0	3.6	0.2	5.3	0.0	0.0	0.0	3.6	1.5	1.3	6.4	2.5	6.8	3.3	7.5	0.6	1.6	0.0	3.3	5.8	0.0	3.1	0.0	0.0	0.0	2.7	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	11.8	22.5	8.8	22.0	10.4	8.2	6.5	9.0	24.1	3.5	0.0	0.0	0.0	0.6	0.2	8.9	201.0	0.0	0.0	1.2	1.8	0.0	10.5	1.7	2.8	2.0	0.1	0.0	0.0	1.5	2.5	2.2	0.3	0.0	0.0	1.6	527.6	0.0	0.0	0.0	11.9	14.1	1.1	0.0	1.0	0.0	7.0	1.3	0.0	21.2	0.3	6.7	6.5	1.4	0.5	1.1	0.6	11.6	0.0	0.0	0.0
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71186757-71572087	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.4;pancreas: 113.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.8;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA					"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	2.4	0.9	14.3	4.3	19.9	0.7	1.1	18.1	15.2	5.8	17.2	4.5	0.1	22.4	0.8	0.7	1.1	1.0	24.9	2.9	13.1	8.1	47.4	9.4	5.8	0.6	9.7	11.2	1.0	113.8	10.0	4.1	1.6	18.1	14.6	17.1	11.1	1.5	1.1	1.3	0.7	10.4	1.3	21.6	0.9	8.3	0.7	8.0	0.0	9.5	0.0	0.6	2.6	0.9	0.0	0.1	0.0	0.0	0.5	2.8	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.1	13.9	1.9	2.3	1.8	0.0	0.1	0.0	0.1	6.3	0.6	0.0	0.2	0.0	5.7	0.0	1.8	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.9	0.0	0.6	1.2	0.0	4.7	0.2	0.1	0.2	0.0	0.0	0.0	0.9	14.9	4.2	1.0	0.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	7.9	0.7	5.7	0.6	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.8	2.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.3	14.3	19.9	18.1	12.4	13.1	8.1	9.7	11.2	18.1	8.0	3.0	32.5	1.3	4.2	0.0	0.0	20.1	107.0	14.7	31.8	24.4	0.0	0.2	13.3	81.5	6.6	1.9	173.4	0.0	21.6	0.1	1.1	63.3	1.1	31.7	0.2	0.0	8.2	1.8	0.6	1.0	0.0	1.0	1.7	1.8	66.7	3.3	19.9	56.6	0.0	149.5	1.1	6.5	2.5	0.1	0.4	0.0	0.2	6.9	42.6	7.0
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 109.1"	"Cell type enhanced"	"Detected in some"	28	"Cone photoreceptor cells: 33.4;Horizontal cells: 158.9;Rod photoreceptor cells: 43.4"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 3.4;pons and medulla: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 14.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA036621	Uncertain					NA	NA					"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.2	0.4	1.0	0.8	0.8	1.6	1.1	3.4	1.2	0.7	0.8	2.5	0.6	0.3	0.9	1.7	0.6	1.4	0.8	0.7	1.2	1.0	0.7	3.2	1.7	1.0	1.0	0.6	1.3	0.9	1.5	2.3	0.6	9.0	0.9	0.3	109.1	1.3	0.8	1.1	3.7	0.7	0.9	1.6	0.7	0.5	16.1	0.7	1.0	21.4	0.6	0.7	0.9	0.9	2.5	5.8	6.1	0.9	1.7	2.5	0.6	0.4	0.8	1.4	1.4	1.5	2.6	1.9	0.4	1.4	0.8	1.2	0.4	1.0	2.2	0.4	0.0	0.5	0.1	1.6	0.2	0.3	1.9	0.9	3.3	1.4	0.8	0.2	1.1	2.3	0.7	2.0	0.1	0.3	0.7	0.5	1.6	0.7	2.4	0.3	5.2	0.5	2.2	1.1	1.0	0.3	1.1	1.4	0.0	0.3	1.0	1.0	2.1	0.5	1.7	2.3	1.4	1.6	2.2	0.0	1.5	2.4	1.6	0.5	14.6	2.0	1.7	0.9	1.2	0.3	6.1	0.9	0.9	1.5	0.8	1.0	1.8	2.3	2.0	0.6	2.5	2.1	2.5	4.2	1.7	0.3	5.8	2.4	0.6	1.0	0.8	3.4	1.2	1.2	1.0	1.0	0.6	9.0	0.7	3.0	6.7	0.0	0.6	0.6	12.6	0.4	2.5	4.0	4.5	0.0	33.4	0.0	0.0	0.3	0.4	0.8	0.0	0.0	0.6	0.0	0.4	0.8	0.0	0.0	0.1	158.9	0.0	0.0	0.0	0.0	1.1	0.2	1.7	0.0	0.1	2.9	0.2	0.0	0.4	0.0	43.4	0.0	0.4	1.7	1.4	0.4	0.0	0.0	0.0	0.5
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Group enriched"	"Detected in many"	10	"Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.9	11.1	10.0	4.6	4.7	8.4	7.1	20.2	9.4	7.8	6.1	3.0	3.1	13.5	1.7	7.8	7.5	2.6	9.5	9.8	12.4	11.4	3.1	6.2	7.6	3.2	8.1	14.0	5.4	6.7	4.3	11.8	38.2	16.5	12.8	8.9	4.1	4.8	16.0	2.1	13.9	3.2	6.6	0.7	11.0	9.5	7.9	2.7	18.3	4.2	2.5	6.3	9.2	6.8	3.1	8.9	15.5	5.4	8.9	18.4	5.1	12.7	15.6	1.8	1.9	7.7	16.1	9.9	8.4	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5	0.0	12.8	13.2	28.2	26.1	65.7	18.7	15.3	5.3	25.0	59.3	691.1	4.5	8.3	13.6	6.7	25.3	5.8	0.0	6.2	23.0	30.2	41.3	23.1	5.9	16.9	6.4	36.7	14.7	33.1	5.9	8.3	36.7	33.7	20.8	50.6	45.2	13.6	12.7	9.2	10.5	667.4	38.8	32.8	32.4	21.7	26.8	6.8	33.0	12.2	33.6
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Predicted membrane proteins"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;pituitary gland: 20.0;testis: 15.3"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 85.2;Cone photoreceptor cells: 168.9;Horizontal cells: 109.7;Spermatocytes: 91.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.6;HMC-1: 12.4;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	1.0	6.5	5.8	2.2	13.3	1.7	3.1	9.2	22.9	2.7	1.1	9.8	0.0	1.4	1.2	5.4	0.7	3.7	1.1	1.0	10.9	5.6	3.2	0.8	2.8	3.0	6.0	9.3	7.3	2.4	1.0	20.0	1.0	28.6	1.4	1.4	2.2	1.5	1.7	0.8	1.0	2.0	1.1	4.7	2.2	3.0	15.3	5.1	0.0	0.8	0.0	2.7	1.0	0.7	1.1	2.6	3.4	3.1	1.7	1.7	0.7	0.2	0.8	9.9	0.1	0.4	0.5	17.6	2.7	4.5	4.4	2.8	5.8	0.2	3.6	0.4	3.6	2.4	0.1	3.9	0.2	4.1	0.7	0.5	1.8	0.3	0.0	0.0	0.6	12.4	0.1	0.2	2.2	0.5	2.6	5.1	1.6	0.1	6.4	2.2	2.1	5.2	1.1	4.3	1.1	2.9	0.1	0.0	0.0	0.5	0.1	13.2	8.9	1.0	1.4	0.0	3.2	1.6	0.4	4.7	2.8	1.5	0.2	3.4	3.2	1.0	0.2	3.9	0.5	0.4	1.3	2.1	3.4	1.7	1.4	0.4	0.6	0.6	1.6	2.6	1.1	0.6	1.0	2.3	1.7	3.1	1.0	0.3	0.7	5.8	13.3	9.2	22.9	10.9	5.6	6.0	9.3	28.6	5.1	0.0	8.3	0.5	0.6	0.0	85.2	1.7	0.0	38.8	9.1	1.8	168.9	1.0	6.6	0.1	48.8	1.1	0.3	0.0	1.2	4.3	0.5	1.0	7.0	0.0	2.1	109.7	5.8	0.6	1.2	22.8	2.6	3.3	1.7	0.0	0.2	13.6	0.1	2.9	3.5	0.8	18.4	0.0	0.8	91.6	6.4	0.1	0.3	2.5	0.0	1.0
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360202-140375143	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.7"	"Cell type enhanced"	"Detected in single"	21	"Distal tubular cells: 1.7"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.8;U-698: 2.0"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Low region specificity"	"Detected in all"			HPA051307	Uncertain					NA	NA					"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	26.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.2	0.0	0.7	0.6	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	3.8	0.0	0.8	0.0	0.4	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.0	1.0	0.5	2.0	0.0	0.1	0.2	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	0.0	0.0	0.1
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 alpha subunit"	Q86UW1	3	196211487-196243178	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 53.9;liver: 59.5"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 130.2;Leydig cells: 57.0;Peritubular cells: 95.5;Sertoli cells: 142.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045488	Enhanced					NA	NA					"HPA045488: "	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	0.5	2.3	0.3	3.8	0.3	2.4	0.4	0.3	0.4	0.5	12.3	0.4	0.7	13.6	0.4	2.8	0.5	0.5	0.5	0.5	0.3	0.1	2.2	59.5	0.8	0.3	0.3	0.3	0.6	0.3	1.4	0.5	0.3	0.3	0.5	0.1	0.3	0.6	0.3	0.5	1.0	53.9	0.3	0.3	0.8	0.2	1.8	0.3	0.6	0.8	0.3	0.5	0.3	0.7	0.2	0.0	1.7	0.6	0.4	0.6	0.1	1.1	1.7	1.4	1.7	0.0	1.1	0.1	0.8	0.0	0.1	0.0	0.7	0.5	0.1	2.0	1.1	0.1	0.9	0.2	0.0	0.0	0.7	2.9	1.0	0.8	1.8	0.2	1.4	1.4	0.3	0.0	0.2	1.3	1.5	0.2	0.3	0.2	3.3	0.0	0.6	0.1	1.2	0.1	0.4	2.0	8.1	0.1	0.5	0.0	0.9	0.3	0.5	0.5	3.3	0.3	0.4	2.4	0.5	0.6	1.7	0.7	1.3	0.9	3.3	4.0	0.6	1.1	0.7	0.6	0.0	0.2	1.7	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.6	1.6	0.4	0.5	0.0	0.1	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.3	0.0	1.9	3.0	0.5	3.3	2.5	10.7	4.5	0.0	3.9	0.5	3.3	0.3	16.2	1.8	130.2	23.3	0.2	0.3	3.1	1.4	0.0	38.6	0.5	1.6	0.0	4.3	3.8	10.3	57.0	3.3	3.3	0.0	0.4	0.3	0.1	8.6	95.5	4.9	0.9	142.3	2.0	2.1	1.1	2.3	0.8	2.6	0.5	2.6
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 beta subunit"	Q86UW2	15	65045370-65053396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 85.0"	"Cell type enriched"	"Detected in many"	6	"Enterocytes: 518.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	0.4	3.8	0.6	0.0	0.4	0.4	0.8	14.0	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1.0	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85.0	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.7	0.1	0.0	0.5	0.3	0.0	1.4	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	16.9	0.0	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	14.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.0	2.5	10.7	0.0	0.0	0.0	0.0	11.6	0.0	48.8	0.0	518.3	0.0	0.0	0.0	0.0	0.0	4.6	1.5	0.1	0.0	1.7	0.6	0.0	9.7	0.3	0.0	0.0	0.0	7.7	0.0	0.0	84.2	0.0	54.0	0.0	6.5	0.0	1.5	0.4	0.0	0.1	0.0	19.7	0.0
SLC52A1	"FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1"	ENSG00000132517	"Solute carrier family 52 member 1"	Q9NWF4	17	5032600-5052009	"Disease related genes, Predicted membrane proteins"	Transport	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 25.6;placenta: 34.6"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 685.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.5;BEWO: 3.8;EFO-21: 3.6;HMC-1: 9.0;SK-BR-3: 5.1;T-47d: 3.0"															NA	NA						"unprognostic (8.81e-3)"	"prognostic favorable (9.54e-4)"	"unprognostic (9.34e-2)"	"unprognostic (7.30e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.19e-2)"	"unprognostic (5.17e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.60e-2)"	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.3	0.6	1.0	20.0	0.2	0.6	24.4	0.5	0.1	1.5	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.2	0.1	1.0	0.1	34.6	0.3	1.4	0.1	0.1	0.5	0.3	0.1	7.4	25.6	0.1	0.1	0.6	0.0	0.7	0.1	0.6	0.2	0.4	0.7	2.5	1.0	1.4	0.6	3.7	0.6	1.4	1.2	0.3	0.2	4.5	0.1	0.2	0.2	0.2	3.8	0.0	0.0	0.6	0.6	0.1	0.2	0.3	3.6	0.1	0.7	0.4	0.0	0.3	0.1	0.1	0.2	0.0	0.7	0.3	0.1	0.1	9.0	0.1	0.1	0.2	0.1	0.2	0.2	0.7	0.1	1.2	0.0	0.3	0.5	0.4	0.4	0.1	0.2	0.1	0.0	0.3	0.1	1.4	0.1	0.3	0.8	5.1	0.1	0.2	3.0	1.4	0.6	0.3	1.1	0.1	0.2	0.3	0.1	0.3	0.2	0.1	0.5	2.6	0.6	0.9	0.7	0.4	0.6	0.6	0.9	1.2	0.2	1.4	1.1	0.8	3.7	1.4	0.4	0.6	0.5	0.3	0.1	0.2	0.3	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.0	1.3	1.0	0.0	0.6	0.0	8.1	0.0	0.0	0.0	134.6	0.0	0.0	0.1	0.1	5.7	0.0	0.0	10.3	1.1	0.3	0.0	0.0	13.6	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.5	685.8	0.0	1.1	0.7
SLC52A2	"D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2"	ENSG00000185803	"Solute carrier family 52 member 2"	Q9HAB3	8	144354135-144361286	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Host cell receptor for virus entry, Receptor"	"Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 51.0"	"Low region specificity"	"Detected in all"							HPA063036	Approved					NA	NA					"HPA063036: AB_2684928"	"unprognostic (7.80e-3)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (7.74e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	16.0	12.8	7.3	13.2	8.8	9.9	23.7	19.2	10.5	10.9	18.1	7.5	19.3	19.6	10.7	19.9	14.6	7.4	16.3	8.0	7.7	9.0	14.7	12.4	10.7	10.7	13.0	5.9	10.6	22.4	7.9	10.9	19.5	9.5	10.8	9.3	7.2	21.3	14.1	7.0	12.6	17.8	8.5	7.9	15.2	16.8	17.0	7.4	11.5	12.4	11.6	14.6	8.6	13.1	7.7	9.0	9.2	7.4	5.7	6.3	1.9	12.8	18.5	2.6	6.9	4.9	3.7	13.4	9.9	7.0	9.0	7.2	14.7	15.5	6.1	16.3	7.1	6.6	15.3	4.4	7.6	1.9	7.5	10.5	10.6	10.6	13.3	16.0	3.9	9.1	5.1	9.2	8.2	6.8	4.4	5.2	5.8	14.5	7.8	4.7	37.4	6.0	10.3	5.6	16.0	51.0	11.2	3.1	13.8	7.3	9.5	8.2	9.8	12.2	12.7	11.4	2.5	10.0	5.1	7.4	7.4	16.8	18.4	14.2	3.9	5.4	4.6	12.2	9.7	8.5	1.2	4.2	9.2	5.9	6.1	3.7	4.2	4.7	6.3	5.2	7.7	4.6	3.1	1.4	5.7	7.4	9.0	5.7	1.9	7.3	8.8	19.2	10.5	7.7	9.0	13.0	5.9	9.5	7.4	6.0	5.4	19.3	19.4	27.7	10.9	2.5	12.7	4.0	14.8	12.2	2.0	74.0	0.0	60.6	2.5	20.6	60.0	0.0	58.0	74.5	27.7	31.3	10.3	4.0	47.5	11.1	16.7	17.8	14.8	4.2	11.8	20.9	28.7	55.1	32.0	13.5	64.4	42.1	18.7	12.9	8.9	19.4	26.4	31.7	39.6	31.6	43.9	20.8	38.1	32.6
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.5"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 22.7;Cytotrophoblasts: 15.8;Enterocytes: 25.3;Syncytiotrophoblasts: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.9;OE19: 17.9;RT4: 6.0;SK-BR-3: 9.5;T-47d: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved					NA	NA					"HPA049391: AB_2680743, HPA059078: AB_2732630"	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.0	0.4	7.3	1.4	5.9	0.5	2.8	3.5	9.0	2.6	9.6	2.1	12.0	13.1	1.8	1.9	4.6	2.0	3.0	3.3	6.6	4.2	10.0	0.4	1.4	0.7	5.6	1.3	1.2	2.2	0.6	0.5	6.7	7.3	7.9	6.3	0.5	5.5	15.8	1.0	1.7	16.3	1.5	4.7	0.4	5.2	32.5	6.0	0.0	0.7	1.2	0.9	4.7	2.2	1.1	0.7	2.4	0.6	1.1	0.8	0.4	3.3	0.9	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.3	25.9	0.0	3.8	0.0	0.2	3.8	0.0	2.8	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	17.9	2.3	0.0	0.0	0.3	0.0	6.0	0.0	0.1	3.8	9.5	0.0	0.4	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.5	0.4	0.2	0.4	0.5	0.4	0.4	0.1	1.1	0.4	0.8	2.2	1.1	0.4	0.7	0.3	0.4	7.3	5.9	3.5	9.0	6.6	4.2	5.6	1.3	7.3	6.0	8.9	1.9	0.0	2.2	0.6	0.4	0.4	0.0	0.0	3.4	22.7	2.0	15.8	1.7	5.6	0.7	2.9	25.3	0.0	1.6	0.7	0.2	5.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.0	0.9	0.3	1.7	0.0	4.9	0.0	4.1	14.4	0.4	0.0	0.0	0.0	0.2	0.5	0.7	1.0	43.6	0.0	9.3	6.2
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 27.0"	"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Not detected"	"Not detected"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	27.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.8	0.6	0.0	111.5	117.2	0.0	4.5	0.0	0.0	0.0	0.0	2.4	40.8	0.0	26.1	0.0	1.2	0.0	0.2	19.7	0.0	0.0	0.0	0.0	24.5	0.0	0.0	54.9	1.1	0.0	0.0	0.0	8.7	0.0	0.6	14.7	1.4	1.9	0.0	0.0	0.0	4.2	0.5	4.8	0.0	0.0	19.6	4.8
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 70.6"	"Group enriched"	"Detected in some"	4	"Late spermatids: 20.1;Proximal tubular cells: 51.2"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 3.0;non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 7.9"	"Cell line enriched"	"Detected in some"	5	"U-937: 11.0"	"Not detected"	"Not detected"							HPA052014	Uncertain					NA	NA					"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.1	0.1	0.1	0.5	0.1	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.1	0.0	70.6	0.4	0.3	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.1	0.1	0.1	0.1	0.7	1.1	0.1	0.2	3.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	1.2	0.1	7.9	0.0	0.6	0.5	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	1.8	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.1	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	11.0	0.0	0.1	0.0	0.0	0.1	3.0	0.0	0.4	0.3	0.0	1.2	0.3	0.6	0.2	0.0	0.0	7.9	0.0	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	8.7	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.0	20.1	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	51.2	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Predicted membrane proteins"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 48.0;intestine: 21.8"	"Group enriched"	"Detected in some"	4	"Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 18.9;Karpas-707: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.6	0.6	4.3	0.6	21.8	0.5	2.8	1.9	11.2	0.6	1.7	29.7	0.0	10.9	0.6	0.5	0.5	0.6	1.4	0.7	12.1	7.4	9.9	1.0	0.6	0.7	48.0	2.4	0.6	0.5	0.5	0.2	0.5	18.3	0.6	0.8	0.0	0.6	0.8	0.7	0.5	21.8	0.5	34.7	0.6	0.6	0.8	22.9	0.0	0.6	0.0	0.7	0.6	0.1	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.3	21.8	1.9	8.0	12.1	7.4	48.0	2.4	18.3	22.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	5.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 145.9"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.6	0.8	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.4	5.2	0.1	0.3	0.2	0.5	3.8	0.7	0.1	0.1	0.0	0.6	0.1	1.1	2.0	0.3	1.7	0.2	0.0	7.8	2.8	0.5	0.6	0.4	0.2	0.4	0.2	2.3	0.7	0.2	0.2	0.0	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	3.5	0.0	0.1	8.3	0.0	0.7	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.3	0.0	145.9	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"kidney: 33.7"	"Group enriched"	"Detected in some"	11	"Early spermatids: 46.9;Late spermatids: 103.8;Proximal tubular cells: 139.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	16	"NK-cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;EFO-21: 2.0;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041603	Enhanced					NA	NA					"HPA041603: AB_10960540"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.6	0.6	0.1	0.4	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	1.2	0.1	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.5	0.0	0.0	0.5	0.1	0.0	1.4	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.3	0.0	1.4	0.0	8.7	0.0	0.2	6.6	0.7	46.9	0.0	0.3	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	103.8	2.0	0.4	0.0	0.0	0.2	0.0	0.7	0.0	1.4	139.8	0.0	0.0	0.0	3.2	0.9	0.3	0.1	0.0	0.6	0.0
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073570-34106262	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	10.1	9.5	10.5	7.3	11.0	3.6	26.6	8.0	10.1	6.5	7.6	4.6	9.4	5.0	11.3	9.1	7.5	8.5	4.9	6.8	11.6	6.8	46.0	9.5	8.5	7.6	11.7	4.7	9.0	5.8	6.3	6.6	15.8	13.6	7.0	8.8	11.3	6.4	6.9	7.8	10.1	7.4	5.9	14.7	4.9	7.8	10.6	9.0	5.9	42.7	4.4	8.0	6.5	22.1	0.8	2.3	0.7	1.0	1.0	2.6	0.7	6.3	5.7	11.9	8.4	10.0	8.2	5.7	7.2	22.1	4.5	6.9	9.4	13.9	10.2	5.9	14.6	8.5	3.3	14.4	4.1	7.7	10.6	3.7	10.6	5.3	3.1	2.6	4.5	4.5	3.9	10.7	12.3	4.9	13.9	2.7	8.5	10.4	2.4	11.6	4.3	4.8	3.7	6.0	2.4	5.6	4.9	2.1	4.6	17.8	8.9	6.2	2.9	15.0	4.0	3.4	7.4	2.4	4.8	2.6	8.9	6.9	16.9	2.9	12.7	10.9	7.7	17.9	6.6	5.9	0.0	1.0	0.2	2.6	0.9	2.1	0.8	1.4	1.7	0.9	0.8	1.9	2.6	0.7	1.0	0.4	2.3	0.4	0.7	10.5	11.0	8.0	10.1	11.6	6.8	11.7	4.7	13.6	9.0	14.9	12.2	8.0	40.9	0.0	28.5	7.6	12.7	16.0	23.9	130.9	19.6	21.2	18.3	3.4	8.6	4.5	28.0	0.0	4.5	15.7	10.7	71.1	41.4	15.3	12.8	35.0	47.1	6.7	12.1	5.2	6.1	9.8	0.0	24.4	48.3	6.0	5.8	46.0	19.4	6.5	20.8	12.9	2.2	12.1	18.9	0.0	23.6	17.3	26.6	32.3
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871973-17895174	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 31.5;salivary gland: 66.8;stomach 1: 32.7"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 5.3;Club cells: 7.9;Spermatogonia: 7.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 31.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 16.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA					"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.1	0.1	0.4	0.1	0.1	2.4	2.3	5.1	0.1	9.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	1.7	0.1	0.1	0.0	0.2	0.2	0.3	2.7	0.0	0.1	0.0	0.2	0.0	31.5	0.1	0.0	5.5	66.8	0.0	0.2	0.2	0.3	0.0	1.9	0.2	32.7	0.4	0.1	0.0	7.1	0.0	0.1	0.0	0.1	1.3	0.8	2.5	1.4	1.0	4.3	0.9	0.0	0.0	0.1	0.1	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.5	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.2	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	3.7	0.0	2.5	0.6	0.4	1.1	1.4	1.3	1.0	3.2	0.6	0.8	1.3	4.3	3.2	2.2	1.0	0.4	0.4	2.0	0.9	0.1	0.4	2.4	2.3	1.7	0.1	0.3	2.7	31.5	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.6	0.0	5.3	7.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.9	0.3	0.0	0.5	0.0	0.0
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.0;placenta: 51.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 69.3;SK-BR-3: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	20.9	4.6	5.0	7.6	8.5	8.5	15.9	7.9	8.1	4.0	6.4	5.6	6.4	10.9	7.4	36.7	5.5	5.9	6.3	3.5	5.3	5.7	5.9	64.0	6.0	6.4	7.0	8.1	5.6	6.0	4.5	4.2	51.7	7.1	4.8	6.6	5.6	6.7	10.6	7.9	4.6	7.6	4.9	4.4	4.8	4.8	17.5	6.1	5.8	5.1	4.3	13.0	4.6	10.1	6.8	10.0	2.0	9.0	6.3	10.4	5.8	16.7	17.4	11.1	14.6	10.3	3.7	69.3	6.1	4.1	9.3	6.4	25.6	6.0	11.6	9.3	3.3	10.1	9.4	23.7	7.0	6.5	9.0	13.9	20.6	7.4	39.2	12.2	26.4	10.8	12.9	6.0	11.4	8.9	2.6	8.3	9.5	30.1	4.8	5.9	34.4	8.9	12.9	32.0	19.4	6.4	15.1	13.1	16.8	5.3	16.1	9.4	13.9	6.6	74.6	8.8	11.3	16.6	5.7	3.8	10.3	14.1	6.2	16.3	8.0	18.3	18.5	5.6	18.6	14.4	0.1	6.5	2.0	8.5	7.3	10.4	6.8	8.3	8.2	9.7	6.7	8.5	10.1	0.3	6.3	9.0	10.0	8.2	5.8	5.0	8.5	7.9	8.1	5.3	5.7	7.0	8.1	7.1	6.1	0.0	4.1	13.4	6.8	7.1	4.5	5.9	7.6	4.0	2.3	7.0	3.9	98.8	1.7	9.6	11.6	3.8	6.0	0.0	7.0	89.2	5.4	7.1	0.0	36.0	19.5	11.1	5.2	7.4	10.0	25.3	6.6	6.5	0.0	78.5	6.8	3.9	6.2	2.9	13.1	3.6	3.4	12.9	5.9	31.1	18.5	5.5	190.6	7.5	13.3	6.4
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"RT4: 8.9;SCLC-21H: 2.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3
SLC5A8	AIT	ENSG00000256870	"Solute carrier family 5 member 8"	Q8N695	12	101155493-101210407	"Predicted membrane proteins"	"Apoptosis, Ion transport, Sodium transport, Symport, Transport"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 2: 7.7;Horizontal cells: 9.5;Intestinal endocrine cells: 30.3;Proximal tubular cells: 10.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SK-BR-3: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (9.04e-6)"	"unprognostic (1.84e-1)"		"unprognostic (1.17e-2)"		"unprognostic (1.27e-3)"		"unprognostic (1.24e-1)"			"unprognostic (5.20e-1)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (6.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.87e-2)"		0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	14.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.8	0.0	1.9	0.0	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.6	0.9	0.0	1.4	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.6	0.0	0.0	7.7	0.0	0.0	0.0	4.0	0.6	0.0	1.4	1.2	1.8	0.0	0.0	1.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	9.5	30.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 77.3"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	33.0	0.1	0.8	26.0	0.1	7.2	0.1	0.2	2.2	0.1	0.0	0.0	3.1	4.9	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	1.0	77.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	1.0	0.0	0.0	0.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	1.7	0.4	5.8	0.0	0.7	0.0	0.2	0.0	0.0	0.1	4.6	4.5	0.1	0.0	0.0	0.0	1.2	7.9	0.3	0.0	0.0	0.0	0.6	0.0	0.1	1.1	0.4	3.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039249	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 56.2;liver: 75.6"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced		Uncertain	Mitochondria		No	NA			Mitochondria		"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.8	2.1	32.2	1.6	31.0	3.0	1.8	15.1	56.2	2.0	1.7	25.4	0.0	1.7	1.9	3.9	4.3	2.4	2.3	3.3	22.2	16.6	2.1	75.6	2.5	1.7	22.7	25.3	2.4	1.4	9.3	1.0	2.0	17.0	2.1	1.8	1.7	1.6	5.0	3.3	1.7	1.7	1.8	13.7	1.9	1.7	4.4	14.3	0.5	1.9	0.0	1.7	1.9	0.9	1.0	0.8	1.2	0.3	0.2	0.8	0.2	0.8	0.6	1.9	1.3	1.5	0.4	1.1	0.7	0.2	0.8	1.1	1.5	1.0	1.6	0.3	0.4	1.8	1.3	2.3	0.9	0.7	0.2	1.8	1.3	4.6	2.8	0.7	2.2	2.3	1.1	0.2	0.2	1.3	0.5	0.3	1.7	1.1	3.7	0.2	1.1	0.7	1.8	0.8	1.2	1.4	1.2	0.2	0.1	0.6	1.8	0.8	0.3	1.0	0.7	0.2	1.1	1.0	1.0	0.3	0.8	0.5	0.7	0.7	1.1	0.3	1.2	0.9	1.7	0.4	0.3	0.3	1.1	0.5	0.1	0.8	0.9	0.6	0.5	0.3	1.0	0.3	0.5	1.2	0.2	0.3	0.8	0.3	0.2	32.2	31.0	15.1	41.5	22.2	16.6	22.7	25.3	17.0	14.3	0.0	0.3	0.0	0.0	0.2	1.8	1.4	17.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	24.5	0.0	0.0	0.0	0.0	1.0	0.2	5.2	0.0	0.0	0.0	0.0	41.9	0.0	0.0	9.6	0.1	3.3	12.9	2.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	12.7	0.0	2.1	0.0	0.0	0.2	0.2	0.0	14.6	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.8	4.4	3.7	0.1	0.0	0.1	4.8	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2	0.0	0.0	0.0	0.2	1.1	7.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	21.8	0.3	0.0	6.3	0.0	1.3	0.0	0.0	0.2	1.5	3.1	0.8	0.0	0.0	1.5
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.1;liver: 59.3"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6"	"Group enriched"	"Detected in many"	51	"dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.6	0.8	6.3	1.3	12.9	0.6	0.8	6.6	14.7	0.9	1.0	4.3	0.0	3.7	1.3	5.6	0.5	3.0	1.2	0.7	7.2	4.6	22.1	59.3	2.2	0.8	8.1	4.9	0.7	1.3	0.6	0.3	0.9	9.4	0.6	1.8	0.2	0.6	0.5	0.5	0.7	1.1	1.2	3.1	0.8	2.3	1.6	8.8	0.0	4.5	0.0	0.7	0.9	0.2	0.0	2.9	3.7	8.6	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.0	0.1	0.0	0.5	0.0	0.0	0.1	3.7	0.3	0.5	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.7	0.0	8.6	0.0	0.0	1.9	6.3	12.9	6.6	14.7	7.2	4.6	8.1	4.9	9.4	8.8	0.0	0.3	0.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	43.6	0.0	0.0	1.7	0.0	3.6	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	17.4	2.4	0.0	0.0	1.3	0.3	3.4	0.6	1.8	0.0	17.2	1.2	6.3	0.0	0.0	0.0	6.8	0.2	6.5	0.0	0.5	1.7	0.4	0.7	0.0	0.8	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 261.2"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 10.0;SuSa: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.3	0.0	0.5	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	10.0	0.1	0.1	0.0	0.1	0.0	0.9	3.7	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0.0	1.1	0.5	0.0	0.0	0.2	1.3	0.0	1.4	0.0	17.4	2.0	0.0	41.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.7	0.0	0.0	0.0	0.6	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.2	0.8	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.0	0.0
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;Hep G2: 8.2;OE19: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0											20.8	100.3	0.0	0.1	0.1	0.0	0.2	0.0	10.7	33.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.2	0.0	28.5	0.0	0.0	5.2	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.1	0.0	101.5	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	3.2
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859488-84913615	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2"	"Cancer enhanced"	"Detected in some"		"melanoma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	1.4	4.5	18.0	2.2	16.2	1.0	2.3	17.8	31.0	1.7	2.2	5.4	0.0	1.4	2.8	1.1	6.7	1.2	1.3	1.0	10.9	18.2	1.5	1.0	1.3	1.1	10.3	16.9	2.1	1.0	1.0	5.6	8.9	14.7	1.8	1.8	9.2	1.4	1.5	1.0	4.9	2.1	1.6	4.9	1.1	1.3	3.6	12.8	0.0	2.0	1.8	1.8	1.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	31.1	19.2	0.0	0.0	6.5	0.5	0.3	0.0	0.0	0.0	0.0	0.2	4.1	0.4	0.0	8.3	0.0	0.0	9.5	0.0	1.5	0.0	11.5	0.0	0.2	10.7	16.0	4.2	43.9	8.5	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	7.8	0.0	9.9	22.1	0.1	0.0	0.0	0.0	4.7	2.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	16.2	17.8	18.6	10.9	18.2	10.3	16.9	14.7	12.8	0.0	0.0	0.0	0.0	2.4	18.0	0.4	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.2	0.0	0.0	30.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.1	0.4	0.5	0.2	0.0	0.0	0.0
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225355-1246189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	32	"kidney: 14.1"	"Group enriched"	"Detected in some"	71	"Distal tubular cells: 6.6;Proximal tubular cells: 21.3"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced					NA	NA					"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225117	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 167.3"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 63.7;Enterocytes: 25.3;Proximal tubular cells: 65.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.4;HEL: 17.6;OE19: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA					"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	55.3	0.0	0.0	44.6	0.1	0.0	0.1	0.1	30.0	0.1	0.1	0.1	28.7	0.5	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.5	1.7	0.0	0.1	0.0	0.1	0.1	167.3	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	63.7	0.0	1.2	1.8	0.0	0.0	1.7	0.0	0.1	0.0	25.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	5.8	0.0	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 107.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	107.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.4	4.7	0.0	0.0	0.0
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.1;OE19: 7.1;SuSa: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain					NA	NA					"HPA029873: AB_10602403"	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.2	0.4	0.4	0.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0	1.6	1.4	0.2	1.1	0.0	0.3	3.1	0.1	0.0	0.2	0.1	0.2	1.3	1.2	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.0	0.5	0.2	0.5	0.0	0.3	0.5	0.3	1.4	7.1	0.3	0.5	0.1	0.4	0.2	0.3	0.4	0.4	1.5	0.2	0.0	10.3	0.3	0.1	0.1	0.5	0.4	0.4	0.3	0.8	0.3	0.1	0.2	0.3	0.1	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3	0.0	5.3	0.0	0.4	0.5	0.0	0.8	12.7	0.0	2.3	0.0	0.0	0.0	0.0	10.1	0.5	0.0	2.6	0.0	0.2	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	6.2	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.4	0.4
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392790-1445430	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 48.4"	"Cell type enriched"	"Detected in single"	5	"Alveolar cells type 2: 2.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	47	"midbrain: 48.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8"	"Group enriched"	"Detected in some"	8	"midbrain: 96.4;thalamus: 31.8"	"Region enriched"	"Detected in single"	138	"midbrain: 362.2"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA			Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.2	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.3	1.1	0.8	0.1	0.8	0.6	0.1	0.0	0.6	0.3	0.0	3.4	0.0	48.4	0.0	1.5	0.0	0.0	0.0	0.1	1.0	0.7	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.8	0.0	2.4	2.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.1	3.8	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	48.4	0.0	1.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7"	"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.7	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.7	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1	14.9	5.3	0.0	0.4	0.1	0.2	0.8	0.0	1.4	3.4	1.8	0.0	90.5	0.0	0.0	2.3	0.5	1.0	0.0	0.0	7.0	1.6	0.3	2.3	0.0	8.4	0.0	0.0	2.5	0.6	1.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.4	0.3	0.9	0.0	1.4	0.0	0.4	0.3	89.0	0.0	0.0	0.3
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599400-20659285	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 21.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 20.8;Late spermatids: 40.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 51.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 33.2"	CAB079052		Supported				NA	NA					"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.1	0.1	0.1	0.0	0.0	0.0	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	5.1	0.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.3	0.1	0.1	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.3	6.2	4.7	8.1	2.5	12.8	7.0	27.8	8.3	6.1	6.3	8.0	13.5	6.4	11.0	12.0	3.7	4.2	5.7	7.4	1.5	5.2	12.8	22.7	9.4	0.2	3.5	27.8	1.3	1.7	7.6	2.0	7.2	9.0	6.3	7.1	2.7	7.3	4.9	9.8	6.8	9.6	6.5	5.0	7.0	7.4	21.1	45.5	9.7	11.5	4.1	5.2	2.8	1.5	24.4	10.7	1.9	22.7	10.6	5.7	2.6	5.0	3.0	3.4	5.0	24.7	6.9	32.4	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6	6.0	22.1	4.7	11.2	43.8	102.1	3.6	2.5	12.0	12.5	19.2	538.0	2.2	0.0	9.6	17.0	16.1	0.7	0.0	7.1	12.8	16.4	5.5	12.7	0.4	26.7	9.5	13.8	11.6	62.5	13.3	16.1	47.4	16.9	129.0	2.9	28.2	21.5	2.9	16.3	26.3	502.9	0.0	8.2	0.5	1.5	20.8	4.2	22.4	1.2	10.6
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150189957-150222788	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 40.2"	"Cell type enhanced"	"Detected in some"	18	"Enterocytes: 2.1;Intestinal endocrine cells: 3.5;Mucus-secreting cells: 4.8;Paneth cells: 8.6;Undifferentiated cells: 3.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.6;HeLa: 1.8;SK-BR-3: 1.4;U-87 MG: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain					NA	NA					"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.5	0.4	3.9	1.0	9.7	0.4	0.5	40.2	22.4	0.6	5.7	0.3	0.0	2.6	0.5	0.6	0.4	0.4	0.5	0.5	6.5	4.5	0.4	0.4	0.5	0.7	1.3	14.5	0.4	0.5	0.4	0.2	0.4	1.6	0.4	7.7	0.0	0.8	0.4	0.5	0.5	4.9	0.7	1.4	0.4	0.4	0.5	0.0	0.0	0.4	0.0	0.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	40.2	22.4	6.5	4.5	1.3	14.5	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.8	0.0	0.1	8.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	3.4	0.1
SLC6A8	"CRTR, CT1"	ENSG00000130821	"Solute carrier family 6 member 8"	P48029	X	153688099-153696593	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 127.1;Enterocytes: 208.5;Horizontal cells: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 42.8;SK-BR-3: 44.4"															NA	NA						"unprognostic (5.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (2.87e-1)"	17.6	19.5	26.3	5.8	39.0	19.3	7.3	23.9	31.9	6.1	26.8	36.6	7.6	32.4	11.2	9.1	20.0	10.6	20.2	53.1	29.3	16.1	27.3	1.9	3.1	1.9	55.6	22.0	5.1	8.3	17.0	7.2	22.6	25.8	12.8	20.2	20.9	31.8	24.9	76.4	28.0	48.3	13.5	28.2	5.1	11.0	16.7	38.9	4.6	2.8	11.0	5.0	40.4	10.1	0.5	0.0	2.6	0.2	0.0	0.0	0.1	40.6	1.7	12.5	42.8	4.0	2.8	2.9	6.1	10.1	7.9	9.8	5.2	0.5	0.0	4.7	7.3	9.3	15.1	25.0	21.0	4.9	0.7	23.8	0.1	14.1	15.5	13.9	0.3	2.8	5.9	4.5	7.9	28.7	15.0	3.9	0.2	9.9	0.6	4.4	2.4	0.2	0.9	12.8	8.1	17.9	1.9	1.4	0.5	8.6	7.9	16.1	18.0	8.9	44.4	28.8	3.0	8.6	6.2	3.9	13.1	20.9	16.8	18.0	1.5	0.7	0.4	29.3	1.2	13.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	26.3	39.0	23.9	30.4	29.3	16.1	55.6	22.0	25.8	38.9	0.0	3.4	2.7	10.6	20.6	127.1	89.0	25.5	8.1	0.0	5.2	104.1	11.0	3.3	3.6	0.6	5.6	208.5	23.3	18.9	27.8	11.2	21.2	4.6	0.8	4.3	112.8	24.9	4.9	1.3	2.2	8.3	1.6	23.6	5.4	32.8	17.4	55.3	41.8	7.8	49.9	48.6	32.3	15.3	2.9	2.8	13.7	76.0	0.0	15.7	17.6
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 26.6;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.9;hTCEpi: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.3	5.5	2.7	7.0	4.4	1.5	6.2	5.9	15.9	9.6	11.9	1.8	2.9	0.1	0.6	16.3	0.0	23.9	4.2	4.7	1.9	0.0	0.7	6.5	13.1	2.1	20.2	1.4	0.3	4.5	41.9	4.7	11.2	6.0	0.2	4.7	5.0	18.8	0.4	4.0	1.0	0.0	2.1	2.8	7.4	0.8	0.0	8.4	0.9	0.8	1.7	1.6	3.0	13.7	2.7	0.7	3.6	3.9	0.1	1.1	4.5	0.9	3.0	20.8	14.3	1.6	3.6	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3	0.0	1.3	0.9	0.7	6.6	26.6	0.6	5.1	8.1	0.0	1.8	15.7	0.4	0.0	3.2	5.8	0.4	9.8	70.0	7.9	0.7	0.9	1.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.4	1.4	0.0	3.3	1.8	2.9	1.2	4.2	2.0	1.4	1.0	10.2	6.5	6.3	0.0	0.4	11.3	0.5	0.0	1.3	2.5
SLC7A1	"ATRC1, CAT-1, ERR, HCAT1, REC1L"	ENSG00000139514	"Solute carrier family 7 member 1"	P30825	13	29509410-29595688	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 42.8"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039721, HPA077838"	Approved					NA	NA					"HPA039721: AB_10672893, HPA077838: "	"unprognostic (1.85e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.20e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.37e-3)"	5.7	4.5	8.5	9.0	11.7	8.6	7.0	8.7	19.6	8.1	8.7	10.7	7.5	9.0	7.3	9.6	42.8	6.9	4.8	6.2	12.2	10.4	4.3	2.4	4.4	7.1	11.4	7.7	5.3	26.6	2.9	6.4	12.9	20.0	7.2	6.8	6.1	16.2	12.6	2.1	14.8	12.9	8.1	11.9	5.7	10.0	8.8	6.9	5.3	8.6	27.7	16.2	6.4	8.3	2.0	3.7	0.5	2.8	0.8	3.3	1.7	12.2	9.9	8.7	17.5	4.5	9.0	9.9	26.2	17.5	22.7	16.9	20.0	21.6	24.3	7.1	39.9	25.4	56.3	15.1	18.5	30.0	22.8	9.0	18.2	10.8	10.8	23.4	26.4	12.0	11.4	39.6	25.2	29.9	5.3	11.1	27.8	11.6	11.4	9.5	16.5	19.2	7.1	8.3	21.8	6.6	13.3	18.0	13.9	14.4	8.2	29.7	14.1	14.9	14.6	23.7	5.7	6.4	22.5	10.4	17.9	12.5	15.7	18.7	12.8	9.2	27.7	14.3	10.7	18.0	0.0	1.1	0.5	3.3	1.2	2.7	2.0	2.4	2.7	1.8	1.4	1.9	3.1	0.0	0.8	2.8	3.7	1.9	1.7	8.5	11.7	8.7	15.9	12.2	10.4	11.4	7.7	20.0	6.9	0.0	5.3	14.9	42.8	44.3	15.1	6.7	10.2	5.3	12.5	68.0	15.7	0.4	1.7	19.5	0.2	14.3	16.1	23.3	49.3	31.4	9.3	41.6	6.9	0.8	6.1	23.8	29.9	3.7	4.3	0.4	5.8	5.2	8.5	4.6	28.0	3.4	45.4	24.5	3.5	0.0	17.8	6.5	9.9	0.5	2.1	30.6	3.3	4.9	24.5	38.1
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 1.8;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.0	0.0
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	1.1	0.9	16.3	4.7	15.8	2.2	1.5	8.2	26.0	2.4	2.0	17.9	0.0	1.5	1.3	13.4	3.3	8.9	3.8	2.5	17.4	6.9	0.9	0.9	2.3	1.5	12.6	16.8	1.7	5.4	1.0	1.2	2.1	17.2	2.0	2.8	0.3	1.6	1.0	0.8	1.9	1.4	1.0	27.2	1.4	9.2	2.2	14.0	0.0	8.9	6.0	2.2	4.0	0.8	0.1	3.8	0.4	0.0	0.1	0.0	0.0	1.6	13.8	6.2	4.8	1.3	1.7	1.7	7.6	5.3	1.7	4.0	1.5	5.8	3.1	10.0	26.5	9.4	2.2	3.3	6.5	7.4	5.9	0.7	2.2	13.1	3.4	20.6	5.8	2.1	4.1	28.6	4.9	22.1	2.6	21.6	3.2	3.0	8.2	9.1	1.2	0.8	0.5	1.2	8.1	3.9	0.9	2.0	3.6	1.0	6.6	2.5	0.5	3.3	0.9	11.7	1.4	1.5	12.4	31.4	2.3	6.5	3.4	6.0	6.9	3.1	3.2	3.9	3.2	46.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	3.8	0.0	0.0	16.3	15.8	8.2	15.9	17.4	6.9	12.6	16.8	17.2	14.0	0.0	5.9	3.7	7.0	4.0	4.0	3.6	2.5	1.4	3.4	0.0	2.0	2.2	0.0	3.6	2.1	1.6	1.1	0.0	21.4	0.5	1.0	37.7	4.6	0.4	0.5	1.6	25.9	3.7	0.0	0.4	2.3	9.0	5.0	90.2	5.4	48.4	27.4	1.1	2.1	0.0	1.9	0.0	1.0	0.7	0.7	2.8	0.9	0.0	1.3	11.1
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 67.7;RT4: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.65e-7)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.4	0.0	0.1	11.3	0.0	7.0	0.5	0.6	3.3	0.0	0.0	2.4	0.0	1.5	0.0	7.5	1.7	2.4	0.0	3.9	0.0	8.1	7.2	67.7	3.1	0.0	9.1	1.4	8.8	8.4	0.0	3.2	0.0	0.0	0.0	7.9	11.0	0.4	3.6	3.8	2.3	0.9	0.0	5.2	5.4	0.8	17.4	0.1	1.4	0.5	0.2	3.1	8.0	0.0	0.3	7.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5	11.9	63.8	0.0	6.1	7.3	1.8	14.3	33.1	84.3	27.3	7.0	33.4	17.0	0.0	4.5	10.8	5.2	0.1	0.0	79.6	13.8	18.2	28.5	2.3	230.6	4.7	0.0	84.5	6.7	6.9	17.4	35.1	1.5	3.3	1.0	2.2	15.0	29.6	0.0	26.2	1.8	38.5	58.2	52.8	0.4	0.4	3.3	21.7	2.5	2.6	1.8
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 5.3;Late spermatids: 1.9"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Group enriched"	"Detected in some"	4	"HAP1: 20.7;NTERA-2: 42.6;SuSa: 53.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	42.6	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869488	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 71.2"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 15.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	8.2	3.2	18.3	14.7	24.5	71.2	4.3	15.9	45.8	7.9	4.6	16.7	8.9	6.2	5.3	30.4	38.7	3.3	6.4	8.2	19.8	22.1	3.6	9.7	3.8	11.1	23.9	9.6	5.1	12.1	1.5	9.0	28.4	23.4	4.3	3.4	34.9	11.5	15.4	11.2	10.7	5.7	4.8	17.7	6.4	12.7	34.9	19.8	3.7	4.2	16.7	15.0	11.5	7.7	0.5	15.9	0.6	0.0	0.2	1.4	0.4	14.9	56.6	1.1	15.9	0.4	0.9	40.8	12.0	4.3	7.3	4.7	36.9	21.4	13.7	10.6	15.2	2.5	67.4	11.7	108.7	5.1	14.3	5.9	11.2	53.1	26.4	17.1	10.4	20.7	3.0	186.8	9.0	66.8	2.4	1.4	48.5	16.7	15.3	5.8	101.2	12.5	15.3	5.2	9.4	13.8	12.2	4.3	20.9	8.1	1.2	9.1	3.6	153.4	30.7	32.9	10.8	14.1	13.8	1.1	2.6	17.1	10.6	9.3	20.0	16.3	59.1	10.1	25.9	24.4	0.6	0.0	0.0	1.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.1	0.4	0.1	0.2	0.0	15.9	1.4	0.4	18.3	24.5	15.9	28.1	19.8	22.1	23.9	9.6	23.4	19.8	0.0	1.1	16.4	11.1	65.1	12.7	2.8	2.5	0.0	0.0	1.8	15.7	12.4	0.0	16.8	0.8	4.3	1.7	70.0	8.0	28.4	10.4	13.9	68.9	14.5	8.2	9.5	82.6	2.5	3.5	4.0	1.7	6.6	37.1	2.8	2.8	13.3	19.5	0.2	1.4	0.5	50.1	0.0	85.8	1.7	2.5	32.9	89.8	8.6	1.6	26.1
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050713	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	25.9	7.6	5.4	12.9	6.7	6.9	18.7	9.0	8.0	5.3	7.1	3.4	6.7	3.6	5.5	14.0	4.0	7.1	4.7	13.1	5.3	3.3	5.4	2.3	9.8	16.3	3.3	4.6	3.0	3.2	2.5	11.1	16.3	5.4	6.6	10.8	9.0	5.8	5.1	58.8	8.4	9.4	8.3	3.4	9.4	5.3	5.2	3.7	31.8	15.0	8.0	19.6	5.7	8.0	7.2	16.2	5.9	3.6	6.7	12.6	1.7	9.4	9.7	7.2	7.7	21.4	12.8	20.3	11.1	8.1	16.6	13.9	41.3	7.2	18.8	8.8	14.2	4.8	14.5	14.0	13.9	18.1	3.8	10.0	10.0	19.1	13.1	3.9	11.8	9.1	8.6	12.2	12.9	6.5	5.3	11.1	9.8	14.7	3.4	9.0	5.1	15.3	8.2	5.4	6.4	3.5	19.5	4.5	15.8	5.8	8.3	10.6	5.8	32.1	9.0	3.8	6.3	13.5	6.4	16.3	11.0	8.4	9.2	13.9	7.2	13.5	21.5	7.0	8.7	7.4	2.5	3.6	3.0	4.9	1.7	6.1	6.6	7.3	4.6	3.4	7.2	12.6	7.4	5.9	6.7	1.4	16.2	3.1	1.7	5.4	6.7	9.0	8.0	5.3	3.3	3.3	4.6	5.4	3.7	38.7	16.8	11.1	8.0	17.4	3.7	17.3	0.0	8.1	3.4	17.4	35.3	20.4	0.0	3.0	4.0	9.0	4.2	0.0	3.4	1.6	10.5	3.0	4.6	1.3	12.0	9.5	2.4	7.4	6.7	14.6	5.5	7.5	10.1	3.6	8.9	2.1	4.1	6.2	3.5	0.3	2.6	0.0	7.3	14.2	9.4	19.2	40.0	17.5	6.9	2.3
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 63.8;intestine: 93.5;kidney: 67.3"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 200.4;Kupffer cells: 312.3;Macrophages: 142.1;Proximal tubular cells: 254.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 59.5;non-classical monocyte: 63.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 44.5;CACO-2: 72.0;EFO-21: 15.6;OE19: 63.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA					"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	10.4	2.8	1.9	8.3	3.1	3.6	3.2	0.7	2.7	2.6	48.0	4.1	0.2	24.1	2.7	2.3	2.1	4.6	7.6	3.0	2.2	1.6	67.3	6.5	15.3	20.5	3.7	1.0	2.6	2.7	26.3	1.0	6.5	3.2	2.7	3.4	2.1	3.3	0.9	1.6	1.8	93.5	3.5	4.5	32.4	3.0	13.4	2.7	2.1	2.8	0.8	5.7	4.1	3.6	3.0	14.6	5.4	63.8	0.0	0.1	17.8	0.0	2.4	0.2	0.1	0.4	0.8	44.5	0.5	3.6	0.1	0.3	72.0	7.3	3.5	15.6	0.3	0.2	2.7	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.7	2.1	0.3	0.3	1.6	0.2	0.2	0.1	0.3	5.5	0.2	0.0	2.8	0.5	0.1	0.0	0.3	0.7	63.3	0.0	0.6	7.8	2.1	0.1	0.2	0.0	0.1	0.1	0.1	0.5	2.1	0.1	1.7	0.3	0.1	0.3	0.1	0.1	0.6	0.1	1.8	0.2	0.1	0.0	0.0	41.2	0.1	0.0	59.5	0.0	3.0	0.0	0.0	14.6	2.3	0.1	0.0	5.4	0.0	63.8	0.5	0.1	17.8	1.9	3.1	0.7	2.7	2.2	1.6	3.7	1.0	3.2	2.7	11.9	10.3	23.7	0.1	0.9	0.0	0.8	58.6	9.4	4.5	3.5	0.0	1.0	10.0	6.7	40.8	4.5	8.6	0.0	5.8	4.5	4.8	0.2	1.1	1.3	200.4	0.0	1.2	22.1	312.3	7.5	3.4	142.1	5.0	34.3	0.4	0.5	7.3	0.0	0.0	254.4	1.2	6.5	2.8	12.2	1.7	0.4	1.5	5.0	0.3	0.0
SLC7A8	"LAT2, LPI-PC1"	ENSG00000092068	"Solute carrier family 7 member 8"	Q9UHI5	14	23125295-23183674	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 204.0"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 97.0;Kupffer cells: 71.7;Proximal tubular cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5"	"Group enriched"	"Detected in many"	46	"granulocytes: 13.2;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"AF22: 21.2;ASC diff: 22.3;BEWO: 38.9;CACO-2: 21.5;K-562: 40.6;NTERA-2: 21.2;SuSa: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046015, HPA051950, HPA060672"	Enhanced					NA	NA					"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.97e-4)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.39e-3)"	"unprognostic (9.44e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.52e-4)"	10.5	5.9	4.6	3.0	6.6	1.3	11.0	10.9	10.7	12.7	5.9	2.5	28.2	11.7	23.0	7.2	13.2	21.7	6.2	3.1	7.8	3.0	37.6	3.0	6.2	5.8	2.4	5.6	33.7	9.1	204.0	16.7	19.8	6.9	13.0	5.1	31.2	9.5	50.9	23.6	11.2	8.8	7.5	1.9	10.0	19.3	10.5	4.7	0.3	12.8	5.2	4.9	15.2	14.5	0.1	0.0	13.2	0.1	0.0	3.5	1.7	0.4	0.0	21.2	0.0	22.3	2.7	38.9	2.1	8.5	0.0	0.6	21.5	1.1	0.1	0.3	4.6	2.2	3.6	2.8	1.1	0.1	0.0	2.0	0.1	0.0	0.0	8.7	0.0	12.1	19.2	10.7	0.3	0.2	5.0	1.7	1.9	40.6	0.0	0.4	0.3	0.0	0.2	21.2	4.0	15.8	0.0	0.2	4.0	0.2	7.9	2.6	0.1	0.0	3.7	10.0	25.5	13.5	0.1	0.1	0.7	0.5	0.2	0.0	0.1	4.6	0.0	2.4	0.0	0.1	7.6	0.1	13.2	0.0	0.1	1.1	0.1	0.9	0.1	0.0	0.0	0.9	3.5	0.4	0.0	0.0	0.0	0.5	1.7	4.6	6.6	10.9	10.7	7.8	3.0	2.4	5.6	6.9	4.7	14.9	16.7	2.9	22.2	2.7	28.0	5.1	0.0	0.0	13.6	15.7	0.0	14.7	5.0	1.3	1.8	1.3	12.9	0.0	2.1	2.2	8.7	34.8	4.7	0.4	47.4	25.4	31.8	97.0	71.7	1.7	8.9	9.7	18.6	0.0	30.8	48.5	3.9	3.5	7.4	98.9	4.2	0.0	3.1	0.3	0.6	2.6	34.6	1.3	18.9	31.8
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869766	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 63.3;kidney: 26.4"	"Cell type enriched"	"Detected in some"	5	"Proximal tubular cells: 55.5"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA					"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	2.7	0.0	5.2	3.9	0.1	1.7	0.0	0.7	0.0	0.0	0.0	6.6	6.5	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	55.5	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 67.7"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 601.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	3.9	2.9	7.7	4.4	14.3	1.4	2.0	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4.0	3.9	5.3	67.7	7.7	6.6	11.0	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1.0	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0.0	1.3	9.8	2.8	0.0	2.4	25.2	6.0	0.0	0.0	0.5	1.5	1.2	1.1	0.1	1.7	3.6	0.0	15.4	6.0	5.1	3.3	0.0	2.5	0.0	1.2	37.3	5.5	0.6	0.3	2.5	5.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	5.9	10.9	2.3	0.4	0.0	0.0	0.2	6.5	0.0	0.4	0.0	0.8	0.1	2.1	4.1	8.1	0.0	1.8	0.2	1.7	0.3	0.0	0.0	0.0	5.6	0.0	0.3	5.2	4.8	0.1	0.0	1.6	0.8	0.0	0.0	0.8	0.9	0.7	0.0	4.9	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	25.2	0.0	6.0	0.1	0.0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5	3.0	3.2	2.9	0.0	1.1	50.8	601.5	2.5	0.0	1.2	33.2	3.9	0.4	0.0	0.0	0.8	3.3	0.0	0.0	0.0	1.4	4.8	0.1	0.0	0.0	28.3	0.0	0.0	20.3	56.6	0.7	0.0	46.7	1.7	1.0	0.6	35.9	0.1	0.0	7.8	0.1	6.9	12.9	19.6	0.2	0.4	2.8	0.9	0.0	0.0	0.0
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47472168	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.9"	"Cell type enriched"	"Detected in some"	8	"Bipolar cells: 16.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 4.4;SCLC-21H: 12.5;SH-SY5Y: 6.7;SiHa: 5.2;U-2 OS: 8.1"	"Group enriched"	"Detected in many"	4	"amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1"	"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced					NA	NA					"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	1.2	4.0	16.6	1.0	18.1	0.9	0.9	50.9	50.7	1.0	2.4	1.8	1.0	1.3	5.4	1.0	2.3	2.2	1.1	0.9	21.4	6.8	1.0	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1.0	2.0	1.4	1.4	0.0	1.2	4.4	0.9	1.0	1.2	5.5	2.0	1.0	1.3	1.9	1.2	0.0	1.0	0.0	0.9	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	4.4	0.6	0.0	0.0	0.0	0.0	0.4	0.1	12.5	6.7	5.2	0.6	0.4	0.4	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2.0	1.2	0.0	0.0	0.0	0.1	0.0	16.2	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.3	1.1	1.7	0.0	0.1	0.0	0.0	0.1
SLC8A3	NCX3	ENSG00000100678	"Solute carrier family 8 member A3"	P57103	14	70044217-70189070	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 17.0;skeletal muscle: 32.1"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 33.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;LHCN-M2: 7.3;SH-SY5Y: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.65e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	0.7	2.8	6.1	1.2	6.1	1.0	0.9	3.8	17.0	1.4	1.1	3.1	0.0	1.1	0.9	1.0	1.1	0.7	1.3	1.5	5.8	8.2	0.6	0.6	1.6	1.0	4.7	7.1	0.6	1.0	0.6	1.5	0.7	6.4	1.2	1.1	1.5	0.6	0.8	32.1	0.8	1.2	1.2	2.8	0.7	1.2	0.8	1.9	0.0	0.6	4.9	0.9	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	23.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.1	6.1	3.8	10.6	5.8	8.2	4.7	7.1	6.4	1.9	0.0	1.1	0.0	0.0	0.1	33.9	1.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	8.1	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC8B1	"FLJ22233, NCKX6, NCLX, SLC24A6"	ENSG00000089060	"Solute carrier family 8 member B1"	Q6J4K2	12	113298759-113359493	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040668	Approved					NA	NA					"HPA040668: AB_10793861"	"prognostic favorable (9.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.54e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (5.02e-4)"	12.6	43.9	7.2	15.0	9.5	12.0	11.0	5.5	7.8	11.8	11.1	9.0	7.9	7.7	9.0	10.9	9.3	7.2	10.4	9.2	6.5	3.7	10.6	18.6	12.2	26.2	8.2	4.5	35.1	13.2	5.5	9.3	15.5	7.0	10.0	7.5	6.2	10.4	9.6	7.1	11.2	14.1	9.3	9.6	20.8	7.6	13.9	8.0	29.5	8.2	8.1	14.4	8.4	10.8	3.1	11.4	18.5	14.7	3.3	18.8	8.4	12.4	2.7	1.6	3.6	8.5	5.9	5.4	4.0	12.6	5.7	5.6	2.9	10.4	3.4	9.4	5.9	4.9	10.1	5.2	3.0	2.7	7.8	1.5	6.4	6.1	3.1	14.1	16.7	14.4	6.0	9.0	6.5	2.8	4.9	13.0	12.6	13.5	1.7	3.2	2.8	5.1	13.5	2.9	4.3	7.1	1.9	2.2	3.9	6.1	17.7	0.1	2.9	11.8	23.8	2.8	2.4	3.7	6.6	26.9	3.9	4.7	11.2	2.5	2.1	5.0	2.5	4.9	9.4	3.1	2.4	9.6	18.5	5.0	14.7	6.4	2.2	9.2	4.9	11.4	3.1	18.8	8.6	6.3	3.3	14.1	8.5	10.9	8.4	7.2	9.5	5.5	7.8	6.5	3.7	8.2	4.5	7.0	8.0	11.9	13.0	4.2	11.4	3.9	1.1	3.3	7.6	4.0	7.9	12.2	9.8	7.1	5.0	11.7	1.3	9.0	25.1	0.0	15.3	7.2	8.7	13.6	20.8	10.2	20.0	0.0	4.7	3.7	16.4	1.3	22.7	20.0	1.7	15.4	12.0	3.2	17.9	13.6	26.5	3.2	0.7	32.3	11.3	0.7	3.8	6.1	8.9	7.5	9.3	15.3
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.7	4.7	4.5	4.5	10.2	7.4	27.6	11.3	17.3	9.9	10.8	5.7	9.0	6.2	9.7	14.7	4.8	17.2	4.4	28.0	6.2	7.4	4.1	9.5	3.1	2.4	31.1	5.5	7.2	9.2	13.6	16.7	23.3	7.2	16.4	4.4	2.6	6.1	14.5	8.2	2.8	2.9	6.2	17.0	9.8	5.1	4.0	2.9	5.2	20.8	5.2	1.6	9.5	13.0	5.7	4.8	6.0	3.5	17.6	10.6	4.2	9.8	6.2	5.5	3.5	1.8	11.3	6.2	6.1	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9	6.0	17.9	5.2	16.2	27.7	6.3	11.3	10.2	0.0	3.4	10.4	0.0	30.0	0.0	8.5	26.9	7.1	52.0	0.0	10.9	16.2	11.0	8.8	26.5	1.0	11.5	19.1	12.0	8.0	4.9	9.7	8.6	6.6	6.8	1.8	12.3	10.8	19.4	22.0	12.4	1.3	3.6	6.5	8.7	1.4	3.4	22.0	44.3	6.7	14.3	16.3
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619707-102711318	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8"	"Cell type enhanced"	"Detected in some"	10	"Early spermatids: 19.1;Enterocytes: 23.6;Late spermatids: 22.4;Mucus-secreting cells: 26.9;Paneth cells: 40.3;Undifferentiated cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.8;OE19: 25.9;RT4: 11.9;SK-BR-3: 10.5;T-47d: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.2	0.4	0.9	10.8	1.4	0.0	1.0	0.5	1.9	1.0	15.0	0.6	8.4	4.6	0.2	5.8	0.5	0.2	16.8	0.2	1.5	1.0	4.6	0.2	0.2	0.0	0.9	0.7	0.2	0.2	0.1	1.7	0.0	1.8	4.5	16.1	0.9	3.7	11.7	4.4	1.3	9.5	0.4	1.3	0.2	19.8	5.3	0.6	1.0	0.6	1.8	3.1	2.8	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	6.8	4.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.1	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.3	2.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.3	0.0	0.0	0.1	25.9	3.6	0.0	0.0	0.0	0.8	11.9	0.0	0.0	0.0	10.5	0.0	0.0	13.2	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.9	1.4	0.5	1.9	1.5	1.0	0.9	0.7	1.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	8.7	0.0	0.4	0.0	0.2	19.1	0.0	23.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.0	9.4	0.0	0.0	22.4	0.6	0.0	0.0	0.0	26.9	0.5	4.9	40.3	0.0	1.0	0.0	0.0	0.3	0.7	0.1	0.5	0.2	0.0	31.4	0.7
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 28.2"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Not detected"	"Not detected"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	7.0	7.4	1.7	2.0	5.5	4.2	2.5	5.2	3.3	9.3	4.9	10.2	5.5	1.9	3.8	7.0	3.9	2.5	2.5	28.2	7.3	4.6	16.5	3.4	2.6	3.4	5.9	2.7	5.2	2.3	3.5	2.6	1.5	4.2	6.1	5.4	1.8	6.6	3.7	16.7	2.6	12.2	6.3	5.6	6.6	5.3	1.8	3.6	7.9	3.3	12.6	3.5	2.6	3.2	8.0	2.7	1.9	6.0	5.3	4.1	2.7	9.1	3.6	5.8	3.8	15.3	3.8	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5	14.9	4.3	0.0	0.0	0.0	0.0	0.6	0.0	5.3	10.3	15.7	0.0	0.0	5.0	7.5	0.0	0.0	1.0	0.0	7.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.2	0.0	0.0	6.5	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473303-102533972	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9"	"Cell type enriched"	"Detected in some"	8	"Collecting duct cells: 24.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;OE19: 11.4;RT4: 7.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 11.6;olfactory region: 8.3"	"Not detected"	"Not detected"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.0	1.1	0.1	0.0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	3.7	2.4	0.7	0.2	0.2	0.0	0.1	0.1	33.9	0.3	0.0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.2	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.4	0.1	2.4	0.0	0.3	0.3	0.0	0.0	0.0	3.9	0.1	0.2	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.1	0.1	1.1	11.4	0.4	0.2	0.5	0.3	0.0	7.1	0.2	0.2	0.1	0.4	0.0	0.3	0.2	0.1	0.5	0.4	1.1	0.7	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1.0	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	3.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	2.7	1.2	24.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272190	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.5;lymphoid tissue: 14.5"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041004, HPA041329"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1.0	1.1	0.5	1.0	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0.0	1.0	0.0	1.3	1.6	0.4	1.5	0.8	1.0	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0.0	0.8	1.6	1.7	0.2	1.0	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	6.3	0.7	1.2	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.2	0.4	0.0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	0.9	1.4	0.3	1.0	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0.0	0.4	0.0	0.0	0.0	0.6	1.5	0.4	0.9	0.1	0.0	0.4	0.4	1.0	0.6	0.5	0.8	0.0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2	3.0	3.2	0.0	0.1	0.6	1.9	1.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.1	0.6	0.4	0.0	0.0	0.1	15.9	1.2	2.5	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.3	0.4	0.0	2.1	0.0	0.6	0.0	0.7	1.7	1.1	0.6	0.0	0.0	0.2	0.1
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599252-46759172	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 42.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	1.7	7.2	4.4	3.8	42.0	4.4	7.9	7.0	12.4	1.8	1.2	1.8	1.2	1.7	1.2	3.8	3.2	2.5	2.2	2.3	3.3	7.1	3.3	4.1	1.8	7.8	3.6	4.3	6.3	4.6	11.5	13.6	1.4	12.7	6.5	1.3	2.3	7.3	2.9	10.0	2.9	2.7	1.0	2.7	4.7	8.2	1.3	8.2	2.8	6.9	1.7	8.2	2.3	2.2	4.3	6.0	2.1	0.6	1.4	0.7	0.5	7.0	5.4	0.8	2.4	0.9	5.4	3.1	6.7	8.4	4.0	3.3	5.5	7.7	15.5	2.1	10.7	7.9	3.3	5.2	7.6	7.4	8.1	2.8	1.6	2.1	2.2	3.3	0.7	12.8	3.4	1.0	11.4	7.6	19.2	5.7	5.4	0.1	0.3	5.5	10.6	1.7	0.8	3.7	3.4	6.5	6.9	0.3	0.2	3.1	7.9	5.8	0.7	3.4	5.2	1.5	6.8	6.9	0.3	0.3	8.7	2.9	1.3	3.9	1.6	0.4	7.8	12.3	0.1	2.8	1.0	0.6	0.3	0.6	0.6	0.4	3.4	0.7	0.3	2.4	4.3	0.4	0.5	2.1	1.4	0.6	6.0	0.7	0.5	4.4	42.0	7.0	8.3	3.3	7.1	3.6	4.3	12.7	8.2	3.0	8.0	17.9	7.5	0.6	10.1	4.5	2.5	0.0	3.4	15.7	3.9	5.5	0.0	15.3	0.0	0.5	0.0	0.0	12.2	0.3	0.4	18.2	0.0	4.9	6.6	12.7	2.4	0.6	4.7	0.4	0.9	9.1	1.7	9.0	1.0	6.6	12.5	0.0	0.4	1.7	3.4	6.5	0.8	0.0	0.9	0.9	6.1	0.5	0.8	11.2
SLC9A8	"KIAA0939, NHE8"	ENSG00000197818	"Solute carrier family 9 member A8"	Q9Y2E8	20	49812713-49892242	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033682	Approved					NA	NA					"CAB033682: AB_2270441"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.96e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.28e-2)"	9.0	14.0	7.6	11.4	13.9	29.8	8.9	10.3	15.1	8.4	9.1	14.0	7.7	9.7	12.2	10.6	16.0	8.6	9.4	6.8	7.3	7.8	8.4	16.2	9.5	10.6	6.6	8.0	7.2	13.5	11.7	12.4	7.2	11.9	9.1	9.0	15.4	13.7	7.9	19.5	7.3	9.8	9.0	8.1	13.9	12.8	19.6	5.8	13.6	11.9	8.4	18.6	11.4	7.6	2.2	1.4	7.1	1.7	0.8	2.5	1.4	4.3	7.9	3.5	3.5	4.5	2.9	9.0	4.5	6.1	8.6	4.1	5.6	9.8	5.2	5.8	6.4	7.0	9.7	3.7	4.5	4.4	4.5	2.0	2.5	5.0	2.8	6.3	4.5	6.3	5.4	5.2	4.5	9.2	4.5	3.6	6.9	4.9	5.4	5.2	4.7	4.1	3.1	2.9	6.5	3.7	3.1	4.2	3.7	5.1	4.7	3.6	3.1	7.4	27.8	5.6	2.5	9.0	7.5	5.5	11.7	6.5	5.7	4.3	8.3	3.6	3.8	16.0	6.1	4.8	2.8	1.4	3.6	2.3	1.1	2.5	1.6	1.7	2.0	1.4	2.2	1.8	1.1	7.1	0.8	1.7	0.7	1.2	1.4	7.6	13.9	10.3	15.1	7.3	7.8	6.6	8.0	11.9	5.8	11.9	9.1	3.0	3.8	2.3	5.5	4.4	2.5	12.0	11.4	3.5	13.7	4.9	1.7	5.1	2.1	4.3	10.5	0.0	5.5	3.3	3.3	6.3	21.9	13.9	4.4	6.4	6.4	6.2	10.0	5.3	3.4	4.1	1.7	4.6	7.1	5.2	7.7	6.0	4.6	3.5	9.5	0.0	3.4	6.5	6.5	1.6	2.9	6.9	6.6	6.7
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848531	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 23.3;Hofbauer cells: 42.3;Ito cells: 25.2;Kupffer cells: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.6;ASC TERT1: 13.8;HSkMC: 9.6;Karpas-707: 33.4;RPMI-8226: 15.5;U-266/70: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					NA	NA		41000			"HPA058234: AB_2683648"	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	17.4	8.4	16.8	11.4	25.9	2.7	7.7	4.5	17.2	10.6	9.6	17.2	2.0	4.5	6.2	5.7	18.0	9.2	13.4	8.2	14.7	11.7	3.7	9.9	8.3	17.5	23.0	7.4	11.8	2.2	1.9	6.5	21.3	18.3	12.9	8.6	4.6	7.1	12.8	3.5	10.3	9.3	12.1	27.5	16.9	7.3	2.9	24.1	10.7	5.7	7.1	17.8	17.3	10.8	4.4	8.7	0.7	10.8	3.9	9.3	4.7	0.3	0.3	0.4	0.5	10.6	13.8	0.1	0.5	3.5	0.2	1.7	0.0	0.1	1.6	0.1	1.6	0.9	0.4	0.5	1.0	0.4	6.8	0.1	0.9	0.2	0.0	1.2	0.4	0.7	9.6	2.8	0.3	0.5	0.6	0.1	1.2	0.0	33.4	2.2	0.0	0.8	0.0	0.1	0.0	0.2	1.3	0.1	15.5	0.0	0.2	0.2	0.0	0.8	0.0	0.0	0.2	0.1	0.3	0.0	1.3	0.3	1.5	0.7	15.6	0.0	0.0	2.3	0.2	0.6	0.1	6.6	0.7	5.2	10.8	4.5	3.7	5.5	8.1	8.7	4.4	3.1	4.6	0.5	3.9	9.2	0.6	9.3	4.7	16.8	25.9	4.5	17.2	14.7	11.7	23.0	7.4	18.3	24.1	0.0	1.4	3.7	9.4	3.3	0.1	1.1	0.0	1.4	2.3	3.5	2.0	0.4	0.0	0.8	3.9	2.8	0.0	23.3	0.2	0.3	9.4	12.5	0.0	0.0	42.3	0.0	0.0	25.2	24.1	2.7	8.6	9.6	6.8	19.8	0.0	3.7	1.0	0.0	6.7	0.4	0.0	0.0	3.1	0.2	0.2	4.4	0.9	10.2	0.0	4.8
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell type enriched"	"Detected in some"	9	"Alveolar cells type 1: 32.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0"					"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.0	0.5	0.8	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	2.9	1.7	0.1	2.1	0.1	0.0	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.4	1.1	0.0	0.3	0.2	0.0	1.3	0.1	0.1	1.2	0.1	0.4	3.4	1.4	0.0	2.0	0.3	0.1	13.3	1.5	0.1	0.1	0.2	9.2	0.0	2.0	1.8	2.3	0.0	0.2	0.2	14.2	2.6	0.7	0.0	0.0	1.4	0.6	0.3	19.8	8.0	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4	32.8	1.9	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.0	1.8	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131202-21239246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	618	"liver: 121.0"	"Cell type enriched"	"Detected in some"	39	"Hepatocytes: 71.0"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.2;A549: 1.9;HeLa: 2.9;NTERA-2: 2.6;RPMI-8226: 3.5;SuSa: 5.6"									HPA050892	Supported					NA	NA					"HPA050892: AB_2681265"			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.8	0.0	0.4	0.0	0.8	0.0	0.0	1.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 88.1"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 91.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	2.5	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	91.8	0.0	0.0	0.0	0.6	1.9	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
SLCO1C1	"OATP-F, OATP1, OATP1C1, SLC21A14"	ENSG00000139155	"Solute carrier organic anion transporter family member 1C1"	Q9NYB5	12	20695355-20753386	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 32.4;retina: 15.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.8;Late spermatids: 10.3;Muller glia cells: 4.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HeLa: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.37e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.76e-2)"	3.5	1.2	11.6	1.0	16.2	0.9	1.2	1.1	32.4	0.9	1.4	6.2	0.0	1.1	0.9	1.3	1.2	0.9	2.1	1.5	10.4	2.8	1.1	0.9	1.2	1.2	6.5	8.0	0.9	1.0	1.5	5.5	1.0	20.3	1.0	1.3	15.3	1.1	1.0	0.9	1.2	1.6	1.2	4.9	0.9	1.0	3.3	8.1	0.0	1.7	0.2	1.4	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	16.2	1.1	11.5	10.4	2.8	6.5	8.0	20.3	8.1	0.0	0.0	0.0	0.0	0.1	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	10.3	1.7	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.1	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932696-134052184	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 112.9;seminal vesicle: 147.1"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 38.0;Ito cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 45.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA013742	Enhanced					NA	NA					"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favorable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	9.3	14.7	1.0	6.0	1.0	0.0	6.2	0.4	1.6	13.9	8.1	1.5	112.9	3.7	18.4	4.5	7.8	11.5	15.3	10.1	0.7	0.5	32.9	4.2	56.8	10.6	0.7	1.2	7.2	9.2	16.1	6.5	40.3	1.8	13.7	7.2	15.1	8.2	147.1	1.5	4.5	10.1	13.6	3.0	17.7	8.3	3.0	0.6	4.6	33.6	8.6	9.0	10.5	7.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	2.0	0.2	0.0	0.0	0.0	0.0	45.0	0.4	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	2.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	2.1	0.7	0.0	1.9	0.0	0.0	10.5	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	1.0	0.4	1.6	0.7	0.5	0.7	1.2	1.8	0.6	0.0	4.5	3.2	8.7	4.5	0.0	2.2	2.5	1.4	2.3	3.5	0.0	0.2	0.0	0.9	0.6	38.0	7.4	0.0	2.9	2.0	1.0	1.5	1.1	0.2	0.2	0.0	1.2	74.3	1.0	0.8	0.3	0.2	0.0	0.0	1.5	0.0	10.3	3.6	0.0	1.7	0.0	0.0	1.0	0.5	0.2	1.5	0.7	0.0	0.4	2.0
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.1"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 171.3;Hofbauer cells: 103.0;Kupffer cells: 116.2;Macrophages: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 36.0;GAMG: 8.9;Hep G2: 8.1;HMC-1: 10.9;OE19: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA					"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	21.4	15.2	15.0	13.4	23.1	1.4	7.8	4.8	15.8	8.6	12.9	22.8	0.8	18.0	5.8	7.7	8.8	8.3	12.3	7.1	15.6	11.9	9.6	98.1	24.9	21.4	23.9	7.4	4.9	9.6	3.7	4.0	18.3	17.7	4.9	10.4	9.1	6.3	4.7	2.6	3.0	21.2	10.9	24.1	23.6	6.5	4.4	21.3	4.0	6.8	3.6	11.8	12.5	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.3	8.1	0.0	0.4	10.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	3.6	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	23.1	4.8	15.8	15.6	11.9	23.9	7.4	17.7	21.3	0.0	12.8	1.5	0.0	1.6	1.6	2.0	20.4	1.4	3.4	0.0	0.0	0.6	1.7	0.0	2.4	12.9	20.2	0.0	0.2	2.1	1.8	0.0	23.0	171.3	103.0	0.0	0.0	3.1	116.2	1.1	10.0	55.1	0.0	3.6	4.4	0.3	0.1	14.0	9.9	7.0	0.2	0.0	0.3	0.5	0.2	0.4	2.1	0.7	9.3	0.0
SLCO3A1	"OATP-D, OATP3A1, SLC21A11"	ENSG00000176463	"Solute carrier organic anion transporter family member 3A1"	Q9UIG8	15	91853695-92172435	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.2;HaCaT: 39.7;HMC-1: 23.4;RPMI-8226: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066327	Approved					NA	NA					"HPA066327: AB_2732743"	"unprognostic (1.05e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (1.03e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.62e-2)"	11.1	8.5	12.3	8.6	19.2	10.6	7.9	7.8	18.4	6.8	4.6	32.8	6.6	2.7	4.5	4.8	9.2	7.7	8.3	24.3	19.5	10.9	7.1	4.1	14.7	7.3	27.0	10.0	4.2	3.2	22.6	5.4	1.7	17.2	4.2	4.9	7.7	4.0	8.9	5.4	15.1	3.5	6.7	31.9	11.5	3.9	15.5	25.0	0.8	10.1	3.2	7.9	8.4	9.3	0.2	2.0	9.5	3.2	0.4	3.2	0.7	4.0	5.0	5.9	0.1	9.0	5.5	0.0	1.6	1.4	0.6	0.1	0.0	26.2	4.9	2.2	0.5	3.8	39.7	1.1	2.6	0.0	3.5	0.1	11.2	9.1	0.0	0.4	0.2	23.4	2.4	2.8	1.2	3.1	2.3	0.0	1.5	0.0	0.0	0.0	0.7	0.0	2.0	1.5	0.0	0.7	0.0	0.4	17.7	5.6	4.1	0.8	1.4	4.3	0.4	0.0	0.9	0.0	3.4	0.0	1.4	2.0	0.0	4.2	10.8	6.3	4.8	1.8	6.9	2.5	5.2	3.2	8.2	1.9	2.4	1.4	0.2	2.0	2.2	2.0	0.0	0.7	0.8	9.5	0.4	1.9	0.0	3.2	0.7	12.3	19.2	7.8	18.4	19.5	10.9	27.0	10.0	17.2	25.0	44.7	23.5	1.9	22.8	34.7	25.0	33.9	28.1	14.7	18.2	48.8	3.9	0.0	1.7	24.0	87.8	19.9	1.6	0.0	7.9	0.0	15.0	14.4	22.0	0.5	4.8	0.0	36.2	31.9	17.3	29.6	4.6	28.3	10.1	12.6	4.7	4.5	6.8	8.6	2.8	0.2	2.9	38.8	42.4	22.8	10.2	52.6	0.0	16.6	6.9	34.6
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642445-62685785	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Extravillous trophoblasts: 195.5;Melanocytes: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;dendritic cells: 2.6;T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 56.2;RPTEC TERT1: 53.9"	"Region enriched"	"Detected in single"	5	"cerebellum: 7.5"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	25.0	5.2	16.4	5.3	22.4	3.9	27.2	11.3	23.8	5.0	6.4	1.6	4.3	4.2	5.5	2.3	24.1	5.2	5.6	18.1	19.0	9.2	16.6	3.1	29.4	5.7	18.1	2.3	3.1	5.4	13.8	1.2	11.9	24.8	2.8	5.5	7.1	20.1	4.1	19.2	16.5	4.4	3.6	9.8	4.5	14.9	3.3	16.5	0.5	4.5	4.0	8.7	7.4	18.5	2.3	2.6	0.0	0.5	0.0	4.3	0.7	4.1	5.3	0.2	3.1	0.7	0.6	7.6	1.3	4.7	4.1	1.4	8.9	4.2	4.9	12.9	0.1	2.8	6.1	4.7	0.3	1.5	0.5	2.7	5.9	6.0	6.5	0.0	4.5	1.9	0.0	1.8	0.0	1.8	1.2	0.7	3.0	4.6	1.3	0.0	4.1	4.6	17.6	1.4	20.5	56.2	8.4	0.3	7.2	53.9	3.9	5.0	7.2	1.1	1.2	4.5	2.0	0.2	2.1	0.8	0.1	3.0	2.0	7.6	2.6	4.2	3.0	11.2	6.5	0.7	0.0	0.0	0.0	0.2	0.5	0.0	2.3	0.5	0.1	2.6	2.0	0.7	0.3	0.0	0.0	0.1	0.0	4.3	0.7	16.4	22.4	11.3	23.8	19.0	9.2	18.1	2.3	24.8	16.5	3.0	2.2	5.7	0.7	24.3	13.2	3.6	2.5	1.4	1.2	24.4	29.5	1.6	0.0	4.0	0.3	26.3	2.1	0.0	2.2	195.5	4.1	2.1	0.0	0.0	5.0	0.0	0.0	17.8	9.9	0.4	0.3	8.4	57.3	0.0	5.1	4.2	7.7	2.3	0.7	4.2	43.2	0.0	6.6	0.2	4.2	14.1	19.7	3.2	6.8	6.3
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837002	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 50.5;SK-BR-3: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	34.0	78.2	16.4	9.3	17.9	14.8	15.5	5.8	22.3	15.7	13.8	31.9	30.4	28.9	8.6	23.4	20.5	15.7	17.6	10.2	13.5	10.3	9.0	49.9	11.9	14.4	20.3	16.7	20.5	7.7	9.6	12.5	16.0	11.8	18.0	6.4	15.1	72.7	33.0	16.8	14.5	27.4	7.1	13.1	7.3	13.6	16.8	16.2	15.2	9.5	13.6	13.8	11.9	15.0	0.6	0.4	4.7	0.8	0.4	2.2	0.5	14.0	33.0	4.1	25.4	8.4	15.4	7.1	5.2	16.5	4.5	11.0	6.7	27.3	8.8	4.9	4.1	4.2	40.0	4.7	13.8	1.1	5.4	2.0	4.8	27.4	7.0	10.5	0.6	9.2	12.0	5.9	6.3	3.9	3.5	5.1	20.1	9.3	31.6	1.0	34.5	11.6	8.1	5.5	10.8	6.6	8.3	3.0	50.5	3.6	7.3	4.9	20.2	6.1	49.0	14.5	3.0	16.6	9.3	5.8	2.4	12.2	5.8	3.2	9.3	0.8	4.0	14.2	6.9	12.6	0.0	0.8	0.4	1.8	0.5	0.4	0.6	0.8	0.3	0.4	0.4	1.6	2.2	4.7	0.4	0.6	0.3	0.2	0.5	16.4	17.9	5.8	22.3	13.5	10.3	20.3	16.7	11.8	16.2	6.0	17.5	8.2	12.6	8.2	22.4	7.3	17.8	5.3	11.4	19.2	27.5	4.6	1.7	13.5	1.8	8.9	29.9	0.0	20.4	13.9	14.1	19.0	14.9	58.7	10.6	55.6	28.7	12.9	10.4	3.0	27.6	8.3	8.5	13.6	18.3	29.8	13.8	13.5	10.3	5.4	29.3	12.9	10.4	11.3	5.8	15.9	16.6	7.5	21.1	21.3
SRPK3	"MSSK1, STK23"	ENSG00000184343	"SRSF protein kinase 3"	Q9UPE1	X	153776412-153785732	"Enzymes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 73.4"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 23.8;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.4;U-266/70: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.47e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.10e-4)"	"unprognostic (8.70e-2)"	"unprognostic (5.38e-7)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.07e-4)"	1.6	1.8	1.3	0.9	1.8	0.8	0.3	7.7	1.5	0.9	4.5	1.1	0.2	1.3	2.5	3.3	2.6	0.7	1.7	16.7	2.0	1.8	0.2	0.2	0.4	0.8	2.0	0.7	0.7	0.7	1.0	5.8	0.3	1.1	2.8	0.8	0.9	2.9	0.5	73.4	2.3	1.3	4.0	2.0	0.8	1.3	0.5	0.9	0.3	0.6	18.3	1.6	2.0	0.8	0.4	2.6	0.9	0.3	0.1	0.6	0.3	3.2	4.4	0.8	2.2	0.0	0.1	1.0	0.4	0.0	0.2	0.0	3.7	0.6	3.3	0.4	0.4	0.3	0.9	0.0	0.1	0.0	2.8	3.1	1.7	2.7	0.6	0.0	0.8	5.1	2.8	0.0	0.0	0.0	0.2	0.0	4.7	2.2	3.9	0.9	7.0	0.6	4.8	0.8	0.2	1.2	1.5	31.4	0.9	0.0	1.5	5.3	2.5	0.0	2.3	1.0	0.3	2.9	3.8	0.1	1.2	2.8	2.3	0.4	13.0	2.1	2.2	0.6	6.2	1.6	0.8	0.3	0.2	0.5	0.1	0.6	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.1	0.0	2.6	0.0	0.3	1.3	1.8	7.7	1.5	2.0	1.8	2.0	0.7	1.1	0.9	0.0	0.0	0.0	1.0	0.6	2.2	23.8	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.7	0.0	0.0	2.8	0.0	0.2	0.0	2.7	0.0	0.1	0.4	0.0	0.0	0.2	0.3
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798505	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 699.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		600000	"Endoplasmic reticulum"		"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favorable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	17.4	30.0	13.2	29.5	22.6	37.5	46.0	12.2	20.6	30.4	31.7	9.0	152.0	30.7	19.1	81.4	21.4	18.3	30.2	40.7	23.0	17.7	21.8	48.0	42.1	136.9	14.5	11.6	18.4	699.0	7.2	67.7	30.3	26.0	24.0	24.0	11.7	83.7	192.6	12.1	16.9	24.1	19.5	26.3	37.9	43.6	19.6	8.2	15.3	22.6	21.0	29.4	27.7	20.0	67.1	171.0	50.7	58.6	62.0	78.7	108.1	34.3	44.2	15.0	84.3	81.0	43.1	31.4	29.4	43.6	30.6	41.8	54.9	30.5	49.0	77.9	44.5	27.6	34.1	26.1	27.3	11.2	19.9	22.4	13.8	41.5	43.1	70.1	37.9	36.8	53.7	38.0	26.3	35.9	27.0	32.8	24.5	15.1	104.1	23.7	61.5	21.5	56.5	9.1	93.4	72.1	24.3	19.5	90.7	38.6	41.0	29.3	24.2	17.5	30.2	31.8	17.1	19.5	81.8	27.2	18.0	20.0	34.7	38.1	154.6	75.5	57.4	38.3	64.8	30.1	50.7	58.6	26.1	63.6	44.4	78.7	67.1	65.5	62.9	58.5	56.6	57.0	58.4	9.3	62.0	35.5	171.0	47.9	108.1	13.2	22.6	12.2	20.6	23.0	17.7	14.5	11.6	26.0	8.2	154.9	288.1	268.7	274.5	228.5	46.7	258.0	412.7	216.8	227.5	301.8	53.0	273.1	142.6	480.5	402.2	256.1	483.1	163.5	550.9	548.3	330.2	594.2	342.0	631.0	408.8	33.4	718.3	247.4	326.6	1155.6	311.8	347.4	1354.7	339.0	538.4	117.5	526.9	501.2	232.3	335.7	57.8	116.4	210.1	119.2	239.9	281.7	472.2	373.9	490.6	402.8
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637065-39663484	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	22.2	34.8	23.3	27.5	28.0	33.5	22.8	27.7	30.1	17.1	23.7	38.1	21.7	26.6	20.6	20.7	22.4	25.6	27.7	17.8	21.0	16.8	18.2	24.0	27.0	31.5	28.5	25.7	21.5	32.7	21.9	23.7	26.9	25.7	19.0	9.7	17.9	21.4	26.7	20.8	24.5	34.2	15.8	27.8	32.3	25.3	26.7	26.1	33.0	21.1	15.1	24.8	28.8	18.7	15.3	23.2	35.3	21.2	21.4	25.3	17.4	7.9	12.6	5.7	10.1	6.9	8.4	8.5	6.5	8.5	8.5	7.8	7.4	13.1	7.1	14.2	5.9	10.5	15.2	3.4	7.7	1.9	9.6	12.9	4.8	5.5	8.6	9.7	9.7	10.8	9.1	6.3	9.6	4.6	6.5	8.2	9.9	11.1	9.2	7.8	7.0	9.1	9.2	6.3	5.4	6.9	7.2	9.8	10.5	5.8	9.0	7.2	7.7	4.9	89.9	16.1	4.0	10.6	11.6	7.7	12.0	8.3	13.1	12.2	8.8	10.8	5.7	10.7	10.5	12.3	12.5	21.2	29.3	25.3	19.6	18.5	11.9	18.3	19.0	23.2	15.3	18.4	16.9	35.3	21.4	15.6	10.8	20.4	17.4	23.3	28.0	27.7	30.1	21.0	16.8	28.5	25.7	25.7	26.1	3.0	9.8	21.7	11.2	14.7	13.5	3.0	20.4	5.3	3.4	10.4	35.3	24.1	8.3	20.7	2.3	23.3	21.4	0.0	30.9	31.1	16.0	17.5	18.5	10.6	45.2	17.5	26.4	42.4	36.6	4.1	15.8	20.8	5.0	17.2	11.7	17.0	30.5	15.8	12.4	8.7	13.2	12.9	9.5	8.4	13.9	14.8	33.4	34.8	12.4	16.9
STRA6	FLJ12541	ENSG00000137868	"Stimulated by retinoic acid 6"	Q9BX79	15	74179466-74212267	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix, uterine: 22.7;placenta: 88.6;retina: 42.8"	"Cell type enhanced"	"Detected in some"	16	"Extravillous trophoblasts: 11.0;Leydig cells: 6.4;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 16.6;CAPAN-2: 47.1;SH-SY5Y: 29.3;WM-115: 70.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040839	Approved					NA	NA					"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.2	1.6	0.2	0.5	0.3	0.0	1.1	0.2	0.5	22.7	0.1	0.3	1.6	0.0	6.9	2.8	1.0	5.0	0.7	0.3	0.4	0.2	7.3	0.0	0.3	1.1	0.1	0.3	0.6	0.2	0.0	5.3	88.6	0.7	5.0	0.0	42.8	0.6	2.6	0.1	0.4	0.2	0.3	1.5	0.3	0.1	2.8	0.1	0.9	0.2	1.4	1.9	1.8	2.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	16.6	1.0	0.0	0.0	0.0	2.8	0.5	0.1	0.0	0.0	5.7	47.1	0.0	11.4	0.0	0.4	1.6	0.9	0.0	0.0	0.0	0.1	1.4	0.6	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	3.0	0.2	1.5	0.0	0.0	0.2	0.0	0.0	0.0	1.5	8.9	29.3	0.0	1.7	0.0	1.9	0.1	0.0	0.0	0.1	3.9	0.3	0.7	0.1	0.1	0.0	0.3	0.0	70.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.4	0.2	0.1	0.3	0.7	0.1	0.0	0.0	0.0	1.0	0.3	0.0	1.0	0.0	4.0	3.4	0.0	0.0	2.0	1.7	0.2	1.2	0.4	0.0	0.0	0.0	11.0	0.9	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	6.4	0.0	1.7	0.0	0.0	0.0	2.8	0.0	3.9	4.1	0.0	0.0	0.4	0.5	0.4	0.0	22.1	0.0	0.0	0.9
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.8;intestine: 31.0"	"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 24.9;Undifferentiated cells: 21.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	10	"classical monocyte: 27.8;intermediate monocyte: 24.0;myeloid DC: 16.2;non-classical monocyte: 11.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.2;monocytes: 27.8"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 40.0;Hep G2: 54.8"									"HPA049500, HPA051051"	Supported					NA	NA		3200000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	1.4	3.8	5.6	4.3	4.9	7.5	2.5	14.0	6.3	2.1	6.7			31.0	2.5	4.5	4.0	3.7	2.0	1.7	5.6	5.2	6.6	10.1	3.8	3.2	4.3		2.9	4.3	8.1	8.0	3.0		5.8	6.1		5.3	5.2	1.5	5.6	17.9	4.0	3.4	5.7	2.7	2.1			6.4		5.8	3.6	2.4	1.5	16.2	1.4	27.8	0.4	2.0	11.2	4.9	10.3	10.3	7.1	9.4	5.4	13.7	5.5	4.6	5.5	6.2	4.3	40.0	5.0	29.0	5.2	3.7	12.9	10.6	4.3	5.4	4.6	7.6	4.0	14.1	54.8	3.8	3.3	9.4	7.6	7.0	6.0	2.1	12.3	6.3	7.0	1.2	31.6	3.7	15.2	2.6	20.9	6.0	10.7	6.0	11.2	4.1	9.1	7.1	4.4	4.0	5.3	1.5	16.2	2.4	3.3	6.1	7.4	2.4	10.9	5.3	8.0	3.2	9.4	8.7	3.1	3.9	5.8	6.4	1.4	27.8	0.1	2.0	24.0	0.3	1.5	0.3	0.6	16.2	0.3	0.3	0.3	0.4	0.4	11.1	0.2	0.3	11.2											11.9	8.1	5.2	1.9	1.8	5.0	1.5	5.1	2.7	11.4	0.0	7.9	4.6	0.0	2.5	1.0	4.5	15.0	0.0	3.6	2.1	2.0	2.8	1.1	2.4	1.3	1.6	1.2	3.1	3.5	0.4	0.9	2.8	1.7	3.6	10.7	2.6	4.3	24.9	1.8	0.3	5.7	0.0	2.0	0.6	0.2	2.4	2.5	3.2	21.1	1.6
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870466-47886397	"Enzymes, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 211.7"	"Cell type enriched"	"Detected in some"	24	"Hepatocytes: 1127.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	34	"Hep G2: 26.6;RT4: 18.1"					"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		210000	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	46.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	11.4	1.1	1.1	8.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	211.7	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.6	0.0	0.1	0.1	3.9	0.1	0.0	42.7	0.1	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.1	0.1	0.6	0.2	1.3	1.0	5.3	0.8	2.3	1.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	26.6	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.2	0.0	18.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.3	0.8	0.7	0.9	0.4	0.6	0.7	1.0	0.6	0.3	1.3	1.3	1.0	3.1	2.3	0.4	1.0	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	7.0	0.5	0.1	0.6	0.6	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.7	0.0	0.0	0.1	0.3	0.0	1127.7	0.0	0.0	0.0	38.6	31.7	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 53.7;Suprabasal keratinocytes: 120.1;Urothelial cells: 113.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 27.6;MCF7: 16.9;OE19: 44.8;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA041724, HPA043539, HPA076510"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	4.5	5.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	27.6	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.9	0.0	0.2	0.0	44.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.3	0.1	0.0	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	17.9	0.3	0.0	28.4	21.4	0.0	0.6	2.5	4.0	13.6	8.7	0.0	2.8	0.0	11.1	0.0	0.3	8.6	0.0	1.0	2.7	2.0	53.7	0.0	0.0	0.6	0.0	4.6	0.0	0.0	0.2	0.3	0.2	11.8	0.0	7.1	1.2	10.8	7.0	0.0	0.8	0.6	0.0	2.8	0.2	7.5	120.1	1.6	0.0	2.6	113.8
SUOX		ENSG00000139531	"Sulfite oxidase"	P51687	12	55997180-56006641	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038208, HPA038209"	Approved					NA	NA		26000			"HPA038208: AB_2675892, HPA038209: AB_10672738"	"unprognostic (1.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.77e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.32e-5)"	12.2	25.4	11.9	6.4	13.3	7.5	11.9	9.7	21.3	12.4	11.8	18.8	15.4	12.8	14.5	22.2	14.1	16.0	13.6	18.9	10.5	9.8	26.8	43.4	10.5	7.0	14.2	15.8	16.1	13.5	45.6	11.9	7.6	15.2	17.5	11.7	17.5	17.4	25.0	25.9	7.0	10.4	12.9	11.6	9.6	13.4	5.5	14.4	3.2	15.1	13.4	11.4	16.5	9.6	1.6	10.0	17.6	11.8	9.2	4.6	7.1	4.7	14.0	8.9	14.4	15.1	6.5	20.5	5.6	6.2	8.0	5.6	13.6	10.4	0.5	9.7	6.7	5.4	6.3	7.0	7.0	4.5	21.1	4.7	7.2	8.4	16.3	5.8	0.1	13.6	10.3	3.0	6.7	4.9	12.0	18.8	0.7	12.9	9.9	8.3	11.5	0.2	4.8	4.0	7.3	10.2	6.4	3.7	10.0	8.9	9.4	4.5	5.9	9.9	21.6	8.0	9.1	35.0	8.8	9.6	4.1	5.3	5.1	3.8	11.3	9.7	0.6	7.1	4.3	6.1	5.9	8.1	17.6	0.1	11.8	0.0	1.6	0.7	0.0	10.0	0.2	0.5	0.2	3.2	9.2	9.4	0.2	4.6	7.1	11.9	13.3	9.7	21.3	10.5	9.8	14.2	15.8	15.2	14.4	8.9	10.4	1.4	3.2	1.1	4.6	19.7	12.7	5.3	13.6	14.0	5.9	25.0	14.9	4.4	0.5	5.2	6.7	0.0	5.5	16.5	5.1	3.2	4.6	41.5	9.0	9.5	5.8	6.7	4.9	0.7	4.0	5.3	1.7	11.8	7.3	7.7	4.3	7.0	8.5	25.1	8.0	6.5	3.1	2.1	0.9	1.9	25.7	2.2	6.8	1.7
TAZ	"BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2"	ENSG00000102125	Tafazzin	Q16635	X	154411518-154421726	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039557	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA039557: AB_10672899"	"unprognostic (1.14e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (4.00e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	11.9	8.7	12.1	15.0	13.6	36.8	11.7	12.4	13.5	10.9	15.4	15.6	12.1	13.9	10.8	13.0	15.1	9.9	14.1	25.9	11.0	8.4	13.3	14.0	14.3	17.3	16.7	9.6	12.6	16.3	10.7	8.9	9.1	13.1	11.1	10.8	12.2	12.7	14.5	27.9	18.6	15.0	11.7	12.8	25.4	12.8	3.4	15.1	17.2	11.8	13.4	14.4	10.8	19.5	16.7	14.7	13.8	10.3	12.3	17.2	7.8	11.0	12.5	4.6	5.1	9.0	5.4	8.8	3.9	7.7	6.0	8.3	4.1	13.8	13.1	21.3	5.7	20.0	16.8	6.5	7.2	4.2	11.2	9.6	2.6	8.0	6.4	10.1	5.0	6.2	5.5	13.2	5.2	11.8	5.6	9.0	16.8	5.2	13.9	5.2	6.7	12.6	15.8	1.3	9.7	13.1	10.5	7.0	17.6	8.2	3.2	5.8	8.2	2.5	7.4	10.7	5.0	4.5	8.9	6.5	4.9	6.3	12.0	5.9	32.4	12.8	27.3	6.0	17.6	5.6	5.7	10.3	13.8	12.1	9.3	11.0	11.3	17.2	15.5	14.7	16.7	14.4	12.5	9.4	12.3	7.4	7.3	12.2	7.8	12.1	13.6	12.4	13.5	11.0	8.4	16.7	9.6	13.1	15.1	6.0	10.2	10.7	6.9	9.6	21.3	18.9	12.7	5.3	13.6	8.7	17.7	4.9	5.0	12.0	0.5	15.0	12.3	0.0	14.5	8.0	9.9	5.6	18.4	7.8	21.2	9.5	5.8	16.0	22.1	1.3	10.6	15.9	13.5	23.4	12.9	15.1	10.8	10.2	8.5	4.4	23.8	12.9	9.2	5.1	0.6	9.8	2.4	23.6	13.6	4.8
TCIRG1	"a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7"	ENSG00000110719	"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3"	Q13488	11	68039016-68050895	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 102.9;Kupffer cells: 127.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.6;RPMI-8226: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038742	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038742: AB_10795138"	"unprognostic (5.35e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.50e-11)"	"unprognostic (2.48e-3)"	"unprognostic (7.88e-3)"	"unprognostic (2.50e-1)"	"prognostic favorable (9.45e-6)"	25.8	24.1	5.0	20.1	7.2	39.5	10.2	1.3	5.4	20.1	21.8	3.9	19.9	20.1	14.1	27.1	11.9	12.5	16.4	5.9	2.4	1.6	8.9	25.2	24.1	20.7	7.1	2.2	11.4	69.6	2.6	4.7	14.4	6.9	15.7	4.1	6.8	18.3	11.0	3.5	5.2	25.8	10.8	7.7	44.7	17.4	4.2	5.5	7.5	11.7	8.3	24.3	13.0	13.4	3.3	13.4	40.4	36.8	8.2	4.9	10.7	9.2	17.1	0.2	0.0	7.9	6.2	12.0	18.4	9.0	5.3	5.0	0.3	27.8	0.8	10.1	6.5	8.1	11.7	1.1	7.1	1.1	24.1	0.5	6.4	20.8	5.5	7.3	4.7	40.6	7.2	4.1	6.5	0.4	0.0	3.6	0.3	3.3	2.5	1.7	3.1	0.2	28.2	1.0	13.2	4.3	7.9	0.3	40.4	5.0	5.2	0.9	0.2	7.8	10.2	5.0	1.9	11.1	12.1	12.6	10.3	8.1	28.6	3.3	0.4	0.3	1.3	23.0	7.9	4.9	5.5	16.6	18.8	4.5	28.8	3.7	3.3	3.4	4.9	13.4	2.2	2.0	2.1	40.4	8.2	36.8	9.0	3.3	10.7	5.0	7.2	1.3	5.4	2.4	1.6	7.1	2.2	6.9	5.5	26.8	66.3	28.6	11.5	5.6	0.7	1.2	17.8	29.4	27.3	7.0	0.0	18.1	0.0	29.8	0.3	15.8	46.0	0.0	58.5	45.5	19.9	9.3	48.5	16.3	102.9	0.0	23.0	17.8	127.9	0.2	5.5	82.1	5.0	46.9	25.2	0.9	44.8	87.7	12.4	2.1	0.7	38.8	16.5	0.1	3.0	4.5	22.2	49.4	25.3	17.1
TIAM2	STEF	ENSG00000146426	"T cell lymphoma invasion and metastasis 2"	Q8IVF5	6	154832697-155257723	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 76.6;Early spermatids: 131.1;Late spermatids: 220.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"AF22: 35.1;HDLM-2: 15.0;RH-30: 22.9"	"Group enriched"	"Detected in many"	5	"amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6"	"Low region specificity"	"Detected in all"			"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.6	2.1	5.3	1.7	9.4	0.7	1.5	7.9	21.1	1.5	11.6	0.7	0.1	11.0	1.2	0.8	1.0	1.2	4.0	3.5	4.7	2.0	0.7	0.7	0.9	2.0	1.7	9.5	0.9	1.8	0.2	1.8	0.8	0.6	3.0	1.1	1.3	2.4	3.6	3.0	1.0	27.4	1.4	0.9	1.2	4.0	15.6	1.9	0.0	7.8	0.0	2.5	2.3	1.2	3.3	0.9	8.3	11.3	0.8	1.8	0.4	4.3	0.8	35.1	4.1	1.5	4.3	0.4	1.8	1.1	1.7	2.9	0.5	2.6	1.0	1.9	3.2	0.6	0.7	1.2	0.0	1.2	15.0	1.9	0.3	0.6	2.0	0.9	0.3	1.1	2.9	0.1	0.6	0.1	1.6	2.4	0.5	0.5	0.1	3.9	0.4	0.4	0.9	2.5	0.2	1.0	4.5	22.9	0.4	0.1	0.2	0.9	8.0	0.1	0.4	0.2	6.9	0.3	0.5	0.8	0.3	8.9	0.3	0.9	0.2	1.7	0.2	0.1	0.5	2.2	0.4	0.2	3.1	0.2	3.2	0.3	3.3	0.5	0.3	0.9	1.0	0.6	0.4	8.3	0.8	11.3	0.3	1.8	0.4	5.3	9.4	7.9	21.1	4.7	2.0	1.7	9.5	0.6	1.9	3.0	1.6	8.1	16.3	2.7	13.8	7.3	7.6	2.7	1.2	1.8	76.6	1.2	0.0	4.7	131.1	3.0	2.9	0.0	2.7	2.1	4.7	7.7	19.6	0.9	1.7	22.3	0.0	7.4	2.1	220.7	9.2	4.7	11.8	14.4	4.2	6.9	4.2	2.0	7.4	0.7	25.2	0.0	3.8	5.2	5.5	2.3	0.3	4.8	2.6	7.4
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	35	"plasmacytoid DC: 31.6"	"Lineage enriched"	"Detected in single"	309	"dendritic cells: 31.6"	"Cell line enhanced"	"Detected in many"		"OE19: 39.2;RT4: 99.8;SuSa: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	25.9	3.7	9.7	8.7	13.6	5.9	7.8	7.4	20.8	9.6	19.3	26.9	1.0	6.4	9.1	3.0	21.8	9.9	18.7	4.1	13.8	16.0	26.2	4.6	9.5	11.5	26.8	7.9	5.0	17.9	35.6	4.4	17.0	29.5	10.2	18.5	3.0	15.2	2.4	3.5	2.7	10.2	8.2	63.4	11.6	30.4	5.8	10.1	11.5	2.9	19.2	16.5	41.2	11.6	0.0	31.6	0.1	0.0	0.0	0.0	0.2	29.2	9.5	9.3	2.9	25.5	7.5	10.5	3.4	6.7	1.0	0.4	16.4	20.7	2.1	13.8	2.4	20.0	17.7	1.3	12.6	0.6	0.0	2.9	0.0	1.2	16.5	14.9	0.4	0.1	13.4	15.1	0.6	11.5	0.8	4.9	1.9	0.7	0.0	0.3	5.7	2.5	0.2	7.3	39.2	9.8	5.4	2.8	3.1	17.7	99.8	6.7	1.4	2.9	2.8	2.4	43.8	2.1	2.0	1.0	2.8	2.5	0.1	3.1	0.0	0.0	3.0	4.5	2.1	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.2	9.7	13.6	7.4	20.8	13.8	16.0	26.8	7.9	29.5	10.1	0.0	12.7	0.0	142.4	21.1	0.6	7.6	35.7	10.7	25.0	1.8	0.0	24.6	13.3	69.3	45.6	5.6	30.3	0.0	25.8	16.8	14.1	135.6	19.6	0.0	20.6	0.0	11.5	1.8	36.8	29.9	2.6	5.8	11.8	0.0	40.2	4.4	63.5	46.7	1.1	48.5	1.3	77.6	16.2	0.6	1.4	8.7	149.4	1.3	14.0	360.8
TPP1	"CLN2, SCAR7"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612763-6619485	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 223.6;Kupffer cells: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		13000000			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	37.4	64.6	32.2	28.8	36.2	43.0	23.1	15.1	33.3	24.0	26.8	41.7	13.2	28.0	32.0	22.3	20.3	18.0	26.9	25.6	24.5	25.1	36.0	45.1	35.9	42.3	31.0	29.3	22.0	14.8	35.1	30.0	56.4	25.4	19.4	28.2	43.4	18.4	29.1	15.4	15.5	31.4	42.4	32.8	69.0	19.8	17.9	24.7	21.7	24.0	9.1	26.9	25.6	29.4	9.4	43.5	12.8	38.9	7.0	15.3	26.2	4.8	9.8	4.9	9.3	57.7	31.9	3.8	9.5	45.1	7.4	12.9	4.0	20.7	6.9	6.3	24.0	45.7	14.5	9.7	13.3	11.2	6.9	5.6	5.6	5.1	10.9	43.6	8.1	34.2	47.8	21.7	8.6	19.2	49.8	31.5	6.5	10.7	21.0	21.6	6.0	2.5	10.0	3.5	11.4	11.8	6.3	4.1	13.6	13.1	7.6	0.6	3.8	10.2	7.6	17.8	16.9	5.0	15.5	36.0	21.4	6.1	19.2	3.4	17.8	17.4	2.4	27.1	19.0	11.2	12.8	37.7	8.9	10.7	38.9	8.7	9.4	8.5	11.0	43.5	8.5	5.8	7.6	6.9	7.0	26.4	24.2	15.3	26.2	32.2	36.2	15.1	33.3	24.5	25.1	31.0	29.3	25.4	24.7	23.8	31.2	61.7	25.6	21.1	22.8	35.0	58.6	10.7	23.9	15.7	11.8	31.4	5.0	32.3	10.2	39.0	51.3	23.3	11.7	36.7	29.8	25.6	62.2	63.8	223.6	14.3	16.0	90.9	312.0	7.8	25.0	115.7	86.0	64.1	29.1	42.4	18.5	39.0	24.8	46.1	22.8	6.5	22.7	0.5	1.1	17.6	73.6	44.8	28.0	23.0
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 640.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	21.6	18.7	28.1	16.3	22.6	20.2	29.6	24.9	16.7	17.6	16.4	28.2	18.5	25.4	19.3	16.9	12.1	28.4	21.1	17.0	21.8	19.0	23.1	33.8	30.3	19.7	12.1	36.0	22.2	15.4	10.3	26.5	20.6	16.3	20.7	14.6	40.7	22.9	18.7	18.7	17.9	9.6	30.9	19.8	6.5	21.2	22.0	22.0	14.4	26.1	15.3	24.3	29.0	19.3	15.6	40.1	21.4	23.0	29.1	17.6	16.8	19.4	30.1	25.1	29.3	23.2	11.3	18.4	15.7	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8	202.5	98.3	78.9	89.1	89.9	87.4	160.6	35.7	133.8	120.6	55.8	74.6	117.3	19.9	88.2	106.7	100.9	41.3	23.3	65.3	89.1	87.0	62.9	77.5	34.3	63.0	93.8	65.1	57.1	60.2	23.6	116.2	74.5	52.3	147.9	49.2	93.4	74.7	52.6	110.3	23.7	104.0	129.4	82.9	640.0	239.5	86.7	126.1	97.0	64.6	75.6
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.0;salivary gland: 47.5"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 49.9;Hepatocytes: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;hTCEpi: 55.1;hTERT-HME1: 64.0;SK-MEL-30: 80.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015272: AB_1858269, HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"	4.8	8.7	1.6	2.8	1.5	9.7	6.0	3.8	4.2	2.5	1.8	1.2	3.6	1.0	2.1	3.1	9.8	1.1	2.7	3.0	1.4	2.0	3.3	39.0	8.2	7.3	1.0	2.4	4.4	13.8	2.0	10.5	6.2	1.6	3.9	1.6	3.7	47.5	5.3	1.5	6.5	2.5	1.3	0.7	7.9	4.4	2.7	0.6	6.7	27.2	4.1	7.0	2.7	5.3	15.5	4.7	3.3	4.4	6.6	11.4	5.1	11.1	5.7	0.7	1.6	1.9	2.5	4.8	3.3	8.9	3.2	6.6	11.7	5.6	4.8	3.3	3.0	14.3	9.0	3.1	14.9	2.9	1.8	2.2	3.7	1.2	19.1	88.9	9.4	1.8	10.3	55.1	6.0	64.0	2.2	6.1	12.2	12.9	21.7	0.3	10.4	0.5	11.4	1.7	16.5	18.5	2.1	0.9	10.4	3.7	4.5	2.1	3.3	0.7	27.1	80.8	1.0	7.8	25.0	3.5	1.7	3.0	0.0	5.1	7.6	9.8	8.6	1.5	8.3	6.1	2.5	4.4	1.0	10.0	3.4	7.1	15.5	9.3	11.4	4.7	10.2	10.7	7.6	3.3	6.6	1.7	2.1	6.4	5.1	1.6	1.5	3.8	4.2	1.4	2.0	1.0	2.4	1.6	0.6	3.0	1.0	7.6	7.2	6.1	3.8	1.2	10.2	2.7	1.2	1.8	3.9	13.1	0.0	49.9	0.0	5.8	0.0	23.3	19.2	4.3	1.5	10.5	4.7	25.3	5.6	0.0	1.2	8.0	2.1	0.0	1.7	4.0	6.8	1.8	6.5	0.5	23.3	2.3	1.4	0.0	6.7	6.5	4.1	1.9	2.2	4.6	5.9	5.0	0.6	4.8
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126916-3150879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	15.2	16.9	17.5	17.8	20.7	8.7	18.2	14.5	22.7	12.9	13.2	13.2	17.4	11.1	18.4	14.7	15.9	12.2	15.6	13.9	17.1	16.0	21.1	16.1	13.7	19.0	17.5	15.6	14.6	13.9	14.3	31.0	19.0	21.3	23.9	16.4	10.1	13.2	13.1	14.8	15.3	12.5	15.3	19.3	20.5	15.5	13.5	15.1	22.1	20.9	10.6	19.8	17.8	13.0	15.1	10.5	29.0	12.0	15.1	16.6	7.4	12.0	17.4	13.5	7.7	16.1	13.8	14.4	13.8	11.5	13.8	14.3	16.1	14.8	22.0	9.2	13.3	22.0	8.7	17.8	12.4	17.6	16.3	8.6	20.4	18.6	16.1	21.5	21.6	16.6	12.9	17.6	14.2	4.8	11.6	13.6	17.0	15.9	9.2	23.7	22.5	13.9	19.5	10.6	18.0	12.7	13.3	18.2	21.4	18.4	18.0	7.7	11.1	20.0	14.5	11.5	19.0	13.4	12.3	11.1	15.6	13.6	16.1	17.7	9.5	18.9	27.7	11.7	19.4	17.4	29.0	8.8	22.5	12.1	11.8	11.9	15.1	15.0	12.7	10.5	9.5	16.6	14.3	11.7	15.1	12.0	9.6	11.1	7.4	17.5	20.7	14.5	22.7	17.1	16.0	17.5	15.6	21.3	15.1	14.9	8.3	13.9	18.6	13.2	12.9	12.1	2.5	10.7	13.6	17.4	13.7	21.8	38.1	16.1	1.5	22.5	9.6	0.0	8.7	14.3	13.9	19.8	22.0	7.8	11.6	9.5	8.1	10.4	12.9	1.9	10.0	11.3	6.8	18.0	9.7	15.8	10.1	8.6	8.1	25.6	16.8	0.0	17.7	20.0	16.9	11.4	23.7	13.8	11.5	18.2
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350305	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 272.3;Urothelial cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 144.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		5900000	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	19.1	79.2	14.1	15.6	16.9	22.6	18.5	11.1	13.7	13.0	21.8	9.7	19.7	23.5	23.5	14.7	16.7	19.0	23.2	32.4	11.0	11.7	25.3	19.6	29.3	18.1	12.0	10.9	16.4	7.9	10.5	16.2	30.8	16.4	25.3	19.1	18.1	10.6	26.5	30.0	5.7	17.0	99.6	10.9	14.9	24.2	14.8	8.9	15.6	16.5	16.9	13.2	73.2	72.0	8.1	14.2	37.6	16.2	8.3	10.2	8.7	22.2	103.7	12.1	11.3	58.1	32.6	42.0	41.4	26.2	18.7	19.4	10.9	33.2	16.7	19.3	144.9	70.2	7.8	23.8	15.9	22.2	8.1	10.3	14.1	81.4	46.1	93.3	21.9	15.4	18.5	16.4	41.4	13.2	57.6	64.1	23.0	19.3	7.9	28.0	10.7	22.4	10.0	11.6	44.8	106.9	22.3	8.4	14.5	21.8	12.3	18.8	11.4	33.5	53.0	33.0	23.9	12.5	13.0	85.6	9.2	19.1	20.6	33.9	8.7	17.0	25.1	19.3	12.2	54.4	33.0	10.6	24.7	9.1	14.0	10.2	8.1	8.4	9.0	14.2	5.2	7.6	6.6	37.6	8.3	16.2	9.2	7.1	8.7	14.1	16.9	11.1	11.2	11.0	11.7	12.0	10.9	16.4	8.9	59.6	55.0	27.6	272.3	92.4	28.0	55.7	38.2	104.4	96.7	15.7	21.6	22.9	34.9	73.1	34.3	40.9	44.4	23.3	68.7	28.0	34.6	217.3	50.9	45.7	36.8	27.0	19.7	50.3	37.2	13.4	63.0	64.0	18.6	55.9	17.9	23.3	183.4	20.3	27.6	28.5	19.7	0.0	58.8	11.6	28.8	63.7	42.9	23.5	24.1	489.6
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559434-140568805	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1"	"Cell type enhanced"	"Detected in single"	24	"Syncytiotrophoblasts: 1.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 9.8;HAP1: 7.1;JURKAT: 2.5"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	2.4	8.4	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	7.1	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.8	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.8	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974667-73983307	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 219.1;lymphoid tissue: 144.8"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 420.4;Hofbauer cells: 378.7;Intestinal endocrine cells: 285.5;monocytes: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 68.0;SK-BR-3: 87.6;U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favorable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	19.8	9.8	5.3	40.4	9.5	24.5	15.9	1.1	4.9	8.1	7.7	10.2	20.3	11.4	4.2	12.0	4.5	37.9	13.1	11.5	4.4	5.5	12.8	10.6	20.2	85.6	7.8	2.4	7.2	4.7	1.2	6.2	8.7	6.5	6.5	8.9	14.2	17.4	17.2	45.3	4.3	24.7	6.4	9.0	91.1	12.3	5.5	5.9	144.8	17.9	19.3	55.7	19.4	2.9	141.6	219.1	101.8	135.3	119.8	180.2	172.1	0.1	14.3	3.3	9.8	1.9	0.0	2.5	2.4	1.6	9.8	2.8	25.1	12.2	68.0	34.0	3.7	0.8	0.6	2.3	0.0	4.6	17.2	0.8	39.7	6.0	5.2	5.9	20.8	16.7	2.2	0.0	9.3	0.0	1.9	1.3	26.2	18.2	27.8	1.9	24.5	21.5	11.2	2.6	1.5	2.9	19.9	22.7	38.5	27.4	40.6	5.0	6.1	12.8	87.6	4.8	9.9	25.8	18.6	1.8	0.0	12.6	2.9	4.7	9.5	4.5	56.6	1.7	8.3	0.1	45.7	81.5	101.8	112.6	135.3	69.9	141.6	92.3	95.0	88.4	134.2	86.9	91.1	11.4	119.8	111.3	219.1	180.2	172.1	5.3	9.5	1.1	4.9	4.4	5.5	7.8	2.4	6.5	5.9	3.0	35.4	250.6	2.3	3.1	0.9	3.6	2.5	93.7	23.9	87.2	7.9	6.6	6.6	1.2	16.1	5.0	4.2	420.4	6.5	10.3	6.7	15.6	84.3	0.6	378.7	0.0	285.5	11.6	244.1	37.5	0.9	160.3	25.3	710.6	23.4	2.9	2.5	37.6	0.4	1.9	6.3	6.5	5.3	14.4	13.4	4.0	9.4	172.7	24.7	21.6
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 14.7;Late spermatids: 10.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.1	2.1	1.8	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.1	0.3	0.4	0.3	2.2	0.8	0.4	0.8	18.3	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.4	0.7	1.0	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.6	1.4	1.6	4.3	0.6	1.1	0.6	1.2	1.3	0.5	0.9	0.7	0.4	0.2	1.1	0.4	0.3	1.4	0.7	1.3	1.6	1.7	0.8	0.3	1.1	0.7	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.1	0.1	2.2	0.5	0.0	2.7	1.2	0.0	0.0	0.3	0.0	0.3	14.7	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.8	10.7	0.0	0.0	0.0	0.0	0.6	0.7	0.3	0.0	0.7	0.0	1.6	0.0	0.1	1.2	0.7	0.3	0.2	2.2	0.6	0.0
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671853-233773300	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 169.8"	"Cell type enhanced"	"Detected in some"	29	"Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"A549: 4.9;RT4: 4.0"															NA	NA												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 831.9"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 10.4"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	34.2	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	831.9	0.1	0.0	0.0	14.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914002-9960021	"Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		5300000	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	27.5	64.8	28.8	21.0	35.5	73.5	27.4	32.9	39.4	24.9	34.3	30.7	19.3	27.8	30.8	23.8	42.3	27.9	29.4	39.9	28.0	30.2	32.7	33.2	35.1	24.6	33.4	28.8	40.6	36.5	25.0	19.4	35.2	48.1	25.2	32.7	18.0	27.9	21.8	55.4	27.6	32.3	28.5	39.1	27.7	34.0	25.2	28.8	36.3	36.4	28.3	22.9	36.0	30.2	24.5	30.6	62.5	37.3	22.2	24.6	39.7	17.3	10.5	12.7	8.3	15.0	16.3	17.8	21.5	17.9	19.6	21.6	14.1	17.3	17.1	20.1	18.8	17.0	12.2	12.3	20.5	22.5	10.6	15.4	27.8	11.2	21.7	35.7	37.5	53.4	15.3	20.8	18.5	22.1	15.4	19.8	14.0	28.0	17.9	17.1	9.3	28.8	21.8	8.2	59.8	16.8	15.1	17.3	23.1	19.1	17.5	18.0	9.8	24.9	15.2	15.4	12.2	14.2	19.4	21.1	32.0	23.8	33.1	26.1	32.1	26.0	20.4	18.1	16.2	21.9	26.1	37.3	62.5	19.3	32.4	22.7	24.5	20.3	20.7	30.6	22.7	22.2	20.4	59.2	22.2	26.4	21.8	24.6	39.7	28.8	35.5	32.9	39.4	28.0	30.2	33.4	28.8	48.1	28.8	119.1	156.9	129.2	289.0	598.2	103.5	201.2	160.5	211.5	124.0	197.1	58.9	238.9	388.0	249.4	7.6	182.0	272.4	70.0	315.1	261.3	247.0	278.9	222.5	128.2	255.8	128.7	138.8	187.9	265.3	9.5	168.5	232.2	264.9	418.4	154.5	119.8	283.7	174.6	203.3	294.2	76.5	187.5	270.9	168.9	212.6	544.1	378.5	153.4	155.5	360.2
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389122-58451101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		220000	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	17.4	31.1	21.8	12.6	24.3	4.8	13.2	16.5	31.8	11.7	16.1	17.0	13.3	22.5	13.0	13.1	14.8	13.7	12.7	24.5	21.4	22.1	21.8	23.5	13.6	10.4	23.2	25.1	17.7	15.5	28.5	16.3	11.1	31.6	15.0	12.1	11.4	17.9	15.7	46.8	15.3	20.6	15.2	24.9	11.4	14.7	9.4	15.8	6.7	26.7	18.8	9.4	11.6	18.5	5.6	4.3	6.8	5.2	6.6	9.5	4.6	10.9	11.0	12.4	6.6	11.4	4.8	11.0	9.8	4.1	15.2	7.5	44.3	10.6	9.7	14.1	6.6	12.1	21.0	9.8	14.1	9.1	4.5	7.4	5.8	12.2	13.9	11.5	5.4	7.4	10.9	16.4	8.4	7.0	7.4	7.5	9.7	13.7	5.5	7.3	34.4	8.5	10.8	6.5	21.5	14.6	8.6	11.5	6.3	11.6	14.7	17.5	12.1	16.2	43.2	16.9	7.1	17.7	8.3	10.3	24.6	12.0	12.3	13.1	7.4	7.9	11.1	20.8	6.0	12.4	3.9	4.4	5.2	7.8	4.4	9.1	5.6	9.0	6.2	4.3	4.7	6.7	9.5	6.8	6.6	5.2	4.3	5.0	4.6	21.8	24.3	16.5	31.8	21.4	22.1	23.2	25.1	31.6	15.8	41.7	23.2	11.7	12.1	10.4	26.4	43.1	25.5	18.7	13.6	29.6	27.5	28.5	29.9	29.7	4.2	20.4	30.7	0.0	26.6	42.2	18.8	15.2	9.2	32.1	14.0	33.4	20.8	14.7	14.0	5.1	17.3	13.9	13.5	24.4	22.3	34.0	29.0	19.2	23.7	31.6	29.2	12.9	20.5	20.4	28.3	9.3	37.2	18.7	24.2	13.6
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.5	20.5	18.1	19.4	12.6	20.0	20.8	35.4	32.0	41.4	42.0	28.7	20.5	20.3	30.5	32.1	21.1	18.7	42.9	27.1	50.4	45.7	26.6	22.2	28.9	32.0	29.7	31.0	25.0	15.7	20.2	36.8	36.5	17.8	23.8	20.7	40.4	10.3	28.0	32.0	37.2	36.9	30.6	13.9	19.6	34.9	21.5	33.6	15.4	14.6	35.3	19.2	17.5	29.2	15.5	21.0	21.0	20.5	25.1	35.0	23.5	29.8	29.4	24.0	30.3	30.1	26.7	32.3	29.5	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8	8.9	13.9	21.7	8.2	16.6	23.8	6.6	2.5	9.4	10.3	22.7	29.5	9.8	6.6	13.3	27.6	10.6	14.7	0.0	16.4	13.9	12.4	15.6	2.3	14.0	19.9	20.6	22.7	8.6	23.4	30.6	10.0	14.7	6.8	27.1	21.5	8.3	18.1	14.0	8.1	5.0	26.3	6.5	11.3	29.5	29.2	18.6	7.0	20.8	17.0	12.6
XPO7	"KIAA0745, RANBP16"	ENSG00000130227	"Exportin 7"	Q9UIA9	8	21919671-22006585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 63.2;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043727, HPA048153"	Uncertain					NA	NA		24000			"HPA043727: AB_2678638, HPA048153: AB_2680289"	"unprognostic (6.30e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (6.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	18.5	22.3	24.4	15.8	34.6	40.1	20.5	33.2	37.1	22.0	18.5	28.5	19.4	12.1	24.0	23.0	21.9	24.3	15.8	23.3	26.8	22.9	31.3	17.0	18.2	18.9	19.2	23.6	31.9	20.1	39.3	27.2	24.0	26.5	20.1	22.4	26.8	18.6	23.6	22.6	22.7	16.9	22.5	19.7	22.0	18.3	29.6	20.4	23.2	27.6	11.4	22.9	19.9	25.5	8.6	8.9	7.2	8.2	5.7	9.5	6.7	17.3	30.8	23.0	16.5	19.4	17.0	18.2	17.1	20.3	25.5	23.2	23.4	10.8	28.5	19.7	21.2	23.3	17.0	32.9	24.6	45.2	8.6	16.7	31.9	25.8	17.1	13.2	15.2	24.4	13.2	17.5	25.4	24.6	18.7	24.5	25.8	37.8	23.0	18.7	13.4	37.7	14.3	29.6	29.7	12.4	21.9	29.6	14.9	16.8	36.2	14.0	22.1	16.2	17.1	17.0	24.4	15.5	12.7	15.9	13.4	17.2	19.0	17.2	8.1	9.0	30.8	20.6	18.7	23.6	7.2	6.0	4.4	9.5	8.2	8.2	8.6	8.6	7.3	8.9	5.9	6.6	8.0	3.0	5.7	7.0	3.2	8.3	6.7	24.4	34.6	33.2	37.1	26.8	22.9	19.2	23.6	26.5	20.4	20.8	10.7	13.7	5.1	12.7	34.5	36.0	7.6	4.0	13.6	17.4	13.7	9.9	3.3	8.9	63.2	9.9	6.7	70.0	9.7	11.1	8.5	9.0	7.0	12.3	12.2	47.7	20.1	11.1	21.8	29.3	14.4	10.3	10.1	7.2	9.5	14.7	9.3	5.8	16.6	11.6	23.7	12.9	6.8	15.5	23.0	10.7	4.7	9.5	12.2	6.7
